Saudi Drug Index (SDI) 2011

Mohammed A. Al-Muhur
M.S. Pharmacy R. Pharmacist (Saudia Arabia, Jordan)

Suadi Drug Index (SDI) 2009, Second edition Copyright © 2008 by Mohammed Ahmad Al-Muhur. All rights reserved. No part of this publication may be reproduced or distributed in any form or by any means, or stored in a database or retrieval system, without the prior written permission of the author. ISBN 978-603-00-0850-6 © Mohammed Ahmad Al-Muhur, 2008 King Fahd National Library Cataloging-in-Publication Data Al-Muhur, Mohammed Ahmad Sulaiman Saudi drug index – sdi – 2008. / Mohammed Ahmad Sulaiman AlMuhur – Riyadh , 2008 276p.; cm. ISBN 978-603-00-0850-6 1. Drugs—Saudi Arabia. I. Title: Saudi Drug Index. 615.13531—dc 1429/3890 L.D. no. 1429/3890 ISBN 978-603-00-0850-6 (٨٩/١/٢٠٠٨) 615.1 Al-Muhur, Mohammed A. Saudi Drug Index (SDI) 2008 / Mohammed A. Al-Muhur. Amman: the Author, 2008. ( )p. Deposit No. : 89/1/2008. Descriptors: Drugs\\Pharmacy\\Chemical Industry\\Saudia Arabia\ ISBN 978-9957-8622-0-6 ‫ا ط‬ ‫اع ى دا ة ا‬ ‫–ر ا‬ ‫ا‬ ‫ا رد‬ ‫ا‬

The author has exerted every effort to ensure that drug selection and dosage set forth in this book are in accord with current recommendations and practice at the time of completion of this book. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any change in indication and dosage and for added warning and precautions. This is particularly important when the recommended agent is a new drug or infrequently employed drug.

Acknowledgements

I would like to thank the following people for their cooperation. TAMER drug store, Mr. Khalaf Al-Dawseri, Dr Uthman Al-fayez.

For correspondence: Email: mohammed_almuhur@yahoo.com Web: http://www.geocities.com/mohammed_almuhur/ Group: http://groups.yahoo.com/clinicalpharmacists

Abbreviations, Measurement systems, Latin Numbers

‫ار نار م‬
Preface:

‫م‬

There is always a gap between what is studied and what is practical. So is the case with drugs in the market. The study of pharmacology classifies drugs in a specific way which is not used in the practical life. Besides the available drug sources are as diverse as the countries they came from. This stimulated me to start this project of classifying drugs in Saudi Arabia. The idea of classifying drugs available necessitated selection of a classifying system from the very diverse systems used in the world. Knowing that even the apparently identical systems of ATC (Anatomical Therapeutic Chemical Classification systems) from different sources are really non-identical, this necessitated more care in placing drugs in the different groups. As a practical drug knowledge resource, some additional information was added to the basic drug information that included indications, contraindications and drug adverse effects. Drug manufacturer, drug distributors listings were added for the benefit of more reliable product verification. The end result of this effort is a book which is titled "Saudi Drug Index". ‫م‬ ‫ّم‬ . ‫ا دو ا و ودة ا وق ا دوا‬ ‫درت‬ ‫وع در وع ا دان ا‬ . ‫ا ر ا ود‬ ‫ا‬ ‫نا‬ ،‫ف‬ ‫. اّ ذ ن‬ ‫ضا‬ ‫دا و د ھ ك رق ن ھو درس و ط ق. و ھذه ھ ا ل‬ ‫ا‬ ‫أن ا را ا‬ . ‫ا ةا‬ ‫ر‬ ‫ا دواء ا دو طر‬ ‫ف ا دو ا داو‬ ‫دء ھذا ا روع‬ ‫ھذه ا را . ھذا ا ن ط‬ ‫ف ا دو ا داو ط ب ا‬ ‫رة‬ ‫ا‬ ‫فا ر‬ ‫ظ ر ن وا ق أ ظ ا‬ ‫و تا‬ ‫ا‬ ‫ف ا دو‬ ‫طب‬ ‫و ت لا‬ ‫ھم ا رف‬ ‫د ل ا دو ا‬ ‫ضا‬ ‫و ت‬ ‫بأ‬ ‫د ھو‬ ‫و د أن إ‬ ‫، و ا م ا وزع ا‬ ‫ج ھذا ا‬

‫ر أن‬

‫ف ا و و ا ول‬ ‫رأ دأظ ا‬ ‫در‬ ‫( ا وذة ن‬ATC) ‫ا‬ . ‫دام و ا‬ ‫ذرا‬ ، ‫دام‬ ‫نا‬ ‫وا‬ .‫ھ ا دواء‬

‫.ا ما‬

‫را‬

"Saudi Drug Index" ‫ودي‬

‫وﷲا‬

‫ا‬ ‫ا‬ ‫أ‬

ii

Abbreviations, Measurement systems, Latin Numbers

Abbreviations used in prescription writing
1. Common Latin abbreviations in use for writing prescriptions
a. Used in the Inscription
Symbol a.a. A.d. Q.S. ss. or P. Latin Word Ana Addatura Quantum suficit Semi or Parta English Meaning Arabic Meaning Of each Complete to Sufficient quantity Half

‫أ‬

b. Used in the subscription
Symbol Buginar. Caps. Caps. Amylac. Cataplasm. Collut. Collyr. Conf. Depilat. Dup. Emp. Emul. Enema. Ext. Ft. Garg. gtt. ht. Inhal. Inj. Lin. Linct. Lot. Mist. Mitt. Neb. Past. Pastill. Pess. Latin Word Buginarium Capsula Capsula Amylacea Cataplasma Collutorium Collyrium Confictio Depilatorium Duplum Emplastrum Emulsio Enemata Etractum Fait Gargarisma Guttae Haustus Inhalatio Injectio Linimentum Linctus Lotio Mistura Mitte Nebula Pasta Pastillus Pessus English Meaning Arabic Meaning Bougies ‫أو ا ذن‬ ‫س‬ Capsule Cachet ‫م‬ Poultice Mouth Wash ‫ل‬ Eye drops ‫ة‬ Confection ‫ت‬ Depilatory Twice ‫ا‬ Plaster ( ) Emulsion Enema Extract Prepare or to be made Gargle ‫ة‬ Drops Draught Inhalation ‫ق‬ ‫ل‬ Injection Liniment ‫دھ ن‬ Linctus ‫ق‬ Lotion ( ‫وخ ) ل ر‬ Mixture Put or Send ‫، أر‬ Spray Solution ‫ل رذاذي‬ Paste Pastille Pessaries ‫س‬ iii

Abbreviations, Measurement systems, Latin Numbers

Pil. Pulu. Suppos. or Supp. Tab. Tr. Troch. Ung.

Pilula Pulvis Suppositorium Tabletta Tinctura Trochiscus Unuentum

Pills Powder Suppositories Tablet Tincture Lozenge Ointment

(

‫ب‬ ‫ق‬ )‫س‬ ‫ص‬ ‫ب‬ ‫ھ‬

c. Used in the Signature
Symbol A. P. D. A.C. Addend. Applicand. Aq. b.d. c.c Coch. Amp. ii. Coch.Amp. Coch.Med. Coch.Min. Deglut. Dim. Dos. Extend. H.S. M. D. S. M. D. U. Mescend. O. Quart. Hor. O. Sec. H. O. Sext. Hor. O. Tert.Hor. O.h. O.M. O.M.N. O.N. P.C. S. or Sum. Latin Word Affrica Parta Dulente Anti Cibos Addendus Applicandus Aqua Bis in die Cum Cochleare Amplum Duo Cochleare Amplum Colcheare Medium Colcheare Minimum Deglutendus Dimidium Dosis Extendendus Hora Somni More dicto sumendum More dicto utendo Miscendus Omni Quartis Horis Omni Secunda hora Omni sextis Horis Omni Tertis Horis Omni hora Omni Mane Omni Mane Nocti Omni Nocti Post Cibos Sumendum English Meaning Arabic Meaning To be rubbed on ‫ا‬ the painful part Before meal ‫ا‬ To be added ‫فإ‬ To be applied ‫ا رج‬ water ‫ء‬ Twice daily with Two ‫ر‬ ‫ء‬ Tablespoonfuls Tablespoonful ‫ر‬ ‫ء‬ Dessertspoonful ‫ء‬ Teaspoonful ‫ي‬ ‫ء‬ to be swallowed The Half Dose To be spread At bed time To be taken as directed To be used as directed To be mixed Every four hours Every second hour Every sex hours Every three hours Every hour Every Morning Every morning and night Every night After meal To be taken ‫ا‬ ‫ا ا ة‬ ‫د‬ ‫ا م‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ت‬ ‫ت‬ ‫أر‬ ‫ا‬

‫ث‬ ‫ح‬ ‫حو‬ ‫ء‬ ‫ا‬

‫ء‬

iv

l.s.C. Sig. Latin Word Half-strength normal saline anti cibos ante prandium auris dextrae ante meridiem auris laevae auris sinister auris utraque ana ad libitum ad libitum English Meaning Arabic Meaning Half-strength ‫ل‬ normal saline Befor meals ‫ا‬ Right ear morning Left ear Each ear Of each up to At pleasure. or Stat.d.d BSA c Cap.d. Latin Numbers S.m. a.O.Abbreviations.u. lib amp.D.t. Or D.c. U.i. Abbreviations commonly used in prescriptions and medication orders Symbol 1/2 NS a. a. Jej Saepe utende Si Opus Sit Semel in die Signatura Statim Sugendus Ter in die sumendum Ventriculo Jejuno To be used frequently When necessary Once daily Directions Immediately To be sucked Three times daily On an empty stomach ( ‫ات‬ ‫ة‬ ‫ورة‬ ‫ا‬ ‫ة‬ ‫إر دات‬ ‫ات م‬ ) ‫ة‬ ‫ث‬ 2.S Sem. T. S. freely ampoule water Twice daily Body Surface Area with capsule Cubic centimeter compound Given of such doses Dextrose 5% solution Dilute discontinue dispense ‫ا‬ ‫ا ذن ا‬ ‫ح‬ ‫ا‬ ‫ا ذن ا ى‬ ‫ا ذ‬ ‫إ‬ ‫ا‬ ‫أ‬ ‫ء‬ ‫ا‬ aqua bis in die Body Surface Area cum capsula cubic centimeter compositus dentur tales doses Dextrose 5% solution dilutis discontinue dispense v ( ) ‫ا‬ %٥ ‫ز‬ ‫لا‬ ‫أو‬ ‫ا ف‬ ‫ا‬ ‫أ‬ . a. St. aq b. a. d. Measurement systems. a. die.p. Sugend. a. Vent. cc comp. aa ad ad. disc. disp.S. D5W dil.

non rep NPO o. H h. or hr.r. q.٩ ‫ا د م‬ night ‫ا‬ Do not repeat ‫ر‬ Nothing by mouth pint ‫رط‬ Right eye ‫ا‬ ‫ا‬ Left eye ‫ا ى‬ ‫ا‬ Left eye ‫ا ى‬ ‫ا‬ each eyes ‫ا‬ Both eyes ‫ا‬ After meals ‫ا‬ Afternoon. o. m2 or M2 mcg ml N&V N. Elix.s.S. o. or N/S or NS Normal Saline noct. or gm or g gr gtt. o.p.c p. Latin Numbers Symbol div. et ex aq fl or fld g. o2 p.d.F.s. ‫،ا ء‬ ‫ا‬ evening By mouth ‫ا‬ ‫ط‬ When required ‫ا‬ powder ‫ق‬ Every day ‫م‬ Every hour vi .l.u. im inj iv IVP IVPB M.m.n pulv. o. q. Latin Word divide Distilled water ex modo prescripto elixir et ex aqua fluidus gramme granum guttae hypodermis hora hora somni intramuscular injectio intravenous Intravenous push Intravenous piggy back misce Square meter microgram milliliter Nausea and vomiting National Formulary N.d. Measurement systems.m. h.Abbreviations. DW e. p. nocti non repetatur null per os octarius oculus dexter oculus laevus oculus sinister oculus utro post cibos post meridiem per os pro re nata pulvis quaque die quaque hora English Meaning Arabic Meaning divide ‫ا‬ Distilled water ‫ء‬ As directed ‫ت‬ ‫ا‬ Elixir ‫إ‬ and ‫و‬ In water ‫ا ء‬ fluid gram ‫ام‬ grain drop ‫ة‬ hypodermic ‫ا‬ hour At bed time ‫و ا م‬ intramuscular injection intravenous ‫ر‬ Intravenous push ‫ور‬ Intravenous piggy ‫ا‬ ‫ور ي‬ back mix ‫ا‬ Square meter microgram ‫و ام‬ milliliter Nausea and ‫نوإ ء‬ vomiting National ‫دو‬ ‫ا ط‬ ‫ا‬ Formulary Normal Saline ‫ر‬ ‫ل‬ %٠.h.o p.

d q.s. q. Measurement systems. Latin Word quater in die quater die sumendus quoque alternis die quantum sufficiat quantum sufficiat ad libitum rectus sine si opus sit signa solutio semis statim suppositorium subcutaneous syrupus ter in die ter die sumendum tabletta tales tales doses Cochleare amplum Cochleare Parvum unit Unite states pharmacopoeia ut dictum recipe unuentum English Meaning Arabic Meaning Four times daily ‫ات‬ Every other day A sufficient quantity A sufficient quantity to make rectal without If there is need Write on label solution One half immediately suppository suspension subcutaneously syrup Three times daily tablet such Such dose tablespoonful tincture teaspoonful unit Unite states pharmacopoeia as directed take ointment ‫م‬ ‫أر‬ ‫م‬ ‫ج‬ ‫ا‬ ‫ط‬ ‫ون‬ ‫إن ن ھ‬ ‫ا‬ ‫ا‬ ‫ل‬ ‫ا‬ ‫اب‬ ‫ث ات‬ ‫ص‬ ‫ھا‬ ‫ھ ها‬ ‫ة‬ ‫ة‬ ‫و ة‬ ‫د ر ا دو ا‬ ‫ت‬ ‫ا‬ ‫ھ‬ vii . ss.Abbreviations. tsp. Dos. sol. tinct.s tab.o. Rx ung. u. Latin Numbers Symbol q.i. syr. tinc. dict. ut.s q. or ss stat. tal.c. or s s.S.. Sig.s.d..d. ad R s. sup. tal. sybc or subq or s. U or u U. t. susp. tr.o. t.i.d.P.d.d q. tbsp.s.

Apothecaries' measure of weight (conversion table) pound (lb) 1 ounce (ξ) 12 1 drachm (ζ) 96 8 1 scruple (Э) 288 24 3 1 grain (gr) 5760 480 60 20 iii. Latin Numbers 3. Measurement systems a.000.5 b.01 Hekta 0.001 Kilo 0. Measurement systems. 000 micro 1.000. Metric system Length unit Meter (m) Weight Gram (g) Volume Liter (L) 1 unit = = = = = = = = 0. Avoirdupois measure of weight (conversion table) pound (lb) 1 ounce (oz) 16 1 grain (gr) 7000 437. Apothecaries' measure of fluid (conversion table) Gallon (gal) 1 Quart (qt) 4 1 Pint (pt) 8 2 1 Fluidounce (fξ) 128 32 16 1 Fluiddrachm (fζ) 1024 256 128 8 1 Minims (η) 61440 15360 7680 480 60 ii.000 milli 1.Abbreviations.1 Deka 10 deci 100 centi 1. Apothecaries system i.000.000 nano = = = = = = = = 10 -3 K 10 -2 H 10 -1 D 10 d 10 2 c 10 3 m 10 6 µ 10 9 η viii .

6 mL 2.) 1 ounce (1/16 pound) 1 pound (avoirdupois) 1 yard (yd) = = = = = = = = = = 65 mg 250 mL 1/20 mL 29.48 cm 3785.57 mL 30. Measurement & Conversion 1 grain (gr) 1 cup 1 drop 1 fluid ounce (oz.6 grams 91. Latin Numerals Latin I II III IV V VI VII VIII IX Number 1 2 3 4 5 6 7 8 9 Latin X XI L LX LXX LXXX XC CC CCC Number 10 11 50 60 70 80 90 200 300 Latin CCCC D DC DCC DCCC DCCCC M MM Number 400 500 600 700 800 900 1000 2000 ix . Latin Numbers c.54 cm 28.44 cm 4. Measurement systems.) 1 foot (ft) 1 gallon (gal.Abbreviations.) 1 inch (in.4 grams 453.

................ iii Gastro-intestinal System .............................................................................................................................. 1 A Index of manufacturers .............. 142 Eye .................................................................................................................................................................................................................................................................. and urinary-tract disorders ................. 189 Registered Suppliers Index ...................................... nose........................................................................................................................................... and oropharynx ......................................... 1 C References ................ 11 Respiratory system .................................................. 131 Musculoskeletal and joint diseases ......................................................................................... 168 Skin .................................................................................................................................................................................................................................................................................ii Abbreviations used in prescription writing ........................... 1 D ٠ ........................................ 31 Central nervous system ............................................................................ 70 Endocrine system ........................................................................................................................... 43 Infections.............. 1 Cardiovascular system .... 184 Anaesthesia ............. gynaecology.................................................................................................................................................................Contents Preface..................................................... 121 Nutrition and blood ............................................................. 115 Malignant disease and immunosuppression................................ 1 B Scientific Name and Trade Name Index ............................................ 152 Ear............. 173 Immunological products and vaccines ............................ 101 Obstetrics......................................................................................................................................................................................................................

...................... 2 Other antispasmodics ............................................ 3 Chronic bowel disorders 3 Aminosalicylates .................... 4 Dyspepsia and gastro-oesophageal reflux disease 4 Antacids and simeticone ....................................... 9 Local preparations for anal and rectal disorders 10 Compound haemorrhoidal preparations with corticosteroids ..................................................................................................................... 5 Prostaglandin analogues...................................................................................................................... 10 ١ .......................... 8 Osmotic laxatives ............................................................................................................................................................................................................................. 4 Ulcer-healing drugs 5 Selective antimuscarinics .................................... 8 Stimulant laxatives ......... 3 Corticosteroids ........ 7 Laxatives 8 Bulk-forming laxatives ........................................................ 3 Drugs affecting intestinal secretions 4 Drugs affecting biliary composition and flow ................................................................. 7 Proton pump inhibitors ........................ 2 Antimotility drugs ................................................................................................................Gastro-intestinal System Acute diarrhoea 2 Adsorbents and bulk-forming drugs .................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 5 Chelates and complexes . 2 Antispasmodics and other drugs altering gut motility 2 Antimuscarinics ..................................................... 5 H2-receptor antagonists ................................

or in conditions such as active ulcerative colitis or antibiotic-associated colitis ‫ا‬ Antispasmodics and other drugs altering gut motility Antimuscarinics Hyoscine Butylbromide BUSCOPAN Tablet smooth muscle spasm . Pectin KAPECT KAPTIN Suspension Suspension diarrhoea ‫ا و‬ ‫ر‬ ‫د ن‬ ‫د‬ Antimotility drugs Diphenoxylate HCl . Atropine SO4 DIAXINE INTARD LOMOTIL Tablet Tablet Tablet ‫ا‬ ‫ر‬ ‫. excessive respiratory secretions dry mouth.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Acute diarrhoea Adsorbents and bulk-forming drugs Kaolin . and constipation porphyria ‫ر‬ ‫ا‬ ‫د‬ SPASMOPAN Injection ‫ا‬ HYOPAN Syrup ‫ا‬ 2 . excessive respiratory secretions dry mouth. urine retention. دى‬ ‫رل‬ ‫ز‬ ‫ا‬ -‫ن‬ ‫ج‬ ( ‫)ا‬ ‫س‬ ‫و‬ ‫ا‬ ‫ر‬ ‫ة‬ ‫ا‬ ‫اط‬ Loperamide IMODIUM Capsule Acute diarrhoea. and constipation porphyria ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا‬ ‫وك‬ ‫ا دوا‬ ‫ار ض‬ ‫ر‬ ‫ر‬ ‫ا رد‬ ‫ج‬ ‫ا دو‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا‬ ‫ا رد‬ ‫ج‬ ‫ا دو‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ا ر‬ ‫ا و‬ ‫ا ود‬ ‫ت‬ ‫ا دوا‬ HYOBAN NOSPASM RIASPASM SCOPINAL SPASMONORE Tablet Tablet Tablet Tablet Suppository Tablet Tablet -----‫ا ة‬ ‫اط‬ ‫د‬ SPASMOPAN ‫ا‬ Hyoscine Nbutylbromide BUSCOPAN Injection SPASMONORE Suppository smooth muscle spasm . Chronic diarrhoea in adults LOPODIUM Capsule conditions where inhibition of peristalsis should be avoided. where abdominal distension develops. urine retention.

rarely. muscle tremor. angioedema) paralytic ileus ‫ا رد‬ ‫ج‬ ‫ا دو‬ ‫ا ز رة‬ ‫و‬ ‫ر‬ ‫و ز‬ . ك ا‬ ‫د. perianal irritation. ك ا‬ ‫و‬ ‫د‬ ‫ا‬ ‫زن‬ ‫دو‬ ‫ر‬ ‫زن‬ ‫دو‬ ‫ر‬ SALOFALK ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ SALOFALK Tablet Corticosteroids Budesonide ENTOCORT ENEMA Tablet Ulcerative colitis involving rectal and recto-sigmoid disease ‫ا را‬ ‫و‬ 3 . headache. bradycardia. allergic reactions (including rash.Scientific Name Trade Name Dosage Form Syrup Syrup Indications Side Effects Contra-indications Manufact urer ‫ار ض‬ ‫ر‬ ‫ر‬ Drug Store ‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ RIASPASM SCOPINAL ‫ر‬ Other antispasmodics Mebeverine HCl BEVACOL Tablet smooth muscle spasm rarely allergic reactions (including rash. ataxia) ‫وس‬ ‫ا و ر‬ ‫و‬ ‫د‬ DUSPAMEN DUSPATALIN Tablet Capsule Tablet Suspension --‫ر‬ MEBAGEN MEVA Tablet Tablet ‫ة‬ ‫ا‬ ‫اط‬ --- SPASMOTALIN VERINE Peppermint COLPERMIN Tablet Tablet Capsule --- Chronic bowel disorders Aminosalicylates Mesalazine ASACOL MEZACOL PENTASA Tablet Tablet Enema Sachet Suppository Tablet Enema treatment of mild to moderate ulcerative colitis and maintenance of remission severe hepatic impairment ‫وس‬ ‫ا و ر‬ ‫ا رد‬ ‫ج ا دو‬ ‫ر‬ ‫اد ر‬ ‫د. ‫ا و د‬ ‫ار ض‬ ‫ر‬ ‫وم‬ ‫دو‬ ‫ا ر‬ ‫ا دوا‬ relief of abdominal colic and distension. particularly in irritable bowel syndrome heartburn. urticaria.

Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Drugs affecting intestinal secretions Drugs affecting biliary composition and flow Volatile Oils ROWACHOL Capsule Drops ‫روا وا ر‬ ‫ا‬ ‫ؤ‬ ‫ن‬ ‫ا‬ Dyspepsia and gastro-oesophageal reflux disease Antacids and simeticone Aluminum Hydroxide. Oxethazine Magnesium Aluminum Silicate . Simethicon Aluminum Hydroxide . hyperphosphatae mia hypophosphataemia DIGEL Suspension Tablet dyspepsia. hyperphosphatae mia hypophosphataemia ‫ا‬ ---‫ا‬ ‫ر‬ ‫ر‬ ‫د‬ hypophosphataemia RIALOX Magaldrate (Aluminum Hydroxide . hyperphosphatae mia dyspepsia. Magnesium Trisilicate Aluminum Hydroxide . hyperphosphatae mia hypophosphataemia ‫س ر‬ ‫ر‬ ‫و‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫د ن‬ ‫د‬ 4 . Magnesium Hydroxide . Magnesium Hydroxide MALUGEL Tablet ‫ا‬ ‫ا رد‬ ‫وا ـث‬ ‫ا رط‬ ‫ر‬ COLOPATHIL Sachet ‫ا ر‬ ‫ا‬ ‫ا رد‬ ‫وك‬ ‫ا‬ ‫ا رد‬ ‫ا س ر‬ ‫ا ر‬ ‫و ك‬ ‫ا و‬ ‫ر‬ ‫ر‬ ‫ا ر‬ ‫ا‬ ‫ا دو‬ ‫ا رد‬ ‫ار ض‬ ‫ر‬ ‫ا ن‬ ‫اط‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫ا و‬ ‫ا‬ ‫ا‬ ‫زن‬ ‫ا دو‬ ‫ا ر‬ ‫د ن‬ ‫د‬ ‫ا‬ ‫اط‬ MUCAINE Suspension MUCOGEL Suspension ALUGEL Suspension ACIDAL HYDROGEL MAALOX MAGALOX MOXAL NOVAGEL Tablet Suspension Suspension Suspension Tablet Suspension Tablet Suspension Tablet Suspension dyspepsia. Magnesium Hydroxide . hyperphosphatae mia hypophosphataemia ‫ـر‬ ‫و‬ ‫ا ر‬ ‫ا ر‬ ‫ا ر‬ ‫دو‬ ‫اط‬ MAALOX PLUS EPICOGEL Suspension Tablet Suspension dyspepsia. Dimethicon ACICONE Tablet Suspension Tablet dyspepsia. Magnesium Carbonate . Magnesium Hydroxide) Aluminum Hydroxide . Attapulgite Aluminum Hydroxide Aluminum Hydroxide . Magnesium Hydroxide .

gastric discomfort.Scientific Name Aluminum Hydroxide . interstitial nephritis ‫ررا ر‬ ‫و ل‬ ‫اس . Simethicon Simethicone Trade Name Dosage Form Suspension Indications Side Effects Contra-indications Manufact urer ‫ا ر‬ Drug Store NOVAGEL dyspepsia. back pain. Zollinger–Ellison syndrome alopecia. headache. vertigo and drowsiness. Drops Ulcer-healing drugs Selective antimuscarinics Pirenzepine Dihydrochloride GASTROZEPIN Tablet ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫ا‬ Chelates and complexes Sucralfate GASTROFAIT ULCAR Tablet Tablet gastric and duodenal ulceration and chronic gastritis.S Suspension Tablet dyspepsia. hyperphosphatae mia dyspepsia DISFLATYL Suspension SALINAL Chewable Tablet. diarrhoea. Simethicone Magaldrate (Al(OH)3. reflux oesophagitis. Mg(OH)2) . very rarely tachycardia. Magnesium Hydroxide . stomal ulcer.‫ان‬ ‫ا و ر‬ ‫ر‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ا‬ ACICONE . nausea. hyperphosphatae mia hypophosphataemia ‫ا‬ ‫ا دو‬ ‫ا رد‬ hypophosphataemia ‫ا ن‬ ‫اط‬ ‫اي‬ . bezoar formation ‫ر‬ ‫ا و‬ ‫ا‬ ‫د ن‬ ‫د‬ ‫ر‬ ‫رو ل‬ ‫ا ف‬ ‫ا ر‬ ‫ر‬ ‫ا‬ ULCICURE ULSAHEAL Tablet Suspension Tablet ‫ا‬ ‫ا رد‬ ‫ا‬ H2-receptor antagonists Cimetidine ADIATIN Tablet benign gastric and duodenal ulceration. dizziness.ا‬ ‫ا‬ ‫دار ا دواء‬ ‫ا رد‬ ‫رودس‬ ‫ا‬ ‫ث‬ ‫ن‬ . dry mouth.‫م‬ ‫ال‬ ‫رو‬ ‫ز‬ ‫ا‬ ‫ر‬ ‫د‬ ‫ا‬ ‫اط‬ ‫أز‬ ‫رة‬ ‫و‬ CIMEDINE CITIUS DYSPAMET Tablet Tablet Suspension 5 . indigestion. rash. hypersensitivity reactions. stress ulceration prophylaxis constipation.

Zollinger–Ellison syndrome . dry mouth. دوم‬ ‫ا و د‬ ‫ا‬ ‫ا ر‬ - Drug Store ‫و‬ TAGAMET Famotidine FAMOCID FAMODAR FAMOGEN PEPCIDIN Tablet Tablet Tablet Injection Tablet Capsule Benign gastric and duodenal ulceration. Gastrooesophageal reflux disease. Gastrooesophageal reflux disease gastric and duodenal ulceration.‫رك‬ ‫ش. dyspepsia. agitation. Zollinger–Ellison syndrome anxiety. visual disturbances. anorexia.‫م‬ ‫ال‬ ‫رو‬ ‫ز‬ ‫ا‬ ‫ا دوا‬ ‫دار ا دواء‬ ‫ا رد‬ ‫ار ض‬ ‫ر‬ . alopecia. very rarely interstitial nephritis ‫ار ض‬ ‫ر‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫أو س‬ ‫ا د‬ ‫و ل‬ ‫ر‬ ‫ا را‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ت‬ ‫ا دوا‬ ‫و و رم‬ ‫ا دودة‬ ‫دا‬ ‫ا رام‬ ‫وك‬ ‫وك‬ ‫ا رد‬ ‫ج‬ ‫ا دو‬ ‫ا ز رة‬ ‫ا ز رة‬ ‫ر‬ ‫ا‬ ‫ا رد‬ ‫رر‬ ‫ا ر و‬ ‫ل اس .Scientific Name Trade Name Dosage Form Injection Tablet Indications Side Effects Contra-indications Manufact urer ‫ث‬ ‫ن‬ . vasculitis .ا‬ ‫ا‬ ‫ر‬ ‫و‬ ‫ا ر‬ ‫ا ود‬ ‫وم‬ ‫دو‬ ‫ار ض‬ ‫ر‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ NADINE Tablet ‫ر‬ ‫ا ز رة‬ ‫ا ؤ‬ ‫ا دة‬ ‫دو‬ ‫ر‬ ‫د‬ NOVORANIDINE PEPTAC RANACID RANID RANIDINE Tablet ‫دة‬ Tablet Syrup Tablet Tablet ‫ا ر‬ ‫ا‬ ‫دو‬ ‫زو‬ ------‫د‬ RANIMAX RANIMAX AC RANTAG ROLAN TANIDINA Tablet Tablet Injection Tablet Injection Tablet ----- ‫ا‬ ‫ر‬ ‫د‬ ZANTAC Injection Tablet Eff tablet Injection Tablet Syrup ---- ZYDAC --‫ة‬ ‫ا‬ ‫اط‬ RIALAC 6 .Gastric acid reduction sweating. NSAIDassociated ulceration. rarely hyperuricaemia tachycardia. cholestatic jaundice --‫ا‬ ‫اط‬ ‫ا ة‬ ‫اط‬ ‫ا‬ ‫و‬ Nizatidine AXID Ranitidine ACICARE ANTAGONIN Tablet Tablet APORANITIDINE GLOTAC Tablet Tablet benign gastric. duodenal or NSAID-associated ulceration. Reflux oesophagitis.

dyspepsia. nausea and vomiting. NSAIDassociated duodenal or gastric ulcer and gastroduodenal erosions. also reported: abdominal pain. hyponatraemia. and hallucinations in the severely ill. Gastrooesophageal reflux disease. Less frequent sideeffects include dry mouth. gynaecomastia.Scientific Name Trade Name Dosage Form Syrup Syrup Indications Side Effects Contra-indications Manufact urer ‫دو‬ ‫ر‬ Drug Store ‫ة‬ ‫ر‬ ‫ا‬ ‫اط‬ ‫ا‬ SEDALAC SOFLAX Prostaglandin analogues Misoprostol CYTOTEC Tablet gastric and duodenal ulceration and NSAID-associated ulceration. and dizziness. NSAID-associated duodenal or gastric ulcer Duodenal or benign gastric ulcer associated with Helicobacter pylori. Zollinger– Ellison syndrome. malaise. vertigo. Prophylaxis of NSAID-induced gastric and duodenal ulcer diarrhoea. rashes. headache. reversible confusion. Zollinger– Ellison syndrome. visual impairment reported with high-dose injection Gastrointestinal disturbances. drowsiness. encephalopathy in severe liver disease. dizziness pregnancy or planning pregnancy ‫. blurred vision. abnormal vaginal bleeding. stomatitis. Gastric acid reduction during general anaesthesia. agitation. دى‬ ‫رل‬ ‫ز‬ ‫ا‬ ‫ر‬ Proton pump inhibitors Lansoprazole LANFAST LANSOMID Capsule Capsule benign gastric and duodenal ulcers. rash. and pruritus. alopecia. Duodenal or benign gastric ulcer associated with Helicobacter pylori. flatulence. ‫ر‬ ‫ا رق‬ ‫ا و ط‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ ‫رو ل‬ ‫ا ف‬ ‫ا ر‬ ‫ا دوا‬ ‫ا ر‬ ‫ا‬ ‫ا دو‬ ‫ا رد‬ ‫ار ض‬ ‫ر‬ ‫وم‬ ‫دو‬ ‫ا را‬ ‫دار ا دواء‬ ‫ا رد‬ ‫وك‬ ‫ا‬ ‫ا رد‬ ‫ر‬ ‫ا و‬ ‫ا ر‬ ‫ار ض‬ ‫ر‬ ‫ا رام‬ ‫ا را‬ ‫ا ز رة‬ ‫ة‬ ‫ا‬ ‫اط‬ --‫و‬ ‫ا‬ ‫اط‬ ---‫ا‬ ‫ا ر‬ ‫د ن‬ ‫د‬ ‫ا ة‬ ‫اط‬ ‫زو‬ ‫و‬ ----‫ا‬ ‫ا ؤ‬ ‫ا دة‬ ‫دو‬ ‫ر‬ ‫ر‬ LANZOR Capsule PEPTAZOLE TAKEPRON Capsule Capsule Tablet --- ULTRAZOLE Omeprazole ACILOC Capsule Capsule benign gastric and duodenal ulcers. LOSEC OMEDAR OMIZ OPRAZOLE RISEK Omeprazole HCl EPIRAZOLE GASTROZOLE HYPOSEC LOSEC OMEPREX OMERAL Injection Tablet Capsule Tablet Capsule Injection Capsule Capsule Capsule Capsule Capsule Tablet 7 . Acid reflux disease paraesthesia. impotence. insomnia. Gastric acid reduction.

‫. abdominal distension. and as adjuncts in ulcerative colitis flatulence. ت‬ ‫ا ر‬ ‫ر‬ EZILAX LACTULOSE LAXOLAC RAMLAC MILK OF MAGNESIA Sachet Solution Solution Solution Solution Suspension ---‫د ن‬ ‫د‬ ‫ا‬ ‫اط‬ ‫زو‬ ‫و‬ Magnesium Hydroxide Constipation colic acute gastrointestinal conditions Sodium Acid Phosphate . endoscopy.Scientific Name Trade Name Dosage Form Capsule Tablet Indications Side Effects Contra-indications Manufact urer ‫وك‬ ‫ا را‬ Drug Store ---‫و‬ OMIZ Omeprazole Magnesium LOSEC MUPS Acid reflux disease. Sodium Phosphate FLEET ENEMA Enema rectal use in constipation. haemorrhoids. cramps. irritable bowel syndrome. ‫ا و د‬ ‫وك‬ ‫ا و‬ ‫ا ر‬ ‫ا ن‬ ‫اط‬ ‫ا رام‬ ‫ث‬ ‫ن‬ ‫] م‬ ‫ر‬ [‫ھ ث‬ ‫ز‬ ‫ا‬ . gastro-intestinal obstruction or impaction. hypersensitivity reported difficulty in swallowing. colonic atony. hepatic encephalopathy (portal systemic encephalopathy) flatulence. bowel evacuation before abdominal radiological procedures. Severe ulcerating reflux oesophagitis ‫ر‬ Pantoprazole PANTOZOL PROTON RAZONE E C tablet E C tablet E C tablet ‫ا‬ ‫ا‬ ‫ا دوا‬ ‫ا رد‬ ‫ج‬ ‫ا دو‬ ‫وك‬ --‫د‬ TOPRAZOLE E C tablet ---- Laxatives Bulk-forming laxatives Ispaghula Husk MUCOFALK Granules colostomy. chronic diarrhoea associated with diverticular disease. faecal impaction ‫د. intestinal obstruction ‫و‬ ‫ر‬ ‫و ز‬ . anal fissure. ك‬ ‫ا‬ ‫زن‬ ‫ا دو‬ ‫ا ر‬ Osmotic laxatives Lactulose DUPHALAC Sachet Solution constipation (may take up to 48 hours to act). Acidrelated dyspepsia. and surgery local irritation acute gastrointestinal conditions ‫وم‬ 8 . and abdominal discomfort galactosaemia. intestinal obstruction. ileostomy.

Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Stimulant laxatives Bisacodyl DULCOLAX Tablet Constipation. severe dehydration ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫ر‬ ‫ا ط‬ ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫ا‬ LAXOCODYL Suppository Tablet Suppository Drops Glycerol Sodium Picosulphate Monohydrate GLICEROLO SUPP LAXOBERAL constipation constipation. acute inflammatory bowel disease. local irritation acute surgical abdominal conditions. bowel evacuation before abdominal radiological and endoscopic procedures on the colon. and surgery severe dehydration 9 . suppositories. Before radiological procedures and surgery tablets. griping.

Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Local preparations for anal and rectal disorders Compound haemorrhoidal preparations with corticosteroids Benzyl Benzoate . Zinc Oxide . Bismuth Subgalate Benzyl Benzoate . Bismuth Subgalate . Bismuth Oxide . Hydrocortisone ANUGESIC Suppository Haemorrhoids ‫رك د ز‬ ‫ز‬ ‫ا‬ ‫رك د ز‬ ‫ز‬ ‫ا‬ Haemorrhoids ‫رك د ز‬ ‫ز‬ ‫ا‬ ‫ا‬ ANUSOL ANUSOL HC Ointment Suppository Ointment Suppository ‫ا‬ ‫ا‬ 10 . Zinc Oxide . Bismuth Oxide .

.............................................................................................................................................................................................................................. 13 Anti-arrhythmic drugs 14 Supraventricular arrhythmias ............................................... 27 Fibrates .............................................................. 13 Potassium-sparing diuretics with other diuretics ................................................................................................................................................................. 14 Beta-adrenoceptor blocking drugs 15 With calcium-channel blocker or diuretic...................................................................................................... 25 Oral anticoagulants ................................................................................................................. 12 Loop diuretics ................................................... 12 Potassium-sparing diuretics and aldosterone antagonists ...... 14 Ventricular arrhythmias ................................................................. 14 Supraventricular and ventricular arrhythmias ...................................... 19 Nitrates.............................................................................................................................. 29 11 ........................................ 25 Antiplatelet drugs 26 Myocardial infarction and fibrinolysis 26 Antifibrinolytic drugs and haemostatics 26 Blood products ......... calcium-channel blockers.............................. 17 Hypertension and heart failure 17 Vasodilator antihypertensive drugs............. 18 Alpha-adrenoceptor blocking drugs .................................................................................................................................................................. 21 Calcium-channel blockers ................... 24 Vasoconstrictor sympathomimetics ................... 22 Sympathomimetics 24 Inotropic sympathomimetics ................................................................................. 17 Centrally acting antihypertensive drugs............................................ 28 Statins.............. 24 Anticoagulants and protamine 25 Parenteral Anticoagulants ....................................................................................Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Cardiovascular system Positive inotropic drugs 12 Cardiac glycosides ........................................................................................................................... and other antianginal drugs 21 Nitrates ................................. 12 Diuretics 12 Thiazides and related diuretics.......................................................... 13 Diuretics with potassium............................................................. 27 Lipid-regulating drugs 27 Anion-exchange resins ............................................ 19 Drugs affecting the renin-angiotensin system................................................................................................................................ 29 Nicotinic acid group ................................................................

visual disturbances. hypertrophic obstructive cardiomyopathy ‫ك‬ ‫و‬ ‫ا و‬ ‫ر‬ ‫د‬ LANOXIN Elixir Injection Tablet Tablet ‫وو م‬ ‫ا‬ LANOXIN PG ‫و‬ ‫ن‬ ‫ث‬ ‫ا را‬ Medigoxin LANITOP Injection Syrup Tablet ‫ك‬ ‫روش‬ ‫دا و‬ ‫أ‬ Diuretics Thiazides and related diuretics Chlorthalidone HYGROTON Tablet Oedema. arrhythmias. increased calcium excretion. rashes refractory hypokalaemia. hypercalcaemia. diarrhoea. hyperglycaemia. confusion. hypokalaemia. hyponatraemia. gout. headache. nausea. hypochloraemic alkalosis. Addison's disease ‫د‬ Indapamide NATRILLIX Tablet Essential hypertension severe hepatic impairment ‫ر‬ ‫ا ر‬ ‫ا‬ Loop diuretics Bumetanide BURINEX Injection Tablet oedema hyponatraemia. muscular cramps. second degree AV block. hypochloraemic alkalosis. hyponatraemia. nausea. hypokalaemia . dizziness. hypochloraemic precomatose states associated with liver cirrhosis.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Positive inotropic drugs Cardiac glycosides Digoxin LANIBOS Injection heart failure. and altered plasma lipid concentration. abdominal pain. fatigue. headache. hallucinations. impotence. depression. hypomagnesaemia. Hypertention. diarrhoea. renal failure with anuria ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ا‬ 12 . dyspepsia. hypokalaemia. hypokalaemia. Heart failure postural hypotension and mild gastrointestinal effects. supraventricular arrhythmias anorexia. vomiting. fatigue. renal failure with anuria ‫و‬ ‫اد ر‬ ‫ا‬ Frusemide DIUSEMIDE Injection Tablet oedema. dizziness. hypotension hyponatraemia. anorexia. oliguria due to renal failure precomatose states associated with liver cirrhosis. hypercalcaemia. heart block intermittent complete heart block. symptomatic hyperuricaemia. and hypomagnesaemia. supraventricular arrhythmias caused by Wolff-ParkinsonWhite syndrome. and hypomagnesaemia. ventricular tachycardia or fibrillation. drowsiness. delirium. constipation. hyperuricaemia.

menstrual irregularities. primary hyperaldosteronism gastro-intestinal disturbances. hydrochlorothiazide ALDACTIDE25 DYAZIDE Tablet Tablet Hypertension. gynaecomastia. hyperkalaemia (discontinue). rashes. oedema. increased calcium excretion. Addison's disease ‫. hydrochlorothiazide AMURETIC APOAMILZIDE Spironolactone . hepatotoxicity. lethargy. slight decrease in blood pressure hyperkalaemia.‫م‬ ‫ال‬ ‫رو‬ ‫ز‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ر‬ ‫ا ز رة‬ ‫ر‬ ‫و‬ Tablet Tablet Diuretics with potassium Bumetanide . osteomalacia. renal failure ‫دار ا دواء‬ ‫ا رد‬ ‫أو س‬ ‫ا د‬ ‫. nephrotic syndrome. hyponatraemia. potassium conservation with thiazide and loop diuretics gastro-intestinal disturbances. malignant ascites. rashes. congestive heart failure. دى‬ ‫رل‬ ‫ز‬ ‫ا‬ ‫ث‬ ‫ن‬ . dry mouth. دى‬ ‫رل‬ ‫ز‬ ‫ا‬ ‫ا رد‬ ‫ج‬ ‫ا دو‬ ‫روش‬ ‫دا و ك‬ ‫أ‬ ‫ر‬ ‫د‬ NORACTONE Tablet SPIROCTAN Tablet Potassium-sparing diuretics with other diuretics Amiloride HCl . hydrofluthiazide Triamterene . oedema and ascites in cirrhosis Congestive heart failure Hypertension. congestive heart failure. headache.Scientific Name Trade Name Dosage Form Injection Tablet Injection Suspension Tablet Indications Side Effects Contra-indications Manufact urer ‫ا ر‬ ‫اد ر‬ ‫أ س ر‬ ‫د‬ ‫دو‬ ‫أم‬ ‫أش‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ر‬ Drug Store ‫ا‬ ‫ر‬ IMPUGAN LASIX alkalosis. impotence. hyponatraemia. and blood disorders reported hyperkalaemia. hypotension OEDEMAX SALURIN Tablet Suspension Tablet ‫ر‬ ‫ر‬ ‫ا‬ Potassium-sparing diuretics and aldosterone antagonists Spironolactone ALDACTONE Tablet oedema and ascites in cirrhosis of the liver. potassium chloride BURINEX-K Tablet ‫و‬ ‫اد ر‬ ‫ا‬ 13 . confusion.

arthralgia. iodine sensitivity. sinus bradycardia. also cinchonism ‫ا را‬ ‫در‬ ‫ا ر‬ ‫و‬ Ventricular arrhythmias 14 .Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Anti-arrhythmic drugs Supraventricular arrhythmias Adenosine ADENOCOR Injection paroxysmal supraventricular tachycardias transient facial flush. rarely myalgia. severe bradycardia reported (requiring temporary pacing). circulatory collapse heart block ‫و‬ ‫و‬ [ ‫] ر‬ ‫ا ر‬ Quinidine sulphate KINIDIN DURULES QUINIDINE SULPHATE Tablet Tablet supraventricular tachycardias and ventricular arrhythmias Procainamide Hydrochloride. hypersensitivity reactions including urticaria and hepatitis. photosensitisation. bronchospasm. thyroid dysfunction. unless pacemaker fitted avoid in severe conduction disturbances or sinus node disease. lightheadedness. ventricular arrhythmias. asthma ‫و‬ ‫و‬ ‫ز‬ ‫ا‬ Amiodarone HCl CORDARONE Injection Supraventricular arrhythmias [ ‫و‬ ‫و‬ ‫] ر‬ ‫ا ر‬ ‫ا وي‬ ‫و‬ ‫ا‬ ‫ر‬ ‫د‬ SEDACORON Injection Supraventricular and ventricular arrhythmias Amiodarone CORDARONE Tablet Paroxysmal supraventricular. pulmonary toxicity (including pneumonitis and fibrosis). It may also be used for tachyarrhythmias associated with Wolff-ParkinsonWhite syndrome nausea. bradycardia . tremor. haemolytic anaemia. choking sensation. atrial fibrillation and flutter. and ventricular fibrillation. raised serum transaminases (may require dose reduction or withdrawal if accompanied by acute liver disorders). vomiting. jaundice. dyspnoea. avoid intravenous use in severe respiratory failure. thrombocytopenia. taste disturbances. ECG may show transient rhythm disturbances second. nausea. sino-atrial heart block. chest pain. also vomiting. nodal and ventricular tachycardias.or thirddegree AV block and sick sinus syndrome (unless pacemaker fitted).

constipation.or thirddegree AV block. angina. marked bradycardia. heart failure. bronchospasm. hypotension. angina. bradycardia. bradycardia. metabolic acidosis. dyspnoea. other CNS effects include confusion. severe myocardial depression. arrhythemias Hypertension: 400 mg PO in 1–2 doses.Scientific Name Lidocaine HCl Trade Name Dosage Form Injection Indications Side Effects Contra-indications Manufact urer Drug Store ------ LIDOCAINE Ventricular arrhythmias LIDOCAINE Injection XYLOCARD Injection dizziness. adjunct in stable moderate to sever heart failure gastro-intestinal disturbances. sick sinus syndrome. hypotension and bradycardia (may lead to cardiac arrest). conduction defects. uncontrolled heart failure. Prinzmetal's angina. atrial fibrillation. cardiogenic shock. bradycardia. headache. uncontrolled heart failure. or drowsiness (particularly if injection too rapid). hypotension. hypotension. paraesthesia. dyspepsia. fatigue. sleep disturbances gastro-intestinal disturbances. arrhythmias: 400–1200 mg/d PO in divided doses Injection Tablet Tablet Bisoprolol fumarate CONCOR CONCOR COR Tablet Tablet Hypertension. all grades of atrioventricular block. diarrhoea. exacerbation of heart failure. heart failure. dry mouth. conduction disorders. torsades de pointes. severe peripheral arterial disease. sick sinus syndrome. taste disturbance. secondor third-degree AV block (unless pacemaker fitted) ‫أ وت‬ ‫ا ر‬ ‫أ ن‬ ‫ا ر د‬ ‫ا را‬ ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا‬ ‫ب‬ ‫ا ل‬ ‫ا ة‬ ‫اط‬ ‫و‬ ‫ر‬ ‫ا‬ Beta-adrenoceptor blocking drugs Atenolol APO-ATENOL BLOKIUM CANAR CARDOL HYPOTEN NORMOTEN NOVOATENOL TENORMIN TENORMIN TENSOTIN Tablet Tablet Tablet Tablet Tablet Tablet Tablet Hypertension. peripheral vasoconstriction (including exacerbation of intermittent claudication and Raynaud’s phenomenon). palpitation. ‫رك‬ ‫ا‬ ‫رك‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ا ة‬ ‫اط‬ 15 . conduction asthma . hypotension. hypotension. hiccups. phaeochromocytoma ‫أو س‬ ‫ا د‬ ‫رودس‬ ‫ا‬ ‫وك‬ ‫ا دوا‬ ‫ا‬ ‫ا رد‬ ‫ا ز رة‬ ‫و و رم‬ ‫ا دودة‬ ‫دا‬ ‫ز‬ ‫ز‬ ‫ر‬ ‫ر‬ ‫ا ز رة‬ ‫أز‬ ‫رة‬ -----‫ا‬ --‫ا ر‬ ‫ا دة‬ ‫دو‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫ا‬ asthma. marked bradycardia. porphyria ‫ا‬ ‫اط‬ ‫ا دودة‬ -----‫ا‬ ‫اط‬ ‫ا دودة‬ ‫ا را‬ ‫ل‬ ‫ل‬ ‫و‬ Lignocaine LIDOCAINE LIGNOCAINE XYLOCAINE MEXITIL Injection Injection Injection Injection Ventricular arrhythmias Mexiletine HCl life-threatening ventricular arrhythmias nausea. rarely hypersensitivity reactions sino-atrial disorders. vomiting. second. exacerbation of arrhythmias. cardiogenic shock. Prinzmetal's angina. respiratory depression and convulsions.

hypotension. dyspnoea.25–50 mg PO BID. metabolic acidosis. asthma. severe peripheral arterial disease. cardiogenic shock. bradycardia. 20. bronchospasm. sinus tachycardia). metabolic acidosis. maximum dose. fatigue. bronchospasm. angina. CHF: dose individualized based on patient response. bradycardia. hypotension. marked bradycardia. peripheral oedema and painful extremities. hypotension. dizziness. adjunct in heart failure Hypertension: 6. headache.or thirddegree AV block. Prinzmetal's angina. fatigue. heart failure. gastrointestinal disturbances.300mg IV Metoprolol HCl LOPRESOR DIVI Tablet Hypertension Extended release: 50–100 mg/d PO disorders. severe peripheral arterial disease. bradycardia.125 mg PO BID. increased gradually to a maximum dose of 50 mg PO BID DILATREND Tablet Esmolol HCl BREVIBLOC Injection short-term treatment of supraventricular arrhythmias (including atrial fibrillation. uncontrolled heart failure. phaeochromocytoma ‫ا دوا‬ --- ‫ك‬ ‫روش‬ ‫دا و‬ ‫أ‬ asthma. postural hypotension. uncontrolled heart failure. initial dose 3. sick sinus syndrome. fatigue. sick sinus syndrome. marked bradycardia. uncontrolled heart failure. phaeochromocytoma ‫د وت‬ ‫ر‬ ‫و ل‬ ‫ا ر‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫و‬ ‫ا رط‬ asthma. peripheral vasoconstriction (including exacerbation of intermittent claudication and Raynaud’s phenomenon). sleep disturbances Bradycardia. Prinzmetal's angina. cardiac insufficiency. eye irritation or disturbed vision.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store 5 mg PO QD. metabolic acidosis. peripheral vasoconstriction (including exacerbation of intermittent claudication and Raynaud’s phenomenon). ‫د‬ 16 . gastro-intestinal disturbances. dry eyes. severe peripheral arterial disease. atrial flutter. phaeochromocytoma. dizziness. hypotension. diarrhea gastro-intestinal disturbances. tachycardia and hypertension in peri-operative period 25–500 mcg/kg/min IV Labetalol HCL TRANDATE Injection Tablet Hypertension: 100-400 mg/d PO in divided doses. second. dry mouth. dyspnoea. cardiogenic shock.or thirddegree AV block. headache. impotence. conduction disorders. occasionally diminished peripheral circulation. fatigue. Prinzmetal's angina. headache. 20 mg PO QD Carvedilol CARVIDOL Tablet Hypertension. second. second.or thirddegree AV block. cardiogenic shock.

hyperosmolar non-ketotic coma. angina Hypertension ‫ز‬ ‫ز‬ ‫ا‬ ‫ا‬ Hypertension and heart failure Vasodilator antihypertensive drugs Diazoxide HYPERSTAT Injection hypertensive emergency including severe hypertension associated with renal disease. and hirsuitism ‫ر‬ ‫و‬ ‫ا‬ ‫ر‬ 17 . cardiogenic shock. cardiogenic shock. nifedipine Atenolol . phaeochromocytoma ‫ز‬ ‫ا ر‬ ‫ا‬ ‫ا‬ ‫ا دو‬ ‫ا رد‬ With calcium-channel blocker or diuretic Atenolol . hyperglycaemia.or thirddegree AV block. Prinzmetal's angina. conduction disorders. uncontrolled heart failure. thrombocytopenia. metabolic acidosis. dyspnoea. leucopenia. angina. peripheral vasoconstriction (including exacerbation of intermittent claudication and Raynaud’s phenomenon). migraine: 80–240 mg/d PO in divided doses heart failure. peripheral vasoconstriction (including exacerbation of intermittent claudication and Raynaud’s phenomenon).Scientific Name Metoprolol tartarate Trade Name Dosage Form Tablet Indications Side Effects Contra-indications Manufact urer Drug Store ‫د‬ LOPRESOR Hypertension. headache. marked bradycardia. sick sinus syndrome. headache. fatigue. phaeochromocytoma asthma . heart failure. second. bradycardia. migraine prophylaxis Arrhythmias: 10–30 mg PO TID. conduction disorders. metabolic acidosis. hyperthyroidism 100–450 mg/d PO. bronchospasm. Angina. hypotension. chlorthalidone NIF-TEN TENORETIC Capsule Tablet Hypertension. sodium and water retention. sleep disturbances gastro-intestinal disturbances. severe peripheral arterial disease. migraine. prophylaxis for myocardial infarction. hypertension: 40– 640 mg/d PO in divided doses. dyspnoea. extended release: 50–100 mg/d PO Propranolol INDERAL INDICARDIN Injection Tablet Tablet Hypertension. hypotension. sick sinus syndrome. severe peripheral arterial disease. fatigue. 5 mg IV. phaeochromocyt oma. Anxiety.or thirddegree AV block. hypoglycaemia tachycardia. hypotension. hypotension. Arrhythemias. bronchospasm. rarely cardiomegaly. marked bradycardia. hypotension. lifethreatening arrhythmias: up to 1–3 mg IV. angina: 10–320 mg/d PO in divided doses. QID. second. arrhythemias.

nocturnal unrest. retrosternal discomfort. apprehension. 250–500 mg q6h IV DOPAMET DOPANORE Tablet Tablet SEMBRINA Tablet dry mouth. 3 g/d. Leber's optic atrophy. stomatitis. idiopathic systemic lupus erythematosus. bradycardia. palpitation. dry mouth. migraine. hypertensive crisis Sodium nitroprusside NIPRIDE Injection SODIUM NITROPRUSSIDE Injection hypertensive crisis. myocardial insufficiency due to mechanical obstruction. Raynaud's phenomenon. hypertensive crisis 250 mg PO BID–TID. active liver disease. porphyria ‫رك‬ ‫رب‬ ‫ودوم‬ ‫ا را‬ ‫ا ر‬ ‫اد ر‬ ‫ا رد‬ ‫ج‬ ‫ا دو‬ ‫روش‬ ‫دا و ك‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫د‬ 18 . hypotension. controlled hypotension in surgery. dizziness. transdermal: 0. flushing. sialadenitis. headache. perspiration. sedation. maintenance dose. severe tachycardia. porphyria severe vitamin B12 deficiency. postural hypotension. nausea. depression. dizziness. headache. oedema. abdominal pain. systemic lupus erythematosuslike syndrome after long-term therapy with over 100 mg daily (or less in women and in slow acetylator individuals associated with over rapid reduction in blood pressure (reduce infusion rate): headache. occasionally reduced platelet count. exacerbation of angina. dizziness. heart failure . menopausal flushing 100–2400 mg/d PO. sedation. phaeochromocytom a.1–0.3 mg/24h Methyl dopa (Methyldopa) (Methyldopate) ALDOMET Tablet Hypertension. fluid retention. cor pulmonale. retching. euphoria. gastrointestinal disturbances. headache. palpitation. ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫ا‬ depression. heart failure tachycardia. nausea.Scientific Name Hydralazine Trade Name Dosage Form Tablet Indications Side Effects Contra-indications Manufact urer ‫در‬ ‫ا ر‬ Drug Store HYDRALAZINE hypertension . fluid retention. bradycardia. rarely impotence gastro-intestinal disturbances. dissecting aortic aneurysm. constipation. high output heart failure. compensatory hypertension ‫روش‬ ‫ا و ر‬ ‫ن‬ ‫ا را‬ ‫ر‬ ‫ا‬ Centrally acting antihypertensive drugs Clonidine CATAPRES Tablet hypertension. dizziness. rash.

arthralgia. Heart Failure . rhinitis. headache. After infarction . paraesthesia. nausea. palpitation. myalgia.g. hypersensitivity to ACE inhibitors (including angioedema) and in known or suspected renovascular disease . headache. benign prostatic hyperplasia postural hypotension. aortic stenosis) ‫زر‬ ‫ا‬ ‫ا‬ Terazosin ITRIN Tablet mild to moderate hypertension . dizziness. Diabetic neuropathy Hypotension. depression. benign prostatic hyperplasia 1–20 mg/d PO ‫أ وت‬ ‫ا ط‬ ‫ب‬ ‫ل‬ ‫ا‬ Drugs affecting the renin-angiotensin system Angiotensin-converting enzyme inhibitors Benazepril CIBACEN Tablet ‫و ر ز‬ ) ( ‫ا و ر‬ Hypertension . headache. tachycardia. nausea. Benign prostatic hyperplasia 1–20 mg/d PO in divided doses not recommended for congestive heart failure due to mechanical obstruction (e. stomatitis. angioedema (onset may be delayed). Congestive heart failure . urinary frequency. rash (which may be associated with pruritus and urticaria). lack of energy. postural hypotension. fatigue. dizziness. weakness. sleep disturbance. asthenia. persistent dry cough. oedema. incontinence and priapism Dizziness. weight loss. mild psychosis. nasal congestion ‫زر‬ ‫ا‬ ‫ا‬ Prazocin HCl MINIPRESS Tablet Hypertension . dyspnea. postural hypotension. Raynaud's syndrome .Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store asthenia. Alpha-adrenoceptor blocking drugs Doxazosin maleate CARDURA Tablet hypertension . serum sickness. pregnancy ‫دار ا دواء‬ ‫ا رد‬ ‫ا دوا‬ ‫ا دوا‬ ‫ا دة‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ ‫و و رم‬ ‫ا دودة‬ ‫دا‬ ‫د‬ Captopril CAPOCARD CAPOTEN CAPRIL MINITEN Tablet Tablet Tablet Tablet ‫ا‬ ‫اط‬ ----‫دي‬ ‫رف‬ ‫ا ر‬ ‫ا‬ ‫دو‬ NOVOCAPTORIL Tablet ‫دة‬ 19 . and renal impairment. vertigo. nightmares. drowsiness.

angioedema (onset may be delayed). persistent dry cough. Heart Failure Hypotension. renovascular disease . rash (which may be associated with pruritus and urticaria) dyspnoea . hydrochlorothiazide Lisinopril CO-RENITEC Tablet ZESTRIL Tablet Perindopril ZINOPRIL COVERSYL Tablet Tablet Hypertension . renovascular disease .د‬ ‫وم ا و د‬ ‫ار ض‬ ‫ر‬ . rash (which may be associated with pruritus and urticaria). and renal impairment. mood and sleep disturbances Hypotension. rash (which may be associated with pruritus and urticaria) hypersensitivity to ACE inhibitors (including angioedema) . and renal impairment. asthenia . and renal impairment. blurred vision hypersensitivity to ACE inhibitors (including angioedema) . pregnancy ‫ا رد‬ ‫ج‬ ‫ا دو‬ ‫ا دوا‬ ‫وك‬ ‫ر‬ ‫ا د‬ ‫ر‬ ‫رك. asthenia . Heart Failure . Heart Failure ENAPRIL ESOPRESS INVORIL NARAPRIL RENITEC RIAPRIL Tablet Tablet Tablet Tablet Tablet Tablet maculopapular rash. angioedema (onset may be delayed). renovascular disease . persistent dry cough.‫رك. Heart Failure Enalapril ANGIOTEC Tablet Hypertension . bronchitis hypotension. Following infarction Quinapril ACUITEL Tablet Hypertension . dyspnoea . persistent dry cough. angioedema (onset may be delayed). and renal impairment. photosensitivity. flushing and acidosis Hypotension.pregnancy ‫روش‬ ‫ا و ر‬ hypersensitivity to ACE inhibitors (including angioedema) . angioedema (onset may be delayed). ش‬ ‫دوم‬ ‫ا و د‬ ‫ا را‬ ‫ز‬ ( ‫)ز‬ ‫ا رط‬ ‫ا ز رة‬ ‫ر‬ ‫ا ر‬ ‫د‬ -----‫إ راھ م‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫ا‬ ‫ا‬ Enalapril . renovascular disease . depression . pregnancy ‫ود‬ ‫ا‬ ‫ا‬ 20 .Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Cilazapril INHIBACE Tablet Hypertension .ش. rash (which may be associated with pruritus and urticaria). persistent dry cough. pregnancy --‫ا‬ hypersensitivity to ACE inhibitors (including angioedema) .

‫رك. Heart Failure vertigo. musculoskeletal pain Pregnancy. hypersensitivity to nitrates.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Angiotensin-II receptor antagonists Candesartan cilexetil ATACAND BLOPRESS Tablet Tablet Hypertension . eczema hepatic impairment . biliary obstruction . breast feeding Losartan potassium Telmisartan COZAAR MICARDIS Tablet Tablet hypertension gastro-intestinal disturbances. Myocardial infarction Pregnancy. ش‬ ‫دوم ا و د‬ ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ا‬ Valsartan DIOVAN Tablet hypertension . and other antianginal drugs Nitrates Glyceryl trinitrate GLYCERYL TRINITRATE NITRO MACK NITRODERM TTS NITRO-DUR NITROGLYCERINE Injection Capsule Transdermal Patch Transdermal Patch Injection prophylaxis and treatment of angina. vomiting . breast feeding ‫د‬ Irbesartan . hypotensive conditions and hypovolaemia. extravasation postural hypotension. ش‬ ‫دوم ا و د‬ . breast feeding . arthralgia. influenza-like symptoms including pharyngitis and sinusitis. cirrhosis. cardiac ‫ن‬ ‫ا را‬ ‫ك‬ ‫ا‬ ‫ر‬ ‫ر‬ ‫د‬ ‫و‬ ‫ر‬ ‫ا ر‬ ‫أ وت‬ ‫ا ر‬ ‫ر‬ ‫ب‬ ‫ل‬ ‫ا‬ ‫ا‬ 21 . leg cramps. throbbing headache. calcium-channel blockers. headache Pregnancy. tachycardia (but paradoxical bradycardia also reported). back pain. hydrochlorothiazide FORTZAAR HYZAAR CO-DIOVAN Tablet Tablet Tablet Nitrates. renal impairment Pregnancy. hydrochlorothiazide COAPROVEL Tablet ‫و‬ ‫و‬ [‫] رو دي‬ ‫ا ر‬ . aortic stenosis.‫رك. fatigue .‫رك. ش‬ ‫دوم ا و د‬ ‫و ر ز‬ ) ( ‫ا و ر‬ ‫ا‬ ‫ا‬ ‫د‬ Losartan potassium . biliary obstruction . renal disease in hypertensive type 2 diabetes mellitus nausea. anal fissure . hydrochlorothiazide Valsartan . left ventricular failure. breast feeding cholestasis ‫ا را‬ ‫ا ر‬ ‫ا‬ ‫ا دو‬ ‫ا رد‬ ‫و‬ ‫و‬ [‫] رو دي‬ ‫ا ر‬ ‫و‬ Irbesartan APROVEL Tablet hypertension . myalgia. hypertrophic obstructive cardiomyopathy.

throbbing headache. hypotension. palpitation. mood changes. left ventricular failure postural hypotension.Scientific Name Trade Name Dosage Form Tablet Injection Indications Side Effects Contra-indications Manufact urer ‫رك د ز‬ ‫ا ر‬ ‫د وت‬ ‫ر و ل‬ ‫ا ر‬ ‫وار ز‬ ‫ر‬ ‫ا‬ ‫ك‬ ‫ا‬ ‫وا ث ا د‬ ‫وا ث ا د‬ ‫و ــت وارد‬ ‫ا ر‬ Drug Store ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ا ر‬ ‫ر‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ ‫ا‬ NITROSTAT TRIDIL dizziness. chest pain. hypertrophic obstructive cardiomyopathy. constrictive pericarditis. adjunct in congestive heart failure postural hypotension. prophylaxis of angina abdominal pain. malaise. tamponade. dizziness. breastfeeding ‫زر‬ ‫ا ر‬ ‫وم‬ ‫دو‬ ‫وك‬ ‫ا‬ --- LOTENSE Tablet ---- Diltiazem HCl BI-TILDIEM Tablet DILZEM RETARD Tablet severe bradycardia. throbbing headache. palpitation. flushing. mitral stenosis. cardiogenic shock. sleep disturbances. bradycardia.or thirddegree AV block ‫و‬ ‫و‬ ‫]رو ن‬ [‫د س‬ ‫ا ر‬ ‫ود‬ ‫ا‬ ‫زو‬ ‫ا‬ 22 . hypotensive conditions and hypovolaemia. rhinitis. dizziness. marked anaemia ‫ا را‬ ‫و‬ Calcium-channel blockers Amlodipine besylate AMLOR AMVASC Tablet Capsule hypertension. aortic stenosis. dizziness. Isosorbide dinitrate ISOKET Injection ISOMACK ISORDIL ISORDIL SUBLINGUAL WESORBIDE Capsule Tablet Tablet Tablet prophylaxis and treatment of angina. dry mouth. dizziness. mitral stenosis. second. hypotensive conditions and hypovolaemia. asthenia. left ventricular failure with pulmonary congestion. tachycardia (but paradoxical bradycardia also reported). nausea. unstable angina. marked anaemia hypersensitivity to nitrates. Isosorbide mononitrate IMDUR Tablet prophylaxis of angina. marked anaemia hypersensitivity to nitrates. syncope. tachycardia (but paradoxical bradycardia also reported). hypotension. fatigue. aortic stenosis. mitral stenosis. significant aortic stenosis. dyspnoea. hypertrophic obstructive cardiomyopathy. AV block. sinoatrial block. cardiac tamponade. taste disturbances. constrictive pericarditis. oedema. constrictive pericarditis. cardiac tamponade. less commonly gastrointestinal disturbances. headache.

flushing.Scientific Name Trade Name Dosage Form Tablet Tablet Capsule Indications Side Effects Contra-indications Manufact urer ‫أو س‬ ‫ا د‬ ‫ود‬ ‫ا‬ ‫و‬ ‫و‬ ‫]رو ن‬ [‫د س‬ ‫ا ر‬ ‫و و رم‬ ‫ا دودة‬ ‫دا‬ ‫ار ض‬ ‫ر‬ ‫و‬ ‫و‬ ‫]رو ن‬ [‫د س‬ ‫ا ر‬ ‫دوز‬ ‫دوز‬ Drug Store ‫ر‬ ‫ا ز رة‬ ‫ا‬ ‫زو‬ APO-DILTAZ DILZEM MONO TILDIEM SR NOVODILTAZEM RIAZEM TILDIEM Tablet headache. fatigue. oedema (notably of ankles). hypotension uncommon. hypertension. flushing. gastro-intestinal disorders. advanced aortic stenosis. porphyria ‫ر‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ا و‬ ‫ا ر‬ ‫دار ا دواء‬ ‫ا رد‬ ‫و و رم‬ ‫ا دودة‬ ‫دا‬ ‫ا ر‬ ‫د ن‬ ‫د‬ ‫ا‬ ‫اط‬ ‫ا ر‬ ‫ا دة‬ ‫دو‬ ‫ا ر‬ within 1 month of myocardial infarction. variation in heartrate. rarely weight gain. hot flushes. pregnancy. Raynaud's phenomenon Nimodipine NIMOTOP Injection Tablet prevention and treatment of ischaemic neurological deficits following aneurysmal subarachnoid haemorrhage headache. localized peripheral oedema. palpitation. unstable angina ‫ر‬ ‫ا‬ ‫ا ر‬ 23 . nausea. rash hypotension. flushing. lethargy. sweating and feeling of warmth. tachycardia and palpitation. rashes headache. unstable angina. rarely rashes (including erythema multiforme and exfoliative dermatitis) (unless pacemaker fitted). breastfeeding ‫دة‬ Capsule Tablet Tablet ‫ا ر‬ ‫ا‬ ‫دو‬ ‫ا ة‬ ‫اط‬ ‫زو‬ Isradipine LOMIR LOMIR SRO Tablet Capsule hypertension Nifedipine ADALAT ADALAT EPILAT NIFECARD NOVONIFEDIN Capsule Tablet Capsule Capsule Capsule prophylaxis of angina. sick sinus syndrome. dizziness. thrombocytopenia and ileus reported cardiogenic shock. headache. within 1 month of myocardial infarction. shortacting preparations may induce an exaggerated fall in blood pressure and reflex tachycardia which may lead to myocardial or cerebrovascular ischaemia. breastfeeding ‫د‬ ‫د‬ cardiogenic shock. gravitational oedema. dizziness. symptomatic or tight aortic stenosis. abdominal discomfort. tachycardia. gastrointestinal disturbances. unstable or acute attacks of angina. within 1 month of myocardial infarction.

ankle oedema. cardiac surgery. phlebitis. bradycardia. hypertension. angina. rarely thrombocytopenia ‫دا‬ ‫رس‬ ‫د‬ ‫إ راھ م‬ ‫ا‬ Dopamine HCl DOPAMIN DOPAMINE INTROPIN Injection Injection Injection cardiogenic shock in infarction or cardiac surgery 2—50 mcg/kg/min IV (infusion rate determined by patient’s response) nausea and vomiting. history of heart failure or significantly impaired left ventricular function. vomiting. tachycardia tachyarrhythmia. hypotension. cardiogenic shock. 2—3 mL/min IV. myalgia.and thirddegree AV block. titrate to patient’s hemodynamic and renal status tachycardia and marked increase in systolic blood pressure indicate overdosage. peripheral ischaemia hypertension (monitor blood pressure and rate of flow frequently).Scientific Name Verapamil HCl Trade Name Dosage Form Injection Tablet Tablet Indications Side Effects Contra-indications Manufact urer ‫أ وت‬ ‫ول‬ ‫أ‬ ‫أ وت‬ ‫ول‬ ‫أ‬ Drug Store ‫ب‬ ‫ل‬ ‫ب‬ ‫ل‬ ISOPTIN ISOPTIN RETARD Supraventricular arrhythmias. pruritus. atrial flutter or fibrillation ‫ا‬ ‫ا‬ Sympathomimetics Inotropic sympathomimetics Dobutamine HCl DOBUJECT Injection inotropic support in infarction. peripheral vasoconstriction. less commonly nausea. even if controlled by therapy. sino-atrial block. pregnancy ‫أ وت‬ ‫ا ر‬ ‫ب‬ ‫ل‬ ‫ا‬ 24 . cardiomyopathies. and cardiogenic shock 2. erythromelalgia. paroxysmal tachyarrhythemias constipation. phaeochromocytoma ‫أ وت‬ ‫ا ر‬ ‫ن‬ ‫ا را‬ ‫د وت‬ ‫ر‬ ‫و ل‬ ‫ا ر‬ ‫ب‬ ‫ل‬ ‫ا‬ ‫ا ر‬ ‫ا ة‬ ‫اط‬ Vasoconstrictor sympathomimetics Noradrenaline acid tartrate LEVOPHED Injection Acute hypotension. hypertension. arthralgia. paraesthesia. dizziness. headache. sick sinus syndrome. rarely allergic reactions (erythema. flushing. angioedema. urticaria. bradycardia. Stevens-Johnson syndrome). cardiac arrest 1 mg/mL in 1000 mL 5% dextrose solution. hypotension. fatigue. arrhythmias. septic shock.5—15 mcg/kg/min IV (up to 40 mcg/kg/min). headache. second. rate adjusted to maintain desired blood pressure‫؛‬ average dose، ٤—٢µg/min hypertension.

skin necrosis. peptic ulcer.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Anticoagulants and protamine Parenteral Anticoagulants Fondaparinux sodium ARIXTRA Injection Prophylaxis of venous thromboembolism bleeding.ب‬ ‫. dyspnoea. rarely hypotension.ب‬ ‫. diarrhoea. oedema. peptic ulcer. bacterial endocarditis ‫و‬ ‫و‬ ‫] رو دي[ا‬ ‫ر‬ Heparin sodium HEPARIN SOD HEPARIN SOD Injection Injection HEPARINE SOD Injection HIKMA HEPARIN MONOPARIN Injection Injection Treatment of deepvein thrombosis and pulmonary embolism. ر‬ ‫و ل‬ ( ‫) وو‬ ‫ز‬ ‫ا‬ ‫و‬ ‫اد ر‬ ‫. Myocardial Infarction. and anaphylaxis). thrombocytopenia. alopecia. Unstable angina. Prophylaxis in orthopaedic surgery. thrombocythaemia. less commonly gastrointestinal disturbances. hyperkalaemia. anaemia. thrombocytopeni a (including history of heparin-induced thrombocytopeni a). chest pain.ب‬ ‫. cough. thrombocytopenia. vertigo. bacterial ‫د وت‬ ‫ر‬ ‫و ل‬ ‫ا ر‬ ‫ة‬ ‫ا‬ ‫اط‬ 25 . headache. osteoporosis after prolonged use (and rarely alopecia) active bleeding. haemorrhage. severe liver disease (including oesophageal varices). pruritus. after major trauma ‫. راون‬ ‫ا‬ ‫ر‬ ‫أ ون‬ (‫)ا ون‬ ‫ا ر‬ ‫ر‬ ‫ا ون‬ (‫)ا ون‬ ‫ا ر‬ ‫ا‬ ‫ا رد‬ ‫. severe hypertension. liver enzyme changes. recent cerebral haemorrhage. hypersensitivity reactions (including urticaria. hypokalaemia. angioedema. rash. purpura. ر‬ ‫و ل‬ ( ‫) وو‬ ‫ز‬ ‫ا‬ ‫أ س ر‬ ‫ا ر‬ ‫و‬ ‫اد ر‬ ‫دي‬ ‫رف‬ ‫ر‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ا‬ OX-HEP LEO Heparinised saline HEPSAL Injection Injection For maintaining patency of peripheral venous catheters ‫ا‬ ‫ا‬ Enoxaparin sodium Tinzaparin sodium CLEXANE INNOHEP Injection Injection ‫و‬ ‫ا‬ Oral anticoagulants Warfarin COUMADIN Tablet prophylaxis of embolisation in rheumatic heart disease and atrial haemorrhage— hypersensitivity. dizziness. Prevention of clotting in extracorporeal circuits MULTIPARIN Injection haemophilia and other haemorrhagic disorders. ر‬ ‫و ل‬ ( ‫) وو‬ ‫ز‬ ‫ا‬ ‫. severe hypertension. rash.

neoplasm or arteriovenous malformation). prophylaxis and treatment of venous thrombosis and pulmonary embolism. rash. stroke within 30 days or any history of haemorrhagic stroke. worsening symptoms of coronary heart disease. rashes nausea. transient ischaemic attacks unexplained drop in haematocrit. pregnancy Antiplatelet drugs Dipyridamole ANTIPLATE Tablet prevent platelet aggregation gastro-intestinal effects. porphyria ‫ا ى‬ ‫ا‬ ‫اوم‬ ‫ا و ر‬ ‫او ر‬ ‫ا و د‬‫ة‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ا‬ severe renal impairment. also nausea. severe hypertension. myalgia. ش‬ ‫دوم‬ ‫ا و د‬ ‫ا‬ Myocardial infarction and fibrinolysis Streptokinase KABIKINASE STREPTAS Injection Injection ‫او ر‬ ‫ا و د‬‫أ س‬ ‫ر‬ (‫) ون‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫ا ز رة‬ Antifibrinolytic drugs and haemostatics Etamsylate AGLUMIN DICYNONE Tranexamic acid CYKLOKAPRON Injection Injection Injection Tablet Fibrinolysis. vomiting. and pancreatitis endocarditis. 26 .Scientific Name Trade Name Dosage Form Tablet Indications Side Effects Contra-indications Manufact urer ‫ور ن‬ ‫وا ر ورد‬ -‫ا دودة‬ ‫ا ر د‬ Drug Store ‫ا ر‬ ‫ا ود‬ ‫دو‬ ‫ا دودة‬ (‫)ا ف‬ WARFARIN fibrillation. jaundice. reversible thrombocytopenia ‫ا ر‬ ‫ا‬ ‫دو‬ ‫رد‬ ‫و و رم‬ ‫دودة‬ ‫دا‬ ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫دة‬ ‫ا ر‬ ‫ا‬ ‫دو‬ ‫ا‬ NOVODIPIRADOL PERSANTIN Tablet Tablet ‫ر‬ Tirofiban HCl monohydrate AGGRASTAT Injection prevention of early myocardial infarction in patients with unstable angina or nonST-segmentelevation myocardial infarction and with last episode of chest pain within 12 hours abnormal bleeding within 30 days. headache. haemorrhagic diathesis. urticaria.‫رك. ‘purple toes'. dizziness. severe bronchospasm .g. prophylaxis after insertion of prosthetic heart valve. increased prothrombin time or INR . hypotension. hot flushes and tachycardia. in blood loss in menorrhagia nausea. vomiting. bleeding (e. angioedema bleeding manifestations. hepatic dysfunction. skin necrosis. throbbing headache. intracranial disease (aneurysm.

‫ا ون‬ ‫ا‬ ‫ر‬ 27 . menorrhagia . fever disseminated intravascular coagulation ‫ر‬ ‫و‬ . epistaxis . Hypertriglyceridaemia may be aggravated. disturbances in colour vision (discontinue) and thromboembolic events reported rarely. particularly type IIa. including chills. hyperfibrinogenae mia after massive doses with earlier products but less likely since fibrinogen content has now been substantially reduced ‫ا ود‬ ‫و رود ت‬ )‫ب‬ (‫ل‬ ‫ا رط‬ ‫او ر‬ ‫وو‬ ‫و‬ ‫ا‬ ‫ا‬ ‫را و ك‬ ‫ور ور ن‬ ( ‫) وو‬ ‫ا ر‬ ‫او ر‬ ‫وو‬ ‫و‬ ‫ا‬ .‫او ر‬ ‫ا ود‬ ‫و رود ت‬ )‫ب‬ (‫ل‬ ‫ا رط‬ ‫او ر‬ ‫وو‬ ‫و‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫ا ؤ‬ ‫ا‬ ‫دو‬ ‫ا‬ ‫اط‬ ‫دة‬ ‫ة‬ OCTANATE Injection Lipid-regulating drugs Anion-exchange resins Colestipol HCl COLESTI Sachet hyperlipidaemias. Constipation is common. thrombolysis diarrhoea (reduce dose). gastrointestinal side-effects predominate. as have nausea. in patients who have not responded adequately to diet and other appropriate measures As colestyramine and colestipol are not absorbed. vomiting. and gastro-intestinal discomfort. giddiness on rapid intravenous injection thromboembolic disease ‫ا‬ Blood products Factor IX OCTANINE F Injection congenital factor IX deficiency (haemophilia B) allergic reactions. but diarrhoea has occurred.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫او ر‬ ‫-ا و د‬ Drug Store prostatectomy and dental extraction in haemophilia) .‫ر‬ ‫او‬ ‫دة‬ ‫ة‬ ‫او‬ ‫وو‬ ‫ا‬ ‫ا‬ ‫ا ؤ‬ ‫ا‬ ‫دو‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ PRECONATIVE REPLENINE-VF Injection Injection OCTANINE F Injection Factor VIII ALPHANATE Injection treatment and prophylaxis of haemorrhage in haemophilia A OCTANATE Injection AHF CONCENTRATE KABI DRIED FACTOR VIII TYPE 8Y Injection Injection allergic reactions including chills.hereditary angioedema. fever.

IV and V in patients who have not responded adequately to diet and other appropriate measures. dizziness. hypoglycaemia. breastfeeding severe hepatic and renal impairment. insomnia. alopecia gastro-intestinal disturbances. photosensitivity to fibrates. IV and V in patients who have not responded adequately to diet and other appropriate measures gastro-intestinal disturbances. fatigue. dizziness. leucopenia. cholestasis. hypoalbuminaem ia. IV. headache. and V in patients who have not responded adequately to diet and other appropriate measures hyperlipidaemias of types IIa. hepatic impairment. III. and interstitial pneumopathies ‫ور ر‬ ‫ا ر‬ ‫ب‬ ‫ل‬ ‫ا‬ gastro-intestinal disturbances. and IV in patients who have not responded adequately to diet alcoholism. IIb. headache. photosensitivity to ketoprofen. eczema. insomnia. pregnancy . impotence. increased risk of bleeding. impotence.breast-feeding ‫ك‬ ‫روش‬ ‫دا و‬ ‫أ‬ Ciprofibrate MODALIM Tablet hyperlipidaemias of types IIa. hepatomegaly. less commonly atrial fibrillation. pregnancy . alopecia gall bladder disease. leucopenia. IIb. fatigue. less commonly. dizziness. vertigo. hypoglycaemia. alcoholism. increased risk of bleeding.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Fibrates Bezafibrate BEZALIP Tablet hyperlipidaemias of types IIa. rarely gallstones. nephrotic syndrome. rash. pancreatitis. paraesthesia. IIb. rarely pancreatitis. IIb. appendicitis. thrombocytopenia. primary biliary cirrhosis. headache. rash. fatigue. disturbances in liver function including hepatitis and cholestatic jaundice. primary prevention of cardiovascular disease in men with hyperlipidaemias that have not responded to diet see under Bezafibrate. hepatic impairment . anaemia. rarely gallstones. rash. gall bladder disease. biliary-tract disease including gallstones. breast-feeding ‫ود‬ ‫ا‬ ‫دة‬ ‫ت‬ ‫ا‬ ‫ا دوا‬ ‫ا رد‬ ‫دي‬ ‫رف‬ ‫ا‬ 28 . pregnancy . pruritus. photosensitivity to fibrates. severe hepatic impairment . III. pruritus. less commonly. cholestasis. hepatomegaly. breast-feeding ‫و‬ ‫و‬ ‫ز‬ ‫ا‬ Fenofibrate LIPANTHYL Capsule Gemfibrozil LOPID LOW-LIP Tablet Tablet hyperlipidaemias of types IIa. also very rarely hepatitis. biliary-tract disease including gallstones. pregnancy . III. thrombocytopenia. III. anaemia.

paraesthesia.‫رك. and gastrointestinal active liver disease (or persistently abnormal liver function tests). and gastrointestinal ‫و رز‬ ‫ا‬ ‫دوز‬ ‫د‬ ‫د‬ Pravastatin LIPOSTAT Tablet Reversible myositis .Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Statins Atorvastatin LIPITOR Tablet primary hypercholesterolaemia. pregnancy. breast-feeding ‫ر‬ ‫ا ط‬ ‫ا‬ 29 . rashes. adjunct to diet to prevent cardiovascular events in patients with hypercholesterolaemia. heterozygous familial hypercholesterolaemia. flushing. urticaria. in pregnancy (adequate contraception required during treatment and for 1 month afterwards) and breast-feeding ‫ود‬ ‫ا‬ ‫ا‬ Fluvastatin LESCOL Capsule LESCOL XL Tablet Reversible myositis . ش‬ ‫دوم‬ ‫ا و د‬ ---‫ا‬ ‫ا‬ Nicotinic acid group Acipimox OLBETAM Capsule hyperlipidaemias of types IIb and IV in patients who have not responded adequately to diet and other appropriate measures vasodilatation. itching. breast-feeding active liver disease (or persistently abnormal liver function tests). epigastric pain. Reversible myositis . dry peptic ulcer. heartburn. altered liverfunction tests (rarely. headache. hepatitis). in pregnancy (adequate contraception required during treatment and for 1 month afterwards) and breast-feeding active liver disease (or persistently abnormal liver function tests). in pregnancy (adequate contraception required during treatment and for 1 month afterwards) . hepatitis). altered liverfunction tests (rarely. altered liverfunction tests (rarely. headache. hepatitis). homozygous familial hypercholesterolaemia or combined (mixed) hyperlipidaemia in patients who have not responded adequately to diet and other appropriate measures adjunct to diet in primary hypercholesterolaemia or combined (mixed) hyperlipidaemia (types IIa and IIb). headache. malaise. nausea. paraesthesia. diarrhoea. and gastrointestinal ‫ا دوا‬ --- Simvastatin SIMVAST Tablet ‫ر‬ ‫ر‬ VASTA ZOCOR Tablet Tablet ‫وك‬ . adjunct to diet to slow progression of coronary atherosclerosis in primary hypercholesterolaemia and concomitant coronary heart disease adjunct to diet for primary hypercholesterolaemia or combined (mixed) hyperlipidaemias in patients who have not responded adequately to dietary control. erythema. headache. paraesthesia.

Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store eyes. rarely angioedema. anaphylaxis 30 . bronchospasm.

......................................................................... 34 Corticosteroids 34 Cromoglicate and related therapy and leukotriene receptor antagonists 35 Antihistamines 36 Non-sedating antihistamines ..................................................................................... 33 Theophylline ...............................Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Respiratory system Bronchodilators 32 Adrenoceptor agonists ........................................................................................................... 39 Mucolytics..... 32 Antimuscarinic bronchodilators ....................................... 36 Sedating antihistamines ....................................................................................................................................................... 37 Respiratory stimulant 38 Cough preparations 38 Antitussives .............................................................................................................. 39 Systemic nasal decongestants 40 31 ......................................................................................................................................................................................................... 38 Expectorants .............................................................................................................................. 33 Compound bronchodilator preparations ........................

Paradoxical bronchospasm. solution Injection Tablet Neb. ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا‬ _ ‫ري ا م‬ ‫ا رط‬ ‫ا ر‬ ‫ا‬ ‫ا دو‬ ‫ا رد‬ ‫ا رد‬ ‫ج‬ ‫ا دو‬ ‫ار ض‬ ‫ر‬ ‫ر‬ ‫ر‬ ‫و س‬ ‫. and palpitation.ا ا ط‬ ‫رر‬ ‫ا ر و ل‬ ‫اس . and disturbances of sleep and behaviour.‫ر‬ ‫د‬ ‫د‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ AIROMIR ASMADIL ASMANORE Syrup Tablet Syrup Syrup Tablet Inhaler ASTHALIN BUTALIN BUTOVENT DISBRON Syrup SALAMAT SALBULASE Syrup Tablet Syrup --‫ا‬ VENTOLIN VINTEC FARCOLIN Terbutaline BRICANYL Syrup Resp. headache. premature labour Fine tremor (particularly in the hands). nervous tension. urticaria. angioedema. arrhythmias. peripheral vasodilation. muscle cramps. hypotension. solution Spray Inhaler Syrup Tablet reversible airways obstruction asthma and other conditions associated with reversible airways obstruction. Solution Syrup Turbohaler Syrup ---‫ا‬ ‫و‬ asthma and other conditions associated with reversible airways obstruction. Tachycardia. solution Tablet Rotacap ‫ن‬ VENTOLIN Diskus ‫و‬ ‫ود‬ ‫و‬ ‫ث‬ ‫ا را‬ ‫و‬ ‫و م‬ ‫ا ر‬ ‫وك‬ ‫رو‬ ‫ا ر‬ ‫ا را‬ ‫ا ر‬ ‫ا‬ ‫ث‬ ‫ر‬ ‫ر‬ ---‫ا دوا‬ ‫رس‬ ‫د‬ ‫إ راھ م‬ ‫ا‬ .Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Bronchodilators Adrenoceptor agonists Short-acting beta2 agonists Fenoterol hydrobromide Salbutamol BEROTEC Resp.ا‬ ‫ا‬ ‫ا دوا‬ ‫ا ر‬ ‫ا و‬ ‫ا ود‬ ‫ت‬ SALBUVENT VENTOLIN Inhaler Tablet Injection ‫دا‬ ‫و‬ ‫ن‬ VENTOLIN Syrup Tablet Inhaler Resp. premature labour TALIN ‫ا رد‬ ‫ج‬ ‫د‬ 32 .

muscle cramps. Other side-effects include tachycardia. and disturbances of sleep and behaviour. headache. Other sideeffects include tachycardia. and disturbances of sleep and behaviour. ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا‬ Antimuscarinic bronchodilators Ipratropium bromide ATROVENT Inhaler Nasal spray Neb. Paradoxical bronchospasm. urticaria. rhinitis Dry mouth. arrhythmias. urticaria. peripheral vasodilation. solution Resp. ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا‬ ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا رط‬ ATROVENT ‫و‬ Theophylline Theophylline AVOLEN THEO-DUR Syrup Tablet Tablet reversible airways obstruction. and palpitation. muscle cramps. Fine tremor (particularly in the hands). nervous tension. and palpitation. headache. Avoid whenever possible. Less suitable and less safe for use as bronchodilators than the selective beta2 agonists. tachycardia. particularly in chronic obstructive pulmonary disease. palpitation. because it is more likely to cause arrhythmias and other sideeffects. constipation. Tachycardia and atrial fibrillation have also been reported. Paradoxical bronchospasm. nausea and ‫وك‬ ‫ر وردا‬ ---‫ا‬ 33 . ‫د‬ OXIS Salmeterol SEREVENT Turbohaler Inhaler ‫ا را‬ ‫و‬ ‫و‬ ‫و م‬ ‫ا ر‬ ‫و‬ ‫ا رط‬ SEREVENT Inhaler Other adrenoceptor agonists Orciprenaline ALUPENT Syrup Reversible airways obstruction. and headache. nervous tension. arrhythmias.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫ا دو‬ Drug Store Long-acting beta2 agonists Formoterol fumarate FORADIL Turbohaler reversible airways obstruction (including nocturnal asthma and prevention of exercise-induced bronchospasm) in patients requiring long-term regular bronchodilator therapy Fine tremor (particularly in the hands). peripheral vasodilation. nausea. solution reversible airways obstruction.

insomnia. CNS stimulation. nausea and other gastrointestinal disturbances. glyceryl guaiacolate BRONQUIUM Elixir reversible airways obstruction. CNS stimulation.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫ا ط‬ ‫ار ض‬ ‫ر‬ ‫ر‬ Drug Store ‫اط‬ ‫ا‬ ‫اط‬ THEOPED THEOPHAR Syrup Syrup acute severe asthma Theophylline . solution ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا ر‬ ‫و‬ Beclomethasone dipropionate BECLOFORTE Inhaler prophylaxis of asthma High doses induce adrenal ‫ر‬ ‫و‬ ---- 34 . also allergy to ethylenediamine can cause urticaria. palpitation.ا‬ ‫ا‬ ‫د‬ ‫ر‬ ‫ر‬ ‫ا‬ ‫ا‬ Compound bronchodilator preparations Salbutamol sulphate . headache. insomnia. ethylene diamine EUPHYLLIN Injection reversible airways obstruction. arrhythmias ‫ة‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫و ل‬ ‫رر‬ ‫ا ر‬ ‫اس . arrhythmias tachycardia. acute severe asthma Theophylline . arrhythmias. arrhythmias tachycardia. headache. palpitation. ipratropium bromide COMBIVENT Inhaler Neb. erythema tachycardia. nausea and other gastrointestinal disturbances. CNS stimulation. CNS stimulation. acute severe asthma other gastrointestinal disturbances. nausea and other gastrointestinal disturbances. palpitation. and convulsions especially if given rapidly by intravenous injection. headache. acute severe asthma Theophylline hydrate EUPHYLLINE RETARD Tablet reversible airways obstruction. headache. insomnia. insomnia.

malaise. suspension Diskus Evohaler Inhaler Neb. bone density may be reduced. myalgia. breast-feeding 35 . insomnia.ا‬ ‫ا ط‬ ‫ر‬ ‫ا‬ Budesonide PULMICORT Fluticasone propionate FLIXOTIDE FLIXOTIDE Inhaler Neb. bone density may be reduced. rarely bleeding disorders. coma and growth retardation. coma and growth retardation. oral candidiasis. hypersensitivity reactions including angioedema and skin reactions. oral candidiasis. arthralgia. sleep disturbances. food allergy. in children adrenal crisis. in children adrenal crisis. hepatic impairment. glaucoma. allergic rhinitis coughing. anxiety. and throat irritation due to inhalation of powder ‫ا دوا‬ ‫ا ون‬ ‫وزى‬ ‫ا‬ ‫أ س‬ ‫) زو ز‬ ( ‫ز‬ ‫ا‬ ‫أ س‬ ‫) زو ز‬ ( ‫ز‬ ‫ا‬ ‫ز‬ --‫ا‬ ‫ر‬ INTAL RYNACROM Inhaler Neb. transient bronchospasm. depression. ‫و‬ ‫ا رط‬ ‫و‬ ‫و م‬ ‫ا ر‬ ‫و‬ ‫ا رط‬ ‫و‬ ‫ن‬ ‫ث‬ ‫ا را‬ ‫و‬ FLIXOTIDE FLIXOTIDE Corticosteroids Cromoglicate and related therapy and leukotriene receptor antagonists Sodium cromoglycate CROMONAL CUSICROM Nasal drops Nasal spray prophylaxis of asthma. Solution Turbohaler Nasal drops Nasal spray Tablet prophylaxis of asthma ‫ر‬ ‫ا‬ Zafirlukast ACCOLATE gastro-intestinal disturbances. hepatitis. hyperbilirubinaemia.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫ا ر‬ ‫ا‬ Drug Store BECODISKS BECOTIDE Diskus Inhaler CLENIL FORTE Inhaler VIAREX Inhaler suppression. glaucoma. Solution ‫ا را‬ prophylaxis of asthma High doses induce adrenal suppression. headache. and behavioural changes including hyperactivity and irritability ‫ود‬ ‫و‬ ‫ا رط‬ ‫ر‬ ‫و‬ ‫ود‬ ‫و س‬ ‫و‬ ‫ا ر‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ر‬ ---- ‫ر‬ ‫.

Scientific Name

Trade Name

Dosage Form

Indications

Side Effects

Contra-indications

Manufact urer

Drug Store

thrombocytopenia; very rarely ChurgStrauss syndrome

Antihistamines
Non-sedating antihistamines
Cetirizine dihydrochloride ARTIZ CETRALON CETRO FINALLERG Tablet Syrup Tablet Syrup Tablet Tablet symptomatic relief of allergy such as hay fever, urticaria Drowsiness ; paradoxical stimulation with high doses or in children and the elderly; headache, psychomotor impairment, and antimuscarinic effects such as urinary retention, dry mouth, blurred vision, and gastrointestinal disturbances; hypotension, pregnancy; and breast-feeding ‫وك‬ ‫ر‬ ‫ا دوا‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ت‬ ‫ا دوا‬ ‫ا ر‬ ‫ا‬ . ‫ا دو‬ ‫ا رد‬ .‫و‬ ‫ا‬ ‫ر‬ ‫ا د‬ ‫ا دوا‬ ‫ا دوا‬ ‫وك‬ ‫رو ل‬ ‫ا ف‬ ‫ا ر‬ ‫وم‬ ‫دو‬ ‫ا دوا‬ ‫ر‬ ‫ا ر‬ ‫ا و‬ ‫ا ود‬ ‫ت‬ ‫ا دوا‬ ‫ا ز رة‬ ‫ا دوا‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ت‬ ‫ا دوا‬ ‫ر‬ ‫د‬ ----. ‫ر‬ ----

--‫ر‬ ‫د‬

NOHIST

Tablet

ZYRTEC

Solution Tablet Tablet Tablet Tablet Tablet Tablet symptomatic relief of allergy such as hay fever, urticaria Seasonal allergic rhinitis ; chronic allergic urticaria symptomatic relief of allergy such as hay fever, urticaria

Desloratadine

AERIUS AERIUS NEORIN

hypersensitivity to Loratadine; pregnancy and breast-feeding breast-feeding

‫و‬

‫ر‬ -------‫ر‬

Fexofenadine hydrochloride

FEXODINE TELFAST

Loratadine

CLARA

Syrup

CLARITINE LOJOUR LORADAY

Syrup Tablet Syrup Syrup Tablet

LORAMAX LORINE TIDILOR

Syrup Tablet Syrup Tablet Syrup Tablet

Drowsiness ; paradoxical stimulation with high doses or in children and the elderly; headache, psychomotor impairment, and antimuscarinic effects such as urinary retention, dry mouth, blurred vision, and gastrointestinal disturbances; hypotension,

pregnancy; and breast-feeding

---

---

‫ا‬

36

Scientific Name

Trade Name

Dosage Form

Indications

Side Effects

Contra-indications

Manufact urer

Drug Store

Sedating antihistamines
Chlorpheniramine ALLERFIN Syrup symptomatic relief of allergy such as hay fever, urticaria; emergency treatment of anaphylactic reactions Drowsiness ; paradoxical stimulation with high doses or in children and the elderly; headache, psychomotor impairment, and antimuscarinic effects such as urinary retention, dry mouth, blurred vision, and gastro-intestinal disturbances; hypotension, Drowsiness ; paradoxical stimulation with high doses or in children and the elderly; headache, psychomotor impairment, and antimuscarinic effects such as urinary retention, dry mouth, blurred vision, and gastro-intestinal disturbances; hypotension, ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ا ھرة‬ ‫ا ر‬ ‫ر‬ ‫ا دوا‬ ‫ا ر‬ ‫ا و‬ ‫ا ود‬ ‫ت‬ ‫ا دوا‬ ‫س‬ ‫و‬ ‫ا‬ ‫ا‬

ANALLERGE CHLOROHIST OL HISTOP LERGICOL

Tablet Tablet Tablet Tablet

‫ا ؤ‬ ‫ا ر‬

--‫ا‬

PIRAFENE

Tablet

Chlorpheniramine maleate

ALLERFIN

Injection

CHLOROHIST OL CHLORPHENI RAMINE GRIPINE HISTOP LERGICOL

Syrup Syrup Syrup Syrup Syrup

symptomatic relief of allergy such as hay fever, urticaria; emergency treatment of anaphylactic reactions

‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ر‬ ‫ار ض‬ ‫ر‬ ‫وك‬ ‫ا دوا‬ ‫ا ر‬ ‫ا و‬ ‫ا ود‬ ‫ت‬ ‫ا دوا‬ ‫س‬ ‫و‬ ‫و‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ا رد‬ ‫رك‬ ‫رب ودوم‬ ‫ا را‬ . .‫و‬ ‫ا‬ ‫ر‬ ‫ار ض‬ ‫ر‬ ‫وك‬ ‫ا رام‬ ‫ا رد‬ ‫ج‬ ‫ا دو‬ ‫ا‬ ‫ا رد‬ ‫ا دوا‬ ‫ة‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ر‬ ‫ة‬

‫ا‬

‫ا‬ ‫اط‬ -----‫ا‬

PIRAFENE POLARAMIN Cyproheptadine HCl CIPTADINE PERIACTIN

Syrup Syrup Tablet Syrup Tablet Syrup Tablet Syrup Tablet Syrup Syrup Tablet Syrup Syrup Tablet Syrup Syrup symptomatic relief of allergy such as hay fever, urticaria; migraine pruritus, anxiety (short-term) allergic conjunctivitis and allergic rhinitis

‫ا‬

Hydroxyzine HCl Ketotifen

ATARAX ASMAFORT HESTOFEN KETOFEN KETONIL TEFANYL

TOTINAL ZADITEN

Drowsiness ; paradoxical stimulation with high doses or in children and the elderly; headache, psychomotor impairment, and antimuscarinic effects such as urinary retention, dry mouth, blurred vision, and gastro-intestinal disturbances;

pregnancy; and breast-feeding pregnancy; and breast-feeding

‫ا‬ ‫اط‬ ---‫زو‬ ‫د‬ ‫ا‬ ---

37

Scientific Name

Trade Name

Dosage Form

Indications

Side Effects

Contra-indications

Manufact urer

Drug Store

hypotension, Promethazine HCl HISTAZIN Tablet symptomatic relief of allergy such as hay fever, urticaria; premedication; emergency treatment of anaphylactic reactions; sedation; motion sickness Drowsiness ; paradoxical stimulation with high doses or in children and the elderly; headache, psychomotor impairment, and antimuscarinic effects such as urinary retention, dry mouth, blurred vision, and gastro-intestinal disturbances; hypotension, ‫دة‬ ‫ت‬ ‫ا‬ ‫دي‬ ‫رف‬ ‫ا ؤ‬ ‫ا‬ ‫دو‬ ‫ا‬

PROMANTINE

Syrup

‫ا دوا‬ ‫ا رد‬ ‫ر‬ ‫را‬ ‫ت اط‬ ‫ا ر‬ ‫ا و‬ ‫ا ود‬ ‫ت‬ ‫ا دوا‬ ‫دة‬

PROMETIN

Syrup

Respiratory stimulant
Doxapram HCl DOPRAM Injection Postoperative respiratory depression; Acute respiratory failure Drug-induced respiratory depression, druginduced postanesthesia, acute respiratory insufficiency 0.5 – 1 mg/kg perineal warmth, dizziness, sweating, moderate increase in blood pressure and heart rate; side-effects reported in postoperative period (causal effect not established) include muscle fasciculation, hyperactivity, confusion, hallucinations, cough, dyspnoea severe hypertension, status asthmaticus, coronary artery disease, thyrotoxicosis, epilepsy, physical obstruction of respiratory tract ‫رو ز‬ ‫ا ر‬ ‫ا‬ ‫اط‬

Cough preparations
Antitussives
Codeine , phenyltoloxamine Carbetapentane Dextromethorphan CODIPRONT TOCLASE CONTRASAL DEXOFAN DEXTROKUF KAFOSED TUSSILAR Dextromethorphan HBr , chlorpheniram NOKOF Syrup Tablet Syrup Syrup Syrup Syrup Tablet Syrup ‫وم‬ ‫ا دوا‬ ‫ا ھرة‬ ‫ا ر‬ --‫ا ؤ‬ ‫ا ر‬ ----

‫كا‬ . .‫و‬ ‫ا‬
‫ا‬ ‫ا رد‬ ‫وك‬

‫ر‬ ‫ر‬ ‫ا‬ ---

38

Scientific Name
maleat , ammonium Cl , sodium citrate

Trade Name

Dosage Form

Indications

Side Effects

Contra-indications

Manufact urer

Drug Store

Expectorants
Menthol , eucalyptus Guaifenesin KARVOL GUPHAN PECTAL RESYL Capsule Syrup Syrup Syrup ‫وس‬ ‫ز‬ ‫ا‬

ROBITUSSIN Guaifenesin , dextromethorphan CHERACHOL D

Syrup Syrup

GUAPHAN DM ROBITUSSIN DM VICKS 44 E

Syrup Syrup Syrup

‫ار ض‬ ‫ر‬ ‫ا ز رة‬ ‫و ر ز‬ ( ‫)ز‬ ‫ا و ر‬ ‫رو ز‬ ‫ا ر‬ ‫ر‬ ‫أ ون‬ (‫)ا ون‬ ‫ا ر‬ ‫ار ض‬ ‫ر‬ ‫رو ز‬ ‫ا ر‬ ‫رو ر ا د‬ ‫ل‬ ‫ا ر‬

‫ب‬ ‫ل‬ ‫ة‬

‫ا‬ ‫ا‬ ‫اط‬

--‫د‬ ‫ا‬ ‫اط‬ ‫ر‬

‫ة‬

‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬

Mucolytics
Ambroxol AMBOLAR AMBROSIA MUCOSOLVAN Syrup Syrup Syrup Tablet Syrup Tablet Sachet reduction of sputum viscosity rarely gastrointestinal bleeding, rashes active peptic ulceration

‫دار ا دواء‬ ‫وم‬ ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا‬ ‫ار ض‬ ‫ر‬ ‫ر ول‬ ‫رز‬ ‫ا ط‬ ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا‬ ‫ا ر‬ ‫ا و‬ ‫ا ود‬ ‫ت‬ ‫ا دوا‬ ‫ر‬ ‫رر‬ ‫ا ر و ل‬ ‫اس .ا‬ ‫ا‬ ‫ار ض‬

‫ا‬ ‫اط‬ ---

RIABROXOL Acetylcyctine MUCOMYST

‫ة‬

‫ا‬ ‫اط‬
‫ا‬

reduction of sputum viscosity reduction of sputum viscosity

rarely gastrointestinal bleeding, rashes rarely gastrointestinal bleeding, rashes

active peptic ulceration active peptic ulceration

Bromhexine

BISOLVON

Elixir Tablet Solution Syrup Tablet

EZOLIN

‫ا‬

MUCOLYTE PULMOTROPIC

Syrup Drops Elixir

‫ر‬ ‫د‬ ‫ة‬ ‫ا‬

RIAXINE

Syrup

39

Scientific Name

Trade Name

Dosage Form

Indications

Side Effects

Contra-indications

Manufact urer ‫ر‬ ‫ا ز رة‬
‫ك‬ ‫و‬ ‫ا و‬ ‫كا‬

Drug Store ‫اط‬ --.‫ر‬ ‫د‬ ‫ر‬ ‫زو‬

SOLVEX Carbocysteine BRONCHOBOS MUCOPRONT RHINATHIOL

Syrup Capsule Capsule Syrup Capsule Syrup

‫و‬ ‫و‬ ‫]رو ن‬ [‫د س‬ ‫ا ر‬

Systemic nasal decongestants
Pseudoephedrine Brompheniramine , pseudoephedrine OTRINOL DIMETAPP ELIXIR ALCOHOL FREE Capsule Elixir Nasal decongestants Nasal decongestants ‫و رز‬ ‫ا‬ ‫رو ز‬ ‫ا ر‬ ‫ا‬ ‫اط‬ ‫د‬

Carbenoxamine maleate , pseudoephedrine HCl Dexbrompheniramine maleate , pseudoephedrine Triprolidine , pseudoephedrine , guaifensin

RHINOSTOP

Oral drops

Nasal decongestants

‫ن اط‬

‫ا‬

‫ا‬ ‫اط‬
‫ر‬

DISOPHROL S/A RINOFED EXPECTORANT UNIFED EXPECTORANT

Tablet

Nasal decongestants Nasal decongestants tachycardia, anxiety, restlessness, insomnia; rarely hallucinations, rash; very rarely angleclosure glaucoma; urinary retention also reported

‫و‬

‫ر‬ ‫ا ر‬ ‫ا ز رة‬

Syrup

---

syrup

‫دة‬ ‫ت‬

‫ا‬ ‫ا دوا‬ ‫ا رد‬ ‫ر‬

‫دي‬ ‫رف‬

ACTIFED EXPECTORANT

Syrup

----

‫و‬ ‫ا ر‬ ‫ا ود‬ ‫رو ز‬ ‫ا ر‬ ‫ار ض ر‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬

Guaifenesin , dextromethorphan , pseudoephedrine Guaifenesin , pseudoephedrine

ROBITUSSIN CF GUAFEDRIN

Syrup

Nasal decongestants Nasal decongestants tachycardia, anxiety, restlessness, insomnia; rarely hallucinations, rash; very rarely angleclosure glaucoma; urinary retention also reported

Syrup

ROBITUSSINPE BRONEX

Syrup

‫رو ز‬ ‫ا ر‬ ‫ا ن اط‬

Oral drops

Triprolidine , pseudoephedrine , paracetamol Triprolidine , pseudoephedrine

RINOFED PLUS

Syrup Tablet Syrup Tablet Syrup

Nasal decongestants

‫ا ز رة‬ ‫و‬ ‫و ما‬ ‫ا دوا‬

---

ACTIFED COLDACT

---

40

Scientific Name

Trade Name

Dosage Form
Syrup

Indications

Side Effects

Contra-indications

Manufact urer
‫ا ر‬ ‫ا دو‬ ‫ا رد‬

Drug Store
‫ا‬

COLFED

DUOFEDINE

Syrup

‫ا ر‬ ‫ا و‬ ‫ا ود‬ ‫ت‬ ‫ا دوا‬ ‫ار ض‬ ‫ر‬ ‫وك‬
‫ا ز رة‬ ‫ا‬ ‫ا رد‬ ‫ا دة‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬

‫ا‬

FLU_CARE

Syrup Syrup Tablet Syrup Tablet Syrup Tablet Syrup

‫ة‬

HISTAFED
RINOFED TRIFED UNIFED

‫ا‬ ‫اط‬ -----‫ا‬

‫دي‬ ‫رف‬

Codeine , pseudroephedrine , triprolidine Cetirizine dihydrochloride , pseudoephedrine HCl Chlorpheniramine maleate , pseudoephedrine

ACTIFED COMPOUND CIRRUS

Linctus

‫و‬ ‫و م‬ ‫ا‬
. .‫و‬ ‫ا‬ ‫ر‬

Capsule

ALLERGETIN

Syrup

‫ا ر‬ ‫ا و‬ ‫ا ود‬ ‫ت‬ ‫ا دوا‬ ‫ار ض‬ ‫ر‬ ‫ار ض‬ ‫ر‬ ‫ة‬

‫ا‬

FLUMED Chlorpheniramine maleate , pseudoephedrine HCl , dextromethorphan HBr Loratadine , pseudoephedrine sulphate Paracetamol , chlorpheniramine , pseudoephedrine

Syrup Syrup

FLUMED DM

‫ا‬ ‫اط‬ ‫ا ة‬ ‫اط‬

CLARINASE LORINASE ADOL ALLERGY SINUS PANADOL COLD & FLU ADOL COLD VICKS DAY QUIL ALCOHOL FREE UNIFED DM

Tablet Syrup Tablet Tablet Caplet

‫و‬

‫ر‬ ‫ا‬ ‫ا دوا‬ ‫ر‬ ‫و‬ ‫و‬

‫ر‬ ---

‫ن‬ Caplet Syrup

Paracetamol , pseudoephedrine , dextromethorphan

‫ث‬ ‫ا را‬ ‫ر‬

Syrup

Paracetamol , pseudoephedrine

ADOL SINUS

SINOFREE
PANADOL SINUS

Tablet Tablet Tablet

‫رو ر ا د‬ ‫ل‬ ‫ا ر‬ ‫ا دة‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ ‫ر‬ ‫ا دوا‬ ‫و‬ ‫ن‬ ‫ث‬

‫دي‬ ‫رف‬

--‫و‬

41

ephedrine FLUTAB Tablet --‫ا‬ FLUDREX Syrup Tablet ‫ت‬ ‫ا ر‬ ‫ا و‬ ‫ا ود‬ ‫ا دوا‬ ‫ا دوا‬ ‫وا ث ا د‬ ‫وك‬ ‫رك د ز‬ ‫ز‬ ‫ا‬ SAPOFEN PLUS ADVIL COLD AND SINUS MENTEX BENAFED Tablet Tablet Syrup Syrup --‫ا‬ ‫اط‬ ---‫ا‬ ‫ة‬ ‫د‬ ‫ا‬ ‫اط‬ RHINOFRIN VIBROCIL Nasal drops Nasal drops Nasal gel Capsule RHINO-PRONT ‫ار ض‬ ‫ر‬ ‫و ر ز‬ ( ‫)ز‬ ‫ا و ر‬ ‫ك‬ ‫ا‬ ‫ر‬ ‫ر‬ Soolan Syrup RHINOTUSSAL Capsule ‫ك‬ ‫ا‬ ‫دو‬ ‫ا ل‬ ‫ر‬ ‫رات‬ ‫اط‬ ‫دة‬ ‫ر‬ ‫ر‬ CODILAR Syrup ‫ا‬ ‫ا ؤ‬ ‫ا‬ ‫دو‬ TUSSIVAN Syrup CODAPHED Syrup 42 . chlorpheniramine Codeine . carbinoxamine Dextromethorphan . dextromethorphan . phenylephrine . chlorpheniramine. chlorpheniramine . phenylephrine Phenylephrine HCl . pseudoephedrine . pnylephrine Dextromethorphan . carbinoxamine maleate Glyceryl guaiacolate . ammonium chloride . phenylephrine . caffeine Ibuprofen . chlorpheniramine . sodium citrate Phenylephrine HCl Dimethindene maleate . pseudoephedrine Diphenhydramine . pseudoephedrine . pseudoephedrine . diphenhydramine Paracetamol .Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫را‬ ‫ا‬ ‫ا دوا‬ Drug Store Paracetamol .

.............. 51 Other antidepressant drugs ........................................................................... 61 Drugs used in status epilepticus ... 65 Drugs used in parkinsonism and related disorders 66 Drugs for dementia 69 43 ............................................................................................................................................ 55 Hyoscine ...................................... 60 Analgesics ................................... 45 Antipsychotics.................................................................................... 45 Antimanic drugs ............................................................................................................................................................... 52 CNS stimulants and drugs used for attention deficit hyperactivity disorder 53 Drugs used in the treatment of obesity 53 Drugs used in nausea and vertigo 54 Antihistamines ........................................................................................................................................................................... 60 Ergot alkaloids ...................... 56 Analgesics 56 Non-opioid analgesics ............................ 48 Monoamine-oxidase inhibitors ..................... 44 Drugs used in psychoses and related disorders .................................................. 56 Opioid analgesics ................................................................................................. 48 Antidepressant drugs 48 Tricyclic and related antidepressant drugs ...................................................................................................................................................................................................................................................................................................... 44 Other anxiolytics ........... 54 Domperidone and Metoclopromide ........................................Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Eine Central nervous system Hypnotics and anxiolytics 44 Benzodiazepins ................................................................................................................................................ 60 5HT1 agonists ................................................................................................................................................. 59 Antimigraine drugs .............................................................................................................................................. 54 5HT3-antagonists ............................................................ 61 Antiepileptics 61 Control of epilepsy..................... 50 Selective serotonin re-uptake inhibitors.............................................................................................................................. 56 Other drugs for Ménière's disease ...........

headache. severe hepatic impairment. febrile convulsions. salivation changes respiratory depression. pregnancy and breast-feeding --‫ا دوا‬ 44 . chest pain. ‫ر‬ ‫أ ون‬ ‫)ا ون‬ ( ‫ا‬ ‫روش‬ ‫ا و ر‬ ‫ر‬ ‫ر‬ ‫ا ر‬ ‫اد ر‬ ‫ا ل دو‬ ‫روش‬ ‫ا و ر‬ ‫ر‬ Bromazepam Diazepam LEXOTANIL DIAZEPAM STESOLID VALINIL VALIUM Tablet Tablet Syrup Tablet Tablet Syrup Tablet short-term use in anxiety or insomnia. and sweating epilepsy. moderate to severe renal impairment. drowsiness. not for use alone to treat depression (or anxiety associated with depression) . dependence. severe hepatic impairment. confusion. lightheadedness. confusion and ataxia (especially in the elderly).Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Hypnotics and anxiolytics Benzodiazepins Alprazolam XANAX Tablet drowsiness and lightheadedness the next day. muscle weakness. 5 – 10 mg initially. muscle spasm. fatigue. amnesia. paradoxical increase in aggression . palpitations. adjunct in acute alcohol withdrawal. dry mouth. rarely tachycardia. seizures. nervousness. may repeat at 5 – 10 min intervals at maximum dose of 30 mg IV insomnia (shortterm use) insomnia (shortterm use) ‫ا‬ ‫ا‬ ‫ؤ‬ ‫ا‬ Lorazepam ATIVAN Tablet ‫وا ـث‬ ‫ا‬ ‫ا ر‬ ‫اد ر‬ ‫روش‬ ‫ا و ر‬ Nitrazepam DUMOLID MOGADON Tablet Tablet ‫زن‬ ‫ا دو‬ ‫ا ر‬ ‫ا‬ Other anxiolytics Buspirone HCL BUSPAR Tablet anxiety (shortterm use) nausea. vertigo. marked neuromuscular respiratory weakness including unstable myasthenia gravis. status epilepticus. dizziness. hypotension. not for chronic psychosis. occasionally: headache. acute pulmonary insufficiency. excitement. sleep apnoea syndrome. peri-operative use 2 – 10 mg/d PO 2 – 4 times/d status epilepticus/ severe recurrent seizures.

CNS depression. fatigue. conventional antipsychotic drugs extrapyramidal symptoms. excitable and overactive patients Comatose states. unless essential. drowsiness. eosinophilia. short-term adjunctive less sedating and fewer antimuscarinic or hypotensive Comatose states. and phaeochromocytom a. particularly with apathy and withdrawal but not mania or psychomotor hyperactivity. psychomotor agitation. history of neutropenia or agranulocytosis. impaired temperature regulation. tachycardia. anorexia. urinary incontinence and retention.‫ھـ‬ ‫ود ك‬ ‫اد ر‬ ‫و‬ ‫و‬ ‫ر ول‬ ‫رز‬ -‫وب‬ ‫اط‬ ‫أ ن‬ ‫ا ر د‬ ‫ة‬ ‫ؤ‬ ‫ا‬ ‫ا‬ ‫اط‬ -‫ن‬ ‫ج‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ 45 . vomiting. depression extrapyramidal symptoms frequent Haloperidol HALDOL Drops Injection Tablet schizophrenia and other psychoses. headache.‫ھـ‬ ‫ود ك‬ ‫اد ر‬ . advisable to discontinue breast-feeding during treatment. Antimuscarinic side-effects Comatose states. severe renal impairment. Photosensitizati on. CNS depression.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Drugs used in psychoses and related disorders Antipsychotics Chlorpromazine HCl LARGACTIL Drops Injection Tablet schizophrenia and other psychoses. seizures. schizophrenia (including psychosis in Parkinson's disease) in patients unresponsive to. Endocrine changes. avoid during pregnancy. nausea. short-term adjunctive management of severe anxiety. and phaeochromocytom a. dry mouth. excitement. paralytic ileus ‫و ر ز‬ ‫ا رط‬ ‫د‬ Fluphenazine decanoate ANATENSOL DECANOATE Injection FLUPHENAZI NE DECANOATE Injection schizophrenia and other psychoses. also excitable and overactive patients Comatose states. advisable to discontinue breast-feeding during treatment ‫ك‬ ‫رون‬ ‫رورر‬ ) ( ‫ا ر‬ ‫ر‬ Clozapin LEPONEX Tablet Flupenthixol (Flupentixol) FLUANXOL DEPOT Injection FLUANXOL Tablet schizophrenia and other psychoses. and violent or dangerously impulsive behaviour . unless essential. advisable to discontinue breast-feeding during treatment. or intolerant of. CNS depression. hypersalivation. hypertension. tremor. depression constipation. avoid during pregnancy. bone-marrow disorders. particularly with apathy and withdrawal but not mania or psychomotor hyperactivity. unless essential. less sedating but extrapyramidal symptoms frequent severe cardiac disorders. and phaeochromocytom a. mania. leucopenia. CNS depression. ECG changes. mania. avoid during pregnancy. and phaeochromocytom .

avoid during pregnancy. drowsiness. mania. excitement. mania. more frequent. Nausea and vomiting Olanzapine ZYPREXA Tablet Schizophrenia. history of arrhythmias or congenital QT prolongation Comatose states. akathisia. advisable to discontinue breast-feeding during treatment. increased appetite less sedating. and violent or dangerously impulsive behaviour. CNS depression. transient antimuscarinic effects (very rarely precipitation of angle-closure glaucoma). avoid during pregnancy. severe psychomotor agitation. serious arrhythmias reported. extrapyramidal symptoms. Short-term sedating. Intractable hiccup. also mild. and phaeochromocytom a. especially dystonia. rarely weight loss. recent heart surgery ‫ا‬ ‫ا رط‬ ‫و‬ Comatose states. abnormal gait. pigmentation and photosensitivity reactions rare. hyponatraemia reported -‫ن‬ ‫ج‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ Prochlorperazin e maleate STEMETIL Injection Suppository Tablet schizophrenia and other psychoses. Agitation and restlessness in the elderly. ‫أ س ر‬ ‫ا رط‬ ‫و‬ 46 . for injection. avoid during pregnancy. also agitation and restlessness in the elderly Comatose states. extrapyramidal symptoms. CNS depression. combination therapy for mania. rarely systemic lupus erythematosus a. hypoglycaemia. asthenia. unless essential. glycosuria and. advisable to discontinue breast-feeding during treatment ‫ر‬ breast-feeding. speech difficulty. short-term adjunctive management of anxiety. exacerbation of Parkinson's disease. particularly at high dosage.Monosymptomatic hypochondriacal psychosis. unstable angina. hallucinations. and ‫ر‬ ‫و‬ ‫ا‬ ‫ر‬ less sedating. and phaeochromocytom a. excitement.Scientific Name Trade Name Dosage Form Injection Indications Side Effects Contra-indications Manufact urer -‫ن‬ ‫ج‬ ‫ا‬ ‫ن‬ ‫ا را‬ ‫و وو‬ ‫ا‬ ‫. antiemetic Schizophrenia . extrapyramidal symptoms. sick sinus syndrome. unless essential. severe hypotension or bradycardia. rarely. دى‬ ‫رل‬ ‫ز‬ ‫ا‬ ‫ا ر‬ ‫اد ر‬ Drug Store ‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ر‬ ‫ا‬ HALDOL DECANOAS HALOPERIDO L KESELAN SERENACE Injection Tablet Tablet SYLADOR Injection Tablet management of psychomotor agitation. and violent or dangerously impulsive behaviour. Monotherapy for mania. paranoid psychosis symptoms. particularly dystonic reactions and akathisia especially in thyrotoxic patients. Control of agitation and disturbed behaviour in schizophrenia or mania Perphenazine TRILAFON Tablet Pimozide ORAP Tablet Schizophrenia and other psychoses. CNS depression. acute myocardial infarction. preventing recurrence in bipolar disorder. advisable to discontinue breast-feeding during treatment. unless essential.

nausea and vomiting. avoid during pregnancy. anxiety. mania Risperidone RISPERDAL CONSTA Injection acute and chronic psychoses. thrombocytopeni a. dyspepsia. mania Risperidone RISPERDAL Solution Tablet acute and chronic psychoses. Shortterm adjunctive management of severe anxiety. gynaecomastia also insomnia. excitement. short-term adjunctive management of psychomotor agitation. hyperprolactinae mia (with galactorrhoea. blurred vision.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store adjunctive management of severe anxiety. fatigue. impaired concentration. more frequent. blurred vision. menstrual disturbances. hyperprolactinae mia (with galactorrhoea. gynaecomastia extrapyramidal symptoms more frequent. fatigue. advisable to discontinue breast-feeding during treatment. respiratory depression may occur in susceptible patients also insomnia. agitation. hyperpyrexia. advisable to discontinue breast-feeding during treatment ‫ث‬ ‫ن‬ . anorexia phaeochromocytom a. children breast-feeding -‫ن‬ ‫ج‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ breast-feeding -‫ن‬ ‫ج‬ ‫ا و ر‬ ‫) جإ ر‬ ‫و ل‬ ( ‫ا و ر‬ ‫ة‬ ‫ا‬ ‫اط‬ Comatose states. constipation. Anti-emetic particularly dystonias. abdominal pain. especially at doses exceeding 6 mg daily. nausea and vomiting. dyspepsia. headache. and phaeochromocytom a. agitation. abdominal pain. avoid during pregnancy. CNS depression. unless essential. unless essential. less commonly drowsiness. anxiety. mania Trifluoperazine STELAZINE SPANSULES Capsule Syrup Tablet Schizophrenia and other psychoses. headache.‫م‬ ‫ال‬ ‫رو‬ ‫ز‬ ‫ا‬ ‫و‬ 47 . pancytopenia. constipation. psychoses. menstrual disturbances. and violent or dangerously impulsive behaviour. less commonly drowsiness. impaired concentration.

Scientific Name Zuclopenthixol Trade Name Dosage Form Drops Tablet Injection Indications Side Effects Contra-indications Manufact urer . difficulty with micturition.‫ھـ‬ ‫ود ك‬ ‫اد ر‬ . Antimuscarinic side-effects Injection Comatose states. tremor.‫ھـ‬ ‫ود ك‬ ‫اد ر‬ . and phaeochromocytom a. sedation. severe liver disease ‫رب‬ ‫را‬ ‫رك‬ ‫ودوم ا‬ ‫ا‬ Amitriptyline HCl SAROTEN RETARD TRYPTIZOL Capsule ‫ھـ. bipolar disorder. Photosensitizati on. blurred vision (disturbance of accommodation. avoid during pregnancy. renal impairment (particularly impaired urinary concentration and polyuria). leucocytosis. mania. fine tremor. migraine prophylaxis dry mouth. و د ك‬ ‫اد ر‬ ‫رب‬ ‫را‬ ‫رك‬ ‫ودوم ا‬ ‫و‬ ‫ا‬ Tablet 48 . aggressive or selfmutilating behaviour gastro-intestinal disturbances. cardiovascular side-effects . advisable to discontinue breast-feeding during treatment Antimanic drugs Lithium carbonate CAMCOLIT Tablet treatment and prophylaxis of mania. behavioural disturbances recent myocardial infarction. hyperparathyroidis m and hypercalcaemia reported ‫ور ن‬ ‫ز‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ Lithium citrate LITAREX Tablet ‫ا ر‬ ‫اد ر‬ ‫ا‬ Lithium sulphate LITHIOFOR Tablet ‫ور‬ ‫إ ر و ل‬ ‫ا و ر‬ ‫زو‬ Valporate sodium CONVULEX Syrup Capsule treatment of manic episodes associated with bipolar disorder ‫روت‬ ‫و‬ ‫ا‬ ‫دي‬ ‫رف‬ Antidepressant drugs Tricyclic and related antidepressant drugs Amitriptyline embonate TRYPTIZOL Syrup depressive illness. also weight gain and oedema (may respond to dose reduction). not indicated in manic phase. Endocrine changes. nausea. neuropathic pain. or exacerbations of chronic psychosis Injection extrapyramidal symptoms. polydipsia. nocturnal enuresis in children.‫ھـ‬ ‫ود ك‬ ‫اد ر‬ Drug Store ‫و‬ ‫و‬ ‫و‬ ‫و‬ CLOPIXOL Zuclopenthixol acetate Zuclopenthixol decanoate Zuclopenthixol dihydrochloride CLOPIXOLACUPHASE CLOPIXOL DEPOT CLOPIXOL short-term management of acute psychosis. constipation. sweating. and recurrent depression .‫ھـ‬ ‫ود ك‬ ‫اد ر‬ . increased intraocular pressure). unless essential. rashes and hypersensitivity reactions . CNS depression. arrhythmias (particularly heart block).

constipation. adjunctive treatment of cataplexy associated with narcolepsy Imipramine IMIPREX Tablet depressive illness. tremor. behavioural disturbances dry mouth. rashes and hypersensitivity reactions . particularly where sedation is required. ‫ل‬ ‫و‬ ‫. not indicated in manic phase. sedation. arrhythmias (particularly heart block). behavioural disturbances dry mouth. rashes and hypersensitivity reactions . arrhythmias (particularly heart block). constipation. nausea. nausea. و د ك‬ ‫اد ر‬ ‫و‬ recent myocardial infarction. sweating. anxiety dry mouth. blurred vision (disturbance of accommodation. arrhythmias (particularly heart block).ف. blurred vision (disturbance of accommodation. arrhythmias (particularly heart block). not indicated in manic phase. sedation. sweating. increased intraocular pressure). cardiovascular side-effects . blurred vision (disturbance of accommodation. behavioural disturbances dry mouth. increased intra- recent myocardial infarction. phobic and obsessional states. cardiovascular side-effects . not indicated in manic phase. not indicated in manic phase. difficulty with micturition. difficulty with micturition.ا‬ ‫ر‬ 49 . increased intraocular pressure). blurred vision (disturbance of accommodation. sedation. neuropathic pain NORTRILEN Tablet Trazodone HCl TRAZOLAN Tablet depressive illness. nausea. tremor. constipation. rashes and hypersensitivity reactions . difficulty with micturition. sweating. cardiovascular side-effects . severe liver disease ‫ا ر‬ ‫اد ر‬ ‫ا‬ ‫د‬ recent myocardial infarction. nocturnal enuresis in children. increased intraocular pressure).Scientific Name Clomipramine HCl Trade Name Dosage Form Tablet Indications Side Effects Contra-indications Manufact urer Drug Store ‫د‬ ANAFRANIL depressive illness. severe liver disease ‫ا‬ ‫ا رط‬ ‫و‬ ‫ھـ. nocturnal enuresis in children TOFRANIL Tablet Nortriptyline AVENTYL Capsule depressive illness. severe liver disease recent myocardial infarction. sedation. tremor.

sweating. nausea. tremor. severe liver disease ‫أ س ر‬ ‫ا رط‬ ‫و‬ Monoamine-oxidase inhibitors Tranylcypromine sulphate PARNATE Tablet depressive illness commonly postural hypotension (especially in elderly) and dizziness. constipation. difficulty with micturition. oedema. blurred vision (disturbance of accommodation.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Trimipramine maleate SURMONTIL Capsule depressive illness. cardiovascular side-effects . sedation. constipation and other gastrointestinal disturbances. myoclonic movement. sweating. cardiovascular side-effects . weakness and fatigue. not indicated in manic phase. constipation. rashes and hypersensitivity reactions . less common sideeffects include drowsiness. cerebrovascular disease. headache. tremor. behavioural disturbances severe liver disease recent myocardial infarction. arrhythmias (particularly heart block). particularly where sedation required ocular pressure). hepatic impairment or abnormal liver function tests. nausea. difficulty with micturition. dry mouth. behavioural disturbances dry mouth. phaeochromocytom a. insomnia.‫م‬ ‫ رو‬‫ز‬ ‫و‬ ‫ا‬ 50 . rashes and hypersensitivity reactions . not indicated in manic phase ‫ن‬ ‫ال‬ ‫ث‬ . increased intraocular pressure).

pyrexia. rarely pulmonary inflammation and palpitation.‫ر‬ ‫د‬ ‫رة و‬ ‫ا وازم‬ ‫ا‬ ‫اط‬ Fluvoxamine maleate FAVERIN Tablet depressive illness. Social anxiety disorder SSRIs should not be used if the patient enters a manic phase ‫ھـ. abnormal SSRIs should not be used if the patient enters a manic phase ‫ھـ. confusion. taste disturbance reported. neuroleptic malignant syndome-like event. paraesthesia. changes in blood sugar. tachycardia. obsessivecompulsive disorder SSRIs should not be used if the patient enters a manic phase ‫و‬ ‫ر‬ ‫و ز‬ . postural hypotension. amnesia. yawning. taste disturbance. coughing. urinary frequency. depersonalisation. panic disorder palpitation. increased salivation. euphoria. impaired concentration. postural hypotension. dyspnoea. malaise. ‫ا و د‬ ‫ر‬ 51 . ataxia. chills. confusion. tachycardia (may also cause bradycardia). abnormal dreams. micturition disorders. fatigue. rarely postural hypotension. impaired concentration. و د ك‬ ‫اد ر‬ ‫و‬ Escitalopram oxalate CIPRALEX Tablet Depressive illness and generalised anxiety disorder. و د ك‬ ‫اد ر‬ ‫و‬ Fluoxetine HCl EVOREX FLOZAK LINZ PROZAC SALIPAX Capsule Capsule Capsule Capsule Capsule Major depression. sleep disturbances. alopecia. sinusitis. malaise.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Selective serotonin re-uptake inhibitors Citalopram CIPRAM Tablet depressive illness. yawning. polyuria. Panic disorder. migraine. rhinitis. paraesthesia. Bulimia nervosa. taste disturbances. yawning. Obsessivecompulsive disorder. paradoxical increased anxiety during initial treatment of panic disorder (reduce dose) also vasodilatation. taste disturbance. confusion. tinnitus. SSRIs should not be used if the patient enters a manic phase ‫ا ز رة‬ ‫ار ض‬ ‫ر‬ ‫وك‬ ‫ا‬ ‫ا رط‬ ‫ا و ر‬ --‫ة‬ ---‫و‬ . pharyngitis. postural hypotension.

dry mouth. rarely panic attacks and paradoxical increased anxiety during initial treatment of panic disorder (reduce dose). menstrual irregularities. headache. impotence. confusion. confusion. palpitation. dizziness. insomnia. and neuroleptic malignant syndrome tachycardia. obsessivecompulsive disorder (under specialist supervision in children). anorexia. pancreatitis. aggressive behaviour. tachycardia. vasodilation. psychosis. urinary retention. depersonalisation. posttraumatic stress disorder in women liver function tests. ال‬ ‫ رو‬‫ز‬ ‫و‬ ‫ا‬ SSRIs should not be used if the patient enters a manic phase ‫ا دوا‬ --- Other antidepressant drugs Reboxetine methanesulph one EDRONAX Tablet major depression nausea. hepatitis. postural hypotension.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Paroxetine HCl SEROXAT Tablet major depression. liver failure. social anxiety disorder. lowering of plasmapotassium concentration pregnancy. post-traumatic stress disorder. impaired visual accommodation. sweating. usually symptomatic (discontinue treatment) also yawning. breastfeeding ‫ر‬ ‫ا ط‬ ‫ا‬ 52 . chills. less commonly arrhythmias. transient changes in blood pressure. amnesia. obsessivecompulsive disorder. panic disorder. generalised anxiety disorder Sertraline HCl LUSTRAL Tablet depressive illness. constipation. thrombocytopenia also reported SSRIs should not be used if the patient enters a manic phase ‫ث‬ ‫ن‬ ‫م. jaundice. paraesthesia. postural hypotension.

dyspnoea. diarrhoea. tooth and gingival disorders. dry mouth. breastfeeding CNS stimulants and drugs used for attention deficit hyperactivity disorder Methylphenidate RITALIN Tablet Part of a comprehensive treatment program for attention-deficit hyperactivity disorder (ADHD) when remedial measures alone prove insufficient. nervousness. abdominal pain. faecal urgency. anxiety chronic malabsorption syndrome. dry mouth. anxiety or agitation. rash. tachycardia. arthralgia. narcolepsy 5 – 60 mg/day PO abdominal pain. severe angina. insomnia. drowsiness. vasodilatation. anorexia. movement disorders. nervousness. hyperthyroidism. arrhythmias. alopecia. changes in serum cholesterol. respiratory infections. nausea. headache. cardiac arrhythmias. faecal incontinence. flatulence. pruritus. anorexia. vomiting. fatigue. cholestasis. chills. generalised anxiety disorder constipation. drowsiness conditions associated with high risk of cardiac arrhythmia. yawning. uncontrolled hypertension. dyspepsia. pregnancy . changes in blood pressure.Scientific Name Venlafaxine HCl Trade Name Dosage Form Tablet Indications Side Effects Contra-indications Manufact urer ‫وا ث ا د‬ Drug Store ‫ا‬ ‫اط‬ EFEXOR major depression. pyrexia. weight changes. nausea. tics or a family history of Tourette syndrome. palpitation. abdominal distension and pain (gastrointestinal effects minimized by reduced fat intake). insomnia. dizziness. breast-feeding ‫د‬ Drugs used in the treatment of obesity Orlistat XENICAL Capsule adjunct in obesity 5 – 15 mg PO onced daily oily leakage from rectum. dizziness. palpitation. hypertension. vomiting. breastfeeding ‫روش‬ ‫ا و ر‬ 53 . liquid or oily stools.

nausea.Scientific Name Sibutramine Trade Name Dosage Form Capsule Indications Side Effects Contra-indications Manufact urer ‫أ وت‬ ‫ول‬ ‫أ‬ Drug Store ‫ب‬ ‫ل‬ REDUCTIL adjunct in obesity constipation. hypertension. congestive heart failure. hepatic impairment. uncontrolled hypertension ‫ا‬ Drugs used in nausea and vertigo Antihistamines Cinnarizine CEREPAR Tablet vestibular disorders. extrapyramidal effects and rashes reported prolactinoma. nausea. and vomiting in Ménière's disease. nausea. lightheadedness. haemorrhoid aggravation. psychiatric illness. where increased gastro-intestinal motility harmful -‫ن‬ ‫ج‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ 54 . diarrhoea. taste disturbances. tachycardia. where increased gastro-intestinal motility harmful -‫ن‬ ‫ج‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ Cinnarizine . hepatic impairment. insomnia. nausea. where increased gastro-intestinal motility harmful ‫ر‬ ‫ا‬ ‫ر‬ Cinnarizine STUGERON Capsule Tablet vestibular disorders. peripheral arterial occlusive disease. paraesthesia. extrapyramidal prolactinoma. such as vertigo. and vomiting in Ménière's disease. and vomiting in Ménière's disease. extrapyramidal effects and rashes reported rarely gastrointestinal disturbances (including cramps). tachycardia. hepatic impairment. raised prolactin concentration. vomiting. history of coronary artery disease. hepatic impairment. where increased gastro-intestinal motility harmful ‫و‬ ‫و‬ ‫]رو ن‬ [‫د س‬ ‫ا ر‬ ‫زو‬ Domperidone and Metoclopromide Domperidone MOTILIUM Suppository Syrup Tablet nausea and vomiting. gastrointestinal haemorrhage. gastrooesophageal reflux rarely gastrointestinal disturbances (including cramps). anxiety history of major eating disorders. dry mouth. acefylline heptaminol SUREPTIL Tablet vestibular disorders. motion sickness rarely gastrointestinal disturbances (including cramps). raised prolactin concentration. headache. motion sickness prolactinoma. motion sickness prolactinoma. raised prolactin concentration. tinnitus. palpitation. Tourette syndrome. arrhythmias. extrapyramidal effects and rashes reported rarely gastrointestinal disturbances (including cramps). such as vertigo. flushing. and of cerebrovascular disease. tinnitus. such as vertigo. arrhythmias. dyspepsia. raised prolactin concentration. tinnitus.

hiccups. migraine PRIMPERAN PYLOMID RIAMIDE Metoclopramide -18-betaglycyrrhetinic acid METAGLIZ effects and rashes reported extrapyramidal effects (especially in children and young adults).Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Metoclopramide METAGLIZ METOSIL PLASIL WITH ENZYMES PREMOSAN Tablet Tablet Tablet Drops Injection Syrup Tablet Drops Injection Suppository Tablet Tablet Syrup Syrup adults. nausea and vomiting. abdominal pain. Prevention of postoperative nausea and vomiting. particularly in gastro-intestinal disorders. occasionally tardive dyskinesia on prolonged administration. depression. headache. headache. perforation or haemorrhage. hypersensitivity reactions reported ‫روش‬ ‫ا و ر‬ ONDANSETRON HCL. pruritus gastro-intestinal obstruction. Postoperative nausea and vomiting constipation. phaeochromocytom a. 3–4 days after gastrointestinal surgery. involuntary movement constipation. fatigue. Postoperative nausea and vomiting Moderately emetogenic chemotherapy or radiotherapy. occasional transient visual disturbances and dizziness following intravenous administration. hypersensitivity reactions reported. restlessness. Treatment of postoperative nausea and vomiting constipation. diarrhoea. neuroleptic malignant syndrome. drowsiness. hyperprolactinae mia. rashes. occasional alterations in liver enzymes. breast-feeding ‫رودس‬ ‫ا‬ ‫ا دوا‬ ‫ت‬ ‫ا ط‬ ‫ر‬ ‫ر‬ ‫و‬ ‫و‬ ‫] زارن‬ [‫د س‬ ‫ا ر‬ ‫ا رد‬ ‫ج ا دو‬ ‫ار ض ر‬ ‫رودس‬ ‫ا‬ ‫رة‬ ‫رة‬ --- ‫أز‬ ‫ر‬ ‫ا‬ ‫زو‬ ‫د‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫أز‬ 5HT3-antagonists GRANISETRON KYTRIL Injection Syrup Tablet Nausea and vomiting induced by cytotoxic chemotherapy or radiotherapy. rash. hypersensitivity reactions ‫و‬ ‫ن‬ ‫ث‬ ‫ر‬ ‫دوز‬ ‫د‬ 55 . dizziness. also reported. Severely emetogenic chemotherapy. diarrhoea. DIHYDRATE ZOFRAN Injection Syrup Tablet TROPISETRON NAVOBAN Capsule Injection Prevention of nausea and vomiting induced by cytotoxic chemotherapy. headache. sensation of warmth or flushing. and treatment with cytotoxics or radiotherapy.

bronchospasm and skin reactions in hypersensitive patients. rashes and pruritus reported phaeochromocytoma ‫و‬ ‫ر‬ ‫و ز‬ . Prolonged administration ‫ت‬ ‫ر‬ ‫ا‬ ‫ا دوا‬ ‫ا طورة‬ ‫ا رد‬ ‫وك‬ ‫ر‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ر‬ ‫ر‬ ‫ا‬ ‫ا رد‬ ‫و و رم‬ ‫ا دودة‬ ‫دا‬ ‫ا ر‬ ‫دة‬ ‫ا‬ ‫ا ر‬ ‫ا‬ ‫دو‬ ‫وا د ت‬ ‫اط‬ ‫ا‬ ‫ا‬ ‫ا ر‬ ‫ؤ‬ ‫ا‬ ASPICARD ASPIRIN ADULT ASPIRIN CHILDREN JUSPRIN KIDIPRIN NOVASEN Tablet Tablet Tablet Tablet Tablet Tablet mild to moderate pain. bronchospasm and hypotension). blurred vision. premedication drowsiness. pyrexia. syncope. dyspnoea. not for treatment of gout. bradycardia. hypersensitivity to Aspirin ---‫ا ر‬ REMIN Tablet 56 . chest tightness.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store reported (including facial flushing. tinnitus and hearing loss associated with Ménière's disease gastro-intestinal disturbances. dry mouth. very rarely angleclosure glaucoma ‫ر‬ ‫ر‬ ‫ا‬ Other drugs for Ménière's disease Betahistine dihydrochloride BETASERC Tablet vertigo. difficulty with micturition. collapse. urticaria. dizziness. previous or active peptic ulceration. haemophilia. ‫ا و د‬ ‫ا ى‬ ‫ا‬ ‫ر‬ Betahistine mesylate MERISLON Tablet ‫ا‬ Analgesics Non-opioid analgesics Acetyl salicylic acid (Aspirin) (ASA) ADIPRIN Tablet Generally mild and infrequent but high incidence of gastro-intestinal irritation with slight asymptomatic blood loss. cardiovascular collapse Hyoscine Hyoscine butyl bromide SCOPINAL Injection motion sickness. headache. increased bleeding time. antiplatelet children and adolescents under 16 years and in breast-feeding (Reye's syndrome).

insomnia. pyrexia nausea.C CEBIOPIRIN ASPRO Tablet effervescent Tablet effervescent Tablet effervescent Tablet ‫ا ر‬ ‫ا‬ ‫اط‬ Acetyl salicylic acid microfined RIVO Lysine acetylsalicylate . less frequently vomiting. urinary retention.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store RHONAL Tablet Acetyl salicylic acid . blurred vision. sodium bicarbonate Acetyl salicylic acid . C BAMYCODE ROBAXISAL Tablet Tablet dispersable Tablet ALKASELTZER ASPIRIN EFFERV. C Acetyl salicylic acid . headache. not indicated for myocardial infarction ‫ا‬ ‫اط‬ ‫ر‬ ‫ر‬ ‫ا‬ ‫ر‬ ‫ر‬ ‫ا‬ 57 . glycine ASPEGIC Tablet Injection ‫ا ؤ‬ ‫ا ر‬ ‫زو‬ Nefopam hydrochloride PAINSTOP Injection moderate pain Paracetamol ADOL ADOL DROPS Suppository Syrup Tablet Tablet chewable Drops mild to moderate pain. Vit. methocarbamol Acetyl salicylic acid . caffeine SEDERGINE ANACIN Tablet effervescent Tablet ‫ا دو‬ ‫ا رد‬ ‫رون ك‬ ‫رورر‬ ) ( ‫ا ر‬ ‫او‬ ‫ا ر‬ ‫وا ت ھول‬ ‫ا ر‬ ‫در‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫رو‬ ‫ا ر‬ ‫ا را‬ ‫رو ز‬ ‫ا ر‬ ‫ر‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫رك‬ ‫ا‬ ‫روش‬ ‫و س‬ ‫ا ر‬ ‫ا ت‬ ‫و‬ ‫و‬ ‫]رو ن‬ [‫د س‬ ‫ا ر‬ ‫ا ن‬ ‫اط‬ ‫ة‬ ‫ر‬ ‫ر‬ ‫زن‬ ‫دو‬ ‫ر‬ ‫ؤ‬ ‫دة‬ ‫دو‬ ‫ا‬ ‫و‬ ‫ا‬ ‫اط‬ ‫ا ر‬ ASKINE Tablet ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ASPINOL Acetyl salicylic acid . dry mouth. blood disorders (including thrombocytopeni a. convulsive disorders. confusion and hallucinations also reported. may colour urine (pink) rashes. neutropenia) reported. tachycardia. codeine Acetyl salicylic acid . drowsiness.WITH VIT. Vit. leucopenia. nervousness. sweating. lightheadedness.

important: liver damage (and less frequently renal damage) --‫ا‬ ‫ا‬ ‫ر‬ --- FEVADOL SF OMOL --‫إ راھ م‬ ‫ا‬ PANACETAM OL Syrup Tablet ‫ا‬ PANADOL Syrup Tablet ‫و‬ PANADOL JUNIOR Sachet ‫و‬ PANADOL SOLUBLE Tablet ‫و‬ PARAMOL Syrup Tablet Suspension Tablet ‫دة‬ REVANIN ‫ا ؤ‬ ‫ا‬ ‫دو‬ ‫ا‬ RIAGESIC TEMPRA TYLENOL Drops Syrup Tablet Drops Syrup Drops Suppository Tablet ‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ VONAL Paracetamol .Scientific Name Trade Name Dosage Form Syrup Indications Side Effects Contra-indications Manufact urer ‫و‬ ‫و م‬ ‫ا‬ ‫ا ز رة‬ ‫ا‬ ‫ا رد‬ ‫ا‬ ‫ا رد‬ ‫او‬ ‫ا ر‬ ‫ا دوا‬ ‫ا دوا‬ ‫ا ر‬ ‫ا وط‬ ‫ت‬ ‫ا دوا‬ ‫ا‬ ‫ا ر‬ ‫ا و‬ ‫ا ود‬ ‫ت‬ ‫ا دوا‬ ‫و‬ ‫و م‬ ‫رود ن‬ ‫ا ر‬ ‫ث‬ ‫ن‬ ‫م‬ ‫] ر‬ [‫ھ ث‬ ‫ز‬ ‫ا‬ ‫و‬ ‫ت‬ ‫ن‬ ‫ا ر د‬ ‫ر‬ ‫را‬ ‫ت اط‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ار ض‬ ‫ر‬ ‫د و ون‬ ‫ا ر‬ -‫ن‬ ‫ج‬ ‫ا و ر‬ ‫) جإ ر‬ ‫و ل‬ ( ‫ا و ر‬ ‫وك‬ Drug Store CALPOL CETAMOL DOLOMOL DOLOMOL DROPS EFFERALGAN FEVADOL Suppository Suppository Syrup Tablet Drops Elixir Suppository Syrup Tablet Syrup Syrup Tablet hypotension also reported on infusion. caffeine ADOL EXTRA FEVADOL MIDRONE Drops Suppository Syrup Tablet Tablet Tablet Tablet ---- ‫ر‬ ‫ا دوا‬ ‫ا رق‬ ‫ا و ط‬ ‫ا‬ --‫ا ؤ‬ ‫ا دة‬ ‫ر‬ 58 .

constipation. somnolence. doxylamine . vitamin-c CAFAMOL Tablet PANADOL ACTIFAST Tablet ‫و‬ EFFERALGAN Tablet effervescent ‫ر‬ Opioid analgesics Fentanyl DUROGESIC TTS Patch breakthrough pain in patients already receiving opioid therapy for chronic cancer pain (lozenges). postoperative pain. lethargy. nausea.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫ت‬ ‫ا دوا‬ ‫ا رد‬ ‫و‬ ‫ت‬ ‫ن‬ ‫ا ر د‬ ‫ك‬ ‫ا‬ ‫ا دوا‬ ‫ث‬ ‫ن‬ ‫م‬ ‫] ر‬ [‫ھ ث‬ ‫ز‬ ‫ا‬ ‫و‬ ‫ت‬ ‫ن‬ ‫ا ر د‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ر‬ ‫و‬ ‫ث‬ ‫ن‬ ‫ا را‬ ‫ا ر‬ ‫و‬ ‫ت‬ ‫ن‬ ‫ا ر د‬ ‫او‬ ‫ا ر‬ Drug Store ‫دو‬ ‫و‬ PANADOL EXTRA Tablet Paracetamol . chronic Sedation. confusion. codeine PRONTOPYRI N PLUS FEVADOL SOLPADEINE Tablet Tablet Capsule ‫ر‬ --‫و‬ SOLPADEINE Tablet ‫و‬ Paracetamol . sweating. caffeine Paracetamol . increased sweating. dizziness. hypotension. chronic intractable pain (patches). dry mouth. ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا رط‬ ‫و‬ 59 . headache vertigo. myocardial infarction. diphenhydramin e ADOL PM PANADOL NIGHT Caplet Tablet ‫ا ر‬ ‫و‬ Paracetamol . patient controlled analgesia. vomiting. nausea. acute pulmonary oedema. caffeine . sodium bicarbonate Paracetamol . Individualized dosage: 25–100 mcg/h as a transdermal patch Sedation. lightheadedness. drowsiness. Premedication before operation. respiratory depression -‫ن‬ ‫ج‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ Morphine sulphate ORAMORPH Solution Acute pain. codeine REVACOD Tablet ‫ا‬ Paracetamol . vomiting.

pressure. coronary vasospasm (including Prinzmetal's . nausea. heat.5–15mg/70 kg IV respiratory depression Tramadol HCl TRAMAL Capsule Tablet Injection Suppository Capsule moderate to severe pain NOMAL TRAMADOL AWD Injection TRAMADONE Injection nausea and vomiting (particularly in initial stages). 5–20 mg IM SC q4h PRN. other side-effects include difficulty with micturition. and occasionally bleeding and ulceration occur. during pregnancy and breast-feeding . and muscle rigidity. and drowsiness. also avoid in raised intracranial pressure or head injury (affects pupillary responses vital for neurological assessment). ‫ا ر‬ ‫ل‬ ‫ر‬ ‫اد ر‬ 5HT1 agonists Rizatriptan benzoate MIGON Tablet treatment of acute migraine attacks Side-effects of the 5HT1 agonists include sensations of tingling. larger doses produce respiratory depression. urticaria or rhinitis have been precipitated by aspirin or any other NSAID). heaviness.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store pain 10–30 mg PO q4h PRN. acute alcoholism and where risk of paralytic ileus. taking oral formulations with milk or food. angioedema. diarrhoea. previous myocardial infarction. constipation. or tightness of any part of the body 5HT1 agonists are contra-indicated in ischaemic heart disease. Systemic as well as local effects of NSAIDs contribute to gastro-intestinal damage.دوم‬ ‫ا و د‬ ‫رب‬ ‫را‬ ‫رك‬ ‫ودوم ا‬ ‫ا‬ MIGON MELT Tablet ‫ا‬ 60 . avoid injection in phaeochromocytoma ‫رو ل‬ ‫ا‬ ‫ب‬ ‫ل‬ ‫ا‬ ‫ر‬ ‫ت‬ ‫ا‬ ‫ا دوا‬ ‫ا طورة‬ ‫ا رد‬ ‫ر‬ ‫ا وو‬ "‫" رس‬ ‫ا‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ؤ‬ ‫ا‬ ‫زو‬ ‫ا‬ Antimigraine drugs Analgesics Tolfenamic acid CLOTAN Capsule treatment of acute migraine attacks Gastro-intestinal discomfort. hypotension. ureteric or biliary spasm.‫رك‬ ‫ش. 2. dry mouth acute respiratory depression. 10–20 mg rectally q4h. or using enteric-coated formula history of hypersensitivity to aspirin or any other NSAID—which includes those in whom attacks of asthma.

some primary generalised seizures. and uncontrolled or severe hypertension. abdominal pain. severe or inadequately controlled hypertension. headache. constipation or diarrhoea. vomiting. obliterative vascular disease and Raynaud's syndrome. marked neuromuscular respiratory weakness including ‫روش‬ ‫ا ط‬ ‫روش‬ ‫ا و ر‬ 61 . visual disturbances (especially diplopia and often associated with peak plasma concentrations). prophylaxis of bipolar disorder unresponsive to lithium all forms of epilepsy. status epilepticus Initial dose upto 1. and occasionally headache provoked (usually because of prolonged excessive dosage or abrupt withdrawal). rarely myocardial infarction peripheral vascular disease. angina). AV conduction abnormalities (unless paced).Scientific Name Sumatriptan succinate Trade Name Dosage Form Tablet Indications Side Effects Contra-indications Manufact urer ‫ر‬ ‫و‬ ‫ود‬ ‫ا ر‬ ‫ا‬ Drug Store ---- IMIGRAN treatment of acute migraine attacks. cluster headache (subcutaneous injection only) (including throat and chest— discontinue if intense. also poor concentration. previous cerebrovascular accident or transient ischaemic attack. history of bone marrow depression. hepatic impairment. acute pulmonary insufficiency. muscle cramps. sepsis. muscle hypotonia. temporal arteritis. vertigo. ‫دوز‬ ‫د‬ Antiepileptics Control of epilepsy Carbamazepin TEGRETOL Suspension Tablet Tablet chewable Tablet Suspension Tablet Tablet Suspension Tablet partial and secondary generalised tonicclonic seizures. caffeine CAFERGOT Tablet treatment of acute migraine attacks and migraine variants unresponsive to analgesics nausea. anorexia drowsiness. hyperthyroidism. Ergot alkaloids Ergotamine tartrate . pregnancy. confusion and agitation (elderly). renal impairment. dizziness. drowsiness. diarrhoea. myocardial and intestinal ischaemia. fatigue. ataxia. myoclonus. may be due to coronary vasoconstriction or to anaphylaxis. precordial pain. porphyria ‫د‬ CARBATOL EPTOL FITZCALM NEUROTOP ‫دار ا دواء‬ ‫ا رد‬ ‫وك‬ ‫ر‬ ‫روت‬ ‫و‬ ‫ا‬ ‫ا‬ ‫اط‬ ---- ‫ا ر‬ ‫دي‬ ‫رف‬ Clonazepam RIVOTRIL Drops RIVOTRIL Tablet respiratory depression.5 mg/d PO in three divided doses. coronary heart disease. dizziness. increase in nausea and vomiting. Maintenance: 800 – 1200 mg/d PO in divide doses trigeminal neuralgia. sleep apnoea syndrome. coordination disturbances.

hepatic unstable myasthenia gravis ‫رك د ز‬ ‫ز‬ ‫ا‬ ‫ا‬ ‫ود‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫و‬ ‫ود‬ ‫ا ر‬ ‫ا‬ ---- 62 . salivary or bronchial hypersecretion in infants and small children. drowsiness. trigeminal neuralgia [unlicensed indication] 50 – 200 mg/d PO in 2 divided doses restlessness. diplopia Skin reactions. seizures associated with LennoxGastaut syndrome. arthralgia.5g/d PO in divided doses. lymphadenopath y. drowsiness. disseminated intravascular coagulation and multi-organ dysfunction). blood disorders. night terrors. amnesia. amnesia. abnormal gait. dry mouth. nausea. hyperkinesia. paraesthesia. neuropathic pain. nystagmus. dysarthria.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store increments of 0.5 – 1 mg q 3d. rarely tongue swelling. dizziness. hypersensitivity syndrome (possibly including rash. vomiting. mild euphoria. weight gain. nausea. rarely gastro-intestinal gastro-intestinal disturbances . fatigue. dependence. less frequently headache. diarrhoea. asthenia. emotional liability. hepatic dysfunction. ataxia. diarrhoea. depression. confusion. dizziness. dyspepsia. trigeminal neuralgia [unlicensed indication] 900 – 3600 mg/d PO TID Lamotrigine LAMICTAL Tablet Tablet dispersable monotherapy and adjunctive treatment of partial seizures and primary and secondarily generalised tonicclonic seizures. tremor. peripheral oedema. anxiety. children 250 mg/d PO Gabapentin NEURONTIN Capsule adjunctive treatment of partial seizures with or without secondary generalisation not satisfactorily controlled with other antiepileptics. and withdrawal. ataxia. maximum dose 20 mg/d Ethosuximide ZARONTIN Capsule Syrup absence seizures Upto 1. hiccup. sleep disturbances. vomiting. fever.

headache Levetiracetam KEPPRA Tablet adjunctive treatment of partial seizures with or without secondary generalisation. dizziness. lethargy. rash (discontinue. . tremor.‫و‬ ‫ا‬ ‫ر‬ Phenobarbitone GARDINAL Tablet all forms of epilepsy except absence seizures. amnesia. also reported confusion. headache. mental depression. depression. headache. vomiting. mental depression. restlessness and confusion in the elderly and hyperkinesia in children. insomnia. trigeminal neuralgia if carbamazepine inappropriate Loading dose: 1g given in three doses (400mg. megaloblastic anaemia (may be treated with folic acid) nausea. paraesthesia. 300 mg. anorexia. vomiting. acne. anorexia. adjunctive treatment of myoclonic seizures nausea. irritability. ataxia. lethargy. status epilepticus 30 – 200 mg/d PO BID. drowsiness. tremor. rash. psychosis. insomnia. ataxia and allergic skin reactions. emotional liability. ataxia and allergic skin . 300 mg) PO q 2h. asthenia. dyspepsia. maintenance dose : started 24 hr after loading dose 300 – 400 mg/d PO ‫ر وردا‬ ‫ا ط‬ ‫ا‬ ‫اط‬ ‫ود‬ ‫ا‬ ‫ا‬ Primidone MYSOLINE Syrup Tablet all forms of epilepsy except absence seizures. transient nervousness. essential tremor ‫ز‬ ‫ا‬ 63 . if mild re-introduce cautiously but discontinue immediately if recurrence). cough. drowsiness. constipation. anxiety. TID ‫ك‬ ‫رون‬ ‫رورر‬ ) ( ‫ا ر‬ ‫ر‬ Phenytoin DINTOINA Tablet EPANUTIN Capsule Suspension all forms of epilepsy except absence seizures. dizziness. diarrhoea. hyperkinesia. paradoxical excitement. drowsiness.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store dysfunction. gingival hypertrophy and tenderness. diplopia.

migraine prophylaxis Vigabatrin SABRIL Tablet initiated and supervised by appropriate specialist. headache. adjunctive treatment of seizures in LennoxGastaut syndrome. abdominal pain. diarrhoea. behavioural disturbances. fatigue. impaired memory and concentration. dyspepsia. hyperactivity. encephalopathic symptoms consisting of marked sedation. speech disorder. taste disturbance. porphyria ‫و‬ ‫و‬ [ ‫] ر‬ ‫ا ر‬ ‫و‬ ‫و‬ [ ‫] رو‬ ‫ر‬ ‫و‬ ‫و‬ [ ‫] ر‬ ‫ا ر‬ ‫وك‬ ‫ر‬ ---‫ر‬ ‫ا‬ breast-feeding ‫ج‬ -‫ن‬ ‫و ر‬ ‫ج‬ ‫ر و ل‬ ( ‫و ر‬ ‫ة‬ ‫ا‬ ) ‫إ‬ ‫ا‬ ‫ا‬ ‫اط‬ visual field defects ‫ر ون‬ ‫رل داوو‬ ‫ا ر‬ ‫ر‬ 64 . aggression. insomnia. drowsiness (rarely. weight loss. drowsiness. family history of severe hepatic dysfunction. anxiety. thrombocytopeni a. and confusion with non-specific slow wave EEG— active liver disease. gastric irritation. hyperammonaem ia. stupor. megaloblastic anaemia (may be treated with folic acid)‫ ك‬also nausea and visual disturbances nausea. adjunctive treatment of partial seizures with or without secondary generalisation not satisfactorily reactions. if dose > 250 mg give in divided doses DEPAKINE CHRONO Tablet DEPAKINE SOLN Solution VALIREC VALOPIN Syrup Syrup Topiramate TOPAMAX Tablet monotherapy and adjunctive treatment of generalised tonicclonic seizures or partial seizures with or without secondary generalisation. paraesthesia. ataxia. less frequently increased alertness.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Up to 500mg PO QID Sodium valproate DEPAKINE Syrup Tablet all forms of epilepsy 10 – 60 mg/kg/d PO. tremor nausea. restlessness and confusion in the elderly and hyperkinesia in children. dry mouth. dizziness. anorexia. transient hair loss (regrowth may be curly). increased appetite. weight gain. hypoaesthesia. paradoxical excitement. diarrhoea. depression.

mental depression. irritability Drugs used in status epilepticus Clonazepam RIVOTRIL Injection all forms of epilepsy. confusion. paradoxical excitement. dependence. dizziness.5 mg/d PO in three divided doses. maximum dose 20 mg/d drowsiness. status epilepticus ‫ك‬ ‫رون‬ ‫رورر‬ ) ( ‫ا ر‬ ‫ر‬ 30 – 200 mg/d PO BID. increase in increments of 0. muscle weakness. fatigue. acute pulmonary insufficiency. salivary or bronchial hypersecretion in infants and small children. not for chronic psychosis. convulsions due to poisoning 2 – 10 mg/d PO 2 – 4 times/d status epilepticus/ severe recurrent seizures. lethargy. status epilepticus Initial dose upto 1. and withdrawal. coordination disturbances. restlessness and confusion in the elderly and hyperkinesia in children. salivation changes drowsiness. myoclonus.5 – 1 mg q 3d. fatigue. dizziness. 5 – 10 mg initially. muscle hypotonia. ataxia and allergic skin reactions. acute pulmonary insufficiency. sleep apnoea syndrome. amnesia. dependence. should not be used alone in depression ‫ا ر‬ ‫اد ر‬ ‫روش‬ ‫ا ر‬ ‫ا‬ Phenobarbitone GARDINAL Injection all forms of epilepsy except absence seizures. vertigo. amnesia. hypotension. monotherapy for management of infantile spasms (West's syndrome) reduce dose or withdraw). megaloblastic anaemia (may be treated with folic acid) respiratory depression. confusion and ataxia (especially in the elderly). sleep apnoea syndrome. marked neuromuscular respiratory weakness including unstable myasthenia gravis ‫روش‬ ‫ا و ر‬ Diazepam STESOLID VALIUM Injection Rectal tube Suppository Injection status epilepticus. marked neuromuscular respiratory weakness including unstable myasthenia gravis. TID 65 . paradoxical increase in aggression .Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store controlled with other antiepileptics. drowsiness and lightheadedness the next day. nervousness. severe hepatic impairment. also poor concentration. occasionally: headache. may repeat at 5 – 10 min intervals at maximum dose of 30 mg IV respiratory depression. visual field defects. restlessness.

and cardiovascular collapse. 300 mg. nausea. endocrine disorders ‫ر‬ ‫ا ط‬ ‫ا‬ 66 . gastro-intestinal disturbances. and second. rashes nausea. StokesAdams syndrome. maintenance dose : started 24 hr after loading dose 300 – 400 mg/d PO cardiovascular and CNS depression (particularly if injection too rapid) with arrhythmias. hypersensitivity to opioids. hepatic impairment. less commonly postural hypotension. pregnancy. history of gastric ulceration. confusion. severe renal impairment. 300 mg) PO q 2h.and third-degree heart block. inability to concentrate. but now obsolete Loading dose: 1g given in three doses (400mg. dizziness. hypotension. nervousness. rarely leucopenia. sino-atrial block. injection-site reactions (including nodule formation and ulceration)— change injection sites in rotation. ‫أ وت‬ ‫ا را‬ ‫ب‬ ‫ل‬ ‫ا‬ Cabergoline DOSTINEX Tablet adjunct to levodopa (with dopadecarboxylase inhibitor) in Parkinson's disease. pregnancy. hallucinations. vomiting . breastfeeding ‫د وت‬ ‫ر و ل‬ ‫ا ر‬ ‫رز‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ Amantadine sulphate PK-MERZ Tablet ‫ا رق‬ ‫ا و ط‬ Apomorphine HCl UPRIMA Sublingual tablet refractory motor fluctuations in Parkinson's disease (‘off' episodes) inadequately controlled by levodopa or other dopaminergics (for capable and motivated patients under specialist supervision) respiratory depression. injection site reactions sinus bradycardia.Scientific Name Phenytoin Trade Name Dosage Form Injection Injection Indications Side Effects Contra-indications Manufact urer ‫رك د ز‬ ‫ز‬ ‫ا‬ ‫ن‬ ‫ا را‬ Drug Store ‫ا‬ ‫ر‬ ‫ا‬ EPANUTIN R. hypotonia or psychiatric effects. porphyria Drugs used in Parkinsonism and related disorders Amantadine HCl SYMMETREL Capsule Parkinson's disease (but not drug-induced extrapyramidal symptoms). livedo reticularis and peripheral oedema. breastfeeding. breathing difficulties. neuropsychiatric problems or dementia. drowsiness. convulsions. blurred vision.M PHENYTOIN status epilepticus. arrhythmias. dykinesias epilepsy. not suitable if ‘on' response to levodopa marred by severe dyskinesia. alterations in respiratory function (including respiratory arrest). hallucinations or feelings of detachment. antiviral 100 – 400 mg/d PO in divided doses anorexia. seizures in neurosurgery. insomnia.

confusion. rhinitis. psychotic reactions (including hallucinations). dizziness. rarely abdominal pain and constipation. pleuritis. dyspepsia. diplopia. reddish discoloration of urine and other body fluids. Lisuride hydrogen maleate DOPERGIN Tablet Parkinson's disease. drowsiness. cardiac valve disease ‫ا‬ ‫ا ر‬ ‫و‬ cerebral haemorrhage. tachycardia. less commonly drowsiness. ‫روش‬ ‫ا و ر‬ pregnancy. breastfeeding severe disturbances of peripheral circulation. breastfeeding . agitation. lethargy. pericardial effusion. dyspnoea. arrhythmias. nervousness. vomiting. hepatic impairment. dyskinesia. pericarditis. . pleural fibrosis. headache. weight gain. used alone or as an adjunct to levodopa Pergolide mesylate PERMAX Tablet alone or as adjunct to levodopa in Parkinson's disease where dopamine receptor agonists other than ergot derivative not appropriate Piracetam NOOTROPIL Capsule Infusion Injection Solution Tablet adjunctive treatment of cortical myoclonus anorexia. dizziness. benserazide MADOPAR Capsule Tablet parkinsonism (but not drug-induced extrapyramidal symptoms). levodopa Trade Name Dosage Form Tablet Tablet Indications Side Effects Contra-indications Manufact urer ‫رب‬ ‫را‬ ‫رب‬ ‫را‬ ‫رك‬ ‫ودوم ا‬ ‫رك‬ ‫ودوم ا‬ Drug Store ‫ا‬ ‫ا‬ SINEMET SINEMETPLUS parkinsonism (but not drug-induced extrapyramidal symptoms). cardiac valvulopathy. drowsiness. insomnia. abdominal pain. rashes.Scientific Name Carbidopa . nausea and vomiting. occasionally severe hypotension. hyperkinesia. abnormal involuntary movements nausea and vomiting. pleural effusion. malaise. dizziness. nausea.‫و‬ ‫ا‬ ‫ر‬ 67 . Levodopa . rarely hypersensitivity. pregnancy. postural hypotension (rarely labile hypertension). Raynaud's phenomenon reported hallucinations. coronary insufficiency ‫اس‬ ‫ر‬ ‫اي ا ر‬ ‫ب‬ ‫ل‬ ‫ا‬ history of fibrotic disorders.

and rash. blurred vision. postural hypotension. confusion. breastfeeding ‫ن‬ ‫ث‬ ‫م ال‬ ‫ ورد‬‫ز‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫اط‬ 68 . insomnia. nausea.ف‬ ‫ز‬ ‫ا‬ ‫و‬ pregnancy. dizziness. ‫وو م‬ (. pathological gambling. moderate to severe restless legs syndrome depression. urinary retention. nausea. confusion.. vomiting. used alone or as adjunct to levodopa. drowsiness (including sudden onset of sleep). ataxia. anxiety. vomiting.‫)و م. constipation. insomnia. Side-effects of antimuscarinics include constipation. hallucinations. restlessness. dizziness. confusion. tachycardia. diarrhoea. moderate to severe restless legs syndrome Procyclidine KEMADRIN Injection Tablet parkinsonism. hallucinations (mostly visual). dyskinesia. asthenia. dry mouth. drowsiness (including sudden onset of sleep). abdominal pain. fatigue. euphoria. either used alone or as an adjunct to levodopa. impaired memory. hallucination. breast-feeding ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫ا‬ Antimuscarinics should be avoided in gastro-intestinal obstruction and myasthenia gravis. headache. peripheral oedema. headache. Angleclosure glaucoma nausea. leg oedema. hypotension. and rash nausea. vertigo. druginduced extrapyramidal symptoms (but not tardive dyskinesia Ropinirole REQUIP Tablet Parkinson’s disease. dizziness. vomiting.Scientific Name Trade Name Dosage Form Capsule Indications Side Effects Contra-indications Manufact urer ‫رودس‬ ‫ا‬ Drug Store ‫أز‬ ‫رة‬ PIRACETAM Pramipexole dihydrochloride monohydrate SIFROL Tablet Parkinson's disease. nervousness. anxiety. syncope. also reported abdominal pain.

anorexia. dyskinesia. dizziness. depression. fever. severe renal impairment. hallucinations. weight loss. dyskinesia. bradycardia. palpitation. micturition difficulties pregnancy. agitation. myalgia. diarrhoea. abdominal pain. used alone or as adjunct to levodopa fatigue. less commonly hypotension. confusion. breastfeeding ‫ج‬ -‫ن‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ 69 . postural hypotension. diarrhoea. vertigo. myocardial infarction. tremor. and increased libido nausea. less commonly arrhythmias. breastfeeding ‫اور ون‬ ‫ا د‬ ‫ا وان‬ Drugs for dementia Galantamine REMINYL Solution Tablet mild to moderate dementia in Alzheimer's disease nausea. dry mouth. syncope. rhinitis. arthralgia. hallucinations. rarely arrhythmias. dyspepsia. headache. headache.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Selegiline H ELDEPRYL Tablet Parkinson's disease. constipation. confusion. sleeping disorders. fatigue. vomiting. confusion. sleep disturbances. mouth ulcers with oral lyophilisate.

.................. 97 Respiratory syncytial virus ............................................................................................................................................ 87 Metronidazole and tinidazole................................................................. 96 Influenza ............................................. 95 Herpesvirus infections .................................................................................. 71 Cephalosporins and other beta-lactams ......................................................................................... 81 Clindamycin ..........................................................................................Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Infections Antibacterial drugs 71 Penicillins.................................... 89 Urinary-tract infections ........................................................... 99 Leishmaniacides ........................ 98 Amoebicides ............................................. 86 Antileprotic drugs .......................................................................................................... 99 Anthelmintics 99 70 ......................................................... 80 Macrolides................................................... 91 Antifungal drugs 91 Antiviral drugs 95 HIV infection ............................................................................. 88 Quinolones ..................................................................................................................................................... 83 Sulphonamides and trimethoprim .................................................................................................... 82 Some other antibacterials ....................................................................................................................................................................................................................................................................................... 98 Antiprotozoal drugs 98 Antimalarials ......................................................................................................................... 74 Tetracyclines ..................... 79 Aminoglycosides... 85 Antituberculous drugs ...............................................................................................................................................................................................................................................

meningococcal disease. vomiting. anthrax. PO. pneumonia. impetigo. rarely CNS toxicity including convulsions. cellulitis. diarrhoea. erysipelas. endocarditis. rashes penicillin hypersensitivity ‫م‬ ‫ث‬ ‫ن‬ ‫ال‬ ‫ورد‬ --‫ة‬ ‫ا‬ ‫اط‬ 71 . interstitial nephritis penicillin hypersensitivity ‫دوز‬ ‫أم ا ش‬ ً ) ( ‫و‬ ‫و‬ ‫ا‬ ‫ر‬ Penicillin-V (Phenoxymethyl penicillin) OSPEN Syrup Tablet ORVEK VIKADAR FORTE OSPEN Suspension Syrup Tablet Syrup Tablet oral infections . rheumatic fever and pneumococcal infection prophylaxis. cellulitis .at least 30 min before food. otitis media. IV. otitis media. nausea. tonsillitis. 0. CNS toxicity . osteomyelitis and in staphylococcal endocarditis.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Antibacterial drugs Penicillins Benzylpenicillin and phenoxymethylpenicillin (Penicillin (G) and Penicillin (V)) Penicillin-G (Benzyl penicillin sodium) PENICILLIN G Injection throat infections. interstitial nephritis penicillin hypersensitivity ‫دوز‬ ‫أم ا ش‬ ً ) ( ‫و‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا رد‬ ‫دار ا دواء‬ ‫ا رد‬ ‫ا دوا‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫اط‬ --- Penicillinase-resistant penicillins Flucloxacillin FLOXAPEN Capsule Suspension Injection infections due to beta-lactamaseproducing staphylococci including otitis externa. rarely CNS toxicity including convulsions . sinusitis. 250– 500 mg q6 h. PO. interstitial nephritis penicillin hypersensitivity ‫ث‬ ‫ن‬ ‫م‬ ‫ال‬ ‫ورد‬ ‫ز‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ Broad-spectrum penicillins Amoxycillin AMOXIL AMOXIL Capsule Syrup Injection ‫ا دوا‬ urinary-tract infections.IM. cellulitis.25–2 g q6 h hypersensitivity reactions. adjunct in pneumonia. 125—500 mg PO q6h or q8h hypersensitivity reactions . otitis media. dosage may also be based on weight hypersensitivity reactions. prophylaxis in limb amputation Up to 20—30 million U/d IV or IM.

history of coamoxiclavassociated or penicillinassociated jaundice or hepatic dysfunction hepatitis. dizziness. anthrax . antibioticassociated colitis ‫ا رد‬ ‫ج‬ ‫ا دو‬ ‫دار ا دواء‬ ‫ا رد‬ ‫ا و‬ ‫ا ر‬ ‫رو دس‬ ‫رو دس‬ ‫و ل ر‬ ‫ا را‬ ‫د و ون‬ ‫ا ر‬ ‫ا دوا‬ ‫ر‬ ‫د‬ ‫ا‬ ‫اط‬ ‫د ن‬ ‫د‬ ‫ؤ‬ ‫ا‬ ‫ؤ‬ ‫ا‬ ‫دة‬ ‫ا ؤ‬ ‫ا‬ ‫دو‬ ‫ا‬ --‫ر‬ ‫ا‬ NOVAMOXIN OMACILLIN Capsule OSPAMOX PENAMOX PRINCIMOX Capsule Suspension Tablet Capsule Suspension Capsule Suspension REMOX ULTRAMOX Capsule Suspension Capsule Suspension ‫و و رم‬ ‫ا دودة‬ ‫دا‬ ‫ا ر‬ ‫ا وط‬ ‫ت‬ ‫ا دوا‬ ‫ا‬ ‫دوز‬ ‫أم ا ش‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا رد‬ ‫ر ول‬ ‫رز‬ ‫وب‬ ‫ا و‬ (‫) و ب‬ ‫ا ز رة‬ ‫ا ر‬ ‫دة‬ ‫ا ر‬ ‫ا‬ ‫دو‬ ‫إ راھ م‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ؤ‬ ‫ا‬ --‫ا‬ Amoxycillin . clauvlanic acid AMOCLAN AUGMENTIN JULMENTIN AUGMENTIN CURAM Injection Suspension Tablet Drops Injection Suspension Syrup Tablet Injection Suspension Tablet Syrup Tablet Suspension Tablet infections due to beta-lactamaseproducing strains (where amoxicillin alone not appropriate) including respiratory-tract infections. adjunct in listerial meningitis . vasculitis reported. genitourinary and abdominal infections. animal bites. headache. listerial meningitis. also endocarditis prophylaxis and treatment. uncomplicated communityacquired pneumonia . cellulitis. bronchitis. invasive salmonellosis. toxic epidermal necrolysis. StevensJohnson syndrome.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫ز‬ ‫ا‬ Drug Store AMOXIPEN Capsule Suspension Capsule Suspension Capsule Suspension Capsule Drops Solutab Syrup Capsule Suspension Capsule Suspension Capsule Suspension Capsule Drops Suspension Capsule AMOXYDAR E-MOX FLEMOXIN FLEMOXIN GLOMOX HICONCIL HYMOX JULPHAMOX oral infections . oral infections . 250—500 mg PO q8h or 875 mg PO BID (discontinue treatment). rarely prolongation of bleeding time. severe dental infection with spreading cellulitis penicillin hypersensitivity. rarely. Helicobacter pylori eradication. Haemophilus influenzae infections. convulsions ‫ا دو‬ ‫ا رد‬ ‫ا‬ ‫ا رد‬ ‫م‬ ‫ث‬ ‫ن‬ ‫ال‬ ‫ورد‬ ‫ز‬ ‫ا‬ ‫ر‬ ‫ا دوا‬ ‫دوز‬ ‫أم ا ش‬ ً ) ( ‫و‬ ‫و‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ر‬ --‫ر‬ ‫ا‬ 72 . exfoliative dermatitis. cholestatic jaundice.

250—500 mg PO q6h --- ‫ر‬ ‫ا ز رة‬ ‫رو دس‬ nausea. bronchitis. rashes (discontinue treatment). vomiting. potassium clavulanate Amoxycillin trihydrate . listerial meningitis. uncomplicated communityacquired pneumonia . clavulanic acid KLAVOX ‫ا ز رة‬ ‫ا دوا‬ ‫ا‬ ‫ا رد‬ ‫م‬ ‫ث‬ ‫ن‬ ‫ال‬ ‫ورد‬ ‫ز‬ ‫ا‬ ‫ا دوا‬ ‫ر‬ ----- AMOCLAN AUGMENTIN Tablet Tablet ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ AUGMENTIN JULMENTIN MEGAMOX Ampicillin AMFIPEN AMFIPEN EPICOCILLIN PENBRITIN Tablet Tablet Tablet Injection Injection Injection Injection urinary-tract infections. antibioticassociated colitis penicillin hypersensitivity ‫رو دس‬ ‫ا و‬ ‫ا ر‬ ‫ث‬ ‫م‬ ‫ن‬ ‫ال‬ ‫ورد‬ ‫ز‬ ‫ا‬ ‫ر ول‬ ‫رز‬ ‫ا ط‬ ‫دوز‬ ‫أم ا ش‬ ً ) ( ‫و‬ ‫و‬ ‫ا‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫زر‬ ‫ا ط‬ ‫ا و‬ ‫ا ر‬ ‫ر ول‬ ‫رز‬ ‫ا ط‬ ‫دوز‬ ‫أم ا ش‬ ً ) ( ‫و‬ ‫و‬ ‫ا‬ ‫د ن‬ ‫د‬ ‫ا‬ ‫ر‬ --‫ؤ‬ ‫ا‬ ‫ا‬ ‫ؤ‬ ‫ا‬ ‫د ن‬ ‫د‬ ‫ا ة‬ ‫اط‬ PENTREXYL Injection ‫ا‬ ‫ر‬ STANDACILLIN Injection Ampicillin . oral infections . diarrhoea. cloxacillin ULTRACLOXAM Injection ‫ا‬ ‫ا‬ Ampicillin . Haemophilus influenzae infections. IV in divided doses of q4—6h See under Ampicillin See under Ampicillin STANDACILLIN Injection 73 . sinusitis.Scientific Name Trade Name Dosage Form Tablet Indications Side Effects Contra-indications Manufact urer ‫و ل ر‬ ‫ا را‬ ‫ر‬ ‫ا دوا‬ Drug Store ‫ا ؤ‬ ‫ا‬ ‫دو‬ ‫ا‬ GLOCLAV JULMENTIN FORTE KLAVOX Suspension Drops Suspension Syrup Tablet Suspension Tablet Syrup 250—500 mg PO q8h or 875 mg q12h** ‫دة‬ ‫ر‬ --- MEGAMOX Amoxycillin . rarely.5—1 g Sulbactam with 1—2 g ampicillin IM or IV q6–8h EPICOCILLIN PENTREXYL Injection Injection See under Ampicillin 1—12 g/d IM. salbactam Ampicillin sodium UNASYN Injection 0. invasive salmonellosis. otitis media.

headache. IM. flushing. injection-site reactions. 0. insomnia. Complicated appendicitis. constipation. hypersensitivity reactions. oedema.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Antipseudomonal penicillins Piperacillin PIPRIL Injection Lower respiratory-tract. hepatitis. IV.5 g IV given as 3. 1 g as a single dose AZACTAM Injection nausea. Infections in neutropenic patients . 25 g/d Piperacillin . diarrhoea. Haemophilus influenzae. nephrotoxicity. 3—4 g q4—6h IV. jaundice and hepatitis. superinfection. vomiting. blood disorders . jaundice. rarely abdominal pain. and septicemia. altered taste. dyspepsia. and Neisseria meningitides. tazobactam TAZOCIN Injection 12 mg/1.rashes. pregnancy ‫ر ول‬ ‫رز‬ -‫وب‬ ‫اط‬ ‫ر ول‬ ‫رز‬ ‫وب‬ ‫ا و‬ (‫) و ب‬ ‫ؤ‬ ‫ا‬ ‫ؤ‬ ‫ا‬ Cephalosporins and other beta-lactams Cephalosporins Cephalosporins : First Generation Cefadroxil BIODROXIL Capsule Suspension Tablet 1–2 g/d PO in divided doses Nausea. vomiting. urinary-tract. intra-abdominal and skin infections. pseudomembran CEFADRIL Capsule Suspension cephalosporin hypersensitivity CEFADROX Capsule Suspension ‫دوز‬ ‫أم ا ش‬ ً ) ( ‫و‬ ‫و‬ ‫ا‬ ‫ا رام‬ ‫ت‬ .375 g q6h nausea. less commonly stomatitis.1 g q8h or 2 g q12h 2g q6–8h for severe infections Urinary-tract infections. maximum dosage. IM. and injection-site reactions. cystitis. mouth ulcers. vomiting. hypotension.‫ا دوا‬ ‫ا رد‬ ‫ا ز رة‬ ‫ر‬ ‫ؤ‬ ‫زو‬ ‫ا ر‬ --- 74 . hypersensitivity reactions. fatigue . Stevens-Johnson syndrome. abdominal cramps. ‫د‬ penicillin hypersensitivity ‫در‬ ‫ا‬ ‫در‬ ‫ا رط‬ Mecillinams Aztreonam AZACTAM Injection Gram-negative infections including Pseudomonas aeruginosa. rarely hypotension. aztreonam hypersensitivity.5–1 g q8–12h Gonorrhoea.IM. diarrhoea. headache. diarrhea.

1–4 g/d PO in divided doses CEPHALEX CEPHALEX CEPOREX Capsule Suspension Capsule Drops Syrup Syrup Capsule Suspension Tablet Suspension Capsule Suspension Tablet Capsule Suspension CEPOREX KEFLEX Diarrhoea and rarely antibioticassociated colitis (CSM has warned both more likely with higher doses).Scientific Name Trade Name Dosage Form Suspension Capsule Indications Side Effects Contra-indications Manufact urer ‫ا ز رة‬ ‫ا دة‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ ‫ا رق‬ ‫ا و ط‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ ‫وك‬ ‫ر ول‬ ‫رز‬ ‫ا ر‬ ‫دوز‬ ‫أم ا ش‬ ً ) ( ‫و‬ ‫و‬ ‫ا‬ ‫وك‬ ‫ا‬ ‫ا رد‬ ‫ر‬ Drug Store --‫دي‬ ‫رف‬ ‫ا ؤ‬ ‫ا‬ ‫دو‬ CEFADROX DROXIL ous colitis MIDROXIL Capsule Suspension ‫دة‬ ROXIL ULTRACEF Capsule Suspension Capsule Suspension Injection perioperative prophylaxis.5–1g IM. perioperative 0. 250 mg–1 g IM. abdominal discomfort. cephalosporin hypersensitivity ‫ر‬ ‫دار ا دواء‬ ‫ا رد‬ ‫وك‬ ‫وك‬ ‫و‬ ‫ا رط‬ ‫و‬ ‫ا رط‬ ‫ا دوا‬ ‫ا‬ ‫ا رط‬ ‫ا‬ ‫ا رد‬ ‫ا رق‬ ‫ا و ط‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ ‫ا ز رة‬ ‫دوز‬ ‫أم ا ش‬ ً ) ( ‫و‬ ‫و‬ ‫ا‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ا‬ ‫ا ر‬ ‫ا ز رة‬ ‫و‬ ‫ا‬ ‫ا‬ ‫اط‬ ------- --- KEFLEX LEXIN ‫ا‬ MIDAFLEX ‫دة‬ ‫ا ؤ‬ ‫ا‬ ‫دو‬ MONOCEF OSPEXIN Capsule Suspension Suspension Tablet --‫ر‬ ULTRASPORIN Capsule Suspension ‫ا‬ Cephalothin sodium Cephradine KEFLIN N CEFADIN Injection Capsule infections due to Diarrhoea and cephalosporin hypersensitivity ‫و‬ --- 75 . allergic reactions. IV 6–12h. headache. IV ---‫ا‬ ‫ر‬ Cefazolin CEFAZOLIN cephalosporin hypersensitivity TAZOLINE CEFAMEZIN Cephalexin CEFRIN CEPHADAR Injection Injection Capsule Suspension Capsule Suspension ---‫ا‬ infections due to sensitive Grampositive and Gramnegative bacteria. nausea and vomiting.

F sensitive Grampositive and Gramnegative bacteria. headache. 1–2 g IV 250–500 mg PO q12h ‫ا ز رة‬ infections due to sensitive Grampositive and Gramnegative bacteria.5 g IM or IV g8h. ZINACEF Injection ---- 76 . nausea and vomiting. nausea and vomiting. nausea and vomiting. allergic reactions. allergic reactions. surgical prophylaxis.Scientific Name (Cefradine) Trade Name Dosage Form Injection Drops Indications Side Effects Contra-indications Manufact urer ‫وك‬ ‫ا‬ ‫ا رد‬ ‫ر‬ Drug Store ---‫ا‬ CEPHRADINE DORAL S. more active against Haemophilus influenzae and Neisseria gonorrhoeae. cephalosporin hypersensitivity ‫ر‬ ‫ر ول‬ ‫رز‬ ‫وب‬ ‫ا ر‬ (‫) و ب‬ ‫ؤ‬ ‫ا‬ ‫ا‬ Cephalosporins : Second Generation Cefaclor BIOCEF CECLOR CECLOR Capsule Suspension Suspension Capsule Suspension Tablet Capsule Suspension Capsule Suspension Capsule Suspension Tablet Injection Injection perioperative prophylaxis 1–2 g IM q6–8h. abdominal discomfort.5–1 g q6 h ESKACEF VELOSEF Capsule Suspension Capsule Injection Suspension rarely antibioticassociated colitis (CSM has warned both more likely with higher doses). PO. 0.‫ر‬ ‫د‬ ‫رة‬ ‫وا وازم‬ ‫ر‬ ‫ا‬ ---- -----‫ا‬ ---- perioperative prophylaxis . surgical prophylaxis.5–1 g q12 h.‫رك. IM. headache. 250 mg PO q8h --‫و‬ --‫ا‬ ‫اط‬ ‫ر‬ ‫ا‬ ---- CLORACEF RECOCEF TABICLOR Diarrhoea and rarely antibioticassociated colitis (CSM has warned both more likely with higher doses). cephalosporin hypersensitivity ‫ا‬ ‫ا رط‬ ‫ا دوا‬ ‫دار ا دواء‬ ‫ا رد‬ ‫ر‬ ‫وك‬ Cefoxitin sodium FOXITIN MEFOXIN cephalosporin hypersensitivity ‫وك‬ . up to 1 g q6 h in severe infections.IV. 250 mg PO BID. cephalosporin hypersensitivity ‫ر ول‬ ‫رز‬ ‫ا ر‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ت‬ ‫ا دوا‬ ‫ر‬ ‫ر‬ ‫و‬ ‫ا ر‬ ‫ا ود‬ ‫وك‬ ‫ا ز رة‬ ‫ا‬ ‫ا رد‬ ‫ر‬ ‫و‬ ‫ود‬ ‫و‬ ‫ا ر‬ ‫ا ر‬ ‫ا‬ ‫ر‬ ‫ا‬ . 750 mg–1. abdominal discomfort. abdominal discomfort. 250–500 mg q6 h or 0. allergic reactions. ش‬ ‫دوم ا و د‬ ---‫ا‬ Cefprozil CEFZIL Suspension Tablet Tablet cephalosporin hypersensitivity Cefuroxime axetil CEFUTIL CEFUZIME ZINNAT Tablet Tablet ZINOXIMOR Cefuroxime sodium CEFOFIX MAXIL ZINACEF Tablet Injection Injection Injection infections due to sensitive Grampositive and Gramnegative bacteria. Lyme disease Diarrhoea and rarely antibioticassociated colitis (CSM has warned both more likely with higher doses). 1–12 g/d IV in equally divided doses. headache. perioperative.

Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫ود‬ ‫و‬ ‫ا رط‬ ‫وك‬ ‫ا ر‬ ‫ا‬ Drug Store ZINACEF ZINOXIME ULTRASPORIN Injection Injection Capsule Suspension perioperative. abdominal discomfort. headache. allergic reactions. surgical prophylaxis. maximum. 12 g/d cephalosporin hypersensitivity ‫ا‬ ‫ا رد‬ ‫ا‬ 77 . nausea and vomiting. 250 mg–2 g IV. (acute infections only). 1. ---- ‫و‬ ‫ر‬ ‫ا‬ ---- Ceftizoxime CEFIZOX Injection 1–2 g (range. Ceptaz IM q8-12h KEFADIM NEGACEF ZIDIME Injection Injection Injection Diarrhoea and rarely antibioticassociated colitis (CSM has warned both more likely with higher doses).. IV in equally divided doses ‫ا‬ ‫ا‬ Ceftazidime FORTUM Injection infections due to sensitive Grampositive and Gramnegative bacteria. abdominal discomfort. headache. gonorrhoea.5 g IV ---‫ا‬ ‫ا دو‬ ‫ا رد‬ Cephalosporins : Third Generation Cefdinir Cefixime OMNICEF MAGNACEF Capsule Suspension Capsule Suspension 300 mg PO q12h or 600 mg q24h PO Cephalosporin hypersensitivity Diarrhoea and rarely antibioticassociated colitis (CSM has warned both more likely with higher doses). allergic reactions. 1–4 g) IM or IV q8–12h. ‫ا‬ ‫ر‬ rarely arrhythmias following rapid injection reported cephalosporin hypersensitivity ---‫ا‬ ‫ا‬ PRIMOCEF Injection Cefperazone CEFOBID Injection 2–8 g/d IM or IV in equally divided doses q6–8h. nausea and vomiting. maximum 12 g/d 2–4 g/d IM. gonorrhoea [unlicensed indication] 400 mg/d as a single dose or divided doses ‫ا‬ WINEX Capsule Suspension Injection Injection ‫وك‬ ‫ا‬ ‫ا رد‬ ‫رو ل‬ ‫ا ف‬ ‫ا ر‬ ‫وك‬ ‫ر‬ ‫ر‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ر‬ ‫ر‬ cephalosporin hypersensitivity ‫زر‬ ‫ا ط‬ ‫ر‬ cephalosporin hypersensitivity ‫و‬ ‫ود‬ ‫ا ر‬ ‫ا‬ ‫ا‬ ‫ا ر‬ ‫ر‬ ‫وك‬ ---- Cefotaxime CEFTAX CLAFORAN FOXIME PRIMOCEF CLAFOTAX Injection Injection Injection infections due to sensitive Grampositive and Gramnegative bacteria. Haemophilus epiglottitis and meningitis perioperative prophylaxis. cephalosporin hypersensitivity ‫ت‬ - ‫ا ز رة‬ ‫ا رام‬ ‫ا دوا‬ ‫ا رد‬ ‫ا‬ ‫ا رد‬ --‫زو‬ SUPRAX Capsule Suspension infections due to sensitive Grampositive and Gramnegative bacteria.

perioperative. headache. 4 g/d. 1 g q24h IV diarrhoea. dyspepsia. melaena. surgical prophylaxis. anorexia. 1-2 g q12h.Scientific Name Ceftriaxone Trade Name Dosage Form Injection Injection Injection Indications Side Effects Contra-indications Manufact urer ‫ر‬ Drug Store ENOXIRT ROCEPHIN ROXCEF SAMIXON Injection infections due to sensitive Grampositive and Gramnegative bacteria. use caution in patients with history of penicillin allergy cephalosporin hypersensitivity ‫رو ل‬ ‫ا ف‬ ‫ا ر‬ ‫ر‬ Cephepime HCl MAXIPIME Injection ‫ر ول‬ ‫رز‬ ‫وب‬ ‫ا ر‬ (‫) و ب‬ ‫ؤ‬ ‫ا‬ Other beta-lactam antibiotics Ertapenem INVANZ Injection abdominal infections. pancreatitis cephalosporin hypersensitivity . constipation. maximum. IV QID. communityacquired pneumonia. nausea. 250 mg IM as a single dose TRIAXONE Injection calcium ceftriaxone precipitates in urine (particularly in very young. gonorrhea. less commonly dry mouth. gonorrhea. vomiting. BID. neonates with jaundice. 4 g/d 0. 1–2 g/d IM. 1 g IV. prophylaxis of meningococcal meningitis [unlicensed indication]. taste disturbances. injection-site reactions. دوم‬ ‫ا و د‬ ‫ا‬ 78 . acute gynecological infections. hypotension. maximum. breast-feeding . dehydrated or those who are immobilized) or in gall bladder— consider discontinuation if symptomatic. rarely prolongation of prothrombin time. IV. perioperative prophylaxis. Lower respiratory tract infections. hypoalbuminaemia. bacteremia. pruritus. antibioticassociated colitis. rash. abdominal pain.5 mg–2 g IV.‫رك‬ ‫ش. IM q12h Use caution with renal failure. complicated upper and lower urinary tract infections. acidosis or impaired bilirubin binding ‫ر‬ ‫روش‬ ‫ا و ر‬ ‫ا ر‬ ‫ا‬ ‫ا‬ ‫ا دو‬ ‫ا رد‬ ‫ا‬ ‫ا رد‬ ‫ا‬ ‫وك‬ ---- Cephalosporins : Fourth Generation Cefpirome CEFROM Injection Septicemia. raised platelet count. diabetic foot infections of the skin and softtissue.

diarrhoea (antibioticassociated colitis reported). and tinnitus Deposition of tetracyclines in growing bone and teeth (by binding to calcium) causes staining and occasionally dental hypoplasia. taste disturbances. blood disorders. neutropenia. malaria treatment and prophylaxis . flushing. urticaria. tooth or tongue discoloration. IM. surgical prophylaxis. or to pregnant or breast-feeding women ‫ود‬ ‫ا را‬ ‫دار ا دواء‬ ‫ا رد‬ ‫ا ر‬ ‫اد ر‬ ‫ر‬ ‫وك‬ ‫زر‬ ‫ا‬ ‫أو س‬ ‫ا د‬ ‫ار ض‬ ‫ر‬ ‫و و رم‬ ‫ا دودة‬ ‫دا‬ ‫ا دة‬ ‫ت‬ ‫ا دوا‬ ‫دي‬ ‫رف‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫ر‬ ‫ا‬ ---‫ا‬ ‫ر‬ ‫ا ز رة‬ ‫ا ة‬ ‫اط‬ ‫ا ر‬ ‫ا دة‬ ‫دو‬ ‫دي‬ ‫رف‬ 79 . positive Coombs' test. positive Coombs' test. leucopenia. gonorrhea: 200 mg PO immediately and 100 mg PO hs then 100 mg PO BID for 3 d. allergic reactions (with rash. disturbances in liver function tests. 100 mg PO q12h first day then 100–200 mg/d PO. pelvic inflammatory disease . impaired hearing.‫رك‬ ‫ش. nausea. hyperaesthesia. syphilis. abdominal pain. not indicated for CNS infections. diarrhoea (antibioticassociated colitis reported). and they should not be given to children under 12 years. Intra-abdominal and tissue infections caused by multiresistant gramnegative organisms.Scientific Name Imipenem . and alopecia. tinnitus.recurrent aphthous ulceration. acute renal failure. hearing loss. cilastatin Trade Name Dosage Form Injection Indications Side Effects Contra-indications Manufact urer . eosinophilia. vomiting. 200 mg IV first day then 100–200 mg/d IV Doxycycline hyclate APO-DOXY DOXYCIN NOVODOXYLIN UNIDOX Capsule dizziness and vertigo (more common in women). ‫ز‬ ‫ا‬ Tetracyclines Doxycycline HCl DORYX DOXYDAR DUMOXIN DURADOX TABOCINE VIBRAMYCIN Capsule Capsule Syrup Tablet Capsule Capsule Capsule Syrup Tablet Capsule Capsule Capsule chronic prostatitis. 500–750 mg q12 h. very rarely systemic lupus erythematosus. rarely anorexia. vomiting. thrombocytopeni a (reduction in partial thromboplastin time reported). sinusitis. treatment and prophylaxis of anthrax [unlicensed indication]. دوم‬ ‫ا و د‬ Drug Store ‫ا‬ TIENAM aerobic and anaerobic Grampositive and Gramnegative infections. IV. hospital-acquired septicemia . paraesthesia. StevensJohnson syndrome. 1 g IV q8h nausea. pruritus. pigmentation (sometimes irreversible). 1–2 g daily (in 3–4 divided doses) Meropenem MERONEM Injection aerobic and anaerobic Grampositive and Gramnegative infections. anorexia.

or to pregnant or breast-feeding women see notes above ‫در‬ ‫ا ر‬ ‫ز‬ ‫ا‬ ‫ر‬ ‫ر‬ ‫زر‬ ‫ا‬ ‫ا‬ ‫ا‬ Deposition of tetracyclines in growing bone and teeth (by binding to calcium) causes staining and occasionally dental hypoplasia. antibiotic‫ن‬ ‫ا را‬ myasthenia gravis ‫ر‬ ‫ا‬ AMIKIN MIACIN Injection Injection 15 mg/kg IM. rosacea. and they should not be given to children under 12 years. brucella (doxycycline with either streptomycin or rifampicin). qd or 300 mg individualized doses q8–12h IM. Other rare side-effects include hepatotoxicity. paraesthesia. rarely. in divided doses. acute renal failure.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫ا رد‬ Drug Store Minocycline HCl MINOCIN Capsule meningococcal carrier state. tinnitus. pseudomembra nous colitis. psittacosis. and lymphogranuloma venereum).5 g/d ‫ا دوا‬ ‫ا‬ --- 80 . not to exceed 1. urethritis. hematologic changes. 250–500 mg IV q12h OXYTETRACY CLINE TERRAMYCIN Ointment Ointment Tetracycline DUMOCYCLIN E TETRACYCLI NE TETRADAR Injection Ointment Capsule Capsule Tetracycline HCl BALKACYCLI NE DUMOCYCLIN OPTICYCLIN Capsule Ointment Chlamydia (trachoma. salpingitis. Borrelia burgdorferi (Lyme disease. 200 mg PO initially then 100 mg IV q12h 100–200 mg initially then 50 mg PO QID Oxytetracycline IMPERACINE Tablet acne vulgaris. discoloration of teeth in fetus and young children Side-effects of the tetracyclines include nausea. vomiting.‫ا دوا‬ ‫ا ردن‬ ‫زر‬ ‫ا‬ ‫ر‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫ا‬ ‫ؤ‬ ‫ا‬ ‫ا‬ ‫ا‬ Aminoglycosides Amikacin sulphate AMIKACIN Injection serious Gramnegative infections resistant to gentamicin vestibular and auditory damage. hypersensitivity reactions. photosensitivity Deposition of tetracyclines in growing bone and teeth (by binding to calcium) causes staining and occasionally dental hypoplasia. rickettsia (including Q-fever). and alopecia. diarrhoea (antibioticassociated colitis reported occasionally). vomiting. hypomagnesae mia on prolonged therapy. and oesophageal irritation. 1–2 g/d PO in 2–4 divided doses TERRAMYCIN TETRACYCLI N Capsule Capsule rarely anorexia. 1–2 g/d PO. dysphagia. hyperesthesia. 250 mg IM. Uri-Tet photosensitivity reactions. pancreatitis. IV. and they should not be given to children under 12 years. impaired hearing. blood disorders. and the spirochaete. pigmentation (sometimes irreversible). diarrhea. acne vulgaris. very rarely systemic lupus erythematosus Nausea. nephrotoxicity. or to pregnant or breast-feeding women ‫ا ر‬ ‫اد ر‬ ‫ر‬ ‫ر‬ ‫دار ا دواء‬ ‫ا رد‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ا ر‬ ‫اد ر‬ ‫ن‬ ‫ت‬ .

also anorexia. blood disorders. hyperactivity. IV q8h ‫ا‬ ‫ا ر‬ ‫ن‬ ‫ا را‬ ‫و‬ Injection ‫ر‬ ‫ا‬ Macrolides Azithromycin AZOMYCIN ZETRON ZIMAX ZITHROMAX AZI-ONCE Suspension Suspension Capsule Suspension Injection Suspension Capsule respiratory-tract infections. mild neutropenia. anxiety. flatulence. otitis media. nausea. ‫ب‬ ‫ل‬ 81 . stomatitis. antibioticassociated colitis. rash. stomatitis. biliarytract infection. vestibular and auditory damage. thrombocytopenia . nephrotoxicity. blood disorders. vomiting. constipation. also reported. rash. syncope. see under Erythromycin. not to exceed 5 mg/kg/d in divided doses associated colitis. acute pyelonephritis or prostatitis. meningitis and other CNS infections. nausea. hepatitis. tooth and tongue discoloration. smell and taste disturbances. rarely. endocarditis. ‫و‬ ‫ر‬ ‫ا د‬ ‫ا دوا‬ ‫رك‬ ‫ة‬ ‫ا‬ ‫ر‬ ‫ر‬ ‫ر‬ --‫ا‬ ‫اط‬ ‫ا‬ myasthenia gravis Tobramycin NEBCIN TOBRAMYCIN Injection 3–5 mg/kg/d IM. paraesthesia. drowsiness. agitation.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫ا رد‬ ‫ر‬ Drug Store ‫ا‬ ‫ر‬ ‫ا‬ MIKACIN Injection Gentamicin sulphate GARAMYCIN Cream Ointment Injection Injection Ointment GENTAM REFOBACIN GENTAL septicemia and neonatal sepsis. headache. pancreatitis. eye . dizziness. 500 mg PO first day then 250 mg/d PO for 4 d AZOMYCIN ZETRON ZITHROMAX ZOCIN Capsule Capsule Capsule Capsule see under Erythromycin. asthenia. also reported. IV. mild to moderate skin and soft tissue infections. also dyspepsia. ear 3 mg/kg/d q8h IM. hypomagnesae mia on prolonged therapy. ‫ر‬ ‫ر‬ hepatic impairment ‫وك‬ ‫ا دوا‬ ‫زر‬ ‫أر‬ ‫وم‬ ‫دو‬ ‫ر‬ ‫ر‬ ‫وك‬ ‫زر‬ ‫ا‬ ‫ر‬ ‫ت‬ ‫ا‬ ‫ا دوا‬ ‫ا طورة‬ ‫ا رد‬ ‫ر‬ ‫ر‬ ‫وك‬ ‫أ وت‬ ‫ا ط‬ ‫ا‬ ---‫ا‬ ‫ؤ‬ ‫ا‬ ‫ا‬ ---‫ا‬ ‫ا‬ -----‫ا‬ --- Clarithromycin CLAMYCIN CLARITT KLACID Tablet Suspension Tablet Suspension Tablet respiratory-tract infections. mild or moderate typhoid due to multipleantibacterialresistant organisms [unlicensed indication]. otitis media. uncomplicated genital chlamydial infections and non-gonococcal urethritis . pneumonia in hospital patients. skin and soft-tissue infections. convulsions. dyspepsia. adjunct in listerial meningitis. vomiting.

pancreatitis. campylobacter enteritis. cholestatic jaundice. glossitis. sulfisoxazole Erythromycin base PEDIAZOLE ERYC Injection Erythromycin Base: 250 mg PO q6h or 333 mg q8h ‫ر‬ ‫ا‬ ‫و‬ ‫ب‬ ‫ل‬ ‫دي‬ ‫رف‬ ‫ا‬ Suspension Topical solution Suspension Capsule Ethylsuccinate: 400 mg PO q6h Esteolate: 250 mg PO q6h IV: Up to 4 g/d IV In divided doses ‫ا‬ Clindamycin Clindamycin CLINDACIN-T Topical solution staphylococcal bone and joint infections. less frequently urticaria. vomiting. diphtheria and whoopen cough ‫أ وت‬ ‫ا ر‬ nausea. antibioticassociated colitis. abdominal discomfort. and headache. rash. reversible hearing loss reported after large doses.Scientific Name Trade Name Dosage Form Tablet Indications Side Effects Contra-indications Manufact urer ‫أ وت‬ ‫ا را‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ Drug Store ‫ب‬ ‫ل‬ ‫ا‬ KLACID XL Helicobacter pylori eradication. 600–2700 mg/d in 2–4 equal doses. rashes and other allergic reactions. very rarely pancreatitis. insomnia. dizziness. respiratory-tract infections (including legionnaires' disease). 250–500 mg PO BID KLARIBAC Tablet stomatitis. less commonly hepatitis. leucopenia. chronic prostatitis. urticaria. endocarditis prophylaxis [unlicensed indication]. abdominal discomfort. and thrombocytopenia reported. skin infections. vomiting. ‫أ وت‬ ‫ا ر‬ ‫أ وت‬ ‫ا ر‬ ‫أ وت‬ ‫ا ر‬ ‫دار ا دواء‬ ‫ا رد‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ن‬ ‫ا را‬ ‫ا‬ ‫ا رد‬ ‫ل‬ ‫ا ر د‬ ‫أ وت‬ ‫ا ر‬ ‫ود‬ ‫را‬ ‫ا‬ ‫ر‬ ‫ب‬ ‫ل‬ ‫ب‬ ‫ل‬ ‫ب‬ ‫ل‬ ‫ب‬ ‫ل‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ا‬ ERYPED ERYTHROCIN ERYTHROCIN PCE ERYTHRODAR ERYTHROMIL ERYTHROMIL FORTE Suspension ‫ا‬ ERYTHROMYCI N LACTOBIONAT E RYTHINATE STIEMYCIN Erythromycin . nongonococcal urethritis. peritonitis. diarrhoea (discontinue treatment). ‫ا‬ Erythromycin EROMYCIN ERYDERM Suspension Tablet Topical solution Solution Injection Suspension Tablet Tablet Suspension Tablet Suspension Tablet ‫ر‬ alternative to penicillin in hypersensitive patients.8 g/d IV. syphilis. IM ‫ر‬ DALACIN-C DERMA-T Capsule Topical solution ‫ر‬ ---- 82 . oesophagitis. jaundice. arthralgia. oral infections. pruritus. diarrhoea (antibioticassociated colitis reported). avoid injections containing benzyl alcohol in neonates ‫دة‬ ‫ت‬ ‫ا‬ ‫دي‬ ‫رف‬ ‫ر‬ ‫ا دوا‬ ‫ا رد‬ ‫ر‬ ‫أ ون‬ (‫)ا ون‬ ‫أر‬ ‫ر‬ ‫أ ون‬ (‫)ا ون‬ ‫أر‬ ‫ا ون‬ ‫ا‬ ‫وك‬ DALACIN Vaginal cream DALACIN T Topical solution 150–450 mg PO q6h. up to 4. anaphylactoid diarrhoeal states. nausea. rarely tinnitus. eosinophilia. and myalgia.

anaphylactoid reactions. leucopenia. peripheral neuritis. urticaria. hydrocortsone acetate Fusidate sodium FUCIDIN H Cream ‫و‬ ‫اد ر‬ Infections caused by penicillinresistant staphylococci. especially after high dosage or rapid infusion (withdraw therapy if persistent). stomatitis. antibioticassociated colitis. as they are well concentrated in bone. jaundice. headache. rash. up to 8 g/d IV diarrhoea (discontinue treatment). they are nausea.Scientific Name Clindamycin HCl monohydrate Clindamycin palmitate Clindamycin phosphate Trade Name Dosage Form Capsule Indications Side Effects Contra-indications Manufact urer ‫ا ون‬ ‫ا‬ ‫ا ون‬ ‫ا‬ ‫أ وت‬ ‫ا ر‬ ‫ر‬ ‫أ ون )ا ون‬ [ ‫ا رط‬ ‫ا ون‬ ‫ا‬ ‫وك‬ Drug Store ‫ر‬ ‫ر‬ ‫ب‬ ‫ل‬ ‫ر‬ ‫ر‬ ---‫ر‬ ‫ا‬ DALACIN C reactions. urticaria. pruritus. 50 mg/kg/d PO. vomiting. peritonitis. 600 mg IM q12– 24h. nausea. porphyria ‫ا ر‬ ‫اد ر‬ ‫ا‬ Fucidic acid . diarrhoea. abdominal discomfort. optic neuritis. endocarditis prophylaxis [unlicensed indication]. erythema multiforme. nausea. 500 mg PO q6–8h. breastfeeding. especially osteomyelitis. depression. vomiting. avoid injections containing benzyl alcohol in neonates ‫ا ون‬ ‫ا‬ Some other antibacterials Chloramphenicol CHLORAMEX Syrup Reserved for the treatment of lifethreatening infections. particularly those caused by Haemophilus influenzae. reversible jaundice. Stevens-Johnson Syndrome diarrhoeal states. rarely ‫ار ض‬ ‫ر‬ ‫و‬ ‫اد ر‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ا‬ BALAD FUCIDIN Ointment Injection Ointment Suspensio n Tablet Medicated guaze FUCIDIN INTER TULLE ‫و‬ ‫اد ر‬ ‫ا‬ 83 . eosinophilia. pregnancy. oesophagitis. Stevens-Johnson Syndrome DALACIN-C CLINDAMYCIN PHOSPHATE DALACIN T Suspension Injection Lotion DALACIN-C DERMA _ T Lincomycin HCl LINCOCIN Injection Lotion Capsule Syrup staphylococcal bone and joint infections. and thrombocytopenia reported. and also for typhoid fever. vomiting. IV in divided doses blood disorders including reversible and irreversible aplastic anaemia (with reports of resulting leukaemia). glossitis.

Scientific Name

Trade Name

Dosage Form
Ointment

Indications

Side Effects

Contra-indications

Manufact urer

Drug Store
---

FUSIBACT

FUSIDERM FUTASOLE UCIDERM ZETA Fusidic acid Fusidic acid BALAD DERMOFUCIN

Ointment Ointment Ointment Ointment Cream Cream

also used for staphylococcal endocarditis. A second antistaphylococc al antibiotic is usually required to prevent emergence of resistant strains

hypersensitivity reactions, acute renal failure (usually with jaundice), blood disorders

‫وم‬ ‫دو‬ ‫ا دوا‬ ‫ر‬ ‫د‬ ‫ا رد‬ ‫وك‬ ‫ار ض‬ ‫ر‬ ‫ن‬ ‫ت‬ - ‫ا دوا‬ ‫ا ردن‬ ‫و‬ ‫اد ر‬

--‫ا ر‬ ‫ا رق‬ ‫ا و ط‬ ---‫ة‬ ‫ا‬ ‫اط‬ ‫ؤ‬ ‫ا‬ ‫ا‬ ---

FUCIDIN FUSIBACT

Cream Gel Cream

FUSIDERM FUTASOLE UCIDERM ZETA Fusidic acid , betamethasone Fusidic acid anhydrouse , betamethasone Fusidic acid anhydrouse , betamethasone valerate Teicoplanin FUSIBACT-B

Cream Cream Cream Cream Cream

‫وم‬ ‫دو‬ ‫ا دوا‬ ‫ر‬ ‫د‬ ‫ا رد‬ ‫وك‬ ‫وم‬ ‫دو‬ ‫ا دوا‬ ‫د‬ ‫ا رد‬ ‫ت‬ ‫ا ط‬

--‫ا ر‬ ‫ا رق‬ ‫ا و ط‬ ------

FUSIDERM B

Cream

--‫ا رق‬ ‫ا و ط‬ ‫ر‬

UCIDERM -B

Cream

TARGOCID

Injection

Thiamphenicol

THIOPHENIC OL

Injection Tablet

serious Grampositive infections including endocarditis, dialysisassociated peritonitis, and serious infections due to Staph.aureus; prophylaxis in endocarditis [unlicensed indication] and in orthopaedic surgery at risk of infection Reserved for the treatment of lifethreatening infections, particularly those caused by Haemophilus influenzae, and also for typhoid fever.

nausea, vomiting, diarrhoea; rash, pruritus, fever, bronchospasm, rigors, urticaria, angioedema, anaphylaxis; dizziness, headache; blood disorders including eosinophilia, leucopenia, neutropenia, and thrombocytopenia; disturbances in liver enzymes,

blood disorders including reversible and irreversible aplastic anaemia (with reports of resulting leukaemia), peripheral neuritis, optic neuritis,

pregnancy, breastfeeding, porphyria

‫و‬ ‫و‬ [- ‫] رو‬ ‫ر‬

84

Scientific Name

Trade Name

Dosage Form

Indications

Side Effects

Contra-indications

Manufact urer

Drug Store

Vancomycin

VANCOCINCP VANCOLON VANCOMYCIN HCL

Injection Injection Injection

Vancomycin HCl

Used by the intravenous route in the prophylaxis and treatment of endocarditis and other serious infections caused by Gram-positive cocci. Vancomycin (added to dialysis fluid) is also used in the treatment of peritonitis associated with peritoneal dialysis
500 mg to 2 g/d PO in divided doses; 500 mg IV q6h or 1 g IV q8— 12h

headache, depression, urticaria, erythema multiforme, nausea, vomiting, diarrhoea, stomatitis, glossitis, after parenteral administration: nephrotoxicity including renal failure and interstitial nephritis; ototoxicity (discontinue if tinnitus occurs); blood disorders including neutropenia (usually after 1 week or cumulative dose of 25 g), rarely agranulocytosis

‫ا‬ ‫ا ر‬ ‫ر‬ ‫ن‬ ‫ا را‬

‫و‬ ‫ر‬ ‫ر‬ ‫ا‬ ‫ا‬

Sulphonamides and trimethoprim
Co-trimoxazole (Trimethoprim, sulphamethoxazole) BACTRIM Injection Syrup Tablet Suspension Tablet Suspension Tablet ‫روش‬ ‫ا و ر‬ ‫ا دوا‬ nausea, diarrhoea; headache; hyperkalaemia; rash (very rarely including StevensJohnson syndrome, toxic epidermal necrolysis, photosensitivity)— discontinue immediately; less commonly vomiting; very rarely glossitis, stomatitis, anorexia, liver damage ‫ا ر‬ ‫ا‬ ‫ا دو‬ ‫ا رد‬ ‫ا ھرة‬ ‫ا ر‬ ‫ا رد‬ ‫ج ا دو‬ ‫در‬ ‫ا‬ ‫ا ر‬ ‫وو م‬ (.‫)و م.ف‬ ‫ز‬ ‫ا‬ ‫و‬ ‫ن‬ ‫ث‬ ‫ا د‬ ‫وو م‬ ‫ا‬ ‫ر‬ ‫و‬ ‫ا ر‬ ‫ا ود‬ ‫س‬ ‫ا و‬ ‫ر‬ ---

BACTRIM BALKATRIN

CHEMOTRIM

Tablet

NORTRIME SEPTAZOLE

Suspension Tablet Tablet

SEPTRIN

Injection Tablet Injection

SEPTRIN

Drug of choice in Pneumocystis jiroveci (Pneumocystis carinii) pneumonia; it is also indicated for toxoplasmosis and nocardiasis. It should now only be considered for use in acute exacerbations of chronic bronchitis and infections of the urinary tract
160 mg TMP/800 mg SMZ PO q12h; 8–10 mg/kg/d , (based on TMP) IV in 2–4 divided doses

‫ا ؤ‬ ‫ا ر‬ ‫د‬ ‫دة‬ ‫ا ؤ‬ ‫ا‬ ‫دو‬ ‫و‬

porphyria

SEPTRIN SEPTRIN

Suspension Tablet

----

SUTRIM TRIMOL

Tablet Suspension Tablet

‫ر‬ ‫ر‬

‫ا‬ ‫ا‬

85

Scientific Name

Trade Name

Dosage Form
Suspension Tablet Suspension Tablet Cream Cream Cream

Indications

Side Effects

Contra-indications

Manufact urer
‫رودس‬ ‫ا‬ ‫ا ز رة‬

Drug Store
‫أز‬ ‫رة‬ --‫ة‬ ‫ا‬ ‫اط‬ ‫ا ة‬ ‫اط‬

URTIUM ZOTRIM Silver sulphadiazine FLAMAZINE FLAMAZINE SILVERIN

Second- and thirddegree burns
Apply to burned area 1–2 times/d

Leukopenia, skin necrosis, skin discoloration, burning sensation

‫و‬

‫ثو‬ ‫ا رط‬ ‫ار ض ر‬ ‫ا رز‬ ‫ا ر‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ ‫دار ا دواء‬ ‫ا رد‬

‫ؤ‬ ‫ا د‬ ‫د ت‬ ‫اط‬ ‫ا‬ ‫اط‬

Trimethoprim

TRIMIDAR

Tablet

urinary-tract infections, acute and chronic bronchitis; pneumocystis pneumonia

gastro-intestinal disturbances including nausea and vomiting, pruritus, rashes, hyperkalaemia, depression of haematopoiesis; rarely erythema multiforme, toxic epidermal necrolysis, photosensitivity and other allergic

blood dyscrasias

Trimethoprim , sulphametrole

LIDAPRIM

Suspension Tablet Tablet

LIDAPRIM FORTE LIDAPRIM PED

Tablet

‫د‬ ‫ھ‬ ‫و د ر‬ ‫و‬ ‫ا‬ ‫د‬ ‫ھ‬ ‫و د ر‬ ‫و‬ ‫ا‬ ‫د‬ ‫ھ‬ ‫و د ر‬ ‫و‬ ‫ا‬

‫ا‬ ‫ا‬ ‫ا‬

Antituberculous drugs
Ethambutol AFIMOCIL Tablet tuberculosis, in combination with other drugs
15–25 mg/kg/d PO

ETHAMBUTOL MYAMBUTOL Isoniazid I.N.H RIMIFON

Tablet Tablet Tablet Tablet
Active TB: up to 300 mg/d PO or up to 300 mg/d IM, to 900 mg IM 2—3 times/wk First-line treatment: 300 mg INH and 600 mg rifampin PO in single dose TB prophylaxis: 30 mg/d PO

optic neuritis, red/green colour blindness, peripheral neuritis, rarely rash, pruritus, urticaria, thrombocytopenia nausea, vomiting, constipation, dry mouth; peripheral neuritis with high doses (pyridoxine prophylaxis) , optic neuritis, convulsions, psychotic episodes, vertigo; hypersensitivity reactions including fever, erythema multiforme, purpura;

optic neuritis, poor vision

‫رودس‬ ‫ا‬ ‫ا ل‬ ‫دو‬ ‫در‬ ‫ا ر‬ ‫ا ل‬ ‫دو‬ ‫روش‬ ‫ا و ر‬ ‫رة‬

‫أز‬

‫ؤ‬ ‫ا‬

drug-induced liver disease

‫ؤ‬ ‫ا‬

86

Scientific Name
Pyrazinamide

Trade Name

Dosage Form
Tablet

Indications

Side Effects

Contra-indications

Manufact urer
‫دوز‬ ‫أم ا ش‬ ً ) ( ‫و‬ ‫و‬ ‫ا‬

Drug Store
‫ر‬

PZA

tuberculosis in combination with other drugs.
15—30 mg/kg/d maximum, 3 g/d rashes PO; 50—70 mg/kg twice weekly PO

TEBRAZID

Tablet

hepatotoxicity including fever, anorexia, hepatomegaly, splenomegaly, jaundice, liver failure; nausea, vomiting, flushing, dysuria, arthralgia, sideroblastic anaemia, rash and occasionally photosensitivity gastro-intestinal symptoms including anorexia, nausea, vomiting, diarrhoea (antibioticassociated colitis reported); headache, drowsiness; those occurring mainly on intermittent therapy include influenza-like symptoms

porphyria

.‫ل‬

‫و‬ .‫ف‬ ‫ا‬

‫ر‬

Rifampicin

RIAFAMPICIN RIFACIN RIFADIN RIMACTANE

Tablet Capsule Capsule Capsule

Rifampicin , I.N.H

RIFINAH RIMACTAZID

Tablet Tablet

Brucellosis, legionnaires' disease, endocarditis and serious staphylococcal infections, in combination with other drugs; Tuberculosis, in combination with other drugs; Leprosy; Prophylaxis of meningococcal meningitis and Haemophilus influenzae (type b). 600 mg PO, IV Initial treatment of pulmonary tuberculosis.
1—2 tablets daily PO

‫ار ض‬ ‫ر‬ ‫وك‬ ‫ت‬ ‫ا ط‬ ‫دوز‬ ‫أم ا ش‬ ً ) ( ‫و‬ ‫و‬ ‫ا‬

‫ة‬

‫ا‬ ‫اط‬ ---‫ر‬ ‫ر‬

jaundice

Streptomycin

STREPTOTHE NATE

Injection

tuberculosis, in combination with other drugs; adjunct to doxycycline in brucellosis; enterococcal endocarditis. Up to 1 g/d IM

see under Aminoglycosides, also hypersensitivity reactions, paraesthesia of mouth

see under Aminoglycosides

‫ت‬ ‫ا ط‬ ‫دوز‬ ‫أم ا ش‬ ً ) ( ‫و‬ ‫و‬ ‫ا‬ ‫رو ل‬ ‫ا‬

‫ر‬ ‫ر‬

‫ب‬ ‫ل‬

‫ا‬

Antileprotic drugs
Clofazimine LAMPRENE Capsule Leprosy 100–200 mg/d PO nausea, vomiting (hospitalize if persistent), abdominal pain; headache, tiredness; brownish-black discoloration of lesions and skin including areas exposed to light; reversible hair discoloration; dry skin; red discoloration of ‫د‬

87

Scientific Name

Trade Name

Dosage Form

Indications

Side Effects

Contra-indications

Manufact urer

Drug Store

Pyrimethamine , dapsone

MALOPRIM

Tablet

leprosy, dermatitis herpetiformis; Pneumocystis jiroveci (Pneumocystis carinii) pneumonia dapsone: 50–300 mg/d PO

faeces, urine and other body fluids (dose-related and uncommon at doses used for leprosy), haemolysis, methaemoglobin aemia, neuropathy, allergic dermatitis (rarely including toxic epidermal necrolysis and Stevens-Johnson syndrome), tachycardia, headache, insomnia

‫وو م‬ (.‫)و م.ف‬ ‫ز‬ ‫ا‬

‫و‬

Metronidazole and tinidazole
Metronidazole AMRIZOLE Injection Suppository Tablet Suspension Tablet Injection Suspension Tablet Vaginal pessaries Cream Tablet ‫ر‬ ‫ت‬ anaerobic infections (including dental), protozoal infections ; Helicobacter pylori eradication; skin
7.5—15 mg/kg IV q6h; 7.5 mg/kg PO q6h

‫ا‬

ANAZOL ELYZOL

ELYZOL VAG.PESSARIES ELYZOLE FLAGICURE

FLAGYL

Ovules Suspension Tablet Tablet Injection Injection Injection

FLAZOL
METRONIDAZOLE METRONIDAZOLE METRONIDAZOLE

gastro-intestinal disturbances (including nausea and vomiting), taste disturbances, furred tongue, oral mucositis, anorexia; very rarely hepatitis, jaundice, pancreatitis, drowsiness, dizziness, headache, ataxia, psychotic disorders, darkening of urine,

‫ا دوا‬ ‫ا ر‬ ‫ا ز رة‬ ‫ا ر‬ ‫اد ر‬ ‫ر‬ ‫ر‬ ‫ر‬ ‫ر‬ ‫ھرة‬ ‫ر‬ ‫ك‬ ‫ا‬ ‫اد‬ ‫ا‬ ‫اد‬ ‫ا‬ ‫ا‬

--‫ا‬ ‫ا‬ ‫ا‬ ‫ا ؤ‬ ‫ا ر‬ ‫ر‬

‫رون‬ ‫رورر‬ ) ( ‫ا ر‬ ‫وك‬

---‫ب‬ ‫ا ل‬ ‫دي‬ ‫رف‬ ------

‫أ وت‬ ‫ا ر‬ ‫. راون‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ا دودة‬ ‫ا رد‬ ‫ج‬ ‫ا دو‬ ‫ر‬ ‫ل‬

METROZOLE

Tablet

‫د‬

NEGAZOLE NIDAZOLE

Tablet Injection Suspension Tablet Tablet Gel Suspension

‫ر‬ ‫ا‬ ‫ا رد‬ ‫ار ض‬ ‫ر‬ ‫در‬ ‫ا ر‬ ‫وك‬ ‫ة‬

‫ا‬ ‫ا‬

RIAZOLE ROZEX Metronidazole FLAZOL

‫ا‬ ‫اط‬ ‫ا ة‬ ‫اط‬ ----

88

Scientific Name
benzoate Tinidazole

Trade Name

Dosage Form
Suspension Tablet Tablet

Indications

Side Effects

Contra-indications

Manufact urer
‫ار ض‬ ‫ر‬ ‫زر‬ ‫ا‬ ‫ر‬ ‫ا ة‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬

Drug Store
‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫ؤ‬ ‫ا‬

RIAZOLE FASIGYN PROTOGYN

anaerobic infections,; protozoal infections; Helicobacter pylori eradication

see under Metronidazole

Quinolones
Ciprofloxacin BACTALL Tablet By mouth, respiratory-tract infections, Urinary-tract infections, Chronic prostatitis, Gonorrhoea, Pseudomonal lower respiratorytract infection in cystic fibrosis, Surgical prophylaxis, Prophylaxis of meningococcal meningitis [not licensed]; flatulence, pain and phlebitis at injection site; rarely dysphagia, pancreatitis, tachycardia, hypotension, oedema, hot flushes, sweating, hyperglycaemia, and erythema nodosum; very rarely movement disorders, tinnitus, vasculitis, and tenosynovitis ‫ا رد‬ ‫ج‬ ‫ا دو‬ ‫ا رد‬ ‫ج‬ ‫ا دو‬ ‫ا ر‬ ‫ا و‬ ‫ا ود‬ ‫ت‬ ‫ا دوا‬ ‫ا ر‬ ‫ا و‬ ‫ا ود‬ ‫ت‬ ‫ا دوا‬ ‫را‬ ‫ا و‬ ‫ا ر‬ ‫دار ا دواء‬ ‫ا رد‬ ‫ا رام‬ ‫ا ر‬ ‫ا‬ ‫ا دو‬ ‫ا رد‬ ‫ار ض‬ ‫ر‬ ‫ا‬ ‫ا رد‬ ‫ا دوا‬ ‫ة‬ ‫ا‬ ‫ت‬ ‫ر‬ ‫ا دوا‬ ‫ا رد‬ CIPRO-SOL Injection ‫ا‬ ‫اط‬ ‫ا دودة‬ CIPROXEN Tablet ‫وم‬ ‫دو‬ FLOXACIN QUINOX SARF Levofloxacin TAVANIC Tablet Tablet Tablet Injection Tablet Tablet By mouth, acute sinusitis, Exacerbation of chronic bronchitis, ‫وك‬ ‫ر‬ ‫ر‬ ‫أ س ر‬ ‫د‬ ‫دو‬ ‫أم أ ش‬ ‫ا‬ ‫ر‬ ‫ا‬ -------‫ل‬ -----‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ --‫ؤ‬ ‫ا‬ ‫ا ر‬ ‫د ن‬ ‫د‬ ‫ا‬ ‫اط‬ ‫زو‬ ‫ا‬ ‫د‬ ‫د‬

BACTALL

Tablet

CIFLOX

Tablet

‫ا‬

CIFLOX

Tablet

CIPROBAY CIPROCIN CIPRODAR CIPROFLACIN CIPROFLOX

Injection Tablet Tablet Tablet Tablet Tablet

250–750 mg PO q12h; 200–400 mg IV q12h

CIPROGEN CIPROLON CIPROMAX CIPROQUIN

Tablet Injection Tablet Tablet

rarely anxiety, tachycardia, hypotension,

89

Scientific Name

Trade Name

Dosage Form

Indications

Side Effects

Contra-indications

Manufact urer

Drug Store

Communityacquired pneumonia, Chronic prostatitis, Skin and soft tissue infections; By intravenous infusion , Complicated urinary-tract infections, Skin and soft tissue infections.
250–500 mg/d PO, IV

hypoglycaemia, pneumonitis, rhabdomyolysis; local reactions and transient hypotension reported with infusion

Moxifloxacin HCl

AVALOX

Tablet

communityacquired pneumonia; exacerbation of chronic bronchitis; sinusitis.
400 mg qd PO

Nalidixic acid

ACIDO NALIDIXICO NALIDRAM NEGRAM

Suspension Tablet Tablet Tablet

urinary-tract infections

Norfloxacin

NORACIN

Tablet

NOROXIN

Tablet

Urinary-tract infections; Chronic relapsing urinary-tract infections; Chronic prostatitis
400 mg PO q12h; 800 mg as single dose for gonorrhea

UROXIN

Tablet

dry mouth, stomatitis, glossitis, flatulence, constipation, arrhythmias, palpitations, peripheral oedema, angina, blood pressure changes, dyspnoea, anxiety, and sweating; rarely hypotension, hyperlipidaemia, agitation, abnormal dreams, in coordination, toxic psychosis, increased intracranial pressure, cranial nerve palsy, metabolic acidosis , anxiety, tinnitus, polyneuropathy, exfoliative dermatitis, pancreatitis, vasculitis

severe hepatic impairment; history of QT-interval prolongation, bradycardia, history of symptomatic arrhythmias, heart failure with reduced left ventricular ejection fraction, electrolyte disturbances, concomitant use with other drugs known to prolong QT-wave interval

‫را‬

‫ا ر‬

‫رودس‬ ‫ا‬ ‫س‬ ‫ا و‬ ‫و‬ ‫و‬ ‫ز‬ ‫ا‬ ‫ا رد‬ ‫ج‬ ‫ا دو‬ .‫رك‬ ‫ش.دوم‬ ‫ا و د‬ ‫ر‬ ‫رة‬ ‫ر‬

‫أز‬ ‫ا‬

‫د‬ ‫ا‬

‫ر‬ tachycardia, transient hypotension, anxiety, unsteady gait, neuropathy, extrapyramidal symptoms, psychotic reactions (discontinue treatment); very ‫أ س ر‬ ‫د‬ ‫دو‬ ‫أم أ ش‬ ‫ا‬ ‫ر‬

‫ا‬

Ofloxacin

TARIVID

Tablet

By mouth, urinary-tract infections, Chronic prostatitis, Lower respiratory-tract infections, Skin and soft-tissue infections, Uncomplicated gonorrhoea, Uncomplicated

90

Scientific Name
Ofloxacin HCl

Trade Name

Dosage Form
Injection

Indications

Side Effects

Contra-indications

Manufact urer
‫أ س ر‬ ‫د‬ ‫دو‬ ‫أم أ ش‬ ‫ا‬

Drug Store
‫ر‬

TARIVID

genital chlamydial infection, nongonococcal urethritis, Pelvic inflammatory disease.
200–400 mg PO, IV q12h

rarely changes in blood sugar and vasculitic reactions; isolated cases of pneumonitis

Urinary-tract infections
Nitrofurantoin COLIFURAN Tablet urinary-tract infections anorexia, nausea, vomiting, and diarrhoea; acute and chronic pulmonary reactions (pulmonary fibrosis reported; possible association with lupus erythematosuslike syndrome); peripheral neuropathy; also reported, hypersensitivity reactions renal impairment; infants less than 3 months old, G6PD deficiency (including pregnancy at term, and breast-feeding of affected infants), porphyria ‫ا ھرة‬ ‫ا ر‬ ‫ا ؤ‬ ‫ا ر‬

Antifungal drugs
Caspofungin CANCIDAS Injection invasive aspergillosis either unresponsive to amphotericin or itraconazole or in patients intolerant of amphotericin or itraconazole; invasive candidiasis; empirical treatment of systemic fungal infections in patients with neutropenia
70 mg loading dose IV, followed by 50 mg/d IV

nausea, vomiting, abdominal pain, diarrhoea; tachycardia, flushing; dyspnoea; fever, headache; anaemia, decrease in serum potassium, hypomagnesaem ia; rash, pruritus, sweating; injection-site reactions; less commonly hypercalcaemia; also reported,

breast-feeding

.‫رك‬ ‫ش.دوم‬ ‫ا و د‬

‫ا‬

Clotrimazole

CANESTEN CANESTIN-1 CLOZOLE DERMATIN MICOTER

Cream Vaginal tab. Vaginal Cr Vaginal Tab Cream Vaginal Cr Powder Cream Cream ‫ة‬ ‫ت‬

‫ر‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫وك‬ ‫رو‬ ‫ا ر‬ ‫ا ون‬ ‫وزى‬ ‫ا‬ ‫ر ا‬

‫ا ر‬ ‫ا ر‬

---‫ا‬ ‫ا‬ ‫ؤ‬ ‫ا‬

Econazole

DERMACORYL

Cream

91

Scientific Name

Trade Name

Dosage Form

Indications

Side Effects

Contra-indications

Manufact urer
‫ا دوا‬ ‫ا رد‬ ‫ر ا‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ -‫ن‬ ‫ج‬ ‫ا و ر‬ ‫) ج‬ ‫إ ر ول‬ ( ‫ا و ر‬ ‫ا دوا‬ -‫ن‬ ‫ج‬ ‫ا و ر‬ ‫) ج‬ ‫إ ر ول‬ ( ‫ا و ر‬ ‫ن‬ ‫ج‬ ‫ا ط‬ ‫ر‬ ‫ت‬ ‫ا‬ ‫ا دوا‬ ‫ا طورة‬ ‫ا رد‬ ‫زر‬ ‫ا ط‬ ‫زر‬ ‫ا ر‬ ‫زر‬ ‫ا را‬ ‫ا‬ ‫ا رد‬

Drug Store

GYNO-CORYL

Vaginal Tab Vaginal Cr

‫ة‬

‫ؤ‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬

GYNOPEVARYL

Vag supp

PEVARYL PEVARYL

Cream Spray powder Spray soln

--‫ة‬ ‫ا‬ ‫اط‬

PEVARYL PV

Foaming sln

‫ة‬

‫ا‬ ‫اط‬ ‫ؤ‬ ‫ا‬

Fluconazole

CANDIVAST

Capsule

DIFLUCAN DIFLUCAN DIFLUCAN FLUCAND

Capsule Capsule Capsule Injection

Vaginal candidiasis and candidal balanitis, Mucosal candidiasis , Tinea pedis, corporis, cruris, pityriasis versicolor, and dermal candidiasis, Invasive candidal infections (including candidaemia and disseminated candidiasis) and cryptococcal infections
50–400 mg/d PO, IV

nausea, abdominal discomfort, diarrhoea, flatulence, headache, rash (discontinue treatment or monitor closely if infection invasive or systemic); less frequently dyspepsia, vomiting, taste disturbance, hepatic disorders, hypersensitivity reactions, nausea, vomiting, diarrhoea; headache; less frequently hepatotoxicity, dizziness, confusion, fatigue, sleep disturbances, impaired coordination, peripheral neuropathy, leucopenia, systemic lupus erythematosus, rash (including rarely erythema multiforme, very rarely nausea, vomiting, severe liver disease; systemic lupus erythematosus (risk of exacerbation); porphyria ; pregnancy (avoid pregnancy during and for 1 month after treatment; men should not father children within 6 months of treatment); breastfeeding

‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬

Griseofulvin

FULCIN

Syrup Tablet Tablet

GRISOVIN

dermatophyte infections of the skin, scalp, hair and nails where topical therapy has failed or is inappropriate
Microsize: 30–50 lb, 125–250 mg/d; >50 lb, 250–500 mg/d PO. Ultramicrosize: 30–50 lb, 82.5–165 mg/d; _50 lb, 165–330 mg/d in divided doses PO Microsize: 500 mg– 1g PO; Ultramicrosize: 330–750 mg PO

‫ز‬ ‫و‬ ‫ا رط‬

‫ا‬

Itraconazole

SPORANOX

Capsule

By mouth, oropharyngeal candidiasis,

-‫ن‬ ‫ج‬ ‫ا‬

‫ة‬

‫ا‬ ‫اط‬

92

Scientific Name

Trade Name

Dosage Form

Indications

Side Effects

Contra-indications

Manufact urer

Drug Store

Vulvovaginal candidiasis, Pityriasis versicolor, Tinea corporis and tinea cruris, Tinea pedis and tinea manuum, Onychomycosis, Histoplasmosis, Systemic aspergillosis, candidiasis and cryptococcosis
200–400 mg/d PO, IV as a single or divided dose

dyspepsia, abdominal pain, diarrhoea, constipation, jaundice, hepatitis , heart failure pulmonary oedema, headache, dizziness, peripheral neuropathy (discontinue treatment)

Ketoconazole

NIZORAL

PHILAZOLE VAVO

Cream Shampoo Tablet Shampoo Cream Shampoo

systemic mycoses, serious chronic resistant mucocutaneous candidiasis, serious resistant gastro-intestinal mycoses, chronic resistant vaginal candidiasis, resistant dermatophyte infections of skin or finger nails (not toe nails);
200 mg/d PO; may increase to 400 mg/d PO

Miconazloe

DAKTARIN

Tinctrue

CANDIZOL

Cream

Prevention and treatment of oral and intestinal fungal infections, Localized lesions,

DAKTARIN

Cream Oral gel Lotion

nausea, vomiting, abdominal pain; pruritus; less commonly diarrhoea, dyspepsia, headache, dizziness, photophobia, rash, and alopecia; rarely paraesthesia, impotence, and thrombocytopeni a; very rarely fatal liver damage nausea and vomiting, diarrhoea (usually on longterm treatment); rarely allergic reactions; isolated reports of hepatitis

-‫ن‬ ‫ج‬ hepatic impairment; breast-feeding ‫ا‬ ‫د‬ ‫ا رد‬ ‫وك‬

‫ة‬

‫ا‬ ‫اط‬

‫ا رق‬ ‫ا و ط‬ ----

hepatic impairment

‫ن‬ ‫ج‬ ‫دة‬ ‫ت‬ ‫ا ر‬ ‫ا‬

‫ة‬

‫ا‬ ‫اط‬

‫دي‬ ‫رف‬ ‫ة‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬

DAKTARIN

GYNO CANDIZOLE

Ovules

GYNODAKTARIN GYNOMIKOZAL HAIRSCIENCE ANTIDANDRUFF SHAMPOO MICONAZ MIKOZAL

Cream

Cream Ovules Shampoo

‫ا دوا‬ ‫ا رد‬ -‫ن‬ ‫ج‬ ‫ا‬ ‫ن‬ ‫ج‬ ‫ا ر‬ ‫ا دة‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ -‫ن‬ ‫ج‬ ‫ا‬ ‫ر‬ ‫ا و ر‬ ‫و ل‬ ‫ا را‬ ‫ا ن‬ ‫اط‬ ‫ر‬

‫دي‬ ‫رف‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫ؤ‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ر‬ ‫ا‬

‫ر‬

Cream Cream

93

000. neomycin . anorexia. --‫وم‬ ‫دو‬ 94 . skin infection 500. gramicidin KENACIN Cream Ointment Suspension Ointment Suspension Tablet Cream ‫ة‬ ‫ا‬ ‫اط‬ ---- ‫ؤ‬ ‫ا د‬ ‫د ت‬ ‫اط‬ ‫ؤ‬ ‫ا‬ Nystatin . diarrhoea at high doses.000–1. hydrocortisone CANDICORT Vaginal capsule Ovules Powder Vaginal suppositories Cream ‫ا‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ ‫ؤ‬ ‫ا د‬ ‫د ت‬ ‫اط‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫ر‬ DAKTACORT Cream MYCOHEAL HC Nystatin DERMOSE CUSI NYSTATIN MIKOSTAT Cream Ointment candidiasis. ringworm abdominal discomfort.000 U TID PO MYCOSAT Cream Ointment Suspension Suspension MYCOSTATIN Suspension nausea. vaginal infection .‫ا دوا‬ ‫ا ردن‬ ‫ر ول‬ ‫رز‬ ‫وب‬ ‫ا‬ ‫ار ض‬ ‫ر‬ ‫وك‬ ‫ا رز‬ ‫ا ر‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ ‫ر ول‬ ‫رز‬ ‫وب‬ ‫ا‬ ‫ا‬ ‫ؤ‬ ‫ا‬ ‫ؤ‬ ‫ا‬ RIANEST SINATEN Nystatin . oral irritation and sensitization. rash (including urticaria) and rarely StevensJohnson syndrome reported ‫ا ون‬ ‫وزى‬ ‫ا‬ ‫ر‬ ‫ر‬ ‫ن‬ ‫ت‬ . vomiting. zinc oxide MULTILIND Ointment Terbinafine LAMIFEN Cream Tablet dermatophyte infections of the nails. oral infection .Scientific Name Trade Name Dosage Form Cream Oral gel Vaginal suppositories Powder Indications Side Effects Contra-indications Manufact urer ‫دار ا دواء‬ ‫ا رد‬ -‫ن‬ ‫ج‬ ‫ا‬ ‫وم‬ ‫دو‬ ‫ا دة‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ -‫ن‬ ‫ج‬ ‫ا‬ ‫ر‬ ‫ا ن‬ ‫اط‬ ‫دار ا دواء‬ ‫ا رد‬ ‫ا رز‬ ‫ا ر‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ -‫ن‬ ‫ج‬ ‫ا‬ ‫دار ا دواء‬ ‫ا رد‬ Drug Store ‫ا‬ ‫اط‬ ‫ة‬ ‫ا‬ ‫اط‬ --‫دي‬ ‫رف‬ ‫ة‬ ‫ا‬ ‫اط‬ MYCOHEAL Miconazole nitrate DAKTARIN DERMIZOL Gel GYNO CANDIZOLE Ovules GYNODAKTARIN GYNOMIKOZAL MICONAZ MYCOHEAL Miconazole nitrate .

headache. diarrhoea.ف‬ ‫ز‬ ‫ا‬ ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا‬ ‫و‬ Abacavir . breast-feeding. zidovudine Lamivudine TRIZIVIR Tablet ‫و‬ EPIVIR Solution HIV infection in combination with other antiretroviral drugs ZEFFIX Solution 150 mg PO BID ZEFFIX Tablet peripheral neuropathy. severe hepatic impairment. hepatitis . lamivudine . nasal symptoms. fever. and myalgia. abdominal pain. fatigue. rarely liver toxicity (including jaundice. toxic epidermal necrolysis .‫)و م. cholestasis and hepatitis)— discontinue treatment. nausea.‫)و م. very rarely StevensJohnson syndrome and toxic epidermal necrolysis. headache. in combination with at least two other antiretroviral drugs 200 mg PO QD or BID rash including StevensJohnson syndrome and rarely.ف‬ ‫ز‬ ‫ا‬ ‫و‬ ‫ث‬ ‫ن‬ ‫ا د‬ ‫و‬ ‫ث‬ ‫ن‬ ‫ا د‬ ‫و‬ ‫و م‬ (.Scientific Name Trade Name Dosage Form Tablet Cream Solution Spray Indications Side Effects Contra-indications Manufact urer ‫و ر ز‬ ‫ا رط‬ ‫و ر ز‬ ( ‫)ز‬ ‫ا و ر‬ Drug Store ‫د‬ ‫د‬ LAMISIL Terbinafine HCl LAMISIL infections (including tinea pedis. rash and urticaria occasionally with arthralgia or myalgia. severity or extent) nausea. less commonly vomiting. postexposure prophylaxis ‫ر‬ ‫ا‬ 95 . and corporis) where oral therapy appropriate (due to site. alopecia breast-feeding ‫و‬ Nevirapine VIRAMUNE Tablet progressive or advanced HIV infection. angioedema Antiviral drugs HIV infection Abacavir ZIAGEN Solution HIV infection in combination with other antiretroviral drugs 300 mg BID ZIAGEN Tablet hypersensitivity reactions. muscle disorders including rhabdomyolysis. less commonly taste disturbance.ف‬ ‫ز‬ ‫ا‬ ‫و‬ ‫و م‬ (. cruris.‫)و م. rash and gastrointestinal disturbances more common in children breast-feeding ‫و‬ ‫ث‬ ‫ن‬ ‫ا د‬ ‫و‬ ‫و م‬ (.

200 mg q4h while awake for a total of 5 capsules/d. vomiting.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store rarely diarrhoea. diarrhoea. loss of mental acuity. chest pain.‫)و م.ف‬ ‫ز‬ ‫ا‬ ‫و‬ Herpesvirus infections Acyclovir ACIVIR CLOVIR CUSIVIRAL OFTALMICO DBL ACYCLOVIR HERPAVIR Cream Cream Tablet Ointment Injection Cream herpes simplex and varicella– zoster nausea. IV. 5–10 mg/kg q8h. ‫ار ض ر‬ ‫ا دوا‬ ‫ا ون وزى‬ ‫ا‬ ‫ن‬ ‫ا را‬ ‫ا رز‬ ‫ا ر‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ ‫ن‬ ‫ت‬ ‫ا دوا‬ ‫ا ردن‬ ‫ر‬ ‫ر‬ ‫ا رام‬ ‫ا‬ ‫زو‬ ‫ا‬ ‫ر‬ ‫ؤ‬ ‫ا د‬ ‫د ت‬ ‫اط‬ ‫ؤ‬ ‫ا‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ --- IMAVIR Cream Oral. breastfeeding ‫و‬ ‫و م‬ (. convulsions and drowsiness).ف‬ ‫ز‬ ‫ا‬ ‫و‬ ‫ث‬ ‫ن‬ ‫ا د‬ ‫و‬ RETROVIR Suspension Zidovudine . pruritus. drowsiness. prevention of maternal-fetal HIV transmission abnormally low neutrophil counts or haemoglobin values (consult product literature). cognitive dysfunction. less commonly anxiety. abdominal pain. jaundice. gynaecomastia anaemia (may require transfusion). neuropathy. neonates with hyperbilirubinaemia requiring treatment other than phototherapy.‫)و م. urinary frequency. topical، apply to lesions q3h LOVRAK VIRUSTAT Cream Ointment Tablet Tablet 96 . breast-feeding ‫ر ول‬ ‫رز‬ ‫ا ر‬ ‫ا‬ Zidovudine RETROVIR Capsule HIV infection in combination with other antiretroviral drugs. hallucinations. pruritus. photosensitivity. Stavudine ZERIT Capsule HIV infection in combination with other antiretroviral drugs 40 mg PO q12h peripheral neuropathy. dyspnoea. convulsions. gynaecomastia. insomnia. headache. abnormal dreams. depression. prevention of maternal-fetal HIV transmission ‫و‬ ‫و م‬ (. urticaria. confusion. very rarely hepatitis. anxiety. myopathy. taste disturbance. fatigue. dizziness. drowsiness. paraesthesia. lamivudine COMBIVIR Tablet HIV infection in combination with other antiretroviral drugs. neurological reactions (including dizziness. or with raised transaminase (consult product literature). depression. rash. influenza-like symptoms.

insomnia. drowsiness.ف‬ ‫ز‬ ‫ا‬ ‫و ث‬ ‫ن ر‬ ‫و ث‬ ‫نا د‬ ‫وو م‬ ‫ا‬ ‫ر‬ ‫و‬ ‫ا ر‬ ‫ا ود‬ ‫و رز‬ ‫ا‬ Drug Store ‫و‬ ZOVIRAX ZOVIRAX ZOVIRAX ZOVIRAX ZOVIRAX ---- Famciclovir FAMVIR Tablet treatment of herpes zoster. rash. diarrhoea. conjunctivitis. dizziness. very rarely vomiting. vomiting. hallucinations. StevensJohnson syndrome. and toxic epidermal necrolysis ‫روش‬ ‫ا و ر‬ 97 . HSV2:125 mg PO BID for 5 d rarely nausea.Scientific Name Trade Name Dosage Form Cream Suspension Injection Ointment Suspension Tablet Indications Side Effects Contra-indications Manufact urer ‫وو م‬ (. epistaxis. confusion. Treatment of influenza 75–150 mg/d PO nausea. dizziness. jaundice. headache. dyspepsia. prevention of cytomegalovirus disease following renal transplantation HSV type 2: 500 mg PO BID for 5 d. fatigue. abdominal pain and fever have been reported in immunocompromised patients see under Aciclovir but neurological reactions more frequent with high doses ‫د‬ Valaciclovir VALTREX Tablet treatment of herpes zoster. acute genital herpes simplex and suppression of recurrent genital herpes Herpes zoster: 500 mg PO q8h for 7 d. treatment of initial and suppression of recurrent herpes simplex infections of skin and mucous membranes including initial and recurrent genital herpes. headache. herpes zoster: 1 g PO TID for 7 d ‫ر‬ ‫و‬ ‫ود‬ ‫ا ر‬ ‫ا‬ ---- Influenza Oseltamivir phosphate TAMIFLU Capsule Prevention of influenza. very rarely hepatitis.‫)و م. abdominal pain. rash. and pruritus.

diarrhoea. drowsiness.‫)و م. or for relapse following previous Administered by aerosol with special aerosol generator pregnancy.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Respiratory syncytial virus Palivizumab SYNAGIS Injection preventing serious lower respiratory-tract disease caused by respiratory syncytial virus in children at high risk of the disease fever. nausea.‫آي‬ ‫ا ر‬ Antiprotozoal drugs Antimalarials Atovaquone . rarely apnoea. pain. particularly where resistance to other antimalarial drugs suspected. and rash. injection-site reactions. hypersensitivity reactions Worsening respiration. bacterial pneumonia. asthenia.ان‬ . rarely nonspecific anaemia and haemolysis hypersensitivity to humanized monoclonal antibodies ‫أ وت‬ ‫ا ر‬ ‫ب‬ ‫ل‬ ‫ا‬ Ribavirin VIRAZOLE Inhalation severe respiratory syncytial virus bronchiolitis in infants and children. constipation. proguanil HCl MALARONE Tablet treatment of acute uncomplicated falciparum malaria and prophylaxis of falciparum malaria. in combination with peg interferon alfa or interferon alfa for chronic hepatitis C not previously treated in patients without liver decompensation. less frequently mouth ulcers. rhinitis. abnormal dreams. anorexia. stomatitis. leucopenia. and pneumothorax reported. blood disorders. cough. fever. less commonly diarrhoea. wheeze. headache. pruritus. haemorrhage. treatment of benign malaria [unlicensed indication] Prevention: 1--2 d before travel 1 tablet PO per day during period of exposure and for 7 days after exposure. dizziness. insomnia. vomiting. vomiting. rash. nervousness.ف‬ ‫ز‬ ‫ا‬ ‫و‬ 98 . hyperkinesia. breast-feeding _ ‫. Treatment: 4 tablets PO daily for 3d abdominal pain. hyponatraemia and hair loss ‫و‬ ‫و م‬ (. cough.

Prevention: 300 mg PO weekly. arthralgia. and rash. vomiting. ECG changes. convulsions (in infants) and rash (including Stevens- ‫ا رد‬ ‫ج‬ ‫ا دو‬ ‫ر‬ -‫ن‬ ‫ج‬ ‫ا‬ ‫د‬ ‫ا ر‬ ‫ا ة‬ ‫اط‬ 99 . convulsions. significant renal impairment. and hookworm infections 100 mg PO morning and PARAZOLE VERMOX Tablet Suspension Tablet very rarely abdominal pain. diarrhoea. fever. nausea.Scientific Name Chloroquine Trade Name Dosage Form Tablet Indications Side Effects Contra-indications Manufact urer ‫ك‬ ‫رون‬ ‫رورر‬ ) ( ‫ا ر‬ ‫ا ر‬ ‫اد ر‬ ‫رون ك‬ ‫رورر‬ ) ( ‫ا ر‬ ‫ر‬ ‫ا‬ ‫رو‬ ‫ا ر‬ ‫ار ض‬ ‫ر‬ ‫ا ر‬ ‫اد ر‬ ‫ر‬ ‫ا‬ Drug Store ‫ر‬ NIVAQUINE MALAREX NIVAQUINE Tablet Injection Syrup chemoprophylaxis and treatment of malaria. flushing. 160–200 mg (4–5 mL) IM and repeat in 6 h if necessary. rarely. substernal pain . abdominal pain. hypersensitivity reactions such as urticaria and angioedema. bonemarrow suppression. breastfeeding ‫ا و‬ ‫ا ر‬ ‫د‬ ‫د ن‬ Leishmaniacides Sodiumstibogluconate PENTOSTAM Injection leishmaniasis anorexia. urticaria. breastfeeding ‫وو م‬ (. treatment: initially 600 mg PO and 300 mg PO 6 h later.‫)و م. vertigo. myalgia. sweating. FURAZOLE metronidazole Tablet flatulence. pruritus). lethargy. skin reactions (rashes. pruritus pregnancy . also hypotension. bleeding from nose or gum. depigmentation or loss of hair. vomiting. vomiting. whipworm. breastfeeding ‫ل وس‬ ‫ز‬ ‫ا‬ ‫با‬ Diloxanide furoate . rarely jaundice. urticaria. diarrhoea. ‫ا‬ ‫ر‬ ‫ا ر‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫ا ر‬ ‫ة‬ Amoebicides Diloxanide furoate FURAMIDE Tablet chronic amoebiasis and as adjunct to metronidazole or tinidazole in acute amoebiasis chronic amoebiasis and as adjunct to metronidazole or tinidazole in acute amoebiasis flatulence. coughing. roundworm. headache. pruritus pregnancy .ف‬ ‫ز‬ ‫ا‬ ‫و‬ Anthelmintics Mebendazole BENDAZOLE Tablet threadworm. visual disturbances. rheumatoid arthritis and lupus erythematosus Treatment: Dose expressed as base. headache. then 300 mg/d PO for 2 d RESOCHIN Chloroquine phosphate CHLOROQUIN PHOSPHATE CHLOROQUINE MALAREX RESOCHIN Injection Syrup Syrup Tablet Syrup Tablet gastro-intestinal disturbances.

dizziness Parenchymal neurocysticerosis due to pork tapeworms. pinworm: 100 mg PO as a single dose Johnson syndrome and toxic epidermal necrolysis) Abnormal liver function tests. hydatid disease (caused by the larval form of the dog tapeworm) >/_60 kg: 400 mg BID: <60 kg: 15 mg/kg/d 100 . abdominal pain.Scientific Name Trade Name Dosage Form Tablet Indications Side Effects Contra-indications Manufact urer ‫ن‬ ‫ج‬ ‫ا ر‬ ‫وك‬ ‫ر‬ Drug Store ‫ة‬ ‫ا‬ ‫اط‬ ---‫ر‬ ‫ا‬ VERMOX WORMAZOL Albendazole ALBENDA Suspension Tablet Suspension Tablet evening for 3 consecutive d. nausea. vomiting. headache.

......................................................................................................................Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Endocrine system Drugs used in diabetes 102 Insulins .......... 102 Oral antidiabetic drugs .................................................................................................................................................................................................................. 112 Posterior pituitary hormones and antagonists ......... 112 Hypothalamic and pituitary hormones and anti-oestrogens 112 Anti-oestrogens ....... 111 Anabolic steroids ................................................... 106 Thyroid and antithyroid drugs 106 Corticosteroids 107 Sex hormones 108 Female sex hormones ................................................... 109 Male sex hormones and antagonists ............................................................................... 103 Treatment of hypoglycaemia ...... 113 Drugs affecting bone metabolism 113 Other endocrine drugs 114 101 ... 112 Anterior pituitary hormones ...................................................................................................................................................................................................................

5 0.5 2 2 3 1 2 3 4 2 4 Peak (h) 2-5 1-3 1-3 2-6 1-3 1-1.5 2-12 2-12 2-12 2-12 2-12 1.5 0.5/1 0.5 1-8 1-8 4-8 4-12 5-10 4-12 2-8 6-12 4-12 7-15 4-16 8-12 7-15 8-24 6-14 10-20 Duration (h) 8 8 5-7 8 8 2-5 24 24 24 24 24 16-18 14-16 14-15 14-15 14-15 24 22 18 24 18-20 24 24 24 24 30 24 28 20-24 36 Biphasic Insulin Human Mixtard 10 (pyr) H Human Mixtard 20 (pyr) H Human Mixtard 30 (pyr) H Human Mixtard 40 (pyr) H Human Mixtard 50 (pyr) H Humulin M1 (prb) H Humulin M2 (prb) H Humulin M3 (prb) H Humulin M4 (prb) H Humulin M5 (prb) H Pork Mixtard P Rapitard MC P/B Insulin zinc suspension (amorphous) Semitard MC p Isophane insulin Human Insulatard (pyr) H Humulin I (prb) H Hypurin Isophane B Pork Insulatard P Insulin zinc suspension (mixed) Human Monotard (pyr) H Humulin Lente (prb) H Hypurin Lente B Lentard MC B/P Insulin zinc suspension (crystalline) Human Ultratard (pyr) H Humulin Zn (prb) H Protamine zinc Hypurin Protamine Zinc B Insulin preparations are classified as being of human (H).5 0.5 0.5-9 1-9. enzymatically modified pork.5 0.5 0. prb.5 0.5 0. emp.5 0. pyr.25 0. proinsulin recombinant bacteria. precursor yeast recombinant.5 0.5 0.5 0. beef (B) or pork (P) origin.5 0.5 0.5 2 2 2 0.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Drugs used in diabetes Insulins Insulin Preparations Neutral Insulin Human Actrapid (pyr) Human velosulin (emp) Human S (prb) Hypurin Neutral Pork velosulin Humalog (Insulin Lispro) Origin H H H B P H Onset (h) 0. 102 .5 1-8.

duration = 24 – 36 hr) Insulin zinc ULTRATARD HM HUMULIN U Injection diabetes mellitus ‫وو‬ ‫ورد ك‬ ‫اد ر‬ ‫ا‬ ‫ا ر‬ ‫ؤ‬ ‫ا‬ ‫و‬ Insulin Zn HM Injection diabetes mellitus 103 . diabetic ketoacidosis diabetes mellitus diabetes mellitus. rash. peak = 18 hr. rarely hypersensitivity reactions including urticaria. diabetic ketoacidosis Insulin nutrale Injection Intermediate-acting insulins (onset = 1 – 4 hr. ‫وو‬ ‫ورد ك‬ ‫اد ر‬ ‫ا‬ ‫ا ر‬ ‫ا‬ ‫ا ر‬ ‫وو‬ ‫ورد ك‬ ‫اد ر‬ ‫وو‬ ‫ورد ك‬ ‫اد ر‬ ‫ؤ‬ ‫ا‬ ‫و‬ ‫و‬ ‫ؤ‬ ‫ا‬ ‫ؤ‬ ‫ا‬ Insulin human HUMULIN-R Injection Human insulin-R Insulin neutral HUMULIN-R ACTRAPID INSULIN HM ACTRAPID HM Injection Injection diabetes mellitus. diabetic ketoacidosis diabetes mellitus. duration = 2 – 4 hr) Insulin lispro HUMALOG Injection Diabetes mellitus ‫ا‬ ‫ا ر‬ ‫و‬ Short-acting insulins (onset = 0. peak = 2 – 4 hr.5 – 1 hr. Insulin HM isophane HUMULIN NPH HUMULIN-NNPH INSULATARD HM MONOTARD Injection Injection Injection diabetes mellitus ‫و‬ ‫و‬ ‫ؤ‬ ‫ا‬ ‫ؤ‬ ‫ا‬ ‫و‬ ‫و‬ Insulin HM monocomponent Insulin lente Insulin lispro .Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Ultra-short-acting insulins (onset = 0 – 0. overdose causes hypoglycaemia. peak = 1 – 2 hr. duration = 16 – 24 hr) Insulin aspart . peak = 6 – 10 hr. local reactions and fat hypertrophy at injection site. duration = 6 – 8 hr) Insulin aspart NOVORAPID Injection diabetes mellitus transient oedema. rarely hypersensitivity reactions including urticaria. insulin protamine Injection diabetes mellitus HUMULIN-L HUMALOG MIX Injection Injection diabetes mellitus diabetes mellitus Long-acting insulins (onset = 4 – 6 hr. overdose causes hypoglycaemia. rash.25 hr. insulin aspart protamine Insulin biphasic NOVOMIX Injection diabetes mellitus ‫وو‬ ‫ورد ك‬ ‫اد ر‬ ‫ا‬ ‫ا ر‬ ‫ا‬ ‫ا ر‬ ‫ا‬ ‫ا ر‬ ‫وو‬ ‫ورد ك‬ ‫اد ر‬ ‫أ س ر‬ ‫د‬ ‫دو‬ ‫أم أ ش‬ ‫ا‬ ‫ا‬ ‫ا ر‬ ‫ا‬ ‫ا ر‬ ‫وو‬ ‫ورد ك‬ ‫اد ر‬ ‫وو‬ ‫ورد ك‬ ‫اد ر‬ ‫ا‬ ‫ا ر‬ ‫ا‬ ‫ا ر‬ ‫ؤ‬ ‫ا‬ ‫و‬ ‫و‬ ‫و‬ ‫ؤ‬ ‫ا‬ ‫ر‬ HUMULIN PROFILE 70/30 HUMULIN PROFILE 80/20 HUMULIN 70/30 MIXTARD Injection diabetes mellitus Injection Injection Injection Insulin glargine LANTUS Injection diabetes mellitus transient oedema. local reactions and fat hypertrophy at injection site.

metformin Gliclazide GLUCOVANC E DIAMICRON DIAMICRON MR GLAZE GLIZIDE Glimepiride AMARYL Tablet ‫دة‬ Tablet Tablet Tablet Tablet Tablet Tablet ‫ا ر‬ ‫ا‬ ‫دو‬ ‫ا ة‬ ‫اط‬ ‫ا‬ ‫ا‬ Glipizide GLIBENESE MINIDIAB SUCRAZIDE Tablet Tablet Tablet type 2 diabetes mellitus ‫ا‬ ‫ا‬ ‫ا‬ ‫اط‬ Biguanides Metformin FORMIT GLUCARE GLUCOPHAGE Tablet Tablet Tablet diabetes mellitus. diarrhoea (usually renal impairment.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Oral antidiabetic drugs Sulphonylureas Chlorpropamide Glibenclamide (Glyburide) DIABINESE APOGLYBURIDE DAONIL Tablet Tablet Tablet type 2 diabetes mellitus type 2 diabetes mellitus ‫زر‬ ‫ا‬ Mild and infrequent and include gastrointestinal disturbances.g. vomiting. polycystic ovary syndrome [unlicensed indication] anorexia. sepsis. withdraw if tissue hypoxia likely (e. hypoglycaemia. Sulphonylureas should be avoided where possible in severe hepatic and renal impairment and in porphyria. Blood disorders. Hypersensitivity. ‫أو س‬ ‫ا د‬ ‫أ س ر‬ ‫د‬ ‫دو‬ ‫أم أ ش‬ ‫ا‬ ‫ا دوا‬ ‫ا ر‬ ‫ا و‬ ‫ا ود‬ ‫ت‬ ‫ا دوا‬ ‫روش‬ ‫دا و ك‬ ‫أ‬ ‫ا دة‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ ‫ا‬ ‫ا رد‬ ‫ر‬ ‫أ ون‬ (‫)ا ون‬ ‫أر‬ ‫و و رم‬ ‫ا دودة دا‬ type 2 diabetes mellitus type 2 diabetes mellitus type 2 diabetes mellitus type 2 diabetes mellitus type 2 diabetes mellitus type 2 diabetes mellitus ‫ار ض ر‬ ‫ر‬ ‫ا ر‬ ‫ر‬ ‫ا ر‬ ‫ا دوا‬ ‫وك‬ ‫أ س ر‬ ‫د‬ ‫دو‬ ‫أم أ ش‬ ‫ا‬ ‫زر‬ ‫ا‬ ‫ر‬ ‫ا ط‬ ‫دار ا دواء‬ ‫ا رد‬ -----‫ر‬ ‫ر‬ ‫ا ز رة‬ ‫ر‬ ‫ا‬ DIATAB DOABETIC Tablet Tablet --‫ا‬ EUGLUCON Tablet GLIBEMIDE Tablet ‫دي‬ ‫رف‬ ‫ا‬ ‫ر‬ GLIBIL MICRONASE Tablet Tablet NOVOGLYBURIDE Glibenclamide . They should not be used while breastfeeding and insulin therapy should be substituted during pregnancy. nausea. disturbance in liver function. ketoacidosis. respiratory ‫ا دوا‬ ‫ا ز رة‬ ‫رك‬ ‫اس ا اس‬ ----‫ة‬ ‫ا‬ ‫اط‬ 104 .

use of iodine-containing X-ray contrast media (do not restart metformin until renal function returns to normal) ‫ا‬ ‫اط‬ ‫ا ر‬ ‫دي‬ ‫رف‬ ‫ة‬ ---‫ا‬ ‫اط‬ ‫ا دوا‬ ‫ا رد‬ ‫ار ض ر‬ ‫وك‬ Rosiglitazone . oedema. pruritus and urticaria. ulcerative colitis. proteinuria. combination with insulin (risk of heart failure). dizziness. less commonly hypoglycaemia. soft stools. pregnancy and breast-feeding. hypersensitivity reactions including pregnancy. abdominal pain. recent myocardial infarction. erythema. Crohn's disease). diarrhoea. hypoaesthesia. visual disturbances. jaundice. vomiting. hernia. insomnia. history of abdominal surgery ‫را‬ ‫ا ر‬ Pioglitazone ACTOS Tablet type 2 diabetes mellitus (alone or combined with metformin or a sulphonylurea) GLUSTIN Tablet hepatic impairment. severe hepatic impairment. hepatic impairment. impotence. rarely. fatigue. and hepatitis reported gastro-intestinal disturbances. vertigo. constipation. decreased vitamin-B12 absorption. diarrhoea (may need to reduce dose or withdraw). history of heart failure. inflammatory bowel disease (e.g. renal impairment. hepatic impairment). headache. hepatitis also reported failure. altered blood lipids. ileus. sweating. partial intestinal obstruction (or predisposition). abnormal liver function tests and skin reactions. breastfeeding. metformin AVANDAMET Tablet ‫ن‬ ‫ث‬ ‫م‬ -‫ر و‬ ‫ور ور و‬ ‫ة‬ ‫ا‬ ‫اط‬ Other antidiabetics Acarbose GLUCOBAY Tablet diabetes mellitus inadequately controlled by diet or by diet with oral antidiabetic drugs flatulence.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫ا ر‬ ‫و وو‬ ‫ا‬ ‫ر‬ ‫دة‬ ‫ت‬ ‫ا‬ Drug Store MELBIN DIALON DIAPHAGE Tablet Tablet Tablet GLUCOPHAGE METFOR Tablet Tablet transient). metallic taste. arthralgia. weight gain. rarely lactic acidosis (withdraw treatment). abdominal pain. haematuria. abdominal distention and pain. breastfeeding ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ا‬ ‫ا ر‬ ‫و‬ ‫ا‬ Repaglinide NOVONORM Tablet type 2 diabetes mellitus (as monotherapy or in combination with metformin when metformin alone inadequate) Ketoacidosis. ‫و و ورد ك‬ ‫اد ر‬ ‫ؤ‬ ‫ا‬ 105 . oedema. anaemia. nausea. rarely hypoglycaemia. pregnancy.

rashes and pruritus. hepatic impairment. jaundice hypersensitivity reactions including coryzalike symptoms. headache. abdominal pain. potassium iodide TINCTURE IODINE Tincture thyrotoxicosis (preoperative) breast-feeding ‫را‬ . rashes. on prolonged treatment ‫روش‬ ‫ا رط‬ Iodine . alopecia. urticaria. history of heart failure. hypoglycaemia.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store pruritus. and visual disturbances Rosiglitazone maleate AVANDIA Tablet type 2 diabetes mellitus (alone or combined with metformin or with a sulphonylurea or with both) gastro-intestinal disturbances. paraesthesia. rarely hypersensitivity reactions phaeochromocytoma ‫وو‬ ‫ورد ك‬ ‫اد ر‬ ‫ا‬ ‫ا ر‬ ‫ؤ‬ ‫ا‬ ‫و‬ GLUCAGON Injection Thyroid and antithyroid drugs Carbimazole NEO MERCAZOLE Tablet hyperthyroidism nausea. oedema. fatigue. rashes. conjunctivitis.‫ك‬ ‫ا‬ ‫ورو‬ 106 . hypotension. mild gastro-intestinal disturbances. Beta-blocker poisoning. anaemia. rarely pulmonary oedema. Diagnostic aid. bone marrow suppression. lacrimation. weight gain. alopecia. less commonly increased appetite. combination with insulin (risk of heart failure). pain in salivary glands. heart failure. nausea. headache. hypokalaemia. vasculitis. breastfeeding ‫ن‬ ‫ث‬ ‫م‬ -‫ر و‬ ‫ور ور و‬ ‫ة‬ ‫ا‬ ‫اط‬ Treatment of hypoglycaemia Glucagon GLUCAGEN Injection Insulin-induced hypoglycaemia. headache. arthralgia. altered blood lipids. dyspnoea. rarely myopathy. vomiting. pregnancy. laryngitis. bronchitis. very rarely angioedema.

diarrhoea. avoid live virus vaccines in those receiving immunosuppress ive doses (serum antibody response diminished) ‫ا‬ ‫ا رد‬ ‫ر‬ ‫ر‬ ‫ر‬ ‫و‬ ‫ا‬ ‫ر‬ ‫و‬ ‫ا‬ ‫ر‬ ‫و‬ ‫ا‬ DECADRON SHOCK PACK Injection ‫رك‬ ‫رب‬ ‫ودوم‬ ‫ا را‬ . tremors. heat intolerance leucopenia. bruising. arrhythmias. nephritis. acne. encephalopathy. skin atrophy. vomiting. headache. telangi-ectasia. ش‬ ‫دوم‬ ‫ا و د‬ ‫و ر ز‬ ) ‫ا‬ ‫ر‬ ‫ر‬ ‫ر‬ ‫ا‬ ‫ا‬ Betamethasone acetate . hepatic necrosis. insomnia. palpitation.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store depression. nose gastro-intestinal . fever. eye. striae. ophthalmic. hypoprothrombin aemia. excitability. insomnia. flushing. congenital adrenal hyperplasia. sweating. thrombocytopeni a. systemic infection (unless specific antimicrobial therapy given). neuropsychiatric. betamethsone sodium phosphate Betamethasone sodium phosphate . lupus erythematouslike syndromes thyrotoxicosis ‫و‬ ‫ود‬ ‫ر‬ ‫ا ر‬ ‫ا‬ ---- ‫در‬ ‫ا ر‬ Corticosteroids Betamethasone BETACORT BETASONE CELESTONE Injection Tablet Tablet suppression of inflammatory and allergic disorders. skeletal muscle cramps. impaired healing. goitre in infants of mothers taking iodides L-thyroxine sodium ELTROXIN Tablet hypothyroidism Propylthiouracil PROPYLTHIOU RACIL Tablet hyperthyroidism anginal pain. impotence. tachycardia.‫رك. endocrine. rarely cutaneous vasculitis. musculoskeletal. restlessness. hepatitis. ear. betamethasone dipropionate Dexamethasone CELESTONE CHRONODOSE Injection DIPROFOS Injection DECADRON Tablet ‫ا‬ ‫د‬ MILLICORTEN 107 . aplastic anaemia.

cerebral oedema associated with malignancy. inflammatory bowel disease. 5—60 mg/d PO Prednisolone gastro-intestinal . gastro-intestinal . acne. musculoskeletal. rheumatic disease. ophthalmic.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Se x ho rm on es Fe ma le se x ho rm on es ORADEXON Methyl prednisolone MEDROL URBASON Tablet Tablet Tablet suppression of inflammatory and allergic disorders. striae. acne. telangi-ectasia. impaired healing. neuropsychiatric. skin atrophy. immunosuppression. Triamcinolone KENACORT-A Injection Suppression of inflammatory and allergic disorders. impaired healing.SUCCINATE SOLU-MEDROL DELTACORTRIL GUPISONE PREDNISOLONE Injection Injection Tablet Tablet Tablet Suppression of inflammatory and allergic disorders. endocrine. skin atrophy. skin gastro-intestinal . asthma. musculoskeletal. under Prednisolone 108 . Prednisolone hydrogen succinate sodium SOLUDACORTIN Injection Suppression of inflammatory and allergic disorders. endocrine. avoid live virus vaccines in those receiving immunosuppress ive doses (serum antibody response diminished) systemic infection (unless specific antimicrobial therapy given). asthma. bruising. avoid live virus vaccines in those receiving immunosuppress ive doses (serum antibody response diminished) systemic infection (unless specific antimicrobial therapy given). inflammatory bowel disease. bruising. skin atrophy. acne. ophthalmic. neuropsychiatric. bruising. rheumatic disease. musculoskeletal. bruising. telangi-ectasia. avoid live virus vaccines in those receiving immunosuppress ive doses (serum antibody response diminished) systemic infection (unless specific antimicrobial therapy given). systemic infection (unless specific antimicrobial therapy given). avoid live virus vaccines in those receiving immunosuppress ive doses (serum antibody response diminished) under Prednisolone Methyl prednisolone sodium succinate METHYL PREDNISOLONE SOD. immunosuppression. musculoskeletal. impaired healing. striae. telangi-ectasia. immunosuppression. impaired healing. rheumatic disease. acne. endocrine. mouth. rheumatic disease. telangi-ectasia. skin atrophy. striae. Prednisone DELTASONE Tablet PREDONE Tablet Suppression of inflammatory and allergic disorders. rheumatic disease. neuropsychiatric. skin. endocrine. neuropsychiatric. ophthalmic. inflammatory bowel disease. striae. ophthalmic. 5—60 mg/d PO gastro-intestinal . asthma.

menorrhagia . weight gain. history of breast cancer. cholestatic jaundice. glucose intolerance. depression. Estradiol . They are also contraindicated in those with genital or breast cancer (unless progestogens are being used in the management of these conditions). dizziness. and in severe liver impairment. breast tenderness). ‫ا و د‬ ‫ر‬ Estradiol . Dubin-Johnson and Rotor syndrome Progestogens should be avoided in patients with a history of liver tumors. weight changes. rashes Progestogens should be avoided in patients with a history of liver tumors. Postponement of menstruation. dydrogestrone FEMOSTON Tablet Menopausal symptoms and osteoporosis prophylaxis . depression. Progestogenic opposition of menopausal oestrogen HRT Side-effects of progestogens include menstrual disturbances. drowsiness. Dysmenorrhoea. Recurrent miscarriage due to inadequate luteal phase . fluid retention. Dysfunctional uterine bleeding. headache. and in severe liver impairment. fluid retention. premenstrual-like syndrome. contraception . in women with intact uterus dysfunctional uterine bleeding. Amenorrhoea. headache. They are also contraindicated in those with genital or breast cancer (unless progestogens are being used in the management of these conditions). drowsiness. breast tenderness). sodium and fluid retention. premenstrual-like syndrome (including bloating. Premenstrual syndrome. pain. also skin reactions nausea and vomiting. breast enlargement and tenderness. in women with intact uterus ‫و‬ ‫ر‬ ‫و ز‬ . ‫ا و د‬ Drug Store ‫ر‬ DUPHASTON Endometriosis. nausea. Endometriosis. or history of recurrent venous thromboembolism. Progestogens should be avoided in patients with a history of liver tumors. Dysmenorrhoea . abdominal cramps and bloating. liver disease . also skin reactions ‫ر‬ ‫ا‬ ‫ب‬ ‫ل‬ ‫ا‬ 109 . Hormone replacement therapy Side-effects of progestogens include menstrual disturbances. premenstrual-like syndrome (including bloating. active thrombophlebitis. norethisterone ESTRACOMB TTS Patch Menopausal symptoms and osteoporosis prophylaxis . Premenstrual syndrome. Dysfunctional uterine bleeding. insomnia. active or recent arterial thromboembolic disease . and in severe liver impairment. pregnancy. altered blood lipids–may lead to pancreatitis. They are also contraindicated in those with genital or breast cancer (unless progestogens are being used in the management of these conditions). oestrogendependent cancer. malignant disease . venous thromboembolism. diarrhoea and flatulence can occur with rectal administration ‫ر‬ ‫ا‬ ‫ب‬ ‫ل‬ ‫ا‬ Norethisterone PRIMOLUT-N Tablet HRT . vitro fertilization or gamete intrafallopian transfer ‫د‬ Hydroxy progesterone caproate PROLUTON DEPOT Injection injection-site reactions. weight gain. nausea. insomnia. dizziness.Scientific Name Dydrogesterone Trade Name Dosage Form Tablet Indications Side Effects Contra-indications Manufact urer ‫و‬ ‫ر‬ ‫و ز‬ .

glucose intolerance. liver disease . altered blood lipids–may lead to pancreatitis. rashes OESTRADIOL VALERATE 2mg+ OESTRADIOL 2mg WITH NORGESTRIL 0. osteoporosis prophylaxis in abdominal pain. active thrombophlebitis.Scientific Name Oestradiol Trade Name Dosage Form Patch Indications Side Effects Contra-indications Manufact urer Drug Store ‫د‬ ESTRADERM MX-100 Menopausal symptoms and osteoporosis prophylaxis ESTRADERM MX-25 Patch ESTRADERM MX-50 VAGIFEM Patch Tablet nausea and vomiting. rashes Tibolone LIVIAL Tablet short-term treatment of symptoms of oestrogen deficiency (including women being treated with gonadotrophin releasing hormone analogues). breast enlargement and tenderness. breast enlargement and tenderness. premenstrual-like syndrome. gastrointestinal disturbances. sodium and fluid retention. oestrogendependent cancer. history of breast cancer. glucose intolerance. cholestatic jaundice. oedema. weight changes. cholestatic jaundice. headache. history of cardiovascular or cerebrovascular disease (e. or history of recurrent venous thromboembolism. depression. leucorrhoea. cholestatic jaundice. active thrombophlebitis. premenstrual-like syndrome. oestrogendependent cancer. venous thromboembolism. weight changes. oestrogendependent cancer. venous thromboembolism. ‫د‬ ‫د‬ ‫وو‬ ‫ورد ك‬ ‫اد ر‬ ‫ر‬ ‫ا‬ ‫ب‬ ‫ل‬ ‫ؤ‬ ‫ا‬ ‫ا‬ ‫وا ث‬ ‫ا د‬ ‫وا ـث‬ ‫ا رط‬ ‫ا‬ ‫اط‬ ‫زن‬ ‫ا دو‬ ‫ا ر‬ ‫ون‬ ‫اور‬ ‫ا و د‬ ‫و‬ 110 .5mg (11+10)TAB PROGYLUTON Tablet Menopausal symptoms and osteoporosis prophylaxis nausea and vomiting. breast enlargement and tenderness. dizziness. vaginal bleeding. abdominal cramps and bloating. or history of recurrent venous thromboembolism. breast pregnancy. venous thromboembolism. glucose intolerance. thrombophlebitis. uninvestigated vaginal bleeding. altered blood lipids–may lead to pancreatitis. liver disease . sodium and fluid retention. thromboembolism). or history of recurrent venous thromboembolism. migraine. weight changes. premenstrual-like syndrome. abdominal cramps and bloating. Dubin-Johnson and Rotor syndrome pregnancy. altered blood lipids–may lead to pancreatitis. history of breast cancer. liver disease .g. facial hair. active or recent arterial thromboembolic disease . sodium and fluid retention. severe liver disease. weight changes. history of breast cancer. active or recent arterial thromboembolic disease . Dubin-Johnson and Rotor syndrome hormonedependent tumors. and rarely amnesia. active thrombophlebitis. rashes Oestrogens conjugated PREMARIN PREMPAK C Tablet Tablet Menopausal symptoms and osteoporosis prophylaxis nausea and vomiting. abdominal cramps and bloating. Dubin-Johnson and Rotor syndrome pregnancy. active or recent arterial thromboembolic disease .

changes in libido. malignant or wasting disease. severe depression. history of thromboembolic disorders. gastrointestinal bleeding. history of primary liver tumors. seborrhoeic dermatosis pregnancy. gynaecomastia. Testicular pain. visual disturbances. headache. testosterone enantate Testosterone undecanoate TESTOVIRON SUSTANON SUSTANON Injection Injection Injection breast cancer in men. polycythaemia. nausea. weight changes. hypertension. arthralgia. anxiety. reduced sebum production (may clear acne). paraesthesia. myalgia. and breast tenderness and enlargement. testosterone enantate Testosterone propionate . cholestatic jaundice. The side-effects of dutasteride and finasteride include impotence.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store women at risk of fractures (secondline) cancer . breastfeeding .prostate cancer fatigue and lassitude. breathlessness. prostate cancer. electrolyte disturbances including (do not apply in prostate cancer) hepatic disease. prostate abnormalities and prostate cancer. ejaculation disorders. decreased libido. breastfeeding Male sex hormones and antagonists Cyproterone acetate ANDROCUR Tablet severe hypersexuality and sexual deviation . hypercalcaemia. hypersensitivity reactions. male-pattern baldness in men PROSCAR Tablet ‫رك‬ ‫رب‬ ‫ودوم‬ ‫ا را‬ ‫رك‬ ‫رب‬ ‫ودوم‬ ‫ا را‬ ‫ا‬ ‫ا‬ Mesterolone PROVIRON Tablet Androgen deficiency and male infertility associated with hypogonadism hypogonadism androgen deficiency androgen deficiency Testosterone enantate Testosterone esters Testosterone propionate . gynaecomastia (rarely leading to galactorrhoea and benign breast nodules). rash and osteoporosis. nephrotic syndrome ‫ر‬ ‫ا‬ ‫ب‬ ‫ل‬ ‫ا‬ ‫ر‬ ‫ون‬ ‫د‬ ‫ون‬ ‫د‬ ‫ا‬ ‫اور‬ ‫ا و‬ ‫اور‬ ‫ا و‬ ‫ر‬ ‫ا‬ ‫ون‬ ‫اور‬ ‫ا و د‬ ‫ب‬ ‫ا ل‬ ‫و‬ ‫و‬ TESTOVIRON Injection androgen deficiency ‫ب‬ ‫ل‬ ‫و‬ ‫ا‬ ANDRIOL Capsule Androgen deficiency 111 . youths under 18 years ‫ر‬ ‫اس اي‬ ‫ا ر‬ ‫ب‬ ‫ل‬ ‫ا‬ Finasteride PROPECIA Tablet benign prostatic hyperplasia. pregnancy . depression. asthenia. severe diabetes (with vascular changes). changes in hair pattern. sicklecell anaemia. rarely hypersensitivity reactions.

There is no justification for their use in primary gonadal failure oedema (particularly in males—reduce dose). headache. male breast cancer. breast tenderness. premature epiphyseal closure. ‫إ ـ‬ ‫ا و ر‬ ‫رو و‬ ‫ا ط‬ ( ‫) وو‬ ‫اور ون‬ ‫ا و د‬ ‫ؤ‬ ‫ن‬ ‫ر‬ ‫و‬ ‫ا‬ ‫ا‬ 112 . depression. local reactions.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Anabolic steroids Nandrolone decanoate DECADURABOLIN ORGAJECT Injection osteoporosis in postmenopausal women (but not recommended). virilisation with high doses including voice changes (sometimes irreversible). endometriosis. hot flushes. rarely diarrhoea. injectionsite reactions. intermenstrual spotting. ovarian hyperstimulation (withdraw). There is no justification for their use in primary gonadal failure. ovarian hyperstimulation syndrome. abnormal liver-function tests reported with high doses. aplastic anaemia acne. porphyria ‫و‬ ‫ون‬ ‫اور‬ ‫ا و د‬ Hypothalamic and pituitary hormones and anti-oestrogens Anti-oestrogens Clomiphene citrate (clomifene) CLOMID Tablet anovulatory infertility visual disturbances (withdraw). inhibition of spermatogenesis. insomnia. depression. convulsions hepatic disease . delayed puberty in the male to stimulate endogenous testosterone Hypogonadotrop hic hypogonadism and associated oligospermia. ectopic pregnancy in previous 3 months. abdominal pain. occasionally nausea. sodium retention with oedema. liver tumor severe hepatic impairment. headache. abdominal discomfort. menorrhagia. headache. tiredness. prostate cancer. active thromboembolic disorders. ovarian cysts. tiredness. amenorrhoea. may aggravate ovarian hyperstimulation. mood changes. gynaecomastia. pregnancy and breast-feeding. vomiting. hormone dependent tumors or abnormal uterine bleeding of undetermined cause. pregnancy (exclude before treatment) ‫ر ون‬ ‫رل داوو‬ ‫ا ر‬ ‫ر‬ Anterior pituitary hormones Chorionic gonadotrophin CHORIOMON PREGNYL PRIMOGONYL PROFASI Injection Injection Injection Injection Hypogonadotrop hic hypogonadism and associated oligospermia. ovarian enlargement or cyst (unless caused by polycystic ovarian disease). multiple pregnancy androgendependent tumors ‫إ ـ‬ ‫ا و ر‬ ‫اور ون‬ ‫ا و د‬ ‫ر‬ ‫ا‬ ‫رو و‬ ‫ا ط‬ ( ‫) وو‬ ‫ؤ‬ ‫ن‬ ‫و‬ ‫ب‬ ‫ل‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ا‬ Human chorionic gonadotrophin CHORIOMON PROFASI Injection Injection HUMEGON Injection nausea. vomiting.

pituitary. chronic nephritis (until reasonable blood nitrogen concentrations attained) ‫ر‬ ‫_ا و د‬ ‫ا‬ Vasopressin tannate PITRESSIN TANNATE Injection pituitary diabetes insipidus. tremor. diarrhoea or constipation. ش. headache. psychogenic polydipsia and polydipsia in alcohol dependence vascular disease (especially disease of coronary arteries) unless extreme caution. Chronic renal insufficiency in children . sweating. Deficiency of growth hormone in children. Adult growth hormone deficiency headache. regurgitation. hypocalcaemia.دوم‬ ‫ا و د‬ ‫ا‬ ‫ا‬ 113 . not to be used after renal transplantation or for growth promotion in children with closed epiphyses (or near closure in PraderWilli syndrome . abdominal pain and distension. Prader-Willi syndrome. musculoskeletal pain. pallor. melaena. ovarian. pregnancy and breast-feeding ‫رك رب‬ ‫ودوم ا را‬ ‫رك. flatulence. nausea and vomiting occur—if papilloedema confirmed consider benign intracranial hypertension (rare cases reported). vascular disease (especially disease of coronary arteries) unless extreme caution. zinc complex CORTROSYN DEPO SYNACTHEN DEPOT GENOTROPIN HUMATROPE Injection Injection Injection Injection test adrenocortical function irritability. ectopic pregnancy and ovarian torsion reported as for corticosteroids hypothalamus. Postoperative polyuria or polydipsia. Primary nocturnal enuresis. breast pain.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Tetracosactrin/ cosyntropin . vertigo. belching. hypersensitivity reactions (including anaphylaxis). nausea. vomiting. chronic nephritis (until reasonable blood nitrogen concentrations attained) fluid retention. uterine or mammary malignancy avoid injections containing benzyl alcohol in neonates ‫ون‬ ‫اور‬ ‫ا و د‬ ‫و‬ ‫د‬ Somatropin NORDITROPIN Injection SAIZEN Injection Gonadal dysgenesis. abdominal cramps.‫ر‬ ‫او‬ ‫ا ود‬ ‫ا‬ ‫ا ر‬ ‫ا‬ ‫و‬ ‫و و ورد ك‬ ‫اد ر‬ ‫رو و‬ ‫ا و ر‬ ‫ؤ‬ ‫ا‬ ‫ر‬ ‫ا‬ Posterior pituitary hormones and antagonists Desmopressin MINIRIN Nasal spray Diabetes insipidus. dyspepsia. fluid retention (peripheral oedema). desire to defaecate. headache. Prevention of postmenopausal osteoporosis. constriction of coronary arteries cardiac insufficiency and other conditions treated with diuretics. funduscopy for papilloedema recommended if severe or recurrent headache. Prevention and treatment of corticosteroidinduced oesophageal reactions . visual problems. abnormalities of oesophagus and other factors which delay emptying. bleeding from oesophageal varices ‫رك د ز‬ ‫أر‬ ‫ا‬ Drugs affecting bone metabolism Alendronate sodium trihydrate FOSAMAX FOSAMAX Tablet Tablet Treatment of postmenopausal osteoporosis and osteoporosis in men. evidence of tumor activity (complete antitumour therapy and ensure intracranial lesions inactive before starting). Growth disturbance in short children .

pruritus. skin reactions including rashes. headache. ensure that patients with amenorrhoea are not pregnant. moderate hepatic impairment ‫و‬ ‫و‬ ‫ز‬ ‫ا‬ Ganirelix acetate ORGALUTRAN Injection adjunct in the treatment of female infertility (under specialist supervision) ‫ون‬ ‫اور‬ ‫ا و د‬ ‫و‬ 114 . uveitis. breastfeeding . photosensitivity and exfoliative dermatitis. dizziness. flushing. weight gain.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store osteoporosis Postmenopausal osteoporosis. visual disturbance hypocalcaemia ‫وك‬ ‫دوز‬ ---‫د‬ ‫وك‬ ‫دوز‬ ---‫د‬ Other endocrine drugs Danazol DANOL Capsule Endometriosis. cough. headache. vomiting. Paget's disease of bone. nervousness. Calcitonin CALCITEC MIACALCIC Nasal spray Nasal spray Injection Nasal spray Calcitoninsalmon synthetic Calcitoninsalmon synthetic CALCITEC Hypercalcaemia of malignancy. oedema. changes in libido. osteoporosis in men: 35—70 mg/wk or 10 mg/d PO. severe hepatic. Paget’s disease: 40 mg/d PO rarely rash. Postmenopausal osteoporosis . fatigue. backache. renal or cardiac impairment. nausea. Severe pain and tenderness in benign fibrocystic breast disease not responding to other treatment. musculoskeletal pain. dizziness. scleritis. anxiety. rhinitis. sinusitis and epistaxis. injection site reactions. moderate renal impairment. headache. erythema. asthenia and malaise also reported pregnancy. diarrhoea. fever. Hereditary angioedema [unlicensed indication]. epigastric and pleuritic pain. less commonly diuresis. thromboembolic disease. porphyria pregnancy . mood changes. dizziness. taste disturbances. androgendependent tumors. menstrual disturbances nausea. abdominal pain. with nasal spray nose and throat irritation. vertigo. breast-feeding . Prevention of acute bone loss due to sudden immobility MIACALCIC Injection nausea. in glucocorticoid induced osteoporosis: 5—10 mg/d PO. photosensitivity. undiagnosed genital bleeding.

.................... 117 Progestogen-only contraceptives .......................... tachycardia.................................................. 116 Treatment of vaginal and vulval conditions 117 Preparations for vaginal atrophy ....... cardiac arrest........................... erectile dysfunction Hypertention........................................................ 119 Drugs used in urological pain ................... thrombophlebitis............. toxemia ‫دوز‬ ‫د‬ Alprostadil (prostaglandin E1) CAVERJECT PROSTIN VR Injection Injection ‫ا ون‬ ‫ا‬ ‫ا ون‬ ‫ا‬ ‫ر‬ ‫ر‬ 115 ........... potent inhibitors of CYP3A4............................ 119 Drugs for erectile dysfunction ... gynaecology.... hypotension..................Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Obstetrics....... threatened spontaneous abortion.. hematuria apnoea (particularly in neonates under 2 kg)....... induction of labor..................... enuresis....................... and incontinence ... 118 Drugs for urinary frequency................................. 115 Myometrial relaxants ............................... fever..... oedema......... and urinary-tract disorders Drugs used in obstetrics 115 Prostaglandins and oxytocics .......... flushing... tinnitus........... bradycardia............................................................ 118 Drugs for genito-urinary disorders 118 Drugs for urinary retention ....... water intoxication.............. Hallucinations.................. diarrhoea..................................................... leg cramps.... hypokalaemia.... convulsions.......... hypertension.......... cortical proliferation of long bones and weakening Hypersensitivity.. 119 Drugs used in obstetrics Methylergometrine maleate (Methylergonovine) METHERGINE Tablet Prevention and treatment of postpartum and post-abortion hemorrhage caused by uterine atony or sub-involution congenital heart defects in neonates prior to corrective surgery.... 117 Contraceptives 117 Combined hormonal contraceptives .......................... disseminated intravascular coagulation..........

flushing. renal or hepatic disease. water intoxication active cardiac. headache. eclampsia and severe pre-eclampsia. eclampsia and severe pre-eclampsia. fetal distress. fever. vomiting. hypotension. vomiting. inserted high into posterior fornix PROPESS Pessary cervical ripening and induction of labour at term PROSTIN E2 Injection Vaginal gel Tablet induction of labour. history of caesarean section or major uterine surgery.Scientific Name Trade Name Dosage Form PREPIDIL Indications Side Effects Contra-indications Manufact urer Drug Store Dinoprostone Injection induction of labour. Oxytocin PITON-S Injection Oxytocin SYNTOCINON Injection Induction of labour for medical reasons or stimulation of labour in hypotonic uterine inertia. diarrhoea. Treatment of postpartum haemorrhage. dizziness. hot flushes. intrauterine growth restriction with abnormal fetal heart rate. inevitable or missed abortion. Incomplete. rash. intrauterine infection. asphyxia and death. maternal hypertension. Caesarean section. or may lead to hypertonicity. Prevention of postpartum haemorrhage. pulmonary or amniotic fluid embolism. hypertonic uterine contractions. abruptio placenta. cardiac disease. intra‫ر‬ ‫_ا و د‬ ‫ا‬ Ritodrine HCl YUTOPAR Tablet uncomplicated premature labour --- 116 . bronchospasm. placenta praevia. pulmonary. tetanic contractions. tachycardia. fetal distress. severe uterine contractions. injection-site reaction. softtissue damage or uterine rupture). fever. severe pre-eclamptic toxaemia or severe cardiovascular disease Prostaglandins and oxytocics Myometrial relaxants Atosiban TRACTOCIL Injection uncomplicated premature labour nausea. ruptured membranes. any condition where spontaneous labour or vaginal delivery inadvisable. vomiting. placenta praevia or unexplained vaginal bleeding during pregnancy. other side-effects include uterine hypertonus. backache uterine spasm (may occur at low doses). rapid cervical dilation. uterine hyperstimulation (usually with excessive doses— may cause fetal distress. less commonly pruritus. intrauterine fetal death. abruptio placenta. antepartum haemorrhage (requiring immediate delivery). hyperglycaemia. inserted high into posterior fornix PROSTIN E2 nausea. insomnia nausea. major cephalopelvic disproportion or fetal malpresentation. avoid prolonged administration in oxytocin-resistant uterine inertia.

thrombosis (more common when factor V Leiden present or in blood groups A. tachycardia. levonorgestrel LOGYNON MICROGYNON30 NORDETTE NEOGYNON Tablet 117 . headache. and hypotension (left lateral position throughout infusion to minimise risk). norgestimate CILEST Tablet Tablet Ethinylestradiol . menstrual symptoms nausea. cord compression ‫ز‬ ‫و‬ Treatment of vaginal and vulval conditions Preparations for vaginal atrophy Oestrogens conjugated PREMARIN Cream applied on a short-term basis to improve the vaginal epithelium in menopausal atrophic vaginitis local irritation pregnancy and breast-feeding ‫وا ث ا د‬ ‫ا‬ ‫اط‬ Contraceptives Combined hormonal contraceptives Drospinenone . changes in libido. hypokalaemia. norethisterone Estradiol valerate . ethinylestradiol Estradiol . chorea.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫و‬ ‫ر‬ . skin reactions. heart disease associated with pulmonary hypertension or risk of embolus. antepartum haemorrhage (requires immediate delivery). gestodene YASMIN ESTRACOMB TTS CLIMEN MARVELON MINULET Tablet Patch Tablet Tablet Tablet contraception. severe or multiple risk factors for arterial disease or for venous thromboembolism. migraine ‫ر‬ ‫ا‬ ‫اس‬ ‫ر‬ ‫اي ا ر‬ ‫اور ون‬ ‫ا و د‬ ‫وا ـث‬ ‫ا‬ ‫ر‬ ‫ا‬ -‫ن‬ ‫ج‬ ‫ا و ر‬ ‫) ج‬ ‫إ ر و ل‬ ( ‫ا و ر‬ ‫اور ون‬ ‫ا و د‬ ‫اور ون‬ ‫ا و د‬ ‫ر‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫وا ـث‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ب‬ ‫ا ل‬ ‫د‬ ‫ب‬ ‫ا ل‬ ‫و‬ ‫زن‬ ‫ا دو‬ ‫ا ر‬ ‫ب‬ ‫ا ل‬ ‫ا ة‬ ‫اط‬ GYNERA Ethinylestradiol . changes in body weight. ‫ا و د‬ Drug Store ‫ر‬ YUTOPAR Tablet Injection sweating. B. personal history of venous or arterial thrombosis. palpitation. intrauterine fetal death. and AB). cyproterone acetate Ethinylestradiol . placenta praevia. vomiting. fluid retention. tremor. breast tenderness. depression. desogestrel Ethinylestradiol . desogestrel GRACIAL MARVELON Tablet Tablet Tablet Tablet Tablet ‫و‬ ‫و‬ ‫ب‬ ‫ل‬ ‫ب‬ ‫ل‬ ‫زن‬ ‫دو‬ ‫ر‬ ‫ب‬ ‫ل‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ Ethinylestradiol . pulmonary oedema uterine infection. uterine bleeding (may be reversed with a nonselective betablocker). pregnancy .

gastrointestinal disturbances (including nausea. injection-site reactions history of breast cancer ‫ون‬ ‫اور‬ ‫ا و د‬ ‫ا ون‬ ‫ا‬ ‫و‬ ‫ر‬ Intra-uterine progestogen-only device Levonorgestrel MIRENA IUD Contraception and menorrhagia. salpingitis and pelvic inflammatory disease. migraine. rarely hirsutism. abdominal pain. rash ‫د‬ ‫رس‬ ‫دا‬ ‫إ راھ م‬ ‫ا‬ Drugs for genito-urinary disorders Drugs for urinary retention Alfuzosin XATRAL Tablet relax smooth muscle in benign prostatic hyperplasia producing an increase in urinary flow Side-effects of selective alpha-blockers include drowsiness. dizziness. nausea. undiagnosed vaginal bleeding. breast discomfort. depression. after evacuation of hydatidiform mole (until return to normal of urine and plasma gonadotrophin values). asthenia. headache. weight changes.Scientific Name Trade Name Dosage Form Tablet Indications Side Effects Contra-indications Manufact urer ‫وا ـث‬ ‫ا‬ Drug Store ‫زن‬ ‫ا دو‬ ‫ا ر‬ ‫زن‬ ‫ا دو‬ ‫ا ر‬ ‫ا‬ ‫ر‬ NORDIOL Ethinylestrodiol . diarrhoea. norgestrel Medroxyprogesterone acetate OVRAL Tablet ‫وا ـث‬ ‫ا‬ ‫ر‬ ‫ا ط‬ ‫ا ون‬ ‫ا‬ FARLUTAL PROVERA Tablet Tablet Progestogen-only contraceptives Oral progestogen-only contraceptives Desogestrel CERAZETTE Tablet contraception menstrual irregularities . depression. porphyria . pelvic pain. disturbance of appetite. back pain. nervousness. ‫و‬ ‫و‬ ‫]رو ن‬ [‫د س‬ ‫ا ر‬ ‫زو‬ 118 . skin disorders. vomiting. hypotension (notably postural hypotension). pruritus. syncope. hair loss. peripheral oedema. history of breast cancer ‫ون‬ ‫اور‬ ‫ا و د‬ ‫و‬ Levornorgestrel MICROLUT Tablet ‫ر‬ ‫ا‬ ‫ب‬ ‫ل‬ ‫ا‬ Parenteral progestogen-only contraceptives Etonogestrel Medroxyprogesterone acetate IMPLANON DEPOPROVERA Implant Injection contraception. vomiting. Alpha-blockers should be avoided in patients with a history of postural hypotension and micturition syncope. Prevention of endometrial hyperplasia during oestrogen replacement therapy. severe arterial disease. liver adenoma. dry mouth. headache. changes in libido pregnancy.

asthenia. myasthenia gravis relax smooth muscle in benign prostatic hyperplasia producing an increase in urinary flow dyspnoea. uncontrolled arrhythmias. serious circulatory insufficiency Alpha-blockers should be avoided in patients with a history of postural hypotension and micturition syncope. ‫د‬ ‫ھ‬ ‫و د‬ ‫ر‬ ‫و‬ ‫ا‬ --- ‫ا‬ Drugs for urinary frequency. uncontrolled hypertension ‫زر‬ ‫أر‬ ‫ا‬ ‫ا رط‬ ‫ا دوا‬ --‫و‬ ‫ا‬ Tadalafil CIALIS SNAFI Tablet Tablet erectile dysfunction back pain 119 . neurogenic bladder. depression. pulmonary hypertension serious cardiovascular events reported hereditary degenerative retinal disorders moderate heart failure. fatigue. syncope. vomiting. enuresis. peripheral oedema. gastrointestinal disturbances (including nausea. and urinary frequency Side-effects of selective alpha-blockers include drowsiness. urgency and incontinence dyspepsia. fatigue. urgency. bladder spasms due to catheterization 100-200 mg PO 3-4 times/d vertigo. muscle twitching. hypotension (notably postural hypotension). Distigmine bromide UBRETID Injection Tablet Tamsulosin HCl OMNIC Capsule postoperative urinary retention . and breast-feeding ‫ر‬ ‫ا ط‬ ‫ا‬ Drugs used in urological pain Volatile Oils ROWATINEX Capsule Drops ‫روا وا ر‬ ‫ا‬ ‫ؤ‬ ‫ن‬ ‫ا‬ Drugs for erectile dysfunction Sildenafil citrate VIAGRA Tablet erectile dysfunction. paraesthesia pregnancy . oedema.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store constipation). and incontinence Flavoxate HCl GENURIN GENURIN FORT Tablet Tablet urinary frequency and incontinence. oedema. severe postoperative shock. eosinophilia gastro-intestinal haemorrhage ‫ر وردا‬ ‫ا ط‬ ‫ر وردا‬ ‫ا ط‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ Tolterodine tartrate DETRUSITOL Tablet urinary frequency. flatulence. dry eyes. headache. dysuria. dry mouth. diarrhoea. chest pain. constipation).

dyspnoea. palpitation. rarely myocardial ischaemia. increased lacrimation. and laryngeal oedema hereditary degenerative retinal disorders 120 . hypotension. epistaxis. anxiety. hypertonia. back pain. and facial oedema. angina.Scientific Name Vardenafil Trade Name Dosage Form Tablet Indications Side Effects Contra-indications Manufact urer ‫ر‬ ‫ا‬ Drug Store ‫ا ر‬ LEVITRA erectile dysfunction less commonly drowsiness. hypertension. tachycardia.

.................................................................... 123 Other antineoplastic drugs .................................... 122 Cytotoxic antibiotics ........... 127 Other immunomodulating drugs .................................. 124 Drugs affecting the immune response 127 Antiproliferative immunosuppressants ...........................................................................................................................Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Malignant disease and immunosuppression Cytotoxic drugs 122 Alkylating drugs...................................................................................... 129 121 .............................................................................................................................................................................................................................................................................................................................................................................................................. 122 Antimetabolites .................... 127 Corticosteroids and other immunosuppressants....... 128 Sex hormones and hormone antagonists in malignant disease 129 Progestogens .................... 122 Vinca alkaloids and etoposide ........... 129 Hormone antagonists ..

childhood neuroblastoma. cardiomyopathy Cardiotoxicity. pregnancy. rashes which can progress to Stevens-Johnson syndrome or to toxic epidermal necrolysis.‫)و م. Hodgkin's disease.ف‬ ‫ز‬ ‫ا‬ ‫و‬ Cyclophosphamide CYCLOPHOSPHAMIDE ENDOXAN Injection Injection Tablet treatment of chronic lymphocytic leukaemia. Supraventricular tachycardia . and a variety of solid tumors Extravasation can cause severe tissue necrosis. breast-feeding ‫اور ون‬ ‫ا د‬ ‫ر‬ ‫ا وو‬ "‫" رس‬ ‫ا‬ ‫ر‬ ‫ا وو‬ "‫" رس‬ ‫ا‬ ‫وو م‬ (. breast-feeding ‫وو م‬ (. Interstitial pneumonitis and life-threatening pulmonary fibrosis hepatic impairment. lymphomas. haemorrhagic cystitis. breast-feeding pregnancy. and polycythaemia vera. and solid tumors Multiple myeloma. Melphalan is also licensed for regional arterial perfusion in localized malignant melanoma of the extremities and localized soft-tissue Ifosfamide HOLOXAN Injection Mesna is routinely given with it to reduce urothelial toxicity. ‫ر‬ ‫ا ط‬ ‫ر‬ ‫ا ط‬ ‫ر‬ ‫ا ط‬ ‫ا وي‬ ‫و‬ ‫ا‬ ‫ر‬ ‫ا ط‬ ‫ا وي‬ ‫و‬ ‫ا‬ ‫ر‬ ‫ا ط‬ ‫ر‬ ‫ا ط‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫د‬ ‫ر‬ EPIRUBICIN FARMARUBICIN EPIRUBICIN FARMORUBICIN Injection Injection Injection Injection breast cancer ‫ا‬ ‫د‬ ‫ر‬ ‫ا‬ ‫ا‬ IDARUBICIN HCL ZAVEDOS hematological malignancies Antimetabolites Cytarabine CYTARABINE CYTOSAR Injection Injection induction of remission of acute myeloblastic leukaemia. the lymphomas. advanced breast cancer.ف‬ ‫ز‬ ‫ا‬ ‫ا وان‬ ‫زو‬ ‫زو‬ Melphalan ALKERAN Tablet ‫و‬ Cytotoxic antibiotics DAUNORUBICIN DOXORUBICIN DAUNOBLASTINA ADRIBLASTINA ADRIBLASTINA DOXORUBICIN Injection Injection Injection Injection acute leukaemias acute leukaemias. and Waldenstrom's macroglobulinaemia Bone-marrow suppression. pregnancy. elevated bilirubin concentration . potent myelosuppressant ‫ن‬ ‫ا را‬ ‫ا ون‬ ‫ا‬ ‫ر‬ ‫ر‬ ‫ا‬ 122 . advanced ovarian adenocarcinoma. nonHodgkin's lymphoma. and solid tumors treatment of chronic lymphocytic leukaemia. the lymphomas.‫)و م. mesna help prevent this If a rash occurs further chlorambucil is contraindicated and cyclophospha mide is substituted.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Cytotoxic drugs Alkylating drugs Chlorambucil LEUKERAN Tablet chronic lymphocytic leukaemia.

ف‬ ‫ز‬ ‫ا‬ ‫و‬ myelosuppression. Immune-mediated haemolytic anaemia. It is also used in the treatment of locally advanced or metastatic pancreatic cancer.5 mg at 12-h intervals for 3 doses once a week ‫اي‬ ‫ا و ر‬ ‫ن‬ ‫ا را‬ ‫ا وي‬ ‫و‬ ‫ا‬ ‫روش‬ ‫ا و ر‬ .‫)و م.5 mg PO once a wk or 2. pulmonary toxicity and influenza-like symptoms have also been reported. and rarely a cerebellar syndrome. and rarely pneumonitis Significant renal impairment because it is excreted primarily by the kidney. ‫و‬ ‫و م‬ (. On prolonged infusion. mucositis. non-Hodgkin's lymphoma. and a number of solid tumors. mucositis. Intrathecal methotrexate is used in the CNS prophylaxis of childhood acute lymphoblastic leukaemia 7. Combined with cisplatin Childhood acute lymphoblastic leukaemia. and neutropenia are less common side-effects. renal impairment.Scientific Name Trade Name Dosage Form Injection Injection Indications Side Effects Contra-indications Manufact urer ‫ن‬ ‫ا را‬ ‫ر‬ ‫ا‬ Drug Store Fludarabine phosphate DBL CYTARABINE FLUDARA lymphomatous meningitis advanced B-cell chronic lymphocytic leukaemia Fluorouracil EFUDIX FLUOROURACIL FLUOROURACIL FLUORO-URACIL FLUORO-URACIL ICN GEMZAR Ointment Injection Injection Injection Injection Injection solid tumors Myelosuppression.‫ان‬ ‫اي‬ ‫ا و ر‬ ‫ا‬ ‫ا ر‬ . thrombocytopenia.‫ان‬ ‫ؤ‬ ‫ا‬ ‫د‬ ‫ر‬ ‫ر‬ ‫ا‬ ‫ؤ‬ ‫ا‬ ‫و‬ Mild gastrointestinal sideeffects and rashes. severe hepatic ‫ا وي‬ ‫ر‬ 123 . Myelosuppression. ‫ن‬ ‫ا را‬ ‫ا وي‬ ‫و‬ ‫ا‬ ‫أ س ر‬ ‫ا ر‬ ‫د‬ ‫در‬ ‫ا‬ ‫د‬ ‫ر‬ ‫ر‬ ‫و‬ ‫ا‬ Vinca alkaloids and etoposide ETOPOSIDE ETOPOSID Injection small cell Alopecia. Haemolytic uraemic syndrome Discontinued if signs of microangiopathic haemolytic anaemia occur. ‫ر‬ ‫ب‬ ‫ل‬ ‫ا‬ ‫ا‬ Gemcitabine HCl Mercaptopurine PURINETHOL Tablet Methotrexate METHOTREXATE Injection METHOTREXATE METHOTREXATE METHOTREXATE Injection Injection Injection palliative treatment or with cisplatin as a first-line treatment for locally advanced or metastatic nonsmall cell lung cancer It is given alone for palliative treatment or with cisplatin as a first-line treatment for locally advanced or metastatic nonsmall cell lung cancer. It is also contra-indicated in patients with severe hepatic impairment. Other uses include choriocarcinoma. a desquamative hand–foot syndrome may occur.

and some solid tumors VINDESINE SULFATE ELDISINE Injection leukaemias. vinblastine. it occurs less often with vindesine. it occurs less often with vindesine. and vinorelbine. it occurs less often with vindesine. Neurotoxicity. neurotoxicity. vinblastine. and vinorelbine. usually as peripheral or autonomic neuropathy. and vinorelbine. lymphomas. vinblastine. impairment.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫و‬ ‫ا‬ ‫ون‬ ‫و‬ ‫ا‬ ‫ر ول‬ ‫ر‬ ‫ا‬ ‫ر ول‬ ‫رز‬ -‫وب‬ ‫اط‬ ‫ا‬ ‫ا ر‬ ‫ن‬ ‫ا را‬ Drug Store ‫د‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫ؤ‬ ‫ا‬ ‫و‬ LASTET Injection carcinoma of the bronchus. lymphomas. Nausea and vomiting are reduced in severity and nephrotoxicity. usually as peripheral or autonomic neuropathy. nausea. cervical. breast-feeding VEPESID Injection Capsule Capsule VEPESID VINBLASTINE SULPHATE VELBE Injection leukaemias. occurs with all vinca alkaloids and is a limiting side-effect of vincristine. and some solid tumors VINBLASTINE Injection VINCRISTINE SULFATE ONCOVIN VINCRISTIN VINCRISTIN Injection Injection Injection leukaemias. Cisplatin requires intensive intravenous hydration and treatment may be complicated by ‫ن‬ ‫ا را‬ ‫ا وي‬ ‫و‬ ‫ا‬ ‫ر ول‬ ‫رز‬ -‫وب‬ ‫اط‬ ‫ا ر‬ ‫ر‬ ‫د‬ ‫ؤ‬ ‫ا‬ Cisplatin CISPLATIN CISPLATIN CISPLATYL Injection Injection Injection Used alone or in combination for the treatment of testicular. and testicular cancer myelosuppression. It is. advanced non-small cell lung cancer Neurotoxicity. bladder. ‫ن‬ ‫را‬ ‫وي‬ ‫و‬ ‫س ر‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫أ‬ ‫ا ر‬ ‫ر‬ ‫د‬ ‫و‬ 124 . lymphomas. Neurotoxicity. Neurotoxicity. and ototoxicity are much less of a problem than with cisplatin. however. and some solid tumors VINORELBINE DITARTRATE NAVELBINE Injection advanced breast cancer. it occurs less often with vindesine. vinblastine. and vinorelbine. usually as peripheral or autonomic neuropathy. and vomiting. lung. occurs with all vinca alkaloids and is a limiting side-effect of vincristine. the lymphomas. pregnancy. more myelosuppressive than cisplatin. occurs with all vinca alkaloids and is a limiting side-effect of vincristine. ‫ر‬ ‫ا‬ ‫ا‬ ‫ا ر‬ ‫ن‬ ‫ا را‬ ‫أ س‬ ‫ر‬ ‫ا ر‬ ‫ا‬ ‫ا رط‬ ‫و‬ ‫ا ر‬ ‫و‬ ‫و‬ ‫ر‬ ‫ر‬ ‫ا ر‬ ‫ر‬ Other antineoplastic drugs Carboplatin CARBOPLATIN CARBOPLATIN PARAPLATIN Injection Injection Injection Advanced ovarian cancer and lung cancer (particularly the small cell type). usually as peripheral or autonomic neuropathy. occurs with all vinca alkaloids and is a limiting side-effect of vincristine.

Dacarbazine DETICENE Injection Docetaxel TAXOTERE Injection Metastatic melanoma and. abdominal pain. or in accelerated phase. soft tissue sarcomas. diarrhoea. or in blast crisis. Cisplatin is toxic. It is also a component of a commonly used combination for Hodgkin's disease Licensed for use in locally advanced or metastatic breast cancer and nonsmall cell lung cancer resistant to other cytotoxic drugs or for initial chemotherapy in combination with other cytotoxic drugs. ototoxicity. asthenia. severe nausea and vomiting. causing nephrotoxicity (monitoring of renal function is essential). ‫أ س ر‬ ‫ا رط‬ ‫و‬ 125 . fatigue.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫ا ر‬ Drug Store head and neck. headache. and ovarian cancer (but carboplatin is preferred for ovarian cancer). Dexamethasone by mouth is recommended for reducing Nausea. licensed for metastatic colorectal cancer in combination with fluorouracil and folinic acid or as monotherapy when treatment containing fluorouracil has failed. side-effects of irinotecan and topotecan include gastro-intestinal effects (delayed diarrhoea requiring prompt treatment may follow irinotecan treatment). ‫أ س ر‬ ‫ا رط‬ ‫و‬ ‫د‬ In addition to doselimiting myelosuppression. and rash. ‫أ س ر‬ ‫ا ر‬ ‫و‬ Imatinib mesilate GLIVEC Capsule Irinotecan CAMPTO Injection Newly diagnosed chronic myeloid leukaemia where bone marrow transplantation is not considered first-line treatment and for chronic myeloid leukaemia in chronic phase after failure of interferon alfa. hypersensitivity reactions also occur. hypomagnesaemia The predominant side-effects are myelosuppression and severe nausea and vomiting. peripheral neuropathy. myalgia. and anorexia. oedema. in combination therapy. alopecia. vomiting. gynaecomastia because of reduced testosterone has been reported. Side-effects are similar to those of paclitaxel but persistent fluid retention (commonly as leg oedema that worsens during treatment) can be resistant to treatment.

pleural effusion. ototoxicity. oedema. Topotecan HCl HYCAMTIN Injection Metastatic ovarian cancer when firstline or subsequent therapy has failed.Scientific Name Oxaliplatin Trade Name Dosage Form Injection Indications Side Effects Contra-indications Manufact urer ‫و‬ ‫و‬ [‫] رو دي‬ ‫ا ر‬ Drug Store ELOXATIN licensed in combination with fluorouracil and folinic acid. Paclitaxel ANZATAX Injection TAXOL Injection Paclitaxel given with carboplatin or cisplatin is used for the treatment of ovarian cancer . Other sideeffects include gastrointestinal disturbances. dyspnoea. Routine premedication with a corticosteroid. weight gain. It is used in previously untreated patients as well as in those who have relapsed after standard chemotherapy or who are refractory to it. hypersensitivity reactions may occur rarely despite premedication. retinoic acid syndrome (fever. hepatic. and myelosuppression. asthenia. Manufacturers advise renal function monitoring in moderate impairment. for the treatment of metastatic colorectal cancer and as adjuvant treatment of colon cancer after resection of the primary tumor. and anorexia. alopecia. renal and multi-organ failure) requires immediate treatment—consult product literature ‫ن‬ ‫ا را‬ ‫ر ول‬ ‫رز‬ ‫ا ر‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ث‬ ‫م‬ ‫ن‬ -‫ور ور ن‬ ‫و وھو ن‬ ‫ا ر‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ة‬ ‫ا‬ ‫ت‬ ‫ر‬ ‫ا دوا‬ ‫ا رد‬ ‫ؤ‬ ‫ا‬ --‫وم‬ ‫دو‬ ‫ول ا ج‬ (‫) ورد ك‬ ‫ا‬ ‫در‬ ‫ا ر‬ -‫ن‬ ‫ج‬ ‫ا و ر‬ ‫) ج‬ ‫إ ر و ل‬ ( ‫ا و ر‬ ‫دار ا دواء‬ ‫ا رد‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ا ة‬ ‫اط‬ SMOODERM Cream ‫ا‬ ‫اط‬ 126 . In addition to doselimiting myelosuppression. an antihistamine and a histamine H2receptor antagonist is recommended to prevent severe hypersensitivity reactions. side-effects of irinotecan and topotecan include gastro-intestinal effects (delayed diarrhoea requiring prompt treatment may follow irinotecan treatment). hypotension. hyperleukocytosis. the combination is also considered appropriate for women whose ovarian cancer is initially considered inoperable. Neurotoxic sideeffects (including sensory peripheral neuropathy) are dose limiting. Tretinoin ACNELIN Cream ACRETIN Cream EUDYNA Gel Cream Cream Cream Gel Solution RETACNYL RETIN-A Induction of remission in acute promyelocytic leukaemia. pulmonary infiltrates. acute respiratory distress.

and doses should be reduced when allopurinol is given Licensed for the prophylaxis of acute rejection in renal or cardiac transplantation when used in combination with ciclosporin and corticosteroids. they are used for prophylaxis of acute rejection in allogenic renal transplantation. usually when corticosteroid therapy alone provides inadequate control.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Drugs affecting the immune response Antiproliferative immunosuppressants Azathioprine AZAMUN Tablet Used for transplant recipients and it is also used to treat a number of autoimmune conditions. myelosuppression ‫دا‬ ‫رس‬ ‫د‬ ‫إ راھ م‬ ‫ا‬ ‫و‬ IMURAN Tablet IMURAN Injection ‫وو م‬ (. They are given with ciclosporin and corticosteroid immunosuppression regimens. their use should be confined ‫د‬ Ciclosporin (cyclosporin) GENGRAF SANDIMMUN Capsule Injection SANDIMMUN NEORAL Capsule Drink ‫أ وت‬ ‫ا ر‬ ‫و ر ز‬ ‫ر‬ (‫) دوز‬ ‫ا و ر‬ ‫و ر ز‬ ‫ر‬ (‫) دوز‬ ‫ا و ر‬ ‫ب‬ ‫ل‬ ‫ا‬ ‫د‬ ‫د‬ 127 .‫)و م. It is metabolized to mercaptopurine. ‫روش‬ ‫ا و ر‬ Mycophenolate sodium MYFORTIC Tablet ‫د‬ Corticosteroids and other immunosuppressants Basiliximab SIMULECT Injection Monoclonal antibodies that prevent T-lymphocyte proliferation.ف‬ ‫ز‬ ‫ا‬ ‫و‬ ‫ث‬ ‫ن ر‬ Mycophenolate mofetil CELLCEPT Tablet Capsule Blood disorders such as leucopenia may be higher.

or in decompensated hepatic impairment. caution is advised in those with a history of these conditions or with cardiac disorders or myelosuppression history of severe depressive illness (or of suicidal ideation). necrosis) and influenza-like symptoms (fever. heart.Scientific Name Tacrolimus Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫ا‬ ‫ا رد‬ Drug Store PROGRAF Capsule Is a potent immunosuppressant which is virtually nonmyelotoxic but markedly nephrotoxic. nausea and vomiting occur occasionally Side-effects reported most frequently include irritation at injection site (including inflammation. myalgia. and hear Neurotoxicity and nephrotoxicity appears to be greater. and chronic hepatitis C ideally in combination with ribavirin relapsing. chills. caution is advised in those with a history of these conditions or with cardiac disorders or myelosuppression ‫رو و‬ ‫ا ط‬ ‫ر‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ب‬ ‫ل‬ ‫ا‬ 128 . ‫ا‬ Other immunomodulating drugs INTERFERON ALFA-2a ROFERON-A Injection treatment of chronic hepatitis B. chills. hypersensitivity. for prevention of graft rejection following bone marrow. and chronic hepatitis C ideally in combination with ribavirin treatment of chronic hepatitis B. and chronic hepatitis C ideally in combination with ribavirin treatment of chronic hepatitis B. or malaise) but these decrease over time. kidney. lung. or malaise) but these decrease over time. history of severe depressive illness (or of suicidal ideation). cardiomyopathy has also been reported. followed by complete or incomplete recovery) who are able to walk unaided. pancreas. myalgia. remitting multiple sclerosis (characterized by at least two attacks of neurological dysfunction over the previous 2 or 3 years. hypersensitivity. remitting multiple sclerosis (characterized by at least two attacks of neurological dysfunction over the previous 2 or 3 years. necrosis) and influenza-like symptoms (fever. or in decompensated hepatic impairment. followed by complete or incomplete recovery) who are able to walk unaided. hypertrichosis appears to be less of a problem than with ciclosporin. in those with inadequately controlled epilepsy. treatment of chronic hepatitis B. liver. nausea and vomiting occur occasionally ‫روش‬ ‫ا و ر‬ Interferon alfa-2b INTRON A Injection ‫ر‬ ‫و ر‬ ‫ا ر دا‬ ‫ر‬ Interferon beta -1a REBIF Injection Interferon beta-1b BETAFERON Injection relapsing. and chronic hepatitis C ideally in combination with ribavirin Side-effects reported most frequently include irritation at injection site (including inflammation. Disturbance of glucose metabolism also appears to be significant. in those with inadequately controlled epilepsy. It has an important role in organ and tissue transplantation.

headache.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Sex hormones and hormone antagonists in malignant disease Progestogens Megestrol acetate MEGACE Capsule Use in breast cancer and renal cell cancer has declined. reduced sperm count. depression. Progestogens are now rarely used to treat prostate cancer. not indicated for premenopausal women ‫ر‬ ‫ا ط‬ ‫ا‬ Flutamide EULEXIN Tablet Goserelin acetate ZOLADEX Injection prostate cancer. advanced breast cancer. vomiting. oestrogenreceptor positive early breast cancer gynaecomastia (sometimes with galactorrhoea). insomnia. alopecia. rash. tiredness. diarrhoea. hot flushes. dyspepsia. oedema transient changes in blood pressure. vomiting. anorexia. paraesthesia. fluid retention. leucopenia pregnancy and breast-feeding. dizziness. nausea. ‫د و ون‬ ‫ا ر‬ ‫ا‬ Hormone antagonists Exemestane AROMASIN Tablet adjuvant treatment of oestrogenreceptor-positive early breast cancer in postmenopausal women following 2–3 years of tamoxifen therapy. Side-effects are mild but may include nausea. headache. asthenia. dizziness. and weight gain. insomnia. and peripheral oedema. constipation. sweating. other sideeffects reported include decreased libido. gastric and chest pain. fatigue. rarely thrombocytopenia. abdominal pain. rarely hypercalcaemia (in patients with metastatic breast cancer) ‫ر‬ ‫و‬ ‫ا‬ ‫ر‬ ‫ز‬ ‫ا‬ 129 . hypertension. increased appetite. advanced breast cancer in postmenopausal women in whom anti-oestrogen therapy has failed advanced prostate cancer. nausea. less commonly drowsiness.

flatulence. hypoglycaemia hot flushes. not indicated for premenopausal women. lightheadedness. gastrointestinal disturbances. vomiting. headache. nausea. suppression of menstruation in some premenopausal women. dyspepsia. osteoporosis. vomiting. early invasive breast cancer in postmenopausal Relief of symptoms associated with neuroendocrine (particularly carcinoid) tumors and acromegaly. appetite increase. Postprandial glucose tolerance may be impaired and rarely persistent hyperglycaemia occurs with chronic administration. constipation. hot flushes. vaginal bleeding and vaginal discharge . headache. anorexia. severe hepatic impairment. depression. ‫دوز‬ ‫دوز‬ ‫د‬ ‫د‬ pregnancy ‫رس‬ ‫د‬ ‫دا‬ ‫ز‬ ‫ا‬ ‫إ راھ م‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫د‬ ‫ر‬ ‫ا‬ ‫ر‬ ‫ا و د‬ ‫ا وي‬ ‫و‬ ‫ا‬ ‫ز‬ 130 . diarrhoea. diarrhoea. alopecia. nausea. rash. pruritus vulvae. pregnancy and breast-feeding Tamoxifen NOLVADEX TAMOFEN Tablet Tablet Breast cancer. fatigue. peripheral oedema. increased sweating.Scientific Name Letrozole Trade Name Dosage Form Tablet Indications Side Effects Contra-indications Manufact urer Drug Store ‫د‬ FEMARA Octreotide Octreotide acetate SANDOSTATIN SANDOSTATIN LAR Injection Injection adjuvant treatment of oestrogenreceptor-positive early breast cancer in postmenopausal women. and steatorrhoea may occur. dizziness. advanced breast cancer in postmenopausal women (including those in whom other anti-oestrogen therapy has failed). Anovulatory infertility TAMOPLEX Tablet TAMOXIFEN NOLVADEX-D Tablet Tablet Anorexia. abdominal pain and bloating. hypercholesterolaemia. musculoskeletal pain.

.................................................. 134 Iron overload ..................................................................................................................................... 139 Vitamin E ................ and renal anaemias ................................................................................................................................................................................... haemolytic............................................................. 136 Vitamin C ........................................... 135 Fluids and electrolytes 135 Minerals 136 Vitamins 136 Vitamin A...................................................................................................................................................................... 136 Vitamin B group ........................................................................ 133 Drugs used in hypoplastic......................................................................................................... 134 Drugs used in neutropenia ................................................................. 132 Drugs used in megaloblastic anaemias ..................................... 139 Multivitamin preparations ......... 139 Vitamin K.............................Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Nutrition and blood Anaemias and some other blood disorders 132 Iron-deficiency anaemias ..... 138 Vitamin D.................................................................................................. 139 131 .....

dyspnoea. abdominal pain. blurred vision.‫م‬ ‫ال‬ ‫رو‬ ‫ز‬ ‫ا‬ ‫ا‬ ‫ا رد‬ ‫أ وت‬ ‫ا را‬ ‫أ وت‬ ‫ا را‬ ‫ا ر‬ ‫و‬ FERAL FERROGRADFOLIC FERROGRADC Capsule Tablet Tablet used during pregnancy in women who are at high risk of developing iron and folic acid deficiency. folic acid Ferric hydroxide polymaltose complex Ferrous fumarate Ferrous gluconate FEROSE . ‫ث‬ ‫ن‬ . rarely diarrhoea. iron-deficiency anaemia ‫ا دوا‬ Gastro-intestinal irritation may occur with iron salts. rash. myalgia. fever. urticaria. vomiting. iron-deficiency anaemia ‫ا‬ ‫ب‬ ‫ل‬ ‫ب‬ ‫ل‬ ‫ا‬ ‫ا‬ Ferrous sulphate . history of allergic disorders including asthma and eczema. anaphylactoid reactions. --- FEROSE Drops Syrup Tablet Syrup Tablet Tablet Tablet Drops ‫ا دوا‬ --- FERUMAT iron-deficiency anaemia ‫ل‬ FERROUS GLUCONATE GLUCOFER iron-deficiency anaemia ‫و‬ . folic acid FEFOL SPANSULES ‫ب‬ ‫ل‬ ‫ا‬ used during pregnancy in women who are at high risk of developing iron and folic acid deficiency.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Anaemias and some other blood disorders Iron-deficiency anaemias Ferric hydroxide polymaltose . infection. arthralgia. sodium ascorbate Ferrous sulphate heptahydrate Iron(III) hydroxide sucrose complex Iron-dextran FERTONIC Drops ‫ا رام‬ ‫ا دوا‬ ‫زو‬ FEROSAC Injection iron-deficiency anaemia IMFERON Injection nausea.F Tablet used during pregnancy in women who are at high risk of developing iron and folic acid deficiency. Nausea and epigastric pain are doserelated but the relationship between dose and altered bowel habit (constipation or diarrhoea) is less clear. flushing. active rheumatoid arthritis --- ‫أ س‬ ‫) زو ز‬ ( ‫ز‬ ‫ا‬ ‫ر‬ 132 . particularly modified-release preparations. injectionsite reactions including phlebitis.ف‬ ‫ا‬ ‫ر‬ ‫ر‬ ‫ا‬ ‫ا رد‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ا‬ Ferrous sulphate FER-IN-SOL DROPS FEROMIN iron-deficiency anaemia Solution Tablet Tablet Drops Syrup Capsule ‫د و ون‬ ‫ا ر‬ ‫ار ض‬ ‫ر‬ ‫أ وت‬ ‫ا را‬ ‫ر‬ ‫ة‬ ‫ا‬ ‫اط‬ FERROGRADUMET KDIRON Ferrous sulphate . Oral iron.‫. numbness.

ا‬ ‫ا ر‬ ‫اد ر‬ ‫ر‬ ‫رك‬ ‫ا‬ ‫ر‬ ‫ت‬ ‫ا دوا‬ ‫ا ر‬ ‫.‫و ل‬ ‫ف.م. chest pain Drugs used in megaloblastic anaemias Folic acid BEFOLVIT Tablet FOLIC ACID FOLICUM FOLIVITA VIFOLIN Tablet Tablet Tablet Tablet In folatedeficient megaloblastic anaemia.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store arrhythmias. For prophylaxis in chronic haemolytic states or in renal dialysis. B12 Vitamin B12 LEUCOVORIN CALCIUM CALCIUM LEUCOVORIN METHYLCOPAL COBAL Injection Injection Injection Tablet folate-deficient megaloblastic anaemia ‫ر‬ ‫ا‬ ‫ا‬ ‫د‬ ‫ر‬ ‫ا‬ ‫ا ر‬ ‫ا ة‬ ‫اط‬ FORTA B-12 BETOLVEX CYNOVIT CYTOBION DEPOVIT B12 Injection Injection Injection Injection Injection ECAVIT-B12 Injection ‫ؤ‬ ‫ا‬ 133 .م‬ ‫ا ل‬ ‫دو‬ ‫ا‬ ‫ة‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ا‬ ---‫ا‬ Calcium folinate (folinic acid) Mecobalamin Mecobalamin (B 12) Vit. For prophylaxis in pregnancy It should not be used in undiagnosed megaloblastic anaemia unless vitamin B12 is administered concurrently otherwise neuropathy may be precipitated ‫ا ر‬ ‫ا و‬ ‫ا ود‬ ‫ت‬ ‫ا دوا‬ ‫ار ض‬ ‫ر‬ ‫ر‬ ‫وك‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ن‬ ‫ا را‬ ‫در‬ ‫ا ر‬ ‫ا ى‬ ‫ا‬ ‫ا رد‬ ‫ج‬ ‫ا دو‬ .ش . hypotension.

avoid injections containing benzyl alcohol in neonates -‫ن‬ ‫ج‬ ‫و ر‬ ‫ج‬ ‫ر و ل‬ ( ‫و ر‬ ‫ة‬ ‫ا‬ ) ‫إ‬ ‫ا‬ ‫ا‬ ‫اط‬ Erythropoietin EPREX Injection RECORMON RECORMON Injection Injection Anaemia associated with chronic renal failure in dialysis patients. avoid injections containing benzyl alcohol in neonates -‫ن‬ ‫ج‬ ‫ا و ر‬ ‫) ج‬ ‫إ ر و ل‬ ( ‫ا و ر‬ ‫ا دوا‬ ‫ك‬ ‫روش‬ ‫دا و‬ ‫أ‬ ‫ة‬ ‫ا‬ ‫اط‬ --- Iron overload Desferrioxamine mesylate DESFERAL Injection iron poisoning. asthma. headache. patients unable to receive thromboprophylaxis.75–1. gastrointestinal disturbances. symptomatic anaemia of renal origin in patients not yet on dialysis. hypertensive crisis with encephalopathylike symptoms and generalised tonic-clonic seizures requiring immediate medical attention dose-dependent increase in blood pressure or aggravation of hypertension. Prevention of anaemia of prematurity in neonates with birth-weight of 0. injection site reactions. disturbances of hearing and vision (including lens opacity and retinopathy). arthralgia and myalgia ‫د‬ 134 . uncontrolled hypertension. haemolytic.5 kg and gestational age of less than 34 pure red cell aplasia following erythropoietin .Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Drugs used in hypoplastic. uncontrolled hypertension. and renal anaemias Erythropoiein recombinant EPREX Injection Anaemia associated with chronic renal failure in patients on haemodialysis dose-dependent increase in blood pressure or aggravation of hypertension. hypotension (especially when given too rapidly by intravenous injection). in isolated patients with normal or low blood pressure. in isolated patients with normal or low blood pressure. hypertensive crisis with encephalopathylike symptoms and generalised tonic-clonic seizures requiring immediate medical attention pure red cell aplasia following erythropoietin . fever. patients unable to receive thromboprophylaxis.

epistaxis. urinary abnormalities (including dysuria. osteoporosis. exacerbation of rheumatoid arthritis. transient hypotension. cutaneous vasculitis. proteinuria. anaemia severe congenital neutropenia (Kostmann's syndrome) with abnormal cytogenetics ‫روش‬ ‫ا و ر‬ Fluids and electrolytes Electrolytes Electrolytes soln PEDIALYTE BABYLYTE Solution Solution fluid and electrolyte loss in diarrhoea. thrombocytopenia. in patients with excessive losses of potassium in the faeces. and haematuria). ‫دي‬ ‫رف‬ ‫ا ؤ‬ ‫ا وط‬ ‫دو و‬ ‫ز ت‬ ‫ا‬ ‫اط‬ 135 . hepatomegaly. راون‬ ‫ا‬ ‫و ر‬ ‫ا‬ ‫ل‬ ‫ل‬ ‫ب‬ ‫ل‬ -----‫ا‬ Potassium chloride POTASSIUM CHLORIDE Injection electrolyte imbalance Potassium gluconate POTASSIUM CHLORIDE ULTRA-K Injection Syrup Compensation for potassium loss is especially necessary: in those taking digoxin or anti-arrhythmic drugs.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Drugs used in neutropenia Filgrastim NEUPOGEN Injection (specialist use only) reduction in duration of neutropenia and incidence of febrile neutropenia in cytotoxic chemotherapy for malignancy (except chronic myeloid leukaemia and myelodysplastic syndromes). ‫أ وت‬ ‫ا ر‬ ‫ا‬ ‫اط‬ ‫ا دودة‬ rapid infusion toxic to heart -----‫ا‬ ‫اط‬ ‫ا دودة‬ ‫. reduction in duration of neutropenia (and associated splenic enlargement. in patients in whom secondary hyperaldosteronism occurs. fluid and electrolyte loss in diarrhoea.

arrhythmias gastro-intestinal disturbances. arrhythmias. arrhythmias gastro-intestinal disturbances. A palmitate DAGRAVIT A-E UNIVIT-A Capsule Capsule Deficiency of vitamin A (retinol) is associated with ocular defects (particularly xerophthalmia) and an increased susceptibility to infections. nausea. bradycardia. Prevention of seizure recurrence in eclampsia. B6 . 4 – 5 g of 50% solution q 4h Vitamins Vitamin A Vit. colic and diarrhoea following oral administration conditions associated with hypercalcaemia and hypercalciuria conditions associated with hypercalcaemia and hypercalciuria conditions associated with hypercalcaemia and hypercalciuria ‫در‬ ‫ا ر‬ ‫وا ث‬ ‫ا د‬ ‫ا ن‬ ‫اط‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ CALSYR Syrup calcium deficiency ‫ا ر‬ ‫ا و‬ ‫ا ود‬ ‫ت‬ ‫ا دوا‬ -----‫ا‬ ‫اط‬ ‫ا دودة‬ ‫ل‬ ‫ا‬ MAGNESIUM SULPHATE Injection Hypomagnesaemia. drowsiness. calcium glubionate Magnesium sulphate HI-CAL Tablet Tablet Syrup calcium deficiency calcium deficiency gastro-intestinal disturbances. Massive overdose can cause rough skin. B6 . and a raised erythrocyte sedimentation rate and raised serum calcium and serum alkaline phosphatase concentrations pregnancy ‫دا را‬ ‫ا و د‬ ‫ا دة‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ ‫ؤ‬ ‫ا ون‬ ‫دي‬ ‫رف‬ Vitamin B group Vitamin B1 (Thiamine HCl) BETABION THIAVIT Vitamin B1 . confusion. A Vit. flushing of skin. coma.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Minerals Calcium carbonate CALTRATE OS-CAL Calcium gluconate . muscle weakness. an enlarged liver. loss of tendon reflexes. nicotinamide Vitamin B1 . arrhythmias generally associated with hypermagnesaemia. B12 BEVIT Injection Tablet Syrup Treatment of vitamin-B deficiency Prophylactic Mild chronic deficiency ‫رك‬ ‫ا‬ ‫ر‬ ‫ر‬ ‫ا دوا‬ ‫ر‬ ‫ر‬ BENEXOL BETRIMAX Tablet Tablet ‫روش‬ ‫ا رط‬ ‫أ ر‬ ‫ر‬ ‫ا‬ ‫ا‬ --‫ة‬ ‫ا‬ ‫اط‬ 3V Tablet 136 . B2 . respiratory depression. but deficiency is rare in the UK (even in disorders of fat absorption). calcium glubionate Calcium lactobionate . bradycardia. vomiting. thirst. dry hair. bradycardia. hypotension. Prevention of seizures in preeclampsia [unlicensed indication].

‫. B6 .N NEUROVITAN SOPALAMIN 3B Injection ‫ا و ر‬ Tablet Tablet Injection ‫ا و ر‬ ‫ا‬ ‫ا رد‬ ‫و ر‬ ‫ا‬ ‫د‬ TRI-B AMP VIONEURIN-6 Injection Tablet Vitamin B1 .ف‬ ‫ا‬ ‫ا ل‬ ‫دو‬ ‫ر‬ ‫ر‬ ‫ر‬ ‫روش‬ ‫ا و ر‬ ‫دا را‬ ‫ا و د‬ ‫رك‬ ‫ا‬ ‫أ وت‬ ‫ا ر‬ ‫ر‬ ‫وك‬ ‫ا ر‬ ‫ا و‬ ‫ا ود‬ ‫ت‬ ‫ا دوا‬ ‫ار ض‬ ‫ر‬ ‫ر‬ ‫ة‬ ‫ر‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫ا‬ ‫ؤ‬ ‫ا ون‬ ‫ا ة‬ ‫اط‬ ‫ب‬ ‫ل‬ ‫ر‬ ‫ا‬ SURBEX VIT.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫رو د‬ ‫ا ر‬ ‫و ل‬ . folic acid Vitamin B6 (Pyridoxine) TRI-B TAB Tablet PYRIDOXIN Tablet Vitamin Bcomplex BECOVIT BECOZYM DAGRAVIT BCOMPLEX POLYBION Tablet Syrup Syrup Tablet Tablet Drops Injection Tablet Tablet Tablet Tablet Treatment of vitamin-B deficiency sideroblastic anemias associated with isoniazid and pyrazinamide. pyidoxine HCl .‫. pyridoxineresponsive anemia . cyanacobalamine Folic acid (Vitamin 9) ‫ا‬ ---‫ا‬ BEFOLVIT Tablet FOLIC ACID FOLICUM Tablet Tablet In folatedeficient megaloblastic anaemia.BCOMPLEX VITA-B Thiamine . For prophylaxis in chronic haemolytic states or in It should not be used in undiagnosed megaloblastic anaemia unless vitamin B12 is administered concurrently 137 .ف‬ ‫ا‬ ‫رك‬ ‫ل‬ ‫و‬ ‫ا‬ ‫وم‬ ‫دو‬ Drug Store FORTANEURIN Injection ‫ر‬ ‫ة‬ ‫ا‬ ‫اط‬ --‫د‬ ‫ر‬ ‫ر‬ ‫ا‬ ‫ا ؤ‬ ‫ا وط‬ ‫دو و‬ ‫ز ت‬ ‫ا‬ ‫اط‬ ‫ؤ‬ ‫ا‬ ‫ر‬ ‫ؤ‬ ‫ا‬ ‫ر‬ ‫ا‬ NEUROBION Injection Tablet Injection NEUROCOMB NEURORUBINE NEURORUBINE FORTE . antiemetic in preganacy Treatment of vitamin-B deficiency ‫ا ل‬ ‫دو‬ ‫و ل‬ . B12 .

‫و ل‬ ‫ف.Scientific Name Trade Name Dosage Form Tablet Tablet Indications Side Effects Contra-indications Manufact urer ‫وك‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ن‬ ‫ا را‬ ‫در‬ ‫ا ر‬ Drug Store ---‫ا‬ FOLIVITA VIFOLIN renal dialysis. For prophylaxis in pregnancy otherwise neuropathy may be precipitated Calcium folinate (folinic acid) LEUCOVORIN CALCIUM CALCIUM LEUCOVORIN Injection Injection folate-deficient megaloblastic anaemia It should not be used in undiagnosed megaloblastic anaemia unless vitamin B12 is administered concurrently otherwise neuropathy may be precipitated ‫ر‬ ‫ا‬ Mecobalamin Mecobalamin (b 12) Vitamin b12 METHYLCOPAL COBAL Injection Tablet ‫ا ى‬ ‫ا‬ ‫ا رد‬ ‫ج‬ ‫ا دو‬ . REDOXON Eff tablet Relatively large doses of vitamin C may cause indigestion. particularly when taken on an empty stomach.ا‬ ‫ا ر‬ ‫اد ر‬ ‫ر‬ ‫رك‬ ‫ر‬ ‫ا ل‬ ‫دو‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫د‬ ‫ر‬ ‫ا‬ ‫ا ر‬ ‫ا ة‬ ‫اط‬ ‫ؤ‬ ‫ا‬ FORTA B-12 BETOLVEX CYNOVIT CYTOBION DEPOVIT B12 ECAVIT-B12 Injection Injection Injection Injection Injection Injection Vitamin C Ascorbic acid CEBION Drops Eff tablet ‫رك‬ ‫ا‬ ‫ا ھرة‬ ‫ا ر‬ ‫و ر‬ ‫ا‬ ‫ا ؤ‬ ‫ا ر‬ ‫ا ؤ‬ ‫ا وط‬ ‫دو‬ ‫ز ت‬ ‫وا‬ ‫اط‬ ‫ؤ ـ‬ ‫د ن د‬ ‫ا دو‬ ‫ةاط‬ ‫ا‬ CEVILENE CEVITAN Drops Eff tablet CEVITIL Eff tablet Scurvy. ‫ر‬ ‫ا و‬ ‫ا‬ UPSA-C Ascorbic acid . sodium ascorbate REDOXON VC VITA-C Eff tablet Ch tablet Ch tablet Ch tablet ‫روش‬ ‫و س‬ ‫ا ر‬ ‫او‬ ‫ا ر‬ ‫روش‬ ‫ا و ر‬ ‫ر‬ ‫ر‬ ‫وك‬ ‫ر‬ ‫ا‬ ---- 138 .

nicotinamide . Osteoporosis Calcitriol CALCIJEX ROCALTROL Capsule Osteomalasia. renal filure. usually respond to parenteral administration of vitamin E. abnormally low vitamin E concentrations found in association with neuromuscular abnormalities. B1 . B6 . poluria.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Vitamin D Vitamin D Alfacalcidol VI-DE-3 ONE-ALPHA Drops Drops Capsule Solution Injection Injection Rickets Rickets. B2 . E TOCOVIT Tablet ‫دو‬ ‫ا ل‬ ‫ؤ‬ ‫ا‬ Vitamin K Vitamin K synthetic KONAKION MM Injection ‫روش‬ ‫ا و ر‬ Multivitamin preparations Ascorbic acid . niacin amide . A . Osteoporosis Hypercalcemia. Vit D Vit. ‫دة‬ ‫ت‬ ‫ا‬ ‫دي‬ ‫رف‬ ‫ا دوا‬ ‫ا رد‬ ‫روش‬ ‫ا و ر‬ ‫رك‬ ‫ا‬ EPHYNAL EVION Tablet Tablet ‫ة‬ ‫ا‬ ‫اط‬ Vit. A +D VITAKID Eff tablet Drops Drops ‫ة‬ ‫ر‬ ‫ا‬ ‫اط‬ ‫ا‬ ---- COVIT VITANERVE Capsule Tablet ‫ا و‬ ‫ا ر‬ ‫وك‬ ‫د ن‬ ‫د‬ ---- 139 . cal. nausea. Vit D3 CAL-C-VITA Eff tablet ‫روش‬ ‫و س‬ ‫ا ر‬ ‫رك‬ ‫ا‬ ‫ر‬ ‫وك‬ CEBION CAL Vit A1 . urinary casts Vitamin D toxicity is treated by discontinuing vitamin D. polydipsia. B6 .B6 . Osteomalasia. and restricting calcium intake. A4 . D3 . anorexia. ‫دوز‬ ‫و اد ر‬ ‫د‬ ‫ا‬ ‫أ وت‬ ‫ا ر‬ ‫ب‬ ‫ا ل‬ ‫روش‬ ‫ا و ر‬ Vitamin E Vitamin E UNIVIT-E Tablet Young children with congenital cholestasis. calcium pantothothenate VIT. B2 . ascorbic acid Vit. If the toxicity is severe blood calcium levels can be further reduced with corticosteroids or bisphosphonates. B1 . vit. carbonate .

calcium pantothenate) Vit. vitamin C Vitamin Bcomplex. pyridoxine . essential minerals Vitamins . B1. nicotinamide . minerals VITAMIN 15 SOLCO Drops Drops Syrup Tablet ‫ا‬ ‫ا‬ Vitamin and mineral deficiency and as adjunct in synthetic diets VIDAYLIN + IRON CENTRUM ENERVIT MATERNA MIXAVIT-M PRAMET FA SUPRADYN THERAGRAN Syrup Tablet Tablet Tablet Tablet Tablet Capsule Tablet Tablet Vitamin and mineral deficiency and as adjunct in synthetic diets ‫ب‬ ‫ل‬ ‫ا‬ ---- ‫ا‬ ‫ا‬ ‫ا‬ ‫ر‬ UNICAP M Tablet 140 . B12. rutin. B12. E. vitamin C Vitamin A . iron Vitamins . rutin. diphenylpyraline Vitamin Bcomplex.ا و ر‬ ‫أ وت‬ ‫ا ر‬ ‫در‬ ‫ا ر‬ ‫وك‬ ‫در‬ ‫ا ر‬ ‫ر‬ ‫أ وت‬ ‫ا ر‬ ‫روش‬ ‫ا و ر‬ ‫ر ول‬ ‫رز و ب‬ ‫ا ر‬ (‫) و ب‬ ‫ر‬ ‫أ ون‬ ‫)ا ون‬ [ ‫ا رط‬ ‫ر‬ ‫ب‬ ‫ل‬ ‫ؤ‬ ‫ا‬ ‫ا‬ ‫ب‬ ‫ل‬ ‫ؤ‬ ‫ة‬ ‫دة‬ ‫ا‬ VITOP Capsule Treatment of vitamin-B deficiency Treatment of vitamin-B deficiency ‫ا ؤ‬ ‫ا‬ ‫دو‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ا‬ JUVELON MULTIBIONTA LAVENTE Capsule Capsule Ointment STRESS Tablet SURBEX C SURBEX T ALVITYL MIXAVIT NEUROTRAT Tablet Tablet Drops Tablet Drops Tablet Tablet Treatment of vitamin-B deficiency Treatment of vitamin-B deficiency ‫ر‬ ‫ا‬ ‫ا‬ ‫ا‬ POLY-VI-SOL VIDAYLIN Vitamins . Vit-C Vitamin A. B6. B2.B12 . riboflavin . B1. folic acid . nicotinamide . vitamin C Vitamins Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store EPARGRISOVIT ADULT Injection ‫ر‬ ‫ا ط‬ ‫ر‬ ‫رات‬ ‫اط‬ ‫ا ى‬ ‫ا‬ ‫رك‬ ‫ا‬ ‫ا ى‬ ‫ا‬ ‫در‬ ‫ا ر‬ ‫أ وت‬ ‫ا ر‬ ‫أ وت‬ ‫ا ر‬ ‫و‬ ‫ا ر‬ ‫ر‬ ‫ب‬ ‫ل‬ ‫ب‬ ‫ل‬ ‫ر‬ ‫ر‬ ‫ول ا ج‬ (‫) ورد ك‬ ‫ا‬ ‫د و ون‬ ‫ا ر‬ ‫أ وت‬ ‫ا ر‬ ‫اي‬ ‫ان.Scientific Name (Thiamine . D2 . E & t-seven . vitamin c Vitamin A. B2. niacinamide . chlorhexidine . B6. nicotinamide .

ferrous sulphate Vitamins .Scientific Name Trade Name Dosage Form Tablet Indications Side Effects Contra-indications Manufact urer ‫ر‬ ‫أ ون‬ ‫)ا ون‬ [ ‫ا رط‬ ‫ا‬ ‫ا رد‬ ‫رو‬ ‫ا ر‬ Drug Store ‫ر‬ UNICAP T Vitamins . Vit C . folic acid . inositol . vitamins KIDIVIT Tablet V-2 Capsule Vitamin and mineral deficiency and as adjunct in synthetic diets Vitamin and mineral deficiency and as adjunct in synthetic diets Vitamin and mineral deficiency and as adjunct in synthetic diets Vitamin and mineral deficiency and as adjunct in synthetic diets ‫ا‬ ‫ا‬ SUPRAVIT Capsule ‫ر‬ ‫و‬ ‫ا ر‬ ‫ا ود‬ ‫در‬ ‫ا رط‬ ‫رك‬ ‫ا‬ ‫در‬ ‫ا ر‬ ‫ة‬ ---- GEVRAL PROTEIN Powder STYPTOBION STRESS Tablet Tablet ‫ا‬ ‫اط‬ 141 . nicotinamide . minerals . rutin Zinc . minerals . biotin Vitamins . iron . minerals . vitamin K . folic acid Vitamins + minerals + proteins Vitamin C.

........................... 148 Drugs which suppress the rheumatic disease process ............................................................................ 148 Gout and cytotoxic-induced hyperuricaemia ............................................. 151 142 ........................................................Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Musculoskeletal and joint diseases Drugs used in rheumatic diseases and gout 143 Non-steroidal anti-inflammatory drugs............... 143 LOCAL CORTICOSTEROID INJECTIONS .................................................................................................. 150 Skeletal muscle relaxants ............. 150 Drugs used in neuromuscular disorders 150 Drugs which enhance neuromuscular transmission ...

hypersensitivity. ankylosing spondylitis: 100–125 mg/d PO in divided doses ‫ر‬ ‫دار ا دواء‬ ‫ا رد‬ ‫دار ا دواء‬ ‫ا رد‬ ‫ا ز رة‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫و و رم‬ ‫ا دودة دا‬ ‫ا و ر‬ ‫ا دوا‬ ‫وك‬ NOVODIFENAC OLFEN Tablet ROFENAC TABIFLEX VOLTAREN VOLTIC VOTREX Diclofenac diethylamine Diclofenac salt of epolamine RAPIDUS FLECTOR EP TISSUGEL Injection Suppository Tablet Injection Suppository Tablet Suppository Injection Suppository Tablet Injection Tablet Injection Suppository Tablet Tablet Patch Gastro-intestinal ulceration . coagulation defects. hypersensitivity. renal failure and hepatic damage Hypersensitivity. hypersensitivity. coagulation defects. acute gout. severe heart failure. porphyria ‫دة‬ ‫ا ر‬ ‫ا‬ ‫دو‬ ‫ر‬ ‫د‬ --- ---‫د‬ ‫وم‬ ‫دو‬ ‫ا‬ ‫ا رد‬ ‫وك‬ ‫إ ـ‬ ‫ا و ر‬ ‫ن‬ --‫ا‬ ---‫ؤ‬ ‫ا‬ 143 . postoperative pain Osteoarthritis: 100–150 mg/d PO in divided doses. renal failure and hepatic damage Hypersensitivity. coagulation defects. rheumatoid arthritis: 150–200 mg/d PO in divided doses. porphyria Hypersensitivity.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Drugs used in rheumatic diseases and gout Non-steroidal anti-inflammatory drugs Systemic NSAIDs (Oral. دى‬ ‫رل‬ ‫ا ر‬ ‫ر‬ ‫رن‬ ‫اي‬ ‫ا ط‬ ‫ا ر‬ ‫ا ر‬ ‫دادا‬ ‫ت‬ ‫اط و‬ ‫ا وازم‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ --‫ا‬ Diclofenac CLOFEN DICLOGESIC DICLOGESIC RETARD DICLOMAX INFLA-BAN Injection Tablet Injection Suppository Tablet Tablet Suppository Tablet Injection Suppository pain and inflammation in rheumatic disease (including juvenile arthritis) and other musculoskeletal disorders. severe heart failure. pregnancy and breast-feeding. pregnancy and breast-feeding. Rectal and Injection) Aluminum aspirin HYPYRIN Tablet pain and inflammation in rheumatic disease and other musculoskeletal disorders (including juvenile arthritis). porphyria ‫ا ىا‬ ‫ا‬ Celecoxib CELEBREX Capsule pain and inflammation in osteoarthritis or rheumatoid arthritis 100–200 mg PO BID as needed Gastro-intestinal ulceration . Gastro-intestinal ulceration . coagulation defects. severe heart failure. renal failure and hepatic damage Hypersensitivity. porphyria ‫. severe heart failure. hypersensitivity. pregnancy and breast-feeding. antiplatelet 325—650 mg PO with up to 8 g/d PO in divided doses. renal failure and hepatic damage Dexketoprofen trometamol KETESSE Tablet short-term treatment of mild to moderate pain including dysmenorrhoea Gastro-intestinal ulceration . pregnancy and breast-feeding.

coagulation defects. hypersensitivity. دى‬ ‫رل‬ ‫ز‬ ‫ا‬ ‫رك رب‬ ‫ودوم ا را‬ ‫دة‬ Capsule Tablet Suppository Tablet Tablet Tablet Suppository Tablet Tablet ‫ا ر‬ ‫ا‬ ‫دو‬ ‫ر‬ ‫د‬ ----‫ا‬ ‫اط‬ ---‫ر‬ ‫ا‬ ‫ة‬ DOLOBID Tablet Etodolac LODINE Capsule pain and inflammation in rheumatic disease and other musculoskeletal disorders. pregnancy and breast-feeding. hypersensitivity. porphyria Hypersensitivity. Maximum dose 1200 mg/d Gastro-intestinal ulceration . severe heart failure. pregnancy and breast-feeding. acute gout Gastro-intestinal ulceration . acute gout. postoperative pain Osteoarthritis: 100–150 mg/d PO in divided doses. coagulation defects. mild to moderate pain including dysmenorrhoea pain and inflammation in rheumatoid arthritis and osteoarthritis Osteoarthritis. pregnancy and breast-feeding. renal failure and hepatic damage Hypersensitivity. rheumatoid arthritis: 150–200 mg/d PO in divided doses. renal failure and hepatic damage ‫وا ـث‬ ‫ا رط‬ ‫زن‬ ‫ا دو‬ ‫ا ر‬ Etoricoxib ARCOXIA Tablet pain and inflammation in osteoarthritis and in rheumatoid arthritis. hypersensitivity. migraine. renal failure and hepatic damage ‫وس‬ ‫ز‬ ‫ا‬ ‫ب‬ ‫ل‬ ‫ا‬ 144 . renal failure and hepatic damage ‫رب‬ ‫را‬ ‫رك‬ ‫ودوم ا‬ ‫ا‬ Flurbiprofen FROBEN Tablet pain and inflammation in rheumatic disease and other musculoskeletal disorders. severe heart failure. coagulation defects. severe heart failure.Scientific Name Diclofenac sodium Trade Name Dosage Form Tablet Tablet Suppository Tablet Capsule Suppository Tablet Capsule Suppository Tablet Indications Side Effects Contra-indications Manufact urer ‫أو س‬ ‫ا د‬ ‫ر‬ ‫دار ا دواء‬ ‫ا رد‬ ‫دار ا دواء‬ ‫ا رد‬ ‫ا ز رة‬ Drug Store ‫ر‬ ‫ا ز رة‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ -----‫ا‬ APO-DICLO CLOFEN DICLOGESIC DICLOGESIC RETARD DICLOMAX DIVIDO INFLA-BAN pain and inflammation in rheumatic disease (including juvenile arthritis) and other musculoskeletal disorders. hypersensitivity. severe heart failure. misoprostol Diflunisal ARTHROTEC Tablet Gastro-intestinal ulceration . rheumatoid arthritis: Maintenance 600–1200 mg/d in divided doses. porphyria Hypersensitivity. ankylosing spondylitis: 100–125 mg/d PO in divided doses NOVODIFENAC OLFEN ROFENAC ROFENAC-D RUMAFEN TABIFLEX Diclofenac sodium . pregnancy and breast-feeding. pregnancy and breast-feeding. mild to moderate pain including dysmenorrhoea. coagulation defects. renal failure and hepatic damage Hypersensitivity. severe heart failure. porphyria Gastro-intestinal ulceration . porphyria Hypersensitivity. coagulation defects. postoperative analgesia. relief of sore throat Up to 300 mg/d Gastro-intestinal ulceration . hypersensitivity. porphyria ‫وك‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫و و رم‬ ‫ا دودة دا‬ ‫ا و ر‬ ‫ا دوا‬ ‫ا دوا‬ ‫ار ض ر‬ ‫وك‬ ‫.

pregnancy and breast-feeding. renal failure and hepatic damage Hypersensitivity. pregnancy and breast-feeding. hypersensitivity. severe heart failure.‫م‬ ‫ رو‬‫ز‬ ‫ا‬ ‫دار ا دواء‬ ‫ا رد‬ ‫ا ر‬ ‫ا و‬ ‫ا ود‬ ‫ت‬ ‫ا دوا‬ ‫ا ز رة‬ ‫وس‬ ‫ز‬ ‫ا‬ ‫ا‬ ‫ا رد‬ ‫ا ر ا وط‬ ‫ت‬ ‫ا دوا‬ ‫ا‬ ‫وك‬ ‫ر‬ ‫ار ض ر‬ ‫ا دوا‬ ‫ا دوا‬ pain and moderate to severe inflammation in rheumatic disease and other acute musculoskeletal disorders. migraine. porphyria --‫ب‬ ‫ل‬ ‫ا‬ ‫ا‬ ‫إ راھ م‬ ‫ا‬ PROF PROFINAL RIAPROFEN SAPOFEN SAPOFEN JUNIOR CONFORTID Suppository Tablet Suspension Tablet Tablet Tablet Suspension Capsule Injection Suppository Syrup Capsule Suppository Capsule Suppository Capsule Suppository Capsule Capsule Capsule Gastro-intestinal ulceration . ش. fever and pain in children. renal failure and hepatic damage Hypersensitivity. hypersensitivity. severe heart failure.2 g/d PO in divided doses. ‫رك‬ ‫ودوم ا‬ ‫ا‬ ‫ا رد‬ ‫ا رد‬ ‫ج ا دو‬ ‫رك. coagulation defects. porphyria ---‫ا ر‬ ‫ا ة‬ ‫اط‬ ----‫ا‬ Indomethacin ‫ا ر‬ ‫اد ر‬ INDOCID INDOMIN METHACIN INDOCID RETARD INDOGESIC INDOMETHAC IN ROTHACIN Ketoprofen KETOFAN ORUVAIL Capsule Tablet Capsule pain and mild inflammation in rheumatic disease Gastro-intestinal ulceration . pregnancy and breast-feeding. coagulation defects. mild to moderate pain including dysmenorrhoea. acute gout. dysmenorrhoea.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store PO in divided doses Ibuprofen ADVIL BALKAPROFE N Tablet Capsule Tablet ‫وا ث ا د‬ ‫ا ر‬ ‫ا‬ ‫اط‬ ‫ا‬ BRUFEN CHILDRENS ADVIL FENBID Tablet Suspension Spansules pain and inflammation in rheumatic disease (including juvenile arthritis) and other musculoskeletal disorders. postimmunization pyrexia Arthritis disorders 1. postoperative analgesia.2–3. closure of ductus arteriosus Anti-inflammatory and analgesic: 25–50 mg PO BID–TID not to exceed 200 mg/d Acute painful shoulder: 75–150 mg/d PO in 3–4 divided doses ‫ب‬ ‫ل‬ ‫و‬ ‫ا‬ ‫ا‬ ‫اط‬ IBUGESIC I-PROFEN Suspension Tablet Tablet ‫ا‬ ‫اط‬ ‫ا‬ JAZOFEN JUNIFEN PAEDIATRIC NUFEN OMAFEN Tablet Suspension Tablet Tablet Gastro-intestinal ulceration .دوم‬ ‫ا و د‬ ‫دار ا دواء‬ ‫ا رد‬ ‫ر‬ ‫رات‬ ‫اط‬ ‫ر‬ ‫ا ر‬ ‫أ س ر‬ ‫ا رط‬ ‫رب‬ ‫را‬ ‫ا‬ ‫ا‬ ‫د‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ا ؤ‬ ‫ا دة‬ ‫دو‬ ‫ر‬ ‫و‬ ‫ا‬ 145 . Hypersensitivity. pain: 400 mg PO q4–6h. dysmenorrhea: 400 mg PO q4h ‫ا دو‬ ‫ا رد‬ ‫وس‬ ‫ز‬ ‫ا‬ ‫وا ث ا د‬ ‫ن‬ ‫ال‬ ‫ث‬ . hypersensitivity.

osteoarthritis. porphyria ‫ك‬ ‫ر‬ Mefenamic acid FENAM FENAM FORTE FENAMIC Syrup Tablet Tablet Capsule FENDOL FENDOL D. severe heart failure. hypersensitivity. renal failure and hepatic damage Naproxen APONAPROXEN NAPROX NAPROX D. severe heart failure. Pain. severe heart failure.S PROXEN RIAPROXEN Tablet Tablet Tablet Suppository Tablet Tablet pain and inflammation in rheumatic disease (including juvenile arthritis) and other musculoskeletal disorders. 1wk of therapy Gastro-intestinal ulceration . coagulation defects. pregnancy and breast-feeding. hypersensitivity. and related conditions. coagulation defects. porphyria ‫ار ض ر‬ ‫وھر ر‬ ‫م‬ ‫ا‬ ‫ا‬ ‫ن‬ ‫ث‬ ‫م ال‬ ‫ ورد‬‫ز‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫أو س‬ ‫ا د‬ ‫ا‬ ‫ا رد‬ ‫ا‬ ‫ا رد‬ ‫رو ل‬ ‫ا‬ ‫ار ض ر‬ ‫ر‬ ‫ا ز رة‬ ‫ا‬ ‫ا‬ ‫ب‬ ‫ا ل‬ ‫ا ة‬ ‫اط‬ Piroxicam FELDENE NOVOPIROCAM ORTHOCAM Capsule Injection Suppository Tablet dispersable Capsule pain and inflammation in rheumatic disease (including juvenile arthritis) and other musculoskeletal disorders. acute gout. MAFEPAIN PANGESIC PONSTAN PONSTAN FORTE TABIGESIC Meloxicam COXICAM MOBIC Capsule Suspension Tablet Tablet Capsule Syrup Tablet Suspension Tablet Tablet Injection Suppository Tablet Suppository Tablet mild to moderate pain in rheumatoid arthritis (including juvenile arthritis).Scientific Name Trade Name Dosage Form Capsule Injection Suppository Tablet Tablet Indications Side Effects Contra-indications Manufact urer ‫ك‬ ‫رون‬ ) ‫رورر‬ ( ‫ا ر‬ ‫رون‬ ) ‫رورر‬ ( ‫ا ر‬ Drug Store ‫ر‬ PROFENID PROFENID L. acute gout 20 mg/d PO as a single dose or 10 mg PO BID ‫ا دوا‬ Gastro-intestinal ulceration . renal failure and hepatic damage Nabumetone RELIFEX pain and inflammation in osteoarthritis and rheumatoid arthritis 1000–2000 mg/d PO Gastro-intestinal ulceration . porphyria --- ‫و و رم‬ ‫ا دودة دا‬ ‫وك‬ ‫دة‬ Capsule ‫ا ر‬ ‫ا‬ ‫دو‬ ---- 146 . acute gout. pregnancy and breast-feeding. mild to moderate pain. pregnancy and breast-feeding. porphyria Hypersensitivity. coagulation defects. renal failure and hepatic damage Hypersensitivity. and after orthopaedic surgery.P and other musculoskeletal disorders. ankylosing spondylitis 7. primary dysmenorrhea: 500 mg initially then 250 mg q6– 8h. pregnancy and breast-feeding. hypersensitivity. severe heart failure. renal failure and hepatic damage Hypersensitivity. dysmenorrhoea Arthritis: 150–300 mg/d in divided doses. hypersensitivity. pregnancy and breast-feeding. dysmenorrhoea and menorrhagia 500 mg followed by 250 mg q6h PO PRN. severe heart failure. maximum dose. porphyria Hypersensitivity.5–15 mg PO QD Gastro-intestinal ulceration . postoperative analgesia. hypersensitivity.S. dysmenorrhoea. coagulation defects. porphyria ‫ت‬ ‫ا ز رة‬ ‫ا ز رة‬ ‫ا ر‬ ‫ا و‬ ‫ا ود‬ ‫ا دوا‬ ‫ا‬ ‫ا رد‬ ‫ا‬ ‫ا رد‬ ‫ا دوا‬ ‫ا رام‬ ‫رك د ز‬ ‫ز‬ ‫ا‬ ‫ود‬ ‫ا‬ ‫وك‬ ----‫ا‬ ‫ا‬ ‫ا‬ --‫زو‬ ‫ا‬ ‫ا‬ ---‫ة‬ ‫ر‬ ‫ا‬ ‫اط‬ ‫ا‬ pain and inflammation in rheumatic disease. coagulation defects. exacerbation of osteoarthritis (shortterm). renal failure and hepatic damage Hypersensitivity. Primary dysmenorrhea: 25–50 mg q6–8h PRN renal failure and hepatic damage coagulation defects. severe heart failure. arthritic disorders: 250– 500 mg PO BID Gastro-intestinal ulceration .

mucous ‫دو ر ت‬ 147 . hypersensitivity. ش. renal failure and hepatic damage ‫ا رد‬ ‫ج ا دو‬ ‫روش‬ ‫ا و ر‬ ‫رو ل‬ ‫ا رط‬ ‫د‬ SURGAM ‫ا ر‬ ‫ا ر‬ ‫دو‬ ‫اط‬ Topical NSAIDs (on skin) Diclofenac DICLOMAX LOCAGEL Gel Gel Musculoskeletal pain hypersensitivity . and inflamed or broken skin. photosensetivity On eyes.Scientific Name Trade Name Dosage Form Gel Tablet Capsule Indications Side Effects Contra-indications Manufact urer Drug Store ORTHOCAM DT UNICAM ‫وك‬ ‫دة‬ ‫ت‬ ‫ا‬ ---‫دي‬ ‫رف‬ ‫ا‬ Sulindac CLINORIL Tablet pain and inflammation in rheumatic disease and other musculoskeletal disorders. asthma. coagulation defects. pregnancy and breast-feeding. mucous membranes. renal failure and hepatic damage Hypersensitivity. asthma. mucous membranes. severe heart failure. acute gout 150–200 mg PO BID for 1–2 wk. asthma. and inflamed or broken skin. On eyes. porphyria Hypersensitivity. coagulation defects. mucous membranes. pregnancy and breast-feeding.دوم‬ ‫ا و د‬ Tenoxicam TENOX TILCOTIL Capsule Injection Suppository Tablet Tablet pain and inflammation in rheumatic disease and other musculoskeletal disorders Gastro-intestinal ulceration . porphyria ‫ا دوا‬ ‫ا رد‬ ‫رك. then reduce dose (not to exceed 400 mg/d) Gastro-intestinal ulceration . discontinue if rash develops ‫دة‬ ‫ت‬ ‫ر‬ ‫ر‬ ‫ا‬ Diclofenac sodium DICLOFEN Gel ‫ا‬ ‫دي‬ ‫رف‬ ‫ا‬ ‫اط‬ ‫ؤ‬ ‫ن‬ ‫ا‬ ‫ا‬ DICLOGESIC FLECTOR EP INFLA-BAN Gel Gel Gel Musculoskeletal pain OLFEN ROFENAC RUMAFEN Gel Gel Gel hypersensitivity . severe heart failure. and inflamed or broken skin. photosensetivity On eyes. photosensetivity On eyes. discontinue if rash develops ‫ا ز رة‬ ‫ر‬ ‫ا ة‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ ‫دو‬ ‫ة‬ ‫د‬ --‫ؤ‬ ‫ا‬ RHEUMARENE VOLTAREN Diclofenac diethylamine CLOFEN Gel Gel Gel ‫ا‬ ‫اط‬ Musculoskeletal pain hypersensitivity . hypersensitivity. discontinue if rash develops ‫ا دوا‬ ‫ا رد‬ ‫دار ا دواء‬ ‫ا رد‬ ‫إ ـ‬ ‫ا و ر‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫د‬ ‫ا و ر‬ ‫ا دوا‬ ‫ار ض‬ ‫ر‬ ‫وك‬ ‫ر‬ ‫ة‬ --‫ا‬ ‫اط‬ ---- Ibuprafen TABIFLEX COOL IBUTOP Gel Gel Musculo- hypersensitivity .

Lead poisoning Initial dose: 125–250 mg/d PO and increased to obtain remission. and skin reactions. discontinue if rash develops PROFENID Gel ‫ك‬ Piroxicam FELDENE ORTHOCAM Gel Gel Musculoskeletal pain hypersensitivity . agranulocytosis and aplastic anaemia. asthma. and inflamed or broken skin. chronic active hepatitis. lupus erythematosus. blood disorders including thrombocytopenia. proteinuria. mucous membranes. leucopenia.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫ا‬ ‫ر‬ ‫دو ر ت‬ ‫ا‬ ‫د‬ ‫ا رد‬ ‫ا دوا‬ ‫اي ر ن‬ ‫ا ط‬ Drug Store ‫ر‬ ‫ر‬ ‫ا‬ ‫ا‬ skeletal pain PROFINAL DOLGIT IBUPHIL SAPOFEN FASTUM Gel Cream Gel Gel Gel asthma.0 g PO initially nausea. and inflamed or broken skin. discontinue if rash develops Ketoprofen Musculoskeletal pain hypersensitivity . Maximum daily dose is 1. discontinue if rash develops ‫رون‬ ‫رورر‬ ) ( ‫ا ر‬ ‫ا دوا‬ ‫وك‬ ‫ا ر‬ ‫ا رق‬ ‫ا و ط‬ --‫ا ر‬ ‫ا ر‬ ‫دادات‬ ‫اط و‬ ‫ا وازم‬ ‫ر‬ ------ LOCAL CORTICOSTEROID INJECTIONS Dexamethasone DECADRON Injection local inflammation of joints and soft tissues consult product literature consult product literature ‫رك‬ ‫رب‬ ‫ودوم‬ ‫ا را‬ ‫اور ون‬ ‫ا و د‬ ‫ا و‬ ‫ا ر‬ ‫ا‬ ‫ا رد‬ ‫ر‬ ‫أ ون‬ (‫)ا ون‬ ‫أر‬ ‫ا ون‬ ‫ا‬ ‫ر ول‬ ‫رز‬ -‫وب‬ ‫اط‬ ‫ا‬ ORADEXON Dexamethasone sodium phosphate Hydrocortisone acetate DEXAMETHASONE SOD. mucous membranes. and cystinuria. rarely haematuria (withdraw immediately).PHOSPHATE ZENOS CORTEF ACETATE Injection Injection Injection Injection ‫و‬ ‫د ن‬ ‫د‬ ‫ا‬ ‫ر‬ local inflammation of joints and soft tissues local inflammation of joints and soft tissues local inflammation of joints and soft tissues local inflammation of joints and soft tissues consult product literature consult product literature consult product literature consult product literature consult product literature consult product literature consult product literature consult product literature Methyl prednisolone acetate Triamcinolone DEPO MEDROL Injection ‫ر‬ ‫ؤ‬ ‫ا‬ KENACORT-A Injection Drugs which suppress the rheumatic disease process D-penicillamine ARTAMIN Capsule Severe active rheumatoid arthritis. Wilson's disease. asthma. photosensetivity membranes. and inflamed or broken skin. photosensetivity On eyes. photosensetivity On eyes. taste loss (mineral supplements not recommended). fever. anorexia. moderate to severe renal impairment ‫دوز‬ ‫أم ا ش‬ ً ) ( ‫و‬ ‫و‬ ‫ا‬ ‫ر‬ 148 .

pruritus). vasospasm. toxic megacolon. neutropenia. hepatitis. bradycardia. diarrhoea. ulcerative colitis 2–4 g/d PO in divided doses hepatic impairment. gastro-intestinal haemorrhage. those occurring less frequently include ECG changes. pulmonary fibrosis. systemic and discoid lupus erythematosus. severe infections ‫و‬ ‫ر‬ ‫ا‬ ‫ر‬ Sulfasalazine SALAZOPYRINEN Tablet active rheumatoid arthritis. retinal damage dyspepsia. gastrointestinal intolerance and. psoriasis. active infection and immunodeficienc y syndromes Aminosalicylates should be avoided in salicylate hypersensitivity ‫در‬ ‫ا ر‬ ‫ا وي‬ ‫و‬ ‫ا‬ ‫ر‬ ‫د‬ ‫ر‬ ‫ا ون‬ ‫ا ود‬ ‫ا‬ 149 . diarrhoea. headache and skin reactions (rashes. abdominal discomfort. constipation. occasional leucopenia. interstitial pneumonitis also anorexia. flushing. palpitation. active and progressive rheumatoid arthritis in patients not previously treated with methotrexate. interstitial pneumonitis Rashes. ecchymosis. inflammatory bowel disease Methotrexate METHOTREXATE Tablet moderate to severe active rheumatoid arthritis. METHOTREXATE Tablet The side-effects of chloroquine and hydroxychloroquine include gastrointestinal disturbances. dermatological conditions caused or aggravated by sunlight 200-600 mg/d PO Infliximab REMICADE Injection severe. haematoma. intestinal ulceration and bleeding. syncope. avoid conception for at least 3 months after stopping). arrhythmias. hepatotoxicity .Scientific Name Hydroxychloroquine so4 Trade Name Dosage Form Tablet Indications Side Effects Contra-indications Manufact urer ‫و‬ ‫و‬ ‫ز‬ ‫ا‬ Drug Store PLAQUENIL active rheumatoid arthritis (including juvenile arthritis). breast-feeding . pregnancy (following administration to a woman or a man. ecchymosis. pulmonary oedema. convulsions. Hematological abnormalities occur usually reverse in the first 3 to 6 months of treatment pregnancy . visual changes. diverticulitis. pleuritic pain. and thrombocytopenia. Crohn’s disease. peripheral ischaemia. breast-feeding . cholecystitis. especially in patients with rheumatoid arthritis.

5—0. prophylaxis of hyperuricaemia associated with cancer chemotherapy 100–800 mg/d PO ZYLORIC Tablet Colchicine COLMEDITEN Tablet GOTINE Tablet acute gout. alopecia. and abdominal pain. prophylaxis of familial Mediterranean fever (recurrent polyserositis) [unlicensed] Acute attack: Initial dose 0. Urinary retention Myasthenia gravis: maintenance dose 15-375 mg/d PO. rashes. excessive sweating. arthralgia. and eosinophilia Most common are nausea. fever. signs of overdosage include bronchoconstriction.5—1. increased salivation. excessive doses may also cause profuse diarrhoea.6 mg/d PO rashes (withdraw therapy. gastrointestinal haemorrhage. vomiting. specific drug for reversal of nondepolarising (competitive) blockade. vomiting. inhibition of spermatogenesis not a treatment for acute gout but continue if attack develops when already receiving allopurinol. 0. prophylaxis: 0.2 mg PO or 2 mg IV then 0. renal and hepatic damage.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Gout and cytotoxic-induced hyperuricaemia Allopurinol APUROL NO-URIC PURINOL UROQUAD Tablet Tablet Tablet Tablet prophylaxis of gout and of uric acid and calcium oxalate renal stones.5—1. diarrhoea. Rarely peripheral neuritis. if rash mild re-introduce cautiously but discontinue immediately if recurrence— hypersensitivity reactions occur rarely and include exfoliation.51 mg IM. lymphadenopathy.2 mg PO q1—2h or 0. shortterm prophylaxis during initial therapy with allopurinol and uricosuric drugs. abdominal cramps (more marked with higher doses). SC q 4-6 hr PRN nausea. increased bronchial secretions.5 mg IV q6h until attack aborted or adverse effects occur. myopathy. involuntary defecation and micturition intestinal or urinary obstruction ‫أ ن‬ ‫ا ر د‬ ‫ة‬ ‫ا‬ ‫اط‬ 150 . and treat attack separately ‫ز رد‬ ‫ا و ر‬ ‫ا و‬ ‫ا ر‬ ‫ا‬ ‫ا رد‬ ‫روش‬ ‫دا و ك‬ ‫أ‬ ‫ر‬ ‫و‬ ‫ا ر‬ ‫ا ود‬ ‫ا ھرة‬ ‫ا ر‬ ‫و ــت وارد‬ ‫ا ر‬ ‫د‬ ‫ا‬ ‫اط‬ ‫د ن‬ ‫ا‬ ---- pregnancy ‫ا ؤ‬ ‫ا ر‬ ‫ا‬ Drugs used in neuromuscular disorders Drugs which enhance neuromuscular transmission Neostigmine methyl sulphate NEOSTIGMINE Injection Myasthenia gravis. lacrimation.

bradycardia. drowsiness. respiratory depression. restlessness. disturbances of vision.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Skeletal muscle relaxants Carisoprodol . dizziness. pruritus. insomnia. nausea. headache. porphyria . drowsiness. dizziness. also gastrointestinal disturbances. anxiety. breastfeeding ‫ا ر‬ ‫اد ر‬ ‫ا‬ Methocarbamol ROBAXIN Injection Tablet short-term symptomatic relief of muscle spasm coma or pre-coma. angioedema. hallucinations and altered liver enzymes (discontinue if persistently raised—consult product literature). paradoxical excitement. weakness. also reported. paraesthesia. epilepsy. myasthenia gravis ‫رو ز‬ ‫ا ر‬ ‫ا‬ ‫اط‬ Tizanidine SIRDALUD Tablet spasticity associated with multiple sclerosis or spinal cord injury or disease severe hepatic impairment ‫دوز‬ ‫د‬ 151 . caffeine SOMADRIL Tablet short term symptomatic relief of muscle spasm drowsiness most common sideeffect. CNS effects including headache. rash. fever. anaphylaxis). hypotension. gastro-intestinal disturbances. rarely agranulocytosis and rashes nausea. dry mouth. amnesia. vomiting. paracetamol . brain damage. hypersensitivity reactions (including urticaria. acute pulmonary insufficiency. tremor. nasal congestion. dyspepsia. confusion. hypotension. fatigue. seizures. blurred vision.

............................................................................................... 153 Antibacterials with Corticosteroids... 157 Other anti-inflammatory preparations.......................................................................................................................................................... 163 Carbonic anhydrase inhibitors and systemic drugs .. 162 Sympathomimetics ......................................................................................... 162 Prostaglandin analogues...................................... 164 Local anaesthetics 165 Miscellaneous ophthalmic preparations 165 Tear deficiency.................................................... 166 152 ........................................................Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Eye Anti-infective eye preparations 153 Antibacterials ........................................................ ocular lubricants............................................................................................................................ 158 Mydriatics and cycloplegics 160 Treatment of glaucoma 162 Beta-blockers .................. and astringents .......................................... 163 PILOCARPINE........................................................................................................................................................ 165 Ocular diagnostic and peri-operative preparations and photodynamic treatment .............................. 155 Corticosteroids and other anti-inflammatory preparations 157 Corticosteroids .............

‫ا ون‬ ‫و رت‬ ‫ا ون‬ ‫و رت‬ ‫ر‬ ‫ا ط‬ ‫و ن‬ ‫وش ا د‬ ‫وب‬ ‫ا رط‬ ‫ا ون‬ ‫وزى‬ ‫ا‬ ‫وم‬ ‫دو‬ ‫ن‬ ‫ت‬ . Eye Drops superficial bacterial infections and corneal ulcers Fucidic acid FUCITHALMIC OPTIFUCIN Eye Drops Eye Drops staphylococcal infections Gentamicin (Gentamycin) GENTACIN ALCOMICIN E/E Drops Eye Oint.‫ا دوا‬ ‫ا ردن‬ ‫ار ض‬ ‫ر‬ ‫و ر ز‬ (‫زون‬ ) ‫ا و ر‬ ‫ا ون‬ ‫ا ر‬ ‫ار ض‬ ‫ر‬ ‫ا دوا‬ ‫ة‬ ‫ب‬ ‫ل‬ ‫ب‬ ‫ل‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫وم‬ ‫ا‬ ISOPTOFENICOL Eye Drops KEMICETINE MINIMS CHLORAMPHENICOL Eye Drops Eye Oint. Eye Drops --‫ؤ‬ ‫ا‬ ‫ة‬ ‫د‬ ‫ب‬ ‫ا ل‬ ‫ا ة‬ ‫اط‬ ----‫وم‬ ‫دو‬ ‫و‬ ‫اد ر‬ ‫ن‬ ‫ت‬ . Eye Drops Ciprofloxacin CILOXAN CIPROCIN CIPROMAX OPTICIN Eye Drops Eye Drops Eye Oint.‫ا دوا‬ ‫ا ردن‬ ‫ار ض‬ ‫ر‬ ‫ا ون‬ ‫و رت‬ ‫ر‬ ‫و‬ ‫ا‬ ‫ؤ‬ ‫ا‬ ‫ة‬ ‫ب‬ ‫ل‬ ‫ر‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫ا‬ ‫اط‬ PHENICOL Eye Drops RIACHOL SPERSANICOL Eye Drops Eye Oint. risk of aplastic anaemia ‫ا ر ن‬ ‫ا ر د‬ ‫ا ون‬ ‫وزى‬ ‫ا‬ Eye Oint.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Anti-infective eye preparations Antibacterials Chloramphenicol CHLOROPTIC COLIRCUSI CHLORAMPHENICOL FENICOL Eye Drops Eye Drops superficial eye infection transient stinging. Eye Drops Eye Oint. Eye Drops OFTHALMOLOSA CUSI CHLORAMPHEN OPTICHLOR Eye Oint. E/E Drops superficial eye infection GARAMYCIN E/E Drops 153 .

neomycin . E/E Drops E/E Drops Eye Drops Eye Drops --‫وم‬ ‫د‬ ‫ب‬ ‫ل‬ ‫ؤ‬ ‫ا‬ ‫وم‬ SPERSAPOLYMYXIN STATROL Eye Drops Eye Oint. polymyxin b sulphate CONJUNCTIN Eye Oint. Eye Drops superficial eye infection local irritation including photophobia. Eye Drops ‫ا‬ ISOPTO CETAMIDE Eye Drops ‫ا‬ ‫ا‬ ‫اط‬ RIACETAMIDE SPERSACET Eye Drops Eye Drops 154 . numbness. nausea and headache reported ‫ا‬ Ofloxacin EYLOX OFLOX Eye Drops OPTIFLOX Eye Drops --‫وم‬ ‫دو‬ ‫و‬ ‫و م‬ (. ‫ن‬ ‫ت‬ ‫ا دوا‬ ‫ا ردن‬ ‫ا دوا‬ ‫ا ون‬ ‫وزى‬ ‫ا‬ ‫رك‬ ‫ا‬ ‫ا ون‬ ‫وزى‬ ‫ا‬ ‫ا دوا‬ superficial eye infection local irritation and dermatitis ‫ا ر ن‬ ‫ا ر د‬ ‫و ر ز‬ (‫زون‬ ) ‫ا و ر‬ ‫ا ون‬ ‫و رت‬ ‫ن‬ ‫ت‬ ‫ا دوا‬ ‫ا ردن‬ ‫ا ر ن‬ ‫ا ر د‬ ‫ا ر‬ ‫ا ر‬ ‫دادات‬ ‫اط‬ ‫وا وازم‬ ‫ؤ‬ ‫ا‬ GENTAM OFTALMOLOSA CUSI GENTAMYCIN REFOBACIN COLIRCUSI GENTAMYCIN GENTAM Neomycin .Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫ا‬ Drug Store MINIMS GENTAMYCIN E/E Drops UNIGENTA Eye Drops ‫و ن‬ ‫وش ا د‬ ‫وب‬ ‫ا رط‬ ‫و د‬ ‫ا و‬ ‫ة‬ ‫ا‬ ‫اط‬ APIGEN E/E Drops Eye Oint. --‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ Eye Oint.‫ا دوا‬ ‫ا ردن‬ ‫ا ون‬ ‫ا ر‬ ‫ا ون‬ ‫وزى‬ ‫ا‬ ‫ا ون‬ ‫و رت‬ ‫ار ض‬ ‫ر‬ ‫و ر ز‬ (‫زون‬ ) ‫ا و ر‬ ‫و‬ Polymixin-b . Eye Oint.ف‬ ‫ز‬ ‫ا‬ ‫ن‬ ‫ت‬ . dizziness. garamicidin Sulphacetamide NEOSPORIN Eye Drops superficial eye infection local irritation and dermatitis APISULFA Eye Drops superficial eye infection ‫ؤ‬ ‫ا‬ ‫ب‬ ‫ل‬ ‫ا‬ ‫ب‬ ‫ل‬ ‫ة‬ ‫د‬ CETAMIDE COLIRCUSI SULPHACETAMIDE Eye Oint.‫)و م.

superficial eye infection Antibacterials with Corticosteroids Betamethasone sodium phosphate . prednisolone . E/E Oint. Eye Drops Eye Oint. cataract and exacerbation of ocular viral infection. superficial eye infection with local inflammation superficial eye infection with local inflammation ‫ا ون‬ ‫و رت‬ ‫ب‬ ‫ا ل‬ Sulphacetamide . chloramphenicol Sulphacetamide. TERACIN Tobramycin TOBREX E/E Oint.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Sulphacetamide . risk of aplastic anaemia glaucoma. nausea and headache reported glaucoma. tetrahydrozolin LOXTRA Eye Drops --‫وم‬ ‫دو‬ Oxytetracycline . cataract and exacerbation of ocular viral infection glaucoma. cataract and exacerbation of ocular viral infection glaucoma. numbness. chloramphenicol BETACHOL Eye Drops superficial eye infection with local inflammation glaucoma. dizziness. cataract and exacerbation of ocular viral infection. cataract and exacerbation of ocular viral infection ‫ار ض‬ ‫ر‬ ‫ة‬ ‫ا‬ ‫اط‬ Tetryzolin HCl . superficial eye infection with local inflammation ‫زر‬ ‫ا‬ ‫ا‬ Sulphacetamide . gentamycin . hypromellose Tetracycline HCl SPERSACET-C Eye Drops superficial eye infection superficial eye infection superficial eye infection (‫ن‬ ISOPTOCETAMIDE Eye Drops DUMOCYCLINE LATYCIN E/E Oint. prednisolone CETAPRED Eye Oint. phenylephrine BLEPHAMIDE Eye Drops ‫ا ر ن‬ ‫ا ر د‬ ‫وم‬ 155 . local irritation including photophobia. transient stinging. dexamethasone COLIRCUSI GENTADEXA Eye Drops superficial eye infection with local inflammation superficial eye infection with local inflammation ‫ا ون‬ ‫وزى‬ ‫ا‬ ‫ا‬ Ofloxacin . polymyxin-b sulphate TERRACORTIL Eye Drops Eye Oint. local irritation and dermatitis glaucoma. prednisolone . cataract and exacerbation of ocular viral infection. hydrocortisone .

polymyxin b sulphate PND UNIMED Eye Drops Tobramycin . dexamethasone sodium . cataract and exacerbation of ocular viral infection.Scientific Name Sulphacetamide. prednisolone . hpmc Trade Name Dosage Form Eye Drops Indications Side Effects Contra-indications Manufact urer ‫ا ون‬ ‫و رت‬ Drug Store ‫ب‬ ‫ل‬ ISOPTOCETAPRED superficial eye infection with local inflammation superficial eye infection with local inflammation superficial eye infection with local inflammation Gentamicin sulphate . cataract and exacerbation of ocular viral infection. cataract and exacerbation of ocular viral infection. cataract and exacerbation of ocular viral infection. Neomycin . superficial eye infection with local inflammation Eye Drops Dexamethasone . superficial eye infection with local inflammation superficial eye infection with local inflammation Fluromethelon . cataract and exacerbation of ocular viral ‫ن‬ ‫ت‬ .‫رك‬ ‫ش. polymyxin so4 . cataract and exacerbation of ocular viral infection glaucoma. dexamethasone OPTIDEX-T Eye Drops TOBRADEX Eye Drops Eye Oint. cataract and exacerbation of ocular viral infection glaucoma. neomycin NEODEX Eye Drops superficial eye infection with local inflammation DECADRON NEO E/E Drops Dexamethasone . cataract and exacerbation of ocular viral infection glaucoma. neomycin FML NEO LIQUIFILM Eye Drops glaucoma. cataract and exacerbation of ocular viral infection glaucoma. cataract and exacerbation of ocular viral infection ‫ا‬ ‫و‬ ‫ر‬ ‫ا‬ ‫ر‬ ‫د‬ ‫و‬ ‫ا و‬ ‫ا ر‬ ‫ا ر‬ ‫دادات‬ ‫اط‬ ‫وا وازم‬ --‫وم‬ ‫دو‬ ‫ا ون‬ ‫و رت‬ ‫ا ون‬ ‫وزى‬ ‫ا‬ ‫ا ون‬ ‫وزى‬ ‫ز‬ (‫زون‬ ‫ر‬ ‫ز‬ (‫زون‬ ‫ر‬ ‫ا‬ ‫و ر‬ ) ‫ا و‬ ‫و ر‬ ) ‫ا و‬ ‫د‬ ‫د‬ ‫ا‬ ‫ب‬ ‫ل‬ ‫ا‬ ‫ا‬ Dexamethasone . hypromellose DECADRON WITH NEOMYCIN MAXITROL E/E Drops Eye Drops Eye Oint. Eye Drops superficial eye infection with local inflammation glaucoma. local irritation and dermatitis glaucoma. transient stinging. transient stinging. local irritation and dermatitis glaucoma. tetryzoline SPERSADEXOLINE Eye Drops superficial eye infection with local inflammation Dexamethasone . betamethasone GARASONE Eye Drops Eye Oint. chloramphenicol COLIRCUSI DEICOL OFTALMOLOSA CUSI DEICOL SPERSADEX COMP Eye Oint.‫ا دوا‬ ‫ا ردن‬ . gentamycin INFECTOFLAM Eye Drops Eye Oint. risk of aplastic anaemia glaucoma.دوم‬ ‫ا و د‬ ‫ا ون‬ ‫ا ر‬ ‫ؤ‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ب‬ ‫ل‬ ‫ا‬ ‫و ر ز‬ (‫زون‬ ) ‫ا و ر‬ ‫ا ر ن‬ ‫ا ر د‬ ‫وم‬ ‫د‬ 156 .‫رك‬ ‫رب ودوم‬ ‫ا ر‬ . chloramphenicol . superficial eye infection with local inflammation Fluorometholone . risk of aplastic anaemia glaucoma.

exacerbation of ocular viral infection steroid glaucoma. cataract and exacerbation of ocular viral infection. transient stinging. exacerbation of ‫ا ون‬ ‫ا ر‬ . exacerbation of ocular viral infection steroid glaucoma. ‫ار ض ر‬ ‫ة‬ ‫ا‬ ‫اط‬ Dexametasone MAXIDEX DECADRON Eye Drops E/E Drops DECADRON E/E Drops SPERSADEX Eye Drops Dexamethasone . neomycin sulphate Prednisolone .C WITH NEOM Eye Drops superficial eye infection with local inflammation superficial eye infection with local inflammation superficial eye infection with local inflammation Hydrocortisone acetate . cataract and exacerbation of ocular viral infection glaucoma. neomycin COLIRCUSI H. steroid cataract.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store infection Hydrocortisone .‫ا دوا‬ ‫ا ردن‬ ‫ا ر ن‬ ‫ا ر د‬ ‫ر‬ ‫ا‬ ‫ؤ‬ ‫ا‬ ‫وم‬ Corticosteroids and other anti-inflammatory preparations Corticosteroids Betamethasone OPTASONE Eye Drops local treatment of inflammation (short-term) local treatment of inflammation (short-term) local treatment of inflammation (short-term) steroid glaucoma. cataract and exacerbation of ocular viral infection. steroid cataract.‫رك‬ ‫ش. رب‬ ‫ودوم‬ ‫ا ر‬ ‫و ر ز‬ (‫زون‬ ) ‫ا و ر‬ ‫ا ون وزى‬ ‫ا‬ ‫ب‬ ‫ل‬ ‫ا‬ ‫ا‬ ‫د‬ ‫ا‬ ‫ا‬ ‫ا ون‬ ‫و رت‬ ‫ب‬ ‫ل‬ ‫ا‬ 157 .P Eye Drops PREDMYCIN-P Eye Drops glaucoma. NEOPRED . local treatment of inflammation (short-term) local treatment of inflammation Fluorometholone FLUCON Eye Drops steroid glaucoma. steroid cataract. steroid cataract. risk of aplastic anaemia glaucoma. exacerbation of ocular viral infection steroid glaucoma. local irritation and dermatitis ‫و ر ز‬ (‫زون‬ ) ‫ا و ر‬ ‫د‬ ‫ا ون‬ ‫وزى‬ ‫ا‬ ‫ر‬ ‫أ ون‬ ‫)ا ون‬ [ ‫ا رط‬ ‫ن‬ ‫ت‬ . polymyxin NEO-CORTEF Eye Oint. steroid cataract. exacerbation of ocular viral infection ‫ار ض ر‬ ‫ة‬ ‫ا‬ ‫اط‬ Betamethasone sodium phosphate OPTASONE Eye Oint. superficial eye infection with local inflammation Hydrocortisone . neomycin . cataract and exacerbation of ocular viral infection glaucoma.دوم‬ ‫ا و د‬ ‫رك. sodium phosphate OFTALMOLOSA CUSI DEXAMETHASONE Eye Oint. chloramphenicol CORTIPHENOL-H Eye Oint.

sodium cromoglycate FLUCA Eye Drops local treatment of inflammation (short-term) local treatment of inflammation (short-term) local treatment of inflammation (short-term) local treatment of inflammation (short-term) Fluorometholone . tetryzoline EFEMOLINE Eye Drops Hydrocortisone acetate OFTALMOLOSA CUSI HYDROCORTISONE Eye Oint. exacerbation of ocular viral infection steroid glaucoma.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫ار ض ر‬ ‫ا ر ن‬ ‫ا ر‬ ‫ا ر ن‬ ‫ا ر د‬ ‫وم‬ ‫دو‬ Drug Store ‫ة‬ ‫وم‬ ‫وم‬ --‫ا‬ ‫اط‬ FLUMETOL FML FML LIQUIFILM OPTILONE Eye Oint. exacerbation of ocular viral infection --‫وم‬ ‫دو‬ ‫و ر ز‬ (‫زون‬ ) ‫ا و ر‬ ‫ا ون وزى‬ ‫ا‬ ‫ا‬ ‫د‬ ‫ز‬ (‫زون‬ ‫ر‬ ‫ز‬ (‫زون‬ ‫ر‬ ‫ت‬ - APICORT Eye Drops ‫و ر‬ ) ‫ا و‬ ‫و ر‬ ) ‫ا و‬ ‫ن‬ ‫د‬ ‫د‬ ‫ؤ‬ ‫ا‬ ECONOPRED PLUS OPTIPRED Eye Drops Eye Drops ‫ا دوا‬ ‫ا ردن‬ ‫ا ون‬ ‫ا ر‬ ‫ب‬ ‫ل‬ ‫ا‬ --- PREDFORTE PREDMILD Rimexolone VEXOL Eye Drops Eye Drops Eye Drops local treatment of inflammation (short-term) steroid glaucoma. exacerbation of ocular viral infection steroid glaucoma. steroid cataract. ULTRACORTENOL Eye Drops steroid glaucoma. naphazaline nitrate Antazoline . tetrahydrozoline OCURED Eye Drops allergic conjunctivitis allergic conjunctivitis ‫ار ض‬ ‫ر‬ ‫ن‬ ‫ت‬ ‫ا دوا‬ ‫ا ردن‬ --‫وم‬ ‫دو‬ ‫ةاط‬ ‫ؤ‬ ‫ا‬ ‫ا‬ APILLERG Eye Drops OPTIZOLIN Eye Drops 158 . steroid cataract. steroid cataract. Eye Drops Eye Drops Eye Drops (short-term) ocular viral infection Fluorometholone . exacerbation of ocular viral infection ‫وم‬ ‫دو‬ ‫ر ن‬ ‫ر د‬ ‫ر ن‬ ‫ر د‬ ‫ون‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫وم‬ ‫وم‬ ‫ب‬ ‫ل‬ ‫ا‬ Other anti-inflammatory preparations Antazolin sulfate . steroid cataract. exacerbation of ocular viral infection steroid glaucoma. Prednisolone ULTRACORTENOL Eye Oint. steroid cataract.

transient burning and stinging. skin reactions. less commonly keratitis. less commonly dry eye. subconjunctival haemorrhage. irritation. local oedema. transient burning or stinging. vernal keratoconjunctivitis seasonal allergic conjunctivitis Sodium cromoglycate APICROM Eye Drops allergic conjunctivitis. dizziness. vernal keratoconjunctivitis Transient burning or stinging. corneal infiltrates (discontinue) and staining. blurred vision. and rhinitis occasionally reported. lacrimation. dry eye. distinctive taste reported local irritation. headache. flushing and dizziness reported. local oedema. keratitis. headache. headache. photophobia. dry eye. asthenia. and dry mouth also reported Mild transient burning. dry nose also reported transient burning and stinging ‫و ر ز‬ (‫زون‬ ) ‫ا و ر‬ ‫د‬ ‫ا ون‬ ‫و رت‬ ‫ل‬ ‫با‬ ‫أ س‬ ‫) زو ز‬ ( ‫ز‬ ‫ا‬ ‫ا ون‬ ‫ا ر‬ ‫ل‬ ‫با‬ ‫ر‬ ‫ن‬ ‫ا دوا‬ ‫ا ردن‬ ‫ا ون‬ ‫وزى‬ ‫ا‬ ‫دار ا دواء‬ ‫ا رد‬ ‫أ س‬ ‫) زو ز‬ ( ‫ز‬ ‫ا‬ ‫وم‬ ‫دو‬ ‫و د‬ ‫ا و‬ ‫ت‬ - ‫ؤ‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ر‬ CUSICROM Eye Drops DADCROME OPTICROM Eye Drops Eye Oint. itching. and lacrimation. photophobia. stinging.Scientific Name Trade Name Dosage Form Eye Drops Indications Side Effects Contra-indications Manufact urer ‫و ر ز‬ (‫زون‬ ) ‫ا و ر‬ ‫ا ون‬ ‫ا ر‬ Drug Store ‫د‬ ‫ل‬ ‫با‬ SPERSALLERG Emedastine difumarate EMADINE Eye Drops seasonal allergic conjunctivitis Ketotifen ZADITEN Eye Drops seasonal allergic conjunctivitis Lodoxamide ALOMIDE Eye Drops allergic conjunctivitis Nedocromil sodium TILAVIST Eye Drops Olopatadine PATANOL Eye Drops allergic conjunctivitis. photophobia. drowsiness. Eye Drops Eye Drops OPTIDRIN --‫ا ر‬ ‫ا ر‬ ‫دادات‬ UNICROM Eye Drops 159 . punctate corneal epithelial erosion.

oedema and conjunctivitis may occur. hyperaemia. local irritation. tetrhydrozolin CROMA Eye Drops Allergic conjunctivitis. local irritation. on prolonged administration. hyperaemia. anterior uveitis Transient stinging and raised intraocular pressure. Contact dermatitis (conjunctivitis) Transient stinging and raised intraocular pressure. vernal keratoconjunctivitis --‫وم‬ ‫دو‬ Mydriatics and cycloplegics Atropine sulphate ATROPINE Eye Drops refraction procedures in young children. Eye Drops Eye Drops producing cycloplegia for refraction in young children Transient stinging and raised intraocular pressure. on prolonged administration. Contact dermatitis (conjunctivitis) ‫و ر ز‬ (‫زون‬ ) ‫ا و ر‬ ‫ا ون‬ ‫وزى‬ ‫ا‬ ‫ا ون‬ ‫ا ر‬ ‫و ن‬ ‫وش ا د‬ ‫وب‬ ‫ا رط‬ ‫ا ون‬ ‫وزى‬ ‫ا‬ ‫ار ض‬ ‫ر‬ ‫ا ون‬ ‫وزى‬ ‫ا‬ ‫ا ون‬ ‫ا ر‬ ‫ل‬ ‫د ور و‬ ‫ا‬ ‫ل‬ ‫د ور و‬ ‫ا‬ ‫و ن‬ ‫وش ا د‬ ‫وب‬ ‫ا رط‬ ‫ا ون‬ ‫ا ر‬ ‫ار ض‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ا و طر‬ ‫دان‬ ‫و‬ ‫ا و طر‬ ‫ا ة‬ ‫اط‬ ‫ب‬ ‫ا ل‬ ‫ا ة‬ ‫اط‬ ‫ب‬ ‫ل‬ ‫دان‬ ‫د‬ COLIRCUSI ATROPINE ISOPTO ATROPINE MINIMS ATROPINE SULPHATE Eye Drops ‫ا‬ ‫ب‬ ‫ل‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫اط‬ Eye Drops Eye Drops OFTALMOLOSA CUSI ATROPINE RIATROPIN Cyclopentolate HCl COLIRCUSICICLOPLEGIC CYCLOGYL CYCLOPENTOLATE Eye Oint. hyperaemia. oedema and conjunctivitis may occur. local irritation. on prolonged administration. ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ Eye Oint.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store ‫اط‬ ‫وا وازم‬ VISACROM VIVIDRIN Eye Drops Eye Drops ‫ا دوا‬ ----- ‫وم‬ ‫دو‬ Sodium cromoglycate . Contact dermatitis (conjunctivitis) Transient stinging and raised intra- Eye Drops Eye Drops CYCLOPENTOLATE Eye Drops MINIMS CYCLOPENTOLATE Eye Drops Homatropine HBr ISOPTO HOMATROPINE HOMAPIN Eye Drops Eye Drops treatment of anterior segment inflammation Phenylephrine MINIMS PHENYLEPHRINE Eye Drops anterior uveitis ‫و ن‬ ‫وش ا د‬ ‫وب‬ ‫ة‬ ‫ا‬ ‫اط‬ 160 . oedema and conjunctivitis may occur.

on prolonged administration. local irritation. pyrilamine maleate PREFRIN -A Eye Drops Eye Drops anterior uveitis Transient stinging and raised intraocular pressure. local irritation. oedema and conjunctivitis may occur. hyperaemia. oedema and conjunctivitis may occur. hyperaemia. local irritation. on prolonged administration. on prolonged administration. zinc sulphate APIFRIN-Z Eye Drops anterior uveitis ‫ن‬ ‫ت‬ ‫ا دوا‬ ‫ا ردن‬ ‫ا ون‬ ‫و رت‬ ‫ؤ‬ ‫ا‬ ‫ب‬ ‫ل‬ ZINCFRIN Eye Drops ‫ا‬ Tropicamide MINIMS TROPICAMIDE Eye Drops facilitate the examination of the fundus of the eye MYDRIACYL Eye Drops ‫و ن‬ ‫وش ا د‬ ‫وب‬ ‫ا رط‬ ‫ا ون‬ ‫و رت‬ ‫و ر ز‬ (‫زون‬ ) ‫ا و ر‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ب‬ ‫ل‬ ‫د‬ ‫ا‬ MYDRIATICUM Eye Drops 161 . Contact dermatitis (conjunctivitis) Transient stinging and raised intraocular pressure. local irritation. Contact dermatitis (conjunctivitis) ‫ا‬ ‫ا‬ ‫ا‬ ‫اط‬ MYDFRIN Phenylephrine H . hyperaemia. Contact dermatitis (conjunctivitis) ‫ب‬ ‫ل‬ ‫وم‬ ‫ا‬ Phenylephrine H . oedema and conjunctivitis may occur. Contact dermatitis (conjunctivitis) Transient stinging and raised intraocular pressure. oedema and conjunctivitis may occur.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer ‫ا رط‬ ‫ا ون‬ ‫وزى‬ ‫ا‬ ‫ا ون‬ ‫و رت‬ ‫و ن‬ ‫وش ا د‬ ‫وب‬ ‫ا رط‬ ‫ا ون‬ ‫ا ر‬ ‫ا ر ن‬ ‫ا ر د‬ ‫ب‬ ‫ل‬ ‫ة‬ Drug Store ANALUX COLIRCUSI ISOPTO FRIN Eye Drops Eye Drops MINIMS PHENYLEPHRINE Eye Drops ocular pressure. hyperaemia. on prolonged administration.

pain. burning. ocular irritation and pain.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Treatment of glaucoma Beta-blockers Betaxolol BETOPTIC Eye Drops ‫ا ون‬ ‫و رت‬ ‫ار ض‬ ‫ر‬ ‫و ر ز‬ (‫زون‬ ) ‫ا و ر‬ ‫ا ون‬ ‫ا‬ ‫ا ر ن‬ ‫ا ر د‬ ‫و ر ز‬ (‫زون‬ ) ‫ا و ر‬ ‫ن‬ ‫ت‬ . erythema.دوم‬ ‫ا و د‬ ‫و د‬ ‫ا و‬ ‫ب‬ ‫ل‬ ‫ة‬ ‫د‬ ‫ر‬ ‫وم‬ ‫د‬ ‫ؤ‬ ‫ا‬ ‫ا‬ ‫د‬ ‫ا‬ ‫اط‬ ‫إ راھ م‬ ‫ا‬ ‫ا‬ ‫اط‬ --‫ة‬ ‫ا‬ ‫ا‬ ‫اط‬ RIALOL Carteolol hydrochloride Latanoprost . bradycardia.ش. heart block. blepharitis. dry eyes and allergic reactions including anaphylaxis and blepharoconjunctivi tis. timolol Levobunolol HCl Timolol TEOPTIC Eye Drops Eye Drops XALACOM BETAGAN NYOLOL Eye Drops Eye Drops Gel APIMOL Eye Drops CUSIMOLOL Eye Drops primary openangle glaucoma NYOLOL OCUMOL OFTAN TIMOLOL OPHTAMOLOL OPTIMOL Eye Drops Eye Drops Eye Drops Eye Drops Eye Drops Ocular stinging. itching. transient ‫ا ون‬ ‫ا‬ ‫ر‬ 162 .‫ا دوا‬ ‫ا ردن‬ ‫ا ون‬ ‫وزى‬ ‫ا‬ ‫زون‬ ‫ا ر‬ ‫ار ض‬ ‫ر‬ ‫رس‬ ‫دا‬ ‫د‬ ‫دار ا دواء‬ ‫ا رد‬ ‫وم‬ ‫دو‬ ‫ر‬ ‫اور‬ ‫ا‬ ‫رك. occasionally corneal disorders have been reported. or uncontrolled heart failure TIMO-COMOD TIMOPTOL Eye Drops Eye Drops ‫ر‬ ‫ا‬ ‫ا‬ TUNOLOL Eye Drops ‫ا ر‬ ‫ا ر‬ ‫دادات‬ ‫اط‬ ‫وا وازم‬ Prostaglandin analogues Latanoprost XALATAN Eye Drops raised intra-ocular pressure in openangle glaucoma and ocular hypertension Brown pigmentation particularly in those with mixedcolour irides. thickening and lengthening of eye lashes. conjunctival hyperaemia. darkening.

photophobia. ‫ا ون‬ ‫ا ر‬ ‫ب‬ ‫ل‬ ‫ا‬ Sympathomimetics Brimonidine tartarate ALPHAGAN Eye Drops raised intraocular pressure ocular reactions include hyperaemia. skin rash. diuresis. darkening. burning. taste alteration. also headache. hypokalaemia. allergy. and peri-operatively in angle-closure glaucoma. hyperchloraemic acidosis. blepharitis. eyelid inflammation. loss of appetite. hyponatraemia. ocular pruritus. sulphonamide hypersensitivity ‫در‬ ‫ا ر‬ ‫در‬ ‫ا ر‬ 163 . flushing. ocular irritation and pain. skin rash. bradycardia. conjunctivitis. epilepsy nausea. thickening and lengthening of eye lashes. stinging. dry mouth. and conjunctival follicles. paraesthesia. secondary glaucoma. severe hepatic impairment. pruritus. conjunctival hyperaemia.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Travoprost TRAVATAN Eye Drops raised intra-ocular pressure in openangle glaucoma and ocular hypertension punctate epithelial erosion. blurring. rarely. renal impairment. occasionally corneal erosion and staining. photophobia. fatigue severe smarting and redness of the eye ‫ا ر ن‬ ‫ا ر د‬ ‫وم‬ Dipivefrin HCl OFTANEX PROPINE Eye Drops Eye Drops primary openangle glaucoma ‫دا‬ ‫رس‬ ‫د‬ ‫ا ر ن‬ ‫ا ر د‬ ‫إ راھ م‬ ‫ا‬ ‫وم‬ Carbonic anhydrase inhibitors and systemic drugs Acetazolamide DIAMOX DIAMOX SUSTETS Injection Tablet Capsule reduction of intraocular pressure in open-angle glaucoma. headache. browache Brown pigmentation particularly in those with mixedcolour irides. diarrhoea. transient punctate epithelial erosion. hypotension. vomiting. and keratitis reported. conjunctivitis. headache. taste disturbance.

depression. metabolic acidosis and electrolyte disturbances on long-term therapy nausea. They should be avoided in acute inflammatory disease of the anterior segment. open-angle glaucoma. lacrimation. rarely hypersensitivity reactions renal impairment. blurred vision. fatigue. polyuria. dry mouth. eyelid inflammation. anterior uveitis and some forms of secondary glaucoma. superficial punctuate keratitis. blurred vision ‫ن‬ ‫ت‬ Miotics are contraindicated in conditions where pupillary constriction is undesirable such as acute iritis. Eye Drops 1-2 gtts in eye 1-6 times/d Pilocarpine hypromellose ISOPTO CARPINE ‫و ن‬ ‫وش ا د‬ ‫وب‬ ‫ا رط‬ ‫ار ض‬ ‫ر‬ ‫ار ض‬ ‫ر‬ ‫و ر ز‬ (‫زون‬ ) ‫ا و ر‬ ‫ا ون‬ ‫ا ر‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ا ة‬ ‫اط‬ ‫د‬ ‫ب‬ ‫ل‬ ‫ا‬ 164 . headache. dizziness. asthenia. bitter taste. ‫ا دوا‬ ‫ا ردن‬ ‫ا ون‬ ‫و رت‬ ‫ؤ‬ ‫ا‬ ‫ب‬ ‫ل‬ ‫ة‬ ISOPTO CARPINE Eye Drops ‫ا‬ ‫ا‬ ‫اط‬ MINIMS PILOCARPINE Eye Drops Glaucoma PILOTINA-2 PILOTINA-4 SPERSACARPINE Eye Drops Eye Drops Eye Drops Eye Oint. pregnancy and breast-feeding . pseudoexfoliative glaucoma either as adjunct to beta-blocker or used alone in patients unresponsive to beta-blockers or if beta-blockers contra-indicated. conjunctivitis. less commonly iridocyclitis.دوم‬ ‫ا و د‬ ‫وم‬ ‫دو‬ ‫ا‬ --- PILOCARPINE Pilocarpine APICARPINE Eye Drops Ciliary spasm leads to headache and browache which may be more severe in the initial 2–4 weeks of treatment (a particular disadvantage in patients under 40 years of age). smarting. reduced libido. Ocular sideeffects include burning. thirst. irritability. ocular irritation.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Dorzolamide HCl TRUSOPT Eye Drops XOLA Eye Drops Raised intraocular pressure in ocular hypertension.‫رك‬ ‫ش. itching. hyperchloraemic acidosis.

and astringents Carbomer . zinc sulphate Polyvinyl alcohol Polyvinyl alcohol . ocular lubricants. sodium chloride Naphazoline nitrate . Na iodide Sodium chloride VITREOLENT Eye Drops Eye Drops APISAL Eye Drops irrigation. NaOH LACRYVISC Gel dry eyes including keratoconjunctivitis sicca. Iodide.‫ا دوا‬ ‫ا ردن‬ ‫و ن وش‬ ‫اد و ب‬ ‫ا رط‬ ‫و د‬ ‫ا و‬ ‫و ر ز‬ (‫زون‬ ) ‫ا و ر‬ ‫ا ر ن‬ ‫ا ر د‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫د‬ Eye Drops LIQUIFILM OPTIFRESH Eye Drops Eye Drops ‫وم‬ --‫وم‬ ‫د‬ ‫ؤ‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ REFRESH Pot.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Local anaesthetics Oxybuprocaine MINIMS BENOXINATE Eye Drops ‫و ن‬ ‫وش ا د‬ ‫وب‬ ‫ا رط‬ ‫و ر ز‬ (‫زون‬ ) ‫ا و ر‬ ‫ا ون‬ ‫و رت‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫د‬ ‫ب‬ ‫ل‬ Oxybuprocaine NOVESINE Eye Drops local anaesthetic Tetracaine HCl TETRACAINE Eye Drops ‫ا‬ Miscellaneous ophthalmic preparations Tear deficiency. povidone CELLUVISC REFRESH PLUS Eye Drops Eye Drops ISOPTO PLAIN DROPS Eye Drops ‫ا ون‬ ‫ا ر‬ MINIMS ARTIFICIAL TEARS OCULOSAN Eye Drops ‫و ن وش‬ ‫اد و ب‬ ‫ا رط‬ allergic conjunctivitis tear deficiency tear deficiency ‫وم‬ ‫دو‬ ‫ا ر ن‬ ‫ا ر‬ ‫و ر ز‬ (‫زون‬ ) ‫ا و ر‬ ‫ن‬ ‫ت‬ . including first-aid removal of harmful substances MINIMS SODIUM CHLORIDE PHYSIOL Eye Drops Eye Drops ‫ا ر‬ ‫ا ر‬ ‫دادات‬ ‫اط‬ 165 .5% Hydroxy ethylcellulose . mannitol . unstable tear film dry eye conditions ‫ا ون‬ ‫و رت‬ ‫ر ن‬ ‫ر‬ ‫ر ن‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ب‬ ‫ا ل‬ ‫وم‬ ‫ب‬ ‫ل‬ ‫وم‬ ‫ا‬ Carboxy methylcellulose sodium (carmellose sodium) Hydroxy propylmethyl cellulose drops 0.

taste disturbance. anterior segment inflammation following postoperative and post-laser trabeculoplasty when corticosteroids contra-indicated 166 . asthenia. lid retraction. hyperaemia. strabismus surgery or argon laser trabeculoplasty. postoperative inflammation in cataract surgery. discomfort and lacrimation (withdraw if ocular intolerance including oedema of lids and conjunctiva).Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store ‫وا وازم‬ Ocular diagnostic and peri-operative preparations and photodynamic treatment Apraclonidine IOPIDINE Eye Drops control of intraocular pressure dry mouth. conjunctival blanching and mydriasis history of severe or unstable and uncontrolled cardiovascular disease ‫ا ون‬ ‫ا ر‬ ‫ب‬ ‫ل‬ ‫ا‬ Diclofenac VOLTAREN OCUGESIC ROFENAC Eye Drops Eye Drops Eye Drops Fluoresceinatesodium FLUORESCEIN SODIUM MINIMS FLUORESCEIN SODIUM FLUORETS Eye Drops Eye Drops inhibition of intraoperative miosis during cataract surgery (but does not possess intrinsic mydriatic properties). ocular pruritus. headache. dry nose. pain in corneal epithelial defects detection of lesions and foreign bodies ‫زون‬ ‫ا ر‬ ‫ار ض ر‬ ‫ا دوا‬ ‫ة‬ --- ‫د‬ ‫ا‬ ‫اط‬ ‫ا ون‬ ‫ا ر‬ ‫و ن وش‬ ‫اد و ب‬ ‫ا رط‬ ‫و ن وش‬ ‫اد و ب‬ ‫ا رط‬ ‫ا ر ن‬ ‫ا ر د‬ ‫ب‬ ‫ل‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ Eye Drops ‫ة‬ ‫وم‬ Flurbiprofen sodium OCUFEN LIQUIFILM Eye Drops inhibition of intraoperative miosis (but does not possess intrinsic mydriatic properties).

It is also licensed for occult subfoveal choroidal neovascularisation with disease progression visual disturbances (including blurred vision. pruritus. rarely lacrimation disorder. hypersensitivity reactions porphyria.Scientific Name Ketorolac tromethamine Trade Name Dosage Form Eye Drops Indications Side Effects Contra-indications Manufact urer ‫ا ر ن‬ ‫ا ر‬ Drug Store ‫وم‬ ACULAR Lignocaine . subretinal or vitreous haemorrhage. flashing lights. asthenia. fever. breastfeeding ‫و ن وش‬ ‫اد و ب‬ ‫ا رط‬ ‫و ن وش‬ ‫اد و ب‬ ‫ا رط‬ ‫و ر ز‬ (‫زون‬ ) ‫ا و ر‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ ‫د‬ Eye Drops ‫ة‬ Verteporfin Injection 167 . back pain. hypercholesterol aemia. fluorescein Rose Bengal MINIMS LIGNOCAINE MINIMS ROSE BENGAL VISUDYNE Eye Drops prophylaxis and reduction of inflammation and associated symptoms following ocular surgery detection of lesions and foreign bodies detection of lesions and foreign bodies Photodynamic treatment of agerelated macular degeneration associated with predominantly classic subfoveal choroidal neovascularisation or with pathological myopia. nausea. visual-field defects).

....................................................... 172 168 ...................................... nose............................................................................................................................. 169 Removal of ear wax ............ 170 Topical nasal decongestants . and oropharynx Drugs acting on the ear 169 Otitis externa ................................................................. 171 Nasal preparations for infection ................................................................................................................ 171 Oropharyngeal anti-infective drugs .. 171 Drugs acting on the oropharynx 171 Drugs for oral ulceration and inflammation......................................................................................Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Ear.. 170 Drugs acting on the nose 170 Drugs used in nasal allergy ....................................................

hydrocortisone OTOSPORIN Ear drops bacterial infection in otitis externa local sensitivity perforated tympanic membrane Gentamicin (Gentamycin) GENTACIN ALCOMICIN E/E Drops E/E Drops ‫ار ض‬ ‫ر‬ ‫ا ون‬ ‫و رت‬ ‫ر‬ ‫و‬ ‫ا‬ ‫ة‬ ‫ب‬ ‫ل‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫ر‬ GARAMYCIN E/E Drops 169 . neomycin DECADRON NEO DECADRON WITH NEOMYCIN E/E Drops E/E Drops Anti-infective preparations Clotrimazole CANESTEN CLOTREX Ear drops Ear drops fungal infection in otitis externa occasional local irritation or sensitivity ‫ر‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫ت‬ ‫ر‬ ‫ا دوا‬ ‫ا رد‬ ‫وك‬ ‫رو‬ ‫ا ر‬ ‫ا ون‬ ‫وزى‬ ‫ا‬ ‫ن‬ ‫ا دوا‬ ‫ا ردن‬ ‫و‬ ‫ن‬ ‫ث‬ ‫ا د‬ ‫ت‬ ‫ؤ‬ ‫ا‬ ‫ا ر‬ CLOZOLE DERMATIN MICOTER Ear drops Ear drops Ear drops ---‫ا‬ ‫ا‬ ‫ؤ‬ ‫ا‬ OTOZOL Ear drops Neomycin so4 .‫رك‬ ‫ش. cinchocaine.دوم‬ ‫ا و د‬ .دوم‬ ‫ا و د‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ DECADRON E/E Drops Dexamethasone . EARCALM CILOPRINE CUM ANAESTHETICO Ear drops Ear drops ‫ج‬ ‫ار ض ر‬ -‫ن‬ ‫و ر‬ ‫ج‬ ‫ر و ل‬ ( ‫و ر‬ ‫ا‬ ) ‫إ‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ا ة‬ ‫اط‬ Otitis externa Anti-inflammatory preparations Dexametasone DECADRON E/E Drops .Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Drugs acting on the ear Benzocaine . phenazone Oxymethurea. polymyxin-b so4 .‫رك‬ ‫رب ودوم‬ ‫ا ر‬ .‫رك‬ ‫ش. acediasulphone nitrate.‫رك‬ ‫رب ودوم‬ ‫ا ر‬ .

nasal polyps . bitter taste (if applied incorrectly) Dryness.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Re mo val of ear wa x Docusate sodium WAXSOL MINIMS GENTAMYCIN E/E Drops APIGEN E/E Drops ‫ت‬ COLIRCUSI GENTAMYCIN GENTAM Ear drops E/E Drops E/E Drops softening ear wax ‫ور ن‬ ‫ز‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ Drugs acting on the nose Drugs used in nasal allergy Azelastin HCl ALLERGODIL Nasal spray allergic rhinitis irritation of nasal mucosa. epistaxis and rarely ulceration. Fluticasone propionate FLIXONASE Nasal drops Nasal spray ‫و‬ ‫ن‬ ‫ث‬ ‫ا را‬ ‫ر‬ ‫و‬ ‫ا ر‬ ‫ا ود‬ ‫ر‬ ‫ا‬ FLIXONASE ---- Mometasone furoate NASONEX Nasal spray ‫و‬ ‫ر‬ 170 . nasal septal perforation and raised intra-ocular pressure or glaucoma may also occur rarely ‫ر‬ ‫ا وو‬ "‫" رس‬ ‫ا‬ ‫و س‬ ‫و‬ ‫ا رط‬ ‫ر‬ ‫و‬ ‫ا ر‬ ‫ا ود‬ ‫ا را‬ ‫و‬ ---‫ر‬ ‫. irritation of nose and throat.ا‬ ‫ا ط‬ ‫زو‬ Beclomethasone dipropionate RINO-CLENIL Nasal spray BECONASE BECONASE Nasal spray Spray prophylaxis and treatment of allergic and vasomotor rhinitis ‫ا‬ ‫اط‬ Budesonide RHINOCORT Nasal spray prophylaxis and treatment of allergic and vasomotor rhinitis.

Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Topical nasal decongestants Xylometazolin NAZIX OTRIVIN Nasal drops Nasal spray Gel Nasal spray Nasal drops Nasal spray nasal congestion May cause a hypertensive crisis if used during treatment with a monoamineoxidase inhibitor including moclobemide. benzocaine HIBITANE LOZENGES Lozenge relief of pain in oral lesions ‫ز‬ ‫ا‬ Lignocaine HCl LIDOCAINE XYLOCAINE Ointment Ointment Topical solution relief of pain in oral lesions ‫ر‬ ‫ر‬ ‫ا را‬ ‫ور ن‬ ‫ز‬ ‫ا‬ ‫ر ول‬ ‫رز‬ ‫وب‬ ‫ا‬ ‫ة‬ ‫و‬ ‫ا‬ ‫اط‬ ‫ؤ‬ ‫ا‬ ‫ا‬ Rhei. Neomycin NEOMYCIN Nasal spray eradication of nasal carriage of staphylococci ‫ر‬ Drugs acting on the oropharynx Drugs for oral ulceration and inflammation Benzoxonium chloride . salicylic acid Triamcinolone acetonide PYRALVEX mild oral and perioral lesions KENALOG IN ORABASE Orabase oral and perioral lesions occasional exacerbation of local infection. Ext. (anthraquinon glycosides) . lidocaine HCl OROFAR Lozenge relief of pain in oral lesions avoid anaesthesia of the pharynx before meals— risk of choking avoid anaesthesia of the pharynx before meals— risk of choking avoid anaesthesia of the pharynx before meals— risk of choking ‫و رز‬ ‫ا‬ ‫د‬ Chlorhexidine . phenylephrine . ‫ا دوا‬ ‫و ر ز‬ ( ‫)ز‬ ‫ا و ر‬ ‫اور‬ ‫ر‬ ‫ا‬ ‫ر‬ ‫ن‬ ‫ت‬ XYLOMET Nasal drops ‫ا دوا‬ ‫ا ردن‬ ‫ار ض‬ ‫ر‬ ‫د‬ --- XYLOCOMOD XYLOLIN DECOZAL ‫ر‬ ‫ر‬ ‫ؤ‬ ‫ا‬ ‫ا‬ ‫ا‬ Nasal spray Nasal drops ‫ة‬ ‫ا‬ ‫اط‬ Nasal preparations for infection Dimethindene. neomycin Mupirocin calcium VIBROCIL Nasal spray eradication of nasal carriage of staphylococci eradication of nasal carriage of staphylococci ‫و ر ز‬ ( ‫)ز‬ ‫ا و ر‬ ‫ث‬ ‫ن‬ ‫م‬ ‫ال‬ ‫ورد‬ ‫ز‬ ‫ا‬ ‫ورا ور ز‬ ‫أ س‬ (‫)ا ر‬ ‫د‬ ‫ة‬ ‫ا‬ ‫اط‬ BACTROBAN Nasal Oint. thrush or other candidal infections untreated oral infection. manufacturer of triamcinolone contra-indicates use on tuberculous and viral lesions 171 .

Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Oropharyngeal anti-infective drugs Nystatin MIKOSTAT MYCOSAT Suspension Suspension candidiasis. rash (including urticaria) and rarely Stevens-Johnson syndrome reported ‫ر‬ ‫ر‬ ‫ن‬ ‫ت‬ ‫ا دوا‬ ‫ا ردن‬ ‫ر ول‬ ‫رز‬ ‫وب‬ ‫ا‬ ‫ار ض‬ ‫ر‬ ‫وك‬ ‫ؤ‬ ‫ا‬ ‫ؤ‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ ---‫ا‬ MYCOSTATIN Suspension RIANEST SINATEN Suspension Suspension 172 . oral infection nausea. oral irritation and sensitization. vomiting. diarrhoea at high doses.

......................................................................................................Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Skin Topical corticosteroids 174 Preparations for eczema and psoriasis 178 Acne and rosacea 179 Preparations for warts and calluses 180 Shampoos and other preparations for scalp and hair conditions 180 Anti-infective skin preparations 181 Antibacterial preparations ................................ 182 Skin cleansers and antiseptics 183 173 . 181 Antifungal preparations .................................

in acne rosacea. and in perioral dermatitis. or viral skin lesions. salicylic acid LOTRIDERM Cream Betamethasone dipropionate . Absorption through the skin can rarely cause adrenal suppression and even Cushing's syndrome Topical corticosteroids are contra-indicated in untreated bacterial. psoriasis Mild and moderately potent topical corticosteroids are associated with few sideeffects but care is required in the use of potent and very potent corticosteroids. and in ‫ا و‬ ‫ا ر‬ ‫ا دوا‬ ‫ر‬ ‫ر‬ ‫ا‬ ‫د ن‬ ‫د‬ --- 174 . gentamycin .Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Topical corticosteroids Class 1 Very potent (up to 600 times as potent as hydrocortisone) Clobetasol propionate CLOBEDERM CLODERM Ointment Ointment Cream short-term treatment only of severe resistant inflammatory skin disorders such as recalcitrant eczemas unresponsive to less potent corticosteroids. Ointment Cream Ointment Betamethasone dipropionate . Absorption through the skin Topical corticosteroids are contra-indicated in untreated bacterial. clotrimazole Betamethasone dipropionate . fungal. or viral skin lesions. potent corticosteroids are contra-indicated in widespread plaque psoriasis ‫ار ض‬ ‫ر‬ ‫ا دة‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ ‫ا دوا‬ ‫ا ون‬ ‫وزى‬ ‫ا‬ ‫وك‬ ‫ر‬ ‫و‬ ‫ا ر‬ ‫ا ود‬ ‫ر‬ ‫ر‬ ‫وم‬ ‫دو‬ ‫ر‬ ‫و‬ ‫ا‬ DIPROSALIC Lotion Ointment Ointment ‫و‬ ‫وم‬ ‫دو‬ ‫ر‬ ‫ا د‬ ‫وم‬ ‫دو‬ BETAZOL Cream ‫وم‬ ‫دو‬ ‫ر‬ ‫ا‬ ‫ب‬ ‫ل‬ --‫ر‬ ‫و‬ ‫ا‬ SALIBET --‫ر‬ ‫ر‬ ‫ا‬ --‫ر‬ ------‫ا‬ ‫اط‬ ‫دي‬ ‫رف‬ ‫ة‬ CORTIMAX DECLOBAN Ointment Cream Ointment --‫ا‬ DERMAL DERMOVATE GAMAVATE PROMAX Cream Ointment Cream Scalp app. fungal. care is required in the use of potent and very potent corticosteroids. miconazole nitrate Diflucortolone valerate DIPROGENTA Ointment Cream Cream BETAZOL G --- NERISONE FORTE Ointment ‫ا‬ Class 2 Potent (I50-100 times as potent as hydrocortisone) Betamethasone BETADERM BETAMET BETASONE Cream Ointment Ointment Cream Ointment severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids. in acne rosacea. miconazole nitrate Betamethasone dipropionate . gentamycin Betamethasone dipropionate .

neomycin FUCIBET FUCICORT BETAVAL-N Cream Cream Ointment Cream --‫ا‬ ‫ا‬ BETNOVATE-N Cream Ointment ---- Betamethasone . chlorquinaldol CELESTODERMV-GARAMYCIN SUPRAPROCT-S Cream Ointment ‫ا‬ ‫ر‬ CELESTODERMV GARAMYCIN SALIDEX NERISONE C Ointment Ointment Solution Cream ‫س‬ ‫ا رق‬ ‫ا و ط‬ ‫ب‬ ‫ا ل‬ 175 . ---- Betamethasone . cinchocaine HCl Betamethasone valerate . fucidic acid Betamethasone . BETNOVATE Cream Ointment can rarely cause adrenal suppression and even Cushing's syndrome perioral dermatitis. gentamycin Dexamethasone . gentamycin sulphate Betamethasone valerate . Ointment Cream Lotion Cream Betamethasone dipropionate DIPROLENE PROBATE Betamethasone valerate BETNOVATE Scalp app. salicylic acid Diflucortolone valerate . potent corticosteroids are contra-indicated in widespread plaque psoriasis ‫ا‬ ‫ا دو‬ ‫ا رد‬ ‫ر‬ ‫و‬ ‫ا ر‬ ‫ا ود‬ ‫ر‬ ‫و‬ ‫ا‬ ‫دار ا دواء‬ ‫ا رد‬ ‫ار ض‬ ‫ر‬ ‫وك‬ ‫ر‬ ‫و‬ ‫ا‬ --‫وم‬ ‫دو‬ ‫ر‬ ‫و‬ ‫ا ر‬ ‫ا ود‬ ‫ا ز رة‬ ‫و‬ ‫اد ر‬ ‫ا ر‬ ‫ا دو‬ ‫ا رد‬ ‫ر‬ ‫و‬ ‫ا ر‬ ‫ا ود‬ ‫ر‬ ‫و‬ ‫ا د‬ ‫ر‬ ‫ر‬ ‫ر‬ ‫و‬ ‫ا د‬ ‫د‬ ‫ا رد‬ ‫ر‬ ‫با‬ ‫ا ط‬ ‫ر‬ ‫ة‬ ‫ر‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ ---‫ر‬ ---- CELESTODERMV DERMESONE RIAVATE TABETA Ointment Cream Ointment Ointment Cream Ointment Scalp app.Scientific Name Trade Name Dosage Form Cream Ointment Indications Side Effects Contra-indications Manufact urer ‫ا ر‬ Drug Store BETAVAL psoriasis.

high strength (0. Absorption through the skin can rarely cause adrenal suppression and even Cushing's syndrome Topical corticosteroids are contra-indicated in untreated bacterial.Scientific Name Diflucortolone valerate Trade Name Dosage Form Ointment Cream Indications Side Effects Contra-indications Manufact urer ‫س‬ ‫ر‬ ‫با‬ ‫ا ط‬ Drug Store ‫ب‬ ‫ل‬ NERISONE severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids. and in perioral dermatitis. diflucortolone valerate Mometasone furate TRAVOCORT severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids. in acne rosacea. salicylic acid Fluprednidene acetate . gentamycin Fluticasone propionate Hydrocortisone butyrate DECODERM SALIDECODREM DECODERM COMPOUND POTENCORT LOCOID Cream Ointment Gel Lotion Cream Ointment Cream ‫ا‬ ‫اط‬ ‫ا ة‬ ‫اط‬ ‫ا ة‬ ‫اط‬ ‫ر‬ ‫ا‬ ‫ؤ‬ ‫ا‬ ‫ؤ‬ Cream Ointment Ointment Cream Lotion Emulsion Cream Cream LOCOID CRELO LOCOID LIPO Isoconazole nitrate . chlormidazole Fluocinolone . chlormidazole . salicylic acid Fluocinolone . psoriasis SYNALAR Fluprednidene acetate Fluprednidene . psoriasis (‫) رو دس‬ (‫) رو دس‬ ‫ؤ‬ (‫) رو دس‬ ‫س‬ ‫ر‬ ‫با‬ ‫ا ط‬ ‫ر‬ ‫و‬ ‫ا د‬ ‫وم‬ ‫دو‬ ‫ب‬ ‫ل‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ا‬ ELOCOM ELICA Lotion Ointment Cream Cream Ointment severe inflammatory skin disorders such as eczemas unresponsive to less potent care is required in the use of potent and very potent corticosteroids. psoriasis care is required in the use of potent and very potent corticosteroids. or viral skin lesions. potent corticosteroids are contra-indicated in widespread plaque psoriasis ‫ا‬ Fluocinolone . fungal. neomycin MYCOSYNALAR MYCOSYNALAR PETRALAR-N Cream Solution ‫ل‬ ‫ر‬ ‫ل‬ ‫ر‬ ‫رو‬ ‫ا و‬ ‫رو‬ ‫ا و‬ ‫ب‬ ‫ل‬ ‫ب‬ ‫ل‬ ‫ا‬ ‫ا‬ Cream ‫ت‬ ‫ا رز‬ ‫ا ر‬ ‫ا دوا‬ ‫ا رد‬ ‫رو ل‬ ‫ا و ر‬ ‫ار ض‬ ‫ر‬ ‫ا رز‬ ‫ا ر‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ ‫رو ل‬ ‫ا و ر‬ ‫رك‬ ‫ا‬ ‫رك‬ ‫ا‬ ‫رك‬ ‫ا‬ ‫ر‬ ‫ؤ‬ ‫ا د‬ ‫د ت‬ ‫اط‬ ‫ب‬ ‫ا ل‬ ‫ا ة‬ ‫اط‬ ‫ؤ‬ ‫ا د‬ ‫د ت‬ ‫اط‬ ‫ب‬ ‫ل‬ ‫ة‬ ‫ا‬ SYNALAR N Fluocinolone acetonide DERMOLAR PETRALAR-F Cream Ointment Cream Ointment Cream inflammatory skin disorders such as eczemas. in acne --- 176 .3%). or viral skin lesions. shortterm treatment of severe exacerbations. fungal. Absorption Topical corticosteroids are contra-indicated in untreated bacterial.

econazole Triamcinolone .Scientific Name Trade Name Dosage Form Lotion Ointment Cream Indications Side Effects Contra-indications Manufact urer ‫ا دوا‬ Drug Store --- METAZ corticosteroids. potent corticosteroids are contra-indicated in widespread plaque psoriasis ‫وم‬ ‫دو‬ Flumethasone . coal tar Flumethasone pivalate Flumethasone pivalate . miconazole nitrate Mometasone furoate . neomycin LOCASALEN LOCACORTEN TAR LOCACORTEN LOCACORTENVIOFORM LOCACORTEN WIYH NEOMYCIN Ointment Ointment ‫د‬ ‫د‬ ‫د‬ ‫د‬ ‫د‬ Ointment Cream Cream Ointment Ointment Class 4 Mild 177 . in acne rosacea. salicylic acid Flumethasone . gramicidin PEVISONE Cream Cream KENACOMB PANDERM ULTRADERM Cream Ointment Ointment Cream Ointment Cream Class 3 Moderate (2-25 times as potent as hydrocortisone) Clobetasone-17butyrate CLOBATE Ointment eczemas and dermatitis of all types. potent corticosteroids are contra-indicated in widespread plaque psoriasis Mometasone . psoriasis. miconazole nitrate . Absorption through the skin can rarely cause adrenal suppression and even Cushing's syndrome --Topical corticosteroids are contra-indicated in untreated bacterial. maintenance between courses of more potent corticosteroids Mild and moderately potent topical corticosteroids are associated with few sideeffects but care is required in the use of potent and very potent corticosteroids. salicylic acid . gentamycin sulphate Mometasone furoate . clioquinol Flumethasone pivalate . and in perioral dermatitis. nystatin . and in perioral dermatitis. or viral skin lesions. through the skin can rarely cause adrenal suppression and even Cushing's syndrome rosacea. neomycin . fungal. salicylic acid MOMENTA Cream ‫وم‬ ‫دو‬ --- ELICA-M Cream ‫وم‬ ‫دو‬ --- ELICASAL Ointment ‫وم‬ ‫دو‬ ‫د‬ ‫ا رد‬ -‫ن‬ ‫ج‬ ‫ا‬ ‫ا دوا‬ ‫ر‬ ‫ر‬ ‫ا ر‬ --‫ا رق‬ ‫ا و ط‬ ‫ة‬ ‫ا‬ ‫اط‬ --‫ا‬ ‫ا‬ ‫ا دو‬ ‫ا رد‬ VOCORT Triamcinolone .

and in perioral dermatitis. in acne rosacea. paraesthesia. or viral skin lesions. Hydrocortisone . herpes simplex and zoster. nystatin . skin infections (including folliculitis and less commonly impetigo. potent corticosteroids are contra-indicated in widespread plaque psoriasis ‫ا ر‬ ‫ا ة‬ ‫اط‬ ‫ؤ‬ ‫ا‬ ‫ر‬ ‫د‬ ‫ا دوا‬ ‫ا رد‬ ‫أ س‬ ‫) زو ز‬ ( ‫ز‬ ‫ا‬ ‫ر‬ ‫رات‬ ‫اط‬ ( ‫) رو دس‬ ‫در‬ ‫ا ر‬ ‫در‬ ‫ا ر‬ ‫ا دوا‬ ‫وك‬ ‫ار ض ر‬ ‫ورا ور ز‬ ‫أ س‬ (‫)ا ر‬ ‫روش‬ ‫رون‬ ‫ا ر‬ ‫ون‬ ‫ة‬ ‫دة‬ ‫ا ؤ‬ ‫ا‬ ‫دو‬ ‫ؤ‬ ‫ا‬ EFFICORT EFFICORT LIPOCREAM CORTIDERM HYDROCORTISONE CLIOCORT Hydrocortisone acetate Hydrocortisone acetate . Absorption through the skin can rarely cause adrenal suppression and even Cushing's syndrome Topical corticosteroids are contra-indicated in untreated bacterial. molluscum contagiosum). infection at treatment site. photosensitivity. clioquinol Hydrocortisone acetate . fungal. erythema. contact with eyes and mucous membranes. congenital epidermal barrier defects. application under occlusion. hydrocortisone ‫ا‬ ‫اط‬ ‫ا ة‬ ‫اط‬ -----‫ة‬ ‫ا‬ ‫اط‬ ‫ر‬ NEOMYCINHYDROCORTISOINE MADECASSOL N-HC Ointment Ointment ‫ؤ‬ ‫ا‬ Preparations for eczema and psoriasis Bufexamac . rarely papilloma. neomycin sulphate Centella extract . neomycin Hydrocortisone aceponate DERMOCORT Cream Cream PIMAFUCORT Cream Ointment Cream Cream Cream Cream Ointment Mild and moderately potent topical corticosteroids are associated with few sideeffects but care is required in the use of potent and very potent corticosteroids. rarely facial or perioral dermatitis. neomycin Calcipotriol FLOGOCID Ointment Cream Ointment Cream plaque psoriasis Local skin reactions . nappy rash. neomycin .Scientific Name Hydrocortisone Trade Name Dosage Form Cream Ointment Cream Ointment Cream Indications Side Effects Contra-indications Manufact urer ‫ر‬ ‫ار ض ر‬ ‫ة‬ ‫ا‬ ‫ت‬ ‫ر‬ Drug Store ALFACORT RIACORT TOPICORT mild inflammatory skin disorders such as eczemas. pruritus. idochlorhydroxyquine Hydrocortisone .C Cream VIOFORM Hydrocortisone . local reactions including pain. skin atrophy They should be avoided by those with calcium metabolism disorders. --‫وم‬ ‫دو‬ ‫و‬ ‫اد ر‬ ‫ا‬ DAIVONEX Coaltar +juniper tar +pine tar shampoo Pimecrolimus POLYTAR Shampoo ‫ل‬ ‫ا ر د‬ acute treatment of mild to moderate atopic eczema (including flares) burning sensation. clioquinol BRAQUINOL H. natamycin . generalised erythroderma ‫و ر ز‬ ‫ا‬ ‫و‬ ‫د‬ ELIDIL Cream 178 .

Eye irritation and oedema Redness and skin peeling might occur initially but settles with time. Temporary changes of skin pigmentation have been reported. Temporary changes of skin pigmentation have been reported. Tretinoin is contra-indicated in personal or familial history of cutaneous epithelioma. oedema. erythema. women of child-bearing age should take adequate contraceptive precautions. dry or peeling skin (discontinue if severe). Tretinoin is contra-indicated in personal or familial history of cutaneous epithelioma. dry or peeling skin (discontinue if severe). women of child-bearing age should take adequate contraceptive precautions. Eye irritation and oedema. Tretinoin is contra-indicated in personal or familial ‫روش‬ ‫ا و ر‬ 179 . pruritus. ‫در‬ ‫ا ر‬ ‫ة‬ ‫ا‬ ‫اط‬ Azelaic acid ACNEDERM Lotion acne vulgaris ‫ا و ر‬ ‫و ل‬ ‫ا را‬ ‫س‬ ‫ر‬ ‫با‬ ‫ا ط‬ ‫وم‬ ‫دو‬ ‫در‬ ‫ا ر‬ ‫ل‬ ‫ا ر د‬ ‫ل‬ ‫ا ر د‬ ‫و‬ ‫و‬ ‫ة‬ ‫ب‬ ‫ل‬ ‫ؤ‬ ‫ا‬ Azelaic acid SKINOREN Cream ‫ا‬ --- Benzoyl peroxide ACNEZOYL Gel acne vulgaris Benzoyl peroxide Benzoyl peroxide Isotretinoin BENZAC PANOXYL ISOTREX Gel Gel Lotion Gel ‫ا‬ ‫اط‬ mild to moderate acne Isotretinoin ISOTREXIN Gel ‫ل‬ ‫ا ر د‬ ‫و‬ Isotretinoin ROACCUTANE Capsule comedonal acne Topical retinoids are contra-indicated in pregnancy. Several months of treatment may be needed to achieve an optimal response Topical retinoids are contra-indicated in pregnancy. stinging. local irritation (reduce frequency or discontinue use temporarily). stinging. erythema. Acne and rosacea Adapalene DIFFERIN Cream Gel mild to moderate acne Local reactions include burning. dryness. Increased sensitivity to UVB light or sunlight occurs. pruritus. women of child-bearing age should take adequate contraceptive precautions. rarely photosensitisation skin irritation (reduce frequency or suspend use until irritation subsides and re-introduce at reduced frequency) Local reactions include burning. Increased sensitivity to UVB light or sunlight occurs.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store peeling. Topical retinoids are contra-indicated in pregnancy.

corns. reversible rise in creatinine and blood urea nitrogen Phaeochromocytoma ‫دار‬ ‫ا دواء‬ ‫ا رد‬ ‫ا‬ ‫اط‬ NEOXIDIL Solution ‫در‬ ‫ا ر‬ ‫ا ون‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ر‬ REGAINE Solution Gel 180 .Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store and the treatment should be continued until no new lesions develop history of cutaneous epithelioma. lactic acid . renal. and CNS effects. hematological. renal. weight gain. Irritation of the treated area. and calluses. lactic acid NOCAL Solution For plantar and mosaic warts. peripheral oedema. oxypolyethoxydodecane COLLOMACK Solution skin irritation Shampoos and other preparations for scalp and hair conditions Minoxidil HAIRGROW Solution male-pattern baldness (men and women) irritant dermatitis. common and plantar warts ‫ا رز‬ ‫ا ر‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ ‫ك‬ ‫ا‬ ‫ؤ‬ ‫ا د‬ ‫د ت‬ ‫اط‬ ‫ر‬ Salicylic acid . discontinue if hair loss persists for more than 2 weeks‫ ك‬sodium and water retention. tachycardia. They can also cause severe systemic toxicity on excessive application including gastrointestinal. They can also cause severe systemic toxicity on excessive application including gastrointestinal. applied weekly in genitourinary clinic Irritation of the treated area. children ‫ور ن‬ ‫ز‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ Podophyllotoxin CONDYLINE Solution Condylomata acuminata affecting the penis or the female external genitalia pregnancy and breast-feeding. skin irritation pregnancy and breast-feeding. allergic contact dermatitis. hypertrichosis. children ‫ؤ‬ (‫) رو دس‬ ‫ا‬ Salicylic acid . hematological. and CNS effects. salicylic acid POSALFILIN Ointment External genital warts. Preparations for warts and calluses Podophyllin resin .

‫ا دوا‬ ‫ا ردن‬ ‫و‬ ‫اد ر‬ ‫وم‬ ‫دو‬ ‫ا دوا‬ ‫ر‬ ‫د‬ ‫ا رد‬ ‫وك‬ ‫وم‬ ‫دو‬ ‫ا دوا‬ ‫د‬ ‫ا رد‬ ‫ا ر‬ ‫اد ر‬ ‫در‬ ‫ا ر‬ Silver sulphadiazine FLAMAZINE Cream ‫ثو‬ ‫و‬ ‫ا رط‬ ‫ار ض‬ ‫ر‬ ‫ثو‬ ‫و‬ ‫ا رط‬ ‫ة‬ ‫ة‬ ‫ة‬ ‫ة‬ ‫ا ر‬ ‫ا رق‬ ‫ا و ط‬ -----‫ا ر‬ ‫ا رق‬ ‫ا و ط‬ ---‫ة‬ ‫ا‬ ‫اط‬ ‫ؤ‬ ‫ا‬ ‫ا‬ --‫ة‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫ا‬ --- BALAD FUCIDIN FUCIDIN INTER TULLE FUSIBACT Ointment Ointment Medicated guaze Ointment FUSIDERM FUTASOLE UCIDERM ZETA Fusidic acid Fusidic acid BALAD DERMOFUCIN Ointment Ointment Ointment Ointment Cream Cream --- FUCIDIN FUSIBACT Cream Gel Cream FUSIDERM FUTASOLE UCIDERM ZETA Fusidic acid . betamethasone Fusidic acid anhydrouse . blood disorders ‫ار ض‬ ‫ر‬ ‫و‬ ‫اد ر‬ ‫و‬ ‫اد ر‬ ‫وم‬ ‫دو‬ ‫ا دوا‬ ‫ر‬ ‫د‬ ‫ا رد‬ ‫وك‬ ‫ار ض‬ ‫ر‬ ‫ن‬ ‫ت‬ . betamethasone valerate Metronidazole FUSIBACT-B Cream Cream Cream Cream Cream --- FUSIDERM B Cream --‫ا رق‬ ‫ا و ط‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ UCIDERM -B Cream ELYZOLE ROZEX Cream Gel FLAMAZINE FLAMAZINE Cream Cream 181 . vomiting. reversible jaundice. especially osteomyelitis. acute renal failure (usually with jaundice).Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Anti-infective skin preparations Antibacterial preparations Fucidic acid . they are also used for staphylococcal endocarditis. A second antistaphylococcal antibiotic is usually required to prevent emergence o nausea. especially after high dosage or rapid infusion (withdraw therapy if persistent). rarely hypersensitivity reactions. as they are well concentrated in bone. hydrocortsone acetate Fusidate sodium FUCIDIN H Cream ‫و‬ ‫اد ر‬ Infections caused by penicillinresistant staphylococci. betamethasone Fusidic acid anhydrouse .

headache. chronic resistant vaginal candidiasis. and thrombocytopenia. impotence. rarely allergic reactions. very rarely fatal liver damage -‫ن‬ ‫ج‬ hepatic impairment. dizziness. and alopecia. serious resistant gastro-intestinal mycoses. vomiting. hydrocortisone CANDICORT Powder Vaginal suppositories Cream ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ ‫ؤ‬ ‫ا د‬ ‫د ت‬ ‫اط‬ 182 . diarrhoea (usually on long-term treatment). Localized lesions. resistant dermatophyte infections of skin or finger nails (not toe nails). prophylaxis of mycoses Prevention and treatment of oral and intestinal fungal infections. less commonly diarrhoea.Scientific Name Trade Name Dosage Form Cream Indications Side Effects Contra-indications Manufact urer ‫ا رز‬ ‫ا ر‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ Drug Store ‫ؤ‬ ‫ا د‬ ‫د ت‬ ‫اط‬ SILVERIN Antifungal preparations Ketoconazole NIZORAL Cream Shampoo Shampoo Cream Shampoo systemic mycoses. isolated reports of hepatitis hepatic impairment ‫ن‬ ‫ج‬ ‫دة‬ ‫ت‬ ‫ا ر‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫دي‬ ‫رف‬ ‫ة‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ ‫ؤ‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫ا‬ ‫اط‬ ‫ا ة‬ ‫اط‬ --‫ر‬ DAKTARIN Lotion HAIRSCIENCE ANTIDANDRUFF SHAMPOO MICONAZ MIKOZAL MYCOHEAL Miconazole nitrate DAKTARIN Shampoo ‫ا دوا‬ ‫ا رد‬ -‫ن‬ ‫ج‬ ‫ا‬ ‫ن‬ ‫ج‬ ‫ا ر‬ ‫ا و ر‬ ‫و ل‬ ‫ا را‬ ‫ا ن‬ ‫اط‬ ‫ر‬ ‫دار ا دواء‬ ‫ا رد‬ -‫ن‬ ‫ج‬ ‫ا‬ ‫وم‬ ‫دو‬ ‫ا ن‬ ‫اط‬ ‫دار ا دواء‬ ‫ا رد‬ ‫ا رز‬ ‫ا ر‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ Cream Cream Cream Powder DERMIZOL Gel MICONAZ MYCOHEAL Miconazole nitrate . rarely paraesthesia. photophobia. serious chronic resistant mucocutaneous candidiasis. nausea. rash. dyspepsia. pruritus. abdominal pain. breast-feeding ‫ا‬ ‫د‬ ‫ا رد‬ ‫وك‬ ‫ة‬ ‫ا‬ ‫اط‬ PHILAZOLE VAVO ‫ا رق‬ ‫ا و ط‬ ---- Miconazloe DAKTARIN Tinctrue CANDIZOL Cream DAKTARIN Cream nausea and vomiting.

Scientific Name Trade Name Dosage Form Cream Indications Side Effects Contra-indications Manufact urer -‫ن‬ ‫ج‬ ‫ا‬ ‫دار ا دواء‬ ‫ا رد‬ Drug Store ‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ ‫ا‬ DAKTACORT MYCOHEAL HC Nystatin DERMOSE CUSI NYSTATIN MIKOSTAT RIANEST Cream Ointment candidiasis. skin infection nausea. oral infection . angioedema ‫وم‬ ‫دو‬ ‫و ر ز‬ ( ‫)ز‬ ‫ا و ر‬ ‫ؤ‬ ‫ا د‬ ‫د ت‬ ‫اط‬ ‫ؤ‬ ‫ا‬ Nystatin . rash and urticaria occasionally with arthralgia or myalgia. cruris. diarrhoea at high doses. and corporis) where oral therapy appropriate (due to site. headache. gramicidin KENACIN Cream ‫ت‬ ‫ا رز‬ ‫ا ر‬ ‫ا دوا‬ ‫ا رد‬ ‫ر ول‬ ‫رز‬ ‫وب‬ ‫ا‬ dermatophyte infections of the nails. ringworm infections (including tinea pedis. diarrhoea. vaginal infection . severity or extent) abdominal discomfort. vomiting. rash (including urticaria) and rarely StevensJohnson syndrome reported ‫ا ون‬ ‫وزى‬ ‫ا‬ ‫ر‬ ‫ار ض‬ ‫ر‬ ‫وك‬ Cream Ointment Cream Ointment Ointment ‫ا ر‬ ‫ا ة‬ ‫اط‬ ---- SINATEN Nystatin . nausea. less commonly taste disturbance. cholestasis and hepatitis)— discontinue treatment. oral irritation and sensitization. neomycin . anorexia. zinc oxide MULTILIND Ointment Terbinafine LAMIFEN Cream --- Terbinafine HCl LAMISIL Cream Solution Spray ‫د‬ Skin cleansers and antiseptics Cetrimide CETAVLEX Cream skin disinfection skin irritation and occasionally sensitization ‫ز‬ ‫ا‬ 183 . rarely liver toxicity (including jaundice.

Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Immunological products and vaccines Vaccines and antisera Immunoglobulins 187 185 184 .

Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Vaccines and antisera Diphetria toxoid . tetanus vaccine Diphtheria . pertussis .3 polio virus Haemophilus conjugate . pertussis. polio DITEPERPOL VACCINE Injection Injection primary immunization of children aged between 2 months and 10 years Diphtheria vaccines for children over 10 years and adults Diphtheria vaccines for children over 10 years and adults primary immunization of children aged between 2 months and 10 years primary immunization of children aged between 2 months and 10 years primary immunization of children aged between 2 months and 10 years primary immunization of children aged between 2 months and 10 years primary immunization of children aged between 2 months and 10 ‫ر‬ ‫ر‬ Diphtheria . tetanus vaccine Diphtheria . ‫ا س‬ ‫ر‬ ‫) ر‬ ( ‫ر‬ ‫ا ر‬ ‫ا س‬ ‫ر‬ ‫) ر‬ ( ‫ر‬ ‫ا ر‬ ‫و‬ TETRA Coq VACCINE Injection ‫ا‬ PENTACT HIB VACCINE Injection ‫ا‬ 185 .tetanus.tetanus toxoid . type 1.2.influenza TETRAMUNE VACCINE Injection ‫در‬ ‫ا ر‬ Diphtheria .T. tetanus vaccine D. pertussis antigens Diphtheria toxoid. ‫و‬ ‫ن‬ . INFANRIX Injection ‫و‬ ‫ن‬ . H. tetanus . pertusis . tetanus . ‫ا س‬ ‫ر‬ ‫) ر‬ ( ‫ر‬ ‫ا ر‬ ‫ر‬ ‫ا و ر‬ ‫ر‬ ‫ا و ر‬ ‫و‬ ‫و‬ TRITANRIX-HB Injection Diphtheria . tetanus &cellular pertussis toxoid Diphtheria toxoid . diphtheria .T. tetanus toxoid. bordetella pertusis . ‫ث‬ ‫ا وو‬ . pertusis D.Coq VACCINE Injection ‫ا‬ DI-TE PER ANATOXAL Diphtheria . ‫ث‬ ‫ا وو‬ . tetanus.VAX ADSORB Injection ‫د ر‬ ( ‫) وو‬ ‫ا ر‬ ‫ر‬ ‫ا و ر‬ ‫ر‬ ‫ا و ر‬ ‫ر‬ ‫ا‬ DI-TE ANATOXAL BERNA FOR ADULT DI-TE ANATOXAL BERNA FOR CHILDREN Injection Injection ‫ر‬ Diphtheria. tetanus . pertussis INFANRIX-HIB Injection primary immunization of children aged between 2 months and 10 years primary immunization of children aged between 2 months and 10 years Diphtheria vaccines for children over 10 years and adults ‫و‬ ‫ن‬ . ‫ث‬ ‫ا وو‬ .

‫ا وو‬ . pertusis Haemophilus influenza type B vaccine Haemophilus influenzae B conjugate TETRACT HIB VACCINE Injection HIBERIX Injection primary immunization of children aged between 2 months and 10 years childhood immunization ‫ا س‬ ‫ر‬ ‫) ر‬ ( ‫ر‬ ‫ا ر‬ Fever.ش. rubella M. mumps . and diarrhoea.‫رك‬ ‫ش.دوم‬ ‫ا و د‬ . convulsions ‫ا‬ Measles virus live . diphtheria.R II Injection Eliminate measles. ‫رك. ‫و‬ ‫ث‬ . measles-like rash. hypersensitivity reactions (including anaphylaxis) and collapse have been reported. ‫ا وو‬ .Scientific Name polio virus Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store years Haemophilus conjugate.دوم‬ ‫ا و د‬ ‫و‬ ‫ن‬ ‫ث‬ . prolonged crying. and pyrexia about a week after injection. ‫ا وو‬ . vomiting.‫رك‬ ‫ش. restlessness. .‫رك‬ ‫ش.M. ‫ا س‬ ‫ر‬ ‫) ر‬ ( ‫ر‬ ‫ا ر‬ ‫را ـــس‬ ‫ا ر‬ ‫رون اس‬ ‫ا‬ ‫ل‬ ‫ت‬ ‫وا‬ ‫ا ط‬ ‫و‬ ‫ن‬ ‫ث‬ .‫رك‬ ‫رب ودوم‬ ‫ا ر‬ ‫ر‬ ‫ا و ر‬ ‫ا س‬ ‫ر‬ ‫) ر‬ ( ‫ر‬ ‫ا ر‬ . ‫ا‬ 186 . and rubella (and congenital rubella syndrome).دوم‬ ‫ا و د‬ ‫ن‬ ‫و‬ ‫ا‬ ACT-Hib Injection ‫ا‬ HIBTITER VACCINE VAXEM HIB Injection Injection ‫د‬ Hepatitis A antigen HAVRIX Injection for individuals at risk of infection ‫و‬ VAQTA AVAXIM Injection Injection ‫ا‬ ‫ا‬ Hepatitis B surface antigen Hepatitis B vaccine HB-VAX DNA Injection ENGERIX B Injection high risk of contracting hepatitis B high risk of contracting hepatitis B ‫ا‬ ‫و‬ HB-VAX DNA Injection ‫ا‬ ‫ا‬ ‫ر‬ Measles vaccine ATTENUVAX Injection MORATEN ROUVAX Injection Injection (In children) mild measles-like syndrome. tetanus. mumps. loss of appetite.دوم‬ ‫ا و د‬ ‫ا س‬ ‫ر‬ ‫) ر‬ ( ‫ر‬ ‫ا ر‬ .

Scientific Name
Meningococal vaccine ACWY

Trade Name

Dosage Form
Injection

Indications

Side Effects

Contra-indications

Manufact urer
‫و‬ ‫ن‬ . ‫ث‬ ‫ا وو‬ .

Drug Store
‫و‬

MENCEVAX ACWY

Immunization for travellers

injection-site reactions , Hypersensitivity reactions including anaphylaxis have been reported redness, swelling, and pain at the site of the injection, mild fever, irritability, drowsiness, dizziness, nausea, vomiting, diarrhoea, anorexia in children, headache, myalgia, rash, urticaria

Meningococcal vaccine A+C

MENCEVAX AC VACCINE

Injection

MENINGOCOCCAL VACCINE

Injection

Childhood immunization, Contacts of infected individuals and laboratory workers

‫و‬ ‫ن‬ ‫ث‬ . ‫ا وو‬ . ‫ا س‬ ‫ر‬ ‫) ر‬ ( ‫ر‬ ‫ا ر‬

‫و‬

‫ا‬

Mumps viral vaccine

MUMPSVAX

Injection

.‫رك‬ ‫رب ودوم‬ ‫ا ر‬

‫ا‬

Immunoglobulins

Anti-hepatitis B immunoglobulin

AUNATIV

Injection

HEPUMAN Antimeasle imunoglobuline Anti-parotitis immunsglobulin Anti-rho(d) immunoglobulin MORUMAN PARUMAN RHESUMAN

Injection Injection Injection Injection

prevention of infection , personnel been accidentally inoculated with hepatitis B virus, infants born to mothers became infected with this virus in pregnancy or are high-risk carriers

‫او ر‬ ‫-ا و د‬

‫ا‬

‫ر‬ ‫ا و ر‬ ‫ر‬ ‫ا و ر‬ ‫ر‬ ‫ا و ر‬ ‫ر‬ ‫ا و ر‬ ‫ا رز‬ ‫ا وط‬ ‫ج‬ ‫ل‬ ‫ا‬ ‫وم‬ ‫ن‬ ‫ا‬ ‫وا رب‬ ‫ا رز‬ ‫ا وط‬ ‫ج‬ ‫ة‬

‫ر‬ ‫ر‬ ‫ر‬ ‫ر‬

Protect from the hazard of haemolytic disease of the newborn.

ANTI-SCORPION VENOM F(ab)2

SCORPION ANTIVENOM

Injection

‫ا‬ ‫اط‬

Anti-venom immunoglobulin

COBRA ANTIVENOM

Injection

‫ة‬

‫ا‬ ‫اط‬

187

Scientific Name

Trade Name

Dosage Form

Indications

Side Effects

Contra-indications

Manufact urer
‫ا‬ ‫وم‬ ‫ن‬ ‫ا‬ ‫وا رب‬ ‫ا رز‬ ‫ا وط‬ ‫ج‬ ‫ل‬ ‫ا‬ ‫وم‬ ‫ن‬ ‫ا‬ ‫وا رب‬ ‫و‬ ‫رود ت‬ )‫ب‬ (‫ل‬ ‫ا رط‬ ‫ر‬ ‫ا و ر‬ ‫ر‬ ‫ا و ر‬ ‫ل‬

Drug Store

Anti-venum immunoglobulin against 6types of snakes

POLYVALENT SNAKE ANTIVENUM

Injection

‫ة‬

‫ا‬ ‫اط‬

Human normal immunoglobulin

VIGAM LIQUID

Injection

protection of susceptible against hepatitis A virus (infectious hepatitis), measles and, to a lesser extent, rubella

may interfere with the immune response to live virus vaccines ,

Patients with known class-specific antibody to immunoglobulin A (IgA).

‫دة‬

‫ا ؤ‬ ‫ا‬ ‫دو‬

Human antidiphtheria immunoglobulin Human antipertussis immunoglobulin Human antitetanus immunoglobulin Human immunoglobin-G

DIPHUMAN BERNA TOSUMAN

Injection

‫ر‬ ‫ر‬ ‫ر‬ ‫ن‬ ‫ا‬

Injection

TETUMAN

Injection

GAMMAGARD S/D

Injection

For the management of tetanus-prone wounds Replacement therapy , idiopathic thrombocytopenic purpura , Kawasaki syndrome, prophylaxis of infection following bone-marrow transplantation

‫ر‬ ‫ا و ر‬ ‫ـر‬ ‫ور ور ن‬ ‫ا ر‬

188

Scientific Name

Trade Name

Dosage Form

Indications

Side Effects

Contra-indications

Manufact urer

Drug Store

Anaesthesia

General anaesthesia 190 Intravenous anaesthetics .................................................................................... 190 Inhalational anaesthetics .................................................................................... 190 Antimuscarinic drugs ......................................................................................... 191 Sedative and analgesic peri-operative drugs ...................................................... 191 Muscle relaxants ................................................................................................ 192 Antagonists for central and respiratory depression ............................................ 193 Local anaesthesia 194

189

Scientific Name

Trade Name

Dosage Form

Indications

Side Effects

Contra-indications

Manufact urer

Drug Store

General anaesthesia
Intravenous anaesthetics
Ketamine HCl TEKAM Injection induction and maintenance of anaesthesia High incidence of hallucinations, nightmares, and transient psychotic effects. Extraneous muscle movements; cardiovascular stimulation, tachycardia, raised arterial pressure. bradycardia, occasionally profound; intravenous administration of an antimuscarinic drug may prevent this., flushing; transient apnoea during induction; less commonly thrombosis, phlebitis; very rarely pancreatitis, pulmonary oedema, sexual disinhibition, arrhythmias, myocardial depression, laryngeal spasm, cough, sneezing, hypersensitivity reactions, rash, injection-site reactions; excessive doses associated with hypothermia and profound cerebral impairment Hypertension and is best avoided in those prone to hallucinations or nightmares. It also has abuse potential and may itself cause dependence, porphyria ‫ا‬ ‫ا رد‬ ‫ا‬

Propofol

DIPRIVAN PROPOFOL

Injection Injection

Induction of anaesthesia, Maintenance of anaesthesia, Sedation in intensive care, Sedation for surgical and diagnostic procedures,

not to be used for sedation of ventilated children and adolescents under 17 years

‫ز‬ ‫ر ز وس‬ ‫د‬ ‫ام‬ ‫اش‬ ‫ا‬ ‫رس‬ ‫د‬ ‫دو‬ ‫ة‬

‫ا‬ ‫ا‬ ‫اط‬

RECOFOL

Injection

‫دا‬

‫إ راھ م‬ ‫ا‬

Thiopentone sodium

INTRAVAL

Injection

THIOPENTAL THIOPENTAL

Injection Injection

induction of general anaesthesia; anaesthesia of short duration; reduction of raised intracranial pressure if ventilation controlled; status epilepticus

porphyria; myotonic dystrophy; breastfeeding

‫أ س ر‬ ‫ا رط‬

‫و‬

‫ا و‬ ‫ا ر‬ ‫دوز‬ ‫أم ا ش‬ ً ) ( ‫و‬ ‫و‬ ‫ا‬

‫د ن‬ ‫د‬ ‫ر‬

Inhalational anaesthetics
Desflurane Isoflurane SUPRANE AERRANE FLORAN FORANE Sevoflurane SEVOFLURANE Inhalation Inhalation Inhalation Inhalation Inhalation ‫اھ دا‬ ‫اھ دا‬ ‫ا‬ ‫ا رد‬ ‫أ وت‬ ‫ا را‬ ‫أ وت‬ ‫ا را‬ ‫ن‬ ‫ن‬ ‫ب‬ ‫ل‬ ‫ب‬ ‫ل‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬

induction and maintenance of anaesthesia

susceptibility to malignant hyperthermia

190

Scientific Name

Trade Name

Dosage Form

Indications

Side Effects

Contra-indications

Manufact urer

Drug Store

Antimuscarinic drugs
Atropine sulphate ATROPINE SULF ATROPINE SULPHATE Injection Injection drying secretions; reversal of excessive bradycardia; with neostigmine for reversal of nondepolarising neuromuscular block; antidote to organophosphorous poisoning, antispasmodic ; bradycardia ; cardiopulmonary resuscitation;
0.4-0.6 mg PO, IM, SC, IV

ATROPINE SULPHATE ATROPINE SULPHATE ATROPINE SULPHATE

Injection Injection

Injection

Constipation, transient bradycardia, reduced bronchial secretions, urinary urgency and retention, dilatation of the pupils with loss of accommodation, photophobia, dry mouth, flushing and dryness of the skin.

Antimuscarinics are contra-indicated in myasthenia gravis , paralytic ileus, pyloric stenosis and prostatic enlargement

‫أ وت‬ ‫ا ر‬ ‫ا‬ ‫اط‬ ‫ا دودة‬ ‫أ ن‬ ‫ا ر د‬ ‫. راون‬ ‫ا‬ ‫أ و ت‬ ‫ا ر‬ ‫ل‬

‫ب‬ ‫ل‬ ------

‫ا‬

‫ا‬ ‫اط‬ ‫دي‬ ‫رف‬

‫ة‬

‫ورو‬

Sedative and analgesic peri-operative drugs
Alfentanil HCl RAPIFEN Injection analgesia especially during short operative procedure and outpatient surgery; enhancement of anaesthesia; analgesia and suppression of respiratory activity in patients receiving intensive care, with assisted ventilation, for up to 4 days analgesia during operation, enhancement of anaesthesia; respiratory depressant in assisted respiration; analgesia in other situations sedation with amnesia; sedation in intensive care; premedication, induction of anaesthesia; status epilepticus [unlicensed use], hypertension, myoclonic movements; less commonly arrhythmias, cough, hiccup, laryngospasm, visual disturbances -‫ن‬ ‫ج‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫اط‬

Fentanyl

FENTANYL CITRATE FENTANYLJANSSEN

Injection Injection

myoclonic movements; less commonly laryngospasm; rarely asystole, insomnia

‫أ ن‬ ‫ا ر د‬ -‫ن‬ ‫ج‬ ‫ا‬

‫ا‬ ‫اط‬ ‫ا ة‬ ‫اط‬

‫ة‬

Midazolam

DORMICUM

Injection

gastro-intestinal disturbances, increased appetite, jaundice; hypotension, cardiac arrest, heart rate changes, anaphylaxis, thrombosis; laryngospasm, bronchospasm, respiratory depression and respiratory arrest

marked neuromuscular respiratory weakness including unstable myasthenia gravis; severe respiratory depression; acute pulmonary insufficiency

‫روش‬ ‫ا و ر‬

191

Scientific Name
Remifentanil HCl

Trade Name

Dosage Form
Injection

Indications

Side Effects

Contra-indications

Manufact urer
‫و‬ ‫ا رط‬

Drug Store

ULTIVA

supplementation of general anaesthesia during induction and analgesia during maintenance of anaesthesia ; analgesia and sedation in ventilated, intensive care patients

hypertension, hypoxia; very rarely asystole and anaphylaxis

left ventricular dysfunction

Sufentanil

SUFENTA

Injection

-‫ن‬ ‫ج‬ ‫ا‬

‫ة‬

‫ا‬ ‫اط‬

Muscle relaxants

Non-depolarizing muscle relaxants
Atracurium besylate ATACURE ATRACURIUM BESYLATE TRACRIUM Injection Injection Injection muscle relaxation (short to intermediate duration) for surgery or during intensive care muscle relaxation (intermediate duration) for surgery or during intensive care muscle relaxation (short duration) for surgery muscle relaxation (long duration) for surgery or during intensive care ‫ا‬ ‫ا رد‬ ‫ن‬ ‫ا را‬ ‫و‬ ‫ن‬ ‫ث‬ ‫ر‬ ‫و‬ ‫ن‬ ‫ث‬ ‫ر‬ ‫و‬ ‫ن‬ ‫ث‬ ‫ر‬ ‫ا‬ ‫ا رد‬ ‫ن‬ ‫ا را‬ ‫اور ون‬ ‫ا و د‬ ‫اور ون‬ ‫ا و د‬ ‫ا‬ ‫ا ر‬ ‫و‬ ‫و‬ ‫ا‬ ‫ر‬ ‫ا‬

Cisatracurium besilate

NIMBEX

Injection

Mivacurium chloride Pancuronium bromide

MIVACRON

Injection

ALPAX PANCURONIUM ESMERON

Injection Injection Injection Injection

Vecuronium bromide

NORCURON

muscle relaxation (intermediate duration) for surgery

Histamine release which can cause skin flushing, hypotension, tachycardia, bronchospasm and rarely, anaphylactoid reactions. Most aminosteroid muscle relaxants produce minimal histamine release. Drugs possessing vagolytic activity can counteract any bradycardia

Depolarizing muscle relaxants
Suxamethonium chloride LYSTHENON SICCUM Injection muscle relaxation (rapid onset, short duration) postoperative muscle pain, myoglobinuria, myoglobinaemia; tachycardia, arrhythmias, cardiac arrest, hypertension, hypotension; bronchospasm, apnea, prolonged respiratory family history of malignant hyperthermia, low plasma cholinesterase activity, hyperkalaemia; major trauma, severe burns, neurological disease involving acute wasting of major muscle, ‫ھ‬ ‫و د‬ ‫ر‬ ‫و‬ ‫أ‬ ‫ر‬ ‫ا وو‬ "‫" رس‬ ‫ا‬ ‫و‬ ‫و م‬ (.‫)و م.ف‬ ‫ز‬ ‫ا‬ ‫د‬ ‫ا‬ ‫زو‬

Suxamethonium chloride

SUCCINYL SICCUM

Injection

Suxamethoniumchloride

MIDARINE

Injection

‫و‬

192

prolonged immobilization Antagonists for central and respiratory depression Flumazenil ANEXATE Injection reversal of sedative effects of benzodiazepines in anesthetic. overdosage with opioids 0. dyspnoea. dyspnoea. transient increase in blood pressure and heartrate in intensive care patients reactions hypotension. saller doses are used for postoperative narcotic depression ‫د وت‬ ‫ر و ل‬ ‫ا ر‬ ‫د وت‬ ‫ر و ل‬ ‫ا ر‬ ‫ا‬ ‫ا رد‬ ‫ن‬ ‫ا را‬ ‫د وت‬ ‫ر و ل‬ ‫ا ر‬ ‫ة‬ ‫ة‬ ‫ا‬ ‫اط‬ ‫ا‬ ‫اط‬ ‫ا‬ NALOXONE Injection ‫ر‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫اط‬ Naltrexone TREXAN Tablet reverse opioid-induced respiratory depression. paraesthesia hypotension. SC 193 . anaphylactic reactions. hyperkalaemia. less commonly agitation. cardiac arrest. and flushing. agitation. pulmonary oedema. hyperventilation. overdosage with opioids Maintenance treatment: 50 mg PO daily or 100 mg every other day or 150 mg every third day. hyperventilation. reversal of neonatal respiratory depression resulting from opioid administration to mother during labour. anxiety. paraesthesia life-threatening condition controlled by benzodiazepines ‫روش‬ ‫ا و ر‬ Naloxone NARCAN Injection NARCAN NEONATAL NAXONE Injection Injection reverse opioid-induced respiratory depression. vomiting. less commonly agitation. pulmonary oedema. and diagnostic procedures nausea. ventricular tachycardia and fibrillation. hyperthermia.Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store depression. excitement. hypertension. ventricular tachycardia and fibrillation. and fear. 2 mL IV. hypertension.2 – 4 mg IV initially additional doses repeated at 2 – 3 min intervals. reversal of neonatal respiratory depression resulting from opioid administration to mother during labour. cardiac arrest. excitement. intensive care.

Scientific Name Trade Name Dosage Form Indications Side Effects Contra-indications Manufact urer Drug Store Local anesthesia Bupivacaine BUCAINE BUPIVACAINE MARCAINE Lidocaine HCl LIDOCAINE Injection Injection Injection Injection ‫ا‬ ‫اط‬ ‫ا دودة‬ ‫ا را‬ ‫وا ر ر‬ ‫ا‬ LIDOCAINE LIDOCATON XYLOCAINE Lignocaine . adrenaline LIDOCATON Injection Injection ‫و‬ ‫ا‬ ‫اط‬ ‫دي‬ ‫رف‬ ‫و‬ ‫و‬ ‫ا ر‬ ‫ب‬ ‫ل‬ ‫ل‬ ‫ؤ‬ ‫ا‬ ‫ا‬ ‫ا‬ RIALOCAINE XYLOCAINE Gel Injection Gel Spray Topical solution Injection Injection XYLOCARD Lignocaine. epinephrine Lignocaine Lignocaine . cetrimide Lignocaine XYLONOR LIDOCAINE LIGNOCAINE LIOCAINE Injection Injection Injection Spray Injection Gel Gel ‫ة‬ ‫ت‬ ‫ا دوا‬ ‫ا رد‬ ‫ار ض‬ ‫ر‬ ‫ا را‬ ‫ة‬ ‫و‬ ‫ا‬ ‫اط‬ ‫. راون‬ ‫ا‬ ‫ر ون‬ ‫ا و ر‬ ‫ا را‬ ‫ود ت‬ ‫ا ر‬ ‫أ وت‬ ‫ا ر‬ ‫ر درق‬ ‫ر‬ ‫ا‬ ‫ل‬ ‫ا‬ ‫ا رد‬ ‫أ وت‬ ‫ا ر‬ ‫ا را‬ ‫ا‬ ‫ب‬ ‫ا ل‬ ‫و‬ ------ XYLOCARD Lidocaine HCl . epinephrine Ropivacaine HCl LIDOCATON WITH EPINEPHRINE NAROPIN ‫ا را‬ ‫ر ون‬ ‫ا و ر‬ ‫ا را‬ ‫و‬ ‫و‬ ‫و‬ Injection 194 .

.......................................................‪١٨ A‬‬ ‫ا‬ ‫م‬ ‫وز .................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................‪٢٥ A‬‬ ‫ا‬ ‫ز ا ر ...........................................................................................‪١٤ A‬‬ ‫ا‬ ‫.................................................................................................................................‪٢٩ A‬‬ ‫دو ا ودة)ا‬ ‫د‬ ‫ا‬ ‫ا‬ ‫( ........................................................................................................‪٢٤ A‬‬ ‫ا‬ ‫ا و ......................‪٢١ A‬‬ ‫ة‬ ‫ا‬ ‫ك ...................‪٢٩ A‬‬ ‫رة )‬ ‫د ا‬ ‫ا‬ ‫ا‬ ‫.....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................‪١٠ A‬‬ ‫ادات ا‬ ‫ا‬ ‫ا‬ ‫) ا ن(.........................................................................................................................................................................................................................‪٨ A‬‬ ‫ر ات )‬ ‫د‬ ‫ا‬ ‫ا‬ ‫.......................‪١٨ A‬‬ ‫ــ‬ ‫ا ر ...............................................................................................................................................................‪١٠ A‬‬ ‫دو ا‬ ‫ا‬ ‫ا‬ ‫وا ازم ...........................‪١١ A‬‬ ‫ا‬ ‫.............................................................................‪١٠ A‬‬ ‫ازم ا‬ ‫ا‬ ‫ا‬ ‫................................................................................................................................................................................‪٢٢ A‬‬ ‫ا‬ ‫ا‬ ‫............................................................................................................................................................‪٢٨ A‬‬ ‫ا‬ ‫ا‬ ‫رة وا ازم ......................................................................‪٢ A‬‬ ‫ان و ا‬ ‫ا‬ ‫...................................................................................................................................................................‪٢٨ A‬‬ ‫( ........................................................................‪٣١ A‬‬ ‫تا‬ ‫دو وا‬ ‫ا ط‬ ‫ا‬ ‫ھ ..........................................................................‪٥ A‬‬ ‫‬‫تا‬ ‫د ا‬ ‫ا‬ ‫ا‬ ‫...................................................................................................‪٦ A‬‬ ‫تا‬ ‫ت ا وا و ا‬ ‫د‬ ‫ا‬ ‫ا‬ ‫) ( ................................ ....................................................‪٢٤ A‬‬ ‫..........................................................................................................ان _ ا‬ ‫رة ...........................................................................................................................................‪٢٨ A‬‬ ‫.......‪٢ A‬‬ ‫إ اھ ا‬ ‫ة .............................................................................................‪٢٥ A‬‬ ‫م دو .......‪٢٦ A‬‬ ‫ا‬ ‫ا‬ ‫......................................................................................................................................................................................................................................................................................................................................‪٢٣ A‬‬ ‫تا‬ ‫د‬ ‫دي ....................‪٢٣ A‬‬ ‫ا‬ ‫ن ا دو ا‬ ‫ا ون ..............................................................................................................................................................................................................................................................................................................................................................................................................‪٢٣ A‬‬ ‫.............‪١٧ A‬‬ ‫أز‬ ‫ة ..........................................................................................................................................................................................................................................................................................‪٣١ A‬‬ ‫ا‬ ‫ا‬ ‫..........................................................‪٣١ A‬‬ ‫تا‬ ‫ة دو وا‬ ‫ا‬ ‫ا‬ ‫ة دو .............‪٢١ A‬‬ ‫د ......................................................................................................................‪٢٧ A‬‬ ‫رو .........‪٣١ A‬‬ ‫و‬ ‫روق و ن‬ ‫‪1–A‬‬ .......................................................................................................................‪٢ A‬‬ ‫............................................................................................................‪٢٤ A‬‬ ‫ا‬ ‫...............................................................................‪٧ A‬‬ ‫ات ا‬ ‫د‬ ‫ا‬ ‫ا‬ ‫(.‪٢٦ A‬‬ ‫ا‬ ‫ا‬ ‫ا ل ...........................................................................................................................................‪٢٠ A‬‬ ‫) ي‬ ‫تا‬ ‫ا ر ات و ا‬ ‫ت ا وا .................................................................................................................‪٢٦ A‬‬ ‫ا ودة ...................................................................................................................................................‪٢٤ A‬‬ ‫م ا ر ...............................................................................‪١٦ A‬‬ ‫ا‬ ‫ا‬ ‫..............................................‪٢ A‬‬ ‫ا‬ ‫ا ان ..................................................................................................‪١٨ A‬‬ ‫ف( ...............................................................................................................................................................................‪٣ A‬‬ ‫ا ةا‬ ‫ا ق ا و .........................................................................................‪١٤ A‬‬ ‫ا‬ ‫ا‬ ‫...................................‪٢ A‬‬ ‫ا‬ ‫......................................‫‪Registered Suppliers Index‬‬ ‫....‪١٧ A‬‬ ‫آي................................‪٥ A‬‬ ‫......‪١٧ A‬‬ ‫را‬ ‫م ..................................................................................................................................................‪٢٤ A‬‬ ‫تا‬ ‫ا د‬ ‫ن .....................................................................................................‪١٧ A‬‬ ‫ت .................................................

V INFUSION SODIUM CHLORIDE 0.9% SOLN.CHLORIDE 0.I. CHLORIDE 0.10 TABLET INVORIL -5 TABLET MIRENA 52MG T-SHAPED IUD OFTAN TIMOLOL 0.V SODIUM CHLORIDE 0.U.V INFUSION MANNITOL 10% W/V INFUSION BOTTLES MANNITOL 20% INFUSION RINGER SOLUTION I.SALINE DEXTRAN_40 5% IN NORMAL SALINE DEXTRAN_70 6% IN N. URO-TAINER NACL 0.5%THILO EYE DROPS CYCLOPENTOLATE 1% THILO EYE DROPS DEXTROSE 5% DIOVENOR TAB.45% + GLUCOSE 5% I.9% P.V SODIUM CHLORIDE 0.3% SODIUM CHLORIDE 0.10% W/O CARBOHYDRATE AMINOFUSIN PAED 900 BENOXINATE 0.5% EYE DROPS OFTANEX 0. _______________________________ ADALAT 30MG LA TAB ADALAT 60MG LA TAB ADALAT CAP 10MG ADALAT RETARD 20MG TABS ALKA-SELTZER EFFERVESCENT TAB ASPIRIN ADULT TAB 300MG ASPIRIN CHILDREN 100mg ASPIRIN EFFERV.INFUSION CARBOMIX 50GM POWDER DEXTRAN_40 10% IN N.225% & GLUCOSE 5% I.TAB 500MG WITH APPLICATOR CIPROBAY 100 INJ CIPROBAY 200 VIAL CIPROBAY 250MG TAB CIPROBAY 500MG TAB CIPROBAY 750MG TAB CLOTAN 200MG CAPS GLUCOBAY 100MG TAB GLUCOBAY 50MG TAB ISOKET 0. CREAM 10% CANESTIN-1 VAG.9% & GLUCOSE 5% I.1% AMPOULE LASONIL OINT LEVITRA 10MG TABLET LEVITRA 5MG TABLET MYCOSPOR CREAM 1% MYCOSPOR GEL 1% MYCOSPOR SOLUTION 1% NIMOTOP 10MG/50ML INFUSION BOTTLE NIMOTOP 30MG TAB RANTUDIL 60MG FORTE CAPS RANTUDIL 90MG RETARD CAPS RESOCHIN AMP 250MG/5ML RESOCHIN TAB 250MG RHEUMON CREAM 10% RHEUMON GEL 50MG/G SCANDICAINE 2% SPECIALE CARTRIDGE SCANDICAINE 3% CARTRIDGE 1. 150 MG.5 G TAB ‫رة‬ DEXTROSE 5%+SOD.8ML SEPTANEST N 1/200000 DENTAL CARTRIDGE SEPTANEST SP 1/100000 DENTAL CARTRIDGE TRASYLOL 100000 K. TAMOFEN 10MG TAB TAMOFEN 20MG TAB URO-TAINER CHLORHEXIDINE1:5000 SOLN URO-TAINER MANDELIC ACID SOLN.V INFUSION GLUCOSE 5% I.V. DEXTROSE 5% INFLAC BOTTLE DEXTROSE 50% SOLU. ‫ا‬ ‫ھ‬ _______________________________ COMPOUND SODIUM LACTATE I.C TABLETS OMOL 120MG\5ML SYRUP OMOL 500MG TABLET ORS 30GM SACHET PRACTO-CLYSS ENEMA RECOFOL 10MG/ML INJECTION SALBUVENT 2MG TAB SALBUVENT 4MG TAB SALBUVENT INHALATION 100MCG/DOSE SODIUM CHLORIDE 0.9% INFUSION SOLN _______________________________ 2– A .C AVALOX 400MG TAB BILTRICIDE 600MG TABS CANESTEN CREAM 1% CANESTEN SOLUTION 1% CANESTEN VAGINAL TAB 100MG CANESTEN-1 VAG.AMPULE TRASYLOL 100000 KIU/10ML AMP TRASYLOL 500000 KIU/50ML INFUSION BOTTLE XYLONOR SPRAY YOMESAN 0.9% INJ RINGER'S INJ SOD.FOR PARE.25% EYE DROPS OFTAN TIMOLOL 0.C.1% EYE DROPS OMACILLIN 250MG CAP OMAFEN 400 MG F.Registered Suppliers Index SODIUM CHLORIDE 0.18%/GLUCOSE 4.WITH VIT.4% THILO CUTISAN POWDER CYCLOPENTOLATE 0.SALINE DEXTRAN-40 10%IN DEXTROSE DEXTRAN-40 5% IN DEXTROSE DEXTRAN-70 6% IN DEXTROSE DEXTROSE 40% SOLU.9% SOLN URO-TAINER SOLUTIO-R URO-TAINER SUBY-G IRRIGATION SOLN.V INFUSION CYCLOPHOSPHAMIDE 1000MG VIAL CYCLOPHOSPHAMIDE 100MG VIAL CYCLOPHOSPHAMIDE 200MG VIAL ELDEPRYL 5MG TABS GLUCOSE 10%I. DOBUJECT 50MG/ML(250MG/5ML) AMPOULE INVORIL.FOR INFUSION ‫ا‬ _______________________________ ‫ا وان‬ ‫دان و ا و طر‬ +966 (01) 4041902: +966 (01) 4022428: AMINOFUSIN L 600 AMINOFUSIN L.V ‫إ راھ م ا‬ ‫ا ر‬ +966 (01) 4021351: +966 (01) 4021432: ‫ھ‬ +966 (01) 2791150: +966 (01) 4632834: ‫ھ‬ _______________________________ AZAMUN 50MG TAB BONEFOS 400MG CAPSULS BONEFOS 60MG/ML CONC.

5MG TAB CONCOR-5-PLUS TAB COUMADIN TAB 10MG COUMADIN TAB 2.FOR SUSP FLOXAPEN 500MG CAPS FLOXAPEN CAPS 250MG FLOXAPEN SYP 125MG/5ML FLOXAPEN VIAL 250MG FLOZAK 20MG CAP FLU_CARE SYRUP FLUMED (2MG+30MG)/5ML SYRUP FLUMED DM ADULT SYRUP FLUMED DM PAED.1% DERMOLAR SKIN CREAM 0.5/MLSYRING DOSER AUGMENTIN TAB 375 MG AVANDAMET TABLET AVANDIA 4MG TAB.1% EYE OINT.CHLORIDE 0.3% E/E DROPS GENTACIN 0.C TABLETS FENTANYL CITRATE 50MCG/ML VIAL FENTANYL-JANSSEN 0.5MG TABLET CYTOBION AMP 1MG DAKTACORT CREAM 20MG/GM DAKTARIN 2% TINCTURE DAKTARIN 2%LOTION DAKTARIN CREAM 2% DAKTARIN ORALGEL 2% DAKTARIN POWDER 2% DECODERM COMPOUND CREAM 0.5ML PREFILLED SYRING EPREX 10000 U /ML PREFILLED SYRING EPREX 2000 U/0.2ML.05MG/ML AMPOULES FEROMIN 190MG TAB FEROMIN ORAL DROPS FLAMAZINE CREAM FLAMAZINE CREAM 1% FLOXAPEN 250MG/5ML POWD. POLYSPECTRAN EYE EAR DROPS RINGER LACTATE 500ML SOD.127% (LIPOPHILIC) ENCEPHABOL 100MG TAB ENCEPHABOL LIQUID 100 MG.5GM AMP CAMCOLIT 250MG TAB CAMCOLIT 400MG C. BETACHOL EYE DROPS (10 ML) BREVIBLOC 100MG VIAL OF 10ML BREVIBLOC 2. BACTROBAN NASAL OINTMENT 2% BACTROBAN OINT 2% BALAD CREAM BALAD OINTMINT 2% BENZAC AC 10% GEL BENZAC AC 2.3ML PREFILLED SYRINGE EPREX 40000IU\ML EPREX 4000IU/0. FAMOGEN 10 MG F. SYRUP FLUMETOL 0.1% CREAM DIFFERIN 0.1% DECODERM CREAM 0.4ML PROFILLED SYRING EPREX NEW STABILIZER 4000IU/ML VIAL EVION 100 MG/TABS.127% (HYDROPHILIC) EFFICORT LIPOCREAM 0. TAB CHLOROQUINE 150MG TAB CHLOROQUINE 50MG/5ML SYRUP CHLORPHENIRAMINE 2MG/5ML SYRUP CILEST TAB CILOPRINE CUM ANAESTHETICO EAR DROP SOLN CIPROCIN 0.Registered Suppliers Index CONCOR 10MG TAB CONCOR 5MG TAB CONCOR COR 2.STRIPS FLUPHENAZINE DECANOATE 25MG/ML INJECTION FOLIC ACID 1MG TAB FOLIC ACID 5MG TAB.5MG COXICAM 15MG TABLET COXICAM 7.AMP.025% DERMOLAR SKIN OINTMENT 0.3% EYE/EAR DROP CIPROGEN 250MG TAB CIPROGEN 500MG TAB CIPROGEN 750MG TAB CLIOCORT OINTMINT CLOBEDERM 0. FLUORETS OPTH.C TABLETS FAMOGEN 40 MG F.5MG COUMADIN TAB 2MG COUMADIN TAB 5MG COUMADIN TAB 7.3% EYE OINTMENT CIPROCIN 0.1% GEL DOXYCIN 100 MG CAPSULES DUROGESIC TTS 100 Ug/HOUR DUROGESIC TTS 25 Ug/HOUR DUROGESIC TTS 50 Ug/HOUR DUROGESIC TTS 75 Ug/HOUR EARCALM EAR DROP EFFICORT CREAM 0.025% DICYNONE 2ML/AMP 250MG DICYNONE TAB 250MG DIFFERIN 0. EFF TAB 1G CEBION DROPS 100MG DROPS CEBION EFFRV TAB 1G CEBIOPIRIN EFFV. 1% TFT THILO 1% EYE DROPS VIDARABINE 3% THILO-EYE OINT.25% EYE DROPS GLAUCONEX 0.TAB CEBION CAL.5% GEL BENZAC AC 5% GEL BETABION 100 MG.C TABLETS FAMOGEN 20 MG F.5ML PREFILLED SYRING EPREX 3000IU/0.5% EYE DROPS KONJUNCTIVAL EYE DROPS PE-900 INJ POLYSPECTRAN EYE &EAR OINT.R. EPREX 1000 U/0.05% W / W OINTMENT COBRA ANTIVENOM (EQUINE) AMP ‫ا‬ ‫ھ‬ _______________________________ 3– A . ‫ةاط‬ +966 (01) 4655075: +966 (01) 4652354: ACICARE 75 MG FILM COATED TABLET ACICARE 150MGTAB ACICARE 300MG TAB ACIVIR 5% CREAM ADRENALINE : 1000 INJ AMINOPHYLLINE 250 Mg INJECTION AMINOSTERIL KE SOLN AMINOSTERIL NEPHRO CARBOHYD FREE AMOXIL VIALS 500 MG ASTHALIN 2MG/5ML SYRUP ATROPINE SULPHATE 600MCG/ML INJ AUGMENTIN 1 G TAB AUGMENTIN 1.9% INJ SOLUBACTER SOLN.2GM VIAL AUGMENTIN 156 Mg/5 ML SYRUP AUGMENTIN 228 MG/5ML SYRUP AUGMENTIN 312MG/5ML SYRUP AUGMENTIN 457MG/5ML SUSP AUGMENTIN 600MG VIAL AUGMENTIN 625MG TAB AUGMENTIN INFANT DROP62. GASTROZOLE 20MG CAP GENPRID 200 MG TABLET GENPRID 50MG CAPSULE GENTACIN .3% EYE OINTMENT GLUCOPHAGE 1 GM TABLETS GLAUCONEX 0.

C.4% MINIMS CHLORAMPHENICOL 0.25% MINIMS PHENYLEPHRINE 2.25% OPHTHALMIC DROP OCUMOL 0.025% CREAM RETACNYL 0.C. GYNO-PEVARYL-150 VAG.U\10ML VIAL OCTANINE F 500 IU OCTAPLAS OCUGESIC 0. MOTILIUM SUPP 60MG FOR ADULT MOTILIUM SYRUP 0.5MG/ML LIVOSTIN NASAL SPRAY 0.5% W/V MINIMS PHENYLEPHRINE HCL 10% MINIMS PILOCARPINE 2% MINIMS PILOCARPINE 4% MINIMS ROSE BENGAL MINIMS SODIUM CHLORIDE 0.05% CREAM RETIN-A CREAM 0.1% EYE DROP OPTASONE 0. PROPOFOL 1% I.025% RETIN-A SOLN.025% DROPS IMODIUM CAP 2MG INTROPIN 200MG/5ML AMP INTROPIN 400 MG/5ML VIAL LIGNOCAINE 1%W/V AMP LIGNOCAINE 2%W/V AMP LIPOVENOS 10% (SOYBEAN OIL) LIPOVENOS 20% (SOYBEAN OIL) LIVOSTIN EYE DROPS 0.1% EYE OINT ORAP FORTE TAB 4 MG ORBENIN 500MG VIAL PARAFON CAPS.Registered Suppliers Index NORGALAX 0.5% MINIMS TROPICAMIDE 1% W/V MOTILIUM SUPP 10MG FOR INFANT MOTILIUM SUPP 30MG FOR CHILD.5% OPHTHALMIC DROP OCURED EYE DROPS OPTASONE 0.3% MINIMS LIGNOCAINE4%+FLUORESCEIN 0. 0.1% RHEUMARENE GEL RHINOFRIN 0.05% SPRAY ILIADIN ADULT 0.5% RELIFEX 500MG F. PENBRITIN VIAL 250 MG PEVARYL PV FOAMING SOLUTION PEVARYL SPRAY POWDER 1% PEVARYL SPRAY SOLUTION 1% PEVISONE CREAM PHORPAIN 5% GEL PILOTINA-2 EYE DROP 2% PILOTINA-4 EYE DROP PLASMA PROTEIN FRACTION 5% SOLUTION POLYBION 2ML AMP POLYBION DROPS POLYBION FORTE COATED TAB.5% MINIMS AMETHOCAINE HCL 1% MINIMS ARTIFICIAL TEARS MINIMS ATROPINE SULPHATE 1% MINIMS BENOXINATE HCL 0. NAZOPHEN NASAL DROPS NEOSTIGMINE 2. POLYVALENT SNAKE ANTIVENUM(EQUINE) AMP POSALFILIN OINT.02MG/ML 2ML AMP NARCAN 0.TABS REMINYL 12MG TABLET REMINYL 4 MG / ML ORAL SOLUTION REMINYL 4MG TABLET REMINYL 8MG TABLET REQUIP 1MG TAB REQUIP 2MG TAB REQUIP 5MG TAB REQUIP0. NEUROBION 3ML AMP NEUROBION TAB NIZORAL 200MG TAB NIZORAL CREAM 2% NIZORAL SHAMPOO 4– A .05% DROPS ILIADIN INFANT 0.25MG TAB RETACNYL 0. SUPPS 150MG GYNO-PEVARYL-50 VAG SUPPS 50MG HALDOL 2MG/ML DROPS HALDOL 5MG TABLET HALDOL 5MG/ML AMP HALDOL DECANOAS INJ 100MG/ML HALDOL DECANOAS INJ 50MG HALDOL TAB 0.9% MINIMS TROPICAMIDE 0.25% NASAL DROPS RIABROXOL 15MG\5ML SYRUP RIABROXOL 30 MG TABLETS RIACETAMIDE -20 EYE DROPS RIACETAMIDE STERILE EYE DROPS 10 % W/ V RIACHOL 0.1% MOTILIUM TAB 10MG MOVICOL SACHET POWDER FOR RECONSTITUTION MULTIBIONTA FORTE CAP NARCAN NEONATAL 0.5MG/ML LOCERYL 5% NAIL LACQUER MEBAGEN 135MG TAB MINIMS AMETHOCAINE HCL 0. OCTAGAM 1GM/20ML I. REFOBACIN AMP 120MG/2ML REFOBACIN AMP 40MG/ML REFOBACIN EYE OINT 0.5% MINIMS CYCLOPENTOLATE HCL 1% MINIMS FLUORESCEIN SODIUM 2% MINIMS GENTAMYCIN 0.TABLET GUAFEDRIN (50+30)/5ML SYRUP GUAPHAN 100MG/5ML SYRUP GUAPHAN DM SYRUP GYNO-DAKTARIN 1200MG VAGINAL CAPSULE GYNO-DAKTARIN CREAM WITH 16 APPLICATORS GYNO-DAKTARIN OVULES 400 MG.V OCTANATE 250IU VIAL OCTANATE 100 I.TABLET GLUCOVANCE(2.5% MINIMS CYCLOPENTOLATE HCL 0.5% EYE DROP RIACHOL 5% EAR DROPS RIACHOL EYE OINT.12G/10G MICRO-ENEMA RECTLTUBE NORGINE ENEMA ADULT NORGINE ENEMA CHILDRIN NORMACOL 62% GRANULE SACHETS NORMACOL PLUS NOSCAM NASAL DROPS NUBAIN 10MG/ML AMP.05% RETIN-A GEL 0.5+500)MG F.5MG/ML AMP NEOXIDIL 2% SOLN.C.4MG/ML AMP. VIAL ILIADIN 0.1% RIACORT 1 % CREAM RIACORT 1% OINTMENT RIAFAMPICIN 300MG TAB RIAGESIC 100 MG / ML ORAL DROPS GLUCOPHAGE 500MG TAB GLUCOPHAGE 850MG TAB GLUCOVANCE (5+500)MG F.5MG HESTOFEN SYRUP 1MG/5ML HOMAPIN EYE DROP 2% HUMAN ALBUMIN 20% HUMAN ALBUMIN 5% HYCAMTIN 4MG I.1% EYE DROP OCULAC EYE DROPS OCUMOL 0.V INJ OR INFUSION PYRALVEX SOLUN RAPIFEN 500MCG/ML AMP REFOBACIN AMP 80MG/2ML REFOBACIN 10MG 2ML AMP.U / ML ( VIAL ) OCTANATE 500IU VIAL OCTANINE F 250IU VIAL OCTANINE F 1000 I.V.

M VIAL RISPERDAL CONSTA 50MG I.5% SIMPLENE EYE DROPS 1% SOLU-DACORTIN AMP 25 MG SPASMONAL 60MG CAPS SPORANOX CAPS 100MG STUGERON 25MG TAB STUGERON FORTE CAP 75 MG STYPTOBION TAB 10 TAB SUFENTA AMP 5MCG/ML SUFENTA FORTE AMP 50MCG/ML SYMMETREL. AMP.C TAB SALI-DECODREM OINT SCORPION ANTIVENOM(EQUINE) AMP SEDALAC SYRUP 3. CAP.5MG TAB HERMESTAS GOLD TAB IBUPHIL 5% GEL LIPO_MERZ RETARD 500MG/CAP.1% RIAVATE CREAM 0.C TAB RIAZOLE 125MG/5ML SUSP RIAZOLE 250MG TAB.TAB.C TAB RUMAFEN 50MG E. OINT GALLO MERZE SPASMLYTIC TAB GALLO MERZE TAB GINGIVITOL PAINT SOLUTION HEPA .5 MG I.4MG MODFIED RELEASE CAPSULE VASEXTEN 10MG CAP YUTOPAR 10MG TABLET 5– A .C. TREXAN 50MG TAB ‫ا رق ا و ط‬ +966 (01) 2941610: +966 (01) 2941443: BOLDOLAXIN TAB CONTRACTUBEX COMP.MERZ GRANULATE HEPA . LIPO-MERZ 300MG CAPS PANTHOPHIL 5% OINTMENT PHILAQUIN FORTE 4% CREAM PHILAZOLE 2% W/W SHAMPOO PK-MERZ 100MG TAB SALIDEX OINTMENT SALIDEX TOPICAL SOLUTION SALIMIST NASAL SPRAY ( 25 ML ) TAENIAPASSIN TABLETS 500MG UCIDERM 2 % CREAM UCIDERM 2% OINTMENT UCIDERM -B CREAM VIRU-MERZ SEROL 10% OINT VOCORT CREAM ‫ھ‬ _______________________________ ‫ت‬ ‫ا‬ ‫ود‬ ‫ا‬ - ‫ا ر‬ ‫ا د‬ _______________________________ DUSPATLIN 135MGTAB FLOXACIN 250 MG COATED TABLET FLOXACIN 500 MG COATED TABLET JOSAXIN OMEPREX 20MG CAP OMEPREX 20MG CAP OMNIC 0. 100 MG TYLENOL. TABLET RIAZEM 60MG F.5% EYE DROPS RIALOX SUSPENSION RIALOX TAB RIAMIDE 5MG/5ML (60ML) RIANEST 100000 IU/G ONITMENT RIANEST 100000 IU\.M VIAL ROYAL VIT G CAPSULE ROZEX GEL 0.5 % EYE DROPS RIATROPINE 1% EYE DROP RIAVATE SKIN OINTMEN 0.1% RIAXINE 4MG/5ML SYRUP (100ML) GLASS RIAZEM 120MG CAP RIAZEM 180MG CAP RIAZEM 240MG CAP RIAZEM 300MG CAP RIAZEM 30MG F.3GM/5ML RIALOCAINE 2% GEL RIALOL .TAB.G CREAM RIANEST 100000IU/1ML ORAL SUSPENSION RIAPHAN 15MG/5ML SYRUP RIAPRIL 10 MG TABLETS RIAPRIL 20 MG TABLETS RIAPRIL 5 MG TABLETS RIAPROFEN 200MG TAB RIAPROFEN 400MG F. SUPP 350 MG TYLENOL.TAB RIAPROXEN 500MG F.C TAB RIAPROFEN FM 200MG TAB RIAPROXEN 250MG F. SUPP. CAP.Registered Suppliers Index TRIDIL 50MG/10ML AMP TYLENOL DROPS 100MG/ML TYLENOL FORTE TAB 500MG TYLENOL.C.TAB.5%W/V XYLOMET ADULT NASAL DROPS XYLOMET PAED NASAL DROPS RIAGESIC 120 MG / 5 ML SYRUP RIAGESIC 500MG TAB RIALAC LIQUID 3. TOPAMAX 25MG/TAB. WAXSOL EAR DROPS 0.TAB RIASPASM 10MG TAB RIASPASM 5MG\5ML SYRUP RIATROPIN 1% EYE OINT RIATROPINE 0.C TAB RIAPROFEN 600MG F. TOPAMAX 200MG F. F.MERZ INFUSION HERMESTAS 12.C.35G/5ML SEPTOPAL CHAIN OF BEADS SIBELIUM.1% EYE DROPS RISPERDAL 1MG TAB RISPERDAL 1MG/ML SOLUTION RISPERDAL 2MG TAB RISPERDAL 3MG TAB RISPERDAL 4MG TAB RISPERDAL CONSTA 25MG I. 200 MG ULTRACARBON 250MG TAB ULTRAZOLE 15MG CAPSULE ULTRAZOLE 30MG CAPSULE VERMOX 100MG TABLET VERMOX 500MG TAB VERMOX SUSPN 2% VERMOX TAB 100 MG WATER FOR INJ. 100 MG TERACIN 1% EYE OINTMENT THEOPED 300MG SR TAB. THEOPED 60MG/5ML SYRUP TOPAMAX 100MG F. 5 MG SIMPLENE EYE DROPS 0. RIAZOLE 500MG TAB RIAZOLIN 0.75% W/W RUMAFEN 1% GEL RUMAFEN 25 MG E.C.C.M VIAL RISPERDAL CONSTA 37.C. SUPP.

05% W/W CORTIMAX OINTMENT 0.C TAB FAMOCID 40 MG F.5 MG TAB CARVIDOL 25 MG TAB CARVIDOL 6.3% EYE/EAR DROPS CIPROMAX 0.3% GLAZE 80MG TAB GLAZE 80MG TAB HISTOP 2MG/5ML SYRUP HISTOP TAB 4MG HYMOX 125MG/5ML SYRUP HYMOX 250MG CAPS HYMOX 250MG/5ML SYRUP HYMOX 500MG CAPS KAFOSED SYRUP 15MG/5ML KEFLEX 125MG/5ML SUSPENSION KEFLEX 250 MG CAPSULE KEFLEX 250MG/5ML SUSPENTION KEFLEX 500MG TAB KENACOMB CREAM KENACOMB OINTMENT KLAVOX 1GM TAB KLAVOX 228MG\5ML SUSP KLAVOX 312.C.1% METOSIL TAB 10MG NAZIX NASAL DROPS 0.C.1% W/W OINTMENT METAZ CREAM 0.C. AMOXIL 500MG CAP.3% EYE/EAR DROPS CIPROMAX 250 MG TABLET CIPROMAX 500 MG TABLET CIPROMAX 750MG TAB CLARITINE 10MG TAB CLARITINE 5MG/5ML SYRUP CLOVIR 200MG TAB CLOVIR 400MG TAB CLOVIR 400MG TAB CLOVIR 5% CREAM COLDACT SYRUP CORTIDERM 1% CREAM CORTIDERM 1% CREAM CORTIMAX CREAM 0. TAB FAMOCID 40 MG F.05% W/V NAZIX NASAL SPRAY 0.3% EYE OINTMENT CIPROMAX 0. FELDENE GEL 0. GENTAM 20MG/2ML AMP GENTAM 80MG/2ML AMP GENTAM E/E DROPS 0.TAB KLAVOX 457MG\5ML SUSP KLAVOX 62.C TAB FORMIT 850 MG F.TAB KLAVOX SYRUP 156MG/5ML LIPOSTAT 10MG TAB LIPOSTAT 20MG TAB LORINASE SYRUP LORINASE TAB LORINE 10MG TAB LORINE 5MG/5ML SYRUP LUSTRAL 50MG TAB MAFEPAIN 500MG TAB METAZ LOTION 0.Registered Suppliers Index FELDENE 20MG DISPERSABLE TAB FELDENE 20MG/ML AMP.1% W/W OINTMENT METAZ 0. FEVADOL PLUS TAB FEVADOL SF 120MG\5ML SYRUP FEVADOL SF 120MG\5ML SYRUP FEVADOL SYRUP 120MG/5ML FEVADOL SYRUP 160MG/5ML SUGAR FREE FEVADOL SYRUP 160MG/5ML SUGAR FREE FLUTAB TABLET FORMIT 500MG F.25MG TABLET CECLOR 125MG/5ML SUSP CECLOR 250 MG/5ML SUSP CECLOR 250MG CAPSULE CECLOR 500MG CAPSULE CECLOR MR 375 MG TAB CECLOR MR 500MG TAB CECLOR MR 750 MG TAB CETRO 10MG F. AMOXIL SYRUP 125MG/5ML AMOXIL SYRUP FORTE 250MG/5ML AUGMENTIN 156MG/5ML SYRUP AUGMENTIN 312MG/5ML SUSP.5% FEROSAC INJ 20MG/ML AMP FEROSE . TAB FELDENE 10MG CAPS FELDENE 10MG DISPERSABLE TAB FELDENE 20MG CAPS 6– A .TO 100MG OF IRON) FEVADOL 100MG SUPPOSITORY FEVADOL 200MG SUPPOSITORY FEVADOL 350MG SUPPOSITORY FEVADOL 500MG TAB FEVADOL 500MG TAB FEVADOL EXTRA TAB. TABLET NOSPASM 10 MG TAB OSPEN 250MG TAB OSPEN 250MG/5ML ORAL SUSP ‫و‬ ‫ت ا دوا‬ ‫ا ر ا ود‬ ‫ز تاط‬ ‫ا‬ +966 (01) 4774481: +966 (01) 4768364: ‫ھ‬ _______________________________ AERIUS 5MG TABLETS AMIKIN AMP 100MG/2ML AMIKIN AMP 500MG/2ML AMOXIL 250MG CAP.C.C TAB FORMIT 850 MG F.05% W/V NAZIX NASAL DROPS 0.5MG DROPS KLAVOX 625MG F.1% METAZ 0.C.1% W/V NAZIX NASAL SPRAY 0. AUGMENTIN 375MG TAB AUGMENTIN TAB 625MG BACTRIM FORTE TAB BACTRIM SUSP(200+40MG/5ML) BETAMET 0.F TABLET FEROSE 50MG/ML DROPS FEROSE SYRUP 50MG/5ML FEROSE TAB (EQV.1% OINTMENT BEVIT SYRUP BUSPAR 10MG TAB BUSPAR 5MG TAB CAPOTEN 25MG TAB CAPOTEN 50MG TAB CAPRIL 25MG/TAB CAPRIL 50MG/TAB CARDOL 100MG TAB CARVIDOL 12.05 W/W CROMONAL NASAL DROPS 2% DIATAB 5MG TAB ENAPRIL 10 MG TAB ENAPRIL 20 MG TAB ENAPRIL 5 MG TAB EXYLIN PEDIATRIC SYRUP EXYLIN SYRUP 14MG/5ML FAMOCID 10MG F.3% EYE OINT.1% W/V NEORIN 5MG F.5 MG/5ML SYRUP KLAVOX 375MG F.C TAB FUSIDERM 2% CREAM FUSIDERM 2% OINTMENT FUSIDERM B CREAM GENTAM 0.C TAB FAMOCID 20 MG F.C TAB CETRO 5MG\5ML SYRUP CIPROMAX 0.

C. ROFENAC 25 MG TAB.C TAB CO-DIOVAN F.5 MG CAPS EXELON 6 MG CAPS FAMVIR 125MGTAB FAMVIR 250MG TAB FEMARA 2. 50 MG MELLERIL TAB 100MG MELLERIL TAB 25MG METHERGINE 0.125 MG.U /ML VIAL ROFENAC 0.5MG COMTAN 200MG F. LUDIOMIL TAB. ZIMAX 250MG CAP.C.5 MG CAPS EXELON 3 MG CAPS EXELON 4.C TABLET PROTON 20MG E.C TAB PROTON 40MG E.5MG LOPRESOR 100MG TAB LOPRESOR 50MG TABS LOPRESOR DIVI TAB 200 MG.5ML PRE FILLED SYRING ANAFRANIL TAB 10MG ANAFRANIL TABLETS 25 MG APRESOLINE 20MG/ML INJ AREDIA 15MG VIAL+SOLVENT AREDIA 30MG VIAL+SOLVENT ATROPINE EYE DROPS 1% BRINERDIN TAB CAFERGOT 1 MG TAB CALCIUM SANDOZ EFF TAB FORTE CALCIUM SANDOZ + VIT. LUDIOMIL TAB.TAB CIBACEN 10MG F.1% EYE DROP ROFENAC 100 MG SUPP ROFENAC 100MG TABLET ROFENAC 12. ROFENAC 50 MG SUPP ROFENAC 50MG TAB ROFENAC 75MG AMP ROFENAC GEL 1% ROFENAC GEL 1% ROFENAC-D 50MG TAB. HYGROTON 50MG TABLETS INFECTOFLAM EYE DROPS INFECTOFLAM EYE OINT.U /ML VIAL RECORMON 2000 I.TAB CIBACEN 5MG F.C TAB SAPOFEN 400MG TAB SAPOFEN 5 % GEL SAPOFEN 5 % GEL SAPOFEN 600 MG TAB SAPOFEN JUNIOR 100MG/5ML SUSPENSION SAPOFEN JUNIOR 100MG/5ML SUSPENSION SAPOFEN PLUS TAB SINOFREE 500MG/30MG TAB SNAFI 20MG TAB STARIL 10MG TAB STARIL 20MG TAB TEMPRA 160MG/5ML SYRUP TEMPRA 160MG/5ML SYRUP VERINE 135MG TAB VISACROM 2% EYE DROPS VISACROM 4% EYE DROPS ZADITEN SYRUP 1MG/5ML ZADITEN TAB 1MG ZIMAX 200MG\5ML SUSP ZIMAX 200MG\5ML SUSP ZIMAX 250MG CAP. LOCASALEN OINT.C AMP CALCIUM SANDOZ +VIT.02% LOCACORTEN OINTMENT LOCACORTEN TAR OINT.5 MG TABLET FENISTIL 1 MG COATED TAB FENISTIL 24 LONG ACTING CAPSULE 4 MG FENISTIL DROPS 0.C TABLET CO-DIOVAN 160MG+12.5MG F. LEPONEX 100MG TAB LEPONEX 25MG TAB LESCOL 40MG CAPS LESCOL XL 80 MG FILM COATED TAB LEUCOMAX 300 MICROGRAM VIAL+SOLVENT AMP LEUCOMAX 400 MICROGRAM VIAL+SOLVENT AMP LIORESAL 10MG TAB LIORESAL 25MG TAB LOCACORTEN CREAM 0.5 MG SUPP ROFENAC 25 MG TAB.C TAB 80MG/12. LOCACORTEN WIYH NEOMYCIN OINT. TABLETS METHERGINE 0. 25 MG ESTRACOMB TTS PATCHES ESTRADERM MX-100 ESTRADERM MX-25 ESTRADERM MX-50 EURAX CREAM 10% EURAX LOTION 10% EXELON 1. 100 MG.1G/100ML FENISTIL GEL FENISTIL SYRUP FORADIL 12MCG CAPS(POWDER FOR INHALATION GLIVEC 100MG CAP HYDERGINE TABLETS 1.TAB _______________________________ 7– A . SALAMAT 2 MG / 5 ML ( 145 ML ) SALAMAT 2MG TABLET SALAMAT 4MG TABLET SAPOFEN 200MG F. LOCACORTEN-VIOFORM CREAM LOCACORTEN-VIOFORM OINT.5 MG.C EFFV. 10 MG LUDIOMIL TAB.C TABLET PROTON 40MG E.1% ELIDIL 1% CREAM ESIDREX TAB. LOMIR SRO CAPS 5MG LOMIR TAB 2. 25 MG. INSIDON 50 MG TAB LAMISIL 1% CREAM LAMISIL 1% SOLUTION LAMISIL 1% SPRAY LAMISIL 250MG TAB LAMPRENE CAPS.U/ML VIAL RECORMON 5000 I. ‫رات ا ط‬ ‫ود‬ ‫ا‬ ‫ا ر‬ (‫) د‬ ‫ھ‬ +966 (01) 4658882: +966 (01) 4630601: ADELPHAN ESIDREX TAB AGRIPPAL S1 45 MG/.C.2MG/ML AMPULES MIACALCIC 100 IU/ML AMP MIACALCIC 200IU NASAL SPRAY MIACALCIC AMP 50 IU/ML PEPTAZOLE 15MG CAPSULE PEPTAZOLE 15MG CAPSULE PEPTAZOLE 30MG CAPSULE PEPTAZOLE 30MG CAPSULE PEVARYL CREAM 1% PROTON 20MG E.C TAB CORTIPHENOL-H EYE OINT DESFERAL 2 GM VIAL DESFERAL VIAL 500MG DIOVAN 160MGTAB DIOVAN 80MG TAB EFEMOLINE EYE DROPS 0.Registered Suppliers Index CO-DIOVAN 160\25 MG F.C TAB RECORMON 1000 I.TAB CIBACEN 20MG F.

TAB TEGRETOL CR 200MG SCORED TAB TEGRETOL CR 400MG SCORED TAB TEGRETOL SUSP 2% TEGRETOL TAB 200MG TEOPTIC 2 % EYE DROPS TOFRANIL 10 MG TAB TOFRANIL 25 MG.FOR INFUSIN 250MG/5ML SANDIMMUN NEORAL 100MG CAPS SANDIMMUN NEORAL 25MG CAPS SANDIMMUN NEORAL 50MG CAP SANDIMMUN NEORAL DRINK 100MG/ML SANDOSTATIN 0. EYE DROPS SPERSANICOL EYE DROPS SPERSANICOL EYE OINT SPERSAPOLYMYXIN DROPS 15000iu SYNACTHEN DEPOT 1MG/ML AMP SYNTOCINON AMP 5 IU/ML TAVEGYL INJ 2MG/2ML TAVEGYL SYRUP 1MG/10 CC ( ) ‫ور دات‬ ‫ود‬ ‫ا‬ ‫ا ر‬ ‫ھ‬ +966 (01) 4124444: +966 (01) 4125350: ACTIFED COMPOUND LINCTUS ACTIFED SYRUP ADENOCOR 6MG/2ML VIAL AMRIZOLE 1GM RECTAL SUPPOSITORY AMRIZOLE 250 Mg TABLET AMRIZOLE 500MG VAGINAL SUPPOSITORIES AMRIZOLE INJ 500MG/100ML BOTTLE AMRIZOLE SUSP 125MG/5ML ANAFLEX POWDER ANCOTIL TAB 500MG ANEXATE 0.05% OTRIVIN NASAL DROPS 0.1%+0. ZADITEN 0. 10MG SANDIMMUN 50MG/ML AMPULE SANDIMMUN CONC.1%(NEBULISER) PARLODEL 2. PILKA DROPS PRELLORAN CREAM PRELLORAN GEL PROCTO-GLYVENOL CREAM PROCTO-GLYVENOL SUPP.V BACTRIM PED SYRUP (200+40mg/5ML) BACTRIM TAB ADULT _______________________________ 8– A . TEGRETOL 100 CHEW.25% EYE DROP NYOLOL 0. 1MG/ML VOLTAREN OPHTHALMIC SDU 0. DROPS.C.5% MYFORTIC 360 MG E.5MG AMP 5ML APROVEL 150MG TAB APROVEL 300MG TAB ARIXTRA 2.1% OTRIVIN GEL 1:1000 OTRIVIN NASAL DROPS 0.3% EYE DROPS ORIMETEN 250MG TAB OROFAR LOZENGE OTRINOL 120MG CAP OTRIVIN DOSING SPRAY 0. 0. SUPP.5ML PRE-FILLED SYRINGE VENORUTON GEL 2% VENORUTON 300MG CAP VIBROCIL NASAL DROPS VIBROCIL NASAL GEL VIBROCIL SPRAY MICRODOSEUR VI-DE-3 4500 I.1% OPHTHALMIC GEL NYOLOL 0.5% EYE DROPS SPERSADEX.TABLET NAVOBAN 5MG CAPS NAVOBAN 5MG/5ML AMP NICOTINELL TTS-10 NICOTINELL TTS-20 NICOTINELL TTS-30 NITRODERM TTS 5 PATCHES NITRODERM TTS-10 SYSTEM NOVESINE EYE DROPS 0. 50 TAB TRIHERPINE EYE DROPS 1% TRIHERPINE EYE OINTMENT 1% TRILEPTAL 300MG F.V VIAL SIRDALUD 2MG TAB SIRDALUD 4MG TAB SPASMO-CANULASE TAB SPASMO-CIBALGIN SUPP.5 MG TAB.25 MG/ML EYE DROPS ZELMAC 6MG TAB ZOMETA 4MG VIAL MILLICORTEN 1 MG MOSEGOR SYRUP MOSEGOR TAB MYDRIATICUM EYE DROPS 0.1% OTRIVIN NASAL SPRAY 0.U/ML ORAL DROPS VIOFORM-HYDROCORTISONE CREAM VISCOTEARS OPTH. TAB VOLTAREN 75 MG AMP VOLTAREN EMUGEL 1% VOLTAREN OPHTHA.C TAB TRILEPTAL 600MG F. NYOLOL 0.Registered Suppliers Index TAVEGYL TAB 1MG. VOLTAREN 50 MG.DROPS ULTRACORTENOL OINTMENT 0.5 MG.C TAB ULTRACORTENOL 0.1MG/ML AMP SANDOSTATIN 0. SIMULECT 20 MG I.2MG/ML 5ML AMP SANDOSTATIN LAR 20MG VIAL SERVIDRAT-EFF-TAB.1% SPERSADEXOLINE EYE DROPS SPERSALLERG. PURSENNID TABLET REGITINE AMP RESOFERON TAB RESYL SYRUP 2% RIMANAL GEL RITALIN TAB.4% NUPERCAINAL 1% OINT.5ML PRE-FILLED SYRINGE ARTANE 2 MG TAB ARTANE 5 MG TAB ASPRO 320 MG TABLETS AURORIX 150MG TAB AURORIX 300MG TAB BACTRIM AMP 5ML I. SPERSADEX COMP.GEL VISKALDIX 10MG+5MG TAB VISKEN TABS 5MG VISUDYNE 15MG POWDER FOR INFUSION VITA-MERFEN. OINT VITAMIN-A 1000E/G EYE OINT VITREOLENT EYE DROPS VOLTAREN 100 MG. SUPP.5% EYE DROP OCULOSAN EYE DROPS OCULOTECT FLIUD SINE 50 MG /ML EYE DROPS OCULOTECT FLUID 50 MG/ ML EYE DROPS OKACIN 0. ADULT SPASMO-CIBALGIN TAB SPERSACARPINE 1% EYE DROPS SPERSACARPINE 2% EYE DROPS SPERSACARPINE 2% EYE OINT SPERSACARPINE 4% EYE DROPS SPERSACET 10% EYE DROPS SPERSACET-C-EYE DROPS.5% 5GM VAXEM HIB 10 MCG/.25 MG / ML SINGLE DOSE UNIT ZADITEN 0.5 MG/0.5% OPTH. VOLTAREN 25 MG TAB VOLTAREN 50 MG. EYE DROPS.05MG/ML AMP SANDOSTATIN 0.1% VOLTAREN RETARD 100MG TAB VOLTAREN SUPP 12. 0.

GRISOVIN TABLETS 500 MG. 9– A .U+1ML WARET FOR INJ VIAL BATRAMYCIN POWDER BECODISKS 100 MCG DISK HALER BECODISKS 200 MCG DISK HALER BECONASE NASAL SPRAY BECOZYM FORTE TAB BECOZYM SYRUP 100 ML. LEXOTANIL TAB.5 MG TABLET CORDARONE 150MG/3ML AMP CORDARONE TABS 200MG DANOL CAPS 100MG DANOL CAPS 200MG DEPAKINE CHRONO 500MG TAB DEPAKINE SOLN 200MG/ML DEPAKINE SYRUP 57.Registered Suppliers Index HEMOCLAR CREAM 0.4 ML FLIXOTIDE 0. 3 MG.C TAB HYDRALAZINE HCL TAB 25MG IMURAN 50MG VIAL INHIBACE 1MG TAB INHIBACE 2.375MG F.V.TAB CALPOL 120MG\5ML SUSP CALTRATE 600 MG TAB. MERCRYL LAURYL SOLUTION METHOTREXATE 2.SOLN 500MG/20ML LPF MINOCIN 100MG PELLET FILLED CAPS MINOCIN 50MG PELLET FILLED CAPS MIVACRON 2MG\ML INJ MODALIM 100MG TAB MOGADON 5 MG TAB MYAMBUTOL 400 MG.5MG\2ML NEBULE FLIXOTIDE 125MCG EVOHALER FLIXOTIDE 250MCG INHALER FLIXOTIDE 25MCG INHALER FLIXOTIDE 2MG\2ML NEBULE FLIXOTIDE 50 MCG EVOHALER FLIXOTIDE DISKUS 100MCG BLISTER POWDER I FLIXOTIDE DISKUS 250MCG BLISTER POWDER FLIXOTIDE DISKUS 500MCG BLISTER POWDER FLIXOTIDE DISKUS 50MCG BLISTER POWDER IN FLIXOTIDE EVOHALER 250MCG FLUORO-URACIL AMP 250MG/5ML FUMAFER TAB 200MG GEVRAL PROTEIN POWDER GRISOVIN TABLETS 125 MG.5ML NIMBEX 2MG\ML SOLUTION FOR INJ NIMBEX 5MG\ML INJ NIPRIDE DOUBLE 50 MG AMP. 6 MG. BEPANTHEN PLUS CREAM BEZALIP 200MG TAB BEZALIP RETARD 400MG TAB CAFAMOL TAB CALCIUM LEUCOVORIN TAB 15MG CALCIUM LEUCOVORIN VIAL 50 MG POWDER CALCIUM RESONIUM POWDER CAL-C-VITA EFFERVESCENT CAL-C-VITA EFFV.25MG\ML INJ LANOXIN PG 0. / 5 ML. CEPOREX DROPS 125MG/1.5ML NEUPOGEN 48 M U\0.1MG LANOXIN 0. ELDOQUIN CREAM 2% ELDOQUIN FORT 4% CREAM ELOXATIN 100MG VIAL ELOXATIN 50MG VIAL EPHYNAL CHEW.60 TAB. 1.6MG/ML LANITOP TAB 0. LEXOTANIL TAB. KONAKION MM PAED 2MG/0.1MG/ML LANITOP LIQUID 0.C TAB HIVID 0.25MG TAB DORMICUM 15MG/3ML AMP.25ML CEPOREX SYRUP 125 MG / 5 ML CEPOREX SYRUP 250 MG. CEPOREX CAPSULES 500 MG. DORMICUM 5MG/5ML AMP.5MG TAB INHIBACE 5MG TAB ISMO 20MG TAB ISOTRIRAUPINE S. 500 MG FLIXONASE NASULE DROPS 400 MCG /0. COAPROVEL 150 / 12. CELLCEPT 250 MG CAPS CELLCEPT 500MG TAB CENTRUM TABLET (ADVANCED FORMULA) CEPOREX CAPSULES 250 MG. NOVANTRONE VIAL 2MG/ML OTOSPORIN EAR DROPS OXSORALEN CAPS 10MG OXSORALEN LOTION I% PEGASYS 135 MCG/ML VIAL PEGASYS 180 MCG/ML VIAL PIPRIL VIAL 1G+SOLVENT 10ML PIPRIL VIAL 2G+SOLVENT 20ML PIPRIL VIAL 4G PIPRIL VIAL 6G PLAQUENIL 200MG TAB PLAVIX 75 MG TABLET PROPYLTHIOURACIL 50MG TAB QUINIDINE SULPHATE 200MG TAB RECORMON 1000 I.5 MG.5 MG TABLET COAPROVEL 300/ 12.U PREFILLED SYRINGE RECORMON 1000 I.DRAGEES 100MG EPIVIR 10 MG \ ML ORAL SOLUTION EUGLUCON TAB 5MG FANSIDAR TAB.2ML AMP KYTRIL 1MG TAB KYTRIL 1MG\ML AMP KYTRIL 200MCG\ML SYRUP KYTRIL 3MG\3ML AMP LANITOP AMP 0.05MG\ML ELIXIR LANOXIN 0.125MG TAB LANOXIN 0. DORMICUM 5MG/1ML AMP.P.64MG/ML DEPAKINE TAB 200 MG DEPAKINE TAB 500 MG DEPOVIT B12 1000 AMP 1ML DIAMOX SUSTETS 500 MG DIAMOX TAB 250 MG DIAMOX TAB 125MG DIAMOX VIALS 500 MG DILATREND 25MG TAB DILATREND 6.5MG TAB METHOTREXATE 50MG/2ML VIAL METHOTREXATE 5MG VIAL PARENTERAL METHOTREXATE INF. BENEXOL 12 TAB BENOQUINE OINTMENT BEPANTHEN 5% CREAM BEPANTHEN 5% OINT. TABLETS NEGRAM 500MG TAB NEO-MERCAZOLE 5MG TAB NEOTIGASON 10MG CAPS NEOTIGASON 25MG CAPS NEUPOGEN 30M U/0. MADOPAR 125MG HBS CAPS MADOPAR 250 MG CAPS MADOPAR 250 MG TABS MATERNA 1.25MG TAB LANOXIN 0.0625MG TABLET LARIAM 250MG TAB LEXOTANIL TAB.5ML KONAKION MM 10MG/ML AMP I.75MG F.5GM/100GM HIBTITER VACCINE HISTARHINE SYRUP HIVID 0.TAB KETOFAN 25MG TAB KONAKION DROPS 2% KONAKION 10MG DRAGEES KONAKION AMP 10MG/ML KONAKION AMP 1MG/0.

TAB SUPRADYN CAP SUPRADYN DRAGEES TAB SUPRADYN EFFERVESCENT TAMIFLU 75 MG CAPSULE TARGET GEL 3% TAZOCIN 2.5ML ROMILAR EXP SYRUP SARIDON TAB SEMBRINA TABLETS 250 MG.10ML I.25MICROGM ROCALTROL CAP 0.25G VIAL TAZOCIN 4.U PREFILLED SYRINGE RECORMON 2000 I.5% GEL KETESSE 25MG F.014 OZ VICKS VAPORUB OINT VIRAZOLE 20MG/MLUPON RECONSTITUTON INHAL XENICAL 120MG CAPSULE ZEFFIX 5MG\ML ORAL SOLUTION ZIAGEN 20MG\ML ORAL SOLUTION ZINACEF INFUSION.5% EYE DROPS TUNOLOL 0.25% OPTHADOSE TUNOLOL 0.5MICROGM ROCEPHIN 1GM VIAL+SOLV. ROCEPHIN 250MG VIAL +SOLV.5% DEXTROSE DIANEAL.5% OPTHADOSE UNICROM 2% EYE DROPS UNICROM 2% OPTHADOSE UNIGENTA 0.5MLI.U+1ML WATER FOR INJ VIAL REDOXON CHEWABLE TAB 500MG REDOXON EFFERVESCENCE TAB RENNIE TAB RETROVIR 50MG\5ML ORAL SUSPENTION RIMIFON 100MG TAB RIVOTRIL 2.Registered Suppliers Index UROQUAD TABS 100 MG UROQUAD TABS 300 MG VALIUM 10MG\2ML AMP VALIUM AMP 10MG/2ML VALIUM SYRUP 2 MG/5 ML VALIUM TAB 10 MG VALIUM TAB 2 MG VALIUM TAB 5MG VENTOLIN 0.PD1 WITH 2.5 G.5G VIAL TETRAMUNE VACCINE THIOPHENICOL 250MG TAB THIOPHENICOL INJ 750MG VIAL+5ML SOLVENT TIBERAL TABLETS 500 MG./AMP.5ML ROFERON-A 18MN. TRISORALEN TABLET 5MG ULCICURE TAB 1 GM ULTIVA 1MG VIAL(LYOPHILIZED) ULTIVA 2MG VIAL(LYOPHILIZED) ULTIVA 5MG VIAL(LYOPHILIZED) UNAT 10MG TAB UNAT 5MG TAB ‫دو ا ط‬ ‫ا ر‬ ‫ا ر‬ _______________________________ DIGEL LIQUID DIGEL TABLETS LASIX PAED. 1.25% EYE DROPS TUNOLOL 0.C. SEPTRIN 240MG SUSP SEPTRIN INJECTION SERETIDE EVOHALER 25/125 SERETIDE EVOHALER 25/50 MCG SERETIDE DISKUS 50\100MCG SERETIDE DISKUS 50\250 MCG SERETIDE DISKUS 50\500 MCG SERETIDE EVOHALER 25/250 MCG SEREVENT 25MCG INHALER SEREVENT 50MCG/ACTUATON ACCUHALER(DISKUS SOLUPARAXIN 1G VIAL+SOLVENT SPASMOTALIN 100MG TAB SPIROCTAN TAB 25MG SPIROCTAN TAB 50MG STRESS TAB 600 STRESS TAB WITH ZINC SUPRADIN EFF. LIQUID PROCTOSEDYL OINT PROCTOSEDYL SUPP.U PREFILLED SYRINGE RECORMON 5000 I.9% TOPICAL SOLUTION PND UNIMED0.5MG\ML INJ VENTOLIN 200MCG ROTACAP VENTOLIN DISKUS 200MCG VENTOLIN ROTAHALER VENTOLIN400MCG ROTACAP VICKS SINEX NASAL SPRAY. ROCEPHIN 1GM VIAL+SOLV. ROCEPHIN 500MG VIAL +SOLVENT ROFERON_A 4.WITH 1.25% DEXTROSE 10– A .5MG RIVOTRIL TAB 2 MG ROACCUTANE 10MG CAPS ROACCUTANE 20MG CAPS ROCALTROL CAP 0.TABLET PHYSIOL 0.WITH 4.3.IU VIAL ROFERON-A 3MIU/0. ZOFRAN 2MG\ML INJECTION ZOFRAN 4MG\5ML SYRUP ZOVIRAX 200MG\5ML SUSP ZOVIRAX 250MG IV INFUSION ZOVIRAX 3% OPTHALMIC OINTMENT RECORMON 2000 I.5 ML ROFERON-A 9MIU/0.5MG /ML ORAL SOLUTION RIVOTRIL AMP 1MG+SOLV 1ML RIVOTRIL TAB 0.M.PD1. TRANDATE TAB 200 MG.5MIU/0. SOFRA-TULLE STRIPS WIDTH 10CM SURGAM 300MG TAB ‫وا وازم‬ ‫دادات ا ط‬ ‫ا ر‬ ‫ا ر‬ ‫ھ‬ +966 (01) 4621188: +966 (01) 4654143: FASTUM 2. TRANXENE 10MG CAPS TRANXENE 5MG CAPS TRIHEMIC 600 MG TAB.V.U+1ML WATER FOR INJ VIAL RECORMON 5000 I. VICKS 44 E PEDIATRIC ALCOHOL FREE SYRUP VICKS DAY QUIL ALCOHOL FREE SYRUP VICKS INHALER 0.5% EYE DROPS _______________________________ (‫ن‬ ‫)ا‬ ‫وازم ا ط‬ ‫ا ر‬ ‫ا ر‬ _______________________________ AERRANE INHALATION ANAESTHITIC DEXTROSE 10% INJ DEXTROSE 5% INJ DIANEAL. TICLID 250MG TAB TILCOTIL 20MG VIAL TILCOTIL SUPP 20MG TILCOTIL TAB 20MG TRACRIUM 10MG\ML TRANDATE INJ.PD1.5% DEXTROSE DIANEAL.20ML TRANDATE TAB 100 MG.1% EYE DROPS TUNOLOL 0. 100 MG.

75MG VIAL+SOLVT DECLOBAN OINTMENT DENTAKE CAPS DERMATIN 1% POWDER DERMATIN CREAM 1% DIANEAL.1MG S.C WITH NEOM COLIRCUSI SULPHACETAMIDE 10% COLIRCUSI SULPHACETAMIDE 20% COLIRCUSI VIRUCIDE 0.U\ML ALBUMIN KABI 20% I.1% OPTH.5%DEXTROS DIANEAL.25% VIAL BUCAINE 0. ADRIBLASTINA 10MG VIAL& SOLV ADRIBLASTINA 50MG VIAL& SOLV AGLUMIN 250MG TABS AGLUMIN AMPULES 250 MG AHF CONCENTRATE KABI 3 I. CONFORTID SYRUP 5MG/ML CONTRASAL 15MG/5ML SYRUP CORTOFTAL 0.T.3% COLIRCUSI H.1% BETAVAL OINT 0. AUNATIV AMP 5ML AVAXIM 160 UNITS VACCINE S. PLASMA PROTEIN FRACTION (HUMAN) 5% RINGER'S & 5% DEXTROSE INJ.CHLORIDE 0.CHLORIDE 0.LOW CALCIUM WITH 2.5GM\10ML VIAL HUMAN ALBUMIN 20% VIAL+INFUSION SET LACTATED RINGER'S INJ OSMITROL 10% INFUSION SOLN.VAX ADSORB DACROLUX ARTIFICIAL TEARS DAUNOBLASTINA 20MG VIAL+SOLV DECAPEPTYL 0.LOW CALCIUM WITH 1.D SYRINGE BALKACYCLINE 250MG CAP BALKAPROFEN 4OOMG CAPS BALKAPROFEN 200 MG CAPS BALKAPROFEN 600MG TAB BALKATRIN FORTE(160+800) TAB BALKATRIN SUSP( 200+40MG/5ML) BALKATRIN TAB BCG VACCINE VIAL+DILUENT AMP BEFLOVIT 1MG TAB BEFOLVIT 5 MG TAB BETACORT 4MG/ML AMP ‫ھ‬ _______________________________ 11– A .5% VIAL CALSYR SYRUP CEFAMEZIN 1GM VIAL I.M VIAL CLAFOTAX 1GM I.V VIAL CLAFOTAX 500MG I.PD4.5MG/5ML ALLERFIN TABLETS 4MG ALLERGETIN SYRUP ALPAX AMP.Coq VACCINE D.V 50MG CONFORTID SUPPOSITORIES 100 MG.5% DROPS COLIRCUSI DEICOL EYE DROPS COLIRCUSI GENTADEXA EYE DROP COLIRCUSI GENTAMYCIN 0.75MG SYRINGE DECAPEPTYL DEPOT NOVUM 3..V VIAL COLFED 120ML COLIMEX TABLETS 1500000 U.2 GM VIAL AMOCLAN 156MG/5ML SUSP AMOCLAN 228MG\5ML SUSP AMOCLAN 375 MG TAB.5%LIDOCAI CEFIZOX 2000 VIAL CEFIZOX 500 VIAL I/V CEFIZOX 500MG I/M VIAL+SOLV 0. BUCAINE 0.SUSP CUSICROM EYE DROPS 2% CUSICROM EYE DROPS 4% CUSICROM NASAL SPRAY 2% CUSIMOLOL 0.25%DEXTROS GAMMAGARD S/D 0.V CEFAMEZIN 250MG INJ IM OR IV CEFAMEZIN 500MG INJ IM OR IV CEFIZOX 1000 VIAL I/V CEFIZOX 1000MG I/M VIAL+SOLV 0.5%LIDOCAIN CEFTAX 1000MG VIAL+SOLVENT CEFTAX 500MG VIAL+SOLVENT CHLORAMEX SYRUP 160MG/5ML CHLOROQUIN PHOSPHATE 80MG/5ML SYRUR CIFLOX 250MG TABLET CIFLOX 500MG TABLET CIPROFLOX 250MG TAB CIPROFLOX 500MG TAB CIPROFLOX 750MG TAB CIPROLON 200 VIAL 100ML CIPTADINE TAB 4MG CLAFOTAX 1GM I.25% EYE DROPS CUSIMOLOL 0.V ALBUTEIN 20% SOLN. AMOCLAN 457MG\5ML SUSP AMOCLAN 600MG VIAL AMOCLAN FORTE 312MG/5ML SUSP AMOCLAN FORTE 625MG TAB ANALUX COLIRCUSI ANTAGONIN 150MG TAB ANTAGONIN 300MG TAB ANTIPLATE 75MG TAB AQUASAL SACHETS AROMASIN 25MG COATED TAB ASMADIL SYRUP ASMADIL TABS 2MG ASPINOL ATACURE 10MG/ML INJ.PD4.5% EYE DROPS CUSIVIRAL OFTALMICO 3% OINT CYKLOKAPRON INJ 100MG/ML 5ML CYKLOKAPRON TAB 500MG D. 2MG/ML ALPHANATE 250 IU VIAL+10ML DILUENT ALUGEL SUSP AMOCLAN 1 GM TAB AMOCLAN 1.2% COLIRCUSI-CICLOPLEGIC 1% COLISTOP SUSP CONFORTID 50MG SUPPOSITORY CONFORTID 25MG CAPS CONFORTID INJ I. INJECTION DECAPEPTYL CR 3.5% drops COLIRCUSI ATROPINE 1% COLIRCUSI CHLORAMPHENICOL 0. RINGER'S INJECTION SOD.T.Registered Suppliers Index BETAVAL CREAM 0. FOR INJ ALLERFIN AMP 10MG/ML ALLERFIN SYRUP 2.1% BETAVAL-N CREAM BETAVAL-N OINT BETOLVEX INJ 1MG BISEKO SOLN 5% BLOPRESS 16 MG TABLETS BLOPRESS 8MG TAB.LOW CALCIUM WITH4.C. COLIOPAN CAPSULES 5MG COLIRCUSI ATROPINE 0.045% INJ SOD.9% INJ SUPRANE INHALATION ANAESTHITIC ‫ا‬ +966 (01) 4793000: +966 (01) 4771374: ACT-Hib VIAL with solvent ACTOS 15MG TABLET ACTOS 30MG TAB ADDAMEL AMP.PD4.5%DEXTROS DIANEAL.

TAB 500MG FERAL CAPS FLORAN 100% LIQUID FLUCAND 200MG/100ML INFUSION VIAL FLUDREX SYRUP FLUDREX TAB GABBRORAL SYRUP GABBRORAL TAB 250MG GAMMA GLOBULIN 16% INJ GENOTROPIN 16IU CARTRIDGE GENOTROPIN 36 IU CARTRIDGE GENOTROPIN 4 IU VIAL+SOLVENT GLIBIL-5 TABS GLICEROLO SUPP 1500MG CHILDREN GLUCOFER 300MG TAB GLYCINE 1.PESSARIES 500MG ELYZOLE 1% CREAM EPARGRISOVIT ADULT AMP. LIDAPRIM FORTE TAB LIDAPRIM ORAL SUSP. POWDER 9 GM ERYTHROMIL 200MG/5ML SUSP. TAB IMPUGAN 10MG/ML INJ. TAB IMIPREX 25 MG. LEXIN CAP. INFLABAN 12.5% IRRIGATION SOLUTION 12– A . FARLUTAL 250MG TAB FARMARUBICIN 10MG VIAL FARMORUBICIN 50MG VIAL FAWAR FRUIT EFFERVESCENT SALT SACHETS 5G FAWAR LEMON EFFERVESCENT SALT SACHETS 5G FENAMIC 250 MG CAP FENDOL 250 MG CAPSULE FENDOL 50MG/5ML SUSP FENDOL D.F 500MG VIAL DOSTINEX 0. LERGICOL 4 MG TABLETS LERGICOL SYRUP LEXIN 125MG/5ML SUSP. 500 MG.FOR CHILD LIDAPRIM PED.5MG SUPP. 500MG ELYZOL VAG.C. 5 MG. KABIKINASE 600000 IU VIAL KABIKINASE VIAL 100000 IU KEMICETIN EYE DROPS 1% KEMICETINE OPHT OINT 1% KIDIPRIN CHEWABLE TABS 100MG KIDIVIT CHEW.V INFUSION DIAXINE TABS DIPHENAM SYRUP DIPHENAM PEDIATRIC SYRUP DIUSEMIDE 20MG/2ML AMP DIUSEMIDE 40 MG TAB DOABETIC 5 MG TABLET DOLOMOL 120MG SUPP DOLOMOL 325MG SUPP DOLOMOL 500MG TAB DOLOMOL 650MG SUPP DOLOMOL DROPS 100 MG/ML DOLOMOL SYRUP 120 MG / 5 ML DOPAMET 250MG TABS DORAL S.5% RESPIRATOR SOLN. INFLA-BAN 50MG ENTERIC COATED TAB INFLA-BAN 50MG SUPP. EYEBEL-D EYE LOTION 5MG EZOLVIN 4MG\5ML SYRUP EZOLVIN 8MGTAB FARCOLIN 0.6MG TAB GUTRON INJECTION 5MG/2ML GUTRON TAB 2.S. 250 MG. TABLETS IPRADOL AEROSOL IPRADOL AMPULES 5MCG/2 ML I-PROFEN 400MG TABLET JUVELON CAPS.5 MG. LEXIN 1G TAB LEXIN 250MG/5ML SUSP.VIAL DUMOCYCLIN 250 MG CAP DUMOCYCLINE 500MG INJ DUMOCYCLINE EYE OINT DUMOLID TAB.100000 I. ERYTHROMIL 250MG TAB ERYTHROMIL FORTE 400MG/5ML SUSP. ELYZOL TAB. IMPUGAN TABLETS 40 MG INACTIVATED RABIES VACCINE SINGLE DOSE S INDICARDIN TAB 40MG INDICARDIN TAB.M.5MG TABLET DUMOCYCLIN 1. INDOMIN 100MG SUPP INDOMIN CAP 25MG INFLA-BAN 100MG SUPP.2ML AMP. 250 MG.Registered Suppliers Index GOTINE 0. LEXIN CAP.5G +50ML DILUENT INTRAGLOBIN 250MG INTRAGLOBIN 500MG+DILUENT INTRALIPID 10% (SOYBEAN OIL) INTRALIPID 20% (SOYBEAN OIL) IPRADOL 0. TAB. EPSIKAPRON AMP 4G+WATER FOR INJ 10ML EPSIKAPRON EFF.TAB KITNOS SYRUP 20MG/ML KITNOS TABLETS 200MG KLARIBAC 250MG TAB KLARIBAC 500 MG FILM COATED TABLETS KOFFEX SYRUP FOR ADULT LACTATED RINGERS INJECTION USP 500 ML LAVENTE OINT. INFLA-BAN 75MG/3ML AMP INFLA-BAN GEL 1% INSTENON TAB INSTENON AMP INTRAGLOBIN 2. DUMOXIN SYRUP 10MG/ML DUMOXIN TAB 100 MG DUOFEDINE SYRUP EDRONAX 4MG TAB ELYZOL INFUSION 5MG/ML ELYZOL SUPP 500MG ELYZOL SUSP 25MG/ML ELYZOL TAB. TAB HIKMA HEPARIN 1000 IU/ML HIKMA HEPARIN 25000IU/ML VIAL HIKMA HEPARIN 5000 IU/ML HOMOCLOMIN TABLETS 10MG HUMAN ALBUMIN 20% +INFUSION SET HUMAN ALBUMIN 5% HYDROGEL SUSP HYOPAN SYRUP 5 MG/5 ML HYPOTEN 100 TAB HYPOTEN 50 TAB HYPYRIN TAB 400MG IMIPREX 10 MG.F 1000MG VIAL DORAL S. 10 MG. TAB 564mg LONGATIN SYRUP 25MG/5ML LONGATIN TAB 25MG LORADAY 10MG TABLET DERMATIN SOLUTION 1% DERMOSE CUSI NYSTATIN OIN.5 MG TAB HAEMOSOL CAPSULES HEALON INJ 10MG/ML HEPATECT AMP HEPSAL AMP 10 UNITS/ML HEXIDINE SOLN 1%V/V MOUTH WASH HIKMA CASCARA S.U DETRUSITOL 2MG FC TAB DEXTRAN 40 10% IN NORMAL SALINE DEXTROKUF 15MG\5ML SYRUP DEXTROSE 10% SOLUTION FOR INJ DEXTROSE 5% I. LIDAPRIM TAB LITAREX. 20 TABS.

V INFUSION 500 ML MAXIL 1500 VIAL MAXIL 750 VIAL MEDROL TAB 4 MG MENINGOCOCCAL VACCINE A&C VIAL MENOGON 75 I. 200MG/5ML SALAZOPYRIN-EN TAB 500MG SALBULASE 2MG/5ML SYRUP SAMIXON 1GM VIAL SAMIXON 500MG VIAL SERMION 10MG TAB SERMION TAB 5MG SINE-UP SYRUP SKAINAR CAPS SOD.V INFUSION SODIUM CHLORIDE 0.05% OFTALMOLOSA CUSI ERYTHROMYCIN 0.3%OINTMENT OFTALMOLOSA CUSI HYDROCORTISONE 1% OFTALMOTRIM EYE DROPS OFTHALMOLOSA CUSI CHLORAMPHEN. SUPP.45% W/V I.TAB ORAGALLIN COATED TAB ORAGALLIN COMP. SPASMOPAN 10MG TAB. STESOLID.D.V INJECTION ROXCEF 500MG I.2MG TAB MINIRIN NASAL SPRAY 0.M INJECTION ROXCEF 500MG I.CHLORIDE 0. CHLORIDE 0. REVACOD 500MG TABS REVANIN 125MG SUPP FOR INFANTS REVANIN 250MG SUPP FOR CHILDREN REVANIN 500MG TAB REVANIN SUSP 125MG/5ML RHEOMACRODEX 10% IN SALINE OR DEXTROSE RHESONATIVE 250 MCG/2ML VIAL RIABAL 30MG TAB RICHBORN CAPS RIDAZINE 100 TAB RIDAZINE 25 TAB RINGERS INJECATION 500 ML SOLUTION ROLAN 50MG\2ML AMP ROUVAX LYOPH. COATED TABS ORAGALLIN PURUM COATED 100MG TAB ORAL POLIOMYLITIS VACCINE ORVEK SYP 125MG/5ML ORVEK-250 SYRUP(250MG/5ML) PANACETAMOL 24MG/ML SYRUP PANACETAMOL 500MG TAB PARIET 10 MG E.C TAB PARIET 20MG E. STROCAIN TAB SUPRAX 100 SUSP SUPRAX 200 CAPS LORADAY 5 MG / 5 ML SYRUP LUBRIFILM EYE OINT.C. PENAMOX 250MG/5ML SUSP.45%+DEXTROSE 5% I.S 500MG TAB NAXONE 0.1MG/ML MONOPARIN 1000 U/ML INJ MONOPARIN 25000 U/ML INJ MONOPARIN 5000 U/MLINJ MULTIPARIN 1000 UNITS/ML INJ MULTIPARIN 25000 UNITS/ML INJ MULTIPARIN 5000 UNITS/ML INJ NAPROX 250MG TAB NAPROX D. SUPP. LYSTHENON SICCUM VIAL MACRODEX 6%SOL. PENTASA 500 MG SLOW RELEASE TABLET PNEUMO 23 VACCINE S.10ML INJ PREDNISOLONE TAB 5MG 30 TABS PREDONE 10MG TAB PREDONE 20MG TAB PROGRAF 5MG CAPS PROGRAF1MG CAPS PROMETIN 5MG\5ML SYRUP PROTAMINE SULPHATE INJ 1% PURINOL 100 MG PURINOL 300 MG REMIN TAB 300 MG.C MERISLON TABLETS 6MG METHAPHYLIN TAB METHYLCOPAL 500 Mcg AMPUL METHYLCOPAL 500 Mcg TABLET MIACIN 100MG/2ML AMP MIACIN 500MG/2ML AMP MICOTER 1% SOLUTION MICOTER CREAM 1% MINIDIAB 5MGTAB MINIRIN 0. 5 MG.C TAB PED-EL 20ML VIAL PENAMOX 125MG/5ML SUSP.18%+DEXTROSE 5 % INFUSION SODIUM CHLORIDE .9% + DEXTROSE 5% SODIUM CHLORIDE 0.M INJECTION ROXCEF 250MG I. STESOLID 5MG RECTAL TUBE STESOLID INJ 10 MG/2 ML STESOLID SYRUP 0.M INJECTION ROXCEF 1GM I.Registered Suppliers Index PENAMOX CAPS 250MG PENAMOX CAPS 500 MG PENTACT HIB VACCINE SD VIAL+SYRINGE PENTAGLOBIN AMP I. SOD.V INJECTION RUDIVAX RYTHINATE SUSP. F/C TAB NIDAZOLE 500MG TAB NIDAZOLE 5MG/ML INFUSION VIAL 100ML NIDAZOLE SUSP 125MG/5ML NIDAZOLE SUSP 200MG/5ML NOHIST 10MG TAB NOVAGEL PLUS SUSPENSION NOVAGEL SUSPENSION NOVAGEL TAB NUFEN 200MG TAB NUFEN 400MG TAB NUFEN 600MG TAB OFTALMOLOSA CUSI ATROPINE 1% OFTALMOLOSA CUSI DEICOL OINT 0.U LH AMPOULES MENOPUR 75 I.V INF.TAB.SYRINGE POXIDIUM TAB PRECONATIVE 500IU+WATER.V PENTASA 1% ENEMA PENTASA 1GM SACHET PENTASA 1GM SUPP.SNGLE DOSE VIAL+DILUENT SYR ROXCEF 1GM I. 13– A . STESOLID TAB.U[FSH+LH] INJ IV&S.V INFUSION SOLAXIN TAB 200MG SOMADRIL COMP.1MG TAB MINIRIN 0.U FSH & 75 I.4MG/ML INJ NEOPHYLLIN TAB 100MG NEOSAMPOON 60MG TABS NEUROVITAN TABS NIDAZOLE 250MG.1% OFTALMOLOSA CUSI DEXAMETHASONE 0.IN DEXTROSE OR NACL MALAREX SYRUP 120MG/5ML MALAREX TABLETS 250mg MALUGEL CHEWABLE TAB MANNITOL 20 % I.5% OFTALMOLOSA CUSI GENTAMYCIN 0. SPASMOPAN 20MG AMP.OINT 1% OLBETAM 250MG CAPS OPRAZOLE 20MG E.9% I. 10 MG.02MG/ML INJ 2ML NAXONE 0. 5 MG.4 MG/ML STESOLID TAB 2 MG STESOLID.V INJECTION ROXCEF 250MG I. STERILE WATER FOR INJ 500 ML STERILE WATER FOR IRRIGATION 500ML STESOLID RECTAL TUBE 10 MG.

5MG TAB SYLADOR INJ 5MG/ML SYLADOR TAB 2 MG./ML 2ML INJ.TAB ACCUZIDE 20 F.FOR INFUSION VAMIN 18 ELECTROLYTE FREE VAMIN FRUCTOSE IV.FOR INFUSION VAXIGRIP SINGLE DOSE SYRINGE 0.Registered Suppliers Index RIVO TAB 320 MG TINEA CURE PAINT 1% TINEACURE CREAM TUSSILAR TAB URISEPT 100MG TABS VIODERM CREAM 3% SUPRAX 400 CAPS SYLADOR 0. TETRA Coq VACCINE TETRACT HIB VACCINE SD VIAL+SYRINGE THEOCOLIN TABLETS 100MG TOLMICEN CREAM 1% TOTINAL SYRUP 1MG/5ML TRACTOCIL 7. CEFOBID 1GM VIAL I/M & I/V CEFOBID 2GM VIAL I/M & I/V CEFZIL 125MG/5ML SUSP CEFZIL 250MG TAB CEFZIL 250MG/5ML SUSP CEFZIL 500MG TAB CETAVLEX CREAM 0.SYRIN UBRETID 0. TAKEPRON 15MG CAP. SOLN VAMIN GLUCOSE PARENTRAL SOLN VAMIN-N SOLN. CAP 500 MG. SYLADOR TAB.5MG TAB COSOPT EYE DROPS COVERSYL 2MG TAB COVERSYL 4MG TAB COZAAR 100MG FILM COATED TABLET COZAAR 50MG TAB DACRINE EYE DROPS DAFLON 500MG TAB DAFLON TAB.5%W/W CLINORIL TAB 200MG COGENTIN 2MG/2ML AMP COGENTIN TAB 2MG COMBANTRIN 250MG TAB CO-RENITEC 20/12.25MG\ML I.TAB ACUITEL 10MG TAB ACUITEL 20MG TAB ADRENALINE HCL SOLN 1:1000 INJ AGGRASTAT 0.5ML VIFOLIN TAB 5 MG VIROMIDIN EYE DROPS 1% VOTREX 100MG SUPP VOTREX 25 TAB VOTREX 50 TAB VOTREX 50MG SUPP VOTREX 75MG/3ML AMP WESORBIDE 10MG TAB WESORBIDE 2.5MG AMP UBRETID 5MG TAB ULSAHEAL 1000 SUSP (1000MG/5ML) ULSAHEAL TAB 1G ULTRACLOXAM 500MG VIAL ULTRADERM CREAM ULTRADERM OINTMENT ULTRAMOX 125MG/5ML ORAL SUSP ULTRAMOX CAPS 250MG ULTRAMOX FORTE 250MG/5ML SUSP. V-2 CAPS V-2 PLUS CAPS VAMIN 14 ELECTROLYTE FREE VAMIN 14 SOLN.5MG/ML 4ML BURINEX AMP 0. 250 MG. OCUM DECADRON 4 MG. CAP.U INJ. ULTRASPORIN.5MG SUBLINGUAL TAB WESORBIDE 20MG TAB WESORBIDE 5MG S/L TAB ZAVEDOS 10MG VIAL ZAVEDOS 5MG VIAL ZENOS AMP 4MG/ML ‫ا‬ +966 (01) 2415320: +966 (01) 2415071: ACCOLATE 20 MG F.C.5MG/5ML BENAFED SYRUP BENYLIN PAEDIATRIC SUGAR&COLOR FREE SYRU BENYLIN SYRUP BI PRETERAX TAB BURINEX AMP 0.5MG/ML VIAL TRAMADONE 50MG/ML(100MG/2ML) AMPOULE TRIFED SYRUP TRIFED TAB TYPHM VI CAPSULAR POLYSACCHRIDE SD.1% E/E SOL. ATTENUVAX VIAL+DILUENT BACACIL 400MG TAB BENADRYL ELIXIR 12. ULTRASPORIN SUSPN. TAKEPRON 30MG CAPS TEKAM 10MG/ML 10ML VIAL TEKAM 50MG/ML 10ML VIAL TETAVAX 40 I. 5 MG. ULTRAMOX FORTE CAPS 500MG ULTRASPORIN 250MG/5ML FORTE SUSP. 150 MG DAIVONEX CREAM 50MCG/G DAIVONEX OINT. CARDURA 4MG TAB.25MG/ML 2ML BURINEX TABLETS 1 MG BURINEX-K TAB CANCIDAS 50 MG VIAL CANCIDAS 70 MG VIAL CARDURA 1MG TAB CARDURA 2MG TAB. 125 MG. 50MCG/G DECADRON 0. ULTRASPORIN.C. ‫ھ‬ _______________________________ ‫ا ر‬ ALGIBAUME CREAM ANALLERGE 4 MG TAB CEVILENE DROPS CHEMOTRIM TABS CITRO-MAG EFFERVESCENT GRANULES COLIFURAN TAB 100MG COLMEDITEN TAB FLAGICURE TABS 250MG FLATIDYL 40MG CHEWABLE TAB PRISOLINE EYE/NASAL DROPS ‫ا ؤ‬ _______________________________ 14– A .V VIAL ALDOMET 250 MG TAB ALDOMET 250MG/5ML INJ AMLOR CAPS 5MG ANUGESIC HC SUPP ANUSOL HC OINTMENT ANUSOL HC SUPP ANUSOL OINTMENT ANUSOL SUPP ARAMINE INJECTION 1% ARCOXIA 120MG TAB ARCOXIA 60MG TAB ARCOXIA 90MG TAB ARIMIDEX 1MG TAB ATROMID-S CAPSULES 500 MG. FORTE.

TAXOL 6 MG\ ML VIAL TEMPRA DROPS 100MG/ML TEMPRA SYRUP 160MG/5ML DECADRON E/E SOL 0.V INFUSION 500MG VIAL FUCIDIN INTER TULLE 2% FUCIDIN OINT 2% FUCIDIN ORAL SUSP 50MG/ML FUCIDIN TAB 250 MG FUCITHALMIC VISCOUS EYE DROPS FULCIN 125 MG TAB FULCIN SYRUP 125MG/5 ML.E/E SOLUTION DECADRON SHOCK PACK 20 MG/ML 5ML VIAL DECADRON TAB 0. MEGACE CAP 40 MG MERONEM 1GM VIAL I/V MERONEM 500MG VIAL I/V MERUVAX II S.M 250MG PARENTRAL AMP EUDYNA CREAM 0. INDOCID 100 MG.R TAB NATRILLIX 2. CREAM 0.05% FASIGYN TAB 500MG FELDENE 20MG SUPPOSITORY FER-IN-SOL DROPS 15MG/0.7ML DILUENT 15– A .0 MICROGM.M.25 MICROGM ONE-ALPHA DROPS 2MICROGRAM/ML ONE-ALPHA SOLN 0. SUPP INDOCID 25 MG.VIAL+DILUENT MIGON MELT 10MG WAFER MIGON 10MG TAB MIGON 5 MG TAB MINIPRESS TAB 1MG MINIPRESS TAB 2MG MINIPRESS TAB 5MG MODURETIC-50MG TAB. CAPS. HYZAAR (50MG/12. INDERAL TABLETS 40 MG. HB-VAX DNA 10MCG/ML VIAL I/M HB-VAX DNA 5MCG/0.5 MG S.1% DECADRON NEO TOP. NIF-TEN CAPS NITROSTAT 0.TAB M.V 20MG VIAL PERIACTIN 2MG/5ML SYRUP PERIACTIN 4 MG TAB PITRESSIN TANNATE IN OIL 5 UNIT/ML POLY-VI-SOL ORAL DROPS PONDOCILLIN 500MG TAB PONSTAN FORTE 500MG F. INDERAL TABLETS 80 MG. CREAM 1% HICONCIL 250MG CAP HICONCIL 500MG CAP HICONCIL POWDER 125/5 ML HICONCIL POWDER 250 MG /5 ML HYPERIUM 1MG TAB.C TAB LIPITOR 40 MG FILM COATED TABLETS LOPID 600MG F.D. ONE-ALPHA 2MCG/ML AMP.5MG COATED TABLET.Registered Suppliers Index MEFOXIN INJ 100MG/ML(1 GM) MEFOXIN INJ 2GM MEGACE CAP 20MG.5MG) F.5ML VACCINE+ 0. CAPSULES INNOHEP 10000 ANTI-XA IU/ML SYRING INNOHEP 10000 ANTI-XA IU/ML VIAL INNOHEP 20000 ANTI-XA IU/ML SYRING INNOHEP 20000 ANTI-XA IU/ML VIAL INVANZ 1GM VIAL KETRAX SYR 40MG/5ML KETRAX TAB 40MG LIPITOR 10MG F. TAB NEURONTIN 100MG CAPS NEURONTIN 300MG CAPS NEURONTIN 400MG CAPS NEUROTRAT FORTE TAB.6ML (ELEMENTAL I FORTZAAR FILM COATED TABLET FOSAMAX 10MG TAB FOSAMAX ONCE WEEKLY 70MG TAB FUCICORT CREAM FUCIDIN CREAM 2% FUCIDIN 2% GEL FUCIDIN H CREAM FUCIDIN I. FULCIN TABLETS 500 MG.5MG DECADRON WITH NEOMYCIN E/E DROPS DELTACORTRIL 5MG TAB DIABINESE TAB 250 MG DIAMICRON MR TABLET (30MG DIAMICRON TAB 80MG DIFLUCAN 150MG CAPS DIFLUCAN 200MG CAPS DIFLUCAN 50MG CAPS DILZEM 60MG TAB DILZEM RETARD 90MG TAB DIPRIVAN VIAL 10MG/ML DOLOBID 500MG TAB DOLOBID TABS 250 MG ENO-EFFERVESCENT SALT EPANUTIN SUSP 30MG/5ML EPANUTIN 100MG CAPS EPANUTIN R.1% DECADRON NEO. GLIBENESE TABLETS 5 MG.5 MG.C TAB PONSTAN SYRUP 50MG/5ML PRETERAX TABLET PROPECIA 1 MG FILM COATED TABLETS PROSCAR 5MG TAB PROTAMINE SULFATE 10MG/ML VIAL 5ML QUESTRAN POWDER 4G/9G SACHET QUIBRON-T SR 300MG DIVITAB RENITEC TAB 10MG RENITEC TAB 20MG RENITEC TAB 5MG SELEXID 400MG VIAL+SOLVENT SELEXID TAB 200MG SEROQUEL STARTER PACK 10 TABLETS SEROQUEL 100 MG TAB SEROQUEL 200 MG TAB SEROQUEL 25 MG TAB SINEMET-110 TAB SINEMET-275 TAB SINEMET-PLUS SINGULAIR 10MG F.C TAB LIPITOR 20MG F.2MICROGM/ML OX-HEP LEO 1000 IU/ML INJ OX-HEP LEO 25000 I. MUCOMYST SACHET MUMPSVAX & DILUENT VIAL MYSOLINE SYRUP MYSOLINE TAB 250TAB NATRILLIX 1.R II 0.C TAB IMPERACINE 250MG TAB INDERAL AMPULES 1MG/ML INDERAL TABLETS 10 MG.05% EUDYNA GEL 0.C. SINGULAIR 5MG CHEWABLE TAB SINGULAIR PAEDIATRIC 4 MG CHEWABLE TAB STABLON 12.U/ML INJ OX-HEP LEO 5000 IU/ML INJ PENTREXYL PARENTRAL 250MG VIAL PENTREXYL PARENTRAL 500MG VIAL PENTREXYL VIAL 1G PEPCIDIN 20MG TAB PEPCIDIN 40MG TAB PEPCIDIN I.5ML HIBISCRUB SOLUTION 4% W/V HIBITANE LOZENGES HIBITANE OBESTET.C/TAB. INDOCID RETARD 75 MG.6 MG TAB NOLVADEX 10 MG TABs NOLVADEX-D TAB 20MG NOROXIN 400MG TAB ONE-ALPHA CAPS 1. ONE-ALPHA CAPS 0.

5% OPTH. AMOXYDAR 125MG/5ML SUSP AMOXYDAR 250 MG/5ML SUSP AMOXYDAR CAPSULES 250 MG AMOXYDAR CAPSULES 500 MG AMURETIC 5MG/50MG TAB APUROL 100MG TAB BLEOCIN 15MG AMP BRONEX ORAL DROPS BUTOVENT 100MCG SPRAY PUFF INHALER CAPOCARD 25MG TAB CAPOCARD 50MG TAB CARBATOL 200MG TAB CEPHADAR 250MG/5ML.2 GM/5ML SYRUP IBUGESIC 100MG/5ML SUSP IBUGESIC 200MG TAB INDOGESIC CAP 25MG ISORDIL 10 MG.LOMEXIN (LOMEXIN) 2% SPRAY DERMA-LOMEXIN (LOMEXIN) 2% CREAM DERMESONE SKIN OINTMENT 0.39 G SACHET DADCROME 2% EYE DROPS DERMA . VIBRAMYCIN TAB 100MG VIOXX 12.AFTER RECONSTIT ZITHROMAX 250MG CAPS ZITHROMAX 500 MG POWDER FOR IV INFUSION ZOCOR 10MG TAB ZOCOR 20MG TAB ZOCOR 40MG TAB ZOLADEX DEPOT 3.V.M.LOMEXIN (LOMEXIN) 2% VAGINAL CREAM GYNO-LOMEXIN (LOMEXIN) 200MG VAGINA SUPP GYNO-LOMEXIN 600MG VAG. 250MG FAMODAR 20MG TAB FAMODAR 40MG TAB GENURIN 100MG TAB GENURIN FORT 200MGTAB GERIATON FORTE CAP GYNO.25% OPTH.S 540MG/5ML SUSP ACICONE . TAB. CEPHADAR CAPSULES 500 MG.SUSP CEPHADAR 125MG/5 ML SUSP CEPHADAR CAPSULES 250MG .1% DIBEKACIN MEIJI INJ 100 MG DIBEKACIN MEIJI INJ 50 MG.5MG TAB LASTET 100MG AMP FOR INFUSION TENORETIC TAB TENORMIN INJ 500MCG/ML TENORMIN TAB 100MG TENORMIN TAB 50MG TERRACORTIL E/E OINTMENT TERRACORTIL E/E SUSP TERRAMYCIN CAPS 250MG TERRAMYCIN EYE OINT 1% TERRAMYCIN TOPICAL OINT TETMASOL SOAP TIENAM 500 MG VIAL I. TABLETS ISORDIL SUBLINGUAL 5 MG.5MG SUPPOSITORY DICLOGESIC 25MG TAB DICLOGESIC 50MG E.05% VIVALAN TAB 50MG ZARONTIN CAP 250MG ZARONTIN SYR 250MG/5ML ZERIT 20MG CAP ZERIT 30MG CAP ZERIT 40MG CAP ZESTORETIC 20 TAB ZESTRIL 10MG TAB ZESTRIL 20MG TAB ZESTRIL 5MG TAB ZITHROMAX 200MG/5ML SUSP.DROPS TOTACEF 1GM VIAL+DILUENT AMP TOTACEF 500MG VIAL+DILUENT AMP TRIVASTAL RETARD 50MG TAB TRUSOPT 2% OPTH.S 720 MG CHEWABLE TAB ACICONE 540MG/5ML SUSP ACICONE 720 MG CHEWABLE TAB ADVIL 200MG TAB ‫ا‬ ‫ھ‬ _______________________________ 16– A .C TAB DICLOGESIC 50MG SUPPOSITORY DICLOGESIC 75MG/3ML AMP DICLOGESIC RETARD 100 MG TABLET DICLOGESIC RETARD 100MG CAPS DIMETAPP ELIXIR ALCOHOL FREE DINTOINA TAB 100MG DOPRAM VIALS 20MG/ML DOXYDAR CAP 100MG EFEXOR 37.C TAB VIAGRA 50MG F.SUPPOSITORY HAIRGROW 2% SOLUTION HI-CAL 1. TIMOPTOL 0. SOLN TRYPTIZOL 10MG TAB TRYPTIZOL 10MG/5ML SYRUP TRYPTIZOL 25 MG TAB TRYPTIZOL 50MG TAB ULTRACEF 250MG PWD.DROPS TIMOPTOL 0.5MG TAB EFEXOR 50MG TAB EFEXOR 75MG TAB ERYTHRODAR 400MG FORT TAB ERYTHRODAR SUSP 200MG/5ML ERYTHRODAR TAB.FOR SUSP ULTRACEF 500MG CAPS ULTRACEF 500MG/5ML SUSP ULTRACEF TAB 1G UNASYN 1000:500MG VIAL UNASYN 2000:1000MG VIAL UNASYN 500:250MG VIAL VAQTA 25U SYRINGE I.5MG TAB VIOXX 25MG TAB VIOXXACUTE 50 MG TABLETS VISINE EYE DROPS 0. VAQTA VACCINE 50 U VIAL VASTAREL 20MG TAB VEPESID 100MG CAPS VEPESID 100MG\5ML AMP VEPESID AMP 100MG/5ML FOR INFUSION VIAGRA 25MG F.6MG S/C INJ SYRINGE ‫اط‬ +966 (01) 2172181: +966 (01) 2172183: ACICONE .Registered Suppliers Index ADVIL COLD AND SINUS CAPLET AGIOCUR GRANULES AGIOLAX GRANULES AMBOLAR 15 MG/5 ML SYRUP.C TAB VIBRAMYCIN SYRUP 10 MG/ML VIBRAMYCIN CAP 100 MG. DICLOGESIC 1% GEL DICLOGESIC 100MG SUPPOSITORIES DICLOGESIC 12. CHILDRENS ADVIL 100MG\5ML SUSPENTION CIMEDINE TAB 200MG CIMEDINE TAB 400MG CIPRODAR 250MG TAB CIPRODAR 500MG TAB CLENIL FORTE 250MCG PUFF METERED INHALER CLORACEF 125MG/5ML SUSP CLORACEF 250MG CAPSULE CLORACEF 250MG/5ML SUSP CLORACEF FORTE 500MG CAPSULE COLOPATHIL3. KESELAN 1.

SOLN.5 GM TAB BLOKIUM TAB 100MG CITIUS TAB 200MG COLESTERINEX TAB. 200 MG.2% OPTHALMIC SOLUTION BETAGAN 0. APO-NAPROXEN 500MG/TAB APO-RANITIDINE 150MG F.C. LIDOCATON 2% 1:100. SUSP PREDMYCIN-P EYE DROPS PREFRIN -A EYE DROPS PROPINE EYE DROPS 0.5% LIQUIFILM OPTH. FML OPTH. TESPAMIN 5MG INJ TETRADAR 250 MG CAP THEO-DUR TAB 200MG THEO-DUR TAB 300MG TRIMIDAR TAB 100MG URALYT-U GRANULES VALONTAN TAB 100MG VIKADAR FORTE TAB 1000000 I.8)ML MICONAZ 2% CREAM MICONAZ 2% POWDER MYCOHEAL 2% ORAL GEL MYCOHEAL 200MG VAGINAL SUPPOSITORY MYCOHEAL 400MG VAGINAL SUPPOSITORIES MYCOHEAL HC CREAM MYCOHEAL VAGINAL CREAM 2% MYOGESIC TAB.TAB.C. SANSILLA GARGLE ‫ھ‬ _______________________________ ‫.03% OFLOX 0.5% EYE DROPS CELLUVISC 1% EYE DROPS CHLOROPTIC OPTH. PROCTOHEAL SUPPOSITORY PROLIXAN 300MG CAPS REMEFLIN 8 MG/PEARL REMEFLIN 8 MG/VIAL 3 ML. SUSP PREDMILD OPTH. REPARIL 20MG TAB REPARIL AMP 5MG REPARIL GEL N RHINOSTOP ORAL DROPS RINO-CLENIL 50MCG/PUFF NASAL SPRAY SOLU. SUSP 0.U VIAL STREPTAS 750000I. 1. PREMARIN VAG CREAM 0.C.000 CARTRIDGES LIDOCATON 2% 1:80.ان _ ا ر‬ ELDOPAQUE 2% CREAM ELDOPAQUE FORTE 4% CREAM .1% REFRESH EYE DROPS REFRESH P. STREPTAS 250000I.EYE OINT.Registered Suppliers Index AFIMOCIL 0.‫آي‬ _______________________________ ‫رة‬ ACIDO NALIDIXICO 500 MG TAB ACIDO NALIDIXICO SUSP.125MG/5ML ‫أز‬ _______________________________ 17– A .M.25% EYE DROPS OPHTAMOLOL 0.U VIAL ‫وم‬ +966 (01) 2766775: +966 (01) 4065050: ACULAR 0. APO-RANITIDINE 300MG F.SOLN 0.5% EYE DROPS OS-CAL TAB 500MG PAINSTOP 20MG/ML AMPOULE PAM INJ 500MG PREMARIN 0.25 MG. 250 MG METAGLIZ 10 MG TAB METAGLIZ 10MG/5ML SOLUTION PERGASTRIC SEDANTE TAB PIRACETAM CAPS 400MG SKILAX DROPS TRES-ORIX SOLUTION TRES-ORIX FORTE CAP URTIUM SUSP URTIUM TAB LAXOLAC SYRUP LEGALON 35MG TAB LEGALON 70 MG TAB.3% EYE DROPS PREDFORTE OPTH.R 100MG TAB APO-DILTAZ 30MG TAB APO-DILTAZ 60MG TAB APO-DOXY 100MG CAPS APO-GLYBURIDE 5MG TAB APO-NAPROXEN 250MG/TAB.TAB APO-DICLO S.U VIKADAR SUSP 200000 IU/5ML VIKADAR TAB 500000 I.6ML CHILD) FML LIQUIFILM 0.C. NAZOLIN NASAL DROPS NIFECARD 10 CAPS OMEDAR 20MG TAB OPHTAMOLOL 0.SOLN ALBALON EYE DROPS 0.625MG PROCTOHEAL OINT.TAB.1% FML NEO LIQUIFILM OPH.TAB APO-DICLO 50MG E.5% OPTH.5% CONJUNCTIN OPTH.000 CARTRIDGES MEDEMYCIN CAPS.1% LACRI-LUBE EYE OINT LIQUIFILM TEARS OCUFEN LIQUIFILM 0. MELBIN 250MG TAB MEPICATON 3% CARTRIDGES (1.1% ALPHAGAN 0.DROPS EUCARBON TAB FLEET ENEMA(133ML ADULT &66.625MG TAB PREMARIN TAB. ROBAXIN INJECTION 10 ML 1GM/AMP ROBAXIN TABLETS 500 MG ROBAXISAL TAB ROBITUSSIN CF SYRUP ROBITUSSIN SYRUP ROBITUSSIN-DM SYRUP ROBITUSSIN-PE SYRUP ROXAMED 150 MG TAB SMOODERM CREAM SORBIT 5 G POWDER PACKET SPASMO-URGENIN TAB SUCRAZIDE 5MG TAB TAMOPLEX 10MG/TAB. BLEPHAMIDE EYE DROPS BOTOX 100UNITS CELLUFRESH(REFRESH PLUS .U ‫ر ا ز رة‬ _______________________________ APO-AMILZIDE 50/5 MG TAB APO-ATENOL 100MG TAB APO-ATENOL 50MG TAB APO-DICLO 25MG E.SOLN.

45% INJ DEXTROSE 40% INJ.SOLUTION 36% ALBOTHYL VAGINAL OVULE 90MG ALFACORT 1% CREAM ALFACORT 1% OINTMENT _______________________________ 18– A .Registered Suppliers Index ALUPENT SYRUP 10MG/5ML ALVEOFACT 50MG/1.CHLORIDE 0. DURADOX 100 MG CAPS EFFORTIL 5MG TAB EFFORTIL DROP 7.V VIAL ENOXIRT 500MG I. SOD.9% FOR IRRIGATION SOD.2MG/DOSE BETASONE 0.5MG/ML.CHLORIDE 0.9% SOD.25%DEXTROSE SOD.C TAB DIAZEPAM TAB 2 MG DIAZEPAM TAB 5 MG DIZINIL 50MG TAB DOBUTAMINE HCL 250MG/20ML VIAL DOLGIT CREAM 50MG/G DOPAMINE HCL 200MG/5ML AMP DULCOLAX 5MG ENTERIC COATED TAB.5% INJ.CHLORIDE 0.M VIAL ‫ت‬ ‫زا‬ ‫وم‬ ‫ھ‬ +966 (01) 4055862: +966 (01) 4035725: _______________________________ DEXTRAN-70 IN 0.1% BEROTEC SPRAY 0.M VIAL ENOXIRT 1GM I. CISPLATIN 1MG/1ML VIAL CLAMYCIN 250 MG TABLET CLAMYCIN 500 MG TAB CLOFEN 25 TAB CLOFEN 50 TAB CLOFEN 75MG INJECTION CLOFEN CREAMAGEL 1% CODAPHED SYRUP CYNOVIT 1MG/1ML I.25GM I.45% INJ.V.03% NASAL SPRAY WITHSPRAYPUMP AZOMYCIN 200MG\5ML SUSP.CHLORIDE 0.CT TROPHAMINE 6%(AMINO ACID)INJ. AZOMYCIN 250MG CAP.M.9% NACL DEXTROSE 10%+SOD. GLYCINE 1.25GM I.1% CREAM BETASONE 0.2ML VIAL AMIKACIN 500MG/2ML INJ VIAL (I.CHLORIDE 0. ENOXIRT 0.CHLORIDE INJ DEXTROSE 5%+SOD.V VIAL ENOXIRT 1GM I.02MG/METERED DOSE INHALER ATROVENT 0. DEXTROSE 5% INJ DEXTROSE 5%+0.IM) AMYDRAMINE EXPECTORANT SYRUP AMYDRAMINE II SUGAR FREE SYRUP AMYDRAMINE PAEDIATRIC SYRUP ANZATAX 6MG/ML VIAL ASMAFORT 1MG\5ML SYRUP ASMAFORT 1MGTAB ATRACURIUM BESYLATE 10MG/ML AMP ATROVENT 0.5% UROLOGICAL IRRIGATION HEPATAMINE INJ 8% LACTATED RINGERS INJ MANNITOL 20% INJ PERITONEAL DIALYSIS SOLN W/4. CEFUZIME 500 MG TAB CETRALON 10 MG TAB CETRALON 5MG/5ML SYRUP CHLOROHISTOL SYP.IN ACCUMED PS.V 500MG/20ML VIAL DBL CYTARABINE 100MG/5ML VIAL DEXIPAN 5% CREAM DIALON 500 MG F.M VIAL ENOXIRT 0. 2 MG / 5 ML CHLOROHISTOL TAB 4 MG.9% INJ SORBITOL IRRIGATION 3. BECOVIT TABLET BECOVIT SYRUP BEROTEC SOLUTION FOR INHALATION 0. ‫ــ م وز ر‬ _______________________________ AXE BRAND UNIVERSAL OIL BEKUNIS TABLET DUBAM SPRAY GOLD MEDAL MEDICATED OIL ‫ر‬ ‫ا‬ ‫ھ‬ +966 (01) 2415188: +966 (01) 2410365: 3V TABLETS ACTILYSE SET(2VLS+2SOLV&INFSET) ADOL 125 MG RECTAL SUPPOSITORIES ADOL 160 MG CHEWABLE TAB ADOL 250 MG RECTAL SUUPPOSITORIES ADOL 500 MG RECTAL SUPPOSITORIES ADOL 500MG CAPLET ADOL ALLERGY SINUS 325MG/2MG/30MG CAPLET ADOL COLD 325MG/30MG/15MG CAPLET ADOL DROPS 100MG/ML ADOL EXTRA CAPLETS ADOL PM 325MG/25MG CAPLET ADOL SINUS 325MG/30MG CAPLET ADOL SYRUP 120MG/5ML AIROMIR INHALER 100MCG/ACTUATION ALBENDA 100MG\5ML SUSP ALBENDA 200 MG TAB ALBOTHYL CONC. INJECTION CYTARABINE 100MG/1ML VIAL DBL ACYCLOVIR 250MG/10ML VIAL DBL ACYCLOVIR I.45% INJ DEXTROSE INJ 10% DEXTROSE INJ 20% DEXTROSE INJ 50% DEXTROSE5%+LACTATED RINGER INJ FREAMINE III 8.20% INJ DEXTROSE 5%+SOD.CHLORIDE 0.1% OINTMENT BETASONE 500MCG TAB BISOLVON 8MG TABLETS BISOLVON ELIXIR 4MG/5ML BISOLVON SOLUTION 2MG/ML BISOLVON TABLETS 4MG BRONCHOLASE SYP BUSCOPAN 20 MG/ML AMP BUSCOPAN TABLETS 10MG BUTALIN SYRUP 2MG/5ML BUTALIN TABS 2MG BUTALIN TABS 4MG CARBOPLATIN 10MG/ML VIAL CATAPRES TABLETS 150MCG CEFRIN 125MG/5ML SUSP CEFRIN 250MG CAPS CEFRIN 250MG/5ML SUSP CEFRIN 500MG CAPS CEFUZIME 125 MG TAB CEFUZIME 250MG TAB.3% IN PLASTIC BAG STERILE WATER FOR INJ STERILE WATER FOR IRRIG.

JULPHAMOX 500MG CAPSULES JUSPRIN 300MG ENTERIC COATED TABLETS JUSPRIN 500MG ENTERIC COATED TABLETS JUSPRIN 81MG ENTERIC COATED TABLETS KAPTIN SUSP KDIRON 200MG\5ML SYRUP KDIRON DROPS LANETAL POWDER LANFAST 30MG CAPSULE LAXOBERAL 7.C TAB PANTOZOL 40MG TAB PARAZOLE 100MG TABLET PERGONAL 75 IU/ AMPOUL PERSANTIN TABLETS 75MG PHENYTOIN 100MG/2ML AMP PHENYTOIN 250MG/5ML AMP PIRAFENE SYRUP 2MG/5ML PIRAFENE TAB 4MG POTENCORT 0.5ML IM AMP MOBIC 7.5MG POWDER FOR SUSP JULPHAMOX 100MG\ML DROPS JULPHAMOX 125MG SUSP. JULMENTIN 625 MG TAB JULMENTIN FORTE 312.5MG JULMENTIN 1.1% EYE DROP IBUTOP 5% GEL IMUKIN 100MCG/0.MITE C.SUCCI. JULPHAMOX 250MG CAPSULE JULPHAMOX 250MG SUSP.25 MG POWDER FOR SUSP JULMENTIN 375 MG TAB JULMENTIN 600MG INJ.C TAB HISTALOC 5MG/5ML SYRUP HISTOL 15MG/5ML SYRUP. HISTALOC 10MG F.V EUPHYLLINE RETARD C. HOLOPON TAB 1MG HYLO-COMOD 0.FOR I.U.05% CREAM PREMOSAN 10MG INJECTION ENOXIRT 500MG I.OVULE GYNO-MIKOZAL 400MG VAG.V OR I.24GM/10ML I.1% GINSAVIT CAPS GLYCERYL TRINITRATE 50MG/10ML I/V AMP GONAL .5ML VIAL INTARD TABS.TAB 350MG EUPHYLLINE RTD.1GM VIAL METRODIN AMP 75 I.005% OINTMENT POTENCORT 0.V VIAL EROMYCIN 200MG/5ML SUSP EROMYCIN 250MG TABLET ERYTHROMYCIN LACTOBIONATE 1G I.V.05% NEGACEF 0.5MG TAB MOXAL PLUS 200MG CHEWABLE TAB MOXAL PLUS SUSPENTION MOXAL SUSP MOXAL SUSP SACHET (10ML) MOXAL TAB MUCOLYTE SYRUP MUCOSOLVAN LIQUID 15MG/5ML MUCOSOLVAN TAB 30MG NALIDRAM TAB NALOXONE HCL 400MCG/ML AMP NALOXONE HCL 40MCG/2ML AMP NARAPRIL 10MG TABLET NARAPRIL 20MG TABLET NARAPRIL 5MG TABLET NASIVIN DROPS 0.05% GAMAVATE OINTMENT 0. NEGAZOLE 500MG TAB.05% GASTROZEPIN 25MG TAB GENTAL SKIN OINT 0.5Mg/Ml DROPS LAXOCODYL 10MG SUPP LAXOCODYL 5 MG TABLET LAXOCODYL 5MG SUPP LAXOLYNE SUPP FOR CHILDREN LAXOLYNE SUPPOSITORIES LEUCOVORIN CALCIUM 15MG/2ML VIAL LEUCOVORIN CALCIUM 50MG/5ML VIAL LEUCOVORINE CALCIUM 3 MG/ML AMP 19– A .Registered Suppliers Index LIDOCAINE 5 % OINTMENT LOJOUR 5MG\5ML SYRUP LOMAX 400MG TAB LOPODIUM 2MG CAPS LOVRAK 5% CREAM (10 GM TUBE) LOVRAK 5% 10GM OINTMENT LOVRAK 800MG TABLET LYNAMINE TAB 20MG MELADININE PAINT MELADININE TAB METALYSE 10000 U I.5 MG SUPPOSITORY MOBIC 7. JULMENTIN 156. NEO MELADININE F.M METHOTREXATE 25MG/1ML VIAL METHYLENE BLUE 1%(50MG/5ML) AMP METHYLPREDNISOLON SOD.SUCCINAT500MG VIAL METHYLPREDNISOLONE SOD. NEGACEF 1GM VIAL NEGAZOLE 250MG TAB.F 150 IU AMPOULE GONAL .OVULE GYNO-MIKOZAL CREAM 78 GM HALOPERIDOL 50MG INJ. MICARDIS 40 MG TAB MICARDIS 80 MG TAB MIKACIN 100MG/2ML INJ.VIAL ESKACEF CAPS 250MG ESKACEF CAPS 500MG ESKACEF SUSP 125MG/5ML ESKACEF SUSP 250MG/5ML EUPHYLLIN AMP 0. MIKACIN 500MG/2 ML AMP MIKOSTAT 100000 U OINTMENT MIKOSTAT 100000U CREAM MIKOSTAT 100000U\ML ORAL SUSP MIKOZAL 2% CREAM MIXAVIT DROPS 15ML MIXAVIT SYRUP MIXAVIT TAB MIXAVIT-M TAB MOBIC 15MG SUPPOSITORIES MOBIC 15MG TAB MOBIC 15MG\1.5MG INJ.TAB 175MG FERROUS GLUCONATE 300MG TAB FITZCALM 200MG TAB FITZECALM 100MG\5ML SUSP FLUOROURACIL 250MG/10ML VIAL FLUOROURACIL 500MG/10ML VIAL FLUPHENAZINE DECANOATE OILY 100MG/ML AMP FLUPHENAZINE DECANOATE OILY 25MG/ML AMP FOLICUM 1 MG TABLETS FOLICUM 5MG TAB FRODAC 750MG CAPLET FUTASOLE 2% OINTMENT FUTASOLE 2%CREAM GAMAVATE CREAM 0.+SOLVENT METRODIN HP 75 IU/AMPOULE MEXITIL 250MG/10ML AMP.R TAB 10MG ORCINOL SYRUP OXYTETRACYCLINE OINT 3% PANCURONIUM 4MG/2ML AMP PANDERM CREAM PANDERM OINT PANTOZOL 20MG E.2GM INJ.V VIAL METHOTREXATE 1G/10ML INJ. 2.025% NASIVIN DROPS 0.F 75 IU AMPOULE GUPISONE TAB 5MG GYNO-MIKOZAL 200MG VAG.

LACTATE INJ CONVULEX 150MG CAPS CONVULEX 500MG CAPS CONVULEX 50MG/ML SYRUP DEXTROSE 10%+SOD.1% NASAL SPRAY XYLOLIN 0.U.CHLORIDE 0.5MG TAB SIFROL 0. SCOPINAL 20MG AMPOULE SCOPINAL 5MG/5ML SYRUP SCOPINAL TAB 10MG SEDOFAN SYRUP.Registered Suppliers Index UROXIN 400MG TAB VALOPIN 200MG\5ML SYRUP VANCOLON 0.45% INJ DEXTROSE 5%+SOD.+SOLVENT PROFINAL 200MG TAB PROFINAL 5% GEL PROFINAL 600MG TAB PROFINAL SUSP 100MG/5ML PROFINAL TABS.V INFUSION SOLN AMINOPLASMAL 10% I.U+SOLVENT PROFASI AMP 5000 I.5% GYNO .CANDIZOL 200 MG VAGINAL OVULES GYNO . 400 MG.05% RISEK 10MG CAP. TRIMOL TAB ‫ر ا ور دات و ا د ت ا ط‬ (‫) دي رف‬ +966 (01) 4616999: +966 (01) 4611118: ‫ھ‬ _______________________________ AMINOPLASMAL 15 % I.C TAB REBIF 22 MCG PRE-FILLED SYRINGE REBIF 44 MCG PRE-FILLED SYRINGE RECOCEF 125 MG/5ML ORAL SUSPENSION RECOCEF 250 MG/5ML ORAL SUSPENSION RECOCEF 250MG CAP RECOCEF 500MG CAP RHINASPRAY CHILD 0.M/ I.9% INJ DEXTROSE 5% INJ DEXTROSE 5%+SOD.1% ADULT NASAL SPRAY PREMOSAN ORAL DROPS 4MG/ML PREMOSAN SYRUP 5MG/5ML PREMOSAN TABS 10MG PRIMOCEF 0.V.SOD.7 MG TAB SILOMAT 20 MG/5ML SYRUP SIMVAST 10MG TAB SIMVAST 20MG TAB SOD.CANDIZOLE 400 MG VAGINAL OVULES HEPARIN SOD(BOVINE) 5000 I.5GM/VIAL I. SEDOFAN TAB SEDOFAN-P 15MG\5ML SYRUP SEROCRYPTIN 2. VANCOMYCIN HCL 1 G VIAL FOR INFUSION VANCOMYCIN HCL 500MG VIAL FOR INFUSION VC CHEWABLE TAB 500MG VINBLASTINE SULPHATE 10MG/10ML VIAL VINCRISTIN SULPH. RUBICALM CREAM SAIZEN 4IU VIAL SALINAL 41.9% INJ DEXTROSE 50% INJ DEXTROSE INJ 10% DEXTROSE INJ 40% DIAPHAGE 500 MG TAB DICLOFEN 1% CREMOGEL DORYX CAPS 100MG DROXIL 500MG CAPS ERYC 250MG CAPS GLIBEMIDE 5 MG TAB GLYCINE IRRIGATION 1.+SOLVENT PROFASI AMP 500 I.05% CREAM COMP.CHLORIDE 0.05%CHILD NASAL SPRAY XYLOLIN 0. A +D ORAL DROPS VIT.2MG/ML ORAL DROPS SALINAL 42MG CHEWABLE TAB SALURIN 40 MG TABLETS SALURIN 5MG\5ML SYRUP SARF 250MG TAB SARF 500MG TAB SARF 750MG TAB.5 GM I. PURGATON TAB 20MG PYRIDOXIN TAB 40MG RANTAG 150MG TAB RANTAG 300MG TAB RANTAG 50MG AMP.CHLORIDE 0.M VIAL PRIMOCEF 1 GM I. TAB ONKOVERTIN_40 IN N.5% EYE DROP TOBRAMYCIN 20MG/2ML VIAL TOBRAMYCIN 80MG/2ML VIAL TRIMOL SUSP.V INFUSION AMINOPLASMAL L-10WITHOUT CARBOHYDRAT INJ AMINOPLASMAL L-5 WITHOUT CARBOHYDRAT INJ AMINOPLASMAL PAED W/O CARBOHYDRATE INJ AMINOPLASMAL-5% E INFUSION ATROPINE SULPHATE 500MCG/ML AMP CALCIUM GLUCONATE 10% AMP CANDIZOL 2% CREAM CLINDACIN-T 1% TOPICAL SOLN CLODERM 0.V VIAL PROFASI AMP 1000 I.05% OINT CLODERM 0.18 MG TAB SIFROL 0. RANTAG 75 MG F.V VIAL PRIMOCEF 1 GM I.25% EYE DROP TIMO-COMOD 0.U. SPIRIVA 18MCG HARD CAPSULE STILAMIN 250MCG AMP+SOLVENT STILAMIN 3MG AMP+SOLVENT SUPRAPROCT-S OINT. RISEK 20 MG CAPS RISEK 40MG INJ ROTHACIN CAPS 25 MG.088 MG TAB SIFROL 0.NITROPRUSSIDE 50MG VIAL SOFLAX SOLUTION SOOLAN SYRUP 100 ML.SALINE 20– A .SALINE ONKOVERTIN_70 IN N.B-COMPLEX TABLET XYLO-COMOD 0. 1MG/ML VIAL VIRAMUNE 200MG TAB VIT.U/ML VIAL 5ML HISTAZIN 5 MG / 5 ML SYRUP LIDOCAINE HCL 2% INJ 20ML LIPOFUNDIN MCT/LCT 10% INFUSION LIPOFUNDIN MCT/LCT 20% INFUSION LIPOFUNDIN-S 10% SOYA OIL LIPOFUNDIN-S 20% SOYA OIL LOW-LIP 600MG TAB METRONIDAZOLE 5MG/ML INFUSION 100ML BOTT MINITEN 25MG TAB MINITEN 50MG TAB NEUROTOP 300MG RETD.TAB NEUROTOP 600MG RETD. SUTRIM TAB TAMBOCOR 100MG TAB TENSOTIN 100 MG TAB TENSOTIN 50MG TAB TETRACYCLIN 250MG CAPS TETRACYCLINE 500MG CAPS TETRACYCLINE SKIN OINT 3% THEOPHAR 60MG/5ML SYRUP THIAVIT 100MG TAB TIMO-COMOD 0.

TAB OMERAL 20MG CAP.C TAB NORMOTEN 50 MG F.1% TOPICAL CREAM CLOZOLE 1% TOPICAL SOLUTION CLOZOLE VAGINAL CREAM DERMA _ T 10MG TOPICAL LOTION DERMAL 0.9% IRRIGATION SOD. ANAZOL 250 MG F.V-I.M CEPHRADINE -TABUK 500MG VIAL (I.U CAPSULE UNIVIT-E 100MG CAPSULE WATER FOR INJ AMP ‫ت ا دوا‬ ‫ا ز رة‬ ‫ر‬ _______________________________ ANAZOL 125MG/5ML SUSP.U NASAL SPRAY CANAR 100 MG TABLET CANAR 50 MG TABLET CEPHALEX 500MG CAPS CEPHALEX CAPS 250MG CEPHALEX ORAL SUSP 250MG/5ML CEPHRADINE -TABUK 1GM VIAL(I.U NASAL SPRAY CALCITEC 200 I.Registered Suppliers Index MONOCEF 250MG/5ML SUSPENSION MONOCEF 500MG CAPSULE NORMOTEN 100 MG F. TAB 21– A .4% INJ SODIUM CHLORIDE INJ 5.C TABLET ASPICARD 81MG TAB AVOLEN 60MG/5ML SYRUP AVOLEN S.05% CREAM DERMA-T SOLUTION DEXOFAN 15MG/5ML SYRUP DIVIDO 75MG DUAL RELEASE CAP ENERVIT F. ANAZOL 200MG/5ML SUSP.M CLARITT 125 MG / 5 ML SUSPENSION CLARITT 250 MG / 5 ML SUSPENSION CLARITT 250 MG FILM COATED CLARITT 500 MG FILM COATED TAB CLOZOLE 0. ONKOVERTIN-40 IN DEXTROSE POTASSIUM CHLORIDE 7.5 GM VIAL CEFOFIX 750 MG VIALS CETAMOL 100 MG SUPP CETAMOL 200MG SUPP CETAMOL 350MG SUPP DICLOMAX 1% EMULGEL DICLOMAX 100 MG SUPP DICLOMAX 12. OMNICEF 125MG/5ML SUSP OMNICEF 125MG/5ML SUSP OMNICEF 300MG CAPSULE PECTAL 100MG\5ML SYRUP PENETREX 200MG TAB PENETREX 400MG TAB RANIMAX 150 MG TAB RANIMAX 300 MG TAB RANIMAX AC TABLET RANIMAX AC TABLET REMOX 125MG/5ML SUSPENSION REMOX 250 MG CAPSULES REMOX 250MG /5ML SUSPENSION REMOX 500 MG CAPSULES REPADERM GEL (100 GM) REPADERM GEL (100 GM) RINOFED EXPECTORANT SYRUP 100 ML RINOFED PLUS SYRUP RINOFED PLUS TAB RINOFED SYRUP RINOFED TAB ROMIN 15 MG/5 ML SYRUP SOLVEX 4MG/5ML SYRUP XEFO 8MG TAB ZINOPRIL 10 MG TAB ZINOPRIL 20 MG TABLET ZINOPRIL 40 MG TABLET ZINOPRIL 5 MG TABLETS ZOFEN SYRUP 0. TAB ANAZOL 500 MG F.CHLORIDE 0.C.R TABLET CALCITEC 100 I.45% INJ AMP POTASSIUM CHLORIDE STRONG(15%) AMP 10ML POTASSIUM PHOSPHATE INJ 20MINIPLASCO AMP PROFILAR 1MG / 5 ML SYRUP SOD.BICARBONATE 4. TAB BIOCEF 125MG/5ML SUSPENSION BIOCEF 250MG CAPSULE BIOCEF 250MG/5ML SUSPENSION BIOCEF 500MG CAPSULE CEFADIN 250MG CAP.C.85% STERILE WATER FOR IRRIGATION UNICAM 20 MG CAPS UNIDOX 100 MG CAPS UNIFED DM SYRUP UNIFED EXPECTORANT SYRUP UNIFED SYRUP UNIVIT-A FORT 50000I.2% INJ SOD.5MG/10ML ZOTRIM FORTE TAB.C.9% SOD. CEFADROX 250MG/5ML SUSPENSION CEFADROX 500MG CAPSULE CEFADROX 500MG/5ML SUSPENSION CEFOFIX 1.5 MG SUPP DICLOMAX 25MG TAB DICLOMAX 50 MG SUPP DICLOMAX 50 MG TAB DUSPAMEN 135MG TAB EVOREX 20MG CAP FENAM 250MG TAB FENAM 50MG/5ML SYRUP FENAM FORTE 500MG TAB FUCIBET CREAM 15 GM GLUCARE 500MG TAB GLUCARE 850 TAB. ZOTRIM SUSP.LACTATE INJ M/6 SODIUM BICARBONATE 8.C TAB NORMOTEN 100 MG F. JAZOFEN 200 MG TAB JAZOFEN 400MG TAB LORAMAX 10MG TABLET LORAMAX 5MG/5ML SYRUP MEGAMOX 156 MG SUSP MEGAMOX 1GM TAB MEGAMOX 228 MG SUSP MEGAMOX 312MG SUSP MEGAMOX 375 MG TAB MEGAMOX 457MG SUSP MEGAMOX 625 MG TAB MEGAMOX 625 MG TAB MONOCEF 125MG/5ML SUSPENSION MONOCEF 250MG CAPSULE ‫وك‬ +966 (01) 4783789: +966 (01) 4782686: ‫ھ‬ _______________________________ ACIDAL CHEWABLE TAB ACIDAL SUSP ARTIZ 10 MG F.U NASAL SPRAY CALCITEC 50 I.CHLORIDE 0. CEFADIN 500MG CAP.V-I.C.

TAZOLINE0. ROXIL 500MG CAPS SINATEN 10 000 IU OINTMENT 15 GM SINATEN 100000 I.TAB. VITA-C 500MG CHEWABLE TAB.C TAB TABIFLEX 100MG/SUPPOSITORY ‫ود‬ ‫ا‬ ‫وا ر‬ ‫ر‬ _______________________________ ACTIFED EXPECTORANT SYRUP ACTIFED TAB BECLOFORTE INHALER 250MCG/INHALATION BECONASE AQUEOUS NASAL SPRAY BECOTIDE INHALER 100MCG/INHALATION BECOTIDE INHALER 50MCG/INHALE BETNOVATE 0. TABIGESIC 250MG TAB TABIGESIC 50MG/5ML SUSP.05% SCALP APPLICATION DERMOVATE 0.M ZINOXIMOR 125MG F.M VIAL+5ML SOLV.V INJ+10ML D.TAB RANACID 75MG\5ML SYRUP RANID 150MG F. QUINOX 500 MG TAB.M+5MLSOLV.C. VONAL 500MG TAB.U VAGINAL TAB.TAB.5GM VIAL IV+10MLWATER FOR INJ TAZOLINE 1GM VIAL I.TAB.05% DERMOVATE OINTMENT 0.5GM VIAL FOR I.C.LIDOCAINE TOPRAZOLE 40 MG E.TABLET EPTOL 100MG/5ML ORAL SUSPENSION EPTOL 200 MG TAB ESOPRESS 10MG TAB EZILAX 10G/15ML SYRUP EZILAX 10GM POWDER SACHET EZIPECT 12.C TAB VAVO 2% CREAM VAVO 2% SHAMPOO VINTEC 2MG/5ML SYRUP VITA-B TAB VITA-C 500MG CHEWABLE TAB. RANID 300MG F.C TAB VONAL 100MG/ML ORAL DROP VONAL 120MG SUPP VONAL 120MG/5ML SYRUP VONAL 200MG/SUPP. RAPIDUS 25MG TABLET RAPIDUS 25MG TABLET RAPIDUS 50 MG TABLET RAPIDUS 50 MG TABLET RIFACIN 150MG CAP.TAB ZINOXIMOR 500MG F. SINATEN 500000 IU \5ML ORAL SUSP TABETA 0. VITAKID ORAL DROPS VITANERVE F.TAB ZINOXIMOR 250 MG F.C.05% 22– A .5MG/5ML SYRUP FEXODINE 120MG TABLET FEXODINE 180MG TABLET FLAZOL 125MG/5ML ORAL SUSP FLAZOL 500MG TAB FOLIVITA TAB FOXIME 1GM VIAL+5ML SOLVENT LIDOCAINE IM FOXIME 1GM VIAL+5ML WATER FOR INJ IV USE FOXIME 500MG VIAL+AMP OF WATER IM/IV USE FOXITIN 1GM VIAL I.5% GEL ORTHOCAM 10 CAPS ORTHOCAM 20 CAPS ORTHOCAM DT 10MG ORTHOCAM DT 20MG PROF 100MG/5ML SUSP PROF 200 MG TAB PROF 200 MG TAB PROF 400 MG TAB PROF 400 MG TAB PROF 600 MG TAB PROF 600 MG TAB QUINOX 250 MG TAB.V INJ ZINOXIME 1.1% SCALP APPLICATION BETNOVATE CREAM 0. WINEX 100MG\5ML ORAL SUSP WINEX 200MG CAP WINEX 400MG CAP WORMAZOL SUSP 2% WORMAZOLE CHEWABLE 100MG TAB ZETA 20MG OINTMENT TUBE ZETA 20MG/GM CREAM ZETRON 200MG\5ML POWDER FOR SUSP ZETRON 200MG\5ML POWDER FOR SUSP ZETRON 250 MG CAPSULE ZIDIME 1GM GLASS VIAL IV/IM ZIDIME 2GM I. RANID 300MG F.5GM VIAL I.C. RANID 150MG F.V ZINOXIME 750MG VIAL FOR I. TABIFLEX SUPPOSITORIES 12.V/ I. RANACID 75MG F.C TABLETS TOPRAZOLE 40 MG E.1% CREAM BETNOVATE-N OINTMENT DERMOVATE 0.TAB TABIFLEX 50MG E.5MG/SUPP.1%OINTMINT TABETA 0.LIDOCAINE TRIAXONE 500MG VIAL I.C. RANID 150MG F.C TABLET KETOFEN 1MG TAB KETOFEN 1MG/5ML SYRUP LINZ 20 MG CAPSULE LOTENSE 5MG CAP MENTEX SYRUP METFOR 500 MG TAB METFOR 850 MG TAB MICOZOL 2%CREAM MICOZOL 2%CREAM OMIZ 10MG CAP OMIZ 20MG CAP ORASOL POWDER ORTHOCAM 0.M+5ML SOLV.C.LIDOCAIN TRIAXONE 1GM VIAL I.C TABLETS TRIAXONE 0.C.V+5MLWATER FOR INJ TRIAXONE1GM VIAL I.1%SCALP APPLICATION TABICLOR 125MG/5ML SUSP TABICLOR 250MG CAPS TABICLOR 250MG/5ML SUSP TABICLOR 375 MG/ 5ML ORAL SUSPNSION TABICLOR 500MG CAPS TABICLOR MR 750MG F.Registered Suppliers Index TABIFLEX 25MG E.TAB.C. TABIGESIC FORTE TAB TABOCINE CAPS 100MG TAZOLINE 0.C.C TAB VASTA 20MG F.M ADMINISTRATI GLIZIDE 80MG TAB GRIPINE 2MG/5ML SYRUP HISTAFED SYRUP HISTAFED TAB.05% SCALP APPLICATION DERMOVATE CREAM 0.TAB.WATER VALIREC 200 MG/5 ML SYRUP VASTA 10MG F.5G I.C.M+5MLSOLV.LIDOCAINE TAZOLINE 1GM VIAL IV+10ML WATER FOR INJ.V OR I. RIFACIN 300 MG CAPS ROXIL 250MG/5ML SUSP.1% BETNOVATE OINTMENT 0.TAB TABIFLEX 50MG/SUPPOSITORUY TABIFLEX COOL 1% GEL TABIFLEX COOL 1% GEL TABIFLEX RETARD 100MG/TAB.C. HYDROCORTISONE-TABUK 1% CREAM HYDROCORTISONE-TABUK 1% CREAM HYOBAN 10MG F.1% BETNOVATE-N 0.

SOLUTION DIAMOX 250MG TAB.01 MMOL/ML I. LODINE 300MG CAPS MINULET 21 TAB MUCAINE SUSP MUCOFALK 5GM GRANULES SACHET(APPLE) MUCOFALK 5GM GRANULES SACHET(ORANGE) NORDETTE 21TAB NORDIOL 21TAB OMNIPAQUE 180MG /ML VIAL OMNIPAQUE 240MG/ML VIAL OMNIPAQUE 300MG /ML VIAL OMNIPAQUE 350MG/ML VIAL OMNISCAN 0. 25MG ‫د‬ ‫ر‬ ‫ون‬ DAGRAVIT A-E CAPS DAGRAVIT B-COMPLEX TAB INSADOL TABS MADECASSOL 10MG TABLET MADECASSOL INJECTION 20MG/ML MADECASSOL N-HC OINT MADECASSOL OINTMENT MADECASSOL POWDER ‫ا‬ ‫ؤ‬ _______________________________ _______________________________ 23– A . 100 MG METROZOLE TAB 250MG MEZACOL 400 MG E.CHILD 7.C TAB SPASMONORE SUPP.5G VIAL ZINACEF 250MG VIAL ZINACEF 750MG VIAL ZINNAT 125MG TAB ZINNAT 125MG/5ML SUSP ZINNAT 250 MG/ 5 ML SUSPENSION ZINNAT 250MG TAB ZINNAT 500MG F.05% OINTMENT FLIXONASE 0.05MG TAB ELTROXIN 0.1MG TAB EUMOVATE 0.5MG TAB MONOZIDE 25MG TAB NORACIN 400MG TAB NORACTONE TAB 25MG NORTRIME SUSP (200+40MG/5ML) NORTRIME TAB PYLOMID 10MG TAB RANIDINE 150MG TAB RANIDINE 300 MG TAB RAZONE 40 MG E.5MG SPASMONORE TAB 10MG TALIN 1.5MMOL/ML VIAL OVRAL TAB PREMPAK -C 0.C TAB ZOFRAN 4MG TAB ZOFRAN 8MG TAB ZOVIRAX 200MG TAB ZOVIRAX 400MG TAB ZOVIRAX 800MG TAB ZYLORIC 100 MG TABLET ‫ودي‬ ‫ا‬ ‫زن ا دو ا ر‬ ‫ر‬ _______________________________ ANACIN 398MG TAB ATIVAN TABLETS 1 MG ATIVAN TABLETS 2 MG BISODOL POWDER BISODOL TAB CATALIN OPH.05% AQUEOUS NASAL SPRAY FORTUM 1G VIAL FORTUM 1G VIAL FORTUM 2G VIAL FORTUM 2G VIAL FORTUM 500MG VIAL FORTUM 500MG VIAL IMIGRAN 100MG TAB IMIGRAN 100MG TAB IMIGRAN 50MG TAB IMIGRAN 50MG TAB LAMICTAL 100MG DISPERSABLE TAB LAMICTAL 100MG TAB LAMICTAL 25 MG TAB LAMICTAL 25MG DISPERSABLE TAB LAMICTAL 25MG DISPERSABLE TAB LAMICTAL 50MG TAB LAMICTAL 5MG DISPERSABLE TAB SEPTRIN 480MG TAB SUPRAVIT CAPS VALTREX 500MG TAB VALTREX 500MG TAB VENTOLIN 2MG TAB VENTOLIN 2MG/5ML SYRUP VENTOLIN 4MG TAB VENTOLIN CR 4MG TAB VENTOLIN INHALER 100MCG/ACTUATION VENTOLIN RESPIRATORY SOLUTIN 0.V INFUSION VISIPAQUE 150MG 1 /ML VIAL VISIPAQUE 270MG 1 /MLVIAL VISIPAQUE 320MG 1 /ML VIAL ‫د تاط‬ AMOXIPEN 250 MG CAP AMOXIPEN 500MG CAP AMOXIPEN SUSP 125MG/5ML AMOXIPEN SUSP 250MG/5ML ANGIOTEC 10MG TAB ANGIOTEC 20MG TAB ANGIOTEC 5MG TAB ASMANORE SYRUP 2MG/5ML ASMANORE TAB 4MG BACTALL 250MG TABLET BACTALL 500MG TABLET BENDAZOLE 100 MG TAB BEVACOL 135MG TABLET COBAL 500MCG TAB DOPANORE TAB 250 MG.Registered Suppliers Index METHACIN SUPP.625MG TAB PREMPAK C 1. METHACIN CAPS.5MG/5ML SYRUP TEFANYL 1 MG TABLETS TEFANYL 1MG\5ML SYRUP TENOX 20MG CAPS VOMINORE TAB ELTROXIN 0.05% CREAM EUMOVATE 0.25MG TABS SALOFALK 4GM/60ML ENEMA SALOFALK 500MG TAB TESLASCAN 0.5% ZANTAC 150MG TAB ZANTAC 150MG TAB ZANTAC 300MG TAB ZANTAC 300MG TAB ZANTAC 50MG/2ML AMP ZANTAC EFFERVESCENT TAB 150MG ZANTAC EFFERVESCENT TAB 300MG ZINACEF 1.C TABLET MONOZIDE 12.ADULT SPASMONORE SUPP.

3% EYE DROPS FLEMOXIN CAPSULES 250 MG. GYNO-CORYL 150 MG VAGINAL OVULES ‫ن‬ ‫ا‬ ‫ؤ‬ _______________________________ CHORIOMON 1000 I.3% E/E DROPS APIGEN 0. EPILAT 10MG CAPS EPIMAG EFFERVESCENT GRANULE SACHET EPIRAZOLE 20MG CAPS(E.PELLETS) FURAZOLE TAB GASTROFAIT TAB 500MG HYDROCORTISONE 100M VIAL+SOLVENT 2ML AMP KAPECT SUSP. APICROM 2% EYE DROPS APIFLOX 0. E-MOX 250MG DRY MIX. NO-URIC TAB 100MG NO-URIC TAB 300MG THIOPENTAL 0.PHOSPHATE 8MG/2ML AMP E-MOX 125MG DRY MIX.9% EYE/NOSE DROPS APISULFA 20% EYE DROPS APIZOLIN 0. 1MG EFUDIX 5% OINTMENT ETHAMBUTOL TAB 250MG EYLOX 0.3% EYE OINTEMENT APILLERG EYE DROPS APIMOL 0.1% EYE DROP AZACTAM 1 GM INJ AZACTAM 1G VIAL AZACTAM 500MG INJ AZACTAM 500MG VIAL CANDIVAST 150MG CAP CANDIVAST 50MG CAP CAPOZIDE TABLET CIPROQUIN 250MG TAB CIPROQUIN 500MG TAB CLOTREX 1% OTIC SOLUTION CODILAR SYR CONDYLINE SOLUTION 5MG/ML DECOZAL 0.5G VIAL THIOPENTAL 1G VIAL _______________________________ 24– A .1% BETADERM OINT 0.05% CREAM ACTRAPID HM PENFILL CARTRAGE ACTRAPID INSULIN HM 100 I.U VIAL+AMP OF SOLVENT FLECTOR EP GEL 1% FLECTOR EP TISSUGEL 1GM PATCHES FOSTIMON HP 150 IU VIAL IM(WOMEN URIN) FOSTIMON HP 75 IU VIAL (IM) USE MERIONAL HP 75 IU VIAL MERIONAL-HP 150 IU VIAL ROWACHOL CAPS ROWACHOL DROPS ROWATINEX CAPS ROWATINEX DROPS ‫د‬ ‫د ن‬ ‫ھ‬ +966 (01) 4056428: +966 (01) 4056264: BETADERM CREAM 0. FLEMOXIN DROPS 100 MG/ML FLEMOXIN SOLUTAB 250MG FLEMOXIN SOLUTAB 500MG FLEMOXIN SYRUP 125 MG/5 ML FLEMOXIN SYRUP 250 MG/5 ML FLUORO-URACIL ICN 250MG\5ML VIAL GLUCAGEN 1MG HYPOKIT FILLED WITH WATER GLUCAGEN 1MG VIAL+WATER FOR INJ. E-MOX 500MG CAPS EPICO EFFERVESCENT SALT EPICOCILLIN VIAL 1G EPICOCILLIN VIAL 500MG EPICOGEL SUSP. PETRALAR 0. ADIPRIN 100MG E.C.05% NASAL DROPS DECOZAL 0.Registered Suppliers Index ‫ر‬ KWELL CREAM KWELL LOTION KWELL SHAMPOO PHAZYME TAB 60MG ‫ما‬ ‫ؤ‬ ‫د تاط‬ ‫د‬ ‫ا‬ ‫ؤ‬ _______________________________ _______________________________ BECTAZON 0.2% OINTMENT CANDICORT CREAM HERPAVIR 5% CREAM KENACIN CREAM LIGNOSOL AEROSOL MULTICIN-Z OINTMENT MULTICIN-Z POWDER MULTISOL AEROSOL SPRAY (150 GM ) NOCAL 10% TOPICAL SOLN. FLEMOXIN CAPSULES 500 MG.3% EYE DROPS APIFRIN-Z EYE DROP APIGEN 0.TAB AMBREDIN TAB AMFIPEN INJECTION 250 MG AMFIPEN INJECTION 500 MG ANATENSOL DECANOATE 25 MG/ML VIAL APICARPINE 2% EYE DROPS APICARPINE 4% EYE DROPS APICORT 0.1% CEVITIL EEFFV.1% NASAL DROPS DE-NOL 120MG TABS DERMA-CORYL 1% CREAM DERMOFUCIN 2% CREAM DERMOFUCIN 2% OINTMENT DEWAX 5MG/ML OTIC DROPS DISFLATYL DROPS 40MG/ML DISFLATYL TAB ECAVIT-B12 AMP.25% CREAM PETRALAR-N CREAM PROCTOLAR CENTER SUPPOSITORY SILVERIN 1% CREAM ‫ا‬ +966 (01) 4646955: +966 (01) 4634362: ‫ؤ‬ ‫ھ‬ _______________________________ ACNEDERM 20% MEDICATED LOTION ACNELIN 0. LACTULOSE 650MG/ML SYRUP 300ML MUCOGEL SUSP.C.025% CREAM PETRALAR-F 0.5% EYE DROPS APISAL 0.TAB 1 GM CIPROCIN 250MG TAB CIPROCIN 500MG TAB COVIT CAPS DEXAMETHASONE SOD.U.12% EYE DROPS APICORT FORTE 10MG/ML EYE SUSP.U VIAL+AMP OF SOLVENT CHORIOMON 5000 I.25% EYE DROPS APIMOL 0.

VIAL HOLOXAN 2GM IV.5ML CARTRIDGE NORDITROPIN SIMPLEX 5MG\1.1% LOCOID OINT 0. VIAL VAGIFEM 25MICROGRAM/ VAGINAL TAB VALINIL TAB 2MG VALINIL TAB 5MG VELOSEF SUSP 125MG/5ML VELOSEF 500MG CAPS VELOSEF CAP 250MG VELOSEF INJ 250MG VIAL VELOSEF INJ 2GM VIAL VELOSEF SUSP 250MG/5ML VELOSEF VIAL 1GM VELOSEF VIAL 500MG VEPESID 100MG CAPSULE VITAMIN 15 SOLCO TAB ZOCIN 250MG CAPSULE ZYMOGEN TAB GYNO-CORYL VAGINAL CREAM HAIRSCIENCE ANTI-DANDRUFF SHAMPOO I. 50MG ENDOXAN. 1GM BI-TILDIEM 120MG TAB BI-TILDIEM 90MG TAB CALCEFOR EFFV.1% LOCOID CRELO 0.U / ML OPTICYCLIN 1 % OINTMENT OPTIFUCIN 1% EYE DROP OTOZOL 1% EAR DROP PANTHINOL AMP 500MG/2ML PARAPLATIN 10MG/ML VIAL PHENICOL 1% OPTHALMIC OINTMENT PHOSPHALUGEL SACHETS PIMAFUCORT CREAM PIMAFUCORT OINT.Registered Suppliers Index TRI-B TAB ULTRATARD HM 100 I. VIAL HOLOXAN 500MG VIAL IV HONVAN AMPOULE 300MG/5 ML HONVAN TABLETS 120MG HYPOSEC 20 MG CAPSULE KERLONE TAB F.1 E/E DROP NEOPRED . VIAL 1 GM. AMP ‫ا‬ ‫ؤ‬ _______________________________ ‫ر‬ ‫ز وا‬ ‫ؤ‬ ‫ھ‬ +966 (01) 4020325: +966 (01) 4021986: ALLERGODIL NASAL SPRAY WITH SPRAYER ASPEGIC INJ.C 20MG KETONIL 1MG/5ML SYRUP LEVSIN TAB 0.125MG LITHIOFOR 660MG TAB MAGNACEF 100MG\5ML SUSP MAGNACEF 200MG CAP.5MG TABLET NOVONORM 1MG TABLET NOVONORM 2MG TABLET NOVORAPID PEN FILL 100 I.N.000IU\ML ORAL SUSP MYCOSTATIN 100000 UNITS/ML ORAL SUSP NEODEX 0.1% MAXIPIME 1 G VIAL MAXIPIME 2 G VIAL MIXTARD 10 NOVO LET . TAB CEFADRIL 250MG\5ML SUSPENSION CEFADRIL 500 MG CAPSULES CIPROFLACIN 250 MG FILM COATED TABLETS CIPROFLACIN 500 MG FILM COATED TABLETS CIPROFLACIN 750 MG FILM COATED TABLETS DEBRIDAT 1.U VIAL NORDITROPIN SIMPLEX 10MG\1.1% LOCOID LOTION 0.U PENSET NORDITROPIN 4 I. 100IU MIXTARD 20 PENFILL 100 IU/ML CARTRIDGE MIXTARD 30 HM 100 IU PENFILL MIXTARD 30 HM 100 IU VIAL MIXTARD 40 NOVO LET .V.U PENSET NORDITROPIN 12 I.U.H TAB 100MG IMAVIR 5% CREAM INSULATARD HM 100 IU PENFILL INSULATARD HM 100 IU VIAL ISILIN SYR KENACORT-A 40MG\ML INJ KENALOG IN ORABASE (PASTE 0.U VIAL NORDITROPIN 24 I.100 IU MIXTARD 10/90U/ML HM PENFILL CARTRIG 3ML MIXTARD 20 NOVO LET . VIAL 200 MG FERTONIC DROPS 30ML HEPT-A-MYL 150MG TAB HEPT-A-MYLDROPS 305MG/ML HOLOXAN 1GM I.5ML CARTRIDGE NORDITROPIN SIMPLEX 15MG\1. ENDOXAN. MAGNACEF 400MG CAP MONO TILDIEM SR 200MG CAPS MONO TILDIEM SR 300MG CAPS OFLACIN 200MG TAB PANGESIC 250MG CAPS PEPTAC 150 MG FILM COATED TABLETS PEPTAC 300 MG FILM COATED TABLETS _______________________________ 25– A . PREVOC 250 MG FILM COATED TABLETS PRINCIMOX CAPS 250MG PRINCIMOX CAPS 500MG PRINCIMOX SUSP 125MG/5ML PRINCIMOX SUSP 250MG/5ML PROTOGYN 500MG TAB SENNA LAX TAB 12MG SERZONE 100MG/TAB SERZONE 200MG/TAB THERAGRAN HEMATINIC TAB THERAGRAN M TAS THIAMETRENE CAP TOCOVIT TAB TOPICORT 1% CREAM TRI-B AMP ‫ا دو‬ WATER FOR INJ.1% TOPICAL EMULSION LOCOID LIPO CREAM 0.5ML CARTRIDGE NOVOMIX 30 FLEXPEN 100U\ML NOVOMIX 30 PEN FILL NOVONORM 0. VIAL 500 MG ENDOXAN.P EYE SUSP NOMAL 50 MG CAPSULE NORDITROPIN 12 I.2 GM/250ML SUSPENSION DECONTRACTYL OINT DECONTRACTYL TAB 250MG DOGMATIL AMP 100MG DOGMATIL CAPS 50MG DOGMATIL FORT TAB 200MG DOGMATIL SYP ENDOXAN TAB.100IU MIXTARD 40/60U/ML HM PENFILL CARTRGE 3ML MIXTARD 50 HM NOVOLET MIXTARD 50 HM PENFILL100IU/ML3mlcartridg MONOTARD HM 100 U/ML 10ML VIAL MULTILIND 30GM OINTMENT MYCOSAT 100.1%) LAVAGINE POWDER LIOCAINE 2% GEL LOCAGEL 30 GM GEL LOCOID CREAM 0.

M INJECTION NOKOF SYRUP OPTICHLOR 0.5MG\ML AMPOULE ATROPINE SULPHATE 0.TABLET VOLTIC 75 MG / 3 ML AMPOULES XOLA OPTHALMIC SOLUTION XOLAMOL EYE DROP ZYDAC 150MG TABLET ZYDAC 150MG TABLET ZYDAC 300MG TABLET ZYDAC 50MG/2 ML SOLUTION FOR IV .C.5MG CAPSULE AMVASC 5MG CAPSULE AZI-ONCE 250MG CAP BETAZOL CREAM BETAZOL G CREAM CIPROXEN 250MG TAB CIPROXEN 500MG TAB CIPROXEN 750MG TAB CLARA 10MG TABLET CLARA 5MG\5ML SYRUP CLOBATE 0. 20MG PRIMPERAN CHILDREN SUPP.025% CREAM ACRETIN 0.6MG\ML AMPOULE ATROPINE SULPHATE 0.5% AMP POTASSIUM CHLORIDE 7.5% OPTHALMIC DROP OPTICIN 0.1% OINTMENT ELICA-M CREAM ELICASAL OINTMENT FLOGOCID CREAM FLOGOCID OINTMENT FLUCA OPTHALMIC SUSP. PRIMPERAN DROPS 0.05% CREAM AMBROSIA 15MG/5ML SYRUP AMVASC 10MG CAPSULE AMVASC 2.05% OINTMENT CROMA EYE DROP DERMIZOL 2% AQUEOUS GEL ELICA 0.1% CREAM ELICA 0.5% AMP POTASSIUM CHLORIDE 7. SOLIAN 200MG TAB SOLIAN 50MG TAB SORBITOL GRANULES 5G/SACHET STILNOX 10MG F.C.5MG TAB XATRAL 5MG S.R.25% OPHTHALMIC SOLUTION OPTIMOL 0.5MG\ML AMPOULE ATROPINE SULPHATE 0.5 % GEL ACNEZOYL 5% GEL ACRETIN 0.05% OINTMENT RELAXON CAP SALIBET OINTMENT VIVIDRIN 2% EYE DROPS VOLTIC 25MG E.TAB ‫دو‬ ‫وم‬ ‫ھ‬ ‫دودة‬ ‫ا‬ ‫لاط‬ ‫ا‬ _______________________________ ATROPINE SULPHATE 0.1% OPTHALMIC SUSPENTION OPTIMOL 0.3% EYE DROPS OPTIDEX-T STERILE OPHTALMIC SUSP OPTIDRIN EYE DROP OPTIFLOX OPTHALMIC SOLUTION OPTIFRESH OPTHALMIC SOLUTION OPTILONE 0. IM ZYDAC 75MG TABLET PRIMPERAN 5MG/ML 2ML/AMP.5% AMP POTASSIUM CHLORIDE INJ 15% AMP POTASSIUM CHLORIDE INJ 15% AMP POTASSIUM CHLORIDE INJ 15% AMP +966 (01) 2766775: +966 (01) 4065050: ACILOC 10MG CAPSULE ACILOC 10MG CAPSULE ACILOC 20MG CAPSULE ACILOC 20MG CAPSULE ACILOC 40MG CAPSULE ACILOC 40MG CAPSULE ACNEZOYL 2.5% OPHTHALMIC SOLUTION OPTIPRED 1% OPTHALMIC SUSP.C TAB SUCCINYL SICCUM 500MG VIAL SUREPTIL 50MG TAB SYSTRAL CREAM 1.6MG\ML AMPOULE BABYLYTE ORAL SOLUTION BABYLYTE ORAL SOLUTION BABYLYTE ORAL SOLUTION BABYLYTE ORAL SOLUTION CIPRO-SOL I.1MG/DROP PRIMPERAN TAB 10MG PROPESS 10MG VAGINAL PESSARY RAMLAC 67GM/100ML SYRUP RHINATHIOL CAPS 375MG RHINATHIOL SYRUP 20MG/ML CHILDREN RHINATHIOL SYRUP ADULT 5OMG/ML RHINATHIOL+ PROMETHAZINE SYR.05% CREAM PROMAX 0. TABLET VOLTIC 50MG E. PRIMPERAN ADULT SUPP.C. OPTIZOLIN OPTHALMIC SOLUTION PROBATE 0.V INFUSION LIDOCAINE 1% VIAL LIDOCAINE 1% VIAL LIDOCAINE HCL 1% AMPOULE LIDOCAINE HCL 1% AMPOULE LIDOCAINE HCL 1% AMPOULE LIDOCAINE HCL 2% INJ LIDOCAINE HCL 2% INJ LIDOCAINE HCL 2% INJ LIDOCAINE HCL 2% INJ MAGNESIUM SULFATE 50% AMPOULE MAGNESIUM SULPHATE 10% INJECTION MAGNESIUM SULPHATE 10% INJECTION METRONIDAZOLE 5MG/ML INFUSIION POTASSIUM CHLORIDE 7.Registered Suppliers Index LAMIFEN 250MG TABLET LAMIFEN 250MG TABLET LOXTRA EYE DROP MEVA 135MG F.5% TIAPRIDAL 100MG TAB TIAPRIDAL AMP TILDIEM 60MG TAB TRAMADOL AWD 100MG/2ML AMPOULE UROMITEXAN 400 MG TAB UROMITEXAN 400MG/4ML AMP UROMITEXAN 600 MG TAB VADILEX-20 TAB 20MG VIRUSTAT 200MG TAB XATRAL XL 10 MG XATRAL 2. FUSIBACT CREAM 2% W/W FUSIBACT OINTMENT2% FUSIBACT-B CREAM LAMIFEN 1% CREAM _______________________________ ‫لاط‬ ‫ب ا‬ ‫ھ‬ +966 (01) 2066646: +966 (01) 2912953: LIGNOCAIN 2 % JELLY _______________________________ 26– A .TABLET MOMENTA CREAM NEUROCOMB I.

ECONOPRED PLUS 1% OPHTHALMIC DROP EMADINE 0. BUPIVACAINE 0. MEGACILLIN VIAL 1000000IU+SOLV 3ML METRONIDAZOLE INJ 5MG/ML MICROGYNON-30 21TAB MICROLUT 0.9% SOD.3% EYE DROPS ALOMIDE EYE DROPS 0. ISOPTO ATROPINE 1% EYE DROPS ISOPTO CARPIN 2% EYE DROPS ISOPTO CARPINE 1% EYE DROPS ISOPTO CARPINE 3% EYE DROPS ISOPTO CARPINE 4% EYE DROPS ISOPTO CETAMIDE 10% EYE DROPS ISOPTO CETAMIDE 15% EYE DROPS ISOPTO FENICOL 0.E.COATED TAB ISOPTIN TABLETS 40 MG.R 240MG F.5% DROPS MYDRIACYL 1% DROPS MYDRIACYL 1% EYE DROPS ‫ل‬ ‫با‬ ‫ھ‬ +966 (01) 4028266: +966 (01) 4029605: _______________________________ ADVANTAN 0.SOLUTION B.S SOLUTION BETAFERON 8MIU\ML VIAL BETOPTIC OPTH. 1G VIAL ERYTHROCIN I.OINT. DEXT. VIAL MURINE EYE DROPS MYCO-SYNALAR CREAM MYCO-SYNALAR SOLUTION MYDFRIN 2. 100MG/5ML KARVOL DECOGESTANT CAPS KLACID 125MG/5ML SUSP KLACID 250MG TAB KLACID 500MG COATED TAB KLACID XL 500MG TAB LACRYVISC EYE GEL LACTATED RINGERS INJ LEVOPHED 4MG/4ML AMP(I.V VIAL FLUORESCEIN SODIUM DROPS 2% FORANE(INH.5% + LACTATED RINGERS. IRUXOL OINT ISOPROTERENOL HCL EMERG.SYRING ISOPTIN AMP 2. ISOPTIN TABLETS 80 MG.CHLORIDE INJ DEXTROSE 5% INJ DEXTROSE 50% INJ.5% EYE DROPS ISOPTO FRIN EYE DROPS 0.OINT.225% SOD. CALCIJEX 1MCG/ML I. ETHRANE BOTTLE(INHAL. FERROGRAD-C TAB FERROGRAD-FOLIC TAB 27– A .S 100MCG/ML AZOPT 1% STERILE OPHTHALMIC SUSPENSION B.S.1:5000 SYRING ISOPROTERENOL1:5000 ADDIT EMER.5% ISOPTOCETAPRED EYE DROPS ISOVIST 240 MG/ML VIAL ISOVIST 300 MG /MLVIAL ITRIN 2MG TAB ITRIN 5MG TAB JUNIFEN PAEDIATRIC SUSP.V. FLUCON OPTH SUSP 0.V. 500MG VIAL ERYTHROCIN PCE 333MG TAB ERYTHROCIN TAB.5% +0.5MG /VIAL MAGNESIUM SULFATE 50% AMP MAGNEVIST INJ.SOLN 0.5MG/ML ISOPTIN RETARD TAB 120MG ISOPTIN S. 500MG.SOLN.CHLORIDE INJ DEXT.V) LIDOCAINE HCL EMERGENCY SYRINGE 1% LIDOCAINE HCL EMERGENCY SYRINGE 2% LIPANTHYL 200MG MICRONISED CAPS LIPOSYN 10% (SAFFLOWER OIL) LIPOSYN II 20% (SOYABEEN OIL) LOGYNON TAB LUPRON DEPOT 3.1%SKIN CREAM AKINETON 2MG TAB AKINETON 5MG/ML AMP AKINETON RETD.VIAL DEXTROSE 70% INJ PARTFILL 500/1000ML DIANE-35 TAB DOPAMIN HCL 40MG/ML INJ VIAL DOPAMIN HCL INJ 40MG/ML SYRING DOPERGIN 0.TABS GYNO-TRAVOGEN CREAM 1% INPERSOL W/1.5% OPTH. ANGIOGRAFIN INFUSION 65% ATROPINE SULF.ANES) EYE STREAM SOLN FENICOL 1% OPTH.1% MAXITROL DROPS MAXITROL EYE OINT.OINT.V.75MG/VIAL LUPRON DEPOT 7.S.25% STERILE PACK AMP. ANES. 4MG TAB ALCAIN DROPS 0.03MG/TAB COATED TAB. 250 MG.5% ALCOMICIN 0. ERYTHROCIN TAB. MAXIDEX DROPS 0.45% SOD.3% EYE DROPS CITRO-SODA GRANULES CLIMEN TAB CLINDAMYCIN PHOSPHATE 150MG/ML INJ CYCLOGYL EYE DROPS 1% CYCLOGYL EYE DROPS 2% DEXT 5%+0.05% EYE DROPS EPINEPHRINE INJ 1:10000 ABBOJECT ERYDERM FOR TOPICAL SOLN 2% ERYPED FOR ORAL SOLN 400MG/5ML ERYTHROCIN GRANULES 200MG/5ML ERYTHROCIN I. E. MULTIPLE TRACE METAL ADD.Registered Suppliers Index FERROGRADUMET TAB.5% DEXTROSE IOPIDINE 0.1% FLUDARA 50MG I.5% BRUFEN 200MG TAB BRUFEN 400 MG TAB BRUFEN TAB 600MG BUPIVACAINE 0.5% STERILE PACK AMP.1% SKIN OINTMENT ADVANTAN 0. CETAPRED OPTH.)100ML BOTTL FROBEN TAB 100MG FROBEN TAB 50MG FURAMIDE 500MG TAB GASTROGRAFIN 76/ORAL AQUEOUS SOLN.S 50MCG/ML ATROPINE SULF. AMP CALCIJEX 2MCG/ML AMP CALCIUM CHLORIDE 10% EMERGENCY SYRINGE CETAMIDE 10% OPTH.2MG TAB DURATEARS OCULAR OINT.CHLORIDE INJ DEXTROSE 10% INJ DEXTROSE 5% + 0. CILOXAN 0.5% GYNERA 21 TAB GYNO-TRAVOGEN 300MG VAG. GENGRAF 100 MG MODIFIED CAPSULE GENGRAF 25MG MODIFIED CAPSULE GLYCINE FOR IRRIGATION 1.12% ISOPTO HOMATROPINE 0.1% AMINOPHYLLINE INJ 250MG AMINOSYN 10% ANDROCUR 50MG TAB.S.5% DROPS ISOPTO HOMATROPINE DROPS 2% ISOPTO PLAIN DROPS 0.

1% OPTH.45% INJ SOD.C TAB 500MG PROXEN F.3% TOBREX OPTH. ADDITIVE POTASSIUM PHOSPHATE 45mM/15ML ADDITIVE POTASSIUM PHOSPHATE FTV 15mM/5MLADDITIVE PRAMET FA TAB PRECEDEX 100 MCG /ML IV.T. SUSPENSION VIDAYLIN + IRON-SYRUP VIDAYLIN DROPS VIDAYLIN M.1% OINTMENT NERISONE C 0. 0.C. DISBRON SYRUP 2MG/5ML DOXORUBICIN 2MG/MLVIAL EPIRUBICIN HCL 2MG/ML I. VIAL PREVETHENAT 10:1 VIAL+5ML SOLV PREVETHENAT 5: 1/2 VIAL+3ML SOLV PREVETHENATE 10: 1/2 VIAL+3ML SOLV PREVETHENATE 4:1/4 VIAL+2ML SOLV PRIMOGONYL 1000 I.5MG AMP I/M OR I/V NAPHCON DROPS 0.ANESTHESIA BOTTLE SKINOREN 20% CREAM SOD.T.50MG/10 ML NORVIR 80MG/ML ORAL SOLN.1% FATTY OINTMENT NERISONE 0. IOPAMIRO 370 INJ ‫رة وا وازم‬ ‫د‬ ‫ر‬ _______________________________ ADIATIN TAB 200MG BRONCHOBOS 375 MG CAPSULES BRONQUIUM ELIXIR CALCIUM FOLINATE(EBEWE) 10MG/ML AMP. GENTAIN VIOLET SOLUTION MERCUROCHROME SOLN TIGER BALSAM TINCTURE IODINE ‫و فا دا‬ _______________________________ IOPAMIRO 150 INJ IOPAMIRO 200 INJ IOPAMIRO 300 INJ.4% INJ. 40MEQ POTASSIUM CHLORIDE 10mEqFTV ADDITIVE INJ POTASSIUM CHLORIDE 20mEq FTV.V & INTRAVESICAL INF 28– A . PEDIALYTE SOLUTION 45MEQ PEDIALYTE SOLUTION 75MEQ PEDIALYTE SOLUTION 90MEQ PEDIAZOLE GRNU. SURBEX C FILMTAB 25TAB SURBEX FILM TAB SURBEX T FILMTAB 30TAB SURVANTA INTRATRACHEAL SUSP.V.T.CHLORIDE 0.5% EMG. ORATROL TAB PATANOL 0.9%FOR IRRIGATION SODIUM ACETATE F.V. AMP PRIMOLUT-N TAB 5 MG. ZINCFRIN EYE DROPS NALADOR 0.TAB 250MG PROXEN SUPP 500MG REDUCTIL 10MG CAP REDUCTIL 15MG CAP SELSUN SHAMPOO SEVOFLURANE INHAL.CHLORIDE 0.VIAL 8ML SYNAGIS 100MG\ML I.3% TPN ELECTROLYTES VIAL TRAMAL 100MG SUPPOSITORIES TRAMAL 50 MG CAPSULE TRAMAL 50 MG/1 ML AMPOULE TRAMAL RETARD 100MG F.CHLORIDE 0.TABLET CEFUTIL 250MG F.M VIAL SYNALAR CREAM SYNALAR GEL SYNALAR LOTION SYNALAR N CREAM ‫ورو‬ _______________________________ ADRENALINE HCL 1MG/ML AMP ATROPINE SULPHATE INJ 1MG/1 ML.1% EYE DROPS NAPHCON-A EYE DROPS NEOGYNON TAB NERISONE 0. DROPS VIDAYLIN SYRUP YASMIN TAB.SYRINGE SODIUM BICARBONATE 8. STERILE WATER FOR INJ STREPSILS PAIN RELIEF PLUS LOZENGE STREPTOTHENATE VIAL 1G +4ML SOLV.1% CREAM NERISONE 0.C TAB TRAVATAN EYE DROP TRAVOCORT CREAM TRAVOGEN 1% CREAM TUBOCURARINE HYDROCHLORIDE INJ F.C.OINTMENT STERILE WATER F.5 ML 25 MG NITROGLYCERINE INJ F.012% NAPHCON FORTE 0.SOLUTION 0. CARBOPLATIN "EBEWE" 50MG/5ML CEFUTIL 125MG F.U AMP PRIMOGONYL 5000/1.1% CREAM NERISONE FORTE FATTY OINT 0. VIAL SODIUM PHOSPHATE 45mM VIAL STATROL EYE DROPS STATROL OPTH.T.OINT.V.C TABLET CISPLATIN 0.SOLN.U.9% INJ SOD.3% NITROGLYCERINE INJ F.T.T. PRIMOSTAT AMP 200MG/2ML AMP PROCTO SYNALAR OINT PROGYLUTON TAB PROLUTON DEPOT AMP 250MG/ML(500mg/2ML) PROTHIADEN 25MG CAPS PROTHIADEN TAB 75MG PROVIRON 25 MG TAB PROVISC 10MG/ML SYRINGE FOR I/O USE PROVISC 10MG/ML SYRINGE FOR I/O USE PROXEN F.V.FOR SUSP PLEGISOL SOLN POTASSIUM ACETATE INJ F.Registered Suppliers Index SYNALAR N OINTMENT SYNALAR OINTMENT TEARS NATURAL FREE TEARS NATURALE TEARS NATURALE II TESTOVIRON DEPOT 100 MG/1ML AMP TESTOVIRON DEPOT 250MG/1ML AMP TETRACAINE DROPS TOBRADEX EYE DROPS TOBRADEX EYE OINT TOBREX OPTH. CALCIUM FOLINATE(EBEWE)3MG/ML AMP.V.V.5MG/ML INJ.40mEq SODIUM BICARBONATE 5% INFUSION SODIUM BICARBONATE 7. ULTRALAN 20MG TAB ULTRALAN 5MG TAB ULTRAVIST 240 ULTRAVIST 370 ULTRAVIST300 UPRIMA 2MG SUBLINGUAL TAB UPRIMA 3MG SUBLINGUAL TAB UROGRAFIN 76% INJ VEXOL 1% OPTH.

FLUANXOL DEPOT INJ 20MG/ML FLUARIX 15McgOF ECH INFUENZA STR.5MG/ML SOLN.5ML JUNIOR VACCI HAVRIX ADULT MONO DOSE VIAL HEXABRIX-320 INJ HIBERIX 10MCG/DOSE VACCINE ETOPOSID "EBEWE" 100MG VIAL ETOPOSID "EBEWE" 200MG VIAL ETOPOSID "EBEWE" 50 MG VIAL FINALLERG 10MG F.C TAB CONRAY 280MG AMP CONRAY 325MG AMP CONRAY 420MG AMP CORTROSYN DEPO VIAL 1MG/2ML DECADURABOLIN ORGAJECT 25MG/ML DECADURABOLIN ORGAJECT 50MG/ML DETICENE 100MG I. ESMERON 10MG\ML VIAL EVISTA 60MG F.FOR RECONSTITUTION CECLOR 250MG/5ML PWD. ESBATAL 50 MG.M AMP FLUANXOL DEPOT 20MG/ML 2 ML.TAB FEFOL SPANSULES FENBID SPANSULES 300MG FLUANXOL 0.TAB BANOCIDE 50 MG.V VIAL+SOLV 10ML AMP DETICENE 200MG I. TABLETS CIPRAM 20MG TAB CISPLATYL 10MG VIAL CISPLATYL 25MG VIAL CISPLATYL 50MG VIAL CITANEST OCTAPRESSIN 3% CLEXANE 20MG\2ML PREFILLED SYRINGE CLEXANE 40MG\4ML PREFILLED SYRINGE CLEXANE 60MG\6ML PREFILLED SYRINGE CLEXANE 80MG\ML PREFILLED SYRINGE CLOPIXOL DEPOT INJ 200MG/ML CLOPIXOL DEPOT INJ 500MG/ML OILY AMP CLOPIXOL DROPS 2% CLOPIXOL INJ 10MG/ML CLOPIXOL TABS 10MG CLOPIXOL TABS 25MG CLOPIXOL TABS 2MG CLOPIXOL-ACUPHASE 50MG/ML OILY AMP COLPERMIN 187MG CAPS COMBIVENT METERED DOSE INHALER COMBIVENT UNIT DOSE VIAL NEBULISER SOLN. BRICANYL AMP.N LACTAB OLFEN 100 RECTOCAPS OLFEN 50 RECTOCAPS OLFEN GEL 1% OLFEN_100 RETARED DEPOCAP.5MG TAB FLUANXOL 1MG TAB FLUANXOL 3MG TAB FLUANXOL DEPOT 100MG/ML I.5MG TAB.TAB. MAGALOX 225 MG + 127MG / ML SUSPENSION MAGALOX CHEWABLE TAB MEPHAQUIN LACTAB 250MG METHOTREXATE "EBEWE 10MG/ML AMP.Registered Suppliers Index BRICANYL TAB 5MG BRICANYL TURBUHALER 0.5MLSRYG GEMZAR 200MG LYPH. COMBIVIR F.C.C.V INFUSION CECLOR 125MG/5ML PWD.FOR RECONSTITUTION CERAZETTE 75MCG TAB CIALIS 20MG TAB CIPRALEX 10 MG F.FOR INHALAT ATROVENT 500MCG/2ML UDV(SOLN FOR INHALAT AVENTYL CAPSULES 10 MG AVENTYL CAPSULES 25 MG AXID 150MG CAPS AXID 300MG CAPS BAMYCODE SOL.V VIAL DOBUTREX 250 MG VIAL DYAZIDE TABS DYSPAMET SUSP 200MG/5ML ELDISINE 5MG VIAL+SOLVENT 5ML ENGERIX B 20MCG ENGERIX-B 10MCG ENTOCORT 20MCG/ML ENEMA AFTER RECONSTITU ESBATAL 10 MG.FOR NEBULISATION BRICANYL SYP _______________________________ 29– A .25MG/2ML INJ.VIAL 5ML GERIATRIC PHARMATON CAPS GINSANA 100MG CAPS GINSANA TONIC 140MG/15ML GLUCAGON 1 MG VIAL+SOLVENT 1ML GLUCAGON 10MG VIAL+SOLVENT GLUSTIN 15MG TAB GLUSTIN 30MG TAB GRACIAL TABLET HAVRIX 720 EFISA UNITS/. OLFEN-25 LACTAB OLFEN-50 LACTAB OLFEN-75 AMP PULMOTROPIC DROPS 2MG/ML PULMOTROPIC ELIXIR 4MG/5ML SALIPAX 20 MG CAPSULE SEDACORON 150 MG/ 3 ML AMPOULES SEDACORON 200MG TAB TAMOXIFEN 10MG EBEWE TANIDINA TAB 150MG TIDILOR 10MG TABLET TIDILOR 5 MG / 5 ML SYRUP ‫دو‬ ‫ا ر ا ود‬ (‫ا دودة)ا ف‬ _______________________________ WARFARIN SODIUM 1MG TAB WARFARIN SODIUM 3MG TAB WARFARIN SODIUM 5 MG TAB (‫و‬ ) ‫رة‬ ‫ود ا‬ ‫ا‬ ‫ا ر‬ ‫ھ‬ +966 (01) 4778144: +966 (01) 4730525: ALKERAN TABLETS 2 MG ALKERAN TABLETS 5 MG ANDREWS LIVER SALT SACHET 5GM ANDRIOL CAPS 40MG ASACOL 400MG F. TAB.C TAB ATACAND 16 MG TAB ATACAND 4 MG TAB ATACAND 8 MG TAB ATACAND PLUS TABLET ATROVENT 250MCG/2ML UDV SOLN. TAB. NADINE 150 MG FILM COATED TABLETS NADINE 300 MG FILM COATED TABLETS NEURORUBINE (B1+B6+B12)1ML AMPOULE NEURORUBINE FORTE . METHOTREXATE "EBEWE" 100MG/ML VIAL METHOTREXATE "EBEWE" 10MG/ML VIAL METHOTREXATE 2.5MG/DOSE BRIETAL SODIUM 500MG / 50ML VIAL CAMPTO 100MG/5ML VIAL FOR I. BRICANYL 2.C TABLET FLUOROURACIL EBEWE AMP 50MG/ML FLUOROURACIL EBEWE VIAL 50MG/ML LANIBOS 0.

25MG TAB PERMAX 1MG TAB PITON-S 10 I.5% MARCAINE INJ. TAB.5ML SYRINGE ORGAMETRIL 5 MG TAB ORUVAIL S/R CAPS 100 MG OXIS TURBUHALER 4. 25MG STIEMYCIN 2%TOPICAL SOLN.U VIALS HUMALOG MIX 25 CATRIDGE HUMALOG MIX 50 CATRIDGE HUMATROPE 4 IU VIAL I/M OR S/C HUMEGON 75 IU.5ML VIAL KINIDIN DURULES 200MG LANVIS 40MG TAB LEUKERAN 2 MG. VIAL KEFZOL 500MG.5 MG TABS ORADEXON AMPULES 5 MG. LIDOCATON 2% W/O VASCONSTR. LEUKERAN 5 MG.25MG\0./ML.U AMP +SOLVENT PUREGON 50IU VIAL PURINETHOL 50MG TAB REMERON 30MG TAB RETROVIR CAPS 100MG RHINOCORT AQUA 64MCG NASAL SPRAY RHINOCORT AQUA NASAL SPRAY WITH PUMP RHINOCORT NASAL AEROSOL 50MCG/DOSE SAROTEN RETARD 25MG CAPS SAROTEN RETARD 50MG CAPS SEPTRIN DOUBLE STRENGTH TAB SEPTRIN I.5MG/ML AMP NEBCIN 20MG/2ML VIAL NEBCIN 80MG/2ML VIAL NEOSPORIN EYE DROPS NEXIUM 20MG TAB NEXIUM 40MG TAB NORCURON 10MG VIAL NORTRILEN TAB. VIAL KEMADRIN INJ 10MG/2ML KEMADRIN TABS 5 MG KIDROLASE 10000 U/2.Registered Suppliers Index ORGALUTRAN 0.5 MG TABS ORADEXON 1. PAVULON 2MG/ML INJ 2ML PEFLACINE 400MG AMP PEFLACINE 400MG COATED TAB PENTOSTAM 100MG/ML INJ PERMAX 0. VIAL KEFZOL 250MG.05% ISOTREXIN GEL JECTOFER AMP.TAB PLENDIL 5MG S. 25 MG.05MG TAB PERMAX 0.5ug/DOSE OXIS TURBUHALER 9ug/DOSE PANADOL 500MG COATED TAB PANADOL 500MG TAB PANADOL ACTIFAST FILM COATED TABLETE PANADOL BABY & INFANT SUSP 120MG/5ML PANADOL COLD & FLU CAPLET PANADOL EXTRA TAB PANADOL JUNIOR SACHET 240MG PANADOL NIGHT CAPLET PANADOL SINUS CAPLET PANADOL SOLUBLE 500MG TAB PANOXYL 10 ACNE GEL PANOXYL 5 ACNE GEL PANOXYL 5 LOTION PARNATE 10 MG. 100 MG KEFADIM INJ 1G VIAL KEFADIM INJ 2G VIAL KEFLEX SUSP.U CARTRIDGE PUREGON 50 I. TABLETS NAROPIN 10MG/ML AMP NAROPIN 2MG/ML PLASTIC AMP NAROPIN 7.U AMP + SOLV PUREGON 100IU VIAL PUREGON 300I. MIDARINE 100MG/2ML AMP MILK OF MAGNESIA SUSP. TAB POLYTAR 1% LIQUID SHAMPOO PREGNYL 1500 IU AMP+SOLVENT PREGNYL 500 IU AMP+SOLVENT PREGNYL 5000 IU AMP+SOLVENT PRIORIX 0./10ML. TAB.5MG TAB LOSEC 20MG CAPS LOSEC 40MG/10ML I/V VIAL LOSEC MUPS 10 MG TAB LOSEC MUPS 20MG TAB MALARONE TAB MALOPRIM TABLETS MARCAINE INJ 0.R.5MG/ML (S. CART 50 LIDOCATON WITH EPINEPHRINE 1:80000 CART LIVIAL 2./10 ML.5MG/ML STEMETIL SUPP 5MG STEMETIL SUPP.R. SURMONTIL CAPS 50MG SUSTANON 100 AMP SUSTANON 250 AMP SYMBICORT TURBUHALER HUMALOG 100 I.5ML PREFILLED SYRINGE INFANRIX-HIB 0.5 ML SYRINGE INFANRIX-IPV+HIB INTRAVAL SOD 500MG VIAL+WATER 20ML ISOTREX GEL 0.U/ML AMP PLENDIL 10MG S. 0. METHOTREXATE ROGER BELLON 5MG V.5ML VIAL METHOTREXATE ROGER BELLON 500MG VIAL METHOTREXATE ROGER BELLON 50MG V. 250 MG/5 ML ./10 ML./2 CC+SOLVENT HUMULIN 70/30 100U/ML HUMULIN NPH100U/ML CARTRIDGE HUMULIN PROFILE70/30 100IU/ML CARTRIDGE HUMULIN PROFILE80/20100IU/ML CARTRIDGE HUMULIN U ULTRALENTE VIAL HUMULIN-L LENTE 100 U/ML HUMULIN-N-NPH 100 U/ML HUMULIN-R 100U/ML CARTRIDGE HUMULIN-R-REGULAR 100 U/ML IMDUR 60MG DURULES IMPLANON 68MG IMPLANT IMURAN 50MG TAB INFANRIX 0. KEFLIN N 2 GM VIAL KEFZOL 1 GM.25MG/ML SINGLE DOSE PLASTIC U PUREGON 100 I.25% MARVELON TAB MENCEVAX AC VACCINE MENCEVAX ACWY 50MCG\0. MYLERAN 2 MG. ONCOVIN 1MG VIAL+SOLVENT 10ML ORADEXON 0.DOSE FOR NUB) SUSP PULMICORT METERED AEROSOL 200MCG/DOSE PULMICORT METERED AEROSOL 50MCG/DOSE PULMICORT TURBUHALER 100MCG/DOSE PULMICORT TURBUHALER 200MCG/DOSE PULMICORT0. ORAMORPH 100MG/5ML UDV FOR ORAL USE ORAMORPH 10MG/5ML UDV FOR ORAL USE ORAMORPH 30MG/5ML UDV FOR ORAL USE 30– A .5ML VIAL PROZAC CAPS 20MG PULMICORT 0.M INJ 3ML SEPTRIN PAED TAB SEROXAT TAB 20MG SOLPADEINE CAPSULE SOLPADEINE SOLUBLE TAB STELAZINE SPANSULES 10MG STELAZINE SPANSULES 15MG STELAZINE SPANSULES 2MG STELAZINE SYRUP 1MG/5ML STELAZINE TAB 1MG STELAZINE TAB 5MG STEMETIL 5MG TAB STEMETIL INJ 12. TAB.

C.Registered Suppliers Index CALAZOL CREAM COLI-URINAL EFFER GRANU DERMOCORT CREAM D-GAM 250IU VIAL D-GAM 500IU VIAL D-GAM 2500IU VIAL DRIED FACTOR VIII TYPE 8Y 25IU/ML VIAL GLOCLAV 375MG TAB GLOCLAV 625MG TABLET GLOMOX 125 MG / 5 ML SUSPENSION GLOMOX 250 MG / 5 ML SUSPENSION GLOMOX 250MG CAP GLOMOX 500MG CAP GLOTAC 150 MG FILM COATED TABLETS GLOTAC 300 MG FILM COATED TABLETS INDOMETHACIN CAPS 25MG LANSOMID 30 MG CAPSULE MIDAFLEX 125MG/5MLSUSP MIDAFLEX 250MG /5ML SUSP.C. TAXOTERE 20MG VIAL +SOLVENT TAXOTERE 80MG VIAL +SOLVENT TRITANRIX HB+ HIBRIX 1 DOSE VIAL TRITANRIX-HB 10ug/ML 0. CAPS.C TAB NOVO-ATENOL 100MG TAB NOVO-ATENOL 50MG TAB NOVO-CAPTORIL 12.TAB ‫ز ت‬ ‫دو وا‬ ‫ا وط‬ ‫ا ؤ‬ ‫اط‬ _______________________________ ALGEX BALSAM BILICANTE 200MG CAPS CEVITAN EFFER. NEO-HAEMORRHAN OINT PARAMOL 500MG TAB.TAB ZIAGEN 300MG TAB ZOVIRAX 800MG/10ML DS SUSP ZOVIRAX CREAM 5% ZYPREXA 10MG F. NOVAMOXIN 500 MG.V BOTTLE VITOP CAP ZENALB-20 STERILE LIQUID TAGAMET 200MG/2ML AMP TAGAMET TABLETS 400 MG. INJ.C TAB NOVASEN 650MG E.TAB OCAL EYE BATH SILVER NITRATE EYE DROP SOPALAMIN 3B VIAL ULTRA-K SYRUP ‫دو وا د ت ا ط‬ ‫دة‬ ‫ا‬ ‫ا ر‬ _______________________________ NOVAMOXIN 250 MG CAPS. PARAMOL SYRUP 120MG/5ML PROMANTINE SYRUP REPLENINE-VF 500IU+10ML STERILISED WATER SEPTAZOLE TAB (400/80) TUSSIVAN SYRUP VIGAM LIQUID 5% I. 5MCG/ML INJ XYLOCAINE 1%WITH ADRENALINE INJ XYLOCAINE 2% JELLY XYLOCAINE 2%+ADREN. SPRAY 10 % XYLOCAINE.8ML XYLOCAINE 2%WITH ADRENALINE INJ SOLN XYLOCAINE 5% HEAVY INJ XYLOCAINE OINT 5% XYLOCAINE VISCOUS 2% XYLOCAINE.5MG TAB NOVO-CAPTORIL 25MG TAB NOVO-CAPTORIL 50MG TAB NOVO-DIFENAC 25MG TAB NOVO-DIFENAC 50MG TAB NOVO-DILTAZEM 30MG TAB NOVO-DILTAZEM 60MG TAB NOVO-DIPIRADOL 25MG TAB NOVO-DIPIRADOL 75MG TAB NOVO-DOXYLIN 100MG CAPS NOVO-GLYBURIDE 5MG TAB NOVO-NIFEDIN 10MG CAPS. NOVASEN 325MG E.C.5% INJ XYLOCAINE 0. NEO-HAEMORRHAN SUPP.5ML PRE-FILLED SYRRINGE VACCI VANCOCIN-CP 500MG/10 ML.5ML VIAL V-CIL-K 250MG TAB VELBE 10MG VIAL+SOLVENT 10ML VINCRISTINE ROGER BELLON 1MG/VIAL XYLOCAIN 10% SPRAY 10MG/DOSE XYLOCAINE TOPICAL SOLN 4% XYLOCAINE 0.TAB ZYPREXA 5MG F. SOLN 2% XYLOCAINE. CART1. VIAL VARILRIX 2000 PFU /0.5%W/ADREN. DNT.INJ SOLN 1% XYLOCARD 20% SYRING XYLOCARD INJ 2% XYLOPROCT SUPP XYLOPROCT OINT ZEFFIX 100MG F. MIDAFLEX 250MG CAPSULE MIDAFLEX 500MG CAPSULE MIDRONE EXTRA TAB MIDROXIL 250MG\5ML SUSP MIDROXIL 500 MG CAPSULE MIDROXIL 500MG\5ML SUSP. NOVO-PIROCAM 10MG CAPS NOVO-RANIDINE 150MG TABLET NOVO-RANIDINE 300MG TAB ‫ون ر و ر ھ‬ ‫روق و‬ ‫ر‬ ‫ھ‬ +966 (01) 4027628: +966 (01) 4010290: ACIDRINE TAB AERIUS 5MG TAB ALBUMAN BERNA ML 20% ALDACTIDE-25 TAB ALDACTONE TAB 100MG ALDACTONE TAB 25MG ALGESAL CREAM 10G/100G ALGESAL SURACTIVE CREAM ALVITYL SYR ALVITYL TAB AMARYL 1MG TAB AMARYL 2MG TAB AMARYL 3MG TAB ARTAMIN 150 MG CAPS ARTAMIN 250 MG CAPS ARTHROTEC TAB ATARAX SYRUP ATARAX TABLETS 10 MG _______________________________ ‫دو‬ ASKINE TAB BAUMALGINE OINT ‫دة‬ ‫ا‬ ‫ا ؤ‬ _______________________________ 31– A .5ML VIAL TRIZIVIR FILM COATED TAB TRUXAL TABLETS 50MG TWINRIX ADULT MONODOSE PREFLLED SYRINGE TYPHERIX 0.

2ML DIPROGENTA CREAM DIPROGENTA OINT DIPROLENE 0.C.25MG/5ML POWDER FOR SUSP CURAM 312.5 MG/5ML POWDER FOR SUSP CURAM 625 MG F. 15 MCG/0.U VIA INTRON A 18 MILIONIU/3ML V INTRON-A 10MN IU.U.V CYTOSAR VIAL 100 MG CYTOSAR VIAL 500MG CYTOTEC TAB 200 MCG DALACIN C 300MG CAPS DALACIN T LOTION 1% DALACIN T TOPICAL SOLN 1% DALACIN VAGINAL CREAM 2% DALACIN-C 150 MG CAPS DALACIN-C GRNU. INJ 1000U/ML HEPARINE SOD. INJ 5000U/ML HEPUMAN BERNA VIAL 400 I.V.VIALS CLARINASE TAB CLOMID 50MG TAB CODIPRONT SYRUP 100 GM COLESTID GRANULES 5GM SACHET COLLOMACK SOLUTION CORTEF ACETATE VIALS 50 MG/ML CURAM 156. ATARAX TABLETS 25 MG BANEOCIN OINTMENT BANEOCIN POWDER BETASERC 16MG TAB BETASERC 8 MG TAB BETRIMAX DRAGEES BIODROXIL 1 GM FILM COATED BIODROXIL 125MG\5ML BIODROXIL 250MG\5ML BIODROXIL 500MG/5ML SUSPENSION BIODROXIL500MG CAP BRAQUINOL H. 100 MG.5 G HEPARIN SOD.V.1% GARASONE E/E DROPS GARASONE E/E OINTMENT GARDINAL AMP 200MG GARDINAL TAB 100MG GARDINAL TAB 10MG GARDINAL TAB 50MG GELFOAM DENTAL GELFOAM SPONGE SIZE 12/7 MM GLOBUMAN BERNA GLUCANTIME AMPULE 1./5 ML FLAGYL 125 MG/5 ML SUSPENSION FLAGYL 250MG TAB FLAGYL 500MG SCORED TABS FLAGYL OVULES 500MG FORTA B-12 AMP FORTANEURIN AMP FORTEPEN 0.C TAB CYTOSAR 1GM VIAL I.TAB LANTUS 100 I.U.1% CELESTODERM-V GARAMYCIN OINTMENT CELESTODERM-V OINTMENT 0.TAB KEPPRA 500MG F.1% LOTION ELOCOM 0.TAB KEPPRA 250MG F.05% 32– A .1% GARAMYCIN OINTMENT 0.5MOL/L GLASS BOTTLE W/STOPPER DOTAREM 376MG/ML PREFILLED SYRINGE DROXARYL CREAM 5% DUPHALAC DRY DUPHALAC ORAL SOLUTION DUPHASTON 10 MG TAB DUSPATALIN 135 MG TAB DUSPATALIN 200MG PROLONGED RELEASE CAPS DUSPATALIN LIQUID 10MG/ML DUVADILAN 20MG TAB DUVADILAN RET 40MG CAPS EFFERALGAN 150 MG/5ML PAED.Registered Suppliers Index DIPROSONE OINTMENT 0. EFFERALGAN EFFERVESCENT TAB ELOCOM 0.5 MG CEREPAR TAB 75MG CHERACHOL-D SYRUP CIRRUS 5MG/120MG CAPSULE CLAFORAN 1 GM I.4GM INJ GARAMYCIN 0.3% E/E DROPS GARAMYCIN CREAM 0.M. HYPERSTAT 15MG/ML I. CREAM BRONCASMA BERNA 1ML AMP BRONCHICUM DROPS BRONCHICUM ELIXIR BUCCALINE BERNA CANDEREL TAB CANDRIL SACHETS CAVERJECT 20MCG VIAL CEFAZOLIN 0.1% CREAM ELOCOM 0./2 ML.SOLU./2ML DIPROFOS INJ.05% DISOPHROL S/A TAB DI-TE ANATOXAL BERNA FOR ADULT DI-TE ANATOXAL BERNA FOR CHILDREN DI-TE PER ANATOXAL BERNA DITEPERPOL VACCINE BERNA 1ML AMP DOTAREM 0.5ML INFLUVAC S.U / ML VIAL LANZOR 15MG CAPSULE LANZOR 30 MG CAPSUL LARGACTIL 100MG TAB LARGACTIL 25 MG. VIAL CLAFORAN 1 GM (LIDOCAINE) IM VIAL CLAFORAN 500 MG I. 75MG/5 ML DALACIN-C VIAL 150 MG / ML DAONIL 5MG TAB DELTASONE 5MG TAB DEPO MEDROL VIAL 40MG/ML SAS DEPO-PROVERA VIAL I/M 150MG/ML DICETEL TAB 50MG DIKACINE INJ 75MG DIPHUMAN BERNA VIAL 300 I.V INJ IMFERON INJECTION 50MG/ML INFLEXAL BERNA 0.1% CELESTODERM-V-GARAMYCIN CREAM CELESTONE CHRONODOSE 6 MG/ML AMP CELESTONE TABLETS 0.INJ.C.1% OINTMENT EULEXIN TAB 250MG EXODERIL CREAM 1% FAVERIN 100MG EC TABS FAVERIN 50MG EC TABS FEMOSTON 2/10 TAB FERRLECIT DROPS FERUMAT SYR.C.VIAL ISOMACK RETARD 20MG CAPS ISOMACK RETARD 40MG CAPS KANACYN AMP 0.C. AMP./I.5GM VIAL CEFAZOLIN 1GM VIAL CEFROM 1GM VIAL+10ML WATER FOR INFUSION CEFROM 2GM VIAL+20ML WATER FOR INFUSION CEFROM 500MG VIAL+5ML WATER FOR INFUSION CELEBREX 100MG CAPS CELEBREX 200MG CAPS CELESTODERM-V CREAM 0.5ML INTAL 5 INHALER INTAL NEBULISER SOLN 1% 2ML AMP INTAL SPINHALER CAPS INTRON A 25 MILION I.05% OINT DIPROLENE CREAM DIPROSALIC LOTION DIPROSALIC OINT DIPROSONE CREAM 0.5G/2 ML KANACYN VIAL 1G/4ML KEPPRA 1000MG F.05% DIPROSONE LOTION 0.

SOLU-MEDROL-INJ. TAB. TAB.5MG CAPS NITRO_DUR 0.WITH SOLVENT RETARPEN 2.VIAL+SOLVENT STANDACILLIN 1G VIAL WITH SOLVENT STANDACILLIN 500MG INJ WITH SOLVENT TARGOCID 200MG VIAL+DILUENT TARIVID 200MG F/C TAB LARGACTIL 25 MG. ROVAMYCIN TAB 1500000 I. 500 MG. LINCOCIN SYRUP 250 MG/5ML LOMOTIL 2. PROFENID 100MG SUPP.5ML SYRINGE MORUMAN BERNA VIALS MUCOPRONT 375MG CAPS MUCOPRONT SYRUP 280MG/ML NASONEX 0.5ML I.5% GEL PROFENID 50MG CAP PROFENID L. 10 MG SOLU CORTEF MOV 100 MG SOLU CORTEF MOV 250 MG VIAL SOLU-MEDROL INJ.4MEGA U.2 TAB MAALOX PLUS SUSP MAALOX PLUS SUSP.VIAL+SOLVENT SOMATOSTATIN-UCB250MCG LYOP.TAB SABRIL 500MG/SACHET SEDERGINE.DER.SYS NITRO-RUR 0. PROSTIN E2 0. NOOTROPIL 12GM/60ML INFUSION SOLU NOOTROPIL 800 MG FILM COATED NOOTROPIL AMP 1GM/5ML NOOTROPIL CAPS 400MG NOOTROPIL SOLN 20% OEDEMAX 40 MG.INF. LARGACTIL DROPS 4% LASIX AMP 20MG/2ML LASIX INFUSION SOLN 250 MG.AMP PROSTIN E2 0. PROFENID 100MG TAB PROFENID 2.U.5ML VIAL PEG-INTRON 50MCG\0.05% PHYSIOTENS 0.SY NITRO-DUR 0.TAB PLASIL WITH ENZYMES TAB POLARAMIN RA TABLETS 6 MG.V.5ML VIAL NETROMYCINE INJ 50MG/2ML VIAL NIFLURIL CREAM 3% TUBE NITRO MACK RETD 2. TAB SERENACE TAB 1./AMP RULID 150MG TAB RYNACROM 4% NASAL SPRAY RYNACROM M 2% WITH PUMP RYNACROM NASAL DROPS RYNACROM NASAL SPRAY 2% SABRIL 500MG F.5ML VIAL PEG-INTRON 150MCG\0. INJ.4 MG F.P 200MG TAB PRONTOPYRIN PLUS TAB.U VIAL.5 MG SERENACE TAB 5MG SERENACE.05% PERDERM OINT 0. OPTICROM 4% EYE OINT OPTICROM EYE DROPS 2% OSPAMOX 125MG/5ML SUSP OSPAMOX 250MG CAPS OSPAMOX 250MG/5ML SUSP. 500 MG. REGAINE 5% TOPICAL SOLUTION REGAINE TOPICAL GEL 2% REGAINE TOPICAL SOLN 2% REMICADE 100MG VIAL FOR INJ RETARPEN 1.2MEGA U. 5 ML.2MG/HR 10CM2TRNSDERM INF. LASIX TAB. TAB. 40 MG. SOLU-MEDROL MOV 40 MG INJ.SYS NIVAQUINE 100MG TAB NIVAQUINE INJECTION 100MG NIVAQUINE SYRUP 5 MG/ML.Registered Suppliers Index PENICILLIN-G SOD 500000 IU VIAL PERDERM CREAM 0.5 MG PROSTIN E2 VAGINAL TAB.2 MG F. EFF.C.05% NASAL SPRAY NAVELBINE 10MG/ML I/V VIAL NAVIDOXINE TABLETS NEO-CORTEF E/E OINT 1.4MG/HR 20CM2 TRAN. RUBEATEN BERNA+SOLV 0.75ML AMP PROSTIN E2 1MG VAGINAL GEL IN APPLICATOR PROSTIN E2 2MG VAGINAL GEL IN APPLICATOR PROSTIN E2 TAB 0.5ML SYRINGE RUBEUMAN-BERNA 30000 I.3MG/HR 15CM2TRNSDERM INF. OSPAMOX 500MG TAB OSPEN 1000 TAB OSPEN 200 GRANULES FOR SUSP OSPEN 400 GRANU.5ML VIAL PENICILLIN G INJ 1 MILLION IU 33– A .FOR SUSP OSPEN 500 TAB OSPEXIN 500MG TABLETS OSPEXIN GRANULES FOR SUSP 250 MG/5ML OSPEXIN IG TABLETS PANKREOFLAT TAB PARUMAN BERNA VIAL PEG-INTRON 100MCG\0.5MG GEL IN 3G SYRINGE PROFENID 100MG I. MAALOX PLUS TAB MAALOX SUSP MAALOX SUSPENSION MEDROL TAB 4 MG MELROSUM SYR MICRONASE 5Mg TABLET MONOMACK 20MG TAB MONOMACK 40MG TAB MORATEN BERNA 0. RIMACTAZID 300MG TAB.5MG TAB LONGIFENE 1% SYRUP LONGIFENE 25 MG TAB LOTRIDERM CREAM LURSELLE TAB 500MG LYSSAVAC N BERNA MAALOX NO.5% NEO-MEDROL ACNE LOTION NEOMYCIN NASAL SPRAY NEOMYCIN-HYDROCORTISOINE OINT NETROMYCINE INJ 150MG/1.5MLVIAL PEG-INTRON 80MCG\0.C TAB PHYSIOTENS O.C. 125 MG SOMATOSTATINE-UCB 3MG LYOP. SOLU-MEDROL.M VIAL+SOLV. VIAL+SOLVENT RETARPEN 600000U+ SOLVENT VIAL RHESUMAN BERNA 250MCG I/M RHINOPRONT CAP RHINO-PRONT NOSE SPRAY RHINOTUSSAL CAP RHONAL TAB 500MG RIFADIN CAP 150 MG RIFADIN CAP 300 MG RIFINAH TAB 150MG RIFINAH TABS 300MG RIMACTANE 150 MG CAP.5ML VIAL PEG-INTRON 120MCG\0. 1000 MG. POLARAMIN SYRUP 2MG/5ML POLARAMINE EXPECTORANT SYP POLIOMYELITIS VACCINE BERNA PREPIDIL 0. RIMACTANE 300 MG CAP. LATYCIN E/E OINT 1% LINCOCIN CAPS. 3 MG PROSTIN VR AMP PROVERA 100MG TAB PROVERA 5MG TAB PZA 500 MG TAB.

FOR INJ XYZAL 5MG F.5G INJ THIOPENTAL 1G VIAL TILADE MINT METERED DOSE AEROSOL 2MG/INH TILAVIST EYE DROPS 2%W/V TINADERM SOLUTION 1% TOCLASE 25MG TAB TOGAMYCIN 2 G.U. VIAL TOLINASE TAB TOSUMAN BERNA TRAZOLAN 100MG TAB TRENTAL 300MG AMP(15 ML) 34– A .TAB TARIVID I.1% ORAL SOLN.V INFUSION TAVANIC 500MG F. TAB 1GM URBASON TABLETS 4 MG VACUMAN BERNA 1000 I. INJ.C.V2MG/MLSOLUTION FOR INFUSION TAVANIC 250MG F.C TAB TE ANATOXAL BERNA TEBRAZID TAB 500MG TELEBRIX 12 SODIUM 120MG/ML INFUSION TELFAST 120 MG FILM COATED TAB TELFAST 180 MG FILM COATED TAB TETANUS ANTITOXIN BERNA 1500 I.25MG XANAX TAB 0. VACUMAN BERNA 500 I.U.C TAB TAVANIC 5 MG /1 ML SOLUTION I. TETANUS ANTITOXIN BERNA 20000 TETANUS ANTITOXIN BERNA 40000 TETUMAN BERNA TEVETEN 600MG TAB THIOPENTAL 0. XENETIX 350MG IODINE/ML SOLN.U.Registered Suppliers Index TRENTAL TAB 400MG TRILAFON 4MG TAB TUSCALMAN SYRUP ULCAR 1G TAB UNICAP M TAB UNICAP T TAB UPSA-C EFFER.5MG XENETIX 300MG IODINE/ML SOLN FOR INJ.TABLET YUTOPAR I/V AMP 50MG/5ML YUTOPAR TAB 10MG ZYRTEC 0. ZYRTEC 10MG F.C. VIVOTIF BERNA CAPS XALACOM EYE DROP XALATAN 50MCG\ML EYE DROP XANAX 1MG TAB XANAX TAB 0. VIAREX INHALER 50MCG/INHALATION VIONEURIN-6 TAB.

ا‬ ‫را‬ ‫س ھ ا‬ ‫ھو ت ا ر ط‬ ‫ھر س ا و ر‬ ‫ا ش ورا ر‬ ‫)ز ( ا ر ط‬ ‫ا راز‬ ‫)ا را( ا و د‬ ‫ا راز‬ ‫ر) ر ر (ا ر‬ ‫ا س‬ ‫ا س ر ) غ( . ت ا ر‬ ‫ر ردأد ر كا ر‬ ‫ا رط‬ ‫ر ور‬ ‫وا ر‬ ‫ـر‬ ‫ك.ش .م‬ ‫ا ر‬ ‫ا دو ا رد‬ ‫ا ر‬ ‫تا و -‬ ‫دو و ا‬ ‫ا ر‬ ‫ا ر )ا ت(‬ ‫را و ك ور ور ن ) و و (‬ ‫ا‬ ‫ا ر‬ ‫ا ر اد ر‬ ‫ا ھرة ا ر‬ ‫ا ون ا ر‬ ‫ا ون وزى ا‬ ‫ا ون و رت‬ ‫ا ر نا ر‬ ‫ا ر نا ر د‬ ‫ت ا دوا ا رد‬ ‫ا دة‬ ‫ت ا دوا ا رد‬ ‫ا ر زا ر‬ ‫ن‬ ‫ل وم ا‬ ‫جا‬ ‫ا ر ز ا وط‬ ‫وا رب‬ ‫ل‬ ‫وا ف ا ر و ا‬ ‫ا ر‬ ‫ا‬ ‫اط‬ ‫ا ناط‬ ‫و ت ا دوا ا ر‬ ‫ا ر‬ ‫ا ل دو‬ ‫ت ا دوا ) د و(‬ ‫او ا‬ ‫ا ر‬ ‫ا ر م ھ ث -ا رو‬ ‫او ا ر‬ ‫اور ون ا و د‬ ‫اور ون ا د‬ ‫او ر -ا و د‬ ‫و‬ ‫او ر و و ا‬ ‫اوم ا و ر‬ ‫ان.‫‪Index of manufacturers‬‬ ‫‪Index of manufacturers‬‬ ‫ا ل ر را ر‬ ‫أ و ت ا ر‬ ‫و‬ ‫أف ر ا‬ ‫. .ا ر د‬ ‫ج ا دو‬ ‫ا رد‬ ‫در ا ر‬ ‫ا‬ ‫ا رد‬ ‫ا‬ ‫ت ا دوا ) ر(‬ ‫ا‬ ‫ت ا دوا -ا رد‬ ‫ا رام‬ ‫ت ا دوا ا رد‬ ‫ا رق ا و ط‬ ‫ت ا دوا و‬ ‫ا ر ا ود‬ ‫ز ت ا ط )ا دوا (‬ ‫ا‬ ‫ت ا دوا‬ ‫ا ر ا و ا ود‬ ‫ت ا دوا ا ر .ان _ ا ر‬ ‫رك د ز ا ر‬ ‫رك د ز ) و ل( ا ر‬ ‫رك د ز ا ر‬ ‫ز‬ ‫رك د زا‬ ‫ـ ر ور ور ن ا ر‬ ‫ر ھ ث ر)اھ دا( ور ر و‬ ‫و‬ ‫ر ا.م. .ا و ر‬ ‫اي‬ ‫اي ر ن ا ط‬ ‫ا وا ر‬ ‫و‬ ‫ا وي ا‬ ‫ا و ر و ل ا را‬ ‫ا ىا‬ ‫ا و را ا ر‬ ‫إ ـ ا و ر‬ ‫أ وت ا ر‬ ‫أ وت ا را‬ ‫أ وت ا ط‬ ‫أو سا د‬ ‫أ س ر ) ون( ا‬ ‫أ نا ر د‬ ‫أ ر رو د ا ر‬ ‫آي.ج )ا و ( ا‬ ‫را‬ ‫را ـــس ا ر‬ ‫را و ا ط‬ ‫ر ول ر ن‬ ‫ر ول رز ا ط‬ ‫ر ول رز و ب -ا ط‬ ‫ر ول رز و ب ا ر‬ ‫ر ول رز و ب ا‬ ‫) و ب(‬ ‫ر ول رز و ب ا ر‬ ‫ر ول رزا ر‬ ‫) و ب(‬ ‫ر ول رز و ب ا و‬ ‫ر ول ر ا‬ ‫رودس ا‬ ‫لا ر‬ ‫رو ر ا د‬ ‫ز‬ ‫وس ا‬ ‫و كا و‬ ‫ما رط‬ ‫وھر ر ا‬ ‫ما ر‬ ‫وھر ر ا‬ ‫م ا‬ ‫وھر را‬ ‫. راون ا‬ ‫ر ا و ر‬ ‫ز‬ ‫م رود س ا‬ ‫ل( ا ر ط‬ ‫و رود ت ب )‬ ‫و ت ) وو ( ا‬ ‫‪1–B‬‬ .

ك ا‬ ‫دا را ا و د‬ ‫دار ا دواء ا رد‬ ‫دو ر ت ا‬ ‫د وت ر و ل ا ر‬ ‫ا د‬ ‫ر‬ ‫روا ر‬ ‫روا وا ر ا‬ ‫رو ز ا ر‬ ‫رو ل ا ف ا ر‬ ‫رو ل ا ر ط‬ ‫روش ا و ر‬ ‫روش ا ط‬ ‫روش ا ر ط‬ ‫روش ا ر‬ ‫روش ر زاخ ا‬ ‫م‬ ‫روش دا و ك ) وھر ر‬ ‫را ر‬ ‫ا‬ ‫روش و س ا ر‬ ‫ا ر (‬ ‫رون ك رورر)‬ ‫(‬ ‫رون ك ) ر ن ا‬ ‫ر رد ن ر ل ا ر ط‬ ‫ر وردا ا ط‬ ‫ز ردا و ر‬ ‫و ] رو دي[ ا ر‬ ‫و‬ ‫ز‬ ‫وا‬ ‫و‬ ‫و] .ا ا ط‬ ‫ت ا دوا -ا ردن‬ ‫ن‬ ‫ر وا ر‬ ‫ر درق‬ ‫ر ون ا و ر‬ ‫ا ط‬ ‫ر‬ ‫ا ون ا و د‬ ‫ر‬ ‫أ ون )ا ون ا ر ط [‬ ‫ر‬ ‫(‬ ‫أ ون )ا ون ا‬ ‫ر‬ ‫أ ون )ا ون( ا ر‬ ‫ر‬ ‫ا و د‬ ‫ر‬ ‫زر ا‬ ‫زر ا ط‬ ‫زر ا‬ ‫زر ا ر‬ ‫زر ا ر‬ ‫زر ا را‬ ‫ر ر ا ر و ل اس .‫‪Index of manufacturers‬‬ ‫(‬ ‫ر‬ ‫دا ا‬ ‫ورا‬ ‫ر د ز د‬ ‫وسا و ر‬ ‫ري ا م _ ا ر ط‬ ‫در ا ر‬ ‫جا ط‬ ‫ن‬ ‫جا ر‬ ‫ن‬ ‫رو ل ا‬ ‫ش ا و ر‬ ‫وا رط‬ ‫وا رط‬ ‫و و م رود ن ا ر‬ ‫ز‬ ‫وو م )و م.رو -[ ا ر‬ ‫و‬ ‫[ ا ر‬‫و] ر‬ ‫و‬ ‫ود ت ا ر‬ ‫لا ر د‬ ‫ ورد‬‫م ال‬ ‫ن‬ ‫ث‬ ‫ز‬ ‫ا‬ ‫م ور ور ن. ا و د‬ ‫و‬ ‫(‬ ‫ر ا‬ ‫ر و ز)‬ ‫و‬ ‫و و وا‬ ‫ز‬ ‫. . دى رل ا‬ ‫.ب .ال ا و ر‬ ‫ل اد ر‬ ‫ر‬ ‫و‬ ‫روت ا‬ ‫د.ا ا‬ ‫ام ا ش‬ ‫د‬ ‫دو‬ ‫ر ز وس‬ ‫ا‬ ‫.‬ ‫ن‬ ‫‪2–B‬‬ .رو‬ ‫ال‬ ‫م.( ا‬ ‫ف ا ت ا را‬ ‫ا‬ ‫ود‬ ‫.و وھو ن‬ ‫ن‬ ‫ث‬ ‫ا ر‬ ‫ث‬ ‫ز‬ ‫ا‬ ‫ن. ر و ل ) و و ( ا‬ ‫د در ا‬ ‫زون ا ر‬ ‫رم ا و ر‬ ‫ر‬ ‫ر ا ر‬ ‫رو و ا ط ) و و (‬ ‫رو و ا ط‬ ‫رو و ا و ر‬ ‫ت ا دوا )ا ز رة(‬ ‫ر ا ز رة‬ ‫و ا ر ا ود‬ ‫ر‬ ‫ت ا دوا ا رد‬ ‫ر ا ة‬ ‫ا دوده‬ ‫ت اط ا‬ ‫ر ا‬ ‫ا ود )ا ر ض ار (‬ ‫ا‬ ‫ر ار ون ا ر =أ ت ا‬ ‫د وت‬ ‫ت ا دوا ا طورة ا رد‬ ‫ر ا‬ ‫وار ز ر ا‬ ‫و ن وش ا د و ب ا ر ط‬ ‫ر ا‬ ‫و ا د‬ ‫ر‬ ‫وا ر‬ ‫ر‬ ‫و ر ا ر دا‬ ‫ر‬ ‫ر سباا ط‬ ‫تا ط‬ ‫ل وا‬ ‫ا‬ ‫رون اس‬ ‫ر اس اي ا ر‬ ‫و ا‬ ‫ر‬ ‫ر و س . دى رل ا ر‬ ‫ز‬ ‫.ف. م ر ا‬ ‫ث‬ ‫ثو وا رط‬ ‫و را‬ ‫ر ا ر‬ ‫و‬ ‫ر و ز .

ا‬ ‫و دا و‬ ‫زون ا و ر ) و ر ز(‬ ‫ا س ر ا ر‬ ‫ر ا‬ ‫ا‬ ‫ت ا دوا‬ ‫ا ر ا دو ا رد‬ ‫ت ا دوا ا‬ ‫ا ر ا وط‬ ‫تا د -‬ ‫ا ر ا ود ا‬ ‫‬‫ر ا‬ ‫اور‬ ‫ا ر‬ ‫ا‬ ‫ا ر‬ ‫ا‬ ‫ا رط‬ ‫ا‬ ‫ول ا‬ ‫أ وت‬ ‫أ س ر ا رط‬ ‫أ س ر ا ر‬ ‫أم أ ش ا‬ ‫د‬ ‫أ س ر دو‬ ‫ز (‬ ‫أ س ) زو ز ا‬ ‫ر ا و و " رس" ا‬ ‫ن ر‬ ‫)‬ ‫جا‬ ‫ن-‬ ‫(‬ ‫ا‬ ‫ن. .‬ ‫.دوم ا و د‬ ‫رك.ا ر د‬ ‫ز‬ ‫ور ن ا‬ ‫ور ن ر ا ر‬ ‫و رزا‬ ‫و ر ز )ز ( ا و ر‬ ‫(ا و ر‬ ‫و ر ز)‬ ‫و ر زا‬ ‫و ر زا رط‬ ‫و ر ز ر ) دوز( ا و ر‬ ‫و و ورد ك ا د ر‬ ‫و و رم ا دودة دا‬ ‫ل.‫‪Index of manufacturers‬‬ ‫ر را‬ ‫ور ر ا ر‬ ‫و د ا را‬ ‫ر _ا و د‬ ‫ر ا‬ ‫ر اد ر‬ ‫(‬ ‫ور ا ر و ل )ا‬ ‫ور إ ر و ل ا و ر‬ ‫ل‬ ‫ور د ل ا و ر .ور ور و‬ ‫ن‬ ‫ث‬ ‫ت ا دوا‬ ‫وك‬ ‫ر‬ ‫ر ھ نا‬ ‫د ا رد‬ ‫‪3–B‬‬ . و د ك ا د ر‬ ‫و‬ ‫د و د ر ا‬ ‫ھ‬ ‫وا ت ھول ا ر‬ ‫وا ـث ا ر ط‬ ‫وا ث اا د‬ ‫وا ـث ا‬ ‫وا ث د ل ا ر د‬ ‫وا ر ر ا‬ ‫و ــت واردا ر‬ ‫وروب ب.ش.ف.ج ا و ر ) ج إ ر و ل‬ ‫ا و ر (‬ ‫رو ل ا و ر‬ ‫ن ا ر د‬ ‫و ت‬ ‫ن ا را‬ ‫و ث‬ ‫.‬ ‫و ث‬ ‫ن ا را‬ ‫و ث‬ ‫نا د‬ ‫و ث‬ ‫ن ر‬ ‫و ث‬ ‫وو ما‬ ‫وو ما ر‬ ‫و ل ر ا را‬ ‫دو ر ا ر‬ ‫(‬ ‫ً و‬ ‫أم ا ش )‬ ‫دوز‬ ‫و‬ ‫ا‬ ‫و ] زارن د س[ ا ر‬ ‫و‬ ‫و ]رو ن د س[ ا ر‬ ‫و‬ ‫ز‬ ‫م ] ر ھ ث[ ا‬ ‫ن‬ ‫ث‬ ‫م ر و.ا‬ ‫روش رون ا ر‬ ‫رت ا ر‬ ‫تا ط‬ ‫وري‬ ‫ي وك‬ ‫و‬ ‫در ا ر‬ ‫در ا ر ط‬ ‫دا‬ ‫رس د‬ ‫واد ر‬ ‫ر ون رل داووا ر‬ ‫كا‬ ‫داوس ا‬ ‫رات ا ط‬ ‫ر‬ ‫ل ا ط ا دوده‬ ‫ا‬ ‫وم دو‬ ‫ل رتا ر‬ ‫ل د ور و ا‬ ‫د ر ) وو ( ا ر‬ ‫س ا و‬ ‫ا‬ ‫د و ون ا ر‬ ‫رز ا‬ ‫رك رب ودوم ا را‬ ‫رك رب ودوم ر‬ ‫ا‬ ‫رك‬ ‫رك.‬ ‫وا‬ ‫ون‬ ‫و دا ر د‬ ‫ھـ. .‬ ‫ن ا وو .‬ ‫ا ر‬ ‫ر رز إ ر ن ا ر‬ ‫رو د را و س ) و د( ا ر ط‬ ‫ول ا ج ) ورد ك( ا‬ ‫و ل. رب ودوم ا ر‬ ‫ر ا‬ ‫ا و ر‬ ‫ل(‬ ‫)‬ ‫وا ر‬ ‫ور ن وا ر وردا دودة.ا و د ) رو دس (‬ ‫و‬ ‫و.

‫‪Index of manufacturers‬‬ ‫ورا ور ز أ س )ا‬ ‫ن ا را‬ ‫اس ا اس ا ر‬ ‫رك‬ ‫و‬ ‫لا‬ ‫رك‬ ‫ر ما و ر‬ ‫و.‬ ‫ر(‬ ‫‪4–B‬‬ . .

96 ADALAT. 73 AMOXYDAR. 14 Adenosine. 112 ANDROCUR. 117 ALUGEL. 58 ADOL PM. 103 ACTRAPID INSULIN HM. 36 AERRANE. 164 ALPHANATE. 41 ADRIBLASTINA. 144 ALUPENT. 18 Alendronate. 42. 13 Amiodarone. 57. 86 AGGRASTAT.Scientific Name And Trade Name Index Scientific Name and Trade Name Index Abacavir. 14 Amitriptyline. 95 Acarbose. 73 AMRIZOLE. 59 ADOL ALLERGY SINUS. 58. 57 ACICARE. 100 Albendazole. 4 Aluminum aspirin. 29 ACIVIR. 35 Acetazolamide. 72. 27 Alprazolam. 100 ALCOMICIN. 40. 71 AMOXIPEN. 37 ANALUX COLIRCUSI. 141 Amantadine sulphate. 168 Acyclovir. 41 ACTOS. 41 ADOL COLD. 80 Amikacin sulphate. 162 ANATENSOL. 4. 26 AHF CONCENTRATE KABI. 57 Acetyl salicylic acid microfined. 88 AMURETIC. 23 Adapalene. 103 ACUITEL. 170 ALDACTIDE. 151 ALOMIDE. 193 ALPHAGAN. 191 AFIMOCIL. 41 ALLERGODIL. 104 AMBOLAR. 123 ALLERFIN. 66 AMARYL. 72 Amoxycillin. 105 ACCOLATE. 105 ACTRAPID HM. 73 AMOXIL. 171 Allopurinol. 56. 57 ADOL EXTRA. 164 Acetyl salicylic acid. 13 ANACIN. 26 AGLUMIN. 13 ALDACTONE. 96 ACNEDERM. 27 ALBENDA. 22 AMOCLAN. 48 ANALLERGE. 41. 22 AMLOR. 187 ACTIFED. 59 ADOL SINUS. 56 ADOL. 154. 71. 72 Ampicillin. 180 ADENOCOR. 48 Amlodipine besylate. 5 ADIPRIN. 140 ALFACORT. 39 AMFIPEN. 80 Amiloride. 57 ALKERAN. 179 Alfuzosin. 44 Alprostadil. 5 ACIDO NALIDIXICO. 72. 56 ANAFRANIL. 20 ACULAR. 37 ALLERGETIN. 90 Acipimox. 41 ADOL DROPS. 146 ADVIL COLD AND SINUS. 73 AMIKACIN. 114 Alfacalcidol. 6 ACICONE. 13 1–C ALDOMET. 123 ADVIL. 194 . 127 ACT-Hib. 180 ACNELIN. 33 ALVITYL. 42 AERIUS. 45 ANDRIOL. 14 ADIATIN. 120 ALKA-SELTZER. 112 ANEXATE. 160 ALPAX.

138 BECOZYM. 21 ATACURE. 171 BECODISKS. 155. 145 ARIXTRA. 10 ANZATAX. 81 Aztreonam. 193 ATRACURIUM BESYLATE. 192 Atropine sulphate. 10 ANUSOL. 155 APO-AMILZIDE. 193 ATROPINE. 159 APIMOL. 20 ANTAGONIN. 128 Azathioprine. 49 AXID. 23 APO-DOXY. 171 Azithromycin. 105 AVANDIA. 188 Anti-venum immunoglob. 138 BEFOLVIT. 140 ASKINE. 159 APICROM. 188 Anti-parotitis immunsglobulin. 85 BAMYCODE. 151 ARCOXIA. 134. 187 AVENTYL. 161. 90 AVANDAMET. 166 APISULFA. 106 AVAXIM. 13 APO-ATENOL. 193 ATARAX. 37 Atenolol. 188 Anti-venom immunoglobulin. 73 AUNATIV. 6 AZACTAM. 160 APIFRIN-Z. 57 ASTHALIN. 56. 32 ATACAND. 6 Apraclonidine. 182 BALKACYCLINE. 84. 83. 33 ATTENUVAX. 29 Atosiban. 74 BACTALL. 188 ANTI-SCORPION VENOM F(ab)2. 187 AUGMENTIN. 189 ANUGESIC. 57 ASPRO. 139. 171 BECOVIT. 79 APO-GLYBURIDE. 161. 3 Ascorbic acid. 104 APO-NAPROXEN. 145 APO-DILTAZ. 192 ATROPINE SULPHATE. 10 ANUSOL HC. 42 Benazepril. 81 AZOMYCIN. 72. 118 Atovaquone. 188 ANTIPLATE. 32 ASPEGIC. 19 2–C . 15. 138 BENAFED. 35 BECONASE. 56 ASMADIL. 159 Antazoline. 80 BALKAPROFEN. 26 Anti-rho(d) immunoglobulin. 37 ASMANORE. 159 Antimeasle imunoglobuline. 57 Basiliximab. 180 Azelastin. 147 APO-RANITIDINE. 21 APUROL. 99 Atracurium besylate. 32 ASMAFORT. 162 APIGEN. 15 APO-DICLO. 172 BALAD. 17 ATIVAN. 128 Azelaic acid. 74 AZAMUN. 89 BACTRIM. 146 BALKATRIN. 44 Atorvastatin. 192 ATROVENT. 161. 163 APISAL. 149 ARTHROTEC. 145 ASACOL. 6 Antazolin sulfate. 167 APROVEL. 128 Beclomethasone dipropionate.Scientific Name And Trade Name Index ANGIOTEC. 165 APICORT. 188 AVALOX. 171 APILLERG. 85 BACTROBAN. 57 ASPINOL. 35. 25 AROMASIN. 57 ASPIRIN. 130 ARTAMIN. 127 APICARPINE.

179 Bumetanide. 175 BETAFERON. 57 CALSYR. 61 Carbenoxamine. 40 BRONEX. 74 Bisacodyl. 140 Calcium carbonate. 59 CAFERGOT. 176 BETASERC. 18 3–C . 176 BETAVAL-N. 16 Caspofungin. 13 Bupivacaine. 3. 60 CALCIJEX. 13 BUSCOPAN. 134. 114. 15 BI-TILDIEM. 166 CARDURA. 12. 19 Captopril. 195 BUPIVACAINE. 156. 40 BRONCHOBOS. 183 CANDIVAST. 137 BETACHOL. 166 Benzocaine . 28 BEZALIP. 115 Calcitriol. 44 BUTALIN. 125 Carboxymethylcellulose. 195 Budesonide. 91 Candesartan. 137 CALTRATE. 32 Cabergoline. 108 BETADERM. 40 Carbomer. 106 Carbocysteine. 140 CALPOL. 140 Calcipotriol. 137 Calcium folinate. 91 CATAPRES. 92 CANDIZOL. 28 BIODROXIL. 35.Scientific Name And Trade Name Index BENDAZOLE. 39 Bisoprolol fumarate. 93. 137 CAMCOLIT. 40 BRONQUIUM. 56 BETASONE. 126 CANCIDAS. 129 BETAGAN. 139 BETOPTIC. 170 Benzoxonium. 171 Bufexamac. 56 Betamethasone. 108. 163 Carvedilol. 66 Carbimazole. 195 BURINEX. 158. 32 BUTOVENT. phenazone. 48 CAMPTO. 137 BEVACOL. 183 CANESTEN. 170 CANESTIN-1. 166 Carboplatin. 91. 175 BETAVAL. 91 CAPOCARD. 176 Betaxolol. 152 Carteolol hydrochloride. 12. 125 CARBOPLATIN. 15 BLOPRESS. 156 BLOKIUM. 34 BRUFEN. 19 Carisoprodol. 180 Benzyl penicillin sodium. 13 BURINEX-K. 108. 139 Calcium gluconate. 32 Brimonidine tartarate. 66 CAFAMOL. 16 BRICANYL. 134. 21 BREVIBLOC. 9 BISOLVON. 22 BLEPHAMIDE. 175. 179 Calcitonin. 146 BUCAINE. 172 Benzoyl peroxide. 44 Brompheniramine. 40 Carbetapentane. 156 BETACORT. 163 BETOLVEX. 2 Buspirone. 38 Carbidopa. 137 Calcium lactobionate. 163 Betahistine. 139 CAL-C-VITA. 100 BENEXOL. 19 CARBATOL. 21 CANDICORT. 137 BENOXINATE. 134. 164 Bromazepam. 3 Bezafibrate. 163 BETRIMAX. 137 CALCIUM LEUCOVORIN. 94. 71 BEROTEC. 32 BETABION.

89 CIPROCIN. 76 CEFUTIL. 77 CEFIZOX. 76 Cefuroxime sodium. 154 Chlorhexidine. 12 CHORIOMON. 113 Chorionic gonadotrophin. 77 Cefixime. 117 CEBION. 170 CILOXAN. 89 CIPTADINE. 172 CHLOROHISTOL. 89 Cilazapril. 75 Cefdinir. 77 Ceftazidime. 154 CHLOROQUIN PHOSPHATE. 37 CHLOROPTIC. 5 Cimetidine. 121 CIBACEN. 139 CEVITAN. 75 CEFAZOLIN. 77 CEFOBID. 74 CEFAMEZIN. 54 CIPRALEX. 37 Chlorpropamide. 176 CELESTODERM-V-GARAMYCIN. 83 Chloramphenicol. 176 CELESTODERM-V GARAMYCIN. 179 CENTRUM. 99 Chloroquine phosphate. 156 CETAVLEX. 83. 76 Cefaclor. 50 CIPROBAY. 76 CEFZIL. 139 CEVITIL. 128 CELLUVISC. 37 4–C . 89. 77 Cefoxitin sodium. 19 CIFLOX. 74 Cefadroxil. 75 Cephepime. 28 CIPROFLACIN. 54 CETAMIDE. 89 CIPROFLOX. 123 CHLORAMEX. 154 CIPRODAR. 85 CHILDRENS ADVIL. 144 CELESTODERM-V. 75 CEPOREX. 78 Cefuroxime axetil. 104 Chlorthalidone. 75 CEFROM. 119 CILOPRINE. 155 CETAPRED. 76 CELEBREX. 77 Cefpirome. 37. 75 Cefazolin. 5 Cinnarizine. 41 CHLORPHENIRAMINE. 36 Cetrimide. 89 Ciprofloxacin. 141 CEPHADAR. 154 CIMEDINE. 57 CECLOR. 113 CIALIS. 75 Cephalothin sodium. 78 Cefprozil. 139. 119 CEREPAR. 140 CEBIOPIRIN. 77 Ceftriaxone. 176 CELESTONE. 41 CETRALON. 76 CEFADRIL. 89 CIPROQUIN. 99 CHLOROQUINE. 51 CIPRAM. 78 CEFTAX. 20 CILEST. 77 Ceftizoxime. 76 CEFUZIME. 75 Cephalexin. 89 CIPROLON. 184 CEVILENE. 78 Cephradine. 108 CELLCEPT.Scientific Name And Trade Name Index CAVERJECT. 144 Celecoxib. 154 CIPROGEN. 139 CHEMOTRIM. 99 Chloroquine. 76 Cefperazone. 76 CEFRIN. 77 Cefotaxime. 146 Chlorambucil. 89. 184 Cetirizine dihydrochloride. 75 CERAZETTE. 166 Centella extract. 99 Chlorpheniramine. 89 Ciprofibrate. 36.

81 CLARINASE. 77 CLAMYCIN. 41. 149 CORTIPHENOL-H. 82 Clindamycin. 41 Clarithromycin. 154 COLIRCUSI DEICOL. 82. 18 CLOPIXOL. 155 CONTRASAL. 123 CYKLOKAPRON. 157 COLIRCUSI GENTADEXA. 42 CO-DIOVAN. 48 Clonazepam. 91 COLIRCUSI ATROPINE. 38 CONVULEX. 181 COLMEDITEN. 83 CLINORIL. 148 CLIOCORT. 50 CITIUS. 70. 181 CONFORTID. 171 CLEXANE. 113 Co-trimoxazole. 123 CYTARABINE. 47 CLORACEF. 175 Clobetasol propionate. 188 CODAPHED. 20 COVIT. 42 CODILAR. 113 Clomiphene citrate. 151 Colestipol. 21 COBAL. 179 CLOBEDERM. 48 CORDARONE. 118 CLINDACIN-T. 123 CYTOTEC. 37 Cyproterone acetate. 158 CORTROSYN. 170 Clotrimazole. 175 Clofazimine. 96 CYCLOGYL. 156 COLIRCUSI GENTAMYCIN. 85 COUMADIN. 124 CYTOBION. 151 COLOPATHIL. 193 Cisplatin. 4 COLPERMIN. 158 COLIRCUSI SULPHACETAMIDE. 113 Clomipramine hcl. 155. 148 CLOMID. 161 COLLOMACK. 161 COLIRCUSI CHLORAMPHENICOL. 125 CISPLATIN. 77 CLAFOTAX. 64 Clonidine. 42 Codeine. 171 COLIRCUSI H. 139 COBRA ANTIVENOM. 7 5–C . 83 CLINDAMYCIN PHOSPHATE. 139 CYTOSAR. 45 Coaltar. 14 CO-RENITEC. 3 COMBIVENT. 81 CLENIL. 61. 35. 170 Clozapin. 144. 134. 161 CYCLOPENTOLATE. 123. 60 CLOTREX. 125 CISPLATYL. 91. 72 CUSICROM. 146 CONJUNCTIN. 41 Cisatracurium besilate. 41 COLIFURAN. 175 Clobetasone. 139 Cyproheptadine. 87 CLOFEN. 112 Cytarabine.Scientific Name And Trade Name Index CIRRUS. 76 CLOTAN. 34 COMBIVIR. 161 Cyclophosphamide. 38 Colchicine. 125 Citalopram. 147 COZAAR. 25 CLIMEN. 163 CUSIVIRAL. 5 CLAFORAN. 134. 178 CLODERM. 96 CONCOR. 21 CURAM. 134. 15 CONDYLINE. 155 COLIRCUSI-CICLOPLEGIC. 27 COLFED. 140 COXICAM. 35. 38. 160 CUSIMOLOL. 25 COVERSYL.C WITH NEOM. 21 CODIPRONT. 26 CYNOVIT. 179 COAPROVEL. 20 CORTEF ACETATE. 145.

108 DIPROGENTA. 186 Dacarbazine. 145. 186 DIPHUMAN. 63 DIOVAN. 114 Desogestrel. 148 Diclofenac. 32 DISFLATYL. 172 DELTACORTRIL. 2 Diphetria toxoid.VAX. 158. 180 DIFLUCAN. 176 DEXAMETHASONE SOD. 191 Desloratadine. 40 Dexketoprofen trometamol. 177 DERMOSE CUSI NYSTATIN. 64 DEPO MEDROL. 104 DAUNOBLASTINA. 157. 177 Diflunisal. 22. 83 DALACIN C. 134. 148. 91. 164 DIPRIVAN. 120 6–C . 170 Dexamethasone. 112 DECLOBAN. 82. 144 Dextromethorphan. 83 Danazol. 17 DICLOFEN. 186 Diphtheria. 65 DIAZEPAM. 40 Dimethindene maleate. 44 Diazoxide. 94. 175. 179 DAKTACORT. 184 DAKTARIN. 99 Diltiazem. 145 Digoxin.Coq. 92 Diflucortolone valerate. 38. 94. 139 DERMA-CORYL. 109 DEPAKINE. 135 Desferrioxamine mesylate. 126. 182 DERMOLAR. 175 DECODERM. 115 DAONIL. 42 Dinoprostone. 184 DESFERAL. 93. 117 DINTOINA. 170 DERMESONE. 189 Dipivefrin. 96 DBL CYTARABINE.Scientific Name And Trade Name Index D. 177 DECOZAL. 12 DILATREND. 21 Diphenhydramine. 157.T. 83 DALACIN T. 126 DADCROME. 119 DEPOVIT B12. 105 DIAMICRON. 5 DISOPHROL. 149 Dexbrompheniramine. 26 DISBRON. 149. 105 DIAXINE. 104 DIALON. 175 DIPROLENE. 124 DECADRON. 22 DILZEM.PHOSPHATE.T. 148 DICYNONE. 137 DAGRAVIT B-COMPLEX. 144. 26 DIFFERIN.toxoid. 42 DIABINESE. 83 DALACIN-C. 170 DECADRON NEO. 144. 82. 135 Desflurane. 23 DIMETAPP. 164 DIAPHAGE. 167 DICLOGESIC. 36 Desmopressin. 108 DELTASONE. 170 DECADURABOLIN. 186 Dipht. 2 Diazepam. 170. 157. 176. 126 DETRUSITOL. 108. 123 DBL ACYCLOVIR. 186 Dipyridamole. 149 DEPO-PROVERA. 149. 158. 104 DIAMOX. 84. 16 Diloxanide furoate. 115 DANOL. 145. 42 Diphenoxylate. 175 Diptheria. 40 Distigmine bromide. 120 Dexametasone. 108. 119 DETICENE. 94. 158. 82. 186 D. 191 DIPROFOS. 176 DERMOCORT. 183 DALACIN. 179 DERMOFUCIN. 138 DAIVONEX. 160 DAGRAVIT A-E. 92 DERMATIN. 176 DIPROSALIC. 44.

159 EDRONAX. 68 ELDISINE. 88. 82 ERYPED. 79 DUOFEDINE. 109 DURADOX. 78 ENTOCORT. 24 Docetaxel. 145 DOLOMOL. 82 ERYDERM. 79 Doxycycline. 18 DOPAMIN. 24 Dopamine. 123 EPIVIR. 19 DOXORUBICIN. 177 ELOXATIN. 67 DOPRAM. 88 ELYZOLE. 82 Erythropoiein recombinant. 57 Domperidone. 139 Econazole. 82 ERYTHROCIN. 79 Dorzolamide. 160 Emedastine difumarate. 60 EROMYCIN. 125 Electrolytes. 123 DOXYCIN. 23 EPINEPHRINE. 109 DYSPAMET. 149 DRIED FACTOR VIII. 170 ECAVIT-B12. 3 DYAZIDE. 12 DOABETIC. 171 DOLGIT. 187 Enoxaparin sodium. 79 DUROGESIC TTS. 24 DOPAMINE. 75 DULCOLAX. 79 D-penicillamine. 156 DUMOLID. 160 E-MOX. 78 ERYC. 104 DOBUJECT. 127 ELYZOL. 38 DORAL. 82 Erythromycin base. 123 ENGERIX B. 159 EFEXOR. 44 DUMOXIN. 81. 135 Erythropoietin. 95 EPREX. 65 EPARGRISOVIT. 165 DOSTINEX. 149 DOLOBID. 135 7–C . 18 DOPERGIN. 82 ERYTHROMYCIN LACTOBIONATE. 140 EPICOCILLIN. 4 EPILAT. 72 Enalapril. 54 DOPAMET.Scientific Name And Trade Name Index DI-TE ANATOXAL BERNA. 136 ELIDIL. 52 EFFERALGAN. 92 ECONOPRED PLUS. 179 EFUDIX. 24 DOPANORE. 25 ENOXIRT. 186 DIUSEMIDE. 182 EMADINE. 7 EPIRUBICIN. 134. 27 Drospinenone. 66 Doxapram. 118 DROXIL. 80. 52 EFEMOLINE. 5 EARCALM. 141 EPHYNAL. 59 DUSPATALIN. 73 EPICOGEL. 179 ELOCOM. 135 Ergotamine tartrate. 82 ERYTHRODAR. 124 ELDEPRYL. 24 Dobutamine. 8 DUPHASTON. 59 EFFICORT. 9 DUMOCYCLIN. 82 Erythromycin. 3 EPANUTIN. 13 Dydrogesterone. 82 ERYTHROMIL. 192 DORYX. 38 Doxazosin. 41 DUPHALAC. 57. 43. 63. 195 EPIRAZOLE. 126 Docusate. 80 DUMOCYCLINE. 82 Ertapenem. 20 ENDOXAN. 76 DORMICUM. 79 DOXYDAR.

32 Fentanyl. 133 FERROGRAD-C. 34 EUPHYLLINE. 51 ESKACEF. 123 FARMORUBICIN. 28 Fenoterol hydrobromide. 191 FLOXAPEN. 88 FLAMAZINE. 144. 167 Fluoresceinate. 155 Famciclovir. 41 FLUANXOL. 130 EUPHYLLIN. 131 FEMOSTON. 6 FAMVIR. 133 FERTONIC. levonorgestrel. 149 FAVERIN. gestodene. 157. 61 FLAGICURE. 133 Ferrous fumarate. 97 FAMODAR. 124 8–C . 104 EULEXIN. 192 FERAL. 127 EUGLUCON. 182 Flavoxate. 146 FENDOL. 133 Ferrous sulphate. 136 FINALLERG. 92 FLUDARA. 147 FENICOL. 194 FLUMED. 133 FERROUS GLUCONATE. 167 FLUORETS. 119 FARMARUBICIN. 110. 61 Etodolac. 133 FERUMAT. 51 FLU_CARE. 109 Estradiol . 133 FER-IN-SOL. 154 Fenofibrate. 89 FASTUM. 36 Finasteride. 145 Etonogestrel. 59. 86. 72 FLIXONASE. 133 FERROGRAD-FOLIC.Scientific Name And Trade Name Index Escitalopram oxalate. 118 Estradiol valerate . 147 FENBID. 8 FLEMOXIN. 167 Fluorometholone. 110 Estradiol . 86 Ethinylestradiol . 120 FLECTOR. norethisterone. 123 FASIGYN. cyproterone acetate. 71 FLOZAK. 147. 118 Ethinylestradiol . 35 FLORAN. 159 Fluorouracil. 45 FLUCAND. 86 ETHAMBUTOL. 119 Etoricoxib. 51 FEFOL. 158 Fluconazole. 119 Ethosuximide. 6 FAMOGEN. 110. 118 ESTRADERM. 133 FELDENE. 124 FLUOROURACIL. 130 EYLOX. 124 Fludarabine phosphate. 42 Flumazenil. 97 FARCOLIN. 193 ESTRACOMB TTS. 119 Ethinylestradiol . 133 FEROMIN. 145 EUDYNA. 177 FLUORESCEIN SODIUM. 133 Ferrous gluconate. 158. 133 Ferric hydroxide polymaltose. 133 Fexofenadine hydrochloride. 34 EVION. 92 Flucloxacillin. 192 FENTANYL. 148 FLEET ENEMA. 71 FLUCON. norgestimate. 178 FLUMETOL. 159 Fluocinolone. 171 FLIXOTIDE. 149 FEMARA. 6 Famotidine. 88 FLAGYL. 112 FITZCALM. 118 Ethambutol. dydrogestrone. 192 FENTANYL-JANSSEN. 124 FLUDREX. 109 FENAMIC. 140 Exemestane. 36 Filgrastim. 41 Flumethasone.sodium. 32 FARLUTAL. 76 ESMERON.

157. 40 Guaifenesin. 114 FROBEN. 106 GLUCOBAY. 33 FORANE. 84. 134. 40 GUAPHAN. 104. 154. 104 Glibenclamide. 92 9–C . 83. 25 FORADIL. 39. 145. 99 Fusidate sodium. 12 FUCICORT. 134. 133 GLUCOPHAGE. 104 GLUSTIN. 63. 7 Gemcitabine hcl. 73 GLOMOX. 21 FOSAMAX. 138 FORTZAAR. 120 GEVRAL PROTEIN. 170. 138 Fondaparinux sodium. 177 Fluprednidene acetate. 124 Gemfibrozil. 62 Galantamine. 139 FORTANEURIN. 124 FLUORO-URACIL. 83. 33 FORTA B-12. 9 Glyceryl guaiacolate. gentamycin. 69 GAMAVATE. 35. 170 GENURIN. 104 Glimepiride. 157 Flutamide. 93. 45 Flupentixol. 182 FUCITHALMIC. 81. 177 Fluprednidene acetate . neomycin. 28 GEMZAR. 21 Goserelin acetate. 124 GENGRAF. 177 Fluvastatin. 104 GLIVEC. 83. 45 Fluphenazine decanoate. 171.Scientific Name And Trade Name Index FLUORO-URACIL. 105 Glyburide. 113 GENTACIN. 119 Griseofulvin. 176 Fucidic acid. 157 Folic acid. 51 FML LIQUIFILM. 92 GUAFEDRIN. 106 GLUCAGON. 176 GARASONE. 45 Fluprednidene. 72 GLOTAC. 154. 104 GLIBENESE. 42 Glyceryl trinitrate. 167 Flurbiprofen sodium. 115 GARAMYCIN. 84. 157 GARDINAL. 130 GOTINE. 182 FUTASOLE. 105 GLUCOFER. 104 GLICEROLO. 134. 21 GLYCERYL TRINITRATE. 65 GASTROFAIT. 151 GRACIAL. 45 FLUPHENAZINE DECANOATE. 92 GRISOVIN. 5 GASTROZEPIN. 154. 134. 29 Fluvoxamine maleate. 138 FOLIC ACID. 142 GLIBEMIDE. 177 Flurbiprofen. 105 GLUCOVANCE. 170 GENTAL. 81 Gentamicin. 159 FML NEO LIQUIFILM. 182 FUCIDIN H. 104 Glipizide. 154. 126 GLOCLAV. 5 GASTROZOLE. 9 Gliclazide. 92 FURAMIDE. 189 Ganirelix acetate. 170 Gentamycin. 182 FUCIDIN. 124 Flupenthixol.CANDIZOLE. 182 Gabapentin. 104 Glycerol. 81. 175 GAMMAGARD. 145 Frusemide. 154 FULCIN. 84. 83. 6 GLUCAGEN. 154. 128 GENOTROPIN. 191 Formoterol fumarate. 182 Fusidic acid. 106 Glucagon. 167 Fluromethelon . 130 Fluticasone propionate. 99 FURAZOLE. 108 GYNO . 39 GUPISONE. 94 GYNO-CORYL. 138 FOLICUM.

12 HYOPAN. 93. 172 HIBTITER. 186. 137 HICONCIL. 128 Indapamide. 186 INFECTOFLAM. 183 HALDOL. 45 Haloperidol. 145. 161 Homatropine. 77. 148 Ibuprofen. 92 Haemophilus. 146 IBUPHIL. 83.Scientific Name And Trade Name Index GYNO-DAKTARIN. 17 HYPOSEC. 150 INHIBACE. 74. 159 HYDROGEL. 103 Insulin glargine. 79 Imipramine. 94 GYNO-PEVARYL. 80 IMPLANON. 72 HIKMA HEPARIN. 49 IMODIUM. 133 Imipenem. 93. 71. 103 Insulin human. 179 HYDROCORTISONE. 20 INNOHEP. 13 IMURAN. 86. 148 Ifosfamide. 146 INDOMIN. 149. 17 INDICARDIN. 49 IMIPREX. 123 Imatinib mesilate. 97 HESTOFEN. 12 INDERAL. sodium chloride. 144. 21 I. 158. 166 Hydroxyethylcellulose . 25 HEPARINE SOD. 15 HYPYRIN. 103 10 – C . 103 HYCAMTIN. 187 HAIRGROW. 25 HISTAZIN. 113 HUMULIN. 25 Heparin sodium. 146 INDOMETHACIN. 186 INFANRIX-HIB. 119 IMPUGAN. 103 Human normal immunoglobulin. 25 HERPAVIR. 84. 18 Hydrocortisone. 149 Ibuprofen. 56 HYPERSTAT. 87 IBUGESIC. 76. 25 INSULATARD. 146 INDOGESIC. 17 INDOCID. 187 HIBITANE. 7 HYPOTEN. 42 IBUTOP. 93.H. 113 HUMATROPE. 146. 189 Human chorionic gonadotrophin. 166 Hydroxyzine. 45 HAVRIX. 187 HB-VAX DNA. 73. 103 Insulin aspart. 157 INFLA-BAN. 181 HAIRSCIENCE. 22 IMFERON. 87. 37 HIBERIX. 2 IMPERACINE. 113 HUMEGON.N. 159. 103 Insulin biphasic. 146 Indomethacin. 37 HYGROTON. 187 HEPARIN SOD. 25 HEPSAL. 144 HYZAAR. 189 Human antipertussis immunoglobulin. 38 HOLOXAN. 189 Human antitetanus immunoglobulin. 2 Hyoscine butyl bromide. 161 HUMALOG. 45 HALOPERIDOL. 97 IMDUR. 25 Heparinised saline. 189 Human antidiphtheria immunoglobulin. 4 Hydroxy propylmethyl cellulose. 123 HOMAPIN. 187 HI-CAL. 10. 126 IMAVIR. 94 GYNO-MIKOZAL. 148 Infliximab. 18 HYDRALAZINE. 146 INFANRIX. 127 Hydralazine. 177.

180 Isradipine. 167 Ipratropium bromide. 16 LACRYVISC. 165 ISOPTO CETAMIDE. 180 ISOTREX. 33 I-PROFEN. 75 KEFLIN N. 95. 22 Isosorbide mononitrate. 103 Insulin neutral.Scientific Name And Trade Name Index Insulin lente. 95 Lamotrigine. 168 Ketotifen. 22 Isotretinoin. 62 KESELAN. 22 Isosorbide dinitrate. 75 KEMADRIN. 142 KINIDIN. 12 LANSOMID. 22 ISOMACK. 155 ISOPTO FRIN. 24 INVANZ. 133 Isoconazole nitrate. 191 INTRON A. 161 ISOPTO CARPIN. 2 KARVOL. 44 LASIX. 103 LANZOR. 184 KENACORT-A. 37. 149 KENALOG. 12 LANOXIN. 191 ISOKET. 146 JUSPRIN. 23 Itraconazole. 20 Iodine. 166 Lactulose. 45 Ketamine. 68 KENACIN. 103 INTAL. 7 LANTUS. 19 JULMENTIN. 78 INVORIL. 133 KEFADIM. 87 LANFAST. 141 KABIKINASE. 77 KEFLEX. 2 KAPTIN. 146 KETONIL. 172 KEPPRA. 162 ISOPTO HOMATROPINE. 165 ISOPTO CARPINE. 160 KIDIPRIN. 73 JULPHAMOX. 161 ISOPTO PLAIN. 14 KLACID. 103 Insulin nutrale. 126 Iron-dextran. 146. 86 ISOPTIN. 7 LANIBOS. 22 Isoniazid. 55 Labetalol. 129 INTRAVAL. 39 KDIRON. 144 Ketoconazole. 82 KLARIBAC. 149 Ketorolac tromethamine. 140 KYTRIL. 2 INTERFERON ALFA-2a. 56 JUVELON. 94. 103 Insulin zinc. 8 LAMISIL. 82 KONAKION. 129 Interferon beta-1b. 157 ISOPTOFENICOL. 103 Insulin lispro. 154 ISORDIL. 146 Irbesartan. 184 Lamivudine. 109. 106 IOPIDINE. 7 Lansoprazole. 93. 191 KETESSE. 166 ISOPTOCETAMIDE. 37 Ketoprofen. 62 LAMPRENE. 72. 24 ISOPTO ATROPINE. 7 LARGACTIL. 2 KAPECT. 129 Interferon alfa-2b. 13 11 – C . 93 ITRIN. 129 Interferon beta -1a. 21 Irinotecan. 26 Kaolin. 35 INTARD. 183 KETOFAN. 81. 12 LANITOP. 129 INTROPIN. 72 JUNIFEN. 156 ISOPTOCETAPRED. 180 ISOTREXIN. 177 Isoflurane. 56 KIDIVIT.

2 LOPID. 119 LOJOUR.R II. 156 LAVENTE. 158 MAXIL. 88 MALUGEL. 195 LIGNOCAINE. 167 Lisinopril. 8 LOTRIDERM. 48 Lithium. 41 Lorazepam. 178 LOCACORTEN-VIOFORM. 148 LOCASALEN. 187 MAALOX. 119 MATERNA. 24 Levornorgestrel. 21 LOSEC. 23 LOMOTIL. 107 Lysine acetylsalicylate . 108. 57 LYSTHENON SICCUM. 145 Lodoxamide. 178 LOCAGEL. 15. 134. 89 Levonorgestrel. 8 LEPONEX. 137 MALAREX. 36 Loratidine. 66 Levofloxacin. 99 MALOPRIM. 195 LIDOCAINE. 195 LIDOCATON. 137 Magnesium sulphate.Scientific Name And Trade Name Index LASTET. mumps . 3 Mebendazole. 134. 149 Medroxyprogesterone acetate. 12 MEDROL. 195 Lignocaine. glycine. 66 MAGALOX. 168. 160 LOGYNON. 36 Loratadine. 163 LATYCIN. rubella. 168. 159. 119 LEXIN. 76 MAXIPIME. 177 LODINE. 139 Medigoxin. 28 LOPODIUM. 175 LOVRAK. 141 LAXOBERAL. 166. 86 Lidocaine. 4 MARCAINE. 28 LIPITOR. 187 Measles virus live . 157. 139 LEUKERAN. 193 M. 36 LOMIR. 3 Mecobalamin. 45 LERGICOL. 9 LAXOLAC. 48 LIVIAL. 2 LOPRESOR. 78 MAXITROL. 29 LIQUIFILM. 44 Losartan potassium. 99 MALARONE. 100 Mebeverine. 179 MADECASSOL N-HC. 121 Levobunolol. 141 MAXIDEX. 125 Latanoprost. 131 LEUCOVORIN. 9 LAXOCODYL. 4 MAGNACEF. 67 LITAREX. 37 LESCOL. 7. 44 LIDAPRIM. 15. 83 LIOCAINE. 83 Lincomycin. 28 L-thyroxine sodium. 195 LIPANTHYL. 163 Levodopa. 172. 123 Levetiracetam. 179 MADOPAR. 29 Letrozole. 20 Lisuride hydrogen maleate. 147 MEFOXIN.M. 119 Mefenamic acid. 157 Measles vaccine. 118. 195 MARVELON. 15. 178 LOCOID. 15. 75 LEXOTANIL. 187 MEBAGEN. 2 Loperamide. 17 LORADAY. 172. 4 MADECASSOL. 111 LOCACORTEN. 48 LITHIOFOR. 120 LEVOPHED. 62 LEVITRA. 76 12 – C . 77 MAGNESIUM. 195 LINCOCIN. 97 LOW-LIP.

161. 79 Mesalazine. 70. 123 MENCEVAX AC VACCINE. 149 METHYLCOPAL. 4 Moxifloxacin. 54 MOXAL. 183 Miconazloe. 55 Metoprolol. 80 MICARDIS. 119 MICRONASE. 117 Methylphenidate. 130 Megestrol acetate. 44 Mometasone. 7 MIVACRON. 124. 88 Metronidazole benzoate. 188 MENINGOCOCCAL VACCINE. 81 MIKOSTAT. 93. 8 13 – C . 134. 130 MELBIN. 192 MIDRONE. 3 MIACALCIC. 112 METAGLIZ. 193 MIXAVIT. 118 MIRENA. 188 MENCEVAX ACWY. 120 Misoprostol. 105 Meloxicam. 193 Midazolam. 183 MICOTER. 19 MINOCIN. 21 MICONAZ. 17 Metronidazole. 54. 103 Morphine sulphate. 23 MONOPARIN. 59 MOTILIUM. 124 MERISLON. 182 METRONIDAZOLE. 181 MINULET. 150 METHOTREXATE. 60 MIKACIN. 94. 141 MIXAVIT-M. 53 Metoclopramide. 15 MEZACOL. 166 MINIMS TROPICAMIDE. 19 MINIRIN. 166 MINIMS ATROPINE. 88 Mexiletine. 104 METHACIN. 184 MIKOZAL. 183 Miconazole. 104 MIDAFLEX. 161 MINIMS BENOXINATE. 188 Menthol. 75 MIDARINE. 167 MINIMS GENTAMYCIN. 171 MINIMS PHENYLEPHRINE. 18 Methyl prednisolone. 119 MICROLUT. 173. 79 Meropenem. 147 MODALIM. 193 Mivacurium chloride. 103 MOBIC. 92. 117 Methocarbamol. 162 MINIMS PILOCARPINE. 8 MILLICORTEN. 115 MIACIN. 80 Minocycline. 90 MUCAINE. 124. 114 MINITEN. 55 Metformin. 178 MONO TILDIEM. 94. 108 MINIDIAB. 150 Methyl dopa. 75 MIGON. 80 Minoxidil. 146 METHERGINE. 88. 168 MINIMS SODIUM CHLORIDE. 4 MUCOFALK. 94. 165 MINIMS ROSE BENGAL. 170 MICROGYNON-30. 3 Mesterolone. 171. 28 MOGADON. 25 MONOTARD. 152 Methotrexate. 154 MINIMS CYCLOPENTOLATE. 94. 155. 54. 89.Scientific Name And Trade Name Index MEGACE. 139 Methylergometrine maleate. 39 Mercaptopurine. 141 MIXTARD. 104 MINIMS ARTIFICIAL. 162 MINIPRESS. 166 MINIMS CHLORAMPHENICOL. 183 MILK OF MAGNESIA. 15 MEXITIL. 177. 58 MIDROXIL. 161 MINIMS FLUORESCEIN SODIUM. 147 Melphalan. 114. 88 METROZOLE. 56 MERONEM. 93.

114 Norethisterone. 162 MYDRIATICUM. 194 NAROPIN. 128 MYSOLINE. 158 NEOSPORIN. 22 NIVAQUINE. 21 NITROSTAT. 21 NITRODERM TTS. 81 Nedocromil sodium. 13 Noradrenaline acid tartrate. 128 MYCOSAT. 131 NOMAL. 95. 39 MULTIBIONTA. 94. 128 Mycophenolate sodium. 21 NITRO-DUR. 170. 20 NARCAN. 141. 162 MYDRIACYL. 177 MYDFRIN. 18 Nitrazepam. 147 NARAPRIL. 59 NOOTROPIL. 160 Nefopam hydrochlride. 176. 155 NEOSTIGMINE. 25 Mumps viral vaccine. 86 MYCOHEAL. 157. 194 Naltrexone. 194 Nandrolone decanoate. 67 NORACIN. 183 NOCAL. 77 NEGAZOLE. 39 MUCOPRONT. 23 Nifedipine. 140. 44 NITRO MACK. 188 MUMPSVAX. 172. 138 NEUROTOP. 170. 162 MYFORTIC. 179 NEOPRED . 23 NIF-TEN. 194 NALOXONE. 175. 184 MYCOHEAL HC. 24 NORCURON. 172 NEOMYCIN. 90 NEO-CORTEF. 155. 4 MUCOLYTE. 12 NAVELBINE. 136 NEUROBION. 90 NALIDRAM.P. 90 NORACTONE. 94.Scientific Name And Trade Name Index MUCOGEL. 119 NORDIOL. 171 NATRILLIX. 178. 57 NEGACEF. 6 NIZORAL. 142 NIDAZOLE. 183. 147 Naproxen. 131 NOLVADEX-D. 93. 151 Neostigmine methyl sulphate. 137. 39 MUCOMYST. 90 Naloxone. 184 MULTIPARIN. 157. 158 NEOGYNON. 21 Nitrofurantoin. 55 NAXONE. 147 NADINE. 181 NERISONE. 40 MUCOSOLVAN. 173 MYCO-SYNALAR. 119 Neomycin. 138 Nevirapine. 119 NORDITROPIN. 99 Nizatidine. 138 NEURONTIN. 194 NEBCIN. 17 NIMBEX. 193 Nimodipine. 125 NAVOBAN. 88 NIFECARD. 112 Naphazoline. 172 MYAMBUTOL. 62 NEURORUBINE. 181 NOHIST. 141 MULTILIND. 96 nicotinamide. 151 NEOXIDIL. 6 Nalidixic acid. 36 NOLVADEX. 173 MYCOSTATIN. 91 NITROGLYCERINE. 141 NEUROVITAN. 166 NAPROX. 195 NASONEX. 110 14 – C . 23 NIMOTOP. 184 Mycophenolate mofetil. 88 NEGRAM. 94. 94. 63 Nabumetone. 61 NEUROTRAT. 177 NEUPOGEN. 23 NIPRIDE. 188 Mupirocin calcium. 193 NORDETTE.

154 ORADEXON. 49 NORTRIME. 46 OLBETAM. 160 OPTICYCLIN. 72 OMAFEN. 95. 80. 166 OCUMOL. 172 ORUVAIL. 163 OPRAZOLE. 19 NOVO-DIFENAC. 75 OTOSPORIN. 163 Nystatin. 80 OPTIFUCIN. 167 OCULOSAN. 143 OCTANATE. 94. 25 OXIS. 103 NOVO-NIFEDIN. 172 OVRAL. 154 Olanzapine. 146 ORVEK. 127 PAINSTOP. 156 OFTALMOLOSA CUSI ATROPINE. 53 OROFAR. 173. 23 NOVONORM. 146 OMEDAR. 148 Olopatadine. 144. 184 OCAL. 163 OFTANEX. 170 OTOZOL. 7. 23 NOVO-DIPIRADOL. 59 ORAP. 29 OLFEN. 161 OFTALMOLOSA CUSI DEXAMETHASONE. 125 ONE-ALPHA. 7 Omeprazole. 167 OCUGESIC. 15 NOVO-CAPTORIL. 33 Oxybuprocaine. 155 OFTALMOLOSA CUSI HYDROCORTISONE. 40 OTRIVIN. 146 NYOLOL. 71 OS-CAL. 49 NO-URIC. 166 NOVO-ATENOL. 27 OCTANINE F. 140 OPHTAMOLOL. 98 OSPAMOX. 26 NOVO-DOXYLIN. 159 OFTAN TIMOLOL. 27 Octreotide. 46 Orciprenaline. 127 OX-HEP LEO. 33 ORGALUTRAN. 90 NOROXIN.Scientific Name And Trade Name Index Norfloxacin. 155 Ofloxacin. 155. 108. 118 OFLOX. 137 Oseltamivir phosphate. 156 OXYTETRACYCLINE. 13 Oestradiol. 80 Oxytocin. 91. 58 15 – C . 119 Oxaliplatin. 72 OSPEN. 145. 170 Oxytetracycline. 104 NOVOMIX. 72 NOVASEN. 90. 4. 71 OSPEXIN. 79 NOVO-GLYBURIDE. 85 Nortriptyline. 110 Oestrogens conjugated. 160 OMACILLIN. 149 ORAMORPH. 111. 5 NOVAMOXIN. 144. 7 OPTASONE. 164 OFTHALMOLOSA CUSI CHLORAMPHEN. 58 ONCOVIN. 170 OTRINOL. 158 OFTALMOLOSA CUSI GENTAMYCIN. 159 OEDEMAX. 103 NUFEN. 115 Orlistat. 6 NOVORAPID. 131 OCUFEN. 56 NOVESINE. 8 OMOL. 163 OCURED. 166 Oxymethurea. 117 Paclitaxel. 98 PANACETAMOL. 145 NOVO-DILTAZEM. 151 NOVAGEL. 158 OPTICROM. 90 NORTRILEN. 57 Palivizumab. 105 NOVO-PIROCAM. 147 NOVO-RANIDINE.

71 PENTACT HIB VACCINE. 149 PITON-S. 20 PERMAX. 111. 46 PERSANTIN. 177 PEVARYL. 100 PENTREXYL. 161 Phenytoin. 179 Pimozide. 159 PREDNISOLONE. 74 PIPRIL. 109 PREDONE. 65 Phenoxymethyl penicillin. 37 POLYBION. 54 PND UNIMED. 6 Pergolide mesylate. 193 Pancuronium bromide. 165 PILOTINA-4. 105 Piperacillin. 166 Pilocarpine. 26 PETRALAR. 158. 160 PEDIAZOLE. 181 Pot. 58 PARAPLATIN. 58. 154 Phenobarbitone. 8 PANTOZOL. 125 PARAZOLE. 193 PANDERM. 150 PLASIL. 92 PEVISONE. 159 PREDMILD. 180 Pantoprazole. Iodide. 67 PERIACTIN. 6 Peppermint. 141 Pramipexole dihydrochloride monohydrate. 157 Podophyllin resin. 3 PEPTAC. 147. 181 POLARAMIN. 159 PREDMYCIN-P. 63. 109 PREFRIN -A. 65 PHILAZOLE. 183 PHYSIOL. 136 POTASSIUM CHLORIDE. 109. 138 Polymixin-b. 136 POTENCORT. 42. 165 PILOTINA-2. 93. 37 Perindopril. 8 Paracetamol. 73 PENICILLIN G. 179 Pimecrolimus. 59 PARAMOL. 66 PLAQUENIL. 165 PIMAFUCORT. 177 PETRALAR-F. 58. 100 PARNATE. 74 Piracetam. 117 PK-MERZ. 155 POLYTAR. 178 PHENICOL. 92 PEVARYL PV. 162 PREGNYL. 67 PIRACETAM. 46 Pioglitazone. 3 PENTOSTAM. 73 PEPCIDIN. 57. 41. 41. 58 PANCURONIUM. 37 Piroxicam. 179 POLYVALENT SNAKE ANTIVENUM. 141 PONSTAN. 41 PANADOL EXTRA. 67 Perphenazine. 50 Paroxetine. 27 PREDFORTE. 54 16 – C . 166 POLY-VI-SOL. 166 Potassium chloride. 147 PANOXYL. 82 PENAMOX. 108. 181 Podophyllotoxin. 118 PREMOSAN. 51 PATANOL. 42.Scientific Name And Trade Name Index PANADOL. 113 PREMARIN. 63. 189 Polyvinyl alcohol. 158 Prednisolone. 71 Phenylephrine. 59 PANADOL ACTIFAST. 68 Pravastatin. 59 PANADOL COLD & FLU. 108 Prednisone. 186 PENTASA. 178 PANGESIC. 72 PENBRITIN. 67 PIRAFENE. 136 Potassium gluconate. 177 PRAMET FA. 65 PHENYTOIN. 147 POSALFILIN. 29 PRECONATIVE. 177 PETRALAR-N.

191 RECORMON. 52 RECOCEF. 112 PROSTIN. 138 Pyrimethamine. 112 PROXEN. 14 QUINIDINE SULPHATE. 147. 147 PROZAC. 42 RHINOSTOP. 17 Propylthiouracil. 149 PROGRAF. 188 RHEUMARENE. 117 PROSTIN E2. 107 PROSCAR. 42 RHINO-PRONT. 6 RAPIFEN. 172 RHESUMAN. 146. 111 PREPIDIL. 87 Quinapril. 51 Pseudoephedrine. 38 Promethazine. 14 RAMLAC. 40 RHINOTUSSAL. 119 PROVIRON. 68 PROFASI. 38 PROMETIN. 39 PURINETHOL. 59 REVANIN. 54 PRINCIMOX. 135 REDOXON. 42 RHONAL. 139 REDUCTIL. 105 REPLENINE-VF. 76 RECOFOL. 155 RIACHOL. 39 RIACETAMIDE. 127 RETIN-A. 129 Reboxetine methanesulphone. 129 PROGYLUTON. 163 17 – C . 72 Prochlorperazine maleate. 117 PROPINE. 164 Propofol. 111 PROLUTON DEPOT. 110 PRIMPERAN. 56 RIABROXOL. 58 PROPECIA. 150 REMIN. 155 REFRESH. 27 REQUIP. 96 REVACOD. 58 Rhei. 68 RESOCHIN. 46 Procyclidine. 147 REMICADE. 40 RHINOCORT. 191 Propranolol. 53 REFOBACIN. 127 RETROVIR. 117 Primidone. 113 PROFENID. 112 PROPESS. 110 PROMANTINE. 20 Repaglinide. 195 RIALOL. 99 RESYL. 38 PRONTOPYRIN. 113 PRIMOLUT-N. 56 REMINYL. 154 RIACORT. 6 Ranitidine. 87 RIAGESIC. 6 RANTAG. 181 RELIFEX. 192 RAZONE. 55 PYRALVEX. 35 PULMOTROPIC. 77 PRIMOGONYL. 124 PURINOL. 149 PROFINAL. 63 PRIMOCEF. 107 PROPYLTHIOURACIL. 58 RIALAC.(anthraquinon glycosides). 148 RHINATHIOL. Ext. 20 Quinidine sulphate. 117 PROTOGYN. 89 PROVERA. 179 RIAFAMPICIN. 88 PZA. 171 RHINOFRIN. 69 RENITEC. 39 RETACNYL. 8 RANIDINE. 172 Pyrazinamide.Scientific Name And Trade Name Index PREMPAK C. 81. 40 PULMICORT. 8 REBIF. 166 REGAINE. 151 PYLOMID. 6 RIALOCAINE. 87 PYRIDOXIN.

191 Sibutramine. 181 SALI-DECODREM. 3. 4 RIAMIDE. 182 SILVERIN. 57 RIVOTRIL. 177 SALIDEX. 53 RIVO. 78 ROZEX. 89 SAROTEN. 152 SKINOREN. 140 ROCEPHIN. 147 RIASPASM. 114 SALAZOPYRIN-EN. 161 Sodium nitroprusside. 66 SINEMET-PLUS. 88. 56 SEMBRINA. 23 RIAZOLE. 3 SALURIN. 18 SEPTAZOLE. 51 Sevoflurane. 180 ROBAXIN. 68 Sildenafil citrate. 98 RIFADIN.Scientific Name And Trade Name Index RIALOX. 146 RIAPROXEN. 4 ROWATINEX. 45 SEREVENT. 127 Sodium chloride. 94. 47 Risperidone. 51 Salmeterol. 57 ROBITUSSIN. 161 RIAVATE. 184 RIAPRIL. 7 RISPERDAL. 5 SIMULECT. 182 RUMAFEN. 145. 152 ROBAXISAL. 121 Silver sulphadiazine. 32 Salbutamol. 33 SEROXAT. 61. 128 SANDOSTATIN. 88. 5 SALIPAX. 87 Rifampicin. 171 RISEK. 195 Rosiglitazone . 60 ROACCUTANE. 191 SEVOFLURANE. 39 RIAZEM. 39. 64 Rizatriptan benzoate. 6 Ropinirole. 146 ROUVAX. 48 SCOPINAL. 40 ROCALTROL. 46. 47 RITALIN. 56 SCORPION ANTIVENOM. 150 SALBULASE. 176 SALINAL. 2. 35 RYTHINATE. 166 Sodium cromoglycate. 87 RIMACTAZID. 180 SMOODERM. 20 RIAPROFEN. 29 Simvastatin. 86. 13 SAMIXON. 55 RIANEST. 131 SARF. 148 RYNACROM. 18 18 – C . 78 ROFERON-A. 120 ROXCEF. 2. 187 ROWACHOL. 33 SALOFALK. 87 RIMACTANE. 68 Ropivacaine. 86 RINO-CLENIL. 35. metformin. 7 SEDERGINE. 86. 46. 64 SAIZEN. 29 SINEMET. 66 SIRDALUD. 105 Rosiglitazone maleate. 159 RIMIFON. 106 ROTHACIN. 128 SIMVAST. 82 SABRIL. 3 RIATROPIN. 14 SEDALAC. 32. 173. 183 Simethicone. 89 Ribavirin. 160. 87 RIFINAH. 34 SALBUVENT. 40 ROBITUSSIN-PE. 40 ROBITUSSIN CF. 87 Rimexolone. 188 SEDACORON. 32 Salicylic acid. 176 RIAXINE. 53 SIFROL. 85 SERENACE. 129 ROLAN. 85 SEPTRIN. 78 SANDIMMUN.

17 TENORMIN. 26 Streptomycin. 2 SPASMOPAN. 186 TEBRAZID. 158 SPERSADEXOLINE. 45 SYMMETREL. 7 SOLPADEINE. 60 SUPRADYN. 46 STESOLID. 13 SPORANOX. 193 Sufentanil. 160 SPERSANICOL. 138. 152 Somatropin. 176 SUPRAX. 93 STANDACILLIN. 108 SOMADRIL. 150 Sulindac. 193 SYLADOR. 112 SUTRIM. 3 SPERSACARPINE. 54 STYPTOBION.Scientific Name And Trade Name Index Sodium valproate. 87 STREPTOTHENATE. 90. 157 Sumatriptan succinate. 77 SURBEX. 117 Tacrolimus. 113 SYNAGIS. 54 SURGAM. 148 SURMONTIL. 64 Sodium-stibogluconate. 165 SPERSACET. 142 STUGERON. 50 SUSTANON. 157. 47 STEMETIL. 131 Tamoxifen. 37 TEGRETOL. 148 TENSOTIN. 177 SYNALAR N. 154 SPERSAPOLYMYXIN. 61 Teicoplanin. 82 STREPTAS. 142 SUCCINYL SICCUM. 104 SUFENTA. 65 STIEMYCIN. 148 Sulphacetamide. 193 Suxamethonium-chloride. 89 TAXOL. 36 Telmisartan. 73 STATROL. 157 SPERSALLERG. 84 TARIVID. 193 Sulfasalazine. 155. 120 TANIDINA. 155 Stavudine. 21 TEMPRA. 156 SPERSADEX. 141 SURBEX C. 13 Spironolactone. 87 TEFANYL. 91 TAVANIC. 191 TELFAST. 44. 96 STELAZINE. 129 Tadalafil. 138 SPASMONORE. 131 Tamsulosin. 7 TALIN. 141. 155 SPIROCTAN. 121 TAGAMET. 155. 100 SOFLAX. 191 SUPRAPROCT-S. 193 Sucralfate. 6 TARGOCID. 6 TAKEPRON. 5 SUCRAZIDE. 148 Tenoxicam. 98 TAMOFEN. 85 Suxamethonium chloride. 163 19 – C . 131 TAMOXIFEN. 126 TAZOCIN. 15 TEOPTIC. 156. 59 SOLU-DACORTIN. 2 SPASMOTALIN. 177 SYNTOCINON. 113 SOPALAMIN. 127 TAXOTERE. 156 SPERSACET-C. 109 SOLU-MEDROL. 131 TAMOPLEX. 58. 98 SYNALAR. 26 Streptokinase. 141 SURBEX T. 87 STRESS. 141 SUREPTIL. 74 TE ANATOXAL. 141 SUPRANE. 15 TENOX. 58 TENORETIC. 32 TAMIFLU. 84 TEKAM. 66 SYNACTHEN.

189 THEO-DUR. 166 TETRACT HIB. 165 TRYPTIZOL. 184 Terbutaline. 182 UCIDERM -B. 84 Tibolone. 34 Theophylline. 60 TRAMAL. 48 TUNOLOL. 148 TILDIEM. 179 Topiramate. 59 TRAMADOL. 22. 156 TETRACYCLINE. 50 TRIMOL. 42 TYLENOL. 34 THEOPED. 182 ULCAR. 177 Travoprost. 191 THIOPHENICOL. 180 TREXAN. 112 TESTOVIRON. 19 Terbinafine. 152 TOBRADEX. 80 TETRAMUNE. 163 Tincture. 50 TRAVATAN. 157 TOBRAMYCIN. 60 Tolterodine tartrate. 80 TETRADAR. 13 TRI-B. 36 TIENAM. 160 TILCOTIL. 138 TRIDIL. 95. 186 Tetryzolin. 49 Tretinoin.Scientific Name And Trade Name Index TERACIN. 191 Thiopentone sodium. 137 THIOPENTAL. 84. 89 Tinzaparin. 38 TUSSIVAN. 194 Triamcinolone. 157 Tobramycin. 5 20 – C . 156 TERRAMYCIN. 26 Tranylcypromine sulphate. 81. 127. 16 Tranexamic acid. 60 TRAMADONE. 34 THEOPHAR. 156 TETUMAN. 120 TOPAMAX. 106 Tinidazole. 32 TERRACORTIL. 64 TOPICORT. 163 Timolol. 85 Triprolidine. 112 TETRA Coq. 86 TRIMIDAR. 47 TRILAFON. 95 Tropicamide. 23 TIMO-COMOD. 34 Thiamine. 84 THIAVIT. 140 TOFRANIL. 26 Tizanidine. 127 TOSUMAN. 140 Thiamphenicol. 37 TRACRIUM. 156 Terazosin. 187 TETRACYCLIN. 31. 120 UCIDERM. 156 TOCLASE. 80 Tetracycline. 106 TINCTURE IODINE. 59 TRANDATE. 49 Tolfenamic acid. 109. 138. 156. 84. 163 TIMOPTOL. 189 TOTINAL. 25 Tirofiban. 193 TRACTOCIL. 166 TETRACAINE. 164 TRAVOCORT. 186 TRIZIVIR. 137. 178 Triamterene. 111 TIDILOR. 79 TILAVIST. 41 Trifluoperazine. 164 Trazodone. 186 Tetracaine. 80. 86 Trimipramine maleate. 118 Tramadol. 80 Testosterone. 49 TRAZOLAN. 40 TRITANRIX-HB. 172. 46 Trimethoprim. 22 TRIFED. 58 UBRETID. 162 TRUSOPT. 163 TUSSILAR. 64 Topotecan. 38 TOCOVIT. 81 TOBREX. 149.

71 VINBLASTINE SULPHATE. 139 URBASON. 172 XYLOMET. B12. 66 UPSA-C. 167 VOTREX. 141 UNICAP T. 72 ULTRASPORIN. 148 UNICAP M. 41 UNIGENTA. 85 VANCOLON. 132. 22 XALACOM. 39 VIDAYLIN. 172 21 – C . 140 Vit. A +D. 110 Valaciclovir. 53 XYLOCAINE. 86 V-2. 142 VITOP. 24 VERMOX. 85 Vancomycin. 139 Vitamins. 64 VIGAM. 187 VC. 163 XALATAN. 195 XYLOCARD. 187 Vardenafil. 35 VIBRAMYCIN. 85 VAQTA. 172. 42. 137. 160 UNIDOX. 108 UROQUAD. 172 Xylometazolin. 44 VALIUM. 172 VICKS. 159 ULTRADERM. 142 VAGIFEM. 103 ULTRAZOLE. 134. 139 Vecuronium bromide. 25 WARFARIN. 138 VITAMIN 15 SOLCO. 96 VIRAZOLE. 140 VIFOLIN. 148. 65 Valporate sodium. 134 VIT. 137 UNIVIT-E. 163 XANAX. 144. 75 ULTRACLOXAM. 85 VANCOMYCIN. 97 VISUDYNE. 125 VELOSEF. 178 VOLTAREN. 144 Warfarin. 151 UROXIN. 44. 168 VIT. 77 ULTRATARD. 136 ULTRAMOX. 48 Valsartan. 52 VENTOLIN. 73 ULTRACORTENOL. 195 XYLO-COMOD. 178 ULTRA-K. 193 ULTRACEF. 168 VEXOL. 90 URTIUM. 26 WAXSOL. 79 UNIFED. 121 Vasopressin tannate. 41 VICKS 44 E. 44 XATRAL.B-COMPLEX. 32 VEPESID. 15. 140 UPRIMA. 39. 142 UNICROM.Scientific Name And Trade Name Index ULCICURE. 21 VANCOCIN-CP. 141 VI-DE-3. 125 Verapamil. 97 VALINIL. 76 Venlafaxine. 159 VIAGRA. 171 WESORBIDE. 40. 193 VELBE. 166 VOCORT. 79 VIBROCIL. 15. 98 VIRUSTAT. 141 Vitamin b1. 125 VIONEURIN-6. 41 UNIFED DM. 7 UNASYN. 134. 114 VAXEM HIB. 120 XENICAL. 138 VIRAMUNE. 121 VIAREX. 5 ULSAHEAL. 134. 155 UNIVIT-A. 139 Vitamin b12. 172 XYLOLIN. 75. 73 UNICAM. 141. 141 VITREOLENT. 5 ULTIVA. 100 Verteporfin. 139 Vigabatrin. 189 VIKADAR.

160 Zafirlukast. 47 ZYPREXA. 118 YUTOPAR. 76. 81 ZOCIN. 35 ZARONTIN. 97 Zuclopenthixol. 96 ZESTRIL. 123 ZEFFIX. 20 ZIAGEN. 149 ZERIT. 77 Zinc. 36 22 – C . 10. 55 ZOLADEX. 37. 81 ZOCOR. 118 ZADITEN. 142 ZINCFRIN. 95 ZENOS. 130 ZOVIRAX.Scientific Name And Trade Name Index XYLONOR. 195 YASMIN. 61 ZAVEDOS. 46 ZYRTEC. 96 ZINACEF. 162 ZITHROMAX. 95 Zidovudine. 29 ZOFRAN.

Barbar J. 3. McGraw-Hil. 2nd edition. Microbial natural products as a source of antifungals. Treatment of uncomplicated genital Chlamydia trachomatis infections in adults . 6th edition. 18. 7. 11th edition. Chowta N. J R Soc Med 1997. Overview of the clinical features of cefixime . Obstet Gynecol 1998 Feb. 2nd edition. M. Dick R.pub2 Adhikari P. McGraw-Hill. The National Department of Health. Veille JC.2(6):453-9 Adair CD. 4. Venkatadri TV. Nancy A. 28. 2000. Cochrane Database of Systematic Reviews 2004. Inc. Bone Care:NPA. Lexi-Comp.10th edition. Medfacts Pocket Guide of Drug Interactions. 2004. 15(4):249255 George R. Pharmacotherapy Handbook. Paediatric Hospital Level. 14. C Cherfan. 20. 17. Pharmacy Practice Manual: A Guide to the Clinical Experience. Standard Treatment Guidelines And Essential Drugs List For South Africa. Cindy W. Standard Treatment Guidelines And Essential Drugs List For South Africa. 12. Malouf R. Lippincott's Illustrated Reviews: Pharmacology. Pamela C. University of Michigan Guidelines for Health System Clinical Care Developed November. Churchil Livingstone. Stovall TG. A.CD002738. 2002 Beverly A. Jacobson MA .References References: 1. 13. Cabello and F. Curtis A. HIV Clin Trials 2001 NovDec. Ernest JM . Lasserson TJ. Oct 2007 WHO Model List of Essential Medicines. 22. G. Clinical Pharmacology. 1st edition. McElroy G. BMJ:RPS. 1997 Updated May. Sally Roach. Bestall JB. Evaluation of safety and efficacy of azithromycin in lower respiratory tract infections (LRTI) Indian J Med Sci 1996 Sep.a. 7th edition. Gunter M. Development of an essential drugs list for Bosnia and Herzegovina. 2004. Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis.l. 38: 15–27 Carballo M. Joseph T. Eric T.44 Suppl 1:1-5 Adams NP. Issue 4. 2005-2006. 2000 British National Formulary. Page 1-D . 2006. Jim L. James E. Chemotherapy 1998 Sep.50(9):313-7 Adimora AA.1002/14651858. McGraw-Hill . Jennifer L. WHO Model List of Essential Medicines for Children. Flamm R. Zulic I. Introductory Clinical Pharmacology. 2003. 1st edition. 7th edition. Textbook of Therapeutics Drug and Disease Management. Churchill Livingstone.9(1):15 Aberg JA. 2002. Lippincott Williams & Willkins. The Use of the World Health Organisation Anatomical Therapeutic Chemical/Defined Daily Dose Methodology in Canada. Clive E. CCM Middle East s. 23. Handbook of Clinical Drug Data. DOI: 10. 1 st edition. Mar 2007 Bennet P. Pai MM . Lippincott Williams & Willkins. Jones PW. 16. 9th edition. Bhat P. A. 15. Notario GF. Clinical Microbiology & Infection 2003 Jan. Clinical Pharmacy and Therapeutics. 2nd edition. The National Department of Health. Wendy L. Wong MK. Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin . 10. Richard A. Peláez. Lloyd Y. Middle East Medical Index. 5. Drug Information Journal. 21. 6. Ingrid S. 2006. Basilio. 27. 26. 2nd edition. Laurence L. 1999. Art. Hegde BM. 2006. No. 2nd edition. 25. William G. 15th edition. 2004. Common Drug Pathways and Interactions.35(Suppl:٢) S183-6 11.r. 24.: CD002738. 2006 Philip O. Beclomethasone versus placebo for chronic asthma. Donna G. Pereira P. Clin Infect Dis 2002 Oct 15.90:331-333 Paediatric Hospital Level. 19. Mary E. 1998. Mary J. Lippincott Williams & Willkins. Kuwait Drug Index.91(2):165-8 Adam D . Ramesh KV. 9. Diabetes Spectrum 2002. Roger W. Goodman & Gilman's the pharmacological Basis of Therapeutics. Serdarevic D. 25th edition. F. 52nd edition. Colleen J. Vicente. erry L. Larry E. 2001. Brown M. 8. 2.

J Egypt Soc Parasitol 2002 Dec. Sanchez S. 5(3):275-86. Peredo-Gonzalez G. Once-daily azithromycin in the treatment of adult skin and skin-structure infections . Apaloaza I. Ito T. 7(1):2-8.5(3):261-74. Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug. Kuye O. Akimoto Y. Alder JD. Andrade-Villanueva J.42(9):2385-90 39. MorfinOtero R. 32(3):969-78 40. Allam AF. in the treatment of respiratory tract infections with the special reference to community-acquired Streptococcus Pneumoniae infections] Jpn J Antibiot 1995 Apr. 2005 Jan. Okano H. Med Mol Morphol.52(2):159-61 Page 2-D . bacteriological and clinical studies on cefpodoxime proxetil in the field of pediatrics] Jpn J Antibiot 1989 Jul. Amsden GW. Akiyama O. Expert Opin Investig Drugs 2001 Mar. Simon M. Breadon G . Kusumoto Y. Amsden GW. Amaya-Tapia G. Ohrt C. Ahren B. Efficacy and Safety of Azithromycin vs Levofloxacin in the Outpatient Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis . Kabe J. Wesche D.31 Suppl E:129-35 42. pharmacokinetic and clinical evaluation of azithromycin in the pediatric field] Jpn J Antibiot 1996 Oct. Foulds G. J Int Med Res 1998 OctNov. Yokota T. A study of the interaction potential of azithromycin and clarithromycin with atorvastatin in healthy volunteers . Type 2 diabetes. Activity of azithromycin as a blood schizonticide against rodent and human plasmodia in vivo . safety and tolerability of azithromycin and coamoxiclav in the treatment of acute periapical abscesses . An open-label. Baird IM. Cabelus LJ . Sato Y. aige L. Gray CL . Sunakawa K . Ewing PJ. Nafziger AN. 2005 Jun. Kawakami H. Aguirre-Avalos G. et al. Andersen G. Ellis W. Dynamics of clarithromycin and azithromycin efficacies against experimental Haemophilus influenzae pulmonary infection .17(4):701-7 43. Sunakawa K. 33. Iwata S. Rodriguez-Noriega E . Adriaenssen CF . Alvarez MP. Akita H. Andersen SL. Ager A. Hart GW. praziquantel and mirazid in treatment of cryptosporidiosis in school children . Ahren B.49(10):899-916 36. Kida K. 38(2):84-91. Am J Trop Med Hyg 1995 Feb. Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers . Simon S. 40(12 Pt 2):1522-7 47. safety.47(1):61-6 45. 2005 May. Nilius AM. Efficacy of azithromycin. Agrawal DK . Genetics of common forms of glycaemia with pathological impact on vascular biology: are we on the right track? Curr Mol Med. 61(3):310-6 38. Rossan R. Amsden GW. J Clin Pharmacol 2002 Apr. Chest 2003 Mar. Clin Ther 1995 Jul-Aug.26(5):257-65 30. J Antimicrob Chemother 1993 Jun. Hirano H. Antimicrob Agents Chemother ١٩٩٨ Sep. Mitten M. 2005 May. Tanaka SK . [Clinical evaluation of cefpodoxime proxetil. 48. [Bacteriological. Islet adaptation to insulin resistance: mechanisms and implications for intervention.References 29. Konno K. [Pharmacovigilance study of azithromycin tablets (500mg) in the treatment of adult patients with respiratory tract infections] Rev Esp Quimioter 2000 Sep. J Oral Maxillofac Surg 2003 Mar. Hairam AR. Kuschner R. Al-Belasy FA. The efficacy of azithromycin in the treatment of acute infraorbital space infection . Shehab AY . Curr Mol Med.42(4):444-9 46. insulin secretion and beta-cell mass. Amsden GW. Diabetes Obes Metab. Comparison of the efficacy. Kudo K. Esparza-Ahumada S. McGreevy P. Takeuchi Y ، Aoyama T.J Clin Pharmacol 2000 Dec. Iwata S. 32.42(7):1547-60 35. Pacini G. [Pharmacokinetic. 34. Akita H. Prieto J . Berman J . J Antimicrob Chemother 2001 Jan.10(3):547-60 31. Amin NM. noncomparative study to evaluate the efficacy. Hansen T. Komatsuzaki K. Tovcimak A ، Oleksijew A.13(3):297-305 41. Wei GC . A study of the pharmacokinetics of azithromycin and nelfinavir when coadministered in healthy volunteers . Schuster BG. Jarvis K. 123(3):772-7 44. Kawakami M. Pedersen O. O-GlcNAc modification of nucleocytoplasmic proteins and diabetes. Ogata M.48(4):522-8 37. Treadway G . Sato Y. and tolerability of azithromycin in the treatment of patients with acute sinusitis . a new oral cephem.

Arguments against Chemoprophylaxis in Areas at Low Risk for Chloroquine-Resistant Plasmodium falciparum .5(3):333-9. Berman J. Auwerx J. Gommersall L. Ellis W.84(1):21-5 69. Shanks GD . Comparison of cefpodoxime proxetil and cefixime in the treatment of acute otitis media in infants and children. Successful double-blinded. Muffat-Joly M ،Pocidalo JJ . Otitis Study Group. J Antimicrob Chemother 2002 Jul. Matsumoto H. Ishigami J. Arakawa S. Ramirez-Ronda CH . J Pediatr 1996 Nov.5(11):2241-9. 59. et al . Pharmacokinetics and pharmacodynamics of oral beta-lactam antibiotics as a two-dimensional approach to their efficacy. IRS-1 and vascular complications in diabetes mellitus. 2005 Feb. Shimada J. Dajani AS. Oizumi K. 54.15(9 Suppl):S15-9 64. Berman JD. Umezu K. Hamami G. Asmar BI.50 Suppl:13-7 68. Onishi S. Omae H.2(1):4-5 62. Berman J . Gordon DM. Hayne D. Takagi S. Ono R.94(6 Pt 1):847-52 67. discussion 60. 52. Bedos JP. Azoulay-Dupuis E. Tanaka H. Anderson PC. A multicenter. Antimicrob Agents Chemother ١٩٩١ Jun.٨٠ 66. Akkerman JW. Kobayashi K. Kamidono S. Satoh K . Vallee E. 63. Armengaud M . Suzuki K. Motoshima H.26(1):146-50 51. placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya . Baba S. [A double-blind comparative study of S 6472 (a longacting cefaclor) versus a conventional cefaclor preparation in complicated urinary tract infections] Jpn J Antibiot 1990 Nov. Expert Opin Pharmacother. Andersen SL. Takeuchi Y.41(9):1309-12 55. Loaiza C. Ann Intern Med 1995 Nov٣-٧٧١:(١٠)١٢٣‫٥١؛‬ 53. 2004 Nov. Del Beccaro MA. Kawamura S. Itoh Y.35(6):1024-8 70. 2005 May. open label trial of azithromycin vs . Aoyama T. Watanabe A.38(8):1862-3 50. Arguedas A. Aleman GM.47(2):195. Sunakawa K. Saito H. Hirooka K. Dunne MW. Auckenthaler R.35(2):82-92. Kuschner R. Comparative trial of 3 days of azithromycin versus ١٠ days of clarithromycin in the treatment of children with acute otitis media with effusion . Iwata S.129(5):761-4 56. et al .References 49. Anderson SL. Kamidono S ، Ito N. amoxicillin/ clavulanate for the management of acute otitis media in children . Shinozaki M.81(8):978. Magill A ، Wellde B. Bol Asoc Med P R 1992 Jan. Insulin resistance in type 2 diabetes -. Dunne M.Clin Infect Dis 1998 Jan. 2005. Argmann CA.9(1):44-50 61. Ishigami J. Andrade Ferreira I. randomized. Peroxisome proliferator-activated receptor gamma: the more the merrier? Eur J Clin Invest. Efficacy of azithromycin as a causal prophylactic agent against murine malaria . Aonuma S. Schuster BG . Herrera ML. J Chemother 1997 Feb. Ragama OB. Ager AL. Wesche D. Mendelman PM. Tsuruzoe K.63(4):617-22. Araki E. Pediatr Infect Dis J 1996 Sep. Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin . Fujii R . [Clinical studies on S 6472 granule preparation (sustained-release cefaclor) in chronic respiratory tract infections] Jpn J Antibiot 1988 Sep. Pediatrics 1994 Dec. [A parallel comparative double blind study of cefixime with cefaclor in the treatment of acute suppurative otitis media in children] Jpn J Antibiot 1987 Jan. 2005 Apr. et al . Hasunuma Y. Treatment of otitis media with cefuroxime axetil . J Travel Med 1995 Mar1. Cock TA.role of the adipokines. Honda Y. Mori Y. Arner P. Matsumoto O. Schneider I. Aviles Santa ML.40(1):1-24 Page 3-D . Tanaka K. Vitam Horm. Igata M. Curr Mol Med. Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers . Tokue Y. Ueda R.73(11):1447-9 65. Schuster BG. South Med J 1988 Aug.43(11):1873-92 58. Konno K. McGreevy P. Kinoshita H. South Med J 1980 Nov. New phosphodiesterase inhibitors in the treatment of erectile dysfunction. Rodriguez F. Andersen SL. Oloo AJ. Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia . Tang DB. Arakawa S. Aronovitz GH . Arya M. Aronovitz G . Matsui T. a new oral cephalosporin . Aronovitz GH .٢٠٩ 57. Treatment of otitis media with cefaclor. The new macrolides: expanding the ways in antibiotic treatment . [A double blind controlled study on S6472 capsules and granules in complicated urinary tract infection] Jpn J Antibiot 1994 Feb. [Polymorphisms of PPARs and metabolic disorders] Nippon Rinsho. Patel HR. Kitamura N. Antimicrob Agents Chemother 1994 Aug. Mohs E .70:25-67.

93. Glickman SE.Jun. Jones RN . Herndon BL. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy. Vaghi A . Comparison of azithromycin and doxycycline in the treatment of erythema migrans .5(10):1094-100.7(4):487-91 77.24(2):113-6 86. Berman S. Lauer BA .10(2):164-78 74. Molino A. Person DA. Mabey DC . J Med Chem 1996 Feb٥-٦٨٠:(٣)٣٩‫٢؛‬ 83. Culig J . Strugar J .Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity . Randomised controlled trial of singledose azithromycin in treatment of trachoma . Henle SK ، Allen BS . Chan DS. Zurenko GE .18 Suppl:٣ S237-42 94. or azithromycin . Wittler RR.59(1):115-39 75. Cynamon MH. Casalini A. Kilburn JO. Upshon PA . Gioia V. Ford CW. Ann Pharmacother 1993 Sep. Bandyk DF . 2005 May. Ball P . Cefaclor af versus amoxycillin/clavulanate in acute bacterial exacerbations of chronic bronchitis: randomised multicentre study . Barsic B. Lamb HM . Beghi G. and clinical efficacy of cefprozil. Zrnic T. as stepdown and abbreviated therapy in respiratory tract infections. Barriere SL . Zierath JR. Suvarna PR . Pediatr Infect Dis J 1998 Jun.38(9):1937-43 91. Cefpodoxime proxetil in upper respiratory tract infections.26(10):1253-61 78. safety.15(4):268-74 82. Pharmacoeconomics 1996 Aug. Claybaugh JR. Hutchinson DK. Azithromycin in an experimental Staphylococcus aureus abscess model . Barbachyn MR. Freitas BC. Genetics of Type 2 diabetes. Short-term treatment of pertussis with azithromycin in infants and young children . Infection 2000 May. 2004 Nov.35(5):623-9 80. Turnak MR. Vincent JM.27(9):1082-9 87. Sisler CL. Balfour JA. Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections . Drugs 2000 Jan. Weisse ME. An appraisal of its use in antibacterial costcontainment programmes. Diabet Med. Benson CA .42 Suppl 3:25-33 96. Toops DS.66(4):504-14. Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease . Diagn Microbiol Infect Dis ١٩٩٦Feb. Lancet 1993 Aug٦-٤٥٣:(٨٨٦٩)٣٤٢‫١٢؛‬ 73. Ann Pharmacother 1992 Oct.53(8):578-83 81. Characteristics of murine model of genital infection with Chlamydia trachomatis and effects of therapy with tetracyclines.18(4):296-8 72. Baltimore RS .Feb.7(2):146-52 92. Carratu L. Consigli G ، D'Anto M. amoxicillin-clavulanic acid. J Antimicrob Chemother 1995 May.26(11):1714-27. Treatment of impetigo: a review . Antimicrobial activity and spectrum of sparfloxacin tested against erythromycin-resistant Streptococcus pneumoniae isolates . Clin Infect Dis 1994 Apr. J Chemother 1995 Apr. 88.13(10):851-6 76. 85. Ballantyne FN . Ader M. Paizis G. Slater LN . Kuzmanovic N. Pediatr Infect Dis 1983 Jan. Amsden GW . Beale AS. Bailey RL. Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections . Role of AMP--activated protein kinase in the control of glucose homeostasis. Bolzon LD. Clin Ther. pharmacokinetic characteristics. Treatment of disseminated disease due to the Mycobacterium avium complex in patients with AIDS . Regnery RL.17(6):447-52 90. Bace A. Brickner SJ. Johns D. Clin Ther 1985. 2005 Apr. Barrett MS.References 71. Barlocco D.5(3):341-8. Bass JW. Majerus L. Eur J Clin Microbiol Infect Dis 1994 Oct. Whittle HC. Bandak SI. Eur J Clin Microbiol Infect Dis 1999 Apr. 95. Bergman RN. 2005 May. a new oral cephalosporin .28(3):153-6 89. 84. Int J Clin Pract 1999 Dec. Berni F. Antibiotics-Why so many and when should we use them‫ ؟‬Semin Vasc Surg 2002 Dec. Benfield P. Maretic T. Freitas AD. Curr Mol Med. LAF-237 (Novartis). Balfour JA.22(5):517-35. Barnes BR. Begovac J.2(1):30-3 Page 4-D . Cefpodoxime proxetil. Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis . A controlled trial of cefaclor versus amoxicillin for treatment of acute otitis media in early infancy . Ballow CH. J Clin Psychiatry. Atypical antipsychotics and glucose homeostasis. Bell DS. Bergogne-Berezin E. Pediatr Infect Dis 1985 Sep-Oct. Curr Opin Investig Drugs. Comparative efficacy of cefadroxil and cefaclor in the treatment of skin and soft-tissue infections . Barroso I. Klemens SP. Grega KC ،Hendges SK.4(5):597601 79. Arullendran P. Drugs 1991. Antimicrob Agents Chemother 1994 Sep. Azithromycin: the first azalide antibiotic . Review of in vitro activity. Bamberger DM. 2004 Oct.

Kafetzis DA. Fundam Clin Pharmacol٩٢-٣٨٧:(٤)١٠‫٦٩٩١؛‬ 102. J Antimicrob Chemother 2000 Apr. J Antimicrob Chemother 1995 Oct. Bluestone CD . Failing K. Members of the Ceftibuten Otitis Media International Study Group . Blondeau JM . Zierath JR. Management of chronic otitis media with effusion . Pediatr Infect Dis J 1993 Jan.Clin Ther 1999 Jan.36(4):641-6 98. Bogdanov MB. A randomized. Cancer Lett. Natale G. Page R. J Antimicrob Chemother 2000 Apr. Blumer JL. Bluestone CD . d'Athis P. J Antimicrob Chemother 1998 Jul. De'Angelis M. Woodnutt G . Page R. Comparative efficacy of gemifloxacin in experimental models of pyelonephritis and wound infection . Acta Otorhinolaryngol Belg٥٦-٤٤:(١)٣٧‫٣٨٩١؛‬ 112.Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease . Biolcati AH . Bevan CD. Recent advances in the pathogenesis. Berry V. Satterfield J. Bermudez LE. multicentre controlled trial of ibuprofen versus acetaminophen and placebo for symptoms of acute otitis media in children .28(4):727-55 113. Wittenbrink MM .42(1):75-82 108.14(7 Suppl):S115-20 116. Senesi S. letrazuril and paromomycin in the treatment of cryptosporidiosis . Gherardi G. 2005 Jun 28.References 97. Pons G. Pediatr Infect Dis 1984 JanFeb.J Int Med Res 2003 JanFeb. Maltinti G. Rothermel CD .19(10):963-7 117. Blanshard C. 111. Pediatr Clin North Am 1981 Nov. and management of otitis media . Mclinn SE. Bjornholm M. Chernen'kaia TV . Biochem Soc Trans. Berstein LM Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer.20 Suppl ١:٣١A-43A 106.283(1):49-60 118. Amsden GW . Singley C. Bertin L. Bellini M.45 Suppl 1:87-93 99. double-blind. Debregeas B. Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis . Olive G . Bluestone CD . Bessette RE. 2005 Feb. Duhamel JF. Tonelli P. Boerner J. Fish D . 107. Singley C.33(Pt 2):354-7. Diabetes Care. diagnosis. [Microbiological evaluation of antibiotics for empirical therapy of community-acquired infections of the lower respiratory tract] Antibiot Khimioter ٨-١٥:(١٠)٤٥‫٠٠٠٢؛‬ Page 5-D . Berry V. Guillot M. Shanson DC. Deabate CA. An open comparative study of the efficacy and safety of sultamicillin versus cefaclor in the treatment of acute otitis media in children . Pilot studies of azithromycin.3(1):25-9 115.Pediatr Infect Dis J 2000 Oct. Epub 2004 Dec 13 101. The safety profile of the fluoroquinolones . Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes. Tacca MD . Malizia T. Int J STD AIDS 1997 Feb. Ridgway GL. Multinational multicenter controlled trial comparing ceftibuten with cefaclor for the treatment of acute otitis media.224(2):203-12. Passali D ، Careddu P .45 Suppl 1:79-85 100. 31(1):45-54 105. Blumer JL. Marveggio C. Perrotta RJ.21(1):3-40. Marchi S. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: influence of test conditions on minimal inhibitory concentration (MIC) values . Satterfield J. Bloomgarden ZT. Comparison of cefaclor and trimethoprimsulfamethoxazole in the treatment of acute otitis media . Husak MP . Expanded activity and utility of the new fluoroquinolones: a review . Thiazolidinediones.22(7):798-817 ‫؛‬discussion 797 103. Bertino JS Jr. J Int Med Res 1992. Ann Pharmacother 1995 Oct. Pediatr Infect Dis J 1995 Jul. Campa M. Boccazzi A. Zentralbl Bakteriol 1995 Nov. Efficacy of azithromycin and rifabutin in preventing infection by Mycobacterium avium complex in beige mice . Treatment of non-HIV cryptosporidial diarrhea with azithromycin . Petrofsky M. Salgado O .29(10):991-3 104.12(1):75-82 114. Bellussi L. Maudelonde C ، Lasfargues G. Marsac A. Woodnutt G . 2005 Apr. Straub R. Gazzard BG .8(2):124-9 109. Costa F. Straub R. Inderlied CB. Comparative in vivo activity of gemifloxacin in a rat model of respiratory tract infection .28(2):488-93. Bertino J Jr. Young LS . discussion ٢-١ 110. Short course therapy with cefitbuten versus azithromycin in pediatric streptococcal pharyngitis . Clin Ther 2000 Jul. Review of cefixime in the treatment of otitis media in infants and children . Blandizzi C.

Kallings I. Menzel F. Lobatto S. Bucchieri R.32(4):401-3 128. Hughes GS. Hegarty BC.37(3):398-402 Page 6-D . Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection . Prestifilippo F. Davidson MG . Tien TV. [Comparative trial of the clinical efficacy and tolerance of cefatrizine (Cefaperos) and cefpodoxime proxetil (Orelox) in superinfections of chronic obstructive bronchopneumopathies in adults in urban practice] Pathol Biol (Paris) 1995 Nov.38(4):524-50 134. Batts DH. Comparison of oral cefpodoxime proxetil and penicillin V potassium in the treatment of group A streptococcal pharyngitis/tonsillitis. Invest Ophthalmol Vis Sci 2000 Dec. Loebenberg D. et al . Efficacy and safety of azithromycin versus lymecyline in the treatment of genital chlamydial infections in women . and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporine . Brown RJ. Bottaro G.43(4):813-21 130. Kaye D . Preliminary observation . Breitschwerdt EB. Manenti F . Armstrong D . Nauta EH.4(11):747-54 136. Osser S. Brihmer C. Faal H. Verbraak FD.43(9):81524 127. McTavish D . Boscia JA. Prud'homme A. Antimicrob Agents Chemother ١٩٩٩ Apr. Edwards FF.28(5):451-4 132. Melillo P. Brook I . Braz LM. Robech M. Benhamou D. Rowley J. Valle-Jones JC .14(3):182-7 120. Nicosia A.134(1):34. Bosch-Driessen LH. Am J Ophthalmol 2002 Jul. Barson WJ.45(5):716-36 135. Mardh PA. Wanger L . A prospective. Kelkel E. Rotolo N. Gilger B ، Hancock SI. Cefixime. Brown ST. Fauche A. Goode VM. Blusse van. Amato Neto V. Drugs 1993 May. Pharmacokinetic properties and therapeutic potential . Onset of Hemophilus influenzae typeb meningitis during cefaclor therapy for preseptal cellulitis . Operational comparison of single-dose azithromycin and topical tetracycline for trachoma .٨ 133. Bradbury F .2(7):494. Clin Ther 1991 Sep-Oct.31 Suppl E:153-62 125. Gulino A. The Cefpodoxime Pharyngitis Study Group. Di Pietro AO. Paediatr Drugs 2002. Loracarbef. Bohte R.145(7):35. Drugs 1989 Oct. Bonforte S.41(13):4074-9 124.٩ 123. Bailey RL . Sikstrom B. [Evaluation of the clinical efficacy of azithromycin in acute respiratory infections in children] Clin Ter 1994 Jul. or trovafloxacin for treatment of experimental Rocky Mountain spotted fever in dogs . Clin Pediatr (Phila) 1987 Mar.Panminerva Med 2000 Sep. Milligan P. Figini G. Cannon HJ Jr. J Antimicrob Chemother 1993 Jun.42(3):197-9 129. Pharmatherapeutica 1980. Eur J Clin Microbiol Infect Dis 1995 Mar. randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis . Muir JF. Suttorp-Schulten MS ، van Ruyven RL. Bregani ER. Brogden RN. Antimicrob Agents Chemother ١٩٩٣ Mar. Brady MT. rifabutin. A review of its antibacterial activity . Van Dehn C. azithromycin.26(3):132-4 126.٤٠ 121. van't Wout JW. Azithromycin in the treatment of Plasmodium falciparum gametocytes. Brodie NH. Azithromycin. JAMA 1987 Feb ٧١-١٠٦٧:(٨)٢٥٧‫٧٢؛‬ 122. Rothova A . Brogden RN. Brambilla C. Oud Alblas A. Bernard EM. Levison ME. McGhie RL. [The evaluation of the efficacy of azithromycin and pyrimethamine used alone or in combination in the treatment of an experimental infection in mice by Toxoplasma gondii] Rev Soc Bras Med Trop 1999 JulAug. Muquit M ، Johnson GJ. Abrutyn E. Franca FO . Knight RA. van den Broek PJ . A double-blind study comparing cefaclor and amoxycillin in the treatment of respiratory tract infections in general practice . Antimicrob Agents Chemother 2000 May. Campoli-Richards DM .13(5):579-88 137. De Luca P ، Ficarra G. Hoyng CB. Grossman LK . Monzani V. Boekhout M. Klok AM.Efficacy of doxycycline. O'Hara J.44(5):1333-6 131. Therapy vs no therapy for bacteriuria in elderly ambulatory nonhospitalized women . A review of its antimicrobial activity ، pharmacokinetic properties and therapeutic efficacy . Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia . Scand J Infect Dis 1996. Greenwald CA. Hermans J. Hare RS . Taytard A. Rahman MK. O'Hara H.References 119. Sillah A. Guerin JC. Brieland JK. Bowman RJ. Kobasa WD. Papich MG. Tong W. Antibacterial therapy for acute group a streptococcal pharyngotonsillitis: shortcourse versus traditional 10-day oral regimens . Efficacy of SCH27899 in an animal model of Legionnaires' disease using immunocompromised A/J mice .

Voi M. Hamilton-Miller JM .110(1-2):128-35 154. Tulkens PM .115(3):485-91.7(9):622-5 150. Cascio A. Pediatr Infect Dis J 1988 Sep. Carlin EM. Nicolau DP . Antimicrob Agents Chemother 1999 Sep. Clin Exp Immunol 1997 Sep. The role of newer macrolides in the treatment of community-acquired respiratory tract infection. J Chemother 1999 Apr. Int J STD AIDS 1996 May-Jun. Rubin R.١٠٢ 140. Bryson HM. Burke T. Heyd A. Van Bambeke F. Carryn S. Cefaclor as a prophylactic agent for recurrent urinary infections: a comparative trial with macrocrystalline nitrofurantoin . Brumfitt W. Antimicrob Agents Chemother 2002 Jul. and streptogramins: effect on extracellular pathogens . Mariano H Jr. Villanueva C. Casali L. A review of its antibacterial activity. 2005 May. Brunton S. Clin Ther 1992 Jul-Aug. Van Bambeke F.46(7):2095-103 157. Barton SE . Huck W. Colomba C. Carbon C.References 138. Campbell IW. Acta Otolaryngol 1990 Jul-Aug. 144. Nightingale CH. Cost effectiveness of antibiotic therapy for otitis media in a military pediatric clinic . Antimicrob Agents Chemother 2002 Jul. 2005 May. contact attendance and patients' treatment preference . and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations .7(3):185-9 155. Mingeot-Leclercq MP. Odkvist L. 151.46(7):2095-103 156. Roberts D . Comparative efficacies of azithromycin and ciprofloxacin against experimental Salmonella typhimurium infection in mice .11(2):107-18 152.23(2):98. Treatment of sinus empyema in adults. Aliment Pharmacol Ther 2000 Dec. Janssen CJ. Biasco G ، Miglioli M . Li C. Cefetamet pivoxil. Rakel R. J Chemother 1999 Jun. Clin Infect Dis 1998 Jul. Clin Ther 1999 Oct. Drugs 1993 Apr.٧ 158. Carmichael B. Rudblad S. Curr Mol Med. Xiang AH. J Antimicrob Chemother 1993 Feb. Olovich KG. Callahan CW Jr . Bui KQ.54(5):445-52. Hamilton-Miller JM. Drugs Exp Clin Res٤٤-٢٣٩:(٦)١٨‫٢٩٩١؛‬ 139. Hamilton-Miller JM . Paterson DL.27(1):28-32 153. Carryn S. gentamicin. Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial . Gestational diabetes mellitus. Brogden RN . gentamicin.43(9):2302-4 146. azalides. Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams ،azithromycin. Zielen S .11(3):163-78 141. Sinusitis Infection Study Group . Pantoprazole. Sorri M. Chronic sinusitis refractory to standard management in patients with humoral immunodeficiencies . Calabrese C.14(4):570. Carenfelt C. Haverstock D. Di Febo G. Infection 1995 Mar-Apr. Tulkens PM . Dere WH . McNabb J. Buehring I. A coordinated Nordic multicenter trial of cefixime vs. Mingeot-Leclercq MP. Church D . Scialpi C.5(3):349-63. Ahrens P. Pharmacodynamics of macrolides. Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams ،azithromycin. Schaaf J. and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations . Brumfitt W.14(12):1613-7 149. A comparative trial of low dose cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infection . Areni A. Poole MD . The Clinical Significance of PPAR Gamma Agonism. Clin Infect Dis 2002 Jan٨-١٥٤:(٢)٣٤‫٥١؛‬ Page 7-D . Schmidt H.21(10):1664-77 147. Melen I. Girard AE . azithromycin and tinidazole: short duration triple therapy for eradication of Helicobacter pylori infection . Lorber D. Azithromycin as the first-line treatment of non-gonococcal urethritis (NGU): a study of follow-up rates. Savolainen S. J Fam Pract. Butler T. 2005 Mar. Titone L . Prellner K. Skaftason S. Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis . cefaclor .45(4):589-621 143. Type 2 diabetes: the role of insulin. Orchard D. Walker S.31(2):313-9 148. Antinori S. Synnerstad B . Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis . pharmacokinetic properties and therapeutic use . Carbon C . J Clin Invest. Buchanan TA. Funnell M. 142. Cefaclor into the millennium .Cefaclor advanced formulation versus cefaclor in the treatment of pneumonia . Olsson O. A review of experimental and clinical data .109(3):468-72 145. Brumfitt W. Friedrich B.

[Clinical study on cefteram pivoxil in asymptomatic bacteriospermia] Jpn J Antibiot 1991 May. Chave JP. Wongher L.44(7):1855-9 176. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis . Boenning DA. J Chemother 1994 Aug.6(4):238-42 173. For acute otitis media in the chinchilla model . Doyle WJ. Di Marco F. Azithromycin in non-gonococcal urethritis . J Chemother 2000 Jun. Current WL . Wain J.91(3A):27S-30S 160. Salzillo A. The Bronchitis Study Group .Antimicrob Agents Chemother 2000 Jul. Matera MG. Biollaz J . Cefaclor in the treatment of infective exacerbations of chronic bronchitis in cigarette smokers . Sevieri G . Califano C ، Calderaro F. Legnani D. Chirurgi VA. Bronchial hyperresponsiveness and bacterial respiratory infections . Church D . Vinciguerra A. Chinh NT.azithromycin for eradicating Helicobacter pylori .28(4):577-80 177. Gentile V.13(1):157. Cefpodoxime proxetil: a new. Nakahara M. Ann Pharmacother 1993 Nov. Godley PJ. Yenyasun N. Cazzola M.33(11):642-6 166. Azithromycin and amoxicillin in the treatment of acute maxillary sinusitis . Cazzola M. J Chemother 1999 Apr. Karp R. Pariyasak W. Chitwarakorn A.114(11):1266-9 169. Antimicrob Agents Chemother 1991 May. Franco C. Di Silverio F . Thong MX. Boveri B. Chan KH. Clinical and economic considerations in the use of third-generation oral cephalosporins. Moukhachen O. Chlamydia trachomatis genitourinary infections : laboratory diagnosis and therapeutic aspects . Godley PJ . Krumpe P. Sukwit S . Araj GF. Dayer P. Chiarini F.46(6):482-5 174. Glauser MP. Evaluation of in vitro and in vivo effectiveness of azithromycin . Antimicrob Agents Chemother ١٩٩٢ May. Palanuvej T. Mansi A.12(3):216-22 161. Sharara AI . In vitro antimicrobial activities of lactoferrin.3(4):245-9 162. J Med Assoc Thai 1997 Jul. Siriwongrangsun P. Ly NT. Chimura T. Khumhaeng M. Mancini V ، Polverino M. Cazzola M. Centanni S . oral cephalosporin.94(1):18-27 Page 8-D . its concomitant use with cefpodoxime proxetil and clinical effect of cefpodoxime proxetil. Parry CM. Chamberlain JM. J Antimicrob Chemother 1991 Oct.27(11):1369-77 178. Chambers ST. Kirst HA. Ceftibuten versus cefaclor for the treatment of bronchitis . Farrar JJ .7(5):416-27 168. and effects on zidovudine disposition . Pharmacoeconomics 1995 May. Swarts JD. Chocas EC. Diep TS. Gioia V. Paap CM. Hirayama T.44(5):538. Comparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay . Clin Pediatr (Phila) 1994 Nov. A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever . Kreaurat M . Centanni S . Cazzola M.27(11):1369-77 179. Clin Ther 1991 Jan-Feb.٤٢ 175. Tanpowpong K. broad-spectrum. White NJ. Chocas EC.Single-dose ceftriaxone versus 10 days of cefaclor for otitis media . Jpn J Antibiot 1993 Jun. Azithromycin in the treatment of chlamydial cervicitis and eradication of Ureaplasma urealyticum in female lower genital tract . Chimura T . Oster SE. Chitwarakorn A. Once-a-week azithromycin in AIDS patients : tolerability. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. J Chemother 1991 Aug. Chatton JY. Aneiro L. Ann Pharmacother 1993 Nov. Ha HD.35(5):903-9 167. Pearce MJ. Murdoch DR. broad-spectrum. Aiken S. Di Perna F. Diamare F. Am J Med 1991 Sep 12. Arch Otolaryngol Head Neck Surg 1988 Nov. Chodosh S. Edelstein H. kinetics. Chedid M. Casiano RR . Ultrashort regimen of lansoprazole-amoxicillin. Pakdeewong S. Tomao P. oral cephalosporin .11(2):119-25 164. Chahine C.References 159. Munafo A. McCabe RE . Klein BL . Rossi F . Charoenwatanachokchai A. De Marco F ، Brunori S.80(7):440-5 171.٧١ 163. Efficacy of a new macrolide (azithromycin). Paap CM. Charoenwatanachokchai A. Am J Health Syst Pharm 2001 Oct ٢٣-١٨١٩:(١٩)٥٨‫١؛‬ 165. Cefpodoxime proxetil: a new. Haverstock D.80(6):343-7 170. Kardatzke DR . Waisman Y ، Ochsenschlager DW.36(5):1013-8 172. J Med Assoc Thai 1997 Jun. Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbation of chronic bronchitis . DeAbate CA. Di Perna F. Cassano KB. Respir Med 2000 Jan. Chamberland S.

Basal insulin therapy.13(1):56-9 201. Yoder SL. Int J STD AIDS 1994 May-Jun. 2004 Oct. De La Rocque F. Bonner DP. A comparison of the efficacy.54 Suppl 2:815. Thurby-Hay L. A review of recent studies in patients with AIDS . Clin Ther 1997 Jul-Aug. Antimicrob Agents Chemother 1999 Jul. Pediatr Infect Dis J 1995 Apr.28(5):1240-4. a new oral cephalosporin. 2005 Mar. Mailloux GB.31(2):226-9 185.18(1):41-7 191. Christenson JC. a novel oral monobactam .References 180. and cefuroxime in volunteer subjects . Gooch WM. Wollner A . Diabetes Care. Mailloux GB. J Antimicrob Chemother 2002 Jul. ciprofloxacin. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. Meservey MA. cephalexin and enoxacin in bacterial infections in chronic bronchitis and asthma . Weinberg DS. Patron RL. Antibiotic chemotherapy of bacterial sexually transmitted diseases in adults: a review . [Randomized study of cefatrizine versus cefaclor in conjunctivitis otitis syndrome] Pathol Biol (Paris) 1990 Jun. Boucherat M. Antimicrob Agents Chemother 1987 Feb. Archer GL. Whitney RR. 189. Cohen R. Pediatr Infect Dis J 2002 Apr. Pizzuto D . Wold SA. Cohen R.19(4):617-25 ‫ ؛‬discussion 603 199. Olsen SJ.4 Suppl:١ S25-S31 182. Bingen E . Musso C. Remuzzi G.43(7):1747-53 187.5(3):165-71 Page 9-D . de Gandt JB . The use of U-500 in patients with extreme insulin resistance. Wold SA. Comparison of two dosages of azithromycin for three days versus penicillin V for ten days in acute group A streptococcal tonsillopharyngitis . Lecompte MD. Cohen R . Diagn Microbiol Infect Dis 1994 Jan. Heifetz CL. Perico N. Cohen R. Bouhanna A. Diagn Microbiol Infect Dis 1994 Jan. Tuck J. Conrad DA . Clinical efficacy and tolerability of grepafloxacin in lower respiratory tract infection . Comley JC. tolerability and safety of azithromycin and co-amoxiclav in the treatment of sinusitis in adults . Sterling AM . Curr Opin Pediatr 2001 Feb. Effect of atovaquone and atovaquone drug combinations on prophylaxis of Pneumocystis carinii pneumonia in SCID mice .28(4):581-6 183.26(2):66-75 186. 2005 May. J Int Med Res 1998 Mar-Apr. Robert M. Gage JW.40(7):1617-22 202. Curr Diab Rep. Chodosh S . Herrod JN. Elbez A. Comparative efficacy and safety of cefprozil and cefaclor in the treatment of acute uncomplicated urinary tract infections . Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin. Roland GE. Deforche D. Scand J Infect Dis Suppl 1988.16 Suppl 1:S34-8. Antimicrob Agents Chemother ١٩٩٦ Jul. Climo MW. Single-dose intrapulmonary pharmacokinetics of azithromycin. Clin Microbiol Infect 1998 Mar.Pediatr Infect Dis J 1995 Apr. Chodosh S. Gorden P. against Staphylococcus aureus and Haemophilus influenzae in mouse infection models . de la Rocque F. Dalvi M. Sykes RB . Cohen R.38(5 ( Pt 2)): 517-20 193. Lin E ، Zurlinden E .discussion 28-9 198. Swenson E. Duncan S. Clinical experience with cefpodoxime proxetil in acute otitis media. Clark JM. 188. Ridgway GL . Clement PA. Gage JW. against Staphylococcus aureus and Haemophilus influenzae in mouse infection models. Palestro B. In vivo therapeutic efficacy of cefdinir (FK482).4(5):342-5. Brahimi N. In vivo evaluation of tigemonam. clarithromycin. Cole P .53:22-8 181.14(4 Suppl):S12-8 195. Corcoran GD. Dual blockade of the renin-angiotensin system: the ultimate treatment for renal protection? J Am Soc Nephrol. Roland GE. Comparative trials of doxycycline versus amoxicillin. Cohen MA. Heifetz CL. Drugs 1997.35(6):1127-30 184. J Antimicrob Chemother 1991 Oct. In vivo therapeutic efficacy of cefdinir (FK482). Yoder SL . Gooch WM 3rd. Levy C. Clinical efficacy of cefpodoxime in respiratory tract infection. Clore JN. Antimicrob Agents Chemother 1991 Jun. Reinert P. Boucherat M. Cohen MA. Navel M.39(4):806-11 200.50 Suppl:23-7 196. Pharmacologic and clinical comparison of cefaclor in immediate-release capsule and extended-release tablet forms . Meservey MA. Christenson JC. Conte JE Jr. Cohn DL . Clinical experience with cefpodoxime proxetil in acute otitis media . Codreanu I.21(4):297-303 194. Cochran E. Golden J. 190. Antimicrob Agents Chemother ١٩٩٥ Apr. Treatment of cat-scratch disease . Comparative efficacy and safety of cefprozil (BMY-28100) and cefaclor in the treatment of acute group A beta-hemolytic streptococcal pharyngitis .14(4 Suppl):S12-8 197. a new oral cephalosporin.18(1):41-7 192. McKenna E. Herrod JN . Swenson E .

Jacobs MR .95 Suppl A:S12-9. 2004 Nov. Pharm Res 2001 Sep.18(9):1310-4 223. 2004 Oct. Pediatr Infect Dis J 1995 Apr. Cox CE. Diabetes Technol Ther. Milatovic D. Muller M. Ruffolo C . Antimicrobial resistance issues of the future. Warner JH. Derendorf H . Drugs 1991. Dautzenberg B .discussion 28-9 222. Prevention and treatment of the metabolic syndrome. McLinn S. Heyd A. Rehak E. Daskalopoulou SS. Targeting insulin resistance and beta-cell dysfunction: the role of thiazolidinediones.17(4):235-9 209. Ceriello A. Craig WA . Johnson CE.13 Spec No١١-١٠٨:(١)١ 216. Leibovitz E. Burch DJ.8(4):371-84 224. Wallrauch C. Respir Med 2000 Nov. Luongo JM . Comparison of azithromycin and co-amoxiclav in the treatment of otitis media in children . Azithromycin versus cefaclor in the treatment of pediatric patients with acute group A beta-hemolytic streptococcal tonsillopharyngitis .19(5):373-83 217.6(5):719-31. Assaloni R. The hidden impact of antibacterial resistance in respiratory tract infection.42 Suppl 3:41-50 204. Culley CM. J Chemother 2001 Nov. Diagn Microbiol Infect Dis 1996 Aug. DeAbate CA. Braveny I .55(6):589-612. Moxifloxacin: clinical efficacy and safety . Todd WM. Church D . Edwards B . Page 10-D .25(4):213-7 208. Angiology. Mikhailidis DP.17(4):235-9 210. Respir Med 2001 Jun. J Antimicrob Chemother 1993 Jun. Cefpodoxime proxetil vs. Pharyngitis/tonsillitis: European and United States experience with cefpodoxime proxetil. Milatovic D. Church D . European Azithromycin Study Group . Rationale for the prevention of disseminated Mycobacterium aviumintracellulare complex disease .12(4):275-9 214. Respir Med 2000 Nov. De La Pena A. Curr Med Chem 2001 Mar. Abughali N. Marchetti P. Braveny I . Da Ros R. De Sarro G .94(11):1029-37 226. Antibiotic prophylaxis in clean surgery: breast surgery and hernia repair . Penetration of cefaclor into the interstitial space fluid of skeletal muscle and lung tissue in rats . Cremer J. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs.19(2):95-104 213. Dajani AS. Am J Med 1991 Sep12. Review of clinical experience in the United States with cefpodoxime proxetil in adults with uncomplicated urinary tract infections. Cremer J. Uden DL. Pediatr Infect Dis J 2000 Feb. Heyd A. Dark D . Pediatr Infect Dis J 1993 Apr. Mathew CP. Webb AI. Kessler SL.54 Suppl 2:1-7. Daniel RR .33 Suppl 3:S233-7 206. Elisaf M. azithromycin in acute otitis media . Cox CE. Review of clinical experience in the United States with cefpodoxime proxetil in adults with uncomplicated urinary tract infections . Does the dose matter ‫ ؟‬Clin Infect Dis 2001 Sep 15. 212.21(11):1249-52. Parimbelli P. Wallrauch C. De Sarro A. Warner JH. DeAbate CA. Mathew CP. an overview on mechanistic aspects . Del Prato S. Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections . Diabet Med. Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections . Azithromycin versus cefaclor in the treatment of pediatric patients with acute group A beta-hemolytic streptococcal tonsillopharyngitis . Talton JD. Am J Med 1991 Sep٣)٩١‫ ٢١؛‬A):31S-35S 219. J Int Med Res 1991 Sep-Oct. penicillin V in pediatric streptococcal pharyngitis/tonsillitis. Drugs 1991. Thyroff-Friesinger U. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis . Reevaluating current antibiotic therapy . Dajani AS. 2004 Nov-Dec. The safety and efficacy of short course (5-day) moxifloxacin vs.42 Suppl 3:41-50 205. Daniel R . Graveline JF. Adverse reactions to fluoroquinolones. 221. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis .94(11):1029-37 225. Dark D . Dalla Costa T. The safety and efficacy of short course (5-day) moxifloxacin vs. Klutman N.31 Suppl E:65-71 218. Graveline JF. Craig WA . D'Amico DF.91(3A):31S-35S 220. Lacy MK. Gross J. Drugs 1997. Eur J Clin Microbiol Infect Dis 1998 Apr. Mendelson R. Craig WA. Am J Health Syst Pharm 2001 Mar٨٨-٣٧٩:(٥)٥٨‫١؛‬ 211. discussion S26-7 207. Eur J Clin Microbiol Infect Dis 1998 Apr.References 203. The preventive anti-oxidant action of thiazolidinediones: a new therapeutic prospect in diabetes and insulin resistance.14(4 Suppl):S7-11 215. Simplified treatment of acute lower respiratory tract infection with azithromycin: a comparison with erythromycin and amoxycillin. Luongo JM. Feris J. Dagan R.

249. Dunn EJ. Rouveix B. Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo . Donaldson JD. Dunger DB. Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus ،Brazil. Clin Ther 1997 Sep-Oct.55 Suppl 4:77-81 237. 240. Gallis HA . Black SA. Antimicrob Agents Chemother 1997 Jul. Espersen F .38 Suppl A:141-54 247. Am J Hosp Pharm 1981 Jan.41(7):1579-83 244. Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis . 2004 Nov. Maltby CC. 1998 . den Hollander JG.19(3):175. Antimicrob Agents Chemother 1998 Feb. pharmacokinetics. Drehobl M. Bartolozzi F ، Candelli M. Brandon ML. Expert Opin Pharmacother. Relevance of the Alexander Project : pharmacodynamic considerations . Mouton JW. 2-methyl and 2.92(6A):53S-57S 230.٨ 241.S. Derouin F. Benzaken AS. Azithromycin--spectrum of activity. Telmisartan . J Chemother 1997 May. Destache CJ. Mono. J Chemother 1989 Aug.19(5):936-53 242. Sex Transm Dis 2001 Sep.killing two birds with one stone. Pichichero ME . Dillon JA. J Antimicrob Chemother 1994 Jul. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections . Martin GF. double-masked. Rubabaza JP. Grant PJ. Derriennic M. Gray BM. Fuursted K ، Frimodt-Moller N. Dumas JL. Campbell JC. Doggrell SA.34(1):111-8 248. Bonnefoy A. Seywerd EB . 2005. Treatment of Staphylococcus aureus infections in children in office practice . Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia .16(3):527-32 236. Endocr Dev. Destache CJ. J Antimicrob Chemother 1996 Jul.5(3):323-32.Beta-ketoester chemistry and ketolides. Dorow P . Childhood and adolescent diabetes. Type 2 diabetes: an atherothrombotic syndrome. Curr Mol Med.68 Suppl 3:S43-6 ‫ ؛‬discussion S46-8 232. Disney FA. Aliment Pharmacol Ther 2002 Mar. Dillon HC Jr.28(9):521-6 238. Chang R. Bretin F. comparative ،multicenter study . Dere WH . Am J Med 1992 Jun22. Dewan N. Lupascu A. Am J Dis Child 1983 Apr. Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis . Bonnet A.5(11):2397-400. Piltan G. Cremonini F.1(4):257. Salisbury JP. Acute bronchitis: results of U. Campbell JC.42(2):377-82 228. Page 11-D . Denis A. Comte R ، Pechere JC . Sardinha JC. Ojetti V. Dere WH .References 227. J Antimicrob Chemother 1999 Mar. Donowitz GR. Tack KJ. Cefaclor AF in the treatment of streptococcal pharyngitis/tonsillitis . Craig WA . Goldstein FW . erbrugh HA. Urick AE. Drew RH. Regan FM. Evaluation of the efficacy of prolonged administration of azithromycin in a murine model of chronic toxoplasmosis . Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis . Di Caro S.43 Suppl A:107-13 235.36(5):997-1001 231. Drusano GL. Antimicrob Agents Chemother 1992 May. Talbot GH .٦٠ 243. Knudsen JD. Angelillo VA . Evaluation of cefaclor . O'Donohue WJ. dos Santos Fernando Filho E . Postgrad Med J 1979. Griffin TJ . O'Donohue WJ. Ware JC . Harman CP. Thoren LM. Zocco MA. Pocidalo JJ . Voi M. Bioorg Med Chem Lett 2000 Sep ٢٢-٢٠١٩:(١٧)١٠‫٤؛‬ 229. Dewan N. The efficacy of pulse-dosed antibiotic therapy in the management of persistent otitis media with effusion . Chau F. Derry JE . Safety and efficacy of cefixime versus cefaclor in respiratory tract infections . Agouridas C . Bianchi P. Postgrad Med J 1992. Li H ، Bandeira MG.137(4):361-4 239. Nista EC. Keyserling CH. Tipping DM. Clinical and laboratory studies with cefaclor : efficacy in skin and soft tissue infections . Acerini CL. Synthesis and antibacterial activity of 2-halogeno. Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized. and European trials of antibiotic therapy . Mermillod B. 2005 May. Piguet PF. Angelillo VA .3 enol-ether ketolides .J Antimicrob Chemother 1999 Mar. Pharmacotherapy٧٣-١٦١:(٣)١٢‫٢٩٩١؛‬ 245.9:107-20.43 Suppl A:107-13 234. Almadany R.9 Suppl 3:3844 246. Drusano GL. and clinical applications . Fromentin C. dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication . Cammarota G ، Gasbarrini A .38(1):54-8 233. J Otolaryngol 1990 Jun.

Totani L.Feb. J Antimicrob Chemother 1993 Jul. Agacfidan A. 2005. Eschwege E. Bach R. 2005 Apr 1622. J Int Med Res 1995 SepOct. 253. Lancet. Curr Med Res Opin. Tognoni G. Prevention of cardiovascular disease in type-2 diabetes: how to improve the clinical efficacy of aspirin. Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine. A trial comparing cefaclor with cotrimoxazole in the treatment of acute otitis media .7 Suppl 6:609-14 269. Standaert ML. Pharmacotherapy 2002 Apr. Fass RJ . Ernst EJ. Erdogru T.20(1):28-33 263. 265. 2005 Apr. Acta Med Croatica 2002.44(9):2590-2 259. 2005 Jan.365(9468):1415-28. Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia: a randomised trial. Petrovec M. Lancet 1999 Sep ٥-٨٩١:(٩١٨٢)٣٥٤‫١١؛‬ 251. Knirsch C .29(1):27-33 266. Atypical protein kinase C in insulin action and insulin resistance. Kemper CA. Bozzette S. Knirsch C . Arch Dis Child 1982 Aug. Glycoside antibiotics alone and combined with tetracyclines for prophylaxis of experimental cryptosporidiosis in neonatal BALB/c mice . Dunne MW. Murphy M. J Cancer Res Clin Oncol. Schatzle W . Marchisio P. Diabetes and cardiovascular risk markers.References 250. [Experience with cefaclor in the treatment of ear. Droghetti R. 261. Strugar J. Int J Antimicrob Agents 2002 Jul. Rotondo S. Influence of outer membrane mutations on susceptibility of Escherichia coli to the dibasic macrolide azithromycin . The metabolic syndrome. Erhardt W. Clin Ther 1998 Jan. Comparative efficacy and safety of 5-day cefaclor and 10-day amoxycillin treatment of group A streptococcal pharyngitis in children . Mattina R ، Principi N. De Ritis G. Hippe F. J Parasitol 1993 Aug. Federspil P. BMS-284756 (T-3811ME) a new fluoroquinolone : in vitro activity against Legionella.21 Suppl 1:S21-8.57(8):594-6 270. Evangelista V. The treatment of nongonococcal urethritis with single dose oral azithromycin .22(4):463. Edelstein MA .32 Suppl A:17-27 267. Muehlbeyer S. pneumophila pneumonia and pharmacokinetics in guinea pigs .79(4):553-8 268.39(1):45-50 Page 12-D . California Collaborative Treatment Group . Farese RV. Antimicrob Agents Chemother 2000 Sep. Aetiology and treatment of community-acquired pneumonia in adults: an historical perspective . Evaluation of survival and pharmacodynamic relationships for five fluoroquinolones in a neutropenic murine model of pneumococcal lung infection . Sattler FR. Badur S. Feldman W. nose and throat infections.33(Pt 2):350-3. Thromb Haemost. Rennie B. 264. Richardson H. Dube MP. Dzelalija B. Esposito S. Indications for cefaclor therapy (author's transl)] Infection 1979. Klepser ME.23(5):386-93 257. Murphy M. Eisenbrand G. 56(2):45-7 252. Shinzato T.44(9):2590-2 258. Dawson P . Forthal D. Bosis S. Avsic-Zupanc T.66(2 Pt 2):1S32-44. 2004 Nov. Fayer R. Ellis W . Establishing criteria for assessment of efficacy of antimicrobial agents in acute otitis media . Weich C. Edelstein PH. Wilhelm HJ. Fernandez-Obregon AC . Epub 2004 Aug 31. Int J Dermatol 2000 Jan.48(5):667-75 254. De Berardis G. Erhardt W. D'Errico G. Clinical comparison of cefaclor twice daily versus amoxicillin-clavulanate or erythromycin three times daily in the treatment of patients with streptococcal pharyngitis . Establishing criteria for assessment of efficacy of antimicrobial agents in acute otitis media Antimicrob Agents Chemother 2000 Sep. Esposito S. [Metabolic syndrome: which definition(s) for which objective(s)?] Ann Endocrinol (Paris). 2005 Apr. J Antimicrob Chemother 2001 Nov. Jakobs S. Hancock RE . Grundy SM. Sajan MP. Havlir D . Petzold CR.Randomized trial of azithromycin in the prophylaxis of Mediterranean spotted fever. Ang O ، Telalloglu S . Li ZS.93(1):8-16. Nicolucci A. 255.20(1):72-9 262.٧٠ 260. Doern GV . 256. Azithromycin for the treatment of acne . Farmer S. Milic TA . Zimmet PZ. Biochem Soc Trans. Onel M. Short Therapy Study Group . Eckel RH. efficacy in a guinea pig model of L. Noviello S. Erdmann E. Lorenzet R. McCutchan JA.130(11):627-35. Tiesler E. Ianniello F . J Antimicrob Chemother ١٩٩٢ Jan.

Zuck P. Featherstone AS. Antimicrob Agents Chemother 2002 Jun. Oreskovic K. Croatian Azithromycin Study Group .25 Suppl A:101-8 280. Liu J. Mikhailidis DP. Ferwerda A. Elisaf MS.References 271.Clin Ther 2002 Aug. Tsarev VN. Gorodischer R. Best Pract Res Clin Gastroenterol. Fierek O.21(3):457-68. Bailey RL. Nikolaides P. Selection of dose regimens of azithromycin . Kubin R. Clarithromycin versus cefaclor in lower respiratory tract infections. Matrapazovski M. J Antimicrob Chemother 1990 Jan.181 Suppl 3:514-8 286. Influence of moxifloxacin. Reichl V. J Infect Dis 2000 Jun. Panzig B . Foulds G. Laforge J. Value of animal models for Chlamydia pneumoniae-related atherosclerosis . Raz R. Bearman J.93(11):656-61 275. Randomized controlled trial of sequential intravenous (i. Wiesinger BA ، Tennenberg A. Hoeffken G . Dmitrieva LA. Clin Invest Med 1995 Apr. Fong IW .117 (11):361-3 282.39(4):295-309 283. Baskerville A .18(6):1125-46. 2005 May 15. Azithromycin: 3-day versus 5-day course in the treatment of respiratory tract infections in children. Kouwenberg JM.9(1):38-43 274. Ogundare F. J Antimicrob Chemother 1993 Jun. Have angiotensin receptor blockers lived up to expectations? Can J Cardiol. J Infect Dis 2000 Jun. 277. Klinar I . Bull World Health Organ ٤٠-٦٣٢:(٧)٧٩‫١٠٠٢؛‬ Page 13-D . Ferrara A. Baskerville A . Grossman R. [Cefaclor and trimethoprim-sulfamethoxazole for recurrent otitis media] Harefuah 1989 Dec 1.46(6):1746-54 278. Flores S. Hop WC. Flockhart DA. Fraser-Hurt N. A multicenter. Hinniger P. Kahn JB . Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis . Fliss DM. 289.18(2):131-8 285. Ficnar B. Fong IW . Kuznetsov EA. Kalinin AI . Filippatos TD. Curr Med Res Opin. Krauss M. Izquierdo JL. 2005 Mar.) and oral moxifloxacin compared with sequential i. Selection of drugs to treat gastro-oesophageal reflux disease: the role of drug interactions . Marchese A. Canton A. Efficacy. Schurmann D. Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophila by aerosol . Fitchett D. 279.31 Suppl E:171-6 281.J Antimicrob Chemother 1993 Jun. Finch R. Infection 2002 Aug. Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis .Am Heart J 1999 Nov. Freitag S.٨ 287. Opazo H. Frank E. randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia . Olson WH. Small D. Valderrama D. Liberopoulos EN. The Canadian Bronchitis Study Group . Lieberman A . Fitzgeorge RB. McGivern J ، Bobbaers H. Dos Santos C.21(7):569-75. de Groot R . Moll HA.181 Suppl 3:S514. Kiortsis DN. Oross MP. Tjon Pian Gi CV. [The prospects for using the new macrolide antibiotic azithromycin (Sumamed) in the combined treatment of periodontitis] Stomatologiia (Mosk) ٥-١٢:(١)٧٤‫٥٩٩١؛‬ 276.31 Suppl E:39-50 290.J Antimicrob Chemother 2001 Apr. Cousens S. Mabey D. Fitzgeorge RB. Huzjak N.24(8):1292-308 291. Johnson RB . Zakhari R . Robben SG. Mahal SK . Obesity: epidemiology and clinical aspects. Collins O. Lever S. J Chemother 1997 Feb. open-label. Fong IW . [Triple therapy of short-term with azithromycin ، amoxycillin and omeprazole for the eradication of Helicobacter pylori] Rev Med Chil 2000 May. 2004 Dec. Kinasewitz G.Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma . Bahal N. A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne Legionnaires' disease .128(5):509-12 284. Faal H ، Mabey DC . and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment . Tellarini MT . Fong IW.v. Dubois J.47(4):441-6 273. Aguilera R. A review of the metabolic effects of sibutramine.v. Filatova NA.30(4):208-11 272. Valderrama S . comparator drugs and some fractions of pulmonary surfactant on adherence of some respiratory pathogens . safety and tolerability of 3 day azithromycin versus 10 day co-amoxiclav in the treatment of children with acute lower respiratory tract infections . Desta Z. Formiguera X. [Antibiotic sensitivity of important pathogens of bacterial respiratory tract infections in Northeast Germany] Med Klin 1998 Nov 15. Moran GJ. Clin Pharmacokinet 2000 Oct.138(5 Pt2):S512-3 288.

3(2):137-58 303.41(12):2652-63 301.48(9):1074-92 296. Paediatr Drugs 2001. Efficacy and tolerability of brodimoprim in bacterial otitis media in children.33(2):218-28 310. Iwata S. Gambini D. Kakazu T. Furman S. Furusawa T. Furudama H. Galova K. Takenouchi T. Frenck RW Jr. Durcanska K. Controlled study versus cefaclor . Intravenous azithromycin . Cantini L. In vitro and in vivo antibacterial activities of CS-834. Kubota M. Goa KL . Saito A. Abe T. Ishii C. Tajima T. Decleva I. Arimasu O. Abe T.18(3):228-34 311. Montanus MS.27(4):226-9 309. Multicenter randomized study of two once daily regimens in the initial management of community-acquired respiratory tract infections in 163 children: azithromycin versus ceftibuten . Perry CM . David J. Cefpodoxime proxetil in the treatment of lower respiratory tract infections. Sakagawa E. Sex Transm Dis 2000 Apr. Ann Pharmacother 1999 Feb. Garey KW. Fukuoka T. Nakamura H. Dallari S. Seage GR 3rd. Krizan S. Mycoplasma genitalium in males with nongonococcal urethritis: prevalence and clinical efficacy of eradication. Bergamini G. [Objectives for antibiotic therapy in acute exacerbations of chronic bronchitis] Presse Med 2001 Oct 27. Berkowicz L. Fujii R.37(4):491-522 295. Fujii R. Marinova I. Inoue S. Schall R . Danisovicova A ، Hrachova I.30(31 Pt 2):17-22 306. Kawada H. Kitayama A. Yoshioka H. Shiraishi H. Harasaki T. Grausova S. Meguro H. [Overall clinical evaluation of cefpodoxime proxetil against infections in pediatric fields] Jpn J Antibiot 1989 Jul. Kukova Z. Antimicrob Agents Chemother 1997 Dec. Friedel HA. Irabu Y. Iseki K. Lupica L. Losina E. Miyaguni T. Hirasawa A. Kubota M. Maegawa M.References 292. Martini A. Gaillat J . Harasaki T. J Int Med Res 1990 May.47 Suppl 3:21-6 304. Cefetamet pivoxil vs cefaclor in the treatment of acute otitis media in children . [Clinical evaluation of cefpodoxime in respiratory tract infections] Jpn J Antibiot 1993 Jan. Iwata M. Drugs 1991. Paediatr Drugs 2001. Nakasone K. et al. et al . Geddes AM. Stopkova K. Perry CM. Koga T. Pediatric Study Group of Azithromycin] Jpn J Antibiot 1995 Sep.46(1):53-9 299. Ishii C. Monici Preti PA . Yokota T. Paltiel AD . Yasuda H. Gauger U. Girgis YF. Efficacy of CS-834 against experimental pneumonia caused by penicillin-susceptible and -resistant Streptococcus pneumoniae in mice. Krupova I ،Krcmery V Jr . J Chemother 1993 Dec. Shigeno Y. Akita H. Kawada H. Murono K. Ghidini A ، Mazzoli M. a novel oral carbapenem. Freedberg KA. Dippenaar J.31(5):1134-8 294. Antimicrob Agents Chemother 1998 Jan. Ghislanzoni M. Inoka P. Steinberg A. The cost-effectiveness of preventing AIDS-related opportunistic infections . Terashima I. Sultamicillin. Raskova J.42(3):231-4 308. Iwata M. Hida S. Kamai Y. Amsden GW . Fulton B. Fukuhara H. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children . Chemotherapy 1996 May-Jun. Hiratake Y. Ooe H. Ohya S. Yasuda H. Itoh M. Masuda N. Sakata H. Ohya S. Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients. Hellenberg DA. et al. Nakagawa K. Germano G. Morsy M . Utsui Y. Girgis NI. Butler TC. Cusini M ، Alessi E . Scharfstein JA. [Evaluation of clinical efficacy and safety of cefpodoxime proxetil (CPDX-PR) in acute uncomplicated cystitis] Hinyokika Kiyo 1994 Sep. Kuwahara S.42(7):1439-55 297. Fukuoka T. Sultan Y. Takahashi Y. [Pharmacokinetic and clinical studies with azithromycin (capsule) in the pediatric field . Craven DE. Kissling M . Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients . Kuwahara S. Weinstein MC. pharmacokinetic properties and therapeutic use . A review of its antibacterial activity.42(1):23-7 300. Galetti G.42 Suppl 3:34-40 Page 14-D . Bassily SB. Mishina T. Takeuchi Y. Fulton B. Drugs 1991.40(9):85360 305. Clinical trials of cefpodoxime proxetil suspension in paediatrics.5(6):551-5 307. Koga T. Stahorska A.42 Suppl 3:57-60 298. Clin Infect Dis 2000 Nov.Jun. Drugs 1994. Campoli-Richards DM. Kakuta M. Drugs 1989 Apr. JAMA 1998 Jan ٦-١٣٠:(٢)٢٧٩‫٤١؛‬ 293. Oshiro H. Meguro H ، Sunakawa K. Nakhla I. Fujii R. et al. Owan T. Sufliarska S.3(2):137-58 302. Abe T. Domon H. Cefetamet in the treatment of acute sinusitis in adult patients .

and oxacillin against Pasteurella multocida . 321. Pharmacokinetic and in vivo studies with azithromycin (CP-62. Depondt J. Girard AE. Management of toxoplasmosis . Georgopoulos A. Laviola L. Retsema JA .183(1):13-30. Flattery AM. Girard AE. English AR.18(12):885-9 318. Kropp H. Bryson HM. 319. [Combined treatment of persisting urogenital chlamydia infection with sumamed and interferon alfa] Antibiot Khimioter 2002. Retsema JA. Barchiesi F. Antimicrob Agents Chemother 1991 May. azithromycin. L-708. Goldstein EJ. Abruzzo GK. What do the new antimicrobials offer? Weighing the advantages and disadvantages compared with traditional agents . Gill CJ. Antimicrob Agents Chemother ١٩٨٨ Feb. clinical efficacy and tolerability in lower respiratory tract infections .26 Suppl E:87-91 313. Cimochowski CR.677. Jacquet P. Giannini S. Antimicrob Agents Chemother 1987 Dec. and cefaclor against experimental Streptococcus pneumoniae respiratory infections in mice . metronidazole against Entamoeba histolytica clinical isolates . Girard D.47(5):12-5 331. Linnau KF. Taillebe M. Wilkening R. 2005 Jan. Gomberg MA . Giacometti A.Antimicrob Agents Chemother ١٩٨٧ Dec. Dewever H.27(10):982-91. Sultan Y. Wightman BJ. Wien Klin Wochenschr 2001 Aug٦-٥٩٣:(١٦-١٥)١١٣‫٦١؛‬ 317. a new macrolide with an extended half-life and excellent tissue distribution . Acta Physiol Scand. Dini M. In vivo evaluation of three acid-stable azalide compounds. amoxicillin-clavulanic acid. Shankaran K. Cirioni O.109(3):87-91 ‫؛‬ quiz 28 328. A review of its antibacterial activity ، pharmacokinetic properties.299 and L-708.48(10):1141-7 320. Denis P. erythromycin. Lack of in vitro efficacy of oral forms of certain cephalosporins.993).53(5):412-7 Page 15-D . Eur J Clin Microbiol Infect Dis 1999 Dec. Drugs 1997 Apr.48(2):179-88 316. Pascarel J. Drugs 1994 Aug.26 Suppl E:87-91 314. Girard D. Simonet M. Simonet M. Sparfloxacin. amoxicillin. Georgiev VS . Efficacy of macrolides vs. J Antimicrob Chemother 1990 Sep. Barry B. Gehanno P. Postgrad Med 2001 Mar. Pediatr Infect Dis J 1998 Sep. Gleckman R . Burzacchini F.365 compared to erythromycin. Coste C ، Ramirez de Los Santos MA.References 312. Barry B. J Antibiot (Tokyo) 1995 Oct. Serio M. Retsema JA . Gisby J. Faiella JA.35(5):831-6 327. Comparison of cefpodoxime proxetil with cefaclor in the treatment of sinusitis . Farid Z ، Mateczun A . Buxbaum A. Short-course cefotaxime compared with five-day co-amoxyclav in acute otitis media in children .32(2):213-5 330. J Antimicrob Chemother 1990 Dec. a new macrolide with an extended half-life and excellent tissue distribution . El-Gendy A. Milisen WB. Bartizal K . Cimochowski CR. Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity. Girard D. Beale AS . Haskell SL. English AR. Pharmacokinetic and in vivo studies with azithromycin (CP-62. Eriksson JW. 2004 Nov.17(9):816-9 326. Faiella JA. Kosowski A . Gehanno P. Comparative efficacies of ciprofloxacin. azithromycin and clarithromycin . Gonzalez de Aledo Linos A. Galli A. Swindell AC . Influence of immunosuppression on the pharmacokinetics and pharmacodynamics of azithromycin in infected mouse tissues . Hoareau J ، Gojon D. Girard AE. Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Goa KL.53(4):700-25 329. Gootz TD. Comparison of cefpodoxime proxetil with cefaclor in the treatment of sinusitis. Gootz TD. Garcia Merino J . Correlation of the extravascular pharmacokinetics of azithromycin with in-vivo efficacy in models of localized infection . Efficacy of treatment with paromomycin. Frenck RW Jr. Haskell SL.993). Markham A . Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis .37 Suppl C:21-35 325. Richwald GA . Giorgino F. Gehanno P.31(12):1948-54 322. [Control of a school outbreak of serogroup B meningococcal disease by chemoprophylaxis with azithromycin and ciprofloxacin] An Esp Pediatr 2000 Nov. Citron DM. and nitazoxanide in a patient with disseminated cryptosporidiosis .25 Suppl A:61-71 324. J Endocrinol Invest. Shabpar A. J Antimicrob Chemother 1990 Dec.26 Suppl A:29-36 315. Regan PA. Dewever H . Depondt J. Scalise G .31(12):1948-54 323. Smith JG. Jackson J ، Kong L. Graninger W . Girard D. J Antimicrob Chemother 1996 Jun. L701. Retsema JA . Girgis N. J Antimicrob Chemother 1990 Jan.

Kastelan M. Drugs 1996 Apr. J Allergy Clin Immunol 1992 Sep. Obes Surg. Am J Med 1992 Apr 6. Wallace RJ Jr . Stasic A . Sanders CV. Semin Respir Infect 1996 Dec. New developments in the treatment of nontuberculous mycobacterial (NTM) disease . Gotfried MH. Hayami H. Am J Med 1981 Nov.12(3):240-3 347.Clin Ther 2002 Apr. Karadede S .10(6):469-73 346. Simonic E. Wallace RJ Jr . 2005 Apr. Griffith DE. Gruber F. Drugs 1994.Azithromycin compared with minocycline in the treatment of acne comedonica and papulo-pustulosa .References 332.٨٤ 350. 351. Gruber F. Couch L. Aslan G. Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB). Sawyer MH. J Chemother 2000 Jun. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis : a fifteen-year experience at the University of Virginia and review of other selected studies . Gumbs AA. Putnam SD. Satici A. Kalayci AG. Ballantyne GH. Curti E. 2005. Zamolo G . Guzey M.Clin Ther 2000 Jun. Lewis AC. Griffith DE. Hinyokika Kiyo 1999 Feb.15(4):462-73.44(4):387-91 353. Murphy DT. Grassi GG . Guay DR . Basar E. Weekly oral azithromycin as prophylaxis for agents causing acute respiratory disease . Antimicrob Agents Chemother 2003 Feb. Schito G. [Correlations between the hypothalamo-pituitary-adrenal axis and the metabolic syndrome] Orv Hetil.45(2):85-9 337.92(4A):108S113S 335. Treatment of early syphilis with azithromycin . Kastelan M.146(2):51-5. Guay DR .51(4):515-36 349.24(4):473-89 348. Girard WM. Deperalta EP. Curr Med Res Opin. Studio Multicentrico con Moxifloxacina nel Trattamento delle Riacutizzazioni de Bronchite Cronica . Lazzaro C. Kawahara M.71(5):841-5 342. Uysal S . Gray GC. Guay DR . Grassi C. Grant PJ. Three-day course of oral azithromycin vs topical oxytetracycline/polymyxin in treatment of active endemic trachoma . Goswick SM. Inflammatory. Jonjic A.47 Suppl 3:35-42 340.9(4):263-6 345. Gruber F. Ozardali I. broad-spectrum oral cephalosporin . Brown BA. 338.22(6):673. Tellarini M. Brajac I . J Infect Dis 1998 Jul.26(1):103-10 341. Korbonits M. Kitagawa T. Single-dose cefaclor therapy of urinary tract infection. Scheld WM. Gurses N. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis . Connor JD . Cassell GH.47(2):524-8 334. Gooch WM 3rd. Initial (6month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodeficiency virus-negative patients .Aug. Brajac I. Goth M. J Antimicrob Chemother 1996 Sep. Sande MA.12(12 Suppl 3):S128-33 333. Pediatr Infect Dis J 1993 Dec. Hubina E. Comparative trial of azithromycin and ciprofloxacin in the treatment of gonorrhea. Gan VN. Lenkovic M. Laurila A. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Greenberg RN. SMART Study Group.11(4):301-10 344. Evaluation of antibody-coated bacteria test and C-reactive protein assay as predictors of cure . Macrolide antibiotics in paediatric infectious diseases .178(1):121-6 343. Marier RL . Jpn J Ophthalmol 2000 Jul. atherothrombotic aspects of type 2 diabetes. Brenner GM .Clarithromycin and cefaclor suspensions in the treatment of acute otitis media in children . Karcher JA. Comparative clinical efficacy of cefetamet pivoxil in lower respiratory tract infection . Ellison WT .38(3):547-50 352. Comparative study of single-dose and three-day therapy for acute uncomplicated cystitis. Short-Course antimicrobial therapy for upper respiratory tract infections . J Chemother 1998 Dec. Lenkovic M. Grubisic-Greblo H. Gwaltney JM Jr. Modlin IM. Islek I.21 Suppl 1:S5-12. McPhate DC. Khurana CM ، Andrews WP Jr . Sydnor A . Corder WT. Goto T. Clin Infect Dis 1998 Jan. 2005 Jan 9. 336. Leinonen M. J Chemother 1997 Aug. Ohi Y. Brajac I. J Chemother 2002 Dec. Casali L. Activities of Azithromycin and Amphotericin B against Naegleria fowleri In Vitro and in a Mouse Model of Primary Amebic Meningoencephalitis . Cefuroxime axetil in the treatment of acute sinusitis in childhood . Cabrijan L. Grubisic-Greblo H.14(6):597-608 339. Cefdinir: an advanced-generation.90(3 Pt 2) : 457-61 ‫؛‬discussion 462 Page 16-D .

Multicenter trial of single-dose azithromycin vs . Yamashita T. Hoivik HO. Postgrad Med J 1992. Plusa T. MarcinkowskaSuchowierska E. Comparative trials of cefaclor AF in uncomplicated cystitis and asymptomatic bacteriuria . A comparative study of cefaclor vs amoxicillin/clavulanate in pediatric pharyngotonsillitis . Mozejko-Pastewka B. Nakao Y.147(1-2):37-9. Laine K. Krecicki T ، Kubik P. Neuvonen PJ. 358. Harrison CJ. Morizaki A. Bardadin J. Odegard T . Slominski J. Ekblad U . Hayle R. Heikkinen T. Kawalski H.26(1):54-7.Int J Antimicrob Agents 2000 Jul.107(6):770. Kobayashi Y. Yaginuma Y. Cassell GH. Katou Y.68 Suppl 3:S60-6 ‫ ؛‬discussion S66-7 360.21(2):107-11 362. Ohnuma K . 2005 Jan. Hammerschlag MR . Mos M. Efficacy and safety of azithromycin versus phenoxymethylpenicillin in the treatment of acute maxillary sinusitis .9(3):PI29-35 356. [Glucose-independent impact of the glitazones on the cardiovascular outcome] MMW Fortschr Med. Comparative study of cefaclor AF vs. Hashimoto N. Med Sci Monit 2002 Jan. Kuno K. ceftriaxone in the treatment of uncomplicated gonorrhea. Pediatr Infect Dis J 1993 Jan. [Clinical examination of S 6472 (sustained release preparations of cefaclor on chronic respiratory tract infection] Jpn J Antibiot 1988 Sep. Zylka S.12(1):62-9 366. Pichichero ME . Eur J Clin Microbiol Infect Dis 1998 May. Hammerschlag MR.42(8):1849-59 370. Hausinger SA. Pediatr Infect Dis J 1992 Aug. Grzelewska-Rzymowska I ، Malolepszy J. 363. 2005 Apr. Chyczewska E. [Clinical studies on cefpodoxime proxetil dry syrup in the field of pediatrics] Jpn J Antibiot 1989 Jul. Hamilton-Miller JM. [The glitazones] Rev Med Interne. Martin DH. Douglas JM Jr.45(11):1558-70 369. Iravani A. Kuno K. cefaclor in pediatric skin and skin structure infections . Byers KS.46(3):213-8 371. Med Sci Monit 2003 Mar. Hayashi H. Mierzwa T. Haruta T. Gryczynski M ، Golabek W. Rek M . cefuroxime axetil in acute exacerbations of chronic bronchitis .66(2 Pt 2):1S59-70.7(5):1016. Milanowski J. 15(11):849-53 374. Haye R.17(10):865-71 365. BJOG 2000 Jun. Kobayashi Y . Haczynski J. Takeuchi H ، Ando Y. Azithromycin versus placebo in acute infectious rhinitis with clinical symptoms but without radiological signs of maxillary sinusitis . Dere WH . 2005 Jan 13. Zawadzka-Glos L. Hoivik HO. Microbiologic and clinical aspects of a trial of once daily cefixime compared with twice daily cefaclor for treatment of acute otitis media in infants and children . Rek M . Haczynski J. Gryczynska D.8(1):PI1-7 357. Schlossberg D . Chemotherapy 2000 May-Jun.17(5):309-12 373. Ishiya T. Kuroki S.Med Sci Monit 2001 SepOct. Hanfling MJ.41(9):1313-8 372. Szendo-Kita J. Oklek K. Kazmierczak H. Haczynski J. Szmygin K. Namyslowski G. Suzuki N. Loracarbef vs. Popiel L . Kito O .٥ Page 17-D . Chartrand SA. Czarnocki KJ. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children . Harris JA. Pediatr Infect Dis J 1998 Oct. Kolokathis A. Halimi S. Squires J . Bien S. Ishikawa M. Odegard T . A comparative study of cefaclor vs . Ando H . The transplacental transfer of the macrolide antibiotics erythromycin. Hayashi I. Haruta T.References 354. Sex Transm Dis 1994 Mar-Apr. Ando Y. 359. Lingaas E.49(10):926-31 367. Azithromycin Gonorrhea Study Group .15(2):149-52 361.11(8 Suppl):S27-30 364. [Laboratory and clinical studies on cefteram pivoxil in the field of pediatrics] Jpn J Antibiot 1989 Aug.42(7):1621-8 368. Dalu ZA. Kawalski H. Roblin PM . [Coming clinical recommendations: where will the glitazones fit in?] Ann Endocrinol (Paris).٢٢ 355. McCarty JM. Prospective randomized study of antibiotic prophylaxis for nonlaparotomy surgery in benign conditions. Hayakawa F. Nakao Y. Brumfitt W. amoxicillin/clavulanate in tonsillopharyngitis . Campbell M. Handsfield HH. Hanefeld M. Chmielik M. [Laboratory and clinical studies on cefprozil in the field of pediatrics] Jpn J Antibiot 1992 Nov. Okura K. Halimi S. Eur J Clin Microbiol Infect Dis ١٩٩٦ Nov. Ogawa A. [Therapeutic efficacy of azithromycin in pediatrics] Jpn J Antibiot 1996 Oct. Ogawa A. Hayakawa F. roxithromycin and azithromycin . Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae . Lingaas E.

Morinaga T. In vivo sensitivity test in otitis media: efficacy of antibiotics . Hiraga Y. 382. Sips AP. Am J Med 1991 Sep12. 92(6A):86S-94S Page 18-D . Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. Hoepelman AI. Comparative double blind clinical studies of sustained release preparations with a regular preparation of cefaclor] Jpn J Antibiot 1985 Apr. Lamb HM. Hoepelman IM. Figgitt DP . Talkington DF. Hurst M. [Clinical evaluation of sustained release preparations of cefaclor in dental infections .38(4):1117-40 390. Verhoef J .41(9):1304-8 379. [Clinical evaluation of S 6472 granule preparation )sustained-release cefaclor) in chronic bronchitis] Jpn J Antibiot 1988 Sep. [Effects of nateglinide in impaired glucose tolerance subjects] Nippon Rinsho. A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillinclavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome .37(4):581. Nishimura T. van Barneveld PW. Hooton TM . The periodontal abscess (II). Hirosawa H. Okada T. Rozenberg-Arska M . J Prosthet Dent 1997 Apr. Int J Antimicrob Agents 1997 Jan. Hurst M. Howie VM. Ramos C. Lamb HM.٨ 378. Watt JP ، Thacker WL.9(3):141-6 385. Horii M. Eland ME.91(3A):23S-26S 387. Hyde TB. J Infect Dis 2001 Mar١٢-٩٠٧:(٦)١٨٣‫٥١؛‬ 396. Zell ER. Takahashi S. Drugs 2002. Bactericidal eradication from carious lesions of prepared abutments by an antibacterial temporary cement . Kimura J. Bischoff W . Zwinkels M. Hoeffken G. Levofloxacin: an updated review of its use in the treatment of bacterial infections . Herrera-Insua I. Respir Med 2001 Jul.27(6):395-404 376. Hori R. Perez P. Hyslop DL. Scott LJ. Short-term clinical and microbiological efficacy of 2 systemic antibiotic regimes . Am J Med 1992 Jun 22. [A double-blind comparison between cefaclor and cephalexin in the treatment of dental infections] Jpn J Antibiot 1984 Jan. Pediatrics 1985 Jan. van de Moosdijk CN. J Infect Dis 1994 Oct. Yamanaka H. Gilbert M.63 Suppl 2:438-43. Levofloxacin: an updated review of its use in the treatment of bacterial infections . Hughes WT.279(5):384-6 386. van Schie MH. Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis . Takada S. Ward DJ. Dalinghaus WH. Hirsch IB. Lamb HM.References 375. Hurst M. Meyer HP. Besser RE . Roldan S. Holmberg SD. Noshi Y. Yamamoto A . Mollers MJ. Scott LJ. Dillard R.62(14):2127-67 395. safety and dosage on cefpodoxime proxetil in pediatric infections] Jpn J Antibiot 1989 Jul. Shimada S. A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis . Oz HS . Rozenberg-Arska M. Martinez P.77(4):348-52 388. et al . Sasaki T. Prieto J . van Helmond JL. Schlosser NJ.37(1):152. Inaba O. Schwartz SB. Palella FJ. A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections . Figgitt DP . Ishikawa Y. Drugs 2002. O'Connor A. Intensifying insulin therapy in patients with type 2 diabetes mellitus. Lawrence B . Matsuda H. Synergistic effect of azithromycin on the phagocytic killing of Staphylococcus aureus by human polymorphonuclear leukocytes . Noshi Y ، Okada T. Navin TR . Loveless MO.95(7):553-64 383. Neve AJ. 2005 May. Von Bargen JC. CAP1 Study Group . Omichi M.42(7):1498-504 380. J Antimicrob Chemother 1993 Jun. The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia . Greefhorst AP. Sasaoka S . Takada S. 2005 Feb. Gomez-Lus ML.170(4):906-11 392. [Study of efficacy.62(14):2127-67 394. Nishimura T. Verhoef L. Kikuchi K. Sasaki T.16(1):13-6 377. Levofloxacin: an updated review of its use in the treatment of bacterial infections . Am J Med. Eur J Clin Microbiol Infect Dis 1997 Jan. Sanz M . et al . Figgitt DP . Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model .62(14):2127-67 393. Sinninghe Damste EJ.٧٥ 389. Kohno S. Drugs 2002. Shimada S. Herrera D.31 Suppl E:147-52 384. Hirose T. Killmar JT. Hiraga Y. Hoshino E . [Clinical studies of cefaclor for respiratory tract infections] Jpn J Antibiot 1984 Apr. HIV Outpatient Study (HOPS) Investigators . J Clin Periodontol 2000 Jun. Horii M. 381. JAMA 1998 Feb4. Takeuchi T. Mol SJ. Azithromycin prophylaxis during a hospital outbreak of Mycoplasma pneumoniae pneumonia . Moorman AC.118(Suppl 5A):21S-6S. Scott LJ. Winter J. Ichihashi H. Yamanaka H.75(1):8-13 391.

2004 Dec. Fogh A.449:43-4 410. Rigner P. Bischoff W . Am J Med 1992 Jun 22. Javaloy J.71 Suppl:S81-7 413. Diagn Microbiol Infect Dis 1997 Mar. [Clinical effect of norfloxacin in pediatric field] Jpn J Antibiot 1990 May.49(11):1030-8 401. A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents.27(3):75-83 418. Lepr Rev 2000 Dec. Jacobson GF.116(5):590-3 417. Kasai K. [Pharmacokinetic and clinical evaluation of azithromycin in pediatric infections] Jpn J Antibiot 1996 Nov. Marsh R . Jacobs MR. Matsui Y. Contopoulos-Ioannidis DG. Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy . Washington JA. von Sydow C. Eur J Clin Microbiol Infect Dis 1993 May. Oxford.47(2):147-52 415.41(12):1965-71 402. Matsuda H.٤٧ 405.References 397. A 187 clinical laboratory center sample in the United States. Daschner FD. Maki T . Jonas D. Cobbe S. Novelli and R. Tauchi N. Doyle CA. Guttenplan M. Clinical Microbiology & Infection 2003 Jan. Ozaki T. Lomborg S . Efficacy of moxifloxacin. Frank U . Balasingam. Taneda Y. Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections . A. P.8(5):879-82 404. Kida K. Br J Ophthalmol 2003 Feb. Jacobsson S.12(5):319-24 409. Autry AM. Follicular conjunctivitis caused by Chlamydia trachomatis in an infant Saharan population : molecular and clinical diagnosis . Alio JL .١٠٠S 399.92(6A):95S.6(12):690-6. 87(2):142-6 412. Lambkin. Jacob S. Kida K. 2005 Jan 18-24. Washington JA. Tom LW. The efficacy of cefaclor vs amoxicillin on recovery after tonsillectomy in children . [Clinical studies on sultamicillin fine granule in pediatric field] Jpn J Antibiot 1988 Dec. Ferrell W. Spitzmuller B.101(3):40-3. Jacobsson S.90(12):1379-83. Sklanskaya OA ، Grigoriev PY.٨٣ 403. J Antimicrob Chemother 2001 Nov. Henriksen EJ Metabolic properties of vasodilating beta blockers: management considerations for hypertensive diabetic patients and patients with the metabolic syndrome. Antibiotic therapy for urinary tract infections . 9(1):1 406. Nagai H. Ferrer C. Diagnosis and treatment of polycystic ovarian syndrome. Mann. World J Gastroenterol 2002 Oct. Wilber RB . Vidal MT. Iravani A. Jadhav S. discussion 1354-6 408. Kirby RS. clinafloxacin and levofloxacin against intracellular Legionella pneumophila . Jones RN. Jones AE. Arch Otolaryngol Head Neck Surg 1990 May. Am J Obstet Gynecol 2001 Jun. Ishikawa J. Chew P. 411. Bondesson G .43(5):877. Cefprozil Multicenter Study Group . Clinical and bacteriological efficacy of amoxycillin/clavulanate (Spektramox) and cefaclor (Kefolor) in children with recurrent AOM or therapy failure . Jonas D. Ji B. Pfaller MA . Potsic W. Engels I. Nakamura H. Durham SJ. Clin Ther 1992 Mar. Yakovenko EP. Engels I. A ١٨٧ clinical laboratory center sample in the United States .184(7):1352-4. Yamaguchi H. Lau J . Ishida Y. Danish-Swedish Study Group . 407.14(2):314-26 400.44(1):35. Matsuura T. Bondarenko OY.27(3):75-83 Page 19-D . Ivashkin VT. Jones J. Daschner FD. Nurs Times.48(5):677-89 398. Motley RU . Wetmore R.Apr. Handler SD. The effect of azithromycin on intracellular 414. S.pylori eradication in active duodenal ulcer. trovafloxacin. J. Gulyaev PV ، Fedchenko VI . Matsuda H ، Murase M . Evaluation of amoxicillin clavulanate twice daily versus thrice daily in the treatment of otitis media in children. Iravani A. Friedhoff C. Jones RN. Lapina TL. [Clinical evaluation of cefixime in pediatric respiratory tract infections] Jpn J Antibiot 1991 Jan. Ioannidis JP. J Clin Hypertens (Greenwich). Kida K. Acta Otolaryngol Suppl 1988. 2004 Dec. Matsuda H . Murase M . J Antimicrob Chemother 2001 Feb. Cefprozil versus cefaclor in the treatment of acute and uncomplicated urinary tract infections . A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents. S. Pfaller MA. Jacobs MR. Liverman EM. Ishikawa J. Diagn Microbiol Infect Dis 1997 Mar. Petrie J. Iwai N. S. A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy . Larsson P. Sattar N. Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation? Heart.Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors. Azithromycin in a triple therapy for H. 416. Frank U . Bossuyt. quiz 697. Vasiliev YV. Grosset J .

Abe T. Matsushita M ، Hikosaka K. Kadappu KK. A randomized trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy. et al . Appelbaum PC. [Clinical studies on T-2588 in the field of otorhinolaryngology] Jpn J Antibiot 1986 Oct. Acta Otolaryngol Suppl١٩٨٨. cefaclor and cephalexin on complicated urinary tract infection by the double-blind method] Jpn J Antibiot 1985 Oct.63 Suppl 2:315-9. Nagaraja MV. Ogihara Y. The edematogenic properties of insulin. Tanimoto K. Expert Opin Pharmacother 2001 Aug. Tsuchihashi N . Clinical efficacy of amoxycillin/clavulanic acid and cefaclor in acute otitis media . Fujii A. Jones S. Ishida H. [Prevalence of penicillin-insensitive Streptococcus pneumoniae and its response to oral beta lactam antibiotics at a primary pediatric office] Kansenshogaku Zasshi 1994 Aug.39(10):2710-5 439.38(10):2735-69 427.68(8):977-81 425. Ohya S.63 Suppl 2:444-50.23(3):413. Pharmacokinetic and therapeutic trial of sultamicillin in acute sinusitis . Kataoka N. Current pharmacotherapy of pertussis . Ohno I. Kaprio E. 435.28(6):832-3 421. Kamidono S. [Comparative studies of the efficacy.48(3):179-81 423. Cefditoren in vitro activity and spectrum: a review of international studies using reference methods . Wagner RL. Kakuta M. Yu VL. Peipert JF . Bondesson G . dermatological area] Jpn J Antibiot 1990 Sep.34(1):27-48. Kalambokis GN. Karpov OI. Kitayama A. 2004 Oct. Hayashibara H. Katayama S. Diagn Microbiol Infect Dis 1991 JanFeb. Ress R . Kanai F. Johnson JT.References 419.70(5):72-6 431. Infect Dis Obstet Gynecol ٢٠٢-١٩٧:(٤)٩‫١٠٠٢؛‬ 422. [Pathophysiological conditions progressing from impaired glucose tolerance: high blood pressure] Nippon Rinsho. Shiraki K.47(9):1202-9 433.44(4):575-90.449:45-6 430. Kacmar J. [A clinical study on S6472. [In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae] Jpn J Antibiot 1999 Aug.52(8):533-40 437. Domon H. Am J Kidney Dis. Zaitseva AA .41(1-2):1-14 420. Rao PV. Jones RN. Yamamoto M. Montagno A. Tsatsoulis AA. Noboru T. Okuda H. Ogawa S. [The clinical study of cefpodoxime proxetil dry syrup preparation in the pediatric field] Jpn J Antibiot 1994 Sep. Karpov OI . Tajima T. Shastry BA . Randomized comparative study of ceftibuten versus cefaclor in the treatment of acute lower respiratory tract infections . Jacobs MR. Fuchs PC . Preston NW . The dyslipidemia of diabetes mellitus: giving triglycerides and high-density lipoprotein cholesterol a higher priority? Endocrinol Metab Clin North Am. Riabova MA. Multi-investigator evaluation of the efficacy and safety of cefprozil. [Comparative trial of 3-day azithromycin versus-١٠ day coamoxilav course efficacy in acute sinusitis] Ter Arkh 1998. Kerr JR. Clin Ther 2001 Mar. J Postgrad Med 2002 JulSep. 2005 Feb. sustained release preparation of cefaclor. Kawasaki Y. Kakuta O. Omata M. In vitro activity and pharmacodynamics of azithromycin and clarithromycin against Streptococcus pneumoniae based on serum and intrapulmonary pharmacokinetics . 429. Fukuoka T. Kafetzis DA . Kawada H. Furuta S. Kays MB.38(7):1750٦٠436.63 Suppl 2:242-5. Utsui Y. Azithromycin as treatment for cryptosporidiosis in human immunodeficiency virus disease . amoxicillin-clavulanate ، cefixime and cefaclor in the treatment of acute otitis media . Sakamoto Y. [The clinical and economic efficacies of short courses of azithromycin in acute sinusitis] Antibiot Khimioter٣٢-٢٨:(١٠)٤٤‫٩٩٩١؛‬ 432. 434. [Effects of mitiglinide in treatment of impaired glucose tolerance] Nippon Rinsho. Hanawa S. 426. Shibata A.14(1):101-5 428. Hirooka K. Cheh E. Denys GA . Haapaniemi J. [Clinical studies of S6472 in otorhinolaryngologic infections] Jpn J Antibiot 1985 Jul. 2005 Mar. 2005 Feb. Katsuta K. et al .Eur J Clin Microbiol Infect Dis 1994 Oct. safety and usefulness of S6472. Kasagi T. Ishii C.43(9):1621-8 438. Arakawa S. Kim HK . 441. Shimatani N. [Glucose intolerance caused by interferon therapy] Nippon Rinsho. Antimicrob Agents Chemother 1985 Dec.2(8):1275-82 Page 20-D . Meguro H. Kendall DM. 2005 Feb. Katahira H. Karpishchenko SA. Kammer RB. Tsianos EV. Umezu K ، Ishigami J. Pfaller MA. Morishima T .13(10):857-65 424. Kawanami T.٢٤ 440. Diagn Microbiol Infect Dis 2001 Sep-Oct.

open label comparison of azithromycin and amoxicillin/clavulanate in acute otitis media among children attending day care or school . Khan WA. Tamura M. Goodman JL . Pediatr Infect Dis J 1995 Apr. Vascular protection in diabetes: a pharmacological view of angiotensin II type 1 receptor blockers. Ann Intern Med 1997 May 1. Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia . controlled trial . 2005 Apr. Pharmacokinetic considerations in the eradication of Helicobacter pylori .16(4):42731 457. Onodera N. [Bacteriological.50(2):206-14 455. Takeda H.Azithromycin versus amoxicillin/clavulanate in the treatment of acute sinusitis . Acta Diabetol. Comparison of singledose azithromycin and 12-dose.42(7):1477-87 449. Fukakusa M. randomized. Eur J Clin Microbiol Infect Dis 1991 Oct. QJM. pharmacokinetic and clinical studies on cefpodoxime proxetil in the pediatric field] Jpn J Antibiot 1989 Jul. 2004 Oct. Ikeda Y. Kintscher U. Saha D. chronic hepatitis C and diabetes: a novel triad. Salam MA. Seas C. 463. Khan WA. Klein JO .٦٠٦ 447. Macrolide-treated Pseudomonas aeruginosa induces paradoxical host responses in the lungs of mice and a high mortality rate . double-dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections . Comparison of azithromycin and ciprofloxacin. King GL. Lancet 2002 Nov٧-١٧٢٢:(٩٣٤٧)٣٦٠‫٠٣؛‬ 443. TNF-{alpha}.117(1):43-51 461.126(9):697-703 444. Wood RG . Khurana CM . double-blind trial . Kligman EW . Histochem Cell Biol. Leberre MA. Pediatr Infect Dis J 1996 Sep. Schattner A. Kinasewitz G.20(1):7-11 456. Eur J Clin Microbiol Infect Dis 1991 Oct. Hayakawa F. Nelson CM. Tanimoto S.15(9 Suppl):S24-9 445. Tateda K. pharmacokinetic and clinical studies on cefpodoxime proxetil in the pediatric field] Jpn J Antibiot 1989 Jul. Shimada K. Salam MA. Knobler H. Dhar U.38(3):243-70 462. Hyperglycemia-induced oxidative stress in diabetic complications. Knudsen JD . [Pharmacokinetic and clinical evaluation of azithromycin in the pediatric field] Jpn J Antibiot 1997 Feb. Yamamoto N. Nakao Y. Kingston M. Eur J Clin Microbiol Infect Dis 1991 Oct. Culig J. Klapan I. bacterial maxillary sinusitis in adults . Klein M. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae . Clin Pharmacokinet 2000 Mar. Oreskovic K. Klotz U . Kuno K. Arvis P. randomized. Treatment of shigellosis: V. A multicenter.45(1):242-50 460. [Clinical studies of cefpodoxime proxetil in pediatric field] Jpn J Antibiot 1989 Jul. Yamaguchi K . Nakao Y. Treatment of sexually transmitted infections with single-dose therapy: a double-edged sword. 454. Aoyama R. Am Fam Physician 1992 Jan. Wood RG . Kiani R .10(10):880-4 446. Kimura H.47(5):313-27 464. Otsuka Y. Ishikawa H. [Study on azithromycin in treatment of diffuse panbronchiolitis] Kansenshogaku Zasshi 1995 Jun. Kudo M. Rahman A. Klossek JM.10(10):872-7 450. 2005 Jan. J Laryngol Otol 2003 Jan. Takeuchi H. amoxicillin-clavulanate in acute lower respiratory tract infections in childhood. Kamiya H. Bennish ML . Konishi K. Kobayashi T. Treatment of otitis media .62(6):871-8 453.122(4):333-8. Kimura H.50(1):59-66 Page 21-D . Yamamoto N. Sinusitis Study Group . Carlin E . Bogaerts J ،Bennish ML . Am J Otolaryngol 1999 JanFeb.14(4 Suppl):S19-22 458. [Bacteriological. Ishikawa H.69(6):711-22 465. Kimura S. Sakayori S. Matrapazovski M ، Radosevic S. Klein MB. Drugs 2002. Hayakawa F. Takeuchi H. Sakurai M . Kinasewitz G.42(7):1593-606 448. Nukiwa T. et al . Nikolaidis P. Double-blind.42(7):1593.41(1):76-9 459. Siegert R. History of macrolide use in pediatrics . Antibiotic susceptibility of the newly ultivated agent of human granulocytic ehrlichiosis : promising activity of quinolones and rifamycins . Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia . Epub 2004 Jul 15. Tsushima N. Unger T.10(10):872-7 451. 452. Kuno K . Antimicrob Agents Chemother ١٩٩٧ Jan. Pediatr Infect Dis J 1997 Apr. Yokoyama M.42 Suppl 1:S26-32. Dan Med Bull 2000 Nov. Loeken MR.98(1):1-6.References 442. International Study Group. Kitamura K. Kawakami Y. A double-blind. Okamoto T. J Antimicrob Chemother 2002 Jul. 3-day erythromycin for childhood cholera: a randomised. Nakano T. Matsumoto T. Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute. Kobayashi H. Miyazaki S ،Watanabe A. Multicenter trial of cefpodoxime proxetil vs.

31(4):801-7 476. Population pharmacokinetics of everolimus in de novo renal transplant patients: impact of ethnicity and comedications .34(1):117-35. in pediatric patients] Jpn J Antibiot 1996 Nov. Silachamroon U. McMahon L. Kobayashi Y. Drugs 1997 Jun. Kunhiraman BP. Phophak N. Wilairatana P. inflammation. Morck DW. Endocrinol Metab Clin North Am. [Cephalosporin treatment of maxillary sinusitis] Laryngorhinootologie 1995 Jun. Hoffken G . Apoptosis. oxidative metabolism and interleukin-8 production in human neutrophils exposed to azithromycin: effects of streptococcus pneumoniae . Cheybani K. Nelson SE. Am J Hypertens. Trujillo M. Williams DJ . Kawasaki H. 478. CastroRodriguez JA . Kohler W. Sanders M. Schonwald S. Schonwald S. Beneficial effects of insulin on endothelial function. Moller M. 480. Scand J Infect Dis 1995. The association of heart failure with insulin resistance and the development of type 2 diabetes. Kuritzky L. 472.70(3):247-54 474. Hsu CH. Kuzman I. Insulin therapy in primary care: practical issues for clinicians. pylori infection: a randomized comparison of four regimens . Landen H. Adult response to initial treatment with ampicillin in community acquired pneumonia in Yaounde ،Cameroon . Antimicrob Agents Chemother ١٩٩٩ Dec. 475.6(3):248-61.29(2):51. Drugs 1991. Paya E. 2005 Mar. Chalermrut K. Rordorf C . 35(2):91-8 469.18(5 Pt 1):731-7. Brogden RN . and atherogenesis and their implications. Martinez MA. Neil G .43(12):2869-72 471. [Azithromycin. Kuritzky L. Berry AJ. Dunne MW. Currier JS. J Fam Pract. Jacobson J. Lowell BB. Clarithromycin. Kuaban C. Esteban DJ. Chin AC. Pediatr Pulmonol 2003 Feb. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients . Lagrange PH .46(1):19-26 468. Quevedo I ،Puppo H. Azithromycin in the treatment of pneumonias caused by Chlamydia spp: a retrospective study . 2005 Jun. Laine L.54(6):S10-11. Culig J . Clin Pharmacol Ther 2001 Sep. Jawa A. Clinical experience in Germany of treating community-acquired respiratory infections with the new 8methoxyfluoroquinolone. Lagrange PH . The mitochondrial uncoupling-protein homologues. 2005 May. Nelson SE. Buret AG . Culig J . Takaya J. Singhasivanon P.39(9):188-92 473. Estrada R. Azithromycin as treatment for disseminated Mycobacterium avium complex in AIDS patients . Krauss S. J Fam Pract. pharmacodynamic evaluation in animal models] Pathol Biol (Paris) 1995 Jun. Smith S. 2005 Jun.94(4):962-6 486. Fonseca VA.42 Suppl 3:1-5 477. Kuzman I. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children. Schenk P . Kumazawa J. moxifloxacin . Nat Rev Mol Cell Biol. Kostis JB. J Int Med Res 2001 Mar-Apr. Kovarik JM. Langtry HD. Tillotson GS. [Clinical study of a macrolide antibiotic ، azithromycin.43(6):515-23 484.54(6):S3-6.٦٠ 487. Zhang CY. Phumratanaprapin W. Kubin R. 479. Koulla-Shiro S. pharmacodynamic evaluation in animal models] Pathol Biol (Paris) 1995 Jun. Rubilar L. A randomized clinical trial of combinations of artesunate and azithromycin for treatment of uncomplicated Plasmodium falciparum malaria in Thailand . Auckenthaler R. Potential cardiovascular benefits of insulin sensitizers. Berthier S. Harada Y. Nagao Y . Girardi G. Oreskovic K. Azithromycin for treatment of community acquired pneumonia caused by Legionella pneumophila: a retrospective study .43(6):515-23 485. Kogan R.References 466. Summary of clinical experience with cefpodoxime proxetil in adults in Japan.49(11):1004-12 467. Once-daily therapy for H. Olson ME. Higashino H. Kino M.27(5):503-5 483. Southeast Asian J Trop Med Public Health 2000 Dec. 2005 Jun. Cent Afr J Med 1993 Sep. Kawamura Y. Cynamon MH. Soldo I. Read RR ، Ceri H. Int J Clin Pharmacol Res ٧-١٠٣:(٥-٤)١٦‫٦٩٩١؛‬ 482. Nelson SE. Koletar SL. 481. Koch CC. 2005 Mar. Krudsood S.Am J Gastroenterol 1999 Apr.54(6):S7-9. Kuritzky L. J Antimicrob Chemother ٢٠٠٠ Jul. Popa C .74(6):355-60 470. Belec L. Yeramian P. J Fam Pract. Assessing the controversies of insulin therapy in patients with type 2 diabetes mellitus. [Azithromycin. Ngu JL . MacGregor RR.53(6):973-1004 Page 22-D .

Testing for linear trends in proportions using correlated otolaryngology or ophthalmology data . Benhamou D . Hooper DC.46(3):385-90 503. Kessler RE . Legnani D . Clin Ther 2000 Jul. Laurent K . J Antimicrob Chemother 1996 Jun. Lecomte F.22(7):818-25 507. Biometrics 1988 Mar. Livermore DM. Fliss DM. Clin Pharmacokinet 1984 Jan. Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection . Comparative studies of azithromycin in skin and soft-tissue infections and sexually transmitted infections by Neisseria and Chlamydia species .29(9):497. Antimicrob Agents Chemother 2002 Jan. Yagupsky P.15(1):97-113 495.71(1):13-7 510.3(7):481. Leigh AP. Economic evaluation of antibacterials in the treatment of acute sinusitis . Raiz S. J Antimicrob Chemother 1990 Jan. An open. Yang H. Drug therapy in patients undergoing haemodialysis.References 488.44(1):299. Desiderio JV. Lau CY. Hotary LH. Keyserling CH.17(12):1126. Brooks JV. Single-dose oral azithromycin versus seven-day doxycycline in the treatment of non-gonococcal urethritis in males . Orme IM .٥٠٢ 491. Lamb HM . Drugs 1998 Sep. Leiberman A. Sex Transm Dis 2002 Sep. safety and tolerability of azithromycin versus roxithromycin in the treatment of acute lower respiratory tract infections . Greenberg D. Laurier C. Rapid in vivo screening of experimental drugs for tuberculosis using gamma interferon gene-disrupted mice .19(4):255-1 500. Genitourin Med 1995 Feb. Saarinen K. Mustonen MT. Chen HY.9(1):42-66 501. Clinical pharmacokinetic considerations . Lassus A . Lawrence LE. [New macrolides] Rev Med Interne 1998 Apr. Diagn Microbiol Infect Dis 1997 Jan-Feb.Feb. Gruppo V. Leitner F. J Antimicrob Chemother 2000 Sep. BMY 28100. Wu J . Lee CS.٣١ 506.31 Suppl E:177-83 492. Lea AP.12(5):596-611 499. Drug treatment of nonviral sexually transmitted diseases: specific issues in adolescents .34(11):764-6 Page 23-D . Paediatr Drugs 2001. A one-year survey of Neisseria gonorrhoeae isolated from patients attending an east London genitourinary medicine clinic: antibiotic susceptibility patterns and patients' characteristics . Tsai YH.46(1):191-5 497. a new oral cephalosporin .37 Suppl C:115-24 493.31(2):238-43 508. Biro FM . Bactericidal activities of BMS-284756. Azithromycin. 502. comparative study of the efficacy and safety of azithromycin and co-amoxiclav in the treatment of upper and lower respiratory tract infections in children. a novel Des-F(6)-quinolone. Dagan R . 2005 Feb. [A randomized control study on the treatment of ١٢٣ cases of bacterial infections with cefteram and cefaclor] Zhonghua Nei Ke Za Zhi 1995 Nov.25 Suppl A:115-21 490. Efficacy. Its use in infections of the respiratory tract. Lauharanta J. Lee YH. Economic evaluation of antibacterials in the treatment of acute sinusitis . Levofloxacin. The evolving role of inflammation in obesity and the metabolic syndrome. Buck RE. Happonen HP . Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials . Marbury TC . Lehmann CE. Qureshi AK . Chaniewski S. Zhang Y. Ducharme M . multicentre. The Paediatric Azithromycin Study Group . skin. J Antimicrob Chemother 1993 Jun. Tack KJ . Lauvau DV. Ison CA. Lachaine J. Piglansky L. Pharmacoeconomics 1997 Nov.5(1):70-5. Barrett JF . Legionella pneumophila in the Mono Mac 6 cell line at serum concentrations attainable in vivo. Press J. Wisdom AR . Pediatr Infect Dis J 1998 Dec.15(1):97-113 494.47(2):783-5 509. Antimicrob Agents Chemother 1987 Feb. soft tissues and urinary tract . Pharmacoeconomics 1999 Jan. Nemeth MA. Lewis DA. Misiek M. Role of oral antibiotics in treatment of community-acquired lower respiratory tract infections . Lachaine J. Bacteriologic efficacy of a three-day intramuscular ceftriaxone regimen in nonresponsive acute otitis media . Hooi AY.٣٠٣ 498. Verbist L . Pursiano TA.56(3):487-515 489. Laurier C.Antimicrob Agents Chemother 2003 Feb. Chisholm DR.25(5):285-95 496. Pharmacoeconomics 1999 Jan. A pharmacoeconomic review of its use as a single-dose regimen in the treatment of uncomplicated urogenital Chlamydia trachomatis infections in women . Pratley RE. Le CT . Curr Diab Rep. Leibovitz E. Ducharme M . Li G. Lamb HM .٩٤ 505. Ryan B. J Int Med Res 1997 SepOct. Langtry HD. Lenaerts AJ. Frosco M. against Staphylococcus aureus strains with topoisomerase mutations .27(1-2):41-7 504.

73(6):506-9 523. Marchetti F. Efficacy of azithromycin compared with spiramycin in the treatment of odontogenic infections .٧٣ 521. Kam KM . Lister PJ. Eliopoulos GM. Lukehart SA. J Chemother 2002 Feb. Pediatr Infect Dis J 1991 Dec.43(7):1560-4 525. Mallory SB . Palma L. J Antimicrob Chemother 1996 Mar.33(7):440-3 512. Effect of antipyretic agents on uptake. Schaberg T .41 Suppl B:29-35 531. P. amoxicillin or placebo for otitis media with effusion in children . Koeppe P. de la Torre C. Loewen PS. Scand J Infect Dis Suppl ٣٣-٨٣:٢٦‫٢٩٩١؛‬ 520. Azithromycin in lower respiratory tract infections . J Antimicrob Chemother 1996 Mar. Palma L . Am J Med 1991 Sep12. Malanoski GJ.31 Suppl E:185-92 514. J Antimicrob Chemother 1998 Mar. Nozza RJ . J Antimicrob Chemother 1993 Jun. [Clinical evaluation of cefpodoxime proxetil on the treatment of bacterial infections] Zhonghua Nei Ke Za Zhi 1994 Jul. Balasingam. Azithromycin in lower respiratory tract infections .7 Suppl 6:536-9 526. In vivo efficacy of cefcanel daloxate in comparison with cefaclor .24(4):547-9 516. Bluestone CD. Barreto DG. Lambkin. Fohn MJ. Schaberg T . MacLoughlin GJ. [The antibacterial efficacy of cefaclor against bacteria resistant to ampicillin.37(3):565-73 527. Hou J. Senesi S . Drugs 1994. Pinetta EA ، del Castillo F. Lode H. Lode H. Rockette HE.pump inhibitors against Helicobacter pylori: a comparative in-vitro study . Ballard RC . Activity of moxifloxacin. J. Nicoletti G . against Streptococcus pneumoniae in an in vitro pharmacodynamic model of infection . Paradise JL. Comparison of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in men . S. Comparative pharmacokinetics of the new oral cephalosporins. Magni L. Pizzarelli G. Lo Bue AM. Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin . tetracycline and co-trimoxazole (author's transl)] Infection 1979. Drugs 1999 Feb. Barreto DG. Baker-Zander SA . Su R. Sammartino R. J Antimicrob Chemother 1990 Jan. Lindan R .sulfisoxazole. Comparison of cefaclor and amoxycillin in the treatment of urinary infections in a chronic disease hospital . Machka K . and release of antimicrobial agents by human polymorphonuclear leukocytes . Oxford. Robinson AJ . S. Chisari G. 9(1):1 524. Systematic review of the treatment of early Lyme disease . J Infect Dis 2002 May ٩-١٣١٤:(٩)١٨٥‫١؛‬ 534. Azithromycin compared with cephalexin in the treatment of skin and skin structure infections . Gismondo MR. Novelli and R. Clinical Microbiology & Infection 2003 Jan. discussion 19-20 517. Chan FC. Moellering RC Jr . Scand J Infect Dis Suppl 1992.57(2):157. Postgrad Med J 1979.14 Suppl 2:22-8 518. Eur J Clin Microbiol Infect Dis ١٩٩٣ Feb. Scand J Infect Dis Suppl1990. Bossuyt. Mandell GL. Lode H. Ann Acad Med Singapore 1995 Jul.10(12):899-906 533. Mandell GL. Ng PS. Wootton M. Ferraro MJ.185(9):1314-9 Page 24-D . Bowker KE. Effect of antipyretic agents on uptake. Campa M. Balechandran T.12(2):131-3 530. Mandel EM. Comparative efficacy of erythromycin.References 511. Ridgway GL. Lo KK. Kao L. Pinetta EA. Tejada M.31 Suppl E:119-27 515.25 Suppl A:91-9 522. M. Coleman EJ . Mann. transport. Malizia T. Schaberg T. transport ،and release of antimicrobial agents by human polymorphonuclear leukocytes . Lode H.Synergic interactions of macrolides and proton. Antimicrob Agents Chemother 1999 Jul.55 Suppl 4:67-9 513. Favini P. A. Borner K. Holt HA . Cefpodoxime proxetil suspension compared with cefaclor suspension for treatment of acute otitis media in paediatric patients. del Castillo F.47 Suppl 3:10-9. An open non-comparative pilot study with azithromycin in the treatment of non-gonococcal urethritis in the sexually transmitted disease clinics in Hong Kong . Lionell C . REVIEW Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors. cefaclor. de la Torre C. MacLoughlin GJ. Li JT. J Infect Dis 2002 May 1. Coleman EJ . an alternative to third generation cephalosporins for the treatment of gonococcal urethritis in the developing world ‫ ؟‬Genitourin Med 1997 Dec. Ho KM. Fassbender M.91(٣A):36S-39S 532. Cefaclor.37(3):565-73 528.74:185-9 529. Improving care for patients with respiratory tract infections . Efficacy of azithromycin for therapy of active syphilis in the rabbit model . Marra CA. Garau J . S. 83:26-33 519. Marra F . J Antimicrob Chemother 1993 Jun. administered once a day. Cefpodoxime proxetil suspension compared with cefaclor suspension for treatment of acute otitis media in paediatric patients . MacGowan AP.

Wong JB. Ruoff GE. Laitinen L. McDonald PJ. Development of erythema migrans in spite of treatment with antibiotics after a tick bite .40(12):2732-6 539. Roxithromycin. Current recommendations and future prospects in the treatment of toxoplasmosis . Kutin SA . McCabe R. Pediatr Infect Dis J 1996 Sep. Markham A. Treatment of acute bronchitis and pneumonia with cefaclor . Scand J Infect Dis Suppl 1992. Mattson K. Mashkilleyson AL. McLinn SE . A multicenter. Johnson RB . Mazzei T. dos Santos JQ . Pruul H . Sorella S. Drugs 1994 Aug. Renkonen OV.39(6):36-8 545. open label trial of azithromycin for the treatment of children with acute otitis media .134(6):560-3 Page 25-D . Renteria A . Clin Infect Dis 1995 Aug. Jannuzzi C. 92(6A):80S-85S 552. Eur J Clin Microbiol Infect Dis 1994 Oct.21(2):409-14 544. Messner RP.92(4):396-403 547. Nikander-Hurme R . Comparative efficacy and safety of cefprozil versus penicillin. Mashkilleison AL ." J Pediatr 1992 Jan. Massimini A . Pavesio D.49(6):1007-22 540. Antibiotic consumption patterns and drug leftovers in 6000 Brazilian households. The Azithromycin for Chlamydial Infections Study Group . Macrolides and the immune system .7(3 Suppl):67S-73S 549. Marliere GL. Manfredi R. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. Drugs 1995 Jun.327(13):921-5 543. Pediatr Infect Dis J 1996 Sep. Spier NA. Am J Med 1992 Apr. Martin DH. [Plasma and tissue antibiotic concentrations: what is their prognostic value‫ ]؟‬Ann Ital Med Int 1992 Jul-Sep. McLinn S . McCormack WM.55 Suppl 4:59-61 548. Mashkilleyson N.٨٧ 551.13(10):846-50 555. Jones RB. N Engl J Med 1992 Sep 24.48(2):297-326 541. Strle F . Treatment of pharyngitis and tonsillitis with cefprozil: review of three multicenter trials . Periti P . A multicenter. Chiodo F . Cefixime. Ferraz MB. A review of its therapeutic efficacy in lower respiratory tract infections . Perrotta R. Mantero E. Principi N.15(9 Suppl):S20-3 557. Rahn DW. Johnson RB .7 Suppl 1:13-5 546. Sala E. Lanzoni L. Longo L. Am J Med 1992 Jun 22. Treatment of syphilis with azithromycin . Int J STD AIDS 1996. An update of its antimicrobial activity. pharmacokinetic properties and therapeutic use .15(9 Suppl):S10-4 553. Mroczkowski TF. Comparison of the efficacy and safety of ceftibuten and cefaclor in the treatment of pneumonia and bronchiectasis . J Chemother 1993 Apr. 83:34-40 556. Comparative study of once-weekly azithromycin and once-daily amoxicillin treatments in prevention of recurrent acute otitis media in children . Steere AC .5(2):124. Martin DH. Am J Dis Child 1980 Jun. Treatment of early Lyme disease . McCarty J. McCarty JM.120(1):72-7 538. Pecco P. McCarty J. double blind comparison of azithromycin and amoxicillin/ clavulanate for the treatment of acute otitis media in children . Sargent SJ. discussion S231-2 554.٣٢ 550. Comparison of azithromycin and ceftriaxone for the treatment of chancroid .Clin Infect Dis 1992 Jun. Marchisio P. Gomberg MA.References 535. Luger SW. Carlin SA. Markham A. Maraspin V. Mini E. Faulds D . Shurin PA .17(1):32-44 542. McCarty JM . Cefaclor in treatment of otitis media and pharyngitis in children . Postgrad Med J 1979. Brogden RN . Johnson RC. cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis . Jacobson KD . [Azithromycin in the treatment of syphilis] Antibiot Khimioter 1994 Jun. Antimicrob Agents Chemother 1996 Dec. Rumans L. Oster S . Wendel GD Jr.14 Suppl:٢ S224-30. Schiavone R. Johnson CE. Lotric-Furlan S.4(6):36470 536. McCabe RE. Mogabgab W . Massarotti EM. Measuring the comparative efficacy of antibacterial agents for acute otitis media: the" Pollyanna phenomenon . Novelli A.Feb.38(6):973. McCarty J . Adv Ther 2000 Jan. Dalu ZA. Marchant CD. Hopkins SJ. J Chemother 1992 Dec. Drugs 1989 Dec. Tempesta A.Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population . Wien Klin Wochenschr 2002 Jul-١٣)١١٤‫١٣؛‬ ٩-٦١٦:(١٤ 537. Clinical comparative study of azithromycin versus erythromycin in the treatment of acute respiratory tract infections in children .

J Chemother 1993 Feb. Meguro H. clarithromycin and beta. Del Beccaro MA. cefpodoxime proxetil in children] Jpn J Antibiot 1989 Jul.53 Suppl 3:S151-5.60(3):597. in the pediatric field] Jpn J Antibiot 1997 Mar. Foschino MP ، Miragliotta G.Clinical efficacy of azithromycin in lower respiratory tract infections . [Azithromycin and genital infections] Pathol Biol (Paris) 1995 Jun. Kinetics-effect relations of insulin-releasing drugs in patients with type 2 diabetes: brief overview. Hiruma F. Measurement of the bactericidal activity of fluoroquinolones against Streptococcus pneumoniae using the bactericidal index method . Shiraishi H. Moody KD. Antimicrob Agents Chemother ١٩٩٤ Jul. Miyazaki S.A comparative study of the efficacy. [Clinical evaluation of a new macrolide antibiotic ، azithromycin.130(9):1341-3 575. Terashima I .121(3):459-65 563. J Am Dent Assoc 1999 Sep. Miller JM.19(1):41-6 578. a new oral cephalosporin.lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice . A comparative study of the efficacy. Dental therapeutic indications for the newer long. Beall B.44(3):153-6 566. O'Brien KL.48(3):42530 571. Tamaya T. 562. Fujii R. Sato Y. Montero L . Izumi K. Arimasu O. Miravitlles M. Martin DH . In vitro and in vivo antibacterial activities of S-1090. J Antimicrob Chemother 1996 Jun. Clin Ther 2000 Feb. a new oral cephalosporin.٦٠٥ 568.38(7):156772 574.44(3):153-6 567. Treatment of Chlamydia trachomatis infections in pregnant women . Kawazoe K. Todd WM. Palmer SM. Matsumoto T. Laclaire L. J Antimicrob Chemother 2000 Apr. Sugamata K. Impact of azithromycin on oropharyngeal carriage of group A Streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae . McNicholl IR.17(1):33-7 579. J Pediatr 1992 Sep. Fujikawa T. Adams RL. Micoud M. Kaneda K. Sato Y.55(7):437-41 570. Morrissey I. Cleary JD . Perduca M. Meguro H. Mendelman PM. Barthold SW . Ros F. Tamaya T .22(2):154-66 564. Montero L .References 558. Int J Clin Pract 2001 Sep. In vitro activity of gemifloxacin and other antimicrobial agents against isolates of Bordetella pertussis and Bordetella parapertussis . J Antimicrob Chemother 2001 Sep. Drugs of choice for the treatment of uncomplicated gonococcal infections . Gherardi G. Cobos A. Mikamo H. Rodgers GL . The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experience .20 Suppl 1:S47-65 576. [A clinical evaluation of cefpodoxime proxetil in pediatrics] Jpn J Antibiot 1989 Jul. Melander A. Cefpodoxime proxetil compared with amoxicillin-clavulanate for the treatment of otitis media. Chemotherapy 1998 May-Jun. Yamaguchi K . Mikamo H. Tajima T. J Antimicrob Chemother 1996 Jun.50(3):265-71 561. Schwartz B . Tillotson G .42(7):1488-97 569. Kubin R. Carnimeo NS . Kawazoe K. Chemotherapy 1998 May-Jun. et al. in the fields of obstetrics and gynecology . Zannini G. Meyers BR . Int J Antimicrob Agents 2001 Jan. safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections . Kahn E. Sugie N. Moran JS.acting macrolide antibiotics .37 Suppl C:125-31 573. Nishimura S. Pediatr Infect Dis J 2000 Jan. Ziska DS. George JT . in the fields of obstetrics and gynecology. Morandini G. safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections . Efficacy of azithromycin. Levine WC . Mortensen JE. Minamitani M. Antiinfectives update: focus on treatment and prevention of viral and associated infections . Morita JY. Clin Infect Dis 1995 Apr.43(6):542-6 565. Abe T. Thompson T. McLinn SE. Pepin LF . Diabetes.42(7):1561-70 560.33(5):60714 559. [Clinical evaluation of a new oral cephem. Tateda K. Moore PA . Hachimori K. Drugs 2000 Sep. Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice . Izumi K. 2004 Dec.5(1):32-6 577. In vitro and in vivo antibacterial activities of S-١٠٩٠.45 Suppl 1:47-9 Page 26-D . Cefaclor revisited . Ann Pharmacother 1999 May.37 Suppl C:125-31 572.

Araki H. Yamashita F ، et al . Handa S. Toyoda A. Oda K. Thanavibul A ، Suprakob K. 2005. Yamada T. Yamashita Y. Ikezawa S. J Antimicrob Chemother 1993 Jun. Sasaki H. Aramaki M.31 Suppl E:163-9 596. 581. The efficacy and tolerance of a three-day course of azithromycin in the treatment of community-acquired pneumonia . Yamashita F. Motohiro T. et al . Kobayashi H . Motohiro T. Kawakami A. Iwata S. Sakata Y. Muller O .7 Suppl 6:617-21 598. Sakata Y. Tanaka K.36(8):1639-43 583. Sato Y. Kato H. Okabayashi S ، et al . Aramaki M. Yamashita F. Motohiro T. Tipawangso P.50(3):272-97 591. Myburgh J. Kawakami A. Southeast Asian J Trop Med Public Health 1996 Sep.23(2):185-91. Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States .24(3):169-77 582. Nabhan F. Fujimoto T. 2005 Mar. Knapp JS. [Basic and clinical studies on cefditoren pivoxil in pediatric field] Jpn J Antibiot 1994 Apr.27(3):522-5 597. [Pharmacokinetics and clinical effects of cefdinir %١٠ fine granules in pediatrics] Jpn J Antibiot 1992 Jan. Gakuen Y. Yamada S. Naber K. Oki S. Nishiyama T. Sunakawa K. Koga T ،Tomita S. Latent autoimmune diabetes of adulthood. Tsumura N. Mukherjee D.٢٧ 589. Matsukuma Y. Takajo N. Dalimi A . [Clinical study on azithromycin in 10% fine granules and 100mg capsules in the field of pediatrics] Jpn J Antibiot 1997 Mar. [Basic and clinical studies on S-1108 in pediatric Field] Jpn J Antibiot 1993 Dec. Sasaki H. Nagel GJ. Petschel E . Oki S. Wattanagoon Y. Handa S. Imai S. Yamada S. Sarafian SK. Oda K. Sato Y. Morita J. Yoshinaga Y ، Aramaki M. J Antimicrob Chemother 1993 Jun. Kubota K.References 580. Sakata Y. Kaldewey W . Mulazimoglu L . Na-Bangchang K. Aramaki M. Oda K. Motohiro T. Oki S. et al . Schmid G . Insulin resistance and type 2 diabetes mellitus: is there a therapeutic role for IGF-1? Endocr Dev.9:121-34. Nagai K. Influence of macrolides on mucoid alginate biosynthetic enzyme from Pseudomonas aeruginosa . Kato H. Motohiro T. et al . Evaluation of the efficacy of atovaquone alone or in combination with azithromycin against acute murine toxoplasmosis . Aramaki M. [Pharmacokinetic and clinical studies on cefprozil granules in the pediatric field] Jpn J Antibiot 1992 Dec. Hayashi M. Oda K. Ono E. Nagino K. Yamada S. Aramaki M.45(12):1700-35 585. 599. Clin Microbiol Infect 1997 Aug. Koga T ، Tomita S. Kato H. Oda K. Sakata Y. Yoshinaga Y ، Sasaki H.18 Suppl 1:S63-70 593. Motohiro T. [Clinical studies on cefprozil granules in pediatric skin soft tissues infections] Jpn J Antibiot 1992 Dec. 2005 May. Oki S. Kawakami A.73(3):239-43 595. [Comparative study of cefaclor versus amoxicillin in urinary tract infections (author's transl)] Infection 1979.45(1):74.117(3):7-12. Moshkani SK. Kobayashi I ، Akita H. Kawakami A. Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infections . Oda K. Kato H.41(10):1503-16 586. Muraoka H. Oda K. Wada M. Cardiol Clin. Emanuele MA. Moses AC. Percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients. Kanda T. [Basic and clinical studies on cefditoren pivoxil in pediatric field] Jpn J Antibiot 1994 Apr. Motohiro T. Yamada S. Sakata Y. Aramaki M. Sakata Y.٨٦ 587. Tsumura N ، Yoshinaga Y. Aoyama T. Kawakami A ، et al . Emanuele N.46(12):1122-44 588. 592. Tanaka K ، Koga T. Yamashita F. Yamada S.45(12):1684-99 584. Aramaki M. Matsuo Y. Ibrahim M.3(4):432-439 Page 27-D .31 Suppl E:13746 594. Yasuoka C. ]Effect of antibiotics and antibody on phagocytic bactericidal activity of polymorphonuclear neutrophils of Bordetella pertussis] Kansenshogaku Zasshi 1999 Mar.47(4):409. Oda K. Handa S. Handa S. Postgrad Med. Treatment of community-acquired pneumonia in hospitalised patients .47(4):409-27 590. Activity of artemether-azithromycin versus artemetherdoxycycline in the treatment of multiple drug resistant falciparum malaria . Int J Antimicrob Agents 2001. Unique features that distinguish it from types 1 and 2. Yoshinaga Y. Zaidi AA. Sakata Y. Motley M. Vet Res Commun 2000 Apr. Saika T. Antimicrob Agents Chemother 1992 Aug. et al. Hashimoto N. [Clinical studies of rokitamycin dry syrup on skin and soft tissue infections in the pediatric fields] Jpn J Antibiot 1988 Oct. Karbwang J . Motohiro T. et al . Sasaki H.

Kawabata S . Nicolau DP . Goss TF . The efficacy and safety of cefaclor in respiratory infections amongst Pakistani children . Naoya M . Sugita K. Chikaoka H.20(4):461-9 604. Antimicrob Agents Chemother 1999 Jun. Goss TF .٩ 608. 2005 Feb. Kawai S. Pediatr Infect Dis J 1997 Apr. Nakazawa S.39(4):107686 606. Iwasaki A. [Evaluation of cefpodoxime proxetil in the pediatric field] Jpn J Antibiot 1989 Jul. for infections in the field of surgery] Jpn J Antibiot 2000 Jun. Nakazawa S. Nightingale CH . Nash MM. Kuno K . [Efficacy and safety of azithromycin in the treatment of female genital Chlamydia trachomatis infections] Ginecol Obstet Mex 1993 Sep. Sato H. Akamatsu H. Use of a urea breath test to evaluate short-term treatments for cats naturally infected with Helicobacter heilmannii . Pharmacokinetics and pharmacodynamics of newer macrolides . Manabe Y. Am J Vet Res 1999 Jul. Kawai S. Iwata N. a new macrolide antibiotic. Gaba I. Nilsen A. Sadler B. [Glucose intolerance with antipsychotic drugs] Nippon Rinsho. Predicting antibacterial response from pharmacodynamic and pharmacokinetic profiles . Nishijima S. J Am Diet Assoc. Pharmacotherapy 2000 Apr. Neiger R. Seiler G. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. Nakazawa S. Nettleton JA. A double blind study of single dose azithromycin and doxycycline in the treatment of chlamydial urethritis in males . Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia . Nishimura T. Genitourin Med 1992 Oct. 614. Narita A. Torud E.49(10):917-25 Page 28-D . Stein GE. Suzuki H. 53 Suppl B: 103-10 609.42(7):1505-18 619. Nakajima K.34(2):171. Burchett S. Bukhari KA. Hassan M. Kawabata S.68(5):325-7 620. Neu HC . J Dermatol 1994 Apr. Akamatsu H.63 Suppl 2:329-32. Makhortykh TZh. Katz R. Namura S.43(6):1516-9 616. Zaltzman JS . Niino K. The ACTG 254 Team . Clinical microbiology of azithromycin . [Some investigations on cefadroxil dry syrup (author's transl)] Jpn J Antibiot 1981 Feb. Miyachi Y.16(4):438-43 618.[Fundamental and clinical studies on cefixime in the pediatric field] Jpn J Antibiot 1986 Apr.91(3A):12S-18S 615. Hisazumi H.60(7):880-3 612. Aqil S. Iqbal A. Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia . Timakov AM. Yamaguchi T . Arredondo Garcia JL .21(4):233-8 622.29 Suppl 2:11-5 617. Ngo LY. Oshinoya Y. [A clinical evaluation of CS-807 in patients with urinary tract infections] Hinyokika Kiyo 1988 Aug. Hassan S. Johansen A. Tarasova IS.105(3):428-40. Sharif MW. Nishijima S.20(4):461-9 603. Hughes WT. Niino K. Walla FL.43(4):30-2 613. Narcio Reyes LE. Takagi M .61:261-4 610.50(9):289-93 602. Hirama Y. Ohkawa M. Nakashima T. J Pak Med Assoc 2000 Sep. Yogev R. Hayakawa F. Nakazawa S. Masood T. [Cephalosporins in the treatment of children with oncohematologic diseases] Antibiot Khimioter 1998. Nakashima S. Uchibayashi T. Hansen E. Najib MM. [Clinical evaluation of azithromycin in pediatric infections] Jpn J Antibiot 1996 Oct. Khan MK. Am J Med 1991 Sep12. Sensitivity of Staphylococcus aureus and Streptococcus pyogenes isolated from skin infections in 1992 to antimicrobial agents. Stein GE. Suzuki H. Matsumoto K. Unadkat JD . Schmassmann A .21(4):233-8 621. Hakamada S. Dankner WM. Nakayama I . Malik BA. Namura S. Infection 2001 Dec. Naitoh H. Nepokul'chitskaia NV.34(8):1515-8 605.Pharmacotherapy 2000 Apr. Kondratchik KL. Sensitivity of Staphylococcus aureus and Streptococcus pyogenes isolated from skin infections in 1992 to antimicrobial agents . Halsos A. Transplantation 1998 Jun ٥-١٦١١:(١٢)٦٥‫٧٢؛‬ 611. Moseng D. Asada Y. Najam Y. 2005 Mar. Asada Y. 601. Malik S. Erina TA. Xu J. Pharmacokinetics of azithromycin administered alone and with atovaquone in human immunodeficiency virus-infected children. Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients . Anestad G. Storvold G .References 600. Narita A. Sato H. Najib MM. J Dermatol 1994 Apr. [Clinical studies of azithromycin.[The clinical study of azithromycin in otolaryngologic infection] Jpn J Antibiot 2000 Jun. Khawar N. Aoki S. Tarar MA . 53 Suppl B: 82-90 607. Casanova Roman G.

multicentre study of the efficacy and tolerance of azithromycin versus clarithromycin in the treatment of adults with mild to oderate community-acquired pneumonia. Harada Y. Unuvar E. Takahashi H. Oizumi K . Int J Pediatr Otorhinolaryngol 2003 Jan. Ishii S. Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis/tonsillitis. Antimicrob Agents Chemother 1997 Nov. Ohtsuka Y. Efficacy of azithromycin in reducing lower genital Ureaplasma urealyticum colonization in women at risk for preterm delivery . Odagiri S. Looareesuwan S .49(11):1024-9 642. Goodwin TM . O'Doherty B .49(11):1039-48 639. Shimazaki Y. Wiedermann G. 2005 May. [Clinical evaluation of BMY-28100 for bacterial pneumonia in comparison with cefaclor in a double-blind study] Jpn J Antibiot 1990 Nov. Miyazaki S. Noedl H. Lowdin E. Acta Trop 2001 Sep ٤٤-٣٩:(١)٨٠‫١؛‬ 625. Machida Y. 624. cefuroxime. J Antibiot (Tokyo) 1988 Jul. Sekiguchi T . Willingmyre GD. Antimicrob Agents Chemother 2001 Nov. Muller O . Hulten K. Wilairatana P ، Kollaritsch H. [Study of finding the optimum dose of cefetamet pivoxil in complicated urinary tract infections] Jpn J Antibiot 1990 Dec. Silverberg J.41(10):1538-44 629. Suzuki K. Suoglu Y. Eur J Clin Microbiol Infect Dis 1998 Dec. Noble J. Odenholt I. Saito T . Oizumi K. Krudsood S. [Clinical studies of cefpodoxime proxetil in respiratory tract infections] Jpn J Antibiot 1988 Oct. Kido T. Okamoto H. Randomized. Yamaki I. Clinical trials of cefprozil for treatment of skin and skin-structure infections: review . Tateda K.51:683-7. Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection . Engstrand L.14 Suppl:٢ S255-63. Sidal M . Takahashi K.17(12):828-33 631. Wernsdorfer WH. Milhous W . Antimicrob Agents Chemother 2002 Aug. Ohmichi M. Ohmori H. et al .15(9):718-24 632. Clin Infect Dis 1992 Jun. Nix DE. Uehara Y.45(11):3250-2 643. Nolen TM .Susceptibility of Chlamydia pneumoniae to azithromycin and doxycycline: methodological aspects on the determination of minimal inhibitory and minimal bactericidal concentrations . Tsuji Y. Yoshimi A. Saito A. Antimalarial activity of azithromycin. Fujieda M. Yamaguchi K . Scand J Infect Dis 1997. Murohashi K.8(1):12-6 633. Kanemasa Y. 3 days azitromycin .49(10):939-46 Page 29-D . Kumon H. Suda T.41(11):2522-6 630. Studies of the killing kinetics of benzylpenicillin. Tomizawa M. 2005 Feb. 634. Konishi K. [Clinical studies on azithromycin in pediatrics] Jpn J Antibiot 1996 Oct. Ogawa Y. discussion S272 626. Cars O . Baerlocher MO. Tomotsune K.67(1):43-51 635. Hashizume H. Matsunaga K. Can Fam Physician. Hjelm E .29(5):513-6 627. Management of type 2 diabetes mellitus. Kurashige T . Tamura M. J Matern Fetal Med 1999 Jan-Feb.46(8):2518-24 638. Okada T. Lee P. Nishino T . O'Doherty B. Paediatric Azithromycin Study Group . [Pharmacokinetic and clinical studies on azithromycin in children] Jpn J Antibiot 1996 Nov. Azithromycin Study Group . Ohrt C.Eur J Clin Microbiol Infect Dis 1996 Sep. Cars O. Nakayama I. a new orally active cephalosporin .43(11):191447 640. [Pharmacokinetic and clinical evaluations of azithromycin in the pediatric field] Jpn J Antibiot 1996 Nov. Gustavsson I. and sparfloxacin on bacteria in the postantibiotic phase . Obana Y.39(9):2104-11 636. Straubinger RM . Role of thiazolidinediones.43(12):2102-32 637. Gomi K. In vitro and in vivo antibacterial activity of KY. Nystrom-Rosander C. [Glucocorticoid-induced diabetes] Nippon Rinsho. Hirai Y.41(7):949-58 628. Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro . Watanabe A. Ishii Y. Okamoto T. Erdamar B. 53 Suppl B: 72-81 641. Ogasawara KK. Oh YK. Hayashi K . Knirsch C.References 623. [Clinical evaluation of azithromycin for respiratory infectious diseases] Jpn J Antibiot 2000 Jun.109.Antimicrob Agents Chemother ١٩٩٥ Sep. Kobayashi N. Etiology of acute otitis media in childhood and evaluation of two different protocols of antibiotic therapy: 10 days cefaclor vs. artemisinin and dihydroartemisinin in fresh isolates of Plasmodium falciparum in Thailand . Numata H.63 Suppl 2:324-8. azithromycin. Dundar G ، Katircioglu S. Hiraga Y. In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae . Oguz F.

Antimicrob Agents Chemother 1992 Dec. Werner K. Quintiliani R . Nicolau DP. O'Reilly T. Int J Clin Pract 2000 Oct. Forsblom B. Onyeji CO. Shimizu T. 2005 Apr 16.٤٢ 660. Plantema FH. Antimicrob Agents Chemother 1996 Apr. Asikainen S. Parish LC. Haponik E. Comparative efficacy and safety of 3-day azithromycin and 10-day penicillin V treatment of group A beta-hemolytic streptococcal pharyngitis in children . Visseren FL. Church D . Abe M. Corti G. Rieffe M. Efficacy and safety of ten day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia. Piergies AA. Cefuroxime axetil in the treatment of cutaneous infections . Fidelholtz J. Martens FM. Efficacy of three-day azithromycin vs. 2005 Mar-Apr. Kikuiri T.15(4):487-92 651. Routh HB. Sande MA. Murakami T. Clin Microbiol Infect 2001.101(5):299-303 657. [A clinical evaluation of sultamicillin fine granules in the treatment of meibomianitis] Jpn J Antibiot 1988 Dec. Respir Med 1998 Aug. Olijhoek JK. Nawrocki RP. Ranucci A. Page 30-D . Pacifico L.Aug. Haverstock D. Pearl J. San Pedro G. Gann LP.16(5):542 654. Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance. Eur J Clin Microbiol Infect Dis ١٩٩٢ Aug. Pajukanta R. Testa RT. de Vries A.92(8):1032-9 647. Asikainen S. Ossewaarde JM. Church D . Haverstock D. J Neurosci Nurs. 659. Muller M. Patsouris D. Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses . Paradisi F. Moxifloxacin versus cephalexin in the treatment of uncomplicated skin infections . Bochenek WJ. Patel T.6(2-3):241-4 656. Reddy SG.40(11):2582-5 646. Werschler P. Jungkind DL ،Witkowski J . Nishihara H.38(5):1112-7 648. cefaclor. Streptococcus pneumoniae as an agent of nosocomial infection: treatment in the era of penicillin-resistant strains . Optimal times above MICs of ceftibuten and cefaclor in experimental intra-abdominal infections . Miyao M . Banga JD. 2004 Oct. Alaluusua S ، Jousimies-Somer H . Miskin B. Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin . Saarela M.37(3):130-5. Effects of hyperglycemia on neurologic outcome in stroke patients. Curr Opin Investig Drugs. Antimicrob Agents Chemother 1994 May. et al . Scand J Dent Res 1993 Oct. Zak O. Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy. Pataracchia M.11(8):693-7 653. Omidvari K. Itoh C.In vitro antimicrobial susceptibility of different serotypes of Actinobacillus actinomycetemcomitans .5(10):1045-50. cephalosporins. FEMS Immunol Med Microbiol ١٩٩٣ Mar. Antimicrobial treatment of otitis media : penicillins. clinical outcomes. Williams J. Community Acquired Pneumonia Study Group . Parkin JL . Yokoyama Y. van Loon AM . [Achievements in molecular genetics studies of diabetes mellitus] Biomed Khim.89(3 Pt 1):376-80 663. 2005 Jun. 645.7 Suppl 4:34. Nightingale CH. Osato MS. Ooishi M. Efficacy of single-dose azithromycin versus doxycycline in the treatment of cervical infections caused by Chlamydia trachomatis . Summer W . Comparative efficacy of new investigational agents against Helicobacter pylori . Karam G. Kersten S. sulfonamides . Pajukanta R. Kurihara Y. Gubbins PO.36(12):2693-7 650. Parish LC. and cost analysis . Oshima S. Sande E. ten-day penicillin V in the treatment of streptococcal pharyngitis . Cinelli R .41(12):2059-64 649. Tauber MG .References 644. Savignoni F.149(16):859-65. Int J Dermatol 1987 Jul. [A double-blind comparative study on the efficacy of S6472.40(4):1005-8 655. Garner KM. beta-Lactamase production and in vitro antimicrobial susceptibility of Porphyromonas gingivalis . Pediatr Infect Dis J 1997 May. Pankov IuA. de Boisblanc BP.26(6):389-93 661. Halinski DM.94(2):97-105 664. Saarela M ، Jousimies-Somer H . Graham DY .51(2):107-17. Pacifico L. in the treatment of bacterial bronchitis] Jpn J Antibiot 1986 Oct. Antimicrob Agents Chemother ١٩٩٦ Nov.39(10):2726-53 652. Takeuchi K. Scopetti F. Respir Med 2000 Feb. Otolaryngol Head Neck Surg 1981 May-Jun. Chiesa C . [The metabolic syndrome: a cluster of vascular risk factors] Ned Tijdschr Geneeskd. Cocchetto DM.54(8):497-503 662. Chiesa C . Aliment Pharmacol Ther 2001 Apr. Kunz S. Paolino AS. Campbell GD Jr . Heyd A. Olsen KM. Nelson S. 658.

Aguilar L. Darden PM . Effective short-course treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis. Jarvis B. Perronne C. Peters DH. Pichichero ME .148(10):1053-60 683. Ripoll M . 21(3):222-8 670. Pharmacokinetic and pharmacodynamic considerations that may improve clinical outcomes . Alkorta M.10(10):821-7 666. McLinn SE ، Maddern B. A review of its antibacterial activity. Moore GF . Arvis P.Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate. Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis.14(3):183-8 684. Perry CM. Perry CM. Garcia-Arenzana JM.32(2):132-44 669.119(1):185-95 680.41(6):629-34 671. Azithromycin. Scand J Infect Dis Suppl 1989.References 665. Chest 2001 Jan.٥٨ 677. communityacquired. Pediatr Infect Dis J 1995 Mar. Moita J.13(2):118-25 672. Zieno SA.36(11):2569-72 681. Schmidt-Gayk H. Pelletier LL Jr . Pichichero CL . and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages . suspected pneumococcal pneumonia in adults . Peloquin CA . Ear Nose Throat J 1995 Dec.South Med J 1990 Oct. Gooch WM. Blumer JL. Empiric antibiotic selection criteria for respiratory infections in pediatric practice . Yonkers AJ. Perez-Gorricho B. in a dose-ranging immunocompetent mouse sepsis model. Linezolid: a review of its use in the management of serious grampositive infections. and amoxicillin-clavulanate potassium suspensions in acute otitis media in infants and children . azithromycin ،temafloxacin. Antimicrobial treatment .16(3 Suppl):S60-4 685. discussion S2445 668. Ann Emerg Med 1995 Mar. CAP5 Moxifloxacin Study Group . Pichichero ME. Pichichero ME. timing and best choice of antibiotic therapy for acute otitis media and tonsillopharyngitis infections in children. Drugs 1996 Jul. Zuck P. Comparison of cefuroxime axetil. Marel M. Outcome-oriented managed care comparing efficacies of cefaclor and amoxicillin in acute and recurrent acute otitis media . Novelli A. J Antimicrob Chemother 1990 Dec. Johnson C. Evaluating the need. Pichichero M. Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams.61(4):525-51 678. Rodriguez W. Picard M. Iturzaeta A. Cefuroxime axetil. Antimicrob Agents Chemother 1992 Nov.Persistent acute otitis media: II. J Chemother 2001 Apr. Pediatr Infect Dis J 2000 Dec. Vicente D. Gooch WM. Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment .Does short-course antibiotic therapy better meet patient expectations ‫؟‬Int J Antimicrob Agents 2003 Mar. [Azithromycin and Mycobacterium avium infection] Pathol Biol (Paris) 1995 Jun. Malouin F . using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin. Grosset J. Musser JM. Perronne C .26 Suppl E:63-9 673. Pedersen SS .83(10):1174-7 682.35(7):1356-9 674. Pechere JC . Gimenez MJ. cefaclor. pharmacokinetic properties and clinical efficacy . Eur J Clin Microbiol Infect Dis 1991 Oct. in-vivo and ex-vivo studies with oral beta-lactams against Streptococcus pneumoniae. Brogden RN . Pichichero ME . Activities of sparfloxacin. Antimicrob Agents Chemother ١٩٩١ Jul.25(3):390-403 686. pharmacokinetic properties and therapeutic efficacy .14 Suppl:٢ S238-43. In-vitro. Clin Infect Dis 1992 Jun. Gikas A.52(1):125. Molecular basis of the efficacy of cefaclor against Haemophilus influenzae . Arch Pediatr Adolesc Med 1994 Oct.74(12):840-4 676. Perez-Trallero E. Ten days of penicillin V vs 5 days or 10 days of cefpodoxime therapy in children. Clinical efficacy of ciprofloxacin in lower respiratory tract infections .44(5):750-99 679. Gomariz M. Truffot-Pernot C.60: 89-97 667. Aronovitz GH. Drugs 1992 Nov. A review of its antimicrobial activity.43(6):565-7 675. Mycobacterium avium complex infection . Aronoff SC. McTavish D . Ryo Y. J Antimicrob Chemother 1998 Jun. Pichichero ME. Jacobs RF. Pediatr Infect Dis J 1997 Mar. Friedel HA. Urueta J. Alkorta M. Perry BP. Petitpretz P. The activity of azithromycin in animal models of infection . Schildwachter G. Vilde JL. Review of the experience with cefprozil for the treatment of lower respiratory tract infections . Clin Pharmacokinet 1997 Feb. Perez-Trallero E. Periti P. Drugs 2001.19(12 Suppl):S131-40 Page 31-D . Pocidalo JJ .

Valerio G . Baudler S. Plouffe J. 2005 May-Jun. Plum L. Efficacy of 5-day cefpodoxime proxetil for recurrent pharyngitis in adults. Rakkar S. Pediatr Infect Dis J 1996 Sep. Portier H. vancomycin and linezolid . Danziger LH. Ranke MB.Cefetamet pivoxil in pediatric otitis media . Diagn Microbiol Infect Dis 1990 Mar. Anzuetto A. Kowalsky S.45(6):1746-50 697.38 Suppl٨-٢:٢٥ 702. Daries W. Fusai T. 691. Chemotherapy 1992. Prospective randomized study comparing the efficacy and safety of ciprofloxacin with cefaclor in the treatment of patients with purulent bronchitis . Quenzer RW. Physiology (Bethesda). Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactions . Pryka R. Chavanet P. Safran C. Aliment Pharmacol Ther 1996 Dec. Towe BF. Gehanno P. Olsen KM. Five day treatment of pharyngotonsillitis with cefpodoxime proxetil. Piscitelli SC. Rapp RP . Quintiliani R . Mosnier J. Ichou F. Chavanet P. Bruning JC. and perspectives. Portier H. Wunderlich FT. In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron . Arnow PM. Chemotherapy 1988. Portier H. Soffiati G. Clermont A. Clin Pharm 1992 Feb. Antimicrob Agents Chemother 2000 Jul. Gezon JA. Rodvold KA .20(7):4869 699. Greenberg RN ، Niederman M. Pukander JS. Clinical comparison of once-daily cefadroxil and thrice-daily cefaclor in the treatment of streptococcal pharyngitis . Properties of azithromycin that enhance the potential for compliance in children with upper respiratory tract infections . Pilotto A. Grey PC. Ciprofloxacin. Clin Microbiol Infect 1997 Aug. Moxifloxacin versus amoxicillin clavulanate in the treatment of acute maxillary sinusitis: a primary care experience . Weber P. Efficacy and tolerability of twice-daily ciprofloxacin 750 mg in the treatment of patients with acute exacerbations of chronic bronchitis and pneumonia . Paladino JA. Sherman BW. Multicentre comparative study of the efficacy and safety of azithromycin compared with amoxicillin/clavulanic acid in the treatment of paediatric patients with otitis media . Bozzola L. Guetat F. Powers JL . Franceschi M. Haverstock D .26(1):59-66 693. Scagnelli M. Inverso J.15(9 Suppl):S30-7 695.18(3):373-90.Apr.26 Suppl E:79-85 692. Clin Ther 1998 Jan-Feb. Graninger W .32(7-8):785-93 Page 32-D . discussion 372 704. Barret E. Di Mario F.16(4):190-7. Suh B.20(1):141-55 701. The Azithromycin Intravenous Clinical Trials Group . Scand J Infect Dis 1994. Parzy D . Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. A comparative study with 10day penicillin V or amoxycillin---clavulanate. Preheim LC. Georgopoulos A. Flores SM. Davis RL. Ichou F. Knirsch CA . Principi N .10(6):1021-7 688. Transgenic and knockout mice in diabetes research: novel insights into pathophysiology.34(6):512-8 706.References 687. Paloheimo SH. Roberts K. Ann Pharmacother 1998 JulAug. Powers JL.23(5):842-9 698. Rogier C.15(9 Suppl):S30-7 696. Dabernat H. Antimicrob Agents Chemother 2001 Jun. Yue M.3(4):447-454 694.44(7):1796-802 690. Heyd A. 707. Snitily MU. Cefixime in the treatment of patients with lower respiratory tract infections: results of US clinical trials . Clin Ther 1996 May-Jun. Gentry MJ .55(5):309-15 705. Eur J Clin Microbiol Infect Dis ١٩٩٥ Aug. Ethanol feeding does not affect the efficacy or pharmacokinetics of azithromycin. Neidhart MM . Presterl E. diabetes mellitus and insulin resistance. Sipila MM . trovafloxacin ، or ceftriaxone in a rat model of pneumococcal pneumonia . teicoplanin. Kolokathis A. Pediatr Infect Dis J 1996 Sep. Leandro G. Warner J . Alcohol Clin Exp Res 1999 May. 2005 Jun. J Antimicrob Chemother 1990 Dec.11(2):137-52 689. Randolph MF . Cure of Helicobacter pylori infection in the elderly : effects of eradication on gastritis and serological markers . Krone W. limitations. Eur J Clin Microbiol Infect Dis 2001 Jul. Kisterman JP. levofloxacin. Pradines B. Gouyon JB. Grisold A. Properties of azithromycin that enhance the potential for compliance in children with upper respiratory tract infections. Trends Endocrinol Metab.14(8):669-76 700. Insulin-like growth factor-I treatment of growth disorders.and methicillin-resistant staphylococcus aureus susceptible to moxifloxacin. Mueller-Uri P. Clarithromycin and azithromycin: new macrolide antibiotics .13(2):143-8 703. Int J Clin Pract 2001 Jun. Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin. Ramirez JA. Fiessinger S.20:152-61. Schwartz DB. Waldner-Combernoux A.

Anderson RL. cefaclor in the treatment of acute otitis media in children: a randomized ، comparative study . Cure through intervention in fat transport and storage. A critical review of the new oral cephalosporins.37(5):987-91 721. Solov'eva NA. Deferrari G.8(3):398-402 724.23(1):29-39 714. JAAPA. J Antimicrob Chemother 1996 May. Compliance with antibiotic therapy: a comparison of deuterium oxide tracer. Ripa S. An open study to compare azithromycin with cefaclor in the treatment of children with acute otitis media .32(2):138. Lopez Aldeguer J. quiz 37-8. Roblin PM.41(1):23-6 713.42(1):194-6 726. Montanari G. Treatment of beta-hemolytic streptococcal pharyngitis with cefaclor or penicillin. Vettoretti S. Arch Fam Med 1994 Nov. Hammerschlag MR . Perez Elias MJ ، Podzamczer Palter D . Diabetes: insulin resistance and derangements in lipid metabolism. Efficacy of a three day course of azithromycin in moderately severe community-acquired pneumonia . Gupta S. Haemophilus influenzae and Branhamella catarrhalis . Diabetes Metab Res Rev. Considerations and place in therapy . Making the transition from oral to insulin therapy. A linear model for the pharmacokinetics of azithromycin in healthy volunteers . Huck W. Prevention and treatment of diabetic nephropathy: the program for irbesartan mortality and morbidity evaluation. 711.[Cerebral toxoplasmosis] Enferm Infecc Microbiol Clin 1998. Zhukhovitskii VG.3(11):975-80 729. An open study to compare azithromycin with cefaclor in the treatment of children with acute otitis media . Sait T.Dec.Pediatr Infect Dis J 1993 Jan. Pichichero ME . Raz I. urine bioassay. Riddle MC. a new once-daily fluoroquinolone .92(4A):130S-135S 723. Girard AE. Pozzoli R. Fraioli P.25 Suppl A:83-9 717. New potential therapies for cryptosporidiosis: an analysis of variables affecting drug efficacy . Concurrent gonococcal and chlamydial infection : how best to treat . Rodman DP. Eur Respir J 1995 Mar. Reinert P. Kaprel'iants AS .37 Suppl C:63-9 730. Rizzato G. Ridgway GL . treat risk factors.21(1):3-14. Retsema JA. 709. Cernea S. Fanti D. Rodriguez WJ. Shafrir E. Ann Pharmacother 1994 Jun. Magliano E . Ratto E. Robinson AJ.S. Dudik TV. Rassman J. Khan W. 719. Rodewald LE. Ripoll L. J Am Soc Nephrol. Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae. Reshetniak VI. Pepin LF. Milisen WB . Arch Fam Med 1994 Nov. Considerations and place in therapy. Chemotherapy 1996 Nov. Cefixime vs. Zazove P . Rizk E . Renkonen OV . bottle weights. Rehg J . J Antimicrob Chemother 1996 Jun.42(6):402-9 720.18(3):30-6.47(2):16-9 716.16 Suppl 1:45-51 718. Rodriguez AF . Ren CL . Update on the management of intestinal cryptosporidiosis in AIDS .37 Suppl C:63-9 731. Il'chenko AA. Becker ES . 2005 Jan-Feb.٤٤ 712. Am J Med 1992 Apr6. The U. Kohlbrenner VM . 2005 Mar. and parental reports . McKnight JT. Prenna M . Antimicrob Agents Chemother١٩٩٨ Jan. Reed BD.References 708. Bell TA ، Akram S. Anderson RL . Folia Parasitol (Praha) 1994. Ravera M.59(4):801. J Fam Pract 1991 Feb.118(Suppl 5A):14S-20S. Ferrante L. Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo . clinical experience with lomefloxacin. Ritchie DJ.١٣ 725. Montemurro L. Lagrange PH . Ribera Pascuet E.3(11):975-80 728. A critical review of the new oral cephalosporins . Rodriguez AF . Eldor R. Interaction of macrolides with alpha dornase during DNA hydrolysis . Drugs 2000 Apr. Clin Rev Allergy Immunol 2002 Aug. Am J Med.123(1):143-7 727. Rodman DP.28(6):767-78 722. Efficacy and interaction with beta-lactamase-producing organisms in the pharynx . Girard D. Scand J Infect Dis Suppl 1983. [Eradication of Helicobacter pylori in patients with duodenal ulcer following the short course of treatment with azitromycin and amoxicillin] Antibiot Khimioter 2002. 2005 May.12(1):70-4 Page 33-D .16 Suppl 1:S48-52. Chhabra OP. J Antimicrob Chemother 1990 Jan.39:106-8 715. J Antimicrob Chemother 1996 Jun. Parodi D. J Pediatr 1993 Jul. 2005 Mar. Use of modulators of airways inflammation in patients with CF . McKnight JT. The metabolic syndrome: modify root causes. Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia . 710.

Scand J Infect Dis 2002. 2004 Dec. Michi K. Linezolid versus ceftriaxone/cefpodoxime in patients hospitalized for the treatment of Streptococcus pneumoniae pneumonia. Sasaki I. [Clinical evaluation of S6472 (prolonged action preparation of cefaclor) in the treatment of skin and soft tissue infections. Sankar R. Koga Y . 749. Sakamoto N.31 Suppl E:103-9 734. Noda T . The Linezolid CommunityAcquired Pneumonia Study Group. Uematsu H. Yura J. Oliphant TH. Schaad UB. Brandt CM. safety and toleration of azithromycin vs. Oh T. Yoshinari N. Sato T.42(1):45-8 735. Ou T. van Loon NH.41(8):1673-6 739. [Therapeutic effects of antibiotics against enterohemorrhagic Escherichia coli (EHEC) O157:H7 (O157) infection: in vivo analysis using germfree mice] Kansenshogaku Zasshi 1999 Oct.112(33):485-8 740.38(10):2716-34 743. Kaneko A. 748. Giles TD Heart failure in diabetes mellitus: causal and treatment considerations. Mayo Clin Proc 1992 Mar. Rous SN . Hoshino E. [Clinical evaluation of cefuroxime axetil in acute dental infections. Murono K. Yoshida H. J Antimicrob Chemother 1993 Jun. Rodriguez-Solares A. Croat Med J 2001 Feb. Tajima N. 744. Neurology. Fujimoto M. Iseki K. Kaneko A. Sakai K. Antiparasitic agents . Oral Microbiol Immunol 1993 Jun.52(6):491-503. et al . Safran C. San Pedro GS.73(10):1054-63 753.82(11):1306-8 737. Prosperi J. Todisco T. Yamane N. Double blind comparative study vs. Tachi Y. cefaclor] Jpn J Antibiot 1990 Dec. et al . Fujita K. [Clinical and pharmacokinetic evaluation of cefpodoxime proxetil in children] Jpn J Antibiot 1989 Jul. Wilson WR . Sakamoto H ، Naitoh H. Antibiotic-resistance patterns of Helicobacter pylori in Croatia: cohort study .8(3):172-6 752. Azithromycin for ocular toxoplasmosis . J Urol 1981 Feb.11(10):543-6 733. 2004 Nov 23. alpha-glucosidase inhibitor in treatment of impaired glucose tolerance] Nippon Rinsho. A comparative study of the efficacy. Patel R. Salopek-Rabatic J . Steckelberg JM. a new oral carbapenem. Br J Ophthalmol 1998 Nov. Hara H.26 Suppl E:93-101 741. Rothova A.27(4):209-11 746. 2005 Feb. Tomita F. Tanaka K. Treffers WF . J Antimicrob Chemother 1990 Dec.34(10):720-8 747. Rosenblatt JE .43(12):2035-68 750. Ishikawa S.42(4):427-37 742.63(10 Suppl 4):S30-9. Rodriguez-Diaz JC. Heynen G . Shinagawa N.125(2):228-9 738. J Antimicrob Chemother 1998 Oct. The Swiss Tonsillopharyngitis Study Group .42(7):1456-63 745. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model] Enferm Infecc Microbiol Clin 1993 Dec. Cefpodoxime proxetil: dosage. Morihana T. Initial treatment of epilepsy with antiepileptic drugs: pediatric issues. Bosch-Driessen LE. Rosandic M . Miro JM. Shibata Y. Cammarata SK. Perez-Gutierrez F. A comparison of cefaclor versus trimethoprim. Sasaki J.15(9):791-5 Page 34-D . safety and tolerance of azithromycin. Kobe A. Takahashi Y. Takahashi K ، Fukuoka F. Evaluation of the efficacy. et al . A double blind comparison of S6472 and cefaclor] Jpn J Antibiot 1985 Oct. dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections . In-vitro and in-vivo antibacterial activities of CS-834. Karakida K. Minerva Cardioangiol.sulfamethoxazole combination in the treatment of acute urinary infections . Pediatr Infect Dis J 1996 Sep. Otsuki M. Rouse MS. Sawamura S. Sakagawa E. Katoh H. Ohne M.48(9):1093118 751. Martin A . CLAO J 2001 Oct. [Effects of acarbose. penicillin V in the treatment of acute streptococcal pharyngitis in children: results of a multicenter.References 732. [Respiratory tract infections: how frequent is antibiotic resistance? In vitro activity of older and recent antibiotics against the significant pathogens] Fortschr Med 1994 Nov 30. Martinez-Fernandez AR . Kakehashi H. In vitro antimicrobial susceptibility to combinations of drugs on bacteria from carious and endodontic lesions of human deciduous teeth . Yoshioka H. efficacy and tolerance in adults suffering from respiratory tract infections. Sander GE. Martinez-Grueiro MM. Ueda T. open comparative study.67(3):276-87 736. Doi S. Antimicrob Agents Chemother ١٩٩٧ Aug. Satoh T. Milgram E. Wilklow FE.63 Suppl 2:451-6. Sakata H. Nishino T. [Comparative clinical study of azithromycin with tosufloxacin tosilate in the treatment of acute odontogenic infection] Jpn J Antibiot 1995 Sep. Chlamydial conjunctivitis in contact lens wearers : successful treatment with single dose azithromycin . Shiiki K. Ruckdeschel G. Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis .

Diabet Med. J Int Med Res 2000 May. Hu FB. Kohrer K ، Jones ME . Verhoef J. Nicoletti G . Kellerhals P. Scherbaum WA. Recommendations for treatment of chancroid. Three-day azithromycin compared with tenday roxithromycin treatment of atypical pneumonia . Optimizing therapeutic strategies to achieve renal and cardiovascular risk reduction in diabetic patients with angiotensin receptor blockers. new therapeutic target in metabolic and cardiovascular diseases] Rev Med Liege. Barsic B. The cost-effectiveness of prophylaxis for Mycobacterium avium complex in AIDS . J Int Med Res 2001 Jul-Aug.14 Suppl 2:13. Paquot N.26:445-67. A multinational. multicentre. randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis . J Chemother 1994 Apr. non-blinded.25 Suppl A:7-10 776. discussion٣٧١ 761.٢١ 760. Schuster FL. Scott LJ. 772. J Chemother 2002 Feb.20 Suppl 1:S39-46 771. Clin Infect Dis 1995 Apr.References 754. J Hypertens. Bassaris H.26(6):706-10 766. grlB. Schonwald S. Visvesvara GS . Cefuroxime axetil: an updated review of its use in the management of bacterial infections . Azithromycin versus pivampicillin in the treatment of acute exacerbations of chronic bronchitis: a singleblind. Scharfstein JA. Scheuring S. J Antimicrob Chemother 1990 Jan. Schmid GP .10(10):877-80 769. J Antimicrob Chemother 1998 Apr. Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias . Olovich KG. Gosev M . Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumonia .45(6):612-8 775. 1993. Car V. Dere WH . Ormrod D. 773. Freedberg KA .٥٠٠ Page 35-D .60(2):89-95. Hansen B. 2005 Jun. Scheen AJ. Rasmussen H. Mathiassen E . Car V. Infection 1999 May. Eur J Clin Microbiol Infect Dis ١٩٩١ Oct. Schmitz FJ.25 Suppl A:123-6 767. Klootwijk M. Clin Ther 2000 Apr.Jun. Primary prevention of diabetes: what can be done and how much can be prevented? Annu Rev Public Health.14(3):470-9 774. Bozinovic D. multicentre study . Perol Y . Skerk V.23(5):905-11.61(10):1455. ofloxacin. [PPAR-gamma receptors. Altwegg M. Burek V.5 g dose in the treatment of patients with atypical pneumonia syndrome--a randomized study . Schaad UB . In-vitro activity of azithromycin against Chlamydia trachomatis . Schonwald S.21(4):304-8 755. Craven DE.6(2):92-8 763. Scand J Infect Dis 1994. Culig J. The Italian Ceftibuten Study Group . Gunjaca M . Gunjaca M . Bianchi A. Weinstein MC.Jun. The Swiss Pharyngitis Study Group . gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus . Paltiel AD. Barthel A. Luckefahr M.28(3):101-10 770. Radosevic S . Ballin I. Reimnitz P.15(3):531-47 758. 762. Chappey B. Susceptibility of respiratory and urinary pathogens to ceftibuten and other comparative drugs: results of an Italian multicenter survey. Azithromycin: single 1. Efficacy of novel antimicrobials against clinical isolates of opportunistic amebas . Schinner S.Jun. 2005 Feb. Int J Technol Assess Health Care 1999 Summer. Oreskovic K. 36. Seage GR ، Losina E. Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children . Molecular mechanisms of insulin resistance. Fluit A. Petricevic I. Skerk V ، Car V.41(4):481-4 765. Schaberg T. Schupbach CW. Schito GC. levofloxacin.Azithromycin versus penicillin V for treatment of acute group A streptococcal pharyngitis . Pediatr Infect Dis J 2002 Apr. The AECB Study Group . Heinz HP.29(4):314. Drugs 2001. Schouenborg P. J Eukaryot Microbiol 1998 Nov-Dec. Schulte JM. Goa KL . Schonwald S. Schmieder RE. Relationship between ciprofloxacin. Schentag JJ . Clin Ther 1992 May. Kuzman I.147(17):32-4. Wickers-Nielsen N. Hampel B. Sparfloxacin: a review . Schaad UB. Schonwald S. Gunjaca M. Kolacny-Babic L.31 Suppl E:81-8 756. Efficacy of cefaclor AF in the treatment of skin and skin-structure infections . double-dummy.22(4):372-87. Schulze MB. Bornstein SR. J Antimicrob Chemother 1990 Jan. Schentag JJ . Huchon G. [Controversial therapeutic strategies in the treatment of type 2 diabetes mellitus] MMW Fortschr Med. Majerus-Misic L. Gerdes N. 764. Pharmacokinetic and pharmacodynamic predictors of antimicrobial efficacy: moxifloxacin and Streptococcus pneumoniae . 759. Vassias I. Schumm-Draeger PM. Scieux C. Hofmann B. 2005 May.22(6):674-82.27(3):198-202 768.٢٨ 757. Klinar I. 2005. 2005 Apr 28. sparfloxacin and moxifloxacin (BAY ٨٠٣٩-١٢ ) MICs and mutations in grlA. J Antimicrob Chemother 1993 Jun.

Nystrom T. 792. The Sinusitis Study Group . J Clin Periodontol 1996 Nov. 2005 Feb 1218. Ohta Y .13(4):330-5. Zeljko Z. Clin Ther 2002 Feb. Azithromycin in the treatment of periodontal disease. Schonwald S. Siddiqui SJ. Azithromycin induces in vitro a timedependent increase in the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes without damaging phagocytes . Danti A . Arrieta A . once-daily dose triple therapy with omeprazole. Barsic B. Roglic S. Silvestri M. Whiley A.52(10):451-6 788. Schonwald S. Singh J. Maskell JP. Single dose oral azithromycin versus seven day doxycycline in the treatment of non-gonococcal mucopurulent endocervicitis . McAdoo MA. Respir Med 2000 Apr. Chehter EZ. Seracini D. Laudanna AA . Talat A.40(1):44-7 780.63 Suppl 2:320-3. Ozkinay E. Lancet. Sesin GP. Klinar I . Barsic B ، Marekovic I. New trends in the drug therapy of localized and disseminated Mycobacterium avium complex infection . Niger J Med. Car V. Ura N. cefaclor and amoxicillin. Sasaki N. Burr B.39(7):47-53 782. Commonly used antibacterial and antifungal agents for hospitalised paediatric patients : implications for therapy with an emphasis on clinical pharmacokinetics .94(4):337-44 789. Yousfani AH.18(4):383-5 781. Foyle D. Vince A. Skerk V. Krhen I. Williams JD . Skerk V. Sefton AM. Bettis RB. Ahmad M . Bagger-Sjoback D ، Ibanez JM. Rossi GA . A multicenter. Awan A. Li NF. Siminialayi IM. Low efficacy of an ultra-short term. J Chemother 2002 Aug. Gehanno P. [Non-comparative open study of the efficacy and tolerance of cefaclor in the prevention of urinary tract infections in children] Pediatr Med Chir 1996 Jul-Aug. Aust N Z J Obstet Gynaecol 2000 Feb.23(11):998-1003 779. An evaluation of cefaclor in Pakistani children with pharyngotonsillitis . 2005 Feb. Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis . Hampel B. J Pak Med Assoc 2002 Oct.36(6):941-50 791.57(1):9-14 790. Effect on microbial flora . Beighton D.123(5):103-8.and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis. Nikolaidis P.References 777. Smales FC.14(4):384-9 Page 36-D . Cajic V . Pacheco R . Guven M . Silva FM. Ishii Y. Watanabe H. Sommerauer B . in the treatment of bacterial pneumonia] Jpn J Antibiot 1986 Mar. Paediatr Drugs 2001. Onodera S. Shibaki H. Dirithromycin . [Use of oral macrolide and azalide antibiotics in children with bronchopulmonary diseases] Antibiot Khimioter 1994 Jul. Eisig JN. Siegert R. Pierce PF. Am J Health Syst Pharm 1996 Nov 1. Nakabayashi T.365(9459):610-2. Ahmad TM. Tuncay G. Materassi M. investigator-blinded study of 5. J Chemother 2000 Apr. Katosova LK . Ekangakic A. Rev Hosp Clin Fac Med Sao Paulo 2002 Jan-Feb. Chimoto T. 794. [Short-term (6 days) eradication of Helicobacter pylori infection in the practice of a health insurance physician] Dtsch Med Wochenschr 1998 Jan30. Markovinovic L. randomized. [A double blind comparative study on the efficacy of S6472.3(10):733.12(2):186-8 795. [Effects of Ca channel blockers on glucose metabolism and insulin sensitivity] Nippon Rinsho. Kanjee S. Stringham D. Tosaka M. Manzi SF. Comparative analysis of azithromycin and doxycycline efficacy in the treatment of female patients with acute urethral syndrome caused by Ureaplasma urealyticum . Terek C. Bioorg Med Chem 1996 Apr. 787. A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. Sher LD. Sheikh S. Shimamoto K.53(21):2585-90 783. New drugs--reports of new drugs recently approved by the FDA. Shimizu T.4(4):521-2 786. Dohmen W .٦١ 793. Oddera S.39(3):853. Glucocorticoids and the insulin resistance syndrome. azithromycin. J Antimicrob Chemother 1995 Dec.٨٦ 785. Eftimiadi C. Shinshi Y. Sheikh GA. et al . Turner MA. Shinkai I. Tatochenko VK. Smith SR.discussion 109 778. Seelis RE. Ikeda Y. Mian FA. 2004 Oct-Dec. Endothelial inflammation in insulin resistance.24(2):269-81 784. Stocks JM. Sereda EV. and secnidazole for Helicobacter pylori eradication in peptic ulcer . Emem-Chioma PC. Rashid A. Shain H. Sendag F. da Silva JJ. Sjoholm A.

Combination drug therapy for cryptosporidiosis in AIDS . Kraus VB. Stevens DL. J Infect Dis 1998 Sep. Stillerman M . 2005 May 1. Gurwith MJ .٩ 797. Azithromycin compared with clarithromycin in the treatment of adult patients with acute purulent tracheobronchitis: a cost of illness study . How to manage diabetes in advanced terminal illnesses. Tilton RC .3(6):591-9 811. Spagna VA. Segura JC. Smyth T. Thorarinsson H. in humans . Vukovic J . Delesen H .25 Suppl A:109-14 812. 800.22(1):2-13. Perkins RL. Chappell CL. Azithromycin and doxycycline in the treatment of female patients with acute urethral syndrome caused by Ureaplasma urealyticum: significance of duration of clinical symptoms . Steingrimsson O. The effects of intravenous doxycycline therapy for rheumatoid arthritis: a randomized. Smith NH. Mehdi MZ. 807.References 796.٥٥ 810. a novel 8-methoxyfluoroquinolone.6(3):211-3 805. Successful treatment with cefaclor of gonococcal urethritis in men . a novel 8-methoxyfluoroquinolone. Wennersten CB. Rusinovic M. in healthy volunteers . against species representative of respiratory tract pathogens . Arthritis Rheum 2001 May. Hyperosmolar hyperglycemic state.3(2):113-7 802. Strapac Z. Skerk V. Int J Antimicrob Agents 1998 Apr. Amoxicillin-potassium clavulanate. Knepper C. Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections. Thorarinsson H. Stevens DL. Gunawan J .101(17):30-2. Pediatr Infect Dis 1986 Nov-Dec. [Report of experiences with the oral cephalosporin-derivative cephaclor in respiratory tract infections] Wien Med Wochenschr 1983 Jan٣٠-٢٧:(١)١٣٣‫٥١؛‬ 806. Solera J. Tilton RC . Olafsson JH. Martinez-Alfaro E. J Chemother 2001 Apr. Johnson RB. 2005 Apr 26-May 2. St Clair EW. Smyth D. Souli M. Effects of sucralfate on the oral bioavailability of moxifloxacin. Prior RB .13(2):176-81 798. Insulino-mimetic and anti-diabetic effects of vanadium compounds. Skerk V. Spath P . Schonwald S. Azithromycin in the treatment of sexually transmitted disease . Sexton DJ. de Tomas E. Srivastava AK. Stoner GD.27(4):135. Vukovic J.23(6):413-22 814. Wilkinson WE. Francetic I ، Krhen I. The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections .Single dose azithromycin treatment of gonorrhea and infections caused by C. placebo-controlled trial . Clin Pharmacokinet 2001. Pisetsky DS. Moller JG. Page 37-D .16(2):123-9 815. Strapac Z.40 Suppl 1:57٦٢ 809. Sex Transm Dis 1994 Jan. Am Fam Physician. Pien F. Diagn Microbiol Infect Dis 1993 Feb. Kubitza D . Beato JL. Clin Pharm 1984 Nov-Dec. trachomatis and U . Beus A.5(6):649-54 817. Stein GE. Pien F.10(1):23-30 804. J Chemother 1998 Feb. Diagn Microbiol Infect Dis 1993 Feb.21(1):43-6 813. Clin Pharmacokinet 2001. Drehobl M. Schonwald S.44(5):1043-7 808. Blot K . double-blind. Lesko V.Feb.40 Suppl 1:49. Azithromycin and gentamicin therapy for the treatment of humans with brucellosis . Schuhly U. a new fluoroquinolone. Yunus F. Eliopoulos GM . Valdez LM.178(3):900-3 799.71(9):1723-30.Sep.10(1):64-8 801. Greenwald RA . Treatment of atypical pneumonia with azithromycin: comparison of a 5-day and a 3-day course . Ryan RW. Comparison of oral cephalosporins with penicillin therapy for group A streptococcal pharyngitis . Leclerq P. Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections . Ryan RW. 2005 Jan. Stass H. Steingrimsson O. Socan M . Drew R.Drugs Exp Clin Res 2001.Respirology 1998 Jun. Drehobl M . Grupo de Estudio de Castilla la Mancha de Enfermedades Infecciosas Group . In vitro activity of BAY 12-8039. Sternon J. Nurs Times. Mangunnegoro H. J Antimicrob Chemother 1990 Jan. Johnson RB. J Int Med Res 1995 Nov-Dec. Diabet Med. Clin Infect Dis 2001 Feb٩-٥٠٦:(٣)٣٢‫١؛‬ 803. Effects of iron supplements on the oral bioavailability of moxifloxacin. urealyticum in men . Sex Transm Dis 1979 Jul. Krhen I. a beta-lactamase-resistant antibiotic combination . Stass H. Cron S. Olafsson JH. Soepandi P. White AC Jr . Duration of clinical symptoms in female patients with acute urethral syndrome caused by Chlamydia trachomatis treated with azithromycin or doxycycline .16(2):123-9 816.

52(2):162-71 Page 38-D . Kierszenbaum JS.103(5):842-6 832. Nakagawa T.365(9467):1333-46. discussion S209-11 823. West Indian Med J 2001 Sep.24(1):80-4 821.52(2):162-71 838. Akita H. Soliman AE .٣٥ 827. Treatment of borrelial lymphocytoma . 819. Kondo Y.20(2):65-9. Morikawa Y.١٠٢ 829. Ramos BD.21(2):199-209. Nishimura S. Swanston WH. 2005 Mar. Kaneko S. 2005 Apr 9-15. Yamanaka N ، Sugimoto M. Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media . Noll G. Hamami G. [Comparative clinical effectiveness and tolerance of azithromycin (sumamed) and erythromycin in patients with sinusitis] Antibiot Khimioter 1993 Jan. Goldstein BJ.14 Suppl:٢ S204-8. Clin Infect Dis 1992 Jun.19(4):208. Asmolovskii VM .46(11):953-8 836.99(7):629. al-Omar O. Nishimura S. 825. Stumvoll M. Gaudet D. van Haeften TW. Sugita R. Luscher TF.References 818.10(6):460-8 824. Abe T. Choudhury AH. St-Pierre J. Morikawa Y. Tajima T.54(3):591-602. [Pharmacokinetic. Tsuji T. 2005 Spring. Kobayashi M. Tsuji T . bacteriological and clinical studies on S-1108 in children] Jpn J Antibiot 1993 Nov. Hagiwara N. metabolic syndrome X. al-Faisal Z . Meguro H ، Sunakawa K. Abe T . Jurca T.38(1):13-6 820. Genetic aspects of diabetes and its cardiovascular complications: contribution of genetics to risk assessment and clinical management. Vohl MC. Strachunskii LS. Despres JP. Yoshida A ، Hagiwara N. Haruta T. Pleterski-Rigler D. Terashima I. Barrow L. Arakawa S. Negishi S. Iwata S. A randomized multicenter trial to compare the influence of cefaclor and amoxycillin on the colonization resistance of the digestive tract in patients with lower respiratory tract infection . Ishigami J. Sunakawa K . Macias MP. A randomized. Cimperman J . and Cushing's syndrome. Takenaka M. [Pharmacokinetic and clinical studies with azithromycin (fine granule) in the pediatric field . Binggeli C. 53 Suppl B: 91 . [Clinical study of S 6472 in urinary tract infection] Jpn J Antibiot 1990 Nov. Esaki E. Takashima T. Summers SA. Swedish Study Group. Arguedas AG . Nakagawa T. Single dose (direct observed) azithromycin therapy for Neisseria gonorrhoeae and Chlamydia trachomatis in STD clinic attenders with genital discharge in Trinidad and Tobago . J Laryngol Otol 1985 Jul. Can J Cardiol. Strle F. Ruschitzka F. Stutman HR. Sudano I. bacteriological and clinical studies on S-1108 in children] Jpn J Antibiot 1993 Nov. Furlonge C . Deguchi K . Nelson DH. [Causative organisms of acute otitis media and acute sinusitis in children and their susceptibility of oral beta-lactam antibiotics] Jpn J Antibiot 1999 Feb. [Summary of the clinical studies with azithromycin in the pediatric fields] Jpn J Antibiot 2000 Jun.48(9):1051-73 834. Single-dose azithromycin in the treatment of trachoma. Tajima T. Tajima T. Takagi S.50(2):200-5 833. Takenaka M. Corti R.46(11):953-8 835.71(4):329-36 826. Matsumoto O. et al . Kobayashi M. Esaki E.١٥ 831. Niimi R. Type 2 diabetes: principles of pathogenesis and therapy. Bacteriological features and chemotherapy of adult acute purulent otitis media . Kondo Y. Fujimaki Y. Maraspin V.50(3):198-202 830. 2005 Feb. Kaneko S. Mahabir BS. Yokota T. Tajima T. Sugihara E . Dillman CA. Fujii R . 822. Diabetes. [Pharmacokinetic. Kamidono S. J Chemother 1998 Dec. Spieker L. Abu-el-Asrar A. Abe T. Infection 1996 Jan-Feb. Kuleshov SE. Niimi R. A role for sphingolipids in producing the common features of type 2 diabetes. Tabbara KF. Effect of macrolide antibiotics on neutrophil function in human peripheral blood . Yoshida A. Cardiovascular effects of coffee: is it a risk factor? Prog Cardiovasc Nurs. A randomized. Infection 1991 Jul-Aug. Poirier P. Augmentin 415 Study Group . Tikhonov VG. bacteriological and clinical studies on azithromycin in children] Jpn J Antibiot 1997 Feb.Ophthalmology 1996 May. [Pharmacokinetic. et al . Umezu K. Fujii R. Lotric-Furlan S ، Ruzic-Sabljic E. Subba Rao SD. controlled study . observer-blind trial of amoxycillin/clavulanate versus cefaclor in the treatment of children with acute otitis media . Haruta T. Lancet. Takashima T. Prabhakar P. Takeuchi Y. Pediatric Study Group of Azithromycin] Jpn J Antibiot 1995 Sep. Hirooka K. Kansenshogaku Zasshi 1997 Apr. [Causative organisms of acute otitis media and acute sinusitis in children and their susceptibility of oral beta-lactam antibiotics] Jpn J Antibiot 1999 Feb. Negishi S.43(11):1850-72 837. 828.

Prospects for development of new antimycobacterial drugs. Am J Health Syst Pharm 2000 Apr٨-٦٦٣:(٧)٥٧‫١؛‬ 850. Tagaya E ، Konno K . Taskinen MR. Antimicrob Agents Chemother ١٩٩٥ Sep. Campanelli C. Nakamori Y .Malaria prophylaxis using azithromycin: a double. Temple ME. Nakata J. Jones RB. 2005 Apr. Block SL. Nahata MC . Takeuchi H. Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practises . Braitman D.28(1):74-81 849. Chartrand SA.40(8):519-23 844. Diagn Microbiol Infect Dis 1992 May-Jun. Ikoma H. [Expectation of new antituberculous drugs and targeting therapy for treatment of mycobacterial infections] Kekkaku 1993 Nov.96(7):1133-40 Page 39-D . Block SL . Asagi K. Tomioka H . [Clinical evaluation of S 6472 granule preparation (sustainedrelease cefaclor) in chronic bronchitis] Jpn J Antibiot 1988 Sep.Clin Infect Dis 2001 Mar 15.43 Suppl C:15-9 852. Genitourin Med 1996 Apr. Basri H. Ootawara S. Tang HJ. Pharmacotherapy of acute sinusitis in children .٢٠ 857. Dovey SM . J Infect Chemother 2000 Mar. Takemura H. Tomioka H . Fryauff DJ. with special reference to a new benzoxazinorifamycin. Tissi L. Picarima H. Sanders CC.54(4):917-27. Lee CL. Ishizu Y. Arch Immunol Ther Exp (Warsz) ٨-١٨٣:(٣)٤٨‫٠٠٠٢؛‬ 860. Tomioka H . Richie TL.41(9):1319-24 846. In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice : comparative study with erythromycin and penicillin G . Takeuchi H.15(4 Suppl):97S-101S 854. Talan DA . Sugihara S. Suzuki T. An open label comparative study of azithromycin and doxycycline in the treatment of non. von Hunolstein C. Jones TR. Prospects for development of new antimycobacterial drugs . Kouzaki Y ، Ishizu Y. KRM-1648 . [Effect of macrolide antibiotics on airway goblet hypersecretion in guinea pigs] Kansenshogaku Zasshi 1996 Jun. 847. Gall SA. Berman J . Ootawara S. A randomized double-blind controlled trial of roxithromycin and cefaclor in the treatment of acute lower respiratory tract infections in general practice .32 Suppl:١ S64-71 842. Ikoma H. Huang KY. J Infect Chemother 2000 Mar. Mosci P.46(11):3580-4 845. Sanders CC. Asagi K. In-vitro activity of levofloxacin against Streptococcus pneumoniae with various levels of penicillin resistance.70(6):591-6 843. Murphy GS. Tamaoki J. Tomioka H . Type 2 diabetes as a lipid disorder. Tan HH.47(1):84-92 841. 2005 May. Suzuki T. In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus . Thomson KS. Antimicrob Agents Chemother 2002 Nov.6(1):8-20 859. Kouzaki Y.gonococcal urethritis in males and Chlamydia trachomatis cervicitis in female sex workers in an STD clinic in Singapore . Curr Mol Med. et al. Tomiyama M . placebo-controlled trial in Irian Jaya ، Indonesia . Singapore Med J 1999 Aug. J Antimicrob Chemother 1999 Jun. [Clinical observation of acute otitis media in children] Nippon Jibiinkoka Gakkai Kaiho 1993 Jul. Thomson KS.72(2):93-7 853. Ko WC. Tanimoto H. Bistoni F. with special reference to a new benzoxazinorifamycin. Stamm WE. Clin Infect Dis 1999 Jan. Clinical perspectives on new antimicrobials: focus on fluoroquinolones . Taylor WR. Widjaja H. Prospects for development of new antimycobacterial drugs. et al .References 839. Chuang YC . Johnson RB . Orefici G . Makino H. Tomioka H . Hook EW 3rd. Thorpe EM Jr. [Clinical evaluation of cefpodoxime proxetil in otorhinolaryngological infections] Jpn J Antibiot 1994 Jan. Nakajima M. Ohrt C ، Tang D. Chan RK . Ortega E. KRM-1648 .blind. 848. Tilyard MW.6(1):8. In-vitro activity of levofloxacin against Streptococcus pneumoniae with various levels of penicillin resistance.68(11):723-30 856. Chang MC. Henry K. Chartrand SA. Tjitra E ، Ganjar A. Whitworth G.43 Suppl C:15-9 851. [Clinical evaluation of cefpodoxime proxetil in otorhinolaryngological infections] Jpn J Antibiot 1994 Jan. Arch Immunol Ther Exp (Warsz) ٨-١٨٣:(٣)٤٨‫٠٠٠٢؛‬ 858. Tataranni PA. Makino H. Sugihara S.5(3):297-308. Takeda Y. J Antimicrob Chemother 1999 Jun.39(9):1938-47 855. A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes. Prospects for development of new antimycobacterial drugs . Nakajima M.47(1):84-92 840.

Ishihara T. Sartori S.46(7):604-28 866. Gulino A. Caselli M. Toyonaga Y. Kosar F. Comparison of once daily cefpodoxime proxetil suspension and thrice daily cefaclor suspension in the treatment of acute otitis media in children . Ishihara T. Koizumi M.31(3):165-70 874.[Bacteriological.12(12):1269-72 871. pharmacokinetic and clinical studies of SY5555 dry syrup in the pediatric field] Jpn J Antibiot 1995 Jan. A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection . pharmacokinetic and clinical studies on cefteram pivoxil in the pediatric field] Jpn J Antibiot 1989 Aug. Ndinya-Achola JO. [Laboratory and clinical studies on norfloxacin in the pediatric field] Jpn J Antibiot 1990 May. Fedeli G. Tezuka T.Clin Infect Dis 1995 Oct. Turkish Thoracic Society COPD Working Group . Sartori S. Efficacy of azithromycin for typhoid fever . Marzullo E.49(11):981-93 864. Cannizzaro O. Lee PI. Ishihara T. Yildirim N. Ruina M. Umut S. [Bacteriological. Nakamura H .38(3):145-9 877. Toyonaga Y. Tezuka T. Toyonaga Y. [Bacteriological. Nakamura H . Yilmaz N.43(5):808. Hsueh PR. [NAVIGATOR trial (nateglinide)] Nippon Rinsho.10(4):306-12 876. Unutmaz S. Tyndall MW. Chinnici V. Lu CY. Cuoco L. Imai H. Tursi A. Abbasciano V . Aliment Pharmacol Ther 1998 Dec.42(8):1799. pharmacokinetic and clinical studies of SY5555 dry syrup in the pediatric field] Jpn J Antibiot 1995 Jan. J Microbiol Immunol Infect 1998 Sep. Vahapoglu H. Yamazaki M ، Hori M . Imai H. Sakaguchi N. Abbasciano V . Toyonaga Y. Habib N. Lee PI. Marletta V.48(1):7191 867. Akman M . Huang LM. Nakamura H . Nakamura H. Gur A. Caselli M ، Verdianelli G. Minneci MS. Ruina M. pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field] Jpn J Antibiot 1993 Jul. Lee CY .31(3):165-70 873. Ishihara T.93(3):390-3 870. Comparison of once daily cefpodoxime proxetil suspension and thrice daily cefaclor suspension in the treatment of acute otitis media in children. Toscano MA. Butler T . Turker H. Musellim B. Sugita M.47(6):249-60 862. Montalto M. 875. Tribble D. Am J Gastroenterol 1998 Mar. Lin HC. Trevisani L. Yilmaz Kuyucu T. Chiu TF. Soysal F. Goylusun V. 2005 Feb. Ilvan A. Plummer FA. Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication . Chiu HH. Nakamura H. Fukushima Y. Gasbarrini G . Arseven O. Ishihara T. [Bacteriological. Tezuka T.21(4):1045-6 872. Erk M.46(7):604. Johns D Jr . Mannino G.٨١٤ 863. [Bacteriological. Malafarina D. Lu CY. J Microbiol Immunol Infect 1998 Sep. [Efficacy and tolerance of azithromycin in respiratory tract infections in children] Minerva Pediatr 1995 Jun.63 Suppl 2:483-7. Sano T.٢٥ 869. Toyonaga Y. Toyonaga Y. Aydin Tosun G. Turik MA. Evaluation of a new ultrashort triple therapy for Helicobacter pylori disease . Tsai HY. Tezuka T. Sugita M ، Fukushima Y. [Pharmacokinetic and clinical evaluation of azithromycin using fine granules or capsules in the pediatric patients] Jpn J Antibiot 1996 Nov. J Chemother 1998 Aug. Sex Transm Dis 1994 Jul-Aug. ciprofloxacin and cefaclor.٢٨ 865. Malisa W. Tutluoglu B. Emanuele A.21(4):231-4 878. pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field] Jpn J Antibiot 1993 Jul. J Chemother 1999 Jun. Determination of the etiological organism during acute exacerbations of COPD and efficacy of azithromycin. Trevisani L. Panminerva Med 1996 Sep. Ozturk S.48(1):7191 868.11(3):211-4 Page 40-D . Erelel M. Huang LM. Girgis N. Chiu TF. Comparison of cefaclor and cefuroxime axetil in the treatment of acute otitis media with effusion in children who failed amoxicillin therapy . Ronald AR . Toyonaga Y. Veneto GM. Yamasaki M . Sano T. Lee CY. ampicillinsulbactam. Chiu HH. Cammarota G. et al . Single dose azithromycin for the treatment of chancroid: a randomized comparison with erythromycin . Lin HC. Salmeri M. Hsueh PR. Verdianelli G. Agoki E. Papa A. Tsai HY. Galvani F.References 861. Tsujii S.

Dmitrovic B. Wagner J. [Omeprazole and azithromycin with and without metronidazole in the eradication of Helicobacter pylori in duodenal ulcer disease Lijec Vjesn 1997 Jul. J Antimicrob Chemother 1993 Jun. J Antimicrob Chemother 1993 Sep. Open study of the safety and efficacy of a single oral dose of azithromycin for the treatment of uncomplicated gonorrhoea in men and women . Lopez G. Multicentre comparison of azithromycin versus erythromycin in the treatment of paediatric pharyngitis or tonsillitis caused by group A streptococci . Tan J ، Sarosi GA. Vijayaraghavan K. Valverde AM. De Saint Martin L. Desmonts JM. Mini Rev Med Chem. Soderqvist A.41(2):9-13 887.23(2):165-83. Musellim B. 883. Takac B. Savolainen S. Turker H. Gur D.20 Suppl 1:S66-71 898. Single-dose azithromycin for Chlamydia in pregnant women . von Sydow C. [Clinico-laboratory evaluation of the effectiveness of azithromycin in the treatment of patients with Chlamydia and mixed Chlamydia-gonorrhea infections] Antibiot Khimioter 1996 Feb. Cardiol Clin. Phillips J. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance? Minerva Med. Pocidalo JJ. Akalin HE .42(7):1471-6 896. Goylusun V. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective.18 Suppl 1:S17-23 884. Tulkens PM . Laverman GD.31 Suppl E:193-8 897.95(5):395-409.29(4):192-9. Yilmaz N. Vcev A. J Chemother 1999 Jun. Van Bambeke F. 885. Antimicrob Agents Chemother ١٩٩٢ Jul. The brown adipose cell: a unique model for understanding the molecular mechanism of insulin resistance. Hahn H . [The evaluation of the clinical efficacy and tolerance of azithromycin in odontostomatological infections] Minerva Stomatol 1998 Jan. Arseven O. Ivandic A. Macrolides: pharmacokinetics and pharmacodynamics . New treatments for Chlamydia trachomatis genital infection . Turkish Thoracic Society COPD Working Group . Koshinami M. Shahem S. Ozturk S. Determination of the etiological organism during acute exacerbations of COPD and efficacy of azithromycin. Tutluoglu B. Preliminary report . Karner I . Pocidalo JJ. Bates J. 893. J Antimicrob Chemother 1993 Jun. Unutmaz S. Bergogne-Berezin E . Correlation between macrolide lung pharmacokinetics and therapeutic efficacy in a mouse model of pneumococcal pneumonia . Horonitz M. 2004 Oct. Ilvan A. Navis G. [The antibacterial efficacy of cefaclor in routine testing of clinical material from two Berlin hospitals (author's transl)] Infection 1979. 2005 May. Int J Antimicrob Agents 2001.7 Suppl 6:547-50 895. Watanabe A. Waugh MA . D'Arcangelo C .5(3):269-78.32(3):473-82 890.Dupuis E .11(3):211-4 880. Aydin Tosun G.31 Suppl E:95-101 Page 41-D . Vahapoglu H. Benito M. Vceva A. ampicillinsulbactam. Hayran M. Yilmaz Kuyucu T. Mihaljevic S. Indorf A. Vallee E. ciprofloxacin and cefaclor. The renin angiotensin system as a therapeutic target to prevent diabetes and its complications. Akman M . 2004 Oct. Soysal F. Deedwania PC. YU VL . Akova M. Yildirim N. Summersgill J. 2005 Mar. Experimental data from a murine model of pneumococcal pneumonia] Pathol Biol (Paris) 1995 Jun. Renoprotection by blockade of the reninangiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Johnson RE . Pocidalo JJ . Veber B. Kocks MJ.47(12):57-62 886. Azoulay.Clin Infect Dis 1995 Apr.27(3):229-34 894. J Chemother 1994 Feb. Gardasanic J. Gur A. Grayston JT. Erelel M. [Antiretroviral therapy and cardiovascular risk] J Mal Vasc. Bressollette L. Wehbeh HA.119(7):210-3 888. Veber B. Vallee E. Weber JT. Vogt L. Arch Intern Med 2000 May٣٠٠-١٢٩٤:(٩)١٦٠‫٨؛‬ 891.43(6):509-14 899.43(6):524-8 889. Efficacy of a three-day course of azithromycin in the treatment of community-acquired pneumococcal pneumonia. Micunovic N.Feb. Vandhuick O. Vukovic D. Varvara G. Scand J Infect Dis 1995. Gazarian IIu . multicenter trial . Treatment of acute maxillary sinusitis-comparing cefpodoxime proxetil with amoxicillin. Ali Y . Uzun O. Vergis EN. Guias B.6(1):53-7 881. Kosar F.References 879. Vasil'ev MM. 892. File TM Jr. Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection . J Reprod Med 1998 Jun. Weippl G . randomized. Erk M. [The particular case of azalides: antibiotic diapedesis. Umut S.36(7):1412-7 882. Azoulay-Dupuis E. [Clinical studies on cefpodoxime proxetil in the pediatric fields] Jpn J Antibiot 1989 Jul. Ruggeirio RM.

Pediatr Infect Dis J 1988 Jan. Kobayashi Y . Cost effectiveness in the choice of antibiotics for the initial treatment of otitis media in children: a decision analysis approach . McNabb J. Comment on "Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients" by Nash and Zaltzman . Efficacy of azithromycin for treating Babesia microti infection in the hamster model . [Decreased first-phase secretion of insulin may play a role in the development of insulin resistance] Orv Hetil. Sefton AM .7(1):23-6 901. Langenbecks Arch Surg.0g oral dose for chlamydial cervicitis. Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin . Deppermann KM. Quintiliani R. Int J STD AIDS 1991 Jul-Aug. Pharmacotherapy 1998 JulAug. new concepts. Davis CH. Melman ST . Ramsey PS. Mumtaz G. J Antimicrob Chemother 1993 Jan. Choong J . Pour PM. Weiss LM . Page 42-D . stress. Azithromycin levels in cervical mucus and plasma after a single 1. Waardenburg FA . Benfield P . [Clinical evaluation of a new oral cephalosporin ، cefprozil. Leophonte P. Wittner M. Tanowitz HB. Brown GW.References 900.Ann Pharmacother 1996 Oct. Kawasaki H. Wiseman LR. Whatley JD. Weiss LM. Expert Opin Pharmacother 2002 Sep. Nightingale CH . 2005 May. 922. Higashino H. Osterlind A . Current strategies for the prevention and treatment of disseminated Mycobacterium avium complex infection in patients with AIDS.67(9):1289-91 911.71(4):244-6 917. Pfragner R . Kohdera U.٩ 908.2(4):248-51 906. Williams JD.45(12):1635-41 916.J Antimicrob Chemother 1999 Oct. Lam SK . Rosenbaum GS. Wasserman S.31 Suppl C:11-26 907. Hollier LM.55(2):219-22 915.18(4):738-47 918.45(2):295-317 913. Wilson R. J Antimicrob Chemother 1993 Mar. Drugs 1994 May. Genitourin Med 1995 Aug. Torres A. 2005 Mar. Nagy J. Hotamisligil GS. J Am Soc Nephrol. Wiseman LR. 2004 Nov 7. Antimicrob Agents Chemother 2001 Mar. Drugs Exp Clin Res 1987. Worm AM. Soltesz G. Wellen KE. Transplantation 1999 May15. Xia HH. Yalniz M. Balfour JA . Thin RN. Sheffield JS. Streptococcus pneumoniae response to repeated moxifloxacin or levofloxacin exposure in a rabbit tissue cage model. Yale JF. Dirithromycin: a new macrolide . 914. Nahata MC . Bui KQ. Clin Infect Dis 2002 Oct 15. Ridgway GL . J Antimicrob Chemother 1993 Jun. Kubin R. Retsema J. A review of its antibacterial activity ، pharmacokinetic properties and clinical efficacy . Bassaris HP. Inflammation. Epub 2004 Apr 9. Comparison of macrolide antibiotics . Woo M. Xuan D. Talley NJ.31(6):963-72 905. Nicolau DP. Ballin I.45(3):794-9 921. Wyrick PB. Wendel GD Jr. 903. Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis . Sanchez PJ . Diabetes mellitus: a risk factor for pancreatic cancer?. Zhong M. Knight ST. Abdel-Rahman SM. Yu Wong BC. polarized human endometrial epithelial cells. Oral antihyperglycemic agents and renal disease: new agents. 2005 Feb. Drugs 1993 Feb. Mattoes H. Tanowitz HB . in pediatrics] Jpn J Antibiot 1992 Dec. Williams KJ. Weiss JC. Nakamura M. Schreurs AJ. Wintermeyer SM. Am J Trop Med Hyg 1996 Aug.115(5):1111-9. Lederman J. Alternative and rescue treatment regimens for Helicobacter pylori eradication. Azithromycin vs doxycycline in the treatment of non-gonococcal urethritis . A review of its antibacterial activity ،pharmacokinetic properties. Wittner M. Oz HS. Ceftibuten. Hill JB. In-vitro activity of azithromycin on Chlamydia trachomatis infected.16 Suppl 1:S7-10. and diabetes. J Clin Invest. Kino M. Hebblethwaite EM. Wettengel R.145(45):226772.390(1):66-72. Treatment of syphilis in pregnancy and prevention of congenital syphilis . Wirnsberger GH. Jermendy G. J Infect Dis 1993 Nov. Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis . 168(5):1289-92 902.47(5):784-808 912.30(10):1141-9 910. Vetter N. Cox DM. Plested SJ . Cefprozil. Wright J . and therapeutic potential. Wittmann I. Atovaquone in the treatment of Babesia microti infections in hamsters.44(4):501-13 909.31(1):139-50 919.3(9):1301-11 920.13(2):95.35(Suppl:٢) S200-9 904. Sommerauer B .

Yamaryo T. Sakakibara O. Arai K. Pharmacokinetics and pharmacodynamics of the new fluoroquinolones: focus on respiratory infections. Noreddin AM . Shibata Y. Morimoto K. Mizuno A.1(5):459٦٣ 943. Drugs 2002. Yamada Y. Fukuhara A. with special reference to the antibody-coated bacteria (ACB) detected by the immunoenzyme technique] Hinyokika Kiyo 1983 Aug. Nagatake T . In vitro and in vivo antibacterial activities of CS-834. Sunakawa K . Ueda T. The role of intensive glycemic control in the management of patients who have acute myocardial infarction.48(1):92-102 933. 930. Yogev R. Arai K . Jpn J Antibiot 1988 Oct. Taguchi J. [Fundamental and clinical studies of SY5555 in pediatrics] Jpn J Antibiot 1995 Jan. Hoban DJ .14(8):495-500 935. Schleupner C. Vercaigne L.29(8):959-68 926. Ando M ، Sakai K.References 923.٦٨ 937. Furuya N. Izumikawa K. against clinical isolates of Mycoplasma pneumoniae in Japan. Matsumoto T. Drugs Exp Clin Res٥٠٠-٤٩٥:(٨)١٤‫٨٨٩١؛‬ 934.67(3):430-3 931. Tanabe M.48(1):92.8(6):475-82 928. Pediatrics 1981 Mar. In vitro activity of telithromycin (HMR3647).42(3):555-63 924. Murase T. Kawata K ، Fukuta N. 2005 May. Yokota T. Tachi Y.38(3):859. and synergy of actericidal activity with serum complement and mouse-cultured macrophages. J Antimicrob Chemother 1996 Jun. Watanabe S. Drugs Exp Clin Res 1988. Tsuchihashi Y ، Matsushima K.44(5):1381-2 925. Shinagawa N. Kita T. Cardiol Clin. Kamihira S.36(1):6-12. Clin Ther 1990 Sep-Oct. Akita H. Jpn J Antibiot 1988 Oct. Fourteenmember macrolides promote the phosphatidylserine receptor-dependent phagocytosis of apoptotic neutrophils by alveolar macrophages. Yura J. Akita H. Curr Mol Med. Nolen TM. Suzuki E. Ito T. Kobe A. Yamaguchi K. Yoshimine H. Sheng Li Ke Xue Jin Zhan.5(3):287-95. 941. a new ketolide. Morimoto K. Yki-Jarvinen H. Nasopharyngeal carriage of Haemophilus influenzae type b: attempted eradication by cefaclor or rifampin. A multicenter trial comparing the efficacy and safety of cefuroxime axetil and cefaclor in pneumonia of adults. Antimicrob Agents Chemother ٢٠٠٠ May. Curr Pharm Des 2002. Jpn J Antibiot 1985 Mar.47(1):48-53 927. Hashimoto I. Ando M. Curr Opin Pharmacol 2001 Oct. [Fundamental and clinical studies of a sustained release preparation of cefaclor in the surgical field]. [Treatment of urinary tract infections by cefaclor. 2005 Jan. Cefpodoxime proxetil. Yokota T. Sakai K. Watanabe S. The fatty liver and insulin resistance.٢٨ 936. its in vitro antibacterial activity. Ohno A. Shinagawa N.23(2):109-17. Yokota T. Tateda K. A double blind comparison of cefpodoxime proxetil and cefaclor]. A double blind comparison of cefpodoxime proxetil and cefaclor]. Smith H. Anthony W . Hashimoto I ، et al . Lowe J. Miyake K . Sunakawa K. Yangco BG. et al. Sato Y. Sato Y. Yamamoto M. [Clinical results of cefaclor treatment of infections of oral regions]. Nakamura T. Shinagawa N. Ishikawa S. Zhanel GG. Design of anti-bacterial drug and anti-mycobacterial drug for drug delivery system. et al .41(10):1517-37 938. comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infections.12(5):440-6 929. Maesaki S. Yanagihara K . affinity to bacterial penicillin-binding proteins. Ennis K.١٠٢ 932. [PPAR family and its relationship to metabolic syndrome]. Walkty A.37(3):318. Mizuno A. Page 43-D .62(1):13-59 942. Zarich SW. Kabat K . Oishi K. Cefpodoxime proxetil. Yokota T.41(10):1517-37 939. Yoshida Y. [Fundamental and clinical studies of SY5555 in pediatrics] Jpn J Antibiot 1995 Jan. A randomized. Antimicrob Agents Chemother 2003 Jan. Guan YF. Hirakata Y.37 Suppl C:103-13 940. Suzuki E. Gin AS ، Embil J. Yamaguchi T. 2005 May. Nakamura T. Ishii K. its in vitro antibacterial activity. Miyazaki S. Zachariah J . Sato K. Kohno S . Zhang XY. Westerbacka J. and synergy of bactericidal activity with serum complement and mouse-cultured macrophages.A critical review of the fluoroquinolones: focus on respiratory infections. Kanematsu N. Domon H. Miyazaki Y. Antimicrob Agents Chemother 1998 Mar. Chen LH. Yura J. Tan JS. Zhanel GG. [Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. Ueda T. Melick C. Iwata S. Tomono K. affinity to bacterial penicillin-binding proteins. Jpn J Antibiot 1984 Mar. [Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. Iwata S. Yura J. a new oral carbapenem. Sato J .

Curr Mol Med. J Antimicrob Chemother 1990 Dec. Infect Dis Clin North Am ١٩٩٥ Sep. Zuckerman JM. Dauria E.9(3):731-45 Page 44-D . Zuck P. Kaye KM . Bernardo L. Lodi F. J Int Med Res 2001 Jul-Aug. Efficacy and tolerance of cefpodoxime proxetil compared with ceftriaxone in vulnerable patients with bronchopneumonia. Type 2 diabetes as an inflammatory cardiovascular disorder. Zuck P .5(3):309-22. 2005 May. [Efficacy of a 5-day treatment with an azalide (azithromycin) in superinfections of chronic bronchitis]. Riva E . Ichou F.References 944. The newer macrolides. Rev Pneumol Clin 1996. Ziegler D. Zuccotti G. 945.52 Suppl:٢ S56-9 948. Clinical and pro-host effects of cefaclor in prophylaxis of recurrent otitis media in HIV-infected children. Torcoletti M. Azithromycin and clarithromycin.29(4):349-54 946. Rio Y.26 Suppl E:71-7 947.

Sign up to vote on this title
UsefulNot useful